Skyward/2025/FY/Annual report: Difference between revisions
doc_archive: publish 3z7a4yrxkn (.md link) |
doc_archive: relink 3z7a4yrxkn (vocabulary update, 198 links) |
||
| (7 intermediate revisions by the same user not shown) | |||
| Line 9: | Line 9: | ||
| publication_date = 2026-03-02 |
| publication_date = 2026-03-02 |
||
| language = English |
| language = English |
||
| pages = 24 |
|||
| source_url = https://www.sec.gov/Archives/edgar/data/1519449/000151944926000015/0001519449-26-000015-index.htm |
| source_url = https://www.sec.gov/Archives/edgar/data/1519449/000151944926000015/0001519449-26-000015-index.htm |
||
| summary_md = File:Skyward-2025-FY-Annual_report.md |
| summary_md = File:Skyward-2025-FY-Annual_report.md |
||
| intro_sentence = This article |
| intro_sentence = This article summarizes Skyward's Annual report published on 2026-03-02 (24 pages). |
||
| wide = yes |
| wide = yes |
||
| document = Document:Skyward/2025/FY/Annual report |
|||
| doc_id = 3z7a4yrxkn |
|||
}} |
}} |
||
''This article |
''This article summarizes Skyward's Annual report published on 2026-03-02 (24 pages).'' |
||
== Cover == |
|||
{{chunk|doc=3z7a4yrxkn|c=1|p=1}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| id="t1" class="wikitable" |
||
|+ Entity Public Float by 12 Months Ended |
|||
|- |
|||
! style="text-align:left" | USD ($) |
! style="text-align:left" | USD ($) |
||
! style="text-align: |
! style="text-align:left" | 12 Months Ended |
||
! style="text-align: |
! style="text-align:right" | |
||
! style="text-align: |
! style="text-align:right" | |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! style="text-align:left" | Dec. 31, 2025 |
! style="text-align:left" | Dec. 31, 2025 |
||
! |
! style="text-align:right" | Feb. 26, [[Definition:Year 2026|2026]] |
||
! |
! style="text-align:right" | Jun. 30, 2025 |
||
|- |
|- |
||
| style="text-align:left" | Cover [Abstract] |
| style="text-align:left" | Cover [Abstract] |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Document Type |
| style="text-align:left" | Document Type |
||
| style="text-align:left" | 10-K |
| style="text-align:left" | 10-K |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Document Annual Report |
| style="text-align:left" | Document Annual Report |
||
| style="text-align:left" | true |
| style="text-align:left" | true |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Document Period End Date |
| style="text-align:left" | Document Period End Date |
||
| style="text-align:left" | Dec. 31, 2025 |
| style="text-align:left" | Dec. 31, 2025 |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Current Fiscal Year End Date |
| style="text-align:left" | Current Fiscal Year End Date |
||
| style="text-align:left" | --12-31 |
| style="text-align:left" | --12-31 |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Document Transition Report |
| style="text-align:left" | Document Transition Report |
||
| style="text-align:left" | false |
| style="text-align:left" | false |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Entity File Number |
| style="text-align:left" | Entity File Number |
||
| style="text-align:left" | 001-41591 |
| style="text-align:left" | 001-41591 |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Entity Registrant Name |
| style="text-align:left" | Entity Registrant Name |
||
| style="text-align:left" | SKYWARD SPECIALTY INSURANCE GROUP, INC. |
| style="text-align:left" | SKYWARD SPECIALTY INSURANCE GROUP, INC. |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Entity Incorporation, State or Country Code |
| style="text-align:left" | Entity Incorporation, State or Country Code |
||
| style="text-align:left" | DE |
| style="text-align:left" | DE |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Entity Tax Identification Number |
| style="text-align:left" | Entity Tax Identification Number |
||
| style="text-align:left" | 14-1957288 |
| style="text-align:left" | 14-1957288 |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Entity Address, Address Line One |
| style="text-align:left" | Entity Address, Address Line One |
||
| style="text-align:left" | 800 Gessner Road |
| style="text-align:left" | 800 Gessner Road |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Entity Address, Address Line Two |
| style="text-align:left" | Entity Address, Address Line Two |
||
| style="text-align:left" | Suite 600 |
| style="text-align:left" | Suite 600 |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Entity Address, City or Town |
| style="text-align:left" | Entity Address, City or Town |
||
| style="text-align:left" | Houston |
| style="text-align:left" | Houston |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Entity Address, State or Province |
| style="text-align:left" | Entity Address, State or Province |
||
| style="text-align:left" | TX |
| style="text-align:left" | TX |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Entity Address, Postal Zip Code |
| style="text-align:left" | Entity Address, Postal Zip Code |
||
| style="text-align:left" | 77024-4284 |
| style="text-align:left" | 77024-4284 |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | City Area Code |
| style="text-align:left" | City Area Code |
||
| style="text-align:left" | 713 |
| style="text-align:left" | 713 |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Local Phone Number |
| style="text-align:left" | Local Phone Number |
||
| style="text-align:left" | 935-4800 |
| style="text-align:left" | 935-4800 |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Title of 12(b) Security |
| style="text-align:left" | Title of 12(b) Security |
||
| style="text-align:left" | Common stock, par value $0.01 |
| style="text-align:left" | Common stock, par value $0.01 |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Trading Symbol |
| style="text-align:left" | Trading Symbol |
||
| style="text-align:left" | SKWD |
| style="text-align:left" | SKWD |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Security Exchange Name |
| style="text-align:left" | Security Exchange Name |
||
| style="text-align:left" | NASDAQ |
| style="text-align:left" | NASDAQ |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Entity Well-known Seasoned Issuer |
| style="text-align:left" | Entity Well-known Seasoned Issuer |
||
| style="text-align:left" | No |
| style="text-align:left" | No |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Entity Voluntary Filers |
| style="text-align:left" | Entity Voluntary Filers |
||
| style="text-align:left" | No |
| style="text-align:left" | No |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Entity Current Reporting Status |
| style="text-align:left" | Entity Current Reporting Status |
||
| style="text-align:left" | No |
| style="text-align:left" | No |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Entity Interactive Data Current |
| style="text-align:left" | Entity Interactive Data Current |
||
| style="text-align:left" | Yes |
| style="text-align:left" | Yes |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Entity Filer Category |
| style="text-align:left" | Entity Filer Category |
||
| style="text-align:left" | Large Accelerated Filer |
| style="text-align:left" | Large Accelerated Filer |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Entity Small Business |
| style="text-align:left" | Entity Small Business |
||
| style="text-align:left" | false |
| style="text-align:left" | false |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Entity Emerging Growth Company |
| style="text-align:left" | Entity Emerging Growth Company |
||
| style="text-align:left" | false |
| style="text-align:left" | false |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | ICFR Auditor Attestation Flag |
| style="text-align:left" | ICFR Auditor Attestation Flag |
||
| style="text-align:left" | true |
| style="text-align:left" | true |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Document Financial Statement Error Correction [Flag] |
| style="text-align:left" | Document Financial Statement Error Correction [Flag] |
||
| style="text-align:left" | false |
| style="text-align:left" | false |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Entity Shell Company |
| style="text-align:left" | Entity Shell Company |
||
| style="text-align:left" | false |
| style="text-align:left" | false |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Entity Public Float |
| style="text-align:left" | Entity Public Float |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | 2,165,161,643 |
||
|- |
|- |
||
| style="text-align:left" | Entity Common Stock, Shares Outstanding |
| style="text-align:left" | Entity Common Stock, Shares Outstanding |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| |
| style="text-align:right" | 44,467,084 |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Documents Incorporated by Reference |
| style="text-align:left" | Documents Incorporated by Reference |
||
| style="text-align:left" | Portions of the Registrant’s Proxy Statement relating to the 2026 annual meeting of stockholders (the |
| style="text-align:left" | Portions of the Registrant’s Proxy Statement relating to the [[Definition:Year 2026|2026]] annual meeting of stockholders (the “[[Definition:Year 2026|2026]] Proxy Statement”), which will be filed within 120 days of December 31, 2025, are incorporated by reference into Part III of this Form 10-K. |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Entity Central Index Key |
| style="text-align:left" | Entity Central Index Key |
||
| style="text-align:left" | 0001519449 |
| style="text-align:left" | 0001519449 |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Amendment Flag |
| style="text-align:left" | Amendment Flag |
||
| style="text-align:left" | false |
| style="text-align:left" | false |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Document Fiscal Year Focus |
| style="text-align:left" | Document Fiscal Year Focus |
||
| style="text-align:left" | 2025 |
| style="text-align:left" | 2025 |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Document Fiscal Period Focus |
| style="text-align:left" | Document Fiscal Period Focus |
||
| style="text-align:left" | FY |
| style="text-align:left" | FY |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
|} |
|} |
||
</div> |
</div> |
||
== Audit Information == |
|||
{{chunk|doc=3z7a4yrxkn|c=2|p=2}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| id="t2" class="wikitable" |
||
|+ Audit Information by Auditor Name, Auditor Location, Auditor Firm ID |
|||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! style="text-align: |
! style="text-align:right" | 12 Months Ended |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! |
! style="text-align:right" | Dec. 31, 2025 |
||
|- |
|- |
||
| style="text-align:left" | Audit Information [Abstract] |
| style="text-align:left" | Audit Information [Abstract] |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Auditor Name |
| style="text-align:left" | Auditor Name |
||
| |
| style="text-align:right" | Ernst & Young LLP |
||
|- |
|- |
||
| style="text-align:left" | Auditor Location |
| style="text-align:left" | Auditor Location |
||
| |
| style="text-align:right" | Houston, Texas |
||
|- |
|- |
||
| style="text-align:left" | Auditor Firm ID |
| style="text-align:left" | Auditor Firm ID |
||
| |
| style="text-align:right" | 42 |
||
|} |
|} |
||
</div> |
</div> |
||
| Line 244: | Line 255: | ||
== Business == |
== Business == |
||
=== Who We Are === |
|||
{{chunk|doc=3z7a4yrxkn|c=3|p=8}} |
|||
* Skyward Specialty was formed as a Delaware corporation on January 3, 2006, as an insurance holding company <sup>p. 1</sup>. |
|||
'''Company formation and overview''' |
|||
* The company operated under the name Houston International Insurance Group, Ltd. until re-branding as Skyward Specialty in November 2020 <sup>p. 1</sup>. |
|||
* The terms "the Company," "we," "our," "us," or like terms refer to the business of Skyward Specialty Insurance Group, Inc. and its subsidiaries <sup>p. 1</sup>. |
|||
* Skyward Specialty is a growing specialty insurance company providing commercial insurance products and solutions primarily in the United States <sup>p. 1</sup>. |
|||
* Products are delivered on both a non-admitted (E&S) and admitted basis <sup>p. 1</sup>. |
|||
* The company focuses on underserved, dislocated markets, or markets where standard insurance coverages are insufficient <sup>p. 1</sup>. |
|||
* Customers typically require highly specialized, customized underwriting solutions and claims capabilities <sup>p. 1</sup>. |
|||
* The portfolio of insured risks is highly diversified across industries, distribution channels, and lines of business <sup>p. 1</sup>. |
|||
* ''Lines of business'' include general liability, excess liability, professional liability (including cyber and media liability insurance), commercial auto, group accident and health, property, agriculture, credit, surety, and workers’ compensation <sup>p. 1</sup>. |
|||
* The company insures both short and medium duration liabilities <sup>p. 1</sup>. |
|||
* The business mix is principally primary insurance, balanced between E&S and admitted markets <sup>p. 1</sup>. |
|||
* A portion of the business is ''specialty reinsurance'', primarily property, agriculture, and credit <sup>p. 1</sup>. |
|||
* Specialty reinsurance focuses on attractive specialty classes where approaching through reinsurance is more efficient due to factors like cost of entry and geographic expansion <sup>p. 1</sup>. |
|||
* Diversification, including businesses not typically aligned with traditional P&C pricing cycles, combined with underwriting and claims expertise, aims to produce consistent growth and profitability across all insurance pricing cycles <sup>p. 1</sup>. |
|||
* The company is led by an entrepreneurial executive management team with decades of insurance leadership experience in the global P&C industry <sup>p. 1</sup>. |
|||
* The leadership is supported by an experienced team with broad skill sets aligned with the company's strategy <sup>p. 1</sup>. |
|||
* High-quality leadership, underwriting and claims teams, technology DNA, advanced analytics capabilities, diversified book of business, and strong competitive position are believed to position the company for profitable growth <sup>p. 1</sup>. |
|||
* The company aims to deliver long-term value for shareholders by generating best-in-class underwriting profitability and book value per share growth across P&C market cycles <sup>p. 1</sup>. |
|||
* All insurance company subsidiaries are group rated <sup>p. 1</sup>. |
|||
* All insurance company subsidiaries have financial strength ratings of "A" (Excellent) from A.M. Best Company, with a stable outlook <sup>p. 1</sup>. |
|||
* Skyward Specialty was formed as a Delaware corporation on January 3, 2006, as an insurance holding company. |
|||
====== Apollo Acquisition ====== |
|||
* The company operated under the name Houston International Insurance Group, Ltd. until re-branding as Skyward Specialty in November 2020. |
|||
{{chunk|doc=3z7a4yrxkn|c=4|p=8}} |
|||
* On September 2, 2025, the company entered into two share purchase agreements (the "Apollo Majority SPAs") with institutional and management shareholders (the "Majority Sellers") of Apollo Group Holdings Limited ("Apollo") <sup>p. 2</sup>. |
|||
'''Business model and market focus''' |
|||
* Pursuant to the Apollo Majority SPAs, the company agreed to acquire all issued shares of Apollo held by the Majority Sellers, representing approximately 87% of Apollo's issued share capital <sup>p. 2</sup>. |
|||
* Closing of the transaction ("Closing") was conditioned upon the company acquiring 100% of Apollo's issued share capital (the “Acquisition”) at Closing through additional short-form share purchase agreements (the "Apollo Minority SPAs") with the remaining minority shareholders (the "Minority Sellers") <sup>p. 2</sup>. |
|||
* The Apollo Minority SPAs and Apollo Majority SPAs are collectively referred to as the "Apollo SPAs" <sup>p. 2</sup>. |
|||
* The Acquisition closed on January 1, 2026 <sup>p. 2</sup>. |
|||
* The consideration for the transaction was satisfied by issuing common stock of the Company to certain sellers and the remainder in cash <sup>p. 2</sup>. |
|||
* Apollo is a leading U.S.-centric specialty underwriting platform operating at Lloyd’s of London <sup>p. 2</sup>. |
|||
* Apollo's business model is characterized by low volatility, high growth, and capital efficiency <sup>p. 2</sup>. |
|||
* Apollo has consistently grown gross written premium since its formation in 2010 <sup>p. 2</sup>. |
|||
* Through Syndicate 1969, Apollo underwrites a multi-class specialty insurance portfolio <sup>p. 2</sup>. |
|||
* Through Syndicate 1971, Apollo provides an innovative platform liability product for the digital and sharing economy <sup>p. 2</sup>. |
|||
* Apollo provides capital to syndicates 1969 and 1971 in exchange for a pro-rata share of underwriting income, with third parties providing the remaining capital <sup>p. 2</sup>. |
|||
* Apollo earns managing agency fees and profit commissions as the managing agent for its own syndicates and for innovative third-party syndicates (platform partners) <sup>p. 2</sup>. |
|||
* The acquisition aligns with Skyward Specialty’s strategy by bringing new specialty niches, a distinctive new economy offering, accelerating innovation, and adding Apollo’s advanced technology capabilities <sup>p. 2</sup>. |
|||
* David Ibeson will continue as CEO of Apollo, leading its growth as a subsidiary of Skyward Specialty, along with Apollo’s management team <sup>p. 2</sup>. |
|||
* Skyward Specialty is a growing specialty insurance company delivering commercial insurance products and solutions on a non-admitted (E&S) and admitted basis, predominantly in the United States. |
|||
====== Our Business and Our Strategy ====== |
|||
* The business focuses on underserved, dislocated markets, or markets where standard insurance coverages are insufficient. |
|||
* Customers typically require highly specialized, customized underwriting solutions and claims capabilities. |
|||
* The company develops and delivers tailored insurance products and services for niche markets. |
|||
* The portfolio of insured risks is highly diversified, covering a wide variety of industries and distributed through multiple channels. |
|||
* [[Definition:Business mix|Lines of business]] include general liability, excess liability, professional liability (including cyber and media liability insurance), commercial auto, group accident and health, property, agriculture, credit, surety, and workers’ compensation. |
|||
* The company insures both short and medium duration liabilities. |
|||
* The [[Definition:Business mix|business mix]] is principally primary insurance and balanced between E&S and admitted markets. |
|||
* A portion of the business is specialty reinsurance (principally property, agriculture, and credit), focused on attractive specialty classes where reinsurance is more efficient due to factors like cost of entry and geographic expansion. |
|||
* This diversification, including businesses not typically aligned with traditional [[Definition:Property & casualty|P&C]] pricing cycles, combined with underwriting and claims expertise, is expected to consistently produce strong growth and profitability across all insurance pricing cycles. |
|||
{{chunk|doc=3z7a4yrxkn|c=5|p=8}} |
|||
* The company operates with one reportable segment, offering insurance coverages across various market niches <sup>p. 3</sup>. |
|||
'''Leadership and strategic positioning''' |
|||
* Nine distinct underwriting divisions exist, each with dedicated leadership and technical staff experienced in their niches <sup>p. 3</sup>. |
|||
* This structure aims to effectively serve customer needs, partner with distributors, and achieve attractive risk-adjusted returns <sup>p. 3</sup>. |
|||
* The company is led by an entrepreneurial executive management team with decades of insurance leadership experience in the global [[Definition:Property & casualty|P&C]] industry. |
|||
* For the year ended December 31, 2025, ''gross written premiums'' were 41% admitted and 59% non-admitted <sup>p. 3</sup>. |
|||
* Leadership is supported by an experienced team aligned with the company's strategy. |
|||
* ''Accident & Health (A&H)'' underwriting division provides medical stop loss to self-insured employers and covers group and single-employer captives <sup>p. 3</sup>. |
|||
* High-quality leadership, underwriting and claims teams, technology DNA, advanced analytics capabilities, diversified book of business, and strong competitive position are expected to enable profitable business growth. |
|||
* ''A&H captives program'' offers tailored medical stop-loss and reinsurance solutions with dedicated underwriting and claims oversight <sup>p. 3</sup>. |
|||
* The aim is to deliver long-term value for shareholders by generating best-in-class underwriting profitability and book value per share growth across [[Definition:Property & casualty|P&C]] market cycles. |
|||
* The A&H division targets small and medium-sized enterprises seeking to control healthcare costs through self-insurance <sup>p. 3</sup>. |
|||
* All insurance company subsidiaries are group rated and have financial strength ratings of "A" (Excellent) from A.M. Best Company with a stable outlook. |
|||
* A&H products are written on an admitted basis and distributed via retail and wholesale brokers <sup>p. 3</sup>. |
|||
* ''Agriculture and Credit (Re)insurance'' underwriting division provides specialty risk-transfer solutions globally <sup>p. 3</sup>. |
|||
=== Apollo Acquisition === |
|||
* This division's portfolio spans agriculture, dairy and livestock revenue protection, and mortgage and credit product lines <sup>p. 3</sup>. |
|||
* It supports insurers, MGAs, and other risk originators with tailored treaty protection using proportional and excess of loss structures <sup>p. 3</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=6|p=8}} |
|||
* The ''global agriculture book'' covers weather, natural peril volatility, and other production/yield risks, helping clients manage catastrophe exposure and seasonal earnings variability <sup>p. 3</sup>. |
|||
'''Apollo acquisition details''' |
|||
* The ''mortgage portfolio'' supports government-sponsored entities and private mortgage insurers against default and loss severity volatility, structured to manage tail risk <sup>p. 3</sup>. |
|||
* The ''credit portfolio'' protects against losses from default risk for single obligors and multi-buyer trade credit across diverse regions and industries <sup>p. 3</sup>. |
|||
* On September 2, 2025, the company entered into two share purchase agreements (Apollo Majority SPAs) with institutional and management shareholders (Majority Sellers) of Apollo Group Holdings Limited (Apollo). |
|||
* The ''dairy and livestock business'' offers revenue protection against price volatility in milk, cattle, and hog markets <sup>p. 3</sup>. |
|||
* The company agreed to acquire all issued shares of Apollo held by the Majority Sellers, representing approximately 87% of Apollo's issued share capital. |
|||
* Derivative instruments, primarily put options and futures, are used to mitigate commodity price risk related to cattle, hog, and milk prices <sup>p. 3</sup>. |
|||
* Closing of the transaction (Closing) was conditioned upon acquiring 100% of Apollo's issued share capital at Closing via additional short-form share purchase agreements (Apollo Minority SPAs) with remaining minority shareholders (Minority Sellers). |
|||
* These instruments are solely for managing adverse price movements, with positions adjusted based on market conditions and risk profile <sup>p. 3</sup>. |
|||
* The Acquisition closed on January 1, [[Definition:Year 2026|2026]]. |
|||
* For more information on derivatives, refer to Note 8, “Derivatives” in the consolidated financial statements in Item 8 of Form 10-K <sup>p. 3</sup>. |
|||
* Consideration for the transaction was satisfied by issuing common stock of the Company to certain sellers and the remainder in cash. |
|||
* ''Captives'' underwriting division provides group captive solutions by leveraging underwriting and claims expertise from other divisions <sup>p. 3</sup>. |
|||
* Apollo is a U.S.-centric specialty underwriting platform operating at Lloyd's of London, characterized by low volatility, high growth, and a capital-light business model. |
|||
* This division writes property, general liability, commercial auto, excess liability, and workers’ compensation on E&S and admitted bases <sup>p. 3</sup>. |
|||
* Apollo has consistently grown [[Definition:Gross written premiums|gross written premium]] since its formation in 2010. |
|||
* Business is often administered through partnerships with third-party captive managers <sup>p. 3</sup>. |
|||
* Through Syndicate 1969, Apollo underwrites a multi-class specialty insurance portfolio. |
|||
* ''Construction & Energy Solutions'' underwriting division focuses on high-severity exposures, offering tailored multi-line solutions including general liability, excess liability, commercial auto, and workers’ compensation <sup>p. 3</sup>. |
|||
* Through Syndicate 1971, Apollo provides a unique, innovative platform liability product for the digital and sharing economy. |
|||
* Products are distributed through retail agents, brokers, and a select network of wholesalers <sup>p. 3</sup>. |
|||
* Apollo provides capital to syndicates 1969 and 1971 in exchange for a pro-rata share of underwriting income, with third parties providing the remaining capital. |
|||
* ''Global Property'' underwriting division provides comprehensive property insurance and reinsurance solutions for commercial clients worldwide <sup>p. 3</sup>. |
|||
* Apollo earns managing agency fees and profit commissions as the managing agent for its own syndicates and for third-party syndicates (platform partners). |
|||
* Offerings protect against physical loss or damage to assets from natural catastrophes and other insured perils <sup>p. 3</sup>. |
|||
* The acquisition aligns with Skyward Specialty's strategy by bringing new specialty niches, a distinctive new economy offering, accelerating innovation, and adding Apollo's advanced technology capabilities. |
|||
* ''Professional Lines'' underwriting division includes management liability, professional liability (including cyber), and allied health (including life sciences) <sup>p. 3</sup>. |
|||
* David Ibeson will continue as CEO of Apollo, leading Apollo's growth as a subsidiary of Skyward Specialty, along with Apollo's management team. |
|||
* Management/Professional liability and allied health provide primary and excess claims-made liability products on E&S and admitted bases <sup>p. 3</sup>. |
|||
* Distribution for Professional Lines is through wholesale and retail brokers, depending on the product <sup>p. 3</sup>. |
|||
=== Our Business and Our Strategy === |
|||
* ''Specialty Programs'' underwriting division partners with program administrators focused on specific markets <sup>p. 3</sup>. |
|||
* This partnership model is used when program administrators have a competitive advantage (scale or proprietary technology) that would be difficult for the company to replicate <sup>p. 3</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=7|p=8}} |
|||
* Specialty Programs writes property, general liability, commercial auto liability, excess liability, and workers’ compensation on E&S and admitted bases <sup>p. 3</sup>. |
|||
'''Reportable segment and premium basis''' |
|||
* ''Surety'' underwriting division provides contract, commercial, and transactional surety solutions <sup>p. 3</sup>. |
|||
* The focus is on small to medium-sized enterprises with aggregate bond programs up to approximately ''$100.0 million'' for contract and ''$125.0 million'' for commercial and transactional <sup>p. 3</sup>. |
|||
* The company has one reportable segment offering a broad array of insurance coverages to various market niches. |
|||
* Surety business is written on an admitted basis and distributed through retail agents and brokers <sup>p. 3</sup>. |
|||
* Each of the nine underwriting divisions has dedicated underwriting leadership and technical staff with deep experience in their niches. |
|||
* ''Transactional E&S'' underwriting division provides primary and excess non-catastrophe prone property and general liability solutions <sup>p. 3</sup>. |
|||
* This structure and expertise aim to serve customer needs, be a value-add partner to distributors, and earn attractive risk-adjusted returns. |
|||
* This division emphasizes risks considered hard to place due to complexity, loss history, or limited operating history (e.g., startups) <sup>p. 3</sup>. |
|||
* For the year ended December 31, 2025, 41% of [[Definition:Gross written premiums|gross written premiums]] were written on an admitted basis and 59% were non-admitted. |
|||
* Success in this market relies on technical underwriting, thoughtful coverage, pricing, and high-quality broker service <sup>p. 3</sup>. |
|||
* Market access for Transactional E&S is exclusively through wholesale brokers <sup>p. 3</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=8|p=8}} |
|||
* The company has "exited business" units and lines that were previously exited and placed into run-off <sup>p. 3</sup>. |
|||
'''Underwriting divisions''' |
|||
* The company's strategy is to lead in chosen market niches and establish sustainable, competitive positions <sup>p. 3</sup>. |
|||
* Accident & Health (A&H): Provides medical stop loss to self-insured employers and covers group and single-employer captives. |
|||
** A&H captives program offers tailored medical stop-loss and reinsurance solutions with dedicated underwriting and proactive claims oversight. |
|||
** Targets small and medium-sized enterprises seeking to control healthcare costs by self-insuring a portion of their healthcare insurance. |
|||
** Products are written on an admitted basis and distributed primarily through retail and wholesale broker partners. |
|||
* Agriculture and Credit (Re)insurance: Provides specialty risk-transfer solutions across a diversified global portfolio. |
|||
** Covers agriculture, dairy and livestock revenue protection, and mortgage and credit [[Definition:Business mix|product lines]]. |
|||
** Supports insurers, MGAs, and other risk originators with tailored treaty protection using proportional and excess of loss structures. |
|||
** Global agriculture book covers weather and natural peril-driven volatility and other production and yield risks. |
|||
** Mortgage portfolio supports government-sponsored entities and private mortgage insurers against default and loss severity volatility. |
|||
** Credit portfolio protects against losses from default risk for single obligors and multi-buyer trade credit across diverse regions and industries. |
|||
** Dairy and livestock business provides revenue protection against price volatility in milk, cattle, and hog markets. |
|||
** Uses derivative instruments (primarily put options and futures) to mitigate commodity price risk, solely for managing exposure to adverse price movements. |
|||
** Positions are adjusted throughout the year based on market conditions and risk profile. |
|||
** Additional information on derivatives is in Note 8, "Derivatives" to consolidated financial statements in Item 8 of Form 10-K. |
|||
* Captives: Provides group captive solutions by leveraging underwriting and claims expertise from other divisions. |
|||
** Creates group captives for companies seeking to self-insure. |
|||
** Writes property, general liability, commercial auto, excess liability, and workers’ compensation lines on an E&S and admitted basis. |
|||
** Business is often administered through partnerships with third-party captive managers. |
|||
* Construction & Energy Solutions: Focuses on high-severity exposures with tailored, often multi-line solutions. |
|||
** Includes general liability, excess liability, commercial auto, and workers’ compensation. |
|||
** Distributed through retail agents, brokers, and a select network of wholesalers. |
|||
* Global Property: Provides comprehensive property insurance and reinsurance solutions for commercial clients worldwide. |
|||
** Offerings protect against physical loss or damage to assets from natural catastrophes and other insured perils. |
|||
* Professional Lines: Includes three underwriting units: management liability, professional liability (including cyber), and allied health (including life sciences). |
|||
** Provides primary and excess claims-made liability products on an E&S and admitted basis. |
|||
** Distributed through wholesale and retail brokers, depending on the product. |
|||
* Specialty Programs: Partners with program administrators focused on specific markets. |
|||
** Believes partnering with program administrators is optimal for profitable participation or market reach. |
|||
** Program administrators often have competitive advantages in scale or proprietary technology. |
|||
** Writes property, general liability, commercial auto liability, excess liability, and workers’ compensation lines on an E&S and admitted basis. |
|||
* Surety: Provides contract, commercial, and transactional surety solutions to trade and services organizations. |
|||
** Focuses on small to medium-sized enterprises with aggregate bond programs up to approximately USD 100.0m for contract and USD 125.0m for commercial and transactional. |
|||
** Written on an admitted basis and distributed through retail agents and brokers. |
|||
* Transactional E&S: Provides primary and excess non-catastrophe prone property and general liability solutions. |
|||
** Emphasizes risks considered hard to place due to complexity, loss history, or limited operating history (e.g., start-ups). |
|||
** Success is determined by technical underwriting, thoughtful coverage, pricing, and high-quality broker service. |
|||
** Accesses the market exclusively through wholesale brokers. |
|||
{{chunk|doc=3z7a4yrxkn|c=9|p=8}} |
|||
'''Exited business''' |
|||
* [[Definition:Business mix|Business units]] and lines previously exited and placed into run-off are referred to as "exited business". |
|||
{{chunk|doc=3z7a4yrxkn|c=10|p=8}} |
|||
'''Strategy''' |
|||
* The company seeks to lead in chosen market niches and establish sustainable, competitive positions. |
|||
* Key elements of the strategy include: |
* Key elements of the strategy include: |
||
** Providing differentiated products, services, and solutions |
** Providing differentiated products, services, and solutions for target markets. |
||
** Attracting and retaining exceptional underwriting and claims talent |
** Attracting and retaining exceptional underwriting and claims talent, incentivizing professionals aligned with organizational goals. |
||
** Amplifying expertise with advanced technology and analytics for risk selection, pricing, and claims management |
** Amplifying expertise with advanced technology and analytics for superior risk selection, pricing, and claims management. |
||
** Empowering underwriting and claims teams with decision-making authority |
** Empowering underwriting and claims teams with significant decision-making authority. |
||
** Fostering a culture |
** Fostering a culture that promotes nimbleness and responsiveness to market opportunities and dislocation. |
||
* This strategy is referred to as |
* This strategy is referred to as "Rule Our Niche". |
||
* It forms the basis for building a strong defensible market position, creating a competitive moat, and winning in chosen markets. |
|||
* The principles of this strategy are considered key to achieving and sustaining best-in-class underwriting results through P&C insurance pricing cycles <sup>p. 3</sup>. |
|||
* The principles of this strategy are believed to be key to achieving and sustaining best-in-class underwriting results through [[Definition:Property & casualty|P&C]] insurance pricing cycles. |
|||
* The company strives for excellence in risk selection, pricing, and claims outcomes, amplified by advanced technology and analytics <sup>p. 3</sup>. |
|||
* The company strives for excellence in risk selection, pricing, and claims outcomes, amplified by advanced technology and analytics. |
|||
=== Our Competitive Strengths === |
|||
{{chunk|doc=3z7a4yrxkn|c=11|p=8}} |
|||
* The company focuses on profitable niches in the market that require technical underwriting and claims management as barriers to entry <sup>p. 4</sup>. |
|||
'''Our Competitive Strengths''' |
|||
* The company targets underserved, dislocated, or complex commercial lines P&C markets where standard products are insufficient <sup>p. 4</sup>. |
|||
* Risks in core markets require efficient, individual underwriting to generate sustainable underwriting profit <sup>p. 4</sup>. |
|||
* The company builds underwriting divisions around deeply experienced underwriters empowered with appropriate authority <sup>p. 4</sup>. |
|||
* Underwriters' experience is augmented with data and predictive analytics to differentiate risk selection and pricing while enhancing efficiency <sup>p. 4</sup>. |
|||
* The company hires and retains underwriting and technical staff for their expertise and experience <sup>p. 4</sup>. |
|||
* Underwriting teams are knowledgeable, experienced, and empowered, which is critical for complex, non-automatable risks <sup>p. 4</sup>. |
|||
* The company allows professionals freedom to use expertise and judgment in evaluating and pricing risks, rather than imposing strict underwriting rules <sup>p. 4</sup>. |
|||
* The company has a specialized team of claims professionals knowledgeable about their niches and lines of business <sup>p. 4</sup>. |
|||
* Claims professionals address first-party claims with fair solutions and third-party claims with comprehensive responses, aiming for consistent and early loss recognition of indemnity and loss adjustment expenses (LAE) <sup>p. 4</sup>. |
|||
* The company responds quickly to claims with specialized adjusters using expertise, advanced technology, and analytics <sup>p. 4</sup>. |
|||
* Technology is deeply embedded in the claims process, from first notice of loss to investigation and settlement <sup>p. 4</sup>. |
|||
* Analytics capabilities provide real-time, detailed information on open claims and benchmarks against closed claims for senior leadership and claims teams <sup>p. 4</sup>. |
|||
* SkyBI, the company's business intelligence platform, provides real-time intelligence for superior decision-making to senior leadership and technical teams <sup>p. 4</sup>. |
|||
* SkyBI reflects best practices learned from management's experience in P&C insurance and technology sectors <sup>p. 4</sup>. |
|||
* SkyBI is a single, comprehensive enterprise-wide data repository for reporting, business intelligence, analytics, and advanced data capabilities <sup>p. 4</sup>. |
|||
* SkyBI provides information and performance metrics across the company in an easy-to-consume visualized format <sup>p. 4</sup>. |
|||
* Data in SkyBI can be filtered by categories such as distributor, customer segment, line of business, industry, individual underwriter, and specific risk feature <sup>p. 4</sup>. |
|||
* The company believes every underwriting and claims decision can be augmented with new types of risk data and advanced technology <sup>p. 4</sup>. |
|||
* Underwriting decisions are backed by historical data and in-depth risk evaluation from intentional investment in data collection and processing <sup>p. 4</sup>. |
|||
* Underwriting and claims capabilities are amplified by combining data with new forms of risk data and predictive analytics <sup>p. 4</sup>. |
|||
* The company utilizes generative artificial intelligence in underwriting and claims handling to aid effectiveness and efficiency, while still relying on employee expertise <sup>p. 4</sup>. |
|||
* The company has built a diversified group of underwriting divisions across multiple product lines, industries, geographies, and distribution channels <sup>p. 4</sup>. |
|||
* The diversified business includes operations not typically aligned with traditional P&C cycles <sup>p. 4</sup>. |
|||
* The company aims to evolve with and adapt to the market, growing certain lines when conditions are favorable and limiting exposure when conditions are less favorable <sup>p. 4</sup>. |
|||
* The diversity of the book allows the company to respond to and capitalize on market opportunities and dislocations across insurance market and pricing cycles <sup>p. 4</sup>. |
|||
* The company has a distinctive winning culture, evidenced by internal surveys, public information (Glassdoor, LinkedIn), and selection as a "Best Places to Work in Insurance" <sup>p. 4</sup>. |
|||
* Key to the culture is a flat structure of communication and decision-making <sup>p. 4</sup>. |
|||
* Staff are trusted to make decisions that produce or exceed desired financial results and are supported by a clear system of performance measurement <sup>p. 4</sup>. |
|||
* The company adopted a hybrid work schedule, providing employees with remote working flexibility <sup>p. 4</sup>. |
|||
* The company maintains an entrepreneurial environment that encourages and rewards a proactive approach to capitalize on market disruption <sup>p. 4</sup>. |
|||
* The leadership team is experienced, innovative, and entrepreneurial, with a track record of success in senior management roles at industry-leading P&C companies and in building new businesses <sup>p. 4</sup>. |
|||
* The leadership team is led by Chairman and CEO, Andrew Robinson <sup>p. 4</sup>. |
|||
* Senior leadership compensation is structured to align with shareholders, with a material portion in long-term and short-term incentives tied to delivering sustainable underwriting returns <sup>p. 4</sup>. |
|||
* Executive leadership has additional long-term incentive targets tied directly to growth in book value per share <sup>p. 4</sup>. |
|||
* Focus on profitable market niches requiring technical underwriting and claims management as barriers to entry. |
|||
====== Our Strategy in Action ====== |
|||
* Niche areas of commercial lines [[Definition:Property & casualty|P&C]] markets are an attractive subset of the [[Definition:Property & casualty|P&C]] insurance market, offering opportunities for attractive risk-adjusted returns. |
|||
* Actively target underserved, dislocated markets or those where standard products are insufficient. |
|||
* Risks in core markets require efficient, individual underwriting to generate sustainable underwriting profit. |
|||
* Underwriting divisions are built around deeply experienced underwriters empowered with authority to make decisions. |
|||
* This structure allows for innovative products and solutions for distribution partners and customers, regardless of risk complexity. |
|||
* Underwriters' experience is augmented with data and predictive analytics to differentiate risk selection and pricing while enhancing efficiency. |
|||
* Focus on hiring and retaining underwriting and technical staff to differentiate the company through expertise and experience. |
|||
* Underwriting teams are knowledgeable, experienced, and empowered, which is critical for success in markets with difficult-to-automate risks. |
|||
* Underwriters have freedom to use expertise and judgment in evaluating and pricing risks, rather than strict underwriting rules. |
|||
* Cultivated a best-in-class, highly specialized team of claims professionals knowledgeable about niches and [[Definition:Business mix|lines of business]]. |
|||
* Claims professionals address first-party claims with fair solutions and third-party claims with holistic responses, ensuring consistent and early loss recognition of indemnity and loss adjustment expenses (LAE). |
|||
* Respond quickly to claims with specialized adjusters using expertise, advanced technology, and analytics. |
|||
* Technology is deeply embedded in the claims process, leveraging a technology-enabled platform from first notice of loss to settlement. |
|||
* Analytics capabilities provide real-time, detailed information on open claims and benchmarks against closed claims for senior leadership and claims teams. |
|||
* Industry expertise, nimble culture, and technology-embedded claims processes enable fair and appropriate claims outcomes. |
|||
* SkyBI, the business intelligence platform, provides real-time intelligence to senior leadership and technical teams for superior decision-making. |
|||
* SkyBI reflects best practices learned from management's experience in [[Definition:Property & casualty|P&C]] insurance and technology sectors. |
|||
* SkyBI is a single, comprehensive enterprise-wide data repository for reporting, business intelligence, analytics, and advanced data capabilities. |
|||
* SkyBI provides information and performance metrics across the company in an easy-to-consume visualized format. |
|||
* Data in SkyBI can be filtered by categories including distributor, customer segment, [[Definition:Business mix|line of business]], industry, underwriter, and risk feature. |
|||
* SkyBI aids in establishing clear line of sight to objectives and facilitating decision-making processes. |
|||
* Underwriting and claims decisions are augmented with new types of risk data and advanced technology. |
|||
* Underwriting decisions are backed by historical data and in-depth risk evaluation from intentional data collection and processing. |
|||
* Underwriting and claims prowess is amplified by combining historical data with new forms of risk data and predictive analytics. |
|||
* Generative artificial intelligence is utilized in underwriting and claims handling to aid effectiveness and efficiency, while still relying on employee expertise. |
|||
* Built a diversified group of underwriting divisions across multiple [[Definition:Business mix|product lines]], industries, geographies, and distribution channels. |
|||
* Business includes areas not typically aligned with traditional [[Definition:Property & casualty|P&C]] cycles. |
|||
* Aims to evolve with and adapt to the market, growing certain lines in favorable conditions and limiting exposure in less favorable conditions. |
|||
* Diversity of the book allows response to and capitalization on market opportunities and dislocations across insurance market and pricing cycles, resulting in a durable insurance franchise. |
|||
* Built a distinctive winning culture, evidenced by internal surveys, public information (Glassdoor, LinkedIn), and selection as a "Best Places to Work in Insurance". |
|||
* Key to culture and operating approach is a flat communication and decision-making structure. |
|||
* Staff are trusted to make decisions that produce or exceed desired financial results and are supported by a clear system of performance measurement. |
|||
* Adopted a hybrid work schedule providing flexibility for remote working. |
|||
* Maintains an entrepreneurial environment that encourages and rewards a proactive approach to capitalize on market disruption. |
|||
* This environment is consistent with identity as a specialty insurer and a foundation for attracting talent and delivering best-in-class results. |
|||
* High-quality, experienced leadership team is aligned with shareholders. |
|||
* Executive leadership team, led by Chairman and CEO Andrew Robinson, is experienced, innovative, and entrepreneurial. |
|||
* Leadership team has a track record of success in senior management roles at industry-leading [[Definition:Property & casualty|P&C]] companies and in starting new businesses. |
|||
* Senior leadership's compensation is structured to ensure alignment with shareholders. |
|||
* A material portion of leaders' compensation is in long-term and short-term incentives tied to delivering sustainable, best-in-class underwriting returns. |
|||
* Executive leadership team has additional long-term incentive targets tied directly to growth in book value per share. |
|||
=== Our Strategy in Action === |
|||
* The company's "Rule Our Niche" strategy guides all activities from recruiting to claims resolution <sup>p. 5</sup>. |
|||
* The strategy aims to achieve best-in-class underwriting profitability within niches and create superior long-term shareholder value through growth in book value per share <sup>p. 5</sup>. |
|||
* Core tenets of the "Rule Our Niche" strategy include attracting and retaining blue-chip underwriting and claims talent <sup>p. 5</sup>. |
|||
* The company seeks to hire technical underwriting professionals with long-standing industry relationships and claims professionals with expertise in their niches to ensure steady access to preferred business <sup>p. 5</sup>. |
|||
* The company believes it is a preferred employer for top talent in the industry and plans to grow its market position by recruiting world-class talent in chosen markets <sup>p. 5</sup>. |
|||
* Another core tenet is leveraging technology to differentiate from competitors <sup>p. 5</sup>. |
|||
* The company has demonstrated an ability to use new risk data forms and advanced technology in complex, high-severity specialty P&C insurance market categories <sup>p. 5</sup>. |
|||
* SkyBI allows for prompt sensing and quick response to market changes <sup>p. 5</sup>. |
|||
* Core operating platforms enable efficient entry into new markets without complex system burdens <sup>p. 5</sup>. |
|||
* The company's technological advantage is believed to position it for profitable growth and expansion into additional specialty market niches <sup>p. 5</sup>. |
|||
* A further tenet is profitably growing existing lines of business and expanding with new underwriting divisions <sup>p. 5</sup>. |
|||
* The company is positioned to capitalize on trends affecting customers in the U.S. and globally <sup>p. 5</sup>. |
|||
* One trend is the rising demand for specialized insurance due to increasing and complex risks from climate change, severe weather, supply chain uncertainty, financial inflation, cyber risk, novel health risks, increased litigation, attorney involvement, jury awards, and healthcare delivery/cost <sup>p. 5</sup>. |
|||
* Another market trend is the emergence of "micro cycles and micro dislocations" where P&C insurance market segments experience hardening and softening at different times <sup>p. 5</sup>. |
|||
* The company has responded quickly to these trends by launching new underwriting units (some not aligned with P&C cycles), entering underserved markets, partnering on advanced technology, and launching new captive solutions <sup>p. 5</sup>. |
|||
* Gross written premium growth and profitability indicate momentum and position the company for continued expansion and growth <sup>p. 5</sup>. |
|||
* Differentiating on daily excellence to drive best-in-class underwriting performance is also a core tenet <sup>p. 5</sup>. |
|||
* Meeting long-term goals, including best-in-class underwriting returns and book value per share growth, depends on day-to-day operational execution across all functional departments (underwriting, product management, claims management) <sup>p. 5</sup>. |
|||
* SkyBI provides senior management with a foundation to monitor performance, including renewal rates, new business pricing, portfolio performance for underwriters, and claims aging, reserving practices, and outcomes for adjusters <sup>p. 5</sup>. |
|||
* Focus on fundamentals driving underwriting excellence is central to the strategy <sup>p. 5</sup>. |
|||
* Cross-functional collaboration ensures underwriting, claims, actuarial, and product management teams regularly review performance and trends to implement portfolio, pricing, and coverage changes quickly <sup>p. 5</sup>. |
|||
* The company aims to use its balance sheet to capture a larger market share <sup>p. 5</sup>. |
|||
* The company is committed to maintaining a strong balance sheet, starting with conservative loss reserves and strong capitalization ratios <sup>p. 5</sup>. |
|||
* This commitment is considered imperative for maintaining confidence among customers, distribution partners, reinsurers, regulators, rating agencies, and shareholders <sup>p. 5</sup>. |
|||
* Claims case reserve practices aim to reserve to the expected ultimate loss within 90 days of the first notice of loss <sup>p. 5</sup>. |
|||
* The company's practice is to maintain incurred but not reported reserves (IBNR) that, combined with case reserves, exceed the actuarial central estimate <sup>p. 5</sup>. |
|||
* Loss reserves represent the company's best estimate of ultimate losses <sup>p. 5</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=12|p=8}} |
|||
====== Marketing and Distribution ====== |
|||
'''"Rule Our Niche" strategy tenets''' |
|||
* The "Rule Our Niche" strategy aims to generate best-in-class underwriting profitability for niches and create superior long-term shareholder value through growth in book value per share. |
|||
* ''Marketing and distribution approach'' mirrors underwriting approach and is a key facet of the "Rule Our Niche" strategy <sup>p. 6</sup>. |
|||
* Core tenets of the "Rule Our Niche" strategy include attracting and retaining blue-chip underwriting and claims talent to expand and enhance market position. |
|||
* ''Underwriting teams'' and the Company have strong relationships with distribution partners and strong reputations, which helps establish affiliations with new partners <sup>p. 6</sup>. |
|||
* The company seeks to hire and retain talented technical underwriting professionals with long-standing industry relationships with distribution partners and claims professionals with expertise in specific niches. |
|||
* ''Distribution partners'' are attracted by deep expertise in niche markets, high-caliber underwriters, culture of innovation, thoughtful product line-up and design, and speed and quality of responsiveness <sup>p. 6</sup>. |
|||
* These relationships are key to steady access to preferred business. |
|||
* ''Underwriting divisions'' invest significant time and effort to sustain and expand distribution partner loyalty and long-term relationships <sup>p. 6</sup>. |
|||
* The company aims to grow its market position by bringing on world-class talent in chosen markets. |
|||
* ''Choice of distribution partners'' is tailored to access specific business the Company seeks to write <sup>p. 6</sup>. |
|||
* ''Products are distributed'' through retail agents, wholesale brokers, select program administrators, and captive managers <sup>p. 6</sup>. |
|||
* ''Distribution approach'' allows effective and efficient access to targeted business based on market niche needs and dynamics <sup>p. 6</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=13|p=8}} |
|||
====== Underwriting ====== |
|||
'''Technology leverage''' |
|||
* The company leverages its technology DNA to differentiate itself from competition. |
|||
* The company's underwriting approach is integral to its "Rule Our Niche" strategy and market success <sup>p. 7</sup>. |
|||
* It has demonstrated a differentiated ability to utilize new forms of risk data and advanced technology within complex, higher severity risk categories of the specialty [[Definition:Property & casualty|P&C]] insurance market. |
|||
* Within its nine divisions, the company further specializes underwriting teams to focus on specific niches within their respective markets <sup>p. 7</sup>. |
|||
* SkyBI provides the ability to promptly sense and quickly respond to market changes. |
|||
* The underwriting approach is built on hiring highly experienced, best-in-class, and diverse teams of technical underwriters with proven track records in specific specialty niche markets <sup>p. 7</sup>. |
|||
* Core operating platforms allow efficient entry into new markets without burdensome systems. |
|||
* Underwriters' skill sets are enhanced with advanced technology and data analytics, and they are given appropriate decision-making authority <sup>p. 7</sup>. |
|||
* Technological advantage positions the company for profitable growth and expansion into additional specialty market niches to establish a strong and defensible market position. |
|||
* This approach is considered key to superior risk selection, pricing, and achieving sustainable best-in-class underwriting results across market cycles <sup>p. 7</sup>. |
|||
* The company aims to improve underwriting professionals' capabilities and experience using new data and analytics for risk selection and pricing <sup>p. 7</sup>. |
|||
* Underwriting data is captured in the company's business intelligence platform, SkyBI <sup>p. 7</sup>. |
|||
* SkyBI serves as a comprehensive data repository for reporting, analytics, and other data capabilities, and is a key tool for senior management and business leaders <sup>p. 7</sup>. |
|||
* The company is highly selective in the policies it binds <sup>p. 7</sup>. |
|||
* Underwriters are encouraged to move on quickly from prospective opportunities if they cannot reasonably expect to bind coverage at premium and coverage terms that meet company standards <sup>p. 7</sup>. |
|||
* When accepting risks, the company carefully establishes terms and prices suited to the underlying exposure <sup>p. 7</sup>. |
|||
* In the admitted market, the company ensures approved forms and filed rates are appropriate and adequate for accepted risks, while allowing flexibility for specific/unique exposures <sup>p. 7</sup>. |
|||
* In the E&S market, the company uses freedom of rate and form to ensure risk and coverage are appropriate for unique needs and exposures <sup>p. 7</sup>. |
|||
* The company endeavors to craft policies that offer affordable and appropriate protection for insureds' exposures, while structuring coverage to make potential losses more predictable and claims costs manageable <sup>p. 7</sup>. |
|||
* Underwriting teams receive support and collaboration from Claims, Actuarial, Product Management, Legal and Compliance, and Finance departments <sup>p. 7</sup>. |
|||
* This collaboration ensures that trends in business, legal and tort developments, and competitor and regulatory actions are analyzed, shared, and acted upon promptly <sup>p. 7</sup>. |
|||
* Underwriters are viewed as central to the company, with all support functions incentivized and measured to help achieve underwriting profitability targets <sup>p. 7</sup>. |
|||
* This structure helps identify opportunities and issues early, contributing to the company's nimbleness and ability to capitalize on market disruptions <sup>p. 7</sup>. |
|||
* Underwriting controls and procedures are regularly reviewed to ensure underwriters operate with clear visibility to profitably underwrite each market served <sup>p. 7</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=14|p=8}} |
|||
====== Claims Management ====== |
|||
'''Business growth and market trends''' |
|||
* The company aims to profitably grow existing [[Definition:Business mix|lines of business]] and expand with new underwriting divisions. |
|||
* Skyward's claims department operates under six guiding principles: prompt and comprehensive claim investigations using advanced analytics and technology; quality claims handling service with customer engagement; timely establishment of reserves reflecting best estimates of ultimate loss; effective pursuit of contribution and subrogation; detection and prevention of fraud; and disciplined litigation management for superior legal defense and cost monitoring <sup>p. 8</sup>. |
|||
* It is positioned to take advantage of trends impacting customers in the United States and globally. |
|||
* Continuous training is provided to claim staff on claim evaluation, strategy, litigation management, good-faith claims handling, and best practices <sup>p. 8</sup>. |
|||
* One trend is the continued rise in demand for specialized insurance solutions due to increasing risks and complexity from climate change/severe weather events, supply chain uncertainty, financial inflation risk, cyber risk, novel health risks, increased litigation, attorney involvement, jury awards, and healthcare delivery and cost. |
|||
* The ultimate goal of the claims department is to achieve timely and optimal claim outcomes <sup>p. 8</sup>. |
|||
* Another market trend is the emergence of "micro cycles and micro dislocations" where different pockets of the [[Definition:Property & casualty|P&C]] insurance market experience hardening and softening at different times. |
|||
* The majority of claims are handled in-house <sup>p. 8</sup>. |
|||
* The company has reacted quickly to these trends by launching new underwriting units (many not aligned with [[Definition:Property & casualty|P&C]] cycles), entering underserved markets, partnering with advanced technology providers, and launching new captive solutions. |
|||
* Third Party Administrators (TPAs) are utilized for certain instances, such as programs, captives, occupational accident, workers' compensation, and runoff claims <sup>p. 8</sup>. |
|||
* [[Definition:Gross written premiums|Gross written premium]] growth and profitability indicate momentum and provide a reference for the company's positioning to expand and grow in target markets. |
|||
* TPAs are actively managed, overseen, and monitored to ensure compliance with claims handling and reserving guidelines and best practices <sup>p. 8</sup>. |
|||
* Regular audits of TPAs are conducted to ensure compliance <sup>p. 8</sup>. |
|||
* For liability claims against an insured, independent legal counsel is retained based on geographical location and expertise <sup>p. 8</sup>. |
|||
* Litigation guidelines have been developed for claims professionals and outside counsel to ensure appropriate defense and reasonable legal costs <sup>p. 8</sup>. |
|||
* A legal spend management solution is used to analyze legal invoices for adherence to case handling and billing practice standards <sup>p. 8</sup>. |
|||
* Technology is leveraged to gain efficiencies in claims handling, including a Claims Development Severity Predictor <sup>p. 8</sup>. |
|||
* The Claims Development Severity Predictor identifies claims likely to lead to large loss development by training on key phrases, allowing for early identification, proactive management, and summarization <sup>p. 8</sup>. |
|||
* This predictive model is integrated into the claims review and management workflow <sup>p. 8</sup>. |
|||
* A "quick strike" program has been implemented for commercial auto claims to respond to claim reports <sup>p. 8</sup>. |
|||
* The "quick strike" program deploys experienced investigators and vendors to accident scenes, ideally within two hours, to evaluate facts and circumstances and facilitate quick resolution of third-party claims if appropriate <sup>p. 8</sup>. |
|||
* Claims handlers and managers are organized by line of business to ensure specialized expertise <sup>p. 8</sup>. |
|||
* Claims managers and adjusters collaborate closely with underwriting partners to inform them of legal trends and emerging claims issues <sup>p. 8</sup>. |
|||
* The goal of this collaboration is to educate underwriters on emerging loss experience to assist in risk selection processes <sup>p. 8</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=15|p=8}} |
|||
====== Technology ====== |
|||
'''Underwriting performance and operational excellence''' |
|||
* The company differentiates on daily excellence to drive best-in-class underwriting performance. |
|||
* ''Technology'' is central to the company's operations and decision-making, aiming to drive long-term success <sup>p. 9</sup>. |
|||
* Meeting long-term goals, including best-in-class underwriting returns and book value per share growth, relies on day-to-day operational execution across all functional departments (underwriting, product management, claims management). |
|||
* The company deploys technology to gain competitive advantages in three primary functional areas <sup>p. 9</sup>. |
|||
* SkyBI provides the foundation for senior management to monitor performance, including renewal rates, new business pricing, portfolio performance for individual underwriters, and claims aging, reserving practices, and outcomes by claims adjusters. |
|||
* ''SkyBI'', the company's business intelligence platform, provides real-time intelligence to senior leadership and technical teams for decision-making <sup>p. 9</sup>. |
|||
* Focus on fundamentals driving underwriting excellence is central to the strategy. |
|||
* SkyBI incorporates best practices from the management team's experience in the P&C insurance and technology sectors <sup>p. 9</sup>. |
|||
* Cross-functional collaboration ensures underwriting, claims, actuarial, and product management teams regularly review performance and trends for quick implementation of portfolio, pricing, and coverage changes. |
|||
* SkyBI serves as a single, comprehensive enterprise-wide data repository for reporting, business intelligence, analytics, and advanced data capabilities <sup>p. 9</sup>. |
|||
* SkyBI provides information and performance metrics across the company in an easy-to-consume visualized format <sup>p. 9</sup>. |
|||
* Data in SkyBI can be filtered by categories such as distributor, customer segment, line of business, specific industry, individual underwriter, and specific risk feature <sup>p. 9</sup>. |
|||
* SkyBI helps establish clear objectives and facilitates decision-making <sup>p. 9</sup>. |
|||
* ''Predictive analytics technology'' is used to augment employee capabilities daily, utilizing new risk data and artificial intelligence for risk selection, pricing, and claims handling <sup>p. 9</sup>. |
|||
* Within each underwriting division, actions are intentional to "Rule Our Niche" <sup>p. 9</sup>. |
|||
* The company aims for constant innovation, with actions specific to each division/market served <sup>p. 9</sup>. |
|||
* ''Core transactional platforms'', including policy administration, underwriting workbench, billing, and claims systems, are designed for nimble scaling and business expansion <sup>p. 9</sup>. |
|||
* The company generally uses customized third-party vendor core operating applications <sup>p. 9</sup>. |
|||
* The core platform organization is used for all business except for accident & health, global property, agriculture and credit (re)insurance, and surety, which require dedicated core processing components due to their unique features <sup>p. 9</sup>. |
|||
* Data from all divisions' core operating platforms flows to the SkyBI platform with comparable data quality and granularity <sup>p. 9</sup>. |
|||
* The use of advanced technology for underwriting and claims, SkyBI, and core operating platforms creates a flywheel effect <sup>p. 9</sup>. |
|||
* This flywheel effect allows underwriters to better select risk, claims professionals to better adjudicate claims, unit leaders to better communicate with reinsurance and third-party partners, and senior leadership to better evaluate business trends <sup>p. 9</sup>. |
|||
* These tools also enable more accurate, effective, and efficient communication with distribution partners, reinsurers, and other third-party partners <sup>p. 9</sup>. |
|||
* The company faces external threats to its information technology systems, including system failure, customer data theft attempts, and ransomware attacks <sup>p. 9</sup>. |
|||
* The technology infrastructure is designed to function through major disruptions <sup>p. 9</sup>. |
|||
* Data is replicated in real-time to a third-party cloud disaster recovery site for use during major system failures <sup>p. 9</sup>. |
|||
* Data is backed up daily for system restoration <sup>p. 9</sup>. |
|||
* Actions to prevent system and data disruptions include: actively monitoring Cybersecurity and Infrastructure Security Agency’s (“CISA”) cybersecurity directives and taking immediate action on identified vulnerabilities <sup>p. 9</sup>. |
|||
* Monthly vulnerability scans are conducted on all network-attached devices at all locations, with patching applied as needed <sup>p. 9</sup>. |
|||
* Two-factor authentication is required for access to all systems <sup>p. 9</sup>. |
|||
* Monthly security training is provided for all employees <sup>p. 9</sup>. |
|||
* Endpoint detection agents are implemented for threat detection and response <sup>p. 9</sup>. |
|||
* Desktop scenarios are performed to practice responses to breaches, involving cybersecurity insurance partners and retained security consultants <sup>p. 9</sup>. |
|||
* Annual penetration testing is conducted <sup>p. 9</sup>. |
|||
* The company constantly reviews its security breach posture and regularly implements updated processes, best practices, and tools <sup>p. 9</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=16|p=8}} |
|||
====== Reinsurance ====== |
|||
'''Balance sheet utilization and strength''' |
|||
* The company uses its balance sheet to capture a larger part of the market it serves. |
|||
* Reinsurance is purchased from third parties to protect capital from severity events (large single event losses or catastrophes) and reduce earnings volatility <sup>p. 10</sup>. |
|||
* It is committed to establishing and maintaining a strong balance sheet, starting with conservative loss reserves and strong capitalization ratios. |
|||
* Reinsurance contracts are predominantly one year in length and renew annually, primarily in January and June <sup>p. 10</sup>. |
|||
* This is imperative to maintain confidence of customers, distribution partners, reinsurers, regulators, rating agencies, and shareholders. |
|||
* Factors influencing reinsurance purchase changes at annual renewal include plans to change underlying insurance coverage, updated loss activity, capital and surplus levels, changes in risk appetite, and the cost and availability of treaties <sup>p. 10</sup>. |
|||
* Claims case reserves practices aim to reserve to the expected ultimate loss within 90 days of the first notice of loss. |
|||
* The company purchases quota share, excess of loss, and facultative reinsurance to limit exposure from losses on any one occurrence <sup>p. 10</sup>. |
|||
* The practice is to maintain incurred but not reported reserves ("IBNR") that, combined with case reserves, are above the actuarial central estimate. |
|||
* The mix of reinsurance purchased considers efficiency, cost, risk appetite, and specific factors of underlying risks <sup>p. 10</sup>. |
|||
* Loss reserves represent the best estimate of ultimate losses. |
|||
* ''Quota share reinsurance'' involves the reinsurer assuming a specified percentage of the ceding company’s losses from a defined business class in exchange for a corresponding percentage of premiums, net of a ceding commission <sup>p. 10</sup>. |
|||
* ''Excess of loss reinsurance'' involves the reinsurer assuming all or a portion of the ceding company’s losses for an individual claim or event above a specified amount, in exchange for a negotiated premium, including the catastrophe reinsurance program <sup>p. 10</sup>. |
|||
* ''Facultative coverage'' is a reinsurance contract for individual risks, used to supplement treaty limits or cover risks/perils excluded from treaty reinsurance <sup>p. 10</sup>. |
|||
* As of December 31, 2025, ''property insurance'' represented 34% of gross written premiums <sup>p. 10</sup>. |
|||
* The company manages and monitors property writings aggregation by geographic area to limit potential loss from severe events like hurricanes, convective storms, and earthquakes <sup>p. 10</sup>. |
|||
* Catastrophe reinsurance is purchased to mitigate property losses from single or series of events <sup>p. 10</sup>. |
|||
* Third-party stochastic and internal deterministic models are used to analyze aggregation risk for catastrophe reinsurance purchases <sup>p. 10</sup>. |
|||
* These models provide a quantitative view of PML (Probable Maximum Loss) events, estimating loss levels for a given return period <sup>p. 10</sup>. |
|||
* Based on modeling, an event beyond a 1 in 250-year PML would be required to exhaust the ''property catastrophe coverage'' of $36.0 million <sup>p. 10</sup>. |
|||
* The company aims to expose no more than 3.0% of stockholders’ equity to a catastrophic loss less than a 1 in 250-year event <sup>p. 10</sup>. |
|||
* The current reinsurance program is believed to provide coverage well in excess of theoretical losses from any recorded historical event <sup>p. 10</sup>. |
|||
* The company seeks to purchase reinsurance from reinsurers rated at least “A-” (“Excellent”) or better by A.M. Best <sup>p. 10</sup>. |
|||
* As of December 31, 2025, ''98% of reinsurance recoverables'' were from reinsurers rated “A-” (Excellent) or better by A.M. Best, or were collateralized <sup>p. 10</sup>. |
|||
* If reinsurers fail to pay claims, the company retains primary liability to policyholders, potentially resulting in losses <sup>p. 10</sup>. |
|||
* Allowances for uncollectible reinsurance are established due to the risk of reinsurer failure <sup>p. 10</sup>. |
|||
* The ''allowance for uncollectible reinsurance'' was $2.3 million at December 31, 2025, and December 31, 2024 <sup>p. 10</sup>. |
|||
=== Marketing and Distribution === |
|||
====== Maximum company retention by line of business ====== |
|||
{{chunk|doc=3z7a4yrxkn|c=17|p=8}} |
|||
'''Marketing and distribution strategy''' |
|||
* The company's marketing and distribution approach mirrors its underwriting approach and is a key facet of its "Rule Our Niche" strategy. |
|||
* Underwriting teams and the company have strong relationships with distribution partners and reputations that facilitate new affiliations. |
|||
* The company wins with distribution partners due to deep expertise in niche markets, high-caliber underwriters, culture of innovation, thoughtful product line-up and design, and speed/quality of responsiveness. |
|||
* All underwriting divisions invest time and effort into sustaining and expanding distribution partner loyalty and long-term relationships. |
|||
* The company tailors its choice of distribution partners to access specific business it seeks to write. |
|||
* Products are distributed through retail agents, wholesale brokers, select program administrators, and captive managers. |
|||
* This distribution approach allows effective and efficient access to targeted business based on market niche needs and dynamics. |
|||
=== Underwriting === |
|||
{{chunk|doc=3z7a4yrxkn|c=18|p=8}} |
|||
'''Underwriting Strategy and Approach''' |
|||
* Underwriting approach is deeply embedded in the "Rule Our Niche" strategy. |
|||
* Underwriting teams are specialized within nine divisions, focusing on specific niches. |
|||
* The underwriting approach is underpinned by hiring experienced, best-in-class, and diverse teams of technical underwriters with established track records in specific specialty niche markets. |
|||
* Underwriters' skill sets are amplified with advanced technology and data analytics. |
|||
* Underwriters are empowered with appropriate authority to make decisions. |
|||
* This approach is believed to be key to superior risk selection, pricing, and producing sustainable best-in-class underwriting results across market cycles. |
|||
* Capabilities and experience of underwriting professionals are augmented using new forms of data and analytics for risk selection and pricing. |
|||
* Underwriting data is captured in the business intelligence platform, SkyBI. |
|||
* SkyBI forms the foundation of reporting, analytics, and other data capabilities, and is a key tool for senior management and business leaders. |
|||
* The company is highly selective in the policies chosen to bind. |
|||
* Underwriters are encouraged to move on quickly if coverage cannot reasonably be bound at a premium and coverage terms meeting company standards. |
|||
* When accepting risks, terms and price are carefully established to suit the underlying exposure. |
|||
* In the admitted market, the company ensures approved forms and filed rates are appropriate and adequate for risks, while allowing flexibility for specific/unique exposures. |
|||
* In the E&S market, freedom of rate and form is used to ensure risk and coverage are appropriate for unique needs and exposures. |
|||
* Policies are crafted to offer affordable and appropriate protection for insureds' exposures, and to construct coverage for more predictable potential losses and better managed claims costs. |
|||
* Underwriting teams are supported by active engagement and collaboration with Claims, Actuarial, Product Management, Legal and Compliance, and Finance departments. |
|||
* Collaboration ensures trends in business, legal and tort developments, and competitor and regulatory actions are analyzed, shared, and acted upon timely. |
|||
* Underwriters are viewed as the center of the company, with all support functions incentivized and measured to support underwriting profitability targets. |
|||
* This structure helps surface opportunities and issues early, contributing to nimbleness and ability to take advantage of market disruptions. |
|||
* Underwriting controls and procedures are regularly reviewed to ensure underwriters act with clear line of sight to profitably underwrite each market. |
|||
=== Claims Management === |
|||
{{chunk|doc=3z7a4yrxkn|c=19|p=8}} |
|||
'''Claims management principles and operations''' |
|||
* Skyward's claims department is guided by principles including prompt and comprehensive claim investigations using advanced analytics and technology. |
|||
* Other principles include providing quality claims handling service, promptly establishing reserves, pursuing contribution and subrogation, detecting and preventing fraud, and disciplined litigation management. |
|||
* Continuous training is provided to claim staff on evaluation, strategy, litigation management, good-faith handling, and best practices to achieve timely and optimal claim outcomes. |
|||
* The majority of claims are handled in-house. |
|||
* Third Party Administrators (TPAs) are utilized for certain instances, such as programs, captives, occupational accident, workers compensation, and runoff claims. |
|||
* TPAs are actively managed, overseen, and regularly audited to ensure compliance with claims handling and reserving guidelines and best practices. |
|||
* Independent legal counsel is retained for liability claims against insureds, selected based on geographical location and expertise. |
|||
* Carefully crafted litigation guidelines are provided for claims professionals and outside counsel. |
|||
* A legal spend management solution is employed to analyze legal invoices for adherence to case handling and billing practice standards, ensuring reasonable legal costs. |
|||
{{chunk|doc=3z7a4yrxkn|c=20|p=8}} |
|||
'''Claims technology and efficiency initiatives''' |
|||
* Technology is leveraged to gain efficiencies in the claims-handling process. |
|||
* A Claims Development Severity Predictor has been created and implemented, which trains on key phrases to identify claims likely to lead to large loss development. |
|||
* This predictive model allows for early identification, proactive claims management, and summarization of development causes, and is integrated into claims review and management workflow. |
|||
* A "quick strike" program has been implemented for commercial auto claims to respond to claim reports. |
|||
* This program deploys experienced investigators and vendors to accident scenes, ideally within two hours, regardless of location. |
|||
* The quick response assists in evaluating facts and circumstances for investigation and, if appropriate, aids in resolving third-party claims quickly. |
|||
{{chunk|doc=3z7a4yrxkn|c=21|p=8}} |
|||
'''Claims team structure and collaboration''' |
|||
* Claims handlers and managers are organized by [[Definition:Business mix|line of business]] to ensure appropriate expertise in handling claims. |
|||
* Managers and adjusters collaborate closely with underwriting partners to inform them of legal trends and emerging claims issues. |
|||
* The goal is to educate underwriters on emerging areas of loss experience to assist in their risk selection processes. |
|||
=== Technology === |
|||
{{chunk|doc=3z7a4yrxkn|c=22|p=8}} |
|||
'''Technology strategy and platforms''' |
|||
* Technology is central to Skyward's operations and decision-making, driving long-term competitive advantages. |
|||
* Skyward deploys technology in three primary functional ways: Superior Business Intelligence Platform, Predictive Analytics Technology, and Core Transactional Platforms. |
|||
* Superior Business Intelligence Platform: SkyBI provides senior leadership and technical teams with real-time intelligence for decision-making. |
|||
* SkyBI incorporates best practices from management's experience in [[Definition:Property & casualty|P&C]] insurance and technology sectors. |
|||
* SkyBI is a single, comprehensive enterprise-wide data repository for reporting, business intelligence, analytics, and advanced data capabilities. |
|||
* SkyBI provides information and performance metrics across the Company in an easy-to-consume visualized format. |
|||
* Data in SkyBI can be filtered by categories including distributor, customer segment, [[Definition:Business mix|line of business]], specific industry, individual underwriter, and specific risk feature. |
|||
* SkyBI helps establish clear line of sight to objectives and facilitates decision-making. |
|||
* Predictive Analytics Technology: Skyward augments employee capabilities using new risk data and predictive analytics, including AI, for risk selection, pricing, and claims handling. |
|||
* Skyward's actions within every underwriting division are intentional to "Rule Our Niche". |
|||
* Skyward aims for constant innovation, with actions specific to each division/market served. |
|||
* Core Transactional Platforms: Core operating platforms (policy administration, underwriting workbench, billing, claims systems) are designed for nimble scaling and business expansion. |
|||
* Skyward generally uses customized third-party vendor core operating applications. |
|||
* The core platform organization is used for all business except accident & health, global property, agriculture, credit (re)insurance, and surety, which require dedicated core processing components due to unique features. |
|||
* Data from all divisions' core operating platforms flows to SkyBI with comparable data quality and granularity. |
|||
* The use of advanced technology for underwriting and claims, SkyBI, and core operating platforms creates a flywheel effect. |
|||
* This flywheel effect allows underwriters to better select risk, claims professionals to better adjudicate claims, unit leaders to better communicate with reinsurance and third-party partners, and senior leadership to better evaluate business trends. |
|||
* These tools also enable more accurate, effective, and efficient communication with distribution partners, reinsurers, and other third-party partners. |
|||
{{chunk|doc=3z7a4yrxkn|c=23|p=8}} |
|||
'''Cybersecurity and data protection''' |
|||
* Skyward faces external threats to IT systems, including system failure, customer data theft attempts, and ransomware attacks. |
|||
* Technology infrastructure is designed to function through major disruptions. |
|||
* Data is replicated in real time to a third-party cloud disaster recovery site for use during major system failures. |
|||
* Data is backed up daily for system restoration. |
|||
* Actions to prevent system and data disruptions include: actively monitoring Cybersecurity and Infrastructure Security Agency’s (“CISA”) cybersecurity directives. |
|||
* Immediate action is taken on any vulnerability identified in a CISA directive. |
|||
* Monthly vulnerability scans are conducted on all network-attached devices at all locations, with patching applied as needed. |
|||
* Two-factor authentication is required for access to any Skyward system. |
|||
* Monthly security training is conducted for all employees. |
|||
* Endpoint detection agents are implemented for threat detection and response. |
|||
* Desktop scenarios are performed to practice responses to breaches with cybersecurity insurance partners and retained security consultants. |
|||
* Annual penetration testing is performed. |
|||
* Skyward constantly reviews its security breach posture and regularly implements updated processes, best practices, and tools. |
|||
=== Reinsurance === |
|||
{{chunk|doc=3z7a4yrxkn|c=24|p=8}} |
|||
'''Reinsurance strategy and types''' |
|||
* Reinsurance is strategically purchased from third parties to protect capital from severity events (large single event losses or catastrophes) and reduce earnings volatility. |
|||
* Reinsurance contracts are predominantly one year in length and renew annually, primarily in January and June. |
|||
* Factors influencing reinsurance purchases at annual renewal include changes to underlying insurance coverage, updated loss activity, capital and surplus levels, risk appetite changes, and the cost and availability of reinsurance treaties. |
|||
* Quota share reinsurance, excess of loss reinsurance, and facultative reinsurance coverage are purchased to limit exposure from losses on any one occurrence. |
|||
* The mix of reinsurance purchased considers efficiency, cost, risk appetite, and specific factors of underlying risks. |
|||
* Quota share reinsurance involves the reinsurer assuming a specified percentage of the ceding company’s losses from a defined class of business in exchange for a corresponding percentage of premiums, net of a ceding commission. |
|||
* Excess of loss reinsurance involves the reinsurer assuming all or a portion of the ceding company’s losses for an individual claim or event above a specified amount, in exchange for a negotiated premium, and includes the catastrophe reinsurance program. |
|||
* Facultative coverage is a reinsurance contract on individual risks, used to supplement treaty limits or cover risks/perils excluded from treaty reinsurance. |
|||
{{chunk|doc=3z7a4yrxkn|c=25|p=8}} |
|||
'''Property catastrophe reinsurance program''' |
|||
* As of December 31, 2025, property insurance represented 34% of [[Definition:Gross written premiums|gross written premiums]]. |
|||
* Aggregation of property writings by geographic area is actively managed and continuously monitored to limit potential loss from severe events like hurricanes, convective storms, and earthquakes. |
|||
* Catastrophe reinsurance is purchased to further mitigate aggregation of property losses due to a single event or series of events. |
|||
* Third-party stochastic and internal deterministic models are used to analyze the risk of aggregation of losses from such events to inform catastrophe reinsurance purchases. |
|||
* These models provide a quantitative view of Probable Maximum Loss (PML) events, which estimate the expected loss level for a given return period. |
|||
* Based on modeling, an event beyond a 1 in 250-year PML would be required to exhaust the USD 36.0m property catastrophe coverage. |
|||
* The company aims to expose no more than 3.0% of stockholders’ equity to a catastrophic loss that is less than a 1 in 250-year event. |
|||
* The current reinsurance program is believed to provide coverage well in excess of theoretical losses from any recorded historical event. |
|||
{{chunk|doc=3z7a4yrxkn|c=26|p=8}} |
|||
'''Reinsurer credit quality and recoverables''' |
|||
* Reinsurance is sought from reinsurers rated at least “A-” (“Excellent”) or better by A.M. Best. |
|||
* As of December 31, 2025, 98% of reinsurance recoverables were from reinsurers rated “A-” (Excellent) or better by A.M. Best, or were collateralized by the reinsurer. |
|||
* Primary liability to policyholders is retained if reinsurers are unable to pay claims, potentially resulting in losses to the company. |
|||
* Allowances for uncollectible reinsurance are established due to the risk of reinsurer failure. |
|||
* The allowance for uncollectible reinsurance was USD 2.3m at December 31, 2025 and 2024. |
|||
* A table sets forth the most significant reinsurers by amount of reinsurance recoverables and their A.M. Best rating as of December 31, 2025. |
|||
{{chunk|doc=3z7a4yrxkn|c=27|p=8}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| id="t1001" class="wikitable" |
||
|+ Maximum Company Retention by [[Definition:Business mix|Line of Business]] |
|||
|- |
|||
! style="text-align:left" | [[Definition:Business mix|Line of Business]] |
|||
! style="text-align:left" | Maximum Company Retention |
! style="text-align:left" | Maximum Company Retention |
||
|- |
|- |
||
| style="text-align:left" | Accident & Health |
| style="text-align:left" | Accident & Health |
||
| style="text-align:left" | $0.90 million per occurrence |
| style="text-align:left" | $0.90 million per occurrence |
||
|- |
|- |
||
| Line 554: | Line 662: | ||
</div> |
</div> |
||
{{fn note|1=1|2=Legal defense expenses can force exposure above the maximum company retention for Excess Casualty, Commercial Auto and General Liability.}} |
|||
{{fn note|1=2|2=Reinsurance is subject to a loss ratio cap or aggregate level of loss cover that exceeds a modeled 1:250-year PML event.}} |
|||
{{fn note|1=3|2=Catastrophe loss protection is purchased up to $36.0 million in excess of $12.0 million retention, which provides cover for a 1:250-year PML event.}} |
|||
====== Reinsurance by company ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| id="t1002" class="wikitable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! style="text-align:right" | |
||
! style="text-align: |
! style="text-align:right" | |
||
|- |
|- |
||
! style="text-align:left" | Reinsurer |
! style="text-align:left" | Reinsurer |
||
! |
! style="text-align:right" | Reinsurance Recoverables |
||
! |
! style="text-align:right" | AM Best Rating |
||
|- |
|- |
||
| style="text-align:left" | eMaxx Capitves (1) |
| style="text-align:left" | eMaxx Capitves (1) |
||
| |
| style="text-align:right" | 197,989 |
||
| |
| style="text-align:right" | n/r |
||
|- |
|- |
||
| style="text-align:left" | Everest Reinsurance Co. |
| style="text-align:left" | Everest Reinsurance Co. |
||
| |
| style="text-align:right" | 123,925 |
||
| |
| style="text-align:right" | A+ |
||
|- |
|- |
||
| style="text-align:left" | General Reinsurance Corp |
| style="text-align:left" | General Reinsurance Corp |
||
| |
| style="text-align:right" | 70,355 |
||
| |
| style="text-align:right" | A++ |
||
|- |
|- |
||
| style="text-align:left" | Partner Reinsurance Co. of the US |
| style="text-align:left" | Partner Reinsurance Co. of the US |
||
| |
| style="text-align:right" | 65,446 |
||
| |
| style="text-align:right" | A+ |
||
|- |
|- |
||
| style="text-align:left" | ACE (Chubb Property & Casulty Ins Company) |
| style="text-align:left" | ACE (Chubb Property & Casulty Ins Company) |
||
| |
| style="text-align:right" | 48,344 |
||
| |
| style="text-align:right" | A+ |
||
|- |
|- |
||
| style="text-align:left" | RGA Reinsurance Company |
| style="text-align:left" | RGA Reinsurance Company |
||
| |
| style="text-align:right" | 43,043 |
||
| |
| style="text-align:right" | A+ |
||
|- |
|- |
||
| style="text-align:left" | Lloyds Syndicate 4711 |
| style="text-align:left" | Lloyds Syndicate 4711 |
||
| |
| style="text-align:right" | 35,860 |
||
| |
| style="text-align:right" | A+ |
||
|- |
|- |
||
| style="text-align:left" | Swiss Reinsurance America Corp |
| style="text-align:left" | Swiss Reinsurance America Corp |
||
| |
| style="text-align:right" | 26,152 |
||
| |
| style="text-align:right" | A+ |
||
|- |
|- |
||
| style="text-align:left" | Lloyds Syndicate 2987 |
| style="text-align:left" | Lloyds Syndicate 2987 |
||
| |
| style="text-align:right" | 25,301 |
||
| |
| style="text-align:right" | A+ |
||
|- |
|- |
||
| style="text-align:left" | Aspen Insurance UK Limited |
| style="text-align:left" | Aspen Insurance UK Limited |
||
| |
| style="text-align:right" | 24,715 |
||
| |
| style="text-align:right" | A |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Top 10 Total</b> |
||
| |
| style="text-align:right" | <b>661,130</b> |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | All Others |
| style="text-align:left" | All Others |
||
| |
| style="text-align:right" | 458,750 |
||
| |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total |
||
| |
| style="text-align:right" | 1,119,880 |
||
| |
| style="text-align:right" | — |
||
|} |
|} |
||
</div> |
</div> |
||
{{fn note|1=1|2=This reinsurer facilitates our eMaxx captive. At December 31, 2025, we held collateral in a statutory trust of $235.2 million on our net reinsurance recoverables.}} |
|||
=== Enterprise Risk Management === |
|||
{{chunk|doc=3z7a4yrxkn|c=28|p=8}} |
|||
* ''Enterprise Risk Management (ERM)'' is integrated into nearly every aspect of the company and guides daily activities <sup>p. 11</sup>. |
|||
'''Enterprise Risk Management overview and governance''' |
|||
* The ERM approach aims to achieve an acceptable risk-adjusted return for shareholders while maintaining trust and reliability for those served <sup>p. 11</sup>. |
|||
* The company is intentional in its underwriting and asset portfolio construction <sup>p. 11</sup>. |
|||
* An example of ERM application is balancing liability duration and market cyclicality of the underwriting portfolio <sup>p. 11</sup>. |
|||
* Reinsurance is used to manage volatility outside of defined risk tolerances <sup>p. 11</sup>. |
|||
* The ''investment strategy'' focuses on a diversified target portfolio that balances yield, liquidity, volatility, and potential for principal loss <sup>p. 11</sup>. |
|||
* The ''Senior Vice President (SVP), Chief Financial Officer (CFO) & Head of ERM - US Operations'' oversees critical ERM processes and chairs the cross-functional corporate ERM Committee <sup>p. 11</sup>. |
|||
* The company formalizes its view of risk and solvency using an ''Economic Capital Model (ECM)'' to measure potential economic loss <sup>p. 11</sup>. |
|||
* The ECM output is used to measure potential earnings and capital loss across various scenarios <sup>p. 11</sup>. |
|||
* These outputs are measured against ''risk tolerances'' set and updated annually by the ERM Committee and discussed with the Risk Committee of the Board of Directors <sup>p. 11</sup>. |
|||
* The ECM provides a probabilistic modeled view of earnings and capital loss, incorporating potential losses from catastrophes, reserving, underwriting, market, credit risk, strategic, and operational risks <sup>p. 11</sup>. |
|||
* The SVP, CFO & Head of ERM, in collaboration with the ERM Committee, reviews and maintains a ''comprehensive risk register'' with accountabilities for mitigation and monitoring <sup>p. 11</sup>. |
|||
* The ''top 10 risks'' are identified, quantified by the SVP, CFO & Head of ERM and the ERM Committee, and reviewed quarterly <sup>p. 11</sup>. |
|||
* Reports on these risks are submitted to the Risk Committee regularly by the SVP, CFO & Head of ERM and the ERM Committee <sup>p. 11</sup>. |
|||
* ''Operational processes and controls'' are constructed to identify, assess, and manage key risks continuously <sup>p. 11</sup>. |
|||
* The ''Underwriting Committee'' is responsible for overseeing changes in risk appetite, product line, and division expansion <sup>p. 11</sup>. |
|||
* Within ''Claims'', practices are monitored against guidelines through regular internal audits, monthly large loss reviews are conducted, and a watchlist of potential high severity claims is maintained <sup>p. 11</sup>. |
|||
* Within ''Actuarial'', quarterly reserve studies are performed, and the Reserve Committee meets quarterly to review and respond to trends in loss emergence <sup>p. 11</sup>. |
|||
* Key observations from Actuarial are discussed with the CEO <sup>p. 11</sup>. |
|||
* Monthly and quarterly, underwriting divisions assess rate change and retention on existing business, new business quality and pricing adequacy, and loss emergence compared to expectations <sup>p. 11</sup>. |
|||
* The ''SkyBI platform'' provides real-time portfolio, underwriting, claims, and actuarial analytics to support these processes <sup>p. 11</sup>. |
|||
* ERM is central to decision-making and daily activities, aiming to achieve market-leading risk-adjusted returns for shareholders and reinforce a culture of accountability, transparency, and sound judgment <sup>p. 11</sup>. |
|||
* Enterprise Risk Management (ERM) is embedded in company operations and guides day-to-day activities. |
|||
====== Reserves ====== |
|||
* The ERM approach aims to achieve an acceptable risk-adjusted return for shareholders and maintain trust and reliability for those served. |
|||
* Underwriting and asset portfolio construction are intentional, balancing liability duration and market cyclicality of the underwriting portfolio. |
|||
* Reinsurance is used to manage volatility outside of risk tolerances. |
|||
* The investment strategy targets a diversified portfolio balancing yield, liquidity, volatility, and potential for principal loss. |
|||
* The Senior Vice President (SVP), Chief Financial Officer (CFO) & Head of ERM - US Operations, oversees critical ERM processes and chairs the cross-functional corporate ERM Committee. |
|||
* The company formalizes its view of risk and solvency using an Economic Capital Model (ECM) to measure potential economic loss. |
|||
* ECM output measures potential earnings and capital loss for various scenarios against risk tolerances. |
|||
* Risk tolerances are set and updated annually by the ERM Committee and discussed with the Board of Directors' Risk Committee. |
|||
* The ECM provides a probabilistic modeled view of earnings and capital loss, integrating potential loss from catastrophes, reserving, underwriting, market, credit risk, strategic, and operational risks. |
|||
* The SVP, CFO & Head of ERM, with the ERM Committee, reviews and maintains a comprehensive risk register with accountabilities for mitigations and monitoring. |
|||
* The top 10 risks are identified and quantified by the SVP, CFO & Head of ERM and the ERM Committee, and reviewed quarterly. |
|||
* Reports on these risks are submitted regularly to the Risk Committee by the SVP, CFO & Head of ERM and the ERM Committee. |
|||
{{chunk|doc=3z7a4yrxkn|c=29|p=8}} |
|||
* Reserves are maintained for specific claims incurred and reported, IBNR reserves, and uncollectible reinsurance when appropriate <sup>p. 12</sup>. |
|||
'''Operational risk management processes''' |
|||
* The ultimate liability may differ from current reserves, and there is always a risk of inadequate reserves in the insurance industry <sup>p. 12</sup>. |
|||
* Reserves are continually monitored using new information on reported claims and statistical analyses <sup>p. 12</sup>. |
|||
* Anticipated inflation is implicitly reflected in the reserving process through cost trend analysis and historical development review <sup>p. 12</sup>. |
|||
* Reserves for losses and LAE are not discounted to reflect estimated present value <sup>p. 12</sup>. |
|||
* When a claim is reported, a ''case reserve'' is established for the estimated ultimate payment after assessing coverage, damages, and other investigations <sup>p. 12</sup>. |
|||
* Case reserve estimates are based on reserving practices and the claims adjuster's experience and knowledge of the claim's nature and value <sup>p. 12</sup>. |
|||
* Case reserves are revised periodically based on subsequent developments <sup>p. 12</sup>. |
|||
* ''IBNR reserves'' are established in accordance with industry practice to cover estimated future loss payments on incurred claims not yet reported and potential development on reported claims <sup>p. 12</sup>. |
|||
* IBNR reserves are estimated using generally accepted actuarial reserving techniques that consider quantitative loss experience data and qualitative factors <sup>p. 12</sup>. |
|||
* Loss reserves are regularly reviewed using various actuarial techniques <sup>p. 12</sup>. |
|||
* Reserve estimates are updated as historical loss experience develops, additional claims are reported and/or settled, and new information becomes available <sup>p. 12</sup>. |
|||
* Reserves can be increased or decreased over time as claims move towards settlement, impacting earnings through adverse development or reserve releases <sup>p. 12</sup>. |
|||
* For additional information on loss reserves, refer to Item 7 of Form 10-K, "Management’s Discussion and Analysis of Financial Condition and Results of Operations - “Results of Operations - Losses and LAE” and “Critical Accounting Policies” <sup>p. 12</sup>. |
|||
* Operational processes and controls are designed to identify, assess, and manage key risks continuously. |
|||
====== Investments ====== |
|||
* The Underwriting Committee oversees changes in risk appetite, [[Definition:Business mix|product line]], and division expansion. |
|||
* Claims handling practices are monitored against guidelines through regular internal audits. |
|||
* Monthly large loss reviews are conducted within Claims. |
|||
* A watchlist of potential high-severity claims is maintained and monitored within Claims. |
|||
* Quarterly reserve studies are performed by Actuarial. |
|||
* The Reserve Committee meets quarterly to review and respond to trends in loss emergence. |
|||
* Key observations from reserve studies are discussed with the CEO. |
|||
* Underwriting divisions assess rate change and retention on existing business, new business quality, pricing adequacy, and loss emergence versus expectations on a monthly and quarterly basis. |
|||
* The SkyBI platform provides real-time portfolio, underwriting, claims, and actuarial analytics to support these processes. |
|||
* ERM is central to decision-making and day-to-day activities. |
|||
* ERM is a core component of the strategy to achieve market-leading risk-adjusted returns for shareholders and foster a culture of accountability, transparency, and sound judgment. |
|||
=== Reserves === |
|||
* The company aims to maintain a balanced investment portfolio primarily consisting of investments that provide predictable and stable returns, complemented by strategic investments for attractive risk-adjusted returns <sup>p. 13</sup>. |
|||
* An Enterprise Based Asset Allocation model is used for the company's investment allocation strategy <sup>p. 13</sup>. |
|||
* This model is integrated into the Economic Capital Model, allowing the company to assess the impact of investment allocation decisions on capital, liquidity, and risk profile across various market scenarios <sup>p. 13</sup>. |
|||
* The company actively manages and monitors investment risk to balance stable growth and liquidity with compliance to insurance regulatory and rating agency frameworks <sup>p. 13</sup>. |
|||
* The investment portfolio mainly consists of cash and cash equivalents and investment-grade fixed-maturity securities, with additional investments fitting the company's risk appetite <sup>p. 13</sup>. |
|||
* The Investment Committee of the Board of Directors reviews and approves the company's investment policy and strategy <sup>p. 13</sup>. |
|||
* This committee meets quarterly to review investment activities, tactics, and new investment opportunities <sup>p. 13</sup>. |
|||
* The portfolio is managed both internally and by selected third-party investment management firms <sup>p. 13</sup>. |
|||
* Additional discussion on investments and related market risks can be found in Item 7 of this Form 10-K, "Management’s Discussion and Analysis of Financial Condition and Results of Operations—Investments" <sup>p. 13</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=30|p=8}} |
|||
====== Competition ====== |
|||
'''Reserve management and methodology''' |
|||
* Reserves are maintained for specific claims incurred and reported, IBNR reserves, and reserves for uncollectible reinsurance. |
|||
* The specialty lines property & casualty insurance market includes many distinct markets and sub-markets, each with unique customer needs, products, services, and economic/structural features <sup>p. 14</sup>. |
|||
* Ultimate liability may differ from current reserves, and there is a risk of inadequate reserves in the insurance industry. |
|||
* Competition in underwriting divisions comes from other specialty and standard insurers, as well as program administrators <sup>p. 14</sup>. |
|||
* Reserves are continually monitored using new information on reported claims and statistical analyses. |
|||
* Competition factors include pricing, general reputation, perceived financial strength, broker relationships, product terms and conditions, independent rating agency ratings, speed and reputation of claims payment, and the experience/reputation of underwriting and claims teams <sup>p. 14</sup>. |
|||
* Anticipated inflation is implicitly reflected in the reserving process through cost trend analysis and historical development review. |
|||
* Due to the diversity of underwriting divisions, competition is broad, with some competitors specific to certain divisions <sup>p. 14</sup>. |
|||
* Reserves for losses and LAE are not discounted to reflect estimated present value. |
|||
* Notable competitors include Markel Corporation, W.R. Berkley Corporation, American Financial Group Inc., Tokio Marine Holdings, Inc., CNA Financial Corporation, Hiscox, Ltd., RLI Corp., Intact Finance Corporation, Kinsale Capital Group, Inc., Arch Capital Group, and AXIS Capital Holdings, Ltd. <sup>p. 14</sup>. |
|||
* Case reserves are established when a claim is reported, based on estimated ultimate payment after assessing coverage, damages, and investigation. |
|||
* Estimates for case reserves are based on reserving practices and the claims adjuster's experience and knowledge. |
|||
* Case reserves are revised periodically based on subsequent developments. |
|||
* IBNR reserves are established for estimated future loss payments on incurred but not yet reported claims and potential development on reported claims. |
|||
* IBNR reserves are estimated using generally accepted actuarial reserving techniques, considering quantitative loss experience data and qualitative factors. |
|||
* Loss reserves are regularly reviewed using various actuarial techniques. |
|||
* Reserve estimates are updated as historical loss experience develops, additional claims are reported/settled, and new information becomes available. |
|||
* Reserves can be increased or decreased over time as claims move towards settlement, impacting earnings through adverse development or reserve releases. |
|||
* Additional information on loss reserves is available in Item 7 of Form 10-K, "Management’s Discussion and Analysis of Financial Condition and Results of Operations - “Results of Operations - Losses and LAE” and “Critical Accounting Policies”. |
|||
=== Investments === |
|||
{{chunk|doc=3z7a4yrxkn|c=31|p=8}} |
|||
* Operations are conducted principally through four insurance companies <sup>p. 15</sup>. |
|||
'''Investment portfolio strategy and oversight''' |
|||
* ''Great Midwest Insurance Company (GMIC)'' is the largest insurance subsidiary, underwriting multiple lines on an admitted basis in all 50 states and the District of Columbia <sup>p. 15</sup>. |
|||
* GMIC is a certified surety bond company listed with the Department of the Treasury <sup>p. 15</sup>. |
|||
* ''Houston Specialty Company (HSIC)'', a subsidiary of GMIC, underwrites multiple lines on a surplus lines basis in 50 states, the District of Columbia, and select foreign countries <sup>p. 15</sup>. |
|||
* ''Imperium Insurance Company (IIC)'', a subsidiary of HSIC, underwrites on an admitted basis in all 50 states and the District of Columbia <sup>p. 15</sup>. |
|||
* ''Oklahoma Specialty Insurance Company (OSIC)'', a subsidiary of IIC, is an approved surplus lines company in 49 states and the District of Columbia <sup>p. 15</sup>. |
|||
* Effective December 31, 2024, the insurance company subsidiaries were restacked into the current organizational structure <sup>p. 15</sup>. |
|||
* This restacking provided the growing surety business with the capital needed to operate more effectively within the surety T-listing market <sup>p. 15</sup>. |
|||
* ''Skyward Re'' is a wholly-owned captive reinsurance company domiciled in the Cayman Islands, incorporated on January 7, 2020 <sup>p. 15</sup>. |
|||
* Skyward Re was established to facilitate the LPT, which was commuted effective January 31, 2025 <sup>p. 15</sup>. |
|||
* Three non-insurance companies are also operated: Skyward Underwriters Agency, Inc., Skyward Service Company, and Skyward Specialty No. 1 Limited Company <sup>p. 15</sup>. |
|||
* ''Skyward Underwriters Agency, Inc.'' is a licensed agent, managing general agent, and reinsurance broker <sup>p. 15</sup>. |
|||
* ''Skyward Service Company'' provides various administrative services to subsidiaries <sup>p. 15</sup>. |
|||
* ''Skyward Specialty No. 1 Limited Company'' is a UK company and an authorized Lloyd’s corporate member <sup>p. 15</sup>. |
|||
* The organizational structure at December 31, 2025, shows each entity is wholly-owned by its immediate parent <sup>p. 15</sup>. |
|||
* ''SKYWARD SPECIALTY INSURANCE GROUP, INC.'' (Delaware corporation) is the top entity <sup>p. 15</sup>. |
|||
* Direct subsidiaries of SKYWARD SPECIALTY INSURANCE GROUP, INC. include: SKYWARD SERVICE COMPANY (Delaware corporation), GREAT MIDWEST INSURANCE COMPANY (Texas stock insurance company), SKYWARD UNDERWRITERS AGENCY, INC. (Texas corporation), SKYWARD SPECIALTY NO. 1 LIMITED (United Kingdom company), and SKYWARD RE (Cayman Islands corporation) <sup>p. 15</sup>. |
|||
* ''GREAT MIDWEST INSURANCE COMPANY'' (Texas stock insurance company) has HOUSTON SPECIALTY INSURANCE COMPANY (Texas stock insurance company) as its direct subsidiary <sup>p. 15</sup>. |
|||
* ''HOUSTON SPECIALTY INSURANCE COMPANY'' (Texas stock insurance company) has IMPERIUM INSURANCE COMPANY (Texas stock insurance company) as its direct subsidiary <sup>p. 15</sup>. |
|||
* ''IMPERIUM INSURANCE COMPANY'' (Texas stock insurance company) has OKLAHOMA SPECIALTY INSURANCE COMPANY (Oklahoma insurance corporation) as its direct subsidiary <sup>p. 15</sup>. |
|||
* The company aims to maintain a balanced investment portfolio with predictable and stable returns, augmented by strategic investments for attractive risk-adjusted returns. |
|||
====== Direct subsidiaries by state ====== |
|||
* An Enterprise Based Asset Allocation model is used for investment allocation strategy, embedded in the Economic Capital Model, to understand the impact of decisions on capital, liquidity, and risk profile across market scenarios. |
|||
* Investment risk is actively managed and monitored to balance stable growth and liquidity with compliance to insurance regulatory and rating agency frameworks. |
|||
* The portfolio primarily consists of cash and cash equivalents and investment-grade fixed-maturity securities, supplemented by additional investments within risk appetite. |
|||
* The Investment Committee of the Board of Directors reviews and approves the investment policy and strategy. |
|||
* The Investment Committee meets quarterly to review investment activities, tactics, and new investment opportunities. |
|||
* The portfolio is directed internally and includes both self-managed investments and portfolios managed by select third-party investment management firms. |
|||
{{chunk|doc=3z7a4yrxkn|c=32|p=8}} |
|||
'''Investment discussion reference''' |
|||
* Additional discussion on investments, including market risks, is available in Item 7 of Form 10-K, "Management’s Discussion and Analysis of Financial Condition and Results of Operations—Investments". |
|||
=== Competition === |
|||
{{chunk|doc=3z7a4yrxkn|c=33|p=8}} |
|||
'''Competition factors and competitors''' |
|||
* The specialty lines [[Definition:Property & casualty|property & casualty]] insurance market has many markets and sub-markets, each with distinct customer needs, products/services, and economic/structural features. |
|||
* Competition in underwriting divisions comes from other specialty and standard insurers, and program administrators. |
|||
* Competition is based on pricing, general reputation, perceived financial strength, broker relationships, product terms and conditions, independent rating agency ratings, speed and reputation of claims payment, and experience/reputation of underwriting and claims teams. |
|||
* Due to the diversity of underwriting divisions, competition is broad, with some competitors specific to only a subset of divisions. |
|||
* Notable competitors include: Markel Corporation; W.R. Berkley Corporation; American Financial Group Inc.; Tokio Marine Holdings, Inc.; CNA Financial Corporation; Hiscox, Ltd.; RLI Corp.; Intact Finance Corporation; Kinsale Capital Group, Inc; Arch Capital Group; and AXIS Capital Holdings, Ltd.. |
|||
=== Our Structure === |
|||
{{chunk|doc=3z7a4yrxkn|c=34|p=8}} |
|||
'''Our Structure''' |
|||
* Operations are conducted principally through four insurance companies. |
|||
* Great Midwest Insurance Company (GMIC) is the largest insurance subsidiary, underwriting multiple lines on an admitted basis in all 50 states and the District of Columbia, and is a certified surety bond company listed with the Department of the Treasury. |
|||
* Houston Specialty Company (HSIC), a GMIC subsidiary, underwrites multiple lines on a surplus lines basis in 50 states, the District of Columbia, and select foreign countries. |
|||
* Imperium Insurance Company (IIC), an HSIC subsidiary, underwrites on an admitted basis in all 50 states and the District of Columbia. |
|||
* Oklahoma Specialty Insurance Company (OSIC), an IIC subsidiary, is an approved surplus lines company in 49 states and the District of Columbia. |
|||
* Effective December 31, 2024, the insurance company subsidiaries were restacked into this organizational structure to provide capital for the growing surety business to operate more effectively within the surety T-listing market. |
|||
* Skyward Re is a wholly-owned captive reinsurance company domiciled in the Cayman Islands, incorporated on January 7, 2020. |
|||
* Skyward Re was established to facilitate the LPT, which was commuted effective January 31, 2025. |
|||
* Three non-insurance companies are operated: Skyward Underwriters Agency, Inc. (a licensed agent, managing general agent, and reinsurance broker), Skyward Service Company (provides administrative services to subsidiaries), and Skyward Specialty No. 1 Limited Company (a UK company and authorized Lloyd's corporate member). |
|||
* The organizational structure at December 31, 2025, shows each entity is wholly-owned by its immediate parent. |
|||
{{chunk|doc=3z7a4yrxkn|c=35|p=8}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1003" class="wikitable fintable" |
||
|+ Our Structure |
|||
! style="text-align:left" | — |
|||
|- |
|||
! style="text-align:left" | |
|||
! class="col-s" style="text-align:right" | 2025 |
! class="col-s" style="text-align:right" | 2025 |
||
|- |
|- |
||
| Line 751: | Line 875: | ||
| style="text-align:right" | 39.9 |
| style="text-align:right" | 39.9 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total |
||
| style="text-align:right" | |
| style="text-align:right" | 100.0% |
||
|} |
|} |
||
</div> |
</div> |
||
{{chunk|doc=3z7a4yrxkn|c=36|p=8}} |
|||
'''Our Structure''' |
|||
[[File:Skyward-2025-FY-Annual report-skwd-20251231_g1.jpg|thumb|Our Structure]] |
[[File:Skyward-2025-FY-Annual report-skwd-20251231_g1.jpg|thumb|Our Structure]] |
||
Chart / Image: |
|||
* SKYWARD SPECIALTY INSURANCE GROUP, INC. is a Delaware corporation. |
|||
* SKYWARD SPECIALTY INSURANCE GROUP, INC. has a subsidiary named SKYWARD SERVICE COMPANY. |
|||
* SKYWARD SERVICE COMPANY is a Delaware corporation. |
|||
* SKYWARD SPECIALTY INSURANCE GROUP, INC. has a subsidiary named GREAT MIDWEST INSURANCE COMPANY. |
|||
* GREAT MIDWEST INSURANCE COMPANY is a Texas stock insurance company. |
|||
* SKYWARD SPECIALTY INSURANCE GROUP, INC. has a subsidiary named SKYWARD UNDERWRITERS AGENCY, INC. |
|||
* SKYWARD UNDERWRITERS AGENCY, INC. is a Texas corporation. |
|||
* SKYWARD SPECIALTY INSURANCE GROUP, INC. has a subsidiary named SKYWARD SPECIALTY NO. 1 LIMITED. |
|||
* SKYWARD SPECIALTY NO. 1 LIMITED is a United Kingdom company. |
|||
* SKYWARD SPECIALTY INSURANCE GROUP, INC. has a subsidiary named SKYWARD RE. |
|||
* SKYWARD RE is a Cayman Islands corporation. |
|||
* GREAT MIDWEST INSURANCE COMPANY has a subsidiary named HOUSTON SPECIALTY INSURANCE COMPANY. |
|||
* HOUSTON SPECIALTY INSURANCE COMPANY is a Texas stock insurance company. |
|||
* HOUSTON SPECIALTY INSURANCE COMPANY has a subsidiary named IMPERIUM INSURANCE COMPANY. |
|||
* IMPERIUM INSURANCE COMPANY is a Texas stock insurance company. |
|||
* IMPERIUM INSURANCE COMPANY has a subsidiary named OKLAHOMA SPECIALTY INSURANCE COMPANY. |
|||
* OKLAHOMA SPECIALTY INSURANCE COMPANY is an Oklahoma insurance corporation. |
|||
=== Ratings === |
|||
{{chunk|doc=3z7a4yrxkn|c=37|p=8}} |
|||
* Skyward Specialty Insurance Group, Inc. holds an "A" (Excellent) rating with a stable outlook from A.M. Best <sup>p. 16</sup>. |
|||
'''A.M. Best rating''' |
|||
* A.M. Best rates insurance companies based on factors relevant to policyholders <sup>p. 16</sup>. |
|||
* A.M. Best assigns 13 ratings to insurance companies, ranging from "A++" (Superior) to "D" (Poor) <sup>p. 16</sup>. |
|||
* The "A" (Excellent) rating is the third highest rating assigned by A.M. Best <sup>p. 16</sup>. |
|||
* A.M. Best evaluates a company's financial and operating performance by reviewing profitability, leverage, liquidity, book of business, reinsurance adequacy and soundness, quality and estimated market value of assets, adequacy of losses and loss expense reserves, surplus adequacy, capital structure, management experience and competence, and market presence <sup>p. 16</sup>. |
|||
* A.M. Best's ratings reflect its opinion on an insurance company’s financial strength, operating performance, and ability to meet obligations to policyholders <sup>p. 16</sup>. |
|||
* These ratings are based on factors relevant to policyholders, agents, insurance brokers, and intermediaries, and are not specifically related to securities issued by the company <sup>p. 16</sup>. |
|||
* Skyward Specialty Insurance Group, Inc. has an "A" (Excellent) rating with a stable outlook from A.M. Best. |
|||
====== Regulation ====== |
|||
* The "A" (Excellent) rating is the third highest among the 13 ratings assigned by A.M. Best, which range from "A++" (Superior) to "D" (Poor). |
|||
* A.M. Best evaluates insurance companies based on profitability, leverage, liquidity, book of business, reinsurance adequacy, asset quality and market value, loss and loss expense reserves adequacy, surplus adequacy, capital structure, management experience and competence, and market presence. |
|||
* A.M. Best ratings reflect its opinion on an insurance company’s financial strength, operating performance, and ability to meet policyholder obligations. |
|||
* These ratings are relevant to policyholders, agents, insurance brokers, and intermediaries, and are not specifically related to securities issued by the company. |
|||
=== Regulation === |
|||
* The company is regulated by insurance regulatory authorities in the states where it conducts business <sup>p. 17</sup>. |
|||
* State insurance laws and regulations are primarily designed to protect policyholders, consumers, and claimants, not stockholders or other investors <sup>p. 17</sup>. |
|||
* State regulation varies by jurisdiction and typically grants broad administrative power to regulators over matters such as capital and surplus requirements, licensing, product form and rate review, reserve adequacy standards, statutory accounting methods, financial report content, affiliate transactions, and investment types and amounts <sup>p. 17</sup>. |
|||
* Insurance company regulation is constantly changing due to governmental agency and legislative reactions to perceived issues <sup>p. 17</sup>. |
|||
* Some state legislatures have considered or enacted laws that increase state authority to regulate insurance companies and holding company systems to prevent federal involvement <sup>p. 17</sup>. |
|||
* The National Association of Insurance Commissioners (NAIC) and some state insurance regulators are re-examining existing laws and regulations, focusing on insurer solvency, interpretations of current laws, and development of new laws <sup>p. 17</sup>. |
|||
* The federal government does not directly regulate insurance, but federal initiatives can affect the industry through treatment of federal subsidiaries, regulation of quasi-governmental entities, and regulations from federal departments <sup>p. 17</sup>. |
|||
* The company operates as an insurance holding company system <sup>p. 17</sup>. |
|||
* The company is subject to insurance holding company laws in Texas, where its primary insurance companies are domiciled, and Oklahoma <sup>p. 17</sup>. |
|||
* These statutes require each insurance company in the system to register with its state of domicile's insurance department <sup>p. 17</sup>. |
|||
* Registered companies must provide information on operations within the holding company system that could materially affect the operations, management, or financial condition of domiciled insurers <sup>p. 17</sup>. |
|||
* All transactions among members of a holding company system must be fair and reasonable <sup>p. 17</sup>. |
|||
* Transactions between insurance subsidiaries and their parents/affiliates generally require disclosure to state regulators <sup>p. 17</sup>. |
|||
* Notice to or prior approval from the applicable state insurance regulator is generally required for any material or extraordinary transaction <sup>p. 17</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=38|p=8}} |
|||
====== Intellectual Property ====== |
|||
'''Regulation''' |
|||
* The company |
* The company is regulated by insurance regulatory authorities in the states where it conducts business. |
||
* State insurance laws and regulations primarily protect policyholders, consumers, and claimants, not stockholders or investors. |
|||
* The company will pursue additional ''trademark registrations'' and other intellectual property protection if deemed beneficial and cost-effective <sup>p. 18</sup>. |
|||
* State regulation varies by jurisdiction, with regulators having broad administrative power over capital and surplus requirements, licensing, product form and rate review/approval, reserve adequacy standards, statutory accounting methods, financial reporting, affiliate transactions, and investment types/amounts. |
|||
* The company monitors its ''trademarks and service marks'' and protects them from unauthorized use as necessary <sup>p. 18</sup>. |
|||
* Insurance company regulation is constantly changing due to governmental agencies and legislatures reacting to issues. |
|||
* Some state legislatures have considered or enacted laws that alter and often increase state authority to regulate insurance companies and holding company systems, partly to prevent federal involvement. |
|||
* The National Association of Insurance Commissioners (NAIC) and some state insurance regulators are re-examining existing laws and regulations, focusing on insurer solvency, interpretations of current laws, and development of new laws. |
|||
* The federal government does not directly regulate insurance but federal initiatives can affect the industry through treatment of federal subsidiaries, regulation of quasi-governmental entities, and regulations from federal departments. |
|||
* The company operates as an insurance holding company system and is subject to insurance holding company laws in Texas (where primary insurance companies are domiciled) and Oklahoma. |
|||
* These statutes require each insurance company in the system to register with its state of domicile's insurance department and provide information on operations within the holding company system that could materially affect the operations, management, or financial condition of domiciled insurers. |
|||
* All transactions among holding company system members must be fair and reasonable. |
|||
* Transactions between insurance subsidiaries and their parents/affiliates generally require disclosure to state regulators, and material or extraordinary transactions typically need notice to or prior approval from the applicable state insurance regulator. |
|||
=== Intellectual Property === |
|||
====== Employees and Human Capital ====== |
|||
{{chunk|doc=3z7a4yrxkn|c=39|p=8}} |
|||
* ''Employees'': approximately 611 as of December 31, 2025 <sup>p. 19</sup>. |
|||
'''Trademark registrations and protection''' |
|||
* Employees are not subject to any collective bargaining agreement, and there are no known current efforts to implement one <sup>p. 19</sup>. |
|||
* The company believes it has good working relations with its employees <sup>p. 19</sup>. |
|||
* The company |
* The company has applied for various trademark registrations in the United States at both federal and state levels. |
||
* The company will pursue additional trademark registrations and other intellectual property protection if deemed beneficial and cost-effective. |
|||
* The company strives to create a culture that fosters diversity of thought, background, and perspective <sup>p. 19</sup>. |
|||
* The company monitors its trademarks and service marks and protects them from unauthorized use as necessary. |
|||
* The company cultivates an exceptional workforce to perpetuate its ownership culture and achieve superior business results <sup>p. 19</sup>. |
|||
* The company's goal is to attract, develop, and retain diverse talent, promoting a culture where different viewpoints are valued, and individuals feel respected, treated fairly, and have opportunities to excel <sup>p. 19</sup>. |
|||
=== Employees and Human Capital === |
|||
* The company offers a competitive benefits package to support employee well-being, including medical, dental, and vision insurance, a 401(k) plan, paid time off, family leave, employee assistance programs, and an employee stock purchase plan <sup>p. 19</sup>. |
|||
* The company emphasizes employee training and development, providing opportunities for further education and professional development <sup>p. 19</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=40|p=8}} |
|||
'''Employee overview and culture''' |
|||
* The company had approximately 611 employees as of December 31, 2025. |
|||
* Employees are not subject to any collective bargaining agreement, and no current efforts to implement one are known. |
|||
* The company believes it has good working relations with its employees. |
|||
* The company aims to be an employer of choice, including outside of insurance. |
|||
* The company strives to create a culture fostering diversity of thought, background, and perspective. |
|||
* The company cultivates an exceptional workforce to perpetuate its ownership culture and achieve superior business results. |
|||
* The goal is to attract, develop, and retain diverse talent, promoting a culture where different viewpoints are valued, and individuals feel respected, treated fairly, and have opportunities to excel. |
|||
{{chunk|doc=3z7a4yrxkn|c=41|p=8}} |
|||
'''Employee compensation and benefits''' |
|||
* The company offers and maintains a competitive benefits package to support employee well-being. |
|||
* Benefits include medical, dental, and vision insurance, a 401(k) plan, paid time off, family leave, and employee assistance programs. |
|||
* An employee stock purchase plan is available to all employees. |
|||
* The company emphasizes employee training and development, providing opportunities for further education and professional development. |
|||
== Risk Factors == |
== Risk Factors == |
||
{{chunk|doc=3z7a4yrxkn|c=42|p=9}} |
|||
* Investing in the company's common stock involves a high degree of risk <sup>p. 20</sup>. |
|||
'''investment risk disclosure''' |
|||
* Investors should carefully consider the risks and uncertainties described in the report, including consolidated financial statements and related notes, and other SEC filings, before investing in common stock <sup>p. 20</sup>. |
|||
* The described risks and uncertainties are not exhaustive; additional unstated, unknown, or currently immaterial risks may also become significant factors <sup>p. 20</sup>. |
|||
* If any of the identified risks occur, the company's business, operating results, financial condition, and prospects could be materially harmed <sup>p. 20</sup>. |
|||
* Such events could lead to a decline in the price of the common stock, potentially resulting in a loss of part or all of an investment <sup>p. 20</sup>. |
|||
* Investing in the common stock involves a high degree of risk. |
|||
====== Summary of Material Risk Factors ====== |
|||
* Investors should carefully consider the risks and uncertainties described in the report, consolidated financial statements, related notes, and other SEC filings before investing. |
|||
* The described risks are not exhaustive; additional unstated, unknown, or currently immaterial risks may also affect the company. |
|||
* If any identified risk occurs, the business, operating results, financial condition, and prospects could be materially harmed, potentially leading to a decline in common stock price and loss of investment. |
|||
=== Summary of Material Risk Factors === |
|||
* ''Financial condition and results of operations'' could be materially adversely affected if underwriting risk is not accurately assessed <sup>p. 21</sup>. |
|||
* ''Competition'' in the industry is intense <sup>p. 21</sup>. |
|||
* ''Reliance on distribution channels'' (insurance retail agents and brokers, wholesalers, program administrators) exposes the business to risks that could adversely affect results <sup>p. 21</sup>. |
|||
* ''Inability to purchase third-party reinsurance'' on desired or commercially acceptable terms could materially adversely affect the business, financial condition, and results of operations <sup>p. 21</sup>. |
|||
* ''Inadequate losses and loss expense reserves'' could materially adversely affect financial condition, results of operations, and cash flows <sup>p. 21</sup>. |
|||
* ''Decline in financial strength rating'' may adversely affect the amount of business written <sup>p. 21</sup>. |
|||
* ''Unexpected changes in interpretation of coverage or provisions'' (including loss limitations and exclusions) in policies could materially adversely affect financial condition and results of operations <sup>p. 21</sup>. |
|||
* ''Reinsurers may not reimburse claims'' on a timely basis or at all, which may materially adversely affect the business, financial condition, and results of operations <sup>p. 21</sup>. |
|||
* ''Failure to accurately and timely pay claims'' could materially and adversely affect the business, financial condition, results of operations, and prospects <sup>p. 21</sup>. |
|||
* ''Adverse economic factors'' (recession, inflation, high unemployment, lower economic activity) could lead to fewer policy sales, increased claim frequency, premium defaults, or falsification of claims, impacting growth and profitability <sup>p. 21</sup>. |
|||
* ''Cyclical nature of the insurance business'' may affect financial performance and cause operating results to vary quarterly, not indicative of future performance <sup>p. 21</sup>. |
|||
* ''Extensive regulation'' may adversely affect the ability to achieve business objectives; non-compliance could result in penalties (fines, suspensions) affecting financial condition and results of operations <sup>p. 21</sup>. |
|||
* ''Loss of key personnel'' or inability to attract and retain qualified personnel could adversely affect the company <sup>p. 21</sup>. |
|||
* ''Failure to achieve and maintain effective internal controls'' could impact operating results and financial condition, and negatively affect the market price of common stock <sup>p. 21</sup>. |
|||
* ''Costs will increase significantly'' due to operating as a public company, requiring substantial management time for compliance with public company regulations <sup>p. 21</sup>. |
|||
* ''Use of derivatives'' to mitigate market price volatility exposure may subject the company to risks such as hedge ineffectiveness, basis risk, collateral and margin call liquidity pressures, and valuation uncertainty, which could adversely affect financial condition <sup>p. 21</sup>. |
|||
* ''Integration of Apollo'' may present unforeseen challenges, including difficulties with technology systems, business processes, and risk management frameworks, potentially leading to operational disruptions, increased costs, or delays in realizing anticipated strategic benefits <sup>p. 21</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=43|p=9}} |
|||
====== Risks Related to Our Business and Industry ====== |
|||
'''General business risks''' |
|||
* The business is subject to numerous risks and uncertainties. |
|||
* ''Underwriting success'' depends on accurately assessing risks and establishing appropriate premium rates <sup>p. 22</sup>. |
|||
* Financial condition and results of operations could be materially adversely affected by inaccurate assessment of underwriting risk. |
|||
* ''Employee decisions'', including management and underwriters, expose the company to risk <sup>p. 22</sup>. |
|||
* Competition in the industry is intense. |
|||
* ''Competition'' in the insurance industry is intense, based on factors like price, reputation, financial strength, distribution relationships, product terms, ratings, claims payment speed, and underwriting team experience <sup>p. 22</sup>. |
|||
* Reliance on insurance retail agents and brokers, wholesalers, and program administrators exposes the business to certain risks that could adversely affect results. |
|||
* ''Industry consolidation'' and new legislative developments could increase competition <sup>p. 22</sup>. |
|||
* ''Increased competition'' may affect the ability to price products, retain existing business, or underwrite new business on favorable terms, potentially impacting operating results <sup>p. 22</sup>. |
|||
* ''Reliance on distribution channels'' (retail agents, brokers, wholesalers, program administrators) exposes the company to risks <sup>p. 22</sup>. |
|||
* ''Distribution through independent retail agents and brokers'' means the company's business model depends on these relationships, as agents and brokers generally own "renewal rights" <sup>p. 22</sup>. |
|||
* ''Relationships with distributors'' can be discontinued or become unprofitable <sup>p. 22</sup>. |
|||
* ''Consolidation of insurance distribution firms'' may increase their influence on commission rates and concentrate business with particular brokers <sup>p. 22</sup>. |
|||
* ''Credit risk'' is assumed when brokers collect premiums directly from policyholders, as payment to the broker may be considered payment to the insurer in certain jurisdictions, even if the company does not receive the premium <sup>p. 22</sup>. |
|||
* ''Failure of brokers to remit premiums'' could require the company to provide coverage despite non-payment, potentially declining underwriting profits and adversely affecting financial condition <sup>p. 22</sup>. |
|||
* ''Review of financial condition'' for new brokers and periodic review of existing distributors are conducted to ensure profitability and alignment with business objectives <sup>p. 22</sup>. |
|||
* ''Restrictions or termination of distributor relationships'' may occur if they do not meet profitability standards or business objectives, subject to contractual and regulatory requirements <sup>p. 22</sup>. |
|||
* ''Deterioration of distributor relationships'' or uncompetitive compensation could lead distributors to place more premium with other carriers <sup>p. 22</sup>. |
|||
* ''Distributors exceeding authority'', failing to transfer collected premiums, or breaching obligations could expose the company to liability <sup>p. 22</sup>. |
|||
* ''Continued consolidation of insurance distribution firms'' could affect sales channels through loss of market access, market share, talent, or increased commission costs due to greater negotiating leverage <sup>p. 22</sup>. |
|||
* ''Digitization acceleration'' poses risks related to distributors' ability to keep pace, as customers may prefer technology-driven experiences <sup>p. 22</sup>. |
|||
* ''Inability to purchase third-party reinsurance'' on desired or commercially acceptable terms could materially adversely affect the business <sup>p. 22</sup>. |
|||
* ''Strategic purchase of reinsurance'' protects capital from severity events and reduces earnings volatility <sup>p. 22</sup>. |
|||
* ''Failure to renew or enter new reinsurance arrangements'' on acceptable terms could increase loss exposure, potentially requiring a reduction in underwriting commitments <sup>p. 22</sup>. |
|||
* ''Reinsurers may exclude certain coverages'' or alter terms, creating gaps in reinsurance protection and exposing the company to greater risk and potential losses <sup>p. 22</sup>. |
|||
* ''Inadequate loss and loss expense (LAE) reserves'' could materially adversely affect financial condition, results of operations, and cash flows <sup>p. 22</sup>. |
|||
* ''Reserves are estimates'' of ultimate claim settlement and administration costs, and actual liability may differ <sup>p. 22</sup>. |
|||
* ''Reserving process'' reviews historical data and considers factors such as claims inflation, claims development patterns, pricing, legislative activity, social/economic patterns, and litigation/judicial/regulatory trends <sup>p. 22</sup>. |
|||
* ''Variables affecting loss exposure'' are influenced by internal and external events, requiring continuous monitoring of loss reserves using new information and statistical techniques <sup>p. 22</sup>. |
|||
* ''Uncertainties impacting reserve adequacy'' include: |
|||
** Time required to fully assess covered losses, leading to potential increases in loss estimates and inadequate reserves <sup>p. 22</sup>. |
|||
** Retroactive enforcement of new theories of liability by courts, potentially nullifying loss limitations or exclusions <sup>p. 22</sup>. |
|||
** Volatility in financial markets, economic events, and inflation increasing claim frequency/severity and loss costs <sup>p. 22</sup>. |
|||
** "Social inflation" (e.g., increased medical/material costs, attorney involvement, litigation financing) increasing claim frequency/severity and affecting reserve adequacy <sup>p. 22</sup>. |
|||
** Increased claim frequency, even without liability, escalating evaluation and handling costs beyond established reserves <sup>p. 22</sup>. |
|||
* ''Inadequate reserves'' would require increases, reducing net income and stockholders' equity in the period identified <sup>p. 22</sup>. |
|||
* ''Future loss experience'' substantially exceeding reserves could materially adversely affect future earnings, liquidity, and financial rating <sup>p. 22</sup>. |
|||
* ''Decline in financial strength rating'' may adversely affect the amount of business written <sup>p. 22</sup>. |
|||
* ''A.M. Best financial strength rating'' is "A" (Excellent) with a stable outlook as of the filing date <sup>p. 22</sup>. |
|||
* ''A.M. Best ratings'' are an independent opinion of an insurer's ability to meet policyholder obligations, not an evaluation for investors <sup>p. 22</sup>. |
|||
* ''Factors that could lead to a rating downgrade'' by A.M. Best include: |
|||
** Changes in business practices from the organizational plan that no longer support the rating <sup>p. 22</sup>. |
|||
** Unfavorable financial, regulatory, or market trends, including excess market capacity <sup>p. 22</sup>. |
|||
** Losses exceeding loss reserves <sup>p. 22</sup>. |
|||
** Unresolved issues with government regulators <sup>p. 22</sup>. |
|||
** Inability to retain senior management or other key personnel <sup>p. 22</sup>. |
|||
** Significant investment portfolio losses or limited liquidity <sup>p. 22</sup>. |
|||
** Alterations in A.M. Best's capital adequacy assessment methodology that adversely affect the rating <sup>p. 22</sup>. |
|||
* ''A rating downgrade or withdrawal'' could cause distribution partners and insureds to choose competitors, increase reinsurance costs or reduce availability, or limit/prevent writing new and renewal insurance contracts <sup>p. 22</sup>. |
|||
* ''Increased scrutiny by rating organizations'' due to financial pressures on institutions could lead to adverse ratings consequences <sup>p. 22</sup>. |
|||
* ''Unexpected changes in interpretation of coverage'' or policy provisions (including loss limitations and exclusions) could materially adversely affect financial condition and results of operations <sup>p. 22</sup>. |
|||
* ''Enforceability of loss limitations or exclusions'' is not assured, as industry practices and legal/judicial/social conditions change <sup>p. 22</sup>. |
|||
* ''Courts or regulatory authorities'' could nullify limitations/exclusions, or legislation could modify/bar their use, leading to higher than anticipated losses and LAE <sup>p. 22</sup>. |
|||
* ''Court decisions'' may interpret policy exclusions narrowly, expanding coverage and requiring new exclusions <sup>p. 22</sup>. |
|||
* ''These issues'' could broaden coverage beyond underwriting intent or increase claim frequency/severity, with the full extent of liability potentially unknown for years <sup>p. 22</sup>. |
|||
* ''Reinsurers may not reimburse claims timely or at all'', materially adversely affecting business, financial condition, and results of operations <sup>p. 22</sup>. |
|||
* ''Reinsurance contracts'' require premium payments to reinsurers who reimburse for covered policy claims, but the company remains primarily liable to policyholders <sup>p. 22</sup>. |
|||
* ''Reinsurers may default'' due to insolvency, lack of liquidity, operational failure, prohibitions, fraud, or disputes over agreement wordings, leading to increased net losses <sup>p. 22</sup>. |
|||
* ''Reinsurance recoverables'' totaled USD 1,119.9m as of December 31, 2025 <sup>p. 22</sup>. |
|||
* ''Failure to accurately and timely pay claims'' could materially and adversely affect business, financial condition, results of operations, and prospects <sup>p. 22</sup>. |
|||
* ''Factors affecting claims payment'' include training/experience of claims representatives (including TPAs), management effectiveness, and appropriate procedures/systems <sup>p. 22</sup>. |
|||
* ''Ineffective TPA management'' or inability of staff/TPAs to handle claim volume could adversely affect workload capacity, potentially slowing growth and decreasing claims work quality <sup>p. 22</sup>. |
|||
* ''Severe weather conditions'', climate change effects, catastrophes, pandemics, and man-made events may adversely affect business <sup>p. 22</sup>. |
|||
* ''Catastrophes'' include natural events (e.g., severe winter weather, storms, earthquakes, fires) and man-made events (e.g., explosions, war, terrorist attacks) <sup>p. 22</sup>. |
|||
* ''Changing weather patterns and climatic conditions'' increase unpredictability and frequency of natural disasters, including in new areas and existing markets <sup>p. 22</sup>. |
|||
* ''Climate change'' may increase frequency and severity of extreme weather events, such as hurricanes and wildfires <sup>p. 22</sup>. |
|||
* ''Catastrophe losses'' can materially adversely affect business, even for events not directly insured against (e.g., 2025 California wildfires), as affected businesses may cancel policies <sup>p. 22</sup>. |
|||
* ''Increased frequency and severity of weather events'' could impact the ability to predict, quantify, reinsure, and manage catastrophe risk, increasing losses <sup>p. 22</sup>. |
|||
* ''Extent of losses from catastrophes'' depends on frequency/severity of insured events and total insured exposure in affected areas <sup>p. 22</sup>. |
|||
* ''Unpredictability of catastrophes'' and severe weather conditions <sup>p. 22</sup>. |
|||
* ''Exposure to losses is managed'' by analyzing probability and severity of loss events and their impact on underwriting/investment portfolios <sup>p. 22</sup>. |
|||
* ''Indirect impact from catastrophes'' can occur if insured businesses are affected, leading to inability or unwillingness to pay premiums on other product offerings <sup>p. 22</sup>. |
|||
* ''Inability to obtain reinsurance coverage'' at reasonable rates for severe weather and catastrophes could materially adversely affect business <sup>p. 22</sup>. |
|||
* ''Exposure to risk from pandemics, outbreaks, public health crises, and geopolitical/social events'' <sup>p. 22</sup>. |
|||
* ''Policy terms and conditions'' are expected to preclude coverage for virus-related claims, but court decisions and governmental actions may challenge exclusions <sup>p. 22</sup>. |
|||
* ''Changes in climate policy programs'' and legislation could have a material adverse effect on business <sup>p. 22</sup>. |
|||
* ''Program administrators with quoting and binding authority'' pose a risk if they fail to comply with guidelines, potentially binding the company to unanticipated risks <sup>p. 22</sup>. |
|||
* ''Marketing and distribution of insurance products'' through program administrators who sell to insureds via retail agents and brokers <sup>p. 22</sup>. |
|||
* ''Failure of program administrators'' to comply with underwriting guidelines could adversely affect operating results <sup>p. 22</sup>. |
|||
* ''Failure of actual renewals or new business from repeat insureds'' to meet expectations could materially adversely affect written premium and future operating results <sup>p. 22</sup>. |
|||
* ''Most contracts are one-year term and renewable''; some insureds are repeat customers with new contracts <sup>p. 22</sup>. |
|||
* ''Assumptions about renewal rates'' and repeat business are made in financial forecasting <sup>p. 22</sup>. |
|||
* ''Cyclical nature of insurance industry'' with intense price-based competition <sup>p. 22</sup>. |
|||
* ''Increased public attention to ESG matters'' may expose the company to negative public perception, reputational harm, additional costs, or impact stock price <sup>p. 22</sup>. |
|||
* ''Failure to respond to ESG expectations'' or backlash related to ESG topics could harm business and reputation <sup>p. 22</sup>. |
|||
* ''Damage to reputation'' from providing policies to certain insureds could decrease demand for products and require resources to rebuild <sup>p. 22</sup>. |
|||
* ''Changes in accounting practices'' and future pronouncements may materially affect reported financial results <sup>p. 22</sup>. |
|||
* ''Compliance with new accounting practices'' may incur considerable additional expenses, especially for retroactive application or comparative purposes <sup>p. 22</sup>. |
|||
* ''Impact of accounting changes'' on net income, shareholder's equity, and other financial statement line items is unpredictable <sup>p. 22</sup>. |
|||
* ''Insurance subsidiaries must comply with Statutory Accounting Principles (SAP)'', which are subject to constant review by the NAIC and state insurance departments <sup>p. 22</sup>. |
|||
* ''Pending proposals'' before NAIC committees could negatively affect insurance industry participants if enacted <sup>p. 22</sup>. |
|||
* ''Use of derivatives to mitigate market price volatility'' may subject the company to risks such as hedge ineffectiveness, basis risk, collateral/margin call liquidity pressures, and valuation uncertainty <sup>p. 22</sup>. |
|||
* ''Risks from derivatives'' include imperfect correlation between derivatives and underlying exposures, futures prices not moving in line with cash market prices, and liquidity pressures from margin calls during adverse market movements <sup>p. 22</sup>. |
|||
* ''Reliance on market-based models'' introduces valuation uncertainty, potentially causing hedges to perform differently than expected <sup>p. 22</sup>. |
|||
* ''These factors'' may prevent hedging strategies from effectively reducing volatility and could materially adversely impact financial results <sup>p. 22</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=44|p=9}} |
|||
====== Risks Related to the Market and Economic Conditions ====== |
|||
'''Reinsurance and claims risks''' |
|||
* Inability to purchase third-party reinsurance on desired or commercially acceptable terms, or terms that adequately protect the company, may materially adversely affect business, financial condition, and results of operations. |
|||
* Adverse economic factors such as recession, inflation, high unemployment, or lower economic activity could lead to fewer policy sales, increased claim frequency, premium defaults, or claim falsification, impacting growth and profitability <sup>p. 23</sup>. |
|||
* Losses and loss expense reserves may be inadequate to cover actual losses, which could materially adversely affect financial condition, results of operations, and cash flows. |
|||
* ''Economic downturns'' characterized by higher unemployment, declining spending, and reduced corporate revenue generally negatively affect demand for insurance products, impacting premium levels and profitability <sup>p. 23</sup>. |
|||
* Negative economic factors may also affect the ability to charge appropriate rates for risk, reduce the number of policies written, and limit opportunities for profitable underwriting <sup>p. 23</sup>. |
|||
* During an economic downturn, customers may reduce insurance coverage, cancel policies, modify coverage, or not renew policies <sup>p. 23</sup>. |
|||
* Existing policyholders might exaggerate or falsify claims to receive higher payments during an economic downturn <sup>p. 23</sup>. |
|||
* A significant collapse in specific economic segments like construction, credit markets, or energy production and servicing could adversely affect results across several underwriting divisions <sup>p. 23</sup>. |
|||
* These outcomes would reduce underwriting profit if not reflected in the rates charged <sup>p. 23</sup>. |
|||
* The insurance business is historically cyclical, which can affect financial performance and cause operating results to vary quarterly, not necessarily indicating future performance <sup>p. 23</sup>. |
|||
* Insurance carriers have historically experienced significant fluctuations in operating results due to competition, catastrophic events, capacity levels, litigation trends, regulatory constraints, and general economic conditions <sup>p. 23</sup>. |
|||
* The supply of insurance is linked to prevailing prices, insured losses, and industry capital, which fluctuate with investment returns in the insurance industry <sup>p. 23</sup>. |
|||
* The insurance industry is characterized by cyclical periods of intense price competition due to excessive underwriting capacity (soft market) and periods of capacity shortages leading to increased premiums (hard market) <sup>p. 23</sup>. |
|||
* Demand for insurance depends on factors like frequency and severity of catastrophic events, capacity levels, new capital providers, and general economic conditions, all of which fluctuate and can contribute to price declines <sup>p. 23</sup>. |
|||
* The profitability of most ''P&C insurance companies'' tends to follow cyclical market patterns, with higher gross written premium growth and improved profitability during hard market cycles <sup>p. 23</sup>. |
|||
* This cyclical market pattern can be more pronounced in the ''E&S market'' than in the standard insurance market <sup>p. 23</sup>. |
|||
* When the standard insurance market hardens, the E&S market typically hardens, and E&S market growth can be significantly more rapid <sup>p. 23</sup>. |
|||
* When conditions soften, customers previously in the E&S market may return to the admitted market, exacerbating the effects of rate decreases on financial results <sup>p. 23</sup>. |
|||
* The market may experience "micro cycles" where specific areas harden or soften independently and potentially more drastically than the overall market <sup>p. 23</sup>. |
|||
* Operating results are subject to fluctuation and have historically varied quarter-to-quarter <sup>p. 23</sup>. |
|||
* Quarterly results are expected to continue fluctuating due to general economic conditions, frequency/severity of catastrophe events, fluctuating interest rates, claims exceeding loss reserves, industry competition, deviations from expected premium retention rates, adverse investment performance, and reinsurance coverage costs <sup>p. 23</sup>. |
|||
* ''Investment portfolio performance'' is subject to various investment risks that may adversely affect financial results <sup>p. 23</sup>. |
|||
* The company aims to hold a diversified investment portfolio managed by professional advisory firms according to its investment policy and reviewed by its Investment Committee <sup>p. 23</sup>. |
|||
* Investments are subject to general economic conditions, market risks, and risks inherent to specific securities <sup>p. 23</sup>. |
|||
* Primary market risk exposures are to changes in interest rates and equity prices <sup>p. 23</sup>. |
|||
* A significant portion of the investment portfolio is in ''fixed maturity securities'', or separately managed accounts and limited partnerships primarily invested in them <sup>p. 23</sup>. |
|||
* Interest rates rose materially during 2022 and 2023 <sup>p. 23</sup>. |
|||
* A low interest rate environment, potentially resulting from federal government actions to slow inflation (e.g., rate cuts, Inflation Reduction Act of 2022), would pressure net investment income, especially for fixed maturity and short-term investments, adversely affecting operating results <sup>p. 23</sup>. |
|||
* Recent and future increases in interest rates could cause the values of fixed income securities portfolios to decline, with the magnitude depending on security duration and the extent of interest rate increases <sup>p. 23</sup>. |
|||
* Some fixed income securities with call or prepayment options create reinvestment risk in declining rate environments <sup>p. 23</sup>. |
|||
* Other fixed income securities, such as mortgage-backed and asset-backed securities, carry prepayment risk or may not prepay as quickly as expected in a rising interest rate environment <sup>p. 23</sup>. |
|||
* All fixed maturity securities, including those in separately managed accounts and limited partnerships, are subject to ''credit risk'' <sup>p. 23</sup>. |
|||
* Credit risk is the risk of investment default or impairment due to deterioration in the financial condition of issuers or guarantors of securities held <sup>p. 23</sup>. |
|||
* Downgrades in credit ratings of fixed maturity securities could significantly negatively affect their market valuation <sup>p. 23</sup>. |
|||
* The company also invests in ''marketable preferred and common equity securities'' and exchange-traded funds, which are carried at fair market value and are subject to potential losses and market value declines <sup>p. 23</sup>. |
|||
* Market and credit risks could reduce net investment income and result in realized investment losses <sup>p. 23</sup>. |
|||
* The investment portfolio is subject to increased valuation uncertainties when investment markets are illiquid, as is the case with fixed maturity securities held to maturity, separately managed accounts, and limited partnership investments <sup>p. 23</sup>. |
|||
* Valuation of investments is more subjective in illiquid markets, increasing the risk that estimated fair value does not reflect actual transaction prices <sup>p. 23</sup>. |
|||
* Risks for all types of securities are managed through an investment policy that sets parameters including maximum investment percentages in certain security types and minimum credit quality levels <sup>p. 23</sup>. |
|||
* These investment parameters are believed to be within applicable guidelines established by the NAIC, the Texas Department of Insurance, and the Oklahoma Department of Insurance <sup>p. 23</sup>. |
|||
* The Investment Committee periodically reviews Enterprise Based Asset Allocation models for overall risk management <sup>p. 23</sup>. |
|||
* While seeking to preserve capital, there is no certainty that investment objectives will be achieved, and results may vary substantially over time <sup>p. 23</sup>. |
|||
* Although investment strategies are sought that are not correlated with insurance and reinsurance exposures, investment portfolio losses may occur concurrently with underwriting losses, exacerbating adverse effects <sup>p. 23</sup>. |
|||
* The company could be forced to sell investments to meet liquidity requirements <sup>p. 23</sup>. |
|||
* Premiums received from insureds are invested until needed to pay policyholder claims <sup>p. 23</sup>. |
|||
* The duration of the investment portfolio is managed based on the duration of losses and LAE reserves to provide sufficient liquidity and avoid liquidating investments to fund claims <sup>p. 23</sup>. |
|||
* Risks such as inadequate losses and LAE reserves or unfavorable litigation trends could necessitate selling investments to fund liabilities <sup>p. 23</sup>. |
|||
* Investments may not be sellable at favorable prices or at all, potentially resulting in significant realized losses depending on general market conditions, interest rates, and credit issues with individual securities <sup>p. 23</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=45|p=9}} |
|||
====== Risks Related to the Regulatory Environment ====== |
|||
'''Financial strength and policy interpretation risks''' |
|||
* |
* A decline in financial strength rating may adversely affect the amount of business written. |
||
* |
* Unexpected changes in the interpretation of coverage or provisions, including loss limitations and exclusions, in policies could materially adversely affect financial condition and results of operations. |
||
* Primary insurance subsidiaries (GMIC, HSIC, IIC) are subject to ''extensive regulation in Texas'' (state of domicile) and other operating states <sup>p. 24</sup>. |
|||
* Most insurance regulations are designed to protect ''policyholder interests'', not investor or stockholder interests <sup>p. 24</sup>. |
|||
* Regulations are administered by state departments of insurance and cover ''capital and surplus requirements, investment and underwriting limitations, affiliate transactions, dividend limitations, changes in control, solvency'', and other financial/non-financial aspects <sup>p. 24</sup>. |
|||
* ''Significant changes in laws and regulations'' could limit discretion or increase business costs <sup>p. 24</sup>. |
|||
* State insurance regulators conduct ''periodic examinations'' and require annual/other reports on financial condition and holding company issues <sup>p. 24</sup>. |
|||
* Regulatory requirements may impose ''timing and expense constraints'' affecting business objectives <sup>p. 24</sup>. |
|||
* Insurance subsidiaries are part of an ''"insurance holding company system"'' under Texas statutes and regulations <sup>p. 24</sup>. |
|||
* Certain transactions between insurance subsidiaries and affiliates require ''prior notice to the Texas Department of Insurance'', potentially causing business delays and additional expenses <sup>p. 24</sup>. |
|||
* Failure to file required notifications or comply with Texas insurance regulations may result in ''significant fines and penalties'' and impair the working relationship with the Texas Department of Insurance <sup>p. 24</sup>. |
|||
* State insurance regulators have ''broad discretion to deny or revoke licenses'' for various reasons, including regulation violations <sup>p. 24</sup>. |
|||
* Practices based on interpretations of regulations or industry norms may differ from ''regulatory authorities' interpretations'' <sup>p. 24</sup>. |
|||
* Lack of requisite licenses/approvals or non-compliance with regulatory requirements could lead to ''preclusion or temporary suspension'' of activities in a state or other penalties <sup>p. 24</sup>. |
|||
* Changes in insurance industry regulation, laws, or interpretations could ''interfere with operations'' and incur additional compliance costs <sup>p. 24</sup>. |
|||
* Insurance subsidiaries are subject to ''risk-based capital requirements'' based on the NAIC model and minimum capital/surplus restrictions under Texas law <sup>p. 24</sup>. |
|||
* These requirements establish the ''minimum risk-based capital'' needed to support business operations and identify inadequately capitalized insurers based on asset/liability risks and net written premium mix <sup>p. 24</sup>. |
|||
* Falling below a calculated threshold may lead to ''regulatory action'', including supervision, rehabilitation, or liquidation <sup>p. 24</sup>. |
|||
* Failure to maintain required risk-based capital levels could adversely affect the ''ability to maintain regulatory authority'' and the A.M. Best Rating <sup>p. 24</sup>. |
|||
* ''Additional government or market regulation'' may have a material adverse impact on the business <sup>p. 24</sup>. |
|||
* Business could be adversely affected by ''changes in laws'' related to asset/reserve valuation, surplus requirements, investment/dividend limitations, enterprise risk, and risk-based capital <sup>p. 24</sup>. |
|||
* The U.S. federal government, while not directly regulating insurance broadly, could consider legislation affecting the industry in areas like ''privatization of Freddie Mac/Fannie Mae, reduction in federal subsidies, tort reform, corporate governance, and taxation of reinsurance companies'' <sup>p. 24</sup>. |
|||
* ''Changes to U.S. tax laws'' and new tax policies could negatively impact the overall economy and the business <sup>p. 24</sup>. |
|||
* ''Legislative or other actions relating to taxes'' could negatively affect the company, investments, or stockholders <sup>p. 24</sup>. |
|||
* The ''rules for U.S. federal income taxation'' are constantly under review by legislators, the IRS, and the U.S. Department of the Treasury <sup>p. 24</sup>. |
|||
* New legislation, U.S. Treasury regulations, administrative interpretations, or court decisions could have ''adverse consequences'' <sup>p. 24</sup>. |
|||
* On ''July 4, 2025'', H.R. 1, the "One Big Beautiful Bill Act" (OBBBA), was signed into law in the United States <sup>p. 24</sup>. |
|||
* The ''OBBBA modifies key business tax provisions'', including restoring 100% bonus depreciation (Section 168(k) IRC), immediate deduction of U.S. domestic research and experimental expenditures (Section 174A IRC), and the EBITDA-based business interest expense limitation (Section 163(j) IRC), and changes to international operations tax computation <sup>p. 24</sup>. |
|||
* Based on current analysis, these OBBBA provisions are not expected to have a ''material impact'' on the business and results of operations <sup>p. 24</sup>. |
|||
* Regulations and IRS guidance implementing the OBBBA may create ''unforeseen issues'', and further tax law changes could occur <sup>p. 24</sup>. |
|||
* There is no assurance that the business will not be ''adversely affected by the OBBBA'' or other tax law changes <sup>p. 24</sup>. |
|||
* The ability to utilize ''net operating loss carryforwards (NOLs)'' and certain other tax attributes may be limited <sup>p. 24</sup>. |
|||
* As of ''December 31, 2025'', there were ''gross federal income tax NOLs of approximately $40.3 million'' available to offset future taxable income, prior to annual limitations <sup>p. 24</sup>. |
|||
* These ''NOLs are set to expire beginning in 2032'' <sup>p. 24</sup>. |
|||
* Under ''Section 382 of the Code'', an "ownership change" (greater than 50% change in equity ownership by certain stockholders over a rolling three-year period) can limit the use of pre-ownership change NOLs to offset post-ownership change income <sup>p. 24</sup>. |
|||
* ''Future ownership changes'' or regulatory changes could limit the ability to utilize NOLs <sup>p. 24</sup>. |
|||
* If unable to offset future taxable income with NOLs, ''net income and cash flows'' may be adversely affected <sup>p. 24</sup>. |
|||
* As a ''holding company'', with substantially all operations conducted by insurance subsidiaries, liquidity at the holding company level (including dividend payments and debt service) depends on obtaining cash dividends or other permitted payments from insurance subsidiaries <sup>p. 24</sup>. |
|||
* The ''continued operation and growth'' of the business will require substantial capital <sup>p. 24</sup>. |
|||
* There is ''no intention to declare and pay cash dividends'' on common stock in the foreseeable future <sup>p. 24</sup>. |
|||
* The ability to pay dividends to stockholders and meet debt obligations largely depends on ''dividends and distributions from primary insurance subsidiaries'' (GMIC, HSIC, IIC) <sup>p. 24</sup>. |
|||
* ''State insurance laws'', including those of Texas, restrict the ability of GMIC, HSIC, and IIC to declare stockholder dividends <sup>p. 24</sup>. |
|||
* State insurance regulators require insurance companies to maintain ''specified levels of statutory capital and surplus'' <sup>p. 24</sup>. |
|||
* ''Dividend payments are limited'' to the portion of available policyholder surplus derived from net profits <sup>p. 24</sup>. |
|||
* State insurance regulators have ''broad powers to prevent reduction of statutory surplus'' to inadequate levels <sup>p. 24</sup>. |
|||
* There is no assurance that dividends up to the ''maximum calculated amounts'' would be permitted <sup>p. 24</sup>. |
|||
* State insurance regulators may adopt ''more restrictive statutory provisions'' regarding dividend payments in the future <sup>p. 24</sup>. |
|||
* Any future dividend determination will be at the ''discretion of the Board of Directors'' and depend on results, financial condition, contractual restrictions, indebtedness, applicable law, and other relevant factors <sup>p. 24</sup>. |
|||
* Investors may need to sell common stock after price appreciation (which may not occur) as the ''only way to realize future gains'' <sup>p. 24</sup>. |
|||
* Investors seeking immediate cash dividends ''should not purchase common stock'' <sup>p. 24</sup>. |
|||
* ''Applicable insurance laws may make it difficult to effect a change of control'' <sup>p. 24</sup>. |
|||
* Under Texas insurance laws, ''written approval from the state insurance commissioner'' is required before acquiring control of a domestic insurer <sup>p. 24</sup>. |
|||
* Approval depends on factors including the ''financial strength of the acquirer, plans for future operations, and potential anti-competitive results'' <sup>p. 24</sup>. |
|||
* Texas insurance laws apply to ''direct and indirect acquisition of 10% or more of the voting stock'' of a Texas-domiciled insurer <sup>p. 24</sup>. |
|||
* Acquisition of ''10% or more of common stock'' would be considered an indirect change of control of Skyward Specialty, triggering change of control filing requirements, unless a disclaimer of control filing is accepted by the Texas Insurance Department <sup>p. 24</sup>. |
|||
* These requirements may ''discourage potential acquisition proposals'' and delay, deter, or prevent a change of control, even if desirable to stockholders <sup>p. 24</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=46|p=9}} |
|||
====== Risks Related to Our Liquidity and Access to Capital ====== |
|||
'''Reinsurer and claims payment risks''' |
|||
* Reinsurers may not reimburse claims on a timely basis or at all, which may materially adversely affect business, financial condition, and results of operations. |
|||
* Future capital requirements depend on factors such as the ability to write new business successfully and establish premium rates and reserves sufficient to cover losses <sup>p. 25</sup>. |
|||
* Failure to accurately and timely pay claims could materially and adversely affect business, financial condition, results of operations, and prospects. |
|||
* If operational cash flows are insufficient or the capital position is adversely impacted by investment portfolio decline, catastrophe losses, or adverse reserve development, additional funds may be needed through financings or growth curtailment <sup>p. 25</sup>. |
|||
* The amount and timing of capital needs are affected by growth rate, profitability, claims experience, reinsurance availability, market disruptions, and other unforeseeable developments <sup>p. 25</sup>. |
|||
* If additional capital is needed, equity or debt financing may not be available or may be on unfavorable terms <sup>p. 25</sup>. |
|||
* Equity financings could lead to dilution for stockholders <sup>p. 25</sup>. |
|||
* Debt financings may impose covenants restricting business operations <sup>p. 25</sup>. |
|||
* Securities from future financings may have rights, preferences, and privileges senior to common stock <sup>p. 25</sup>. |
|||
* Inability to obtain adequate capital on favorable terms could prevent implementation of operating plans and materially adversely affect business, financial condition, or results of operations <sup>p. 25</sup>. |
|||
* Access to credit under the Revolving Credit Facility is subject to conditions that may limit borrowing <sup>p. 25</sup>. |
|||
* Failure to satisfy conditions for the Revolving Credit Facility would prevent borrowing, potentially affecting liquidity, financial position, and results of operations <sup>p. 25</sup>. |
|||
* A breach of covenants under the Term Loan Facility and Revolving Credit Facility could trigger an event of default <sup>p. 25</sup>. |
|||
* Upon an event of default, all outstanding amounts and accrued interest could be declared immediately due and payable by lenders <sup>p. 25</sup>. |
|||
* Assets may be insufficient to repay payments due under credit agreements if an event of default occurs <sup>p. 25</sup>. |
|||
* Current credit market environment and macro-economic challenges may adversely impact the ability to borrow sufficient funds or sell assets/equity to repay existing debt <sup>p. 25</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=47|p=9}} |
|||
====== Risks Related to Our Operations ====== |
|||
'''Economic and cyclical risks''' |
|||
* Adverse economic factors, including recession, inflation, high unemployment, or lower economic activity, could lead to fewer policy sales, increased claim frequency, premium defaults, or falsification of claims, affecting growth and profitability. |
|||
* The company's ability to attract and retain experienced and seasoned personnel is crucial for its business <sup>p. 26</sup>. |
|||
* The insurance business is historically cyclical, which may affect financial performance, cause quarterly operating results to vary, and may not be indicative of future performance. |
|||
* The talent pool for recruitment is limited and subject to market dynamics, potentially leading to increased compensation expectations and difficulties in retaining or recruiting key personnel <sup>p. 26</sup>. |
|||
* Loss of key personnel or inability to attract talent could adversely affect the company's competitive position and results of operations <sup>p. 26</sup>. |
|||
* The business is highly dependent on information technology and telecommunications systems for underwriting, claims processing, policy preparation, premium processing, actuarial functions, and financial reporting <sup>p. 26</sup>. |
|||
* Some systems may rely on third-party services not under the company's direct control <sup>p. 26</sup>. |
|||
* Events like natural catastrophes, terrorist attacks, industrial accidents, computer viruses, and cyber-attacks can cause system failures or inaccessibility <sup>p. 26</sup>. |
|||
* Sustained or repeated system failures could limit the company's ability to write new business, process renewals, provide customer service, pay claims, or operate normally <sup>p. 26</sup>. |
|||
* Computer viruses, hackers, employee misconduct, and other external hazards can expose systems to security breaches and cyber-attacks <sup>p. 26</sup>. |
|||
* The company has implemented security measures but systems may still be subject to breaches or interference <sup>p. 26</sup>. |
|||
* A data incident occurred where attackers acquired certain company data, but an investigation determined it was immaterial, with no evidence of nation-state involvement or misuse of information <sup>p. 26</sup>. |
|||
* Future cybersecurity events could lead to operational disruptions, unauthorized access, disclosure or loss of proprietary or customer data, legal claims, regulatory scrutiny, reputational damage, and increased costs <sup>p. 26</sup>. |
|||
* SEC and state law requirements for public notification of incidents could exacerbate harm to the business <sup>p. 26</sup>. |
|||
* Third parties to whom functions are outsourced are also subject to these risks, and while their cybersecurity controls are reviewed, successful prevention of compromises or disclosures cannot be ensured <sup>p. 26</sup>. |
|||
* Increased use of third-party services (e.g., cloud technology, software as a service) can complicate identification and response to cyberattacks <sup>p. 26</sup>. |
|||
* The rapid growth of artificial intelligence (AI) and machine learning may alter the competitive landscape <sup>p. 26</sup>. |
|||
* The company uses AI for risk selection, pricing, and claims handling and continues to research and implement AI-based solutions <sup>p. 26</sup>. |
|||
* The company's competitive position could be harmed if competitors leverage AI solutions more quickly or effectively <sup>p. 26</sup>. |
|||
* If AI applications produce deficient, inaccurate, or biased content, analyses, or recommendations, the company's business, financial condition, results of operations, and reputation may be adversely affected <sup>p. 26</sup>. |
|||
* The continuous evolution of AI technology may lead to costs for adopting and deploying technologies that become obsolete earlier than expected <sup>p. 26</sup>. |
|||
* There is uncertainty in the legal and regulatory landscape for AI at federal and state levels <sup>p. 26</sup>. |
|||
* Future laws, regulations, or industry standards for AI could be burdensome, costly, and restrict the company's ability to develop, adopt, and deploy AI technologies <sup>p. 26</sup>. |
|||
* Future business growth may require additional capital, systems development, and skilled personnel <sup>p. 26</sup>. |
|||
* Failure to manage growth effectively, including meeting capital needs, expanding systems, optimizing human resources, and integrating acquisitions, could materially adversely affect the business <sup>p. 26</sup>. |
|||
* Success of inorganic growth through acquisitions depends on identifying appropriate targets, negotiating favorable terms, completing transactions, and successful integration <sup>p. 26</sup>. |
|||
* Anticipated benefits from acquisitions, such as revenue growth, operational efficiencies, or synergies, may not be realized <sup>p. 26</sup>. |
|||
* The company has experienced rapid growth in recent years, but these rates may not be indicative of future growth <sup>p. 26</sup>. |
|||
* Future revenue growth may not be sustainable at rates consistent with recent history <sup>p. 26</sup>. |
|||
* Revenue growth depends on factors including effective product pricing, successful product deployment and renewals, attracting qualified underwriters and claims professionals, enhancing infrastructure and data reporting systems, creating new distribution channels, introducing new products, competing effectively, and increasing brand awareness <sup>p. 26</sup>. |
|||
* Failure to accomplish these objectives makes forecasting future results of operations difficult <sup>p. 26</sup>. |
|||
* Historical growth rates should not be considered indicative of future performance and may decline <sup>p. 26</sup>. |
|||
* Future revenue could grow more slowly or decline, and operating expenses could increase, potentially harming the business and preventing profitability <sup>p. 26</sup>. |
|||
* The acquisition and integration of Apollo, completed on January 1, 2026, may adversely affect the business <sup>p. 26</sup>. |
|||
* The Apollo acquisition is expected to provide strategic benefits, expand specialty insurance capabilities, and enhance presence in the Lloyd’s market <sup>p. 26</sup>. |
|||
* Integration risks include challenges in combining operations, systems, technology platforms, and personnel, potentially diverting management attention, disrupting business, and incurring unexpected costs or delays <sup>p. 26</sup>. |
|||
* There is no assurance that anticipated benefits from the acquisition, such as growth opportunities, will be realized within the expected timeframe or at all <sup>p. 26</sup>. |
|||
* The success of the acquisition depends on retaining key Apollo employees, partners, and customers, with loss potentially negatively impacting the acquired business and overall operations <sup>p. 26</sup>. |
|||
* Cultural and operational differences between the company and Apollo, particularly regarding the Lloyd’s market, may create challenges in harmonizing policies and procedures <sup>p. 26</sup>. |
|||
* Financial and accounting risks include significant changes to financial statements, recognition of goodwill and intangible assets subject to impairment, undisclosed liabilities or risks, and the need to convert Apollo's U.K. GAAP financial statements to U.S. GAAP <sup>p. 26</sup>. |
|||
* Regulatory and compliance risks increase due to expansion into new jurisdictions and markets, including the Lloyd’s market, potentially leading to fines or penalties for non-compliance <sup>p. 26</sup>. |
|||
* Additional indebtedness incurred for the acquisition could limit financial flexibility or increase the cost of capital <sup>p. 26</sup>. |
|||
* The integration process may divert management's attention from existing business, negatively impacting ongoing operations and financial performance <sup>p. 26</sup>. |
|||
* Failure to successfully integrate Apollo, realize anticipated benefits, or manage expanded business risks could materially and adversely affect the company <sup>p. 26</sup>. |
|||
* The company continually faces risks associated with various types of litigation, including insurance claims and general commercial and corporate litigation <sup>p. 26</sup>. |
|||
* While not currently involved in out-of-the-ordinary litigation, other insurance industry members face class action lawsuits and other litigation with unpredictable outcomes and substantial or indeterminate amounts <sup>p. 26</sup>. |
|||
* Social inflation, particularly in third-party claims, can lead to oversized judgments <sup>p. 26</sup>. |
|||
* Litigation costs and settlement amounts can be inflated even when cases do not reach judgment <sup>p. 26</sup>. |
|||
* The company cannot predict future involvement in such litigation or its impact on the business <sup>p. 26</sup>. |
|||
* The company relies on services and products from many vendors in the United States and abroad, including those for computer hardware, software, claim adjustment, human resource benefits management, and investment management <sup>p. 26</sup>. |
|||
* Vendor bankruptcy, inability to provide services, system breaches, or failure to protect confidential information could lead to operational impairments and financial losses <sup>p. 26</sup>. |
|||
* Failure to properly assess vendor risks, including security and stability, could materially and adversely affect financial condition and results of operations <sup>p. 26</sup>. |
|||
* The company anticipates continued reliance on third-party software <sup>p. 26</sup>. |
|||
* While commercially reasonable alternatives to current third-party software are believed to exist, this may not always be the case, or replacement could be difficult or costly <sup>p. 26</sup>. |
|||
* Integration of new third-party software may require significant work and investment of time and resources <sup>p. 26</sup>. |
|||
* Obtaining license agreements for additional or alternative third-party software may not be possible on commercially reasonable terms or at all <sup>p. 26</sup>. |
|||
* Risks associated with third-party software use cannot be eliminated and could negatively affect the business <sup>p. 26</sup>. |
|||
* The company may fail to protect its intellectual property rights for its proprietary technology platform and brand, or may face infringement lawsuits <sup>p. 26</sup>. |
|||
* Success and ability to compete depend partly on intellectual property, including brand rights and proprietary technology in certain product lines <sup>p. 26</sup>. |
|||
* The company primarily relies on copyright and trade secret laws, and confidentiality agreements to protect intellectual property rights <sup>p. 26</sup>. |
|||
* Steps taken to protect intellectual property may be inadequate <sup>p. 26</sup>. |
|||
* Efforts to enforce intellectual property rights may face defenses, counterclaims, and countersuits challenging validity, enforceability, and scope <sup>p. 26</sup>. |
|||
* Failure to secure, protect, and enforce intellectual property rights could adversely affect the brand and business <sup>p. 26</sup>. |
|||
* Success also depends on not infringing on the intellectual property rights of others <sup>p. 26</sup>. |
|||
* Third parties may claim infringement of their intellectual property rights, potentially leading to significant expenses, substantial damages, ongoing royalty payments, prevention from offering services, or other unfavorable terms <sup>p. 26</sup>. |
|||
* Even if successful in a dispute, litigation could be costly, time-consuming, and divert management attention <sup>p. 26</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=48|p=9}} |
|||
====== Risks Related to Ownership of Our Common Stock ====== |
|||
'''Regulatory and personnel risks''' |
|||
* Extensive regulation may adversely affect the ability to achieve business objectives; non-compliance could result in penalties, including fines and suspensions, adversely affecting financial condition and results of operations. |
|||
* The company expects to incur increased costs and management time due to operating as a public company <sup>p. 27</sup>. |
|||
* The loss of key personnel or inability to attract and retain qualified personnel could adversely affect the company. |
|||
* As a public company and large accelerated filer, the company incurs significant legal, accounting, and other expenses not present as a private company <sup>p. 27</sup>. |
|||
* Federal securities laws, including the Sarbanes-Oxley Act and Dodd-Frank Act, and SEC/Nasdaq rules impose requirements on public companies, increasing compliance costs and management time <sup>p. 27</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=49|p=9}} |
|||
* The company may not be able to produce reliable financial statements or file them timely with the SEC, or comply with Nasdaq listing requirements <sup>p. 27</sup>. |
|||
'''Internal controls and public company risks''' |
|||
* Pursuant to Section 404 of the Sarbanes-Oxley Act, the company must perform system and process evaluation and testing of internal control over financial reporting <sup>p. 27</sup>. |
|||
* Compliance with Section 404 requires substantial accounting expense and significant management effort, including maintaining staff and consultants with public company reporting, technical accounting, and internal control knowledge <sup>p. 27</sup>. |
|||
* Failure to achieve and maintain effective internal controls could impact operating results and financial condition, and negatively affect the market price of common stock. |
|||
* The company engages in a costly and challenging process to document and evaluate internal control over financial reporting to comply with Section 404 <sup>p. 27</sup>. |
|||
* Costs will increase significantly as a public company, requiring management to devote substantial time to complying with public company regulations. |
|||
* There is a risk that neither the company nor its independent registered public accounting firm will conclude that internal control over financial reporting is effective within the prescribed timeframe, potentially leading to adverse financial market reactions or SEC investigations <sup>p. 27</sup>. |
|||
* As a public company, the company must maintain disclosure controls and procedures designed to ensure timely and accurate reporting of information required by the Exchange Act <sup>p. 27</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=50|p=9}} |
|||
* The company's disclosure controls and procedures or internal control over financial reporting may not prevent or detect all errors and fraud, as control systems provide only reasonable, not absolute, assurance <sup>p. 27</sup>. |
|||
'''Derivative and acquisition integration risks''' |
|||
* Due to inherent limitations, misstatements due to error or fraud may occur and not be detected <sup>p. 27</sup>. |
|||
* If the company is unable to achieve and maintain effective internal controls, its operating results and financial condition could be harmed, and the market price of its common stock negatively affected <sup>p. 27</sup>. |
|||
* Use of derivatives to mitigate market price volatility exposure may subject the company to risks such as hedge ineffectiveness, basis risk, collateral and margin call liquidity pressures, and valuation uncertainty, any of which could adversely affect financial condition. |
|||
* The company must document and test internal control procedures to satisfy Section 404(b) of the Sarbanes-Oxley Act, requiring annual management assessments of effectiveness <sup>p. 27</sup>. |
|||
* The integration of Apollo may present unforeseen challenges, including difficulties in integrating technology systems, business processes, and risk management frameworks, potentially leading to operational disruptions, increased costs, or delays in realizing anticipated strategic benefits from the acquisition. |
|||
* During assessments, the company may identify deficiencies that cannot be remediated timely, and testing/maintaining internal controls may divert management's attention <sup>p. 27</sup>. |
|||
* If the company concludes its internal control over financial reporting is not effective, remediation costs and operational effects could be significant <sup>p. 27</sup>. |
|||
=== Risks Related to Our Business and Industry === |
|||
* Material weaknesses or deficiencies in internal control could impede timely and accurate SEC reporting, potentially causing loss of investor confidence or Nasdaq listing suspension/termination <sup>p. 27</sup>. |
|||
* The company identified a material weakness in its internal control over information technology general controls ("ITGCs") as of December 31, 2024, which was remediated by December 31, 2025 <sup>p. 27</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=51|p=9}} |
|||
* Failure to maintain an effective system of internal controls could adversely affect the market price of the common stock <sup>p. 27</sup>. |
|||
'''Underwriting risk assessment''' |
|||
* The effectiveness of controls is subject to inherent limitations, and there is no assurance controls will prevent or detect all misstatements <sup>p. 27</sup>. |
|||
* An effective system of internal control over ITGCs provides only reasonable, not absolute, assurance <sup>p. 27</sup>. |
|||
* Financial condition and results of operations could be materially adversely affected if underwriting risk is not accurately assessed. |
|||
* Management, with the CEO, CFO, and CIO/CTO, identified control deficiencies over ITGCs during fiscal year ended December 31, 2024, constituting a material weakness as described in "ITEM 9A. CONTROLS & PROCEDURES" of the 2024 Annual Report on Form 10-K <sup>p. 27</sup>. |
|||
* Underwriting success depends on accurately assessing risks and establishing appropriate premium rates. |
|||
* The company has taken measures to remediate the material weakness and believes it is remediated <sup>p. 27</sup>. |
|||
* Misunderstanding the nature or extent of risks can lead to inappropriate premium rates, adversely affecting financial results. |
|||
* If additional material weaknesses or significant deficiencies are identified, the company may be unable to provide timely and reliable financial information or may incorrectly report it <sup>p. 27</sup>. |
|||
* Decisions by employees, including management and underwriters, expose the company to risk. |
|||
* Untimely financial statement filings could lead to adverse action by shareholders, Nasdaq, the SEC, or other regulatory authorities <sup>p. 27</sup>. |
|||
* Material weaknesses or significant deficiencies could negatively affect reputation or investor perceptions, impacting the common share trading price, and incur additional remediation costs <sup>p. 27</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=52|p=9}} |
|||
* The company cannot assure that additional material weaknesses or restatements will not arise in the future due to inadequate internal controls <sup>p. 27</sup>. |
|||
'''Industry competition''' |
|||
* Current controls and procedures may not be adequate in the future to prevent or identify irregularities/errors or facilitate fair financial statement presentation <sup>p. 27</sup>. |
|||
* The company's operating results and stock price may be volatile or decline regardless of operating performance, leading to potential loss of investment <sup>p. 27</sup>. |
|||
* Competition in the industry is intense. |
|||
* The market price of the common stock has been and is likely to remain highly volatile due to factors beyond the company's control <sup>p. 27</sup>. |
|||
* Competition comes from specialty insurance companies, standard insurance companies, and underwriting agencies. |
|||
* Securities markets worldwide have experienced significant price and volume fluctuations, which, along with general economic, market, or political conditions, could cause wide price fluctuations in the company's shares <sup>p. 27</sup>. |
|||
* Competition factors include price, reputation, financial strength, distribution relationships, product terms, rating agency ratings, claims payment speed, and underwriting team experience. |
|||
* Investment in the common stock is considered risky, requiring tolerance for significant loss and wide market value fluctuations <sup>p. 27</sup>. |
|||
* Increasing consolidation in the insurance industry may further increase competition. |
|||
* Factors affecting stock price include: |
|||
* New industry or legislative developments could also increase competition. |
|||
** ''Market conditions'' in the broader stock market <sup>p. 27</sup>. |
|||
* Inability to compete successfully could change supply and demand for insurance, affect pricing at risk-adequate rates, and impact retention or new business acquisition on favorable terms. |
|||
** ''Fluctuations'' in quarterly financial and operating results <sup>p. 27</sup>. |
|||
* Increased competition limiting business transactions could adversely affect operating results. |
|||
** ''Introduction of new products or services'' by the company or competitors <sup>p. 27</sup>. |
|||
** ''Issuance of new or changed securities analysts’ reports'' or recommendations <sup>p. 27</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=53|p=9}} |
|||
** ''Operating results'' varying from expectations of securities analysts and investors <sup>p. 27</sup>. |
|||
'''Distribution channel reliance''' |
|||
** ''Short sales, hedging, and other derivative transactions'' in the common stock <sup>p. 27</sup>. |
|||
** ''Guidance'' provided to the public, changes in guidance, or failure to meet guidance <sup>p. 27</sup>. |
|||
* Business depends on insurance retail agents, brokers, wholesalers, and program administrators, exposing it to risks from these distribution channels. |
|||
** ''Strategic actions'' by the company or competitors <sup>p. 27</sup>. |
|||
* Most products are distributed through independent retail agents and brokers who own "renewal rights". |
|||
** ''Announcements'' by the company, competitors, or acquisition targets <sup>p. 27</sup>. |
|||
* Business model relies on relationships with and success of retail agents and brokers. |
|||
** ''Sales, or anticipated sales'', of large blocks of stock by directors, executive officers, and principal stockholders <sup>p. 27</sup>. |
|||
* Dependence also extends to relationships wholesalers and program administrators maintain with agents and brokers. |
|||
** ''Additions or departures'' in the Board of Directors, senior management, or other key personnel <sup>p. 27</sup>. |
|||
* Relationships with distributors can be discontinued or become unprofitable. |
|||
** ''Regulatory, legal, or political developments'' <sup>p. 27</sup>. |
|||
* Consolidation of insurance distribution firms may increase their influence on commission rates and concentrate business with particular brokers. |
|||
** ''Public response'' to press releases or other public announcements by the company or third parties, including SEC filings <sup>p. 27</sup>. |
|||
* Premiums collected by brokers for payment to the company carry credit risk, as payment to the broker may be considered payment to the company in certain jurisdictions. |
|||
** ''Litigation and governmental investigations'' <sup>p. 27</sup>. |
|||
* Instances where brokers collect but do not remit premiums have not been material to date, but could require the company to provide coverage despite non-payment. |
|||
** ''Changing economic conditions'', including social inflation <sup>p. 27</sup>. |
|||
* Limitations on canceling policies for non-payment could reduce underwriting profits and adversely affect financial condition and results. |
|||
** ''Changes in accounting principles'' <sup>p. 27</sup>. |
|||
* The company reviews financial condition of new brokers and periodically reviews existing distributors to identify those not meeting profitability standards or business objectives. |
|||
** ''Indebtedness'' incurred or securities issued in the future <sup>p. 27</sup>. |
|||
* Measures like restricting access to products or terminating relationships may not achieve desired results due to contractual and regulatory limitations. |
|||
** ''Default'' under agreements governing indebtedness <sup>p. 27</sup>. |
|||
* Deterioration in distributor relationships or uncompetitive compensation could lead distributors to place more premium with other carriers. |
|||
** ''Exposure to capital and credit market risks'' affecting the investment portfolio or capital resources <sup>p. 27</sup>. |
|||
* Distributors exceeding authority, failing to transfer collected premiums, or breaching obligations could expose the company to liability. |
|||
** ''Changes in credit ratings'' <sup>p. 27</sup>. |
|||
* Continued consolidation of insurance distribution firms could materially affect sales channels, including loss of market access or share. |
|||
** ''Other events or factors'', including natural disasters, war, acts of terrorism, or responses to these events <sup>p. 27</sup>. |
|||
* Negative impacts could arise from loss of talent following acquisitions or increased commission costs due to larger distributors gaining negotiating leverage. |
|||
* Stock markets, including Nasdaq, have experienced extreme price and volume fluctuations unrelated to company operating performance <sup>p. 27</sup>. |
|||
* Digitization acceleration poses risks if distributors cannot keep pace with customer demand for digital experiences. |
|||
* These broad market fluctuations, and general market, economic, and political conditions, may negatively affect the common stock price <sup>p. 27</sup>. |
|||
* Extreme price and volume fluctuations could cause the stock price to fall and expose the company to securities class action litigation, which could be costly, divert management attention, or harm the business <sup>p. 27</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=54|p=9}} |
|||
* Management has the authority to change underwriting guidelines or strategy without stockholder notice or approval <sup>p. 27</sup>. |
|||
'''Reinsurance availability and terms''' |
|||
* This allows fundamental changes to operations without stockholder approval, potentially resulting in a strategy or underwriting guidelines materially different from those described in the "Business" section or other filings <sup>p. 27</sup>. |
|||
* Anti-takeover provisions in organizational documents, Delaware law, and regulations could prevent or delay a beneficial change of control and limit share price <sup>p. 27</sup>. |
|||
* Inability to purchase third-party reinsurance on desired or commercially acceptable terms could materially adversely affect business, financial condition, and results. |
|||
* Provisions in the certificate of incorporation and by-laws, and applicable laws, may discourage, delay, or prevent mergers, tender offers, or other change of control events <sup>p. 27</sup>. |
|||
* Reinsurance is strategically purchased to protect capital from severity events and reduce earnings volatility. |
|||
* These provisions impose procedural requirements that could make it more difficult for shareholders to effect certain corporate actions, potentially adversely affecting the common stock price <sup>p. 27</sup>. |
|||
* Failure to renew expiring contracts, enter new arrangements, or expand coverage could increase loss exposure and potential losses. |
|||
* Charter documents permit the ''Board of Directors'' to establish the number of directors and fill vacancies/new directorships <sup>p. 27</sup>. |
|||
* Increased loss exposure could necessitate reducing underwriting commitments, adversely affecting business, financial condition, and results. |
|||
* The ''Board of Directors'' will be classified into three classes with staggered, three-year terms, and directors may only be removed for cause <sup>p. 27</sup>. |
|||
* Reinsurers may exclude certain coverages or alter terms, leading to gaps in reinsurance protection and greater risk exposure. |
|||
* ''Super-majority voting'' is required to amend provisions in the certificate of incorporation and bylaws <sup>p. 27</sup>. |
|||
* ''Blank-check preferred stock'' allows the Board to set preference rights and terms, potentially delaying or preventing transactions or changes in control that might benefit stockholders <sup>p. 27</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=55|p=9}} |
|||
* The ''ability of stockholders to call special meetings'' is eliminated <sup>p. 27</sup>. |
|||
'''Loss and loss expense reserves adequacy''' |
|||
* ''Special meetings'' of stockholders can only be called by the Board of Directors, the chairman, or the chief executive officer <sup>p. 27</sup>. |
|||
* ''Stockholder consent action'' is prohibited unless by unanimous written consent <sup>p. 27</sup>. |
|||
* Losses and loss expense (LAE) reserves may be inadequate, materially adversely affecting financial condition, results, and cash flows. |
|||
* ''Vacancies on the Board of Directors'' may be filled only by a majority of directors then in office, even if less than a quorum <sup>p. 27</sup>. |
|||
* Success depends on accurately assessing risks for insured businesses and people. |
|||
* ''Cumulative voting'' in the election of directors is prohibited <sup>p. 27</sup>. |
|||
* |
* Reserves are established as the best estimate for ultimate payment of incurred claims and related adjustment costs. |
||
* Reserves are estimates, and ultimate liability may differ from the estimate. |
|||
* As a Delaware corporation, the company is subject to ''Section 203 of the Delaware General Corporation Law'', which may prohibit large stockholders (owning 15% or more) from merging or combining with the company for a period <sup>p. 27</sup>. |
|||
* Reserving process reviews historical data and considers factors such as claims inflation, claims development patterns, pricing, legislative activity, social/economic patterns, and litigation/judicial/regulatory trends. |
|||
* The certificate of incorporation and bylaws designate the ''Court of Chancery of the State of Delaware'' as the exclusive forum for substantially all disputes between the company and its stockholders <sup>p. 27</sup>. |
|||
* Variables are affected by internal and external events that could increase loss exposure. |
|||
* This could limit stockholders' ability to obtain a favorable judicial forum for disputes with the company or its directors, officers, or employees <sup>p. 27</sup>. |
|||
* Loss reserves are continually monitored using new information, statistical techniques, and modeling simulations. |
|||
* The ''exclusive forum'' applies to: |
|||
* The process assumes past experience, adjusted for current developments and trends, is an appropriate basis for predicting future events. |
|||
** Any derivative action or proceeding brought on the company's behalf <sup>p. 27</sup>. |
|||
* No precise method exists for evaluating the impact of specific factors on reserve adequacy, and actual results may deviate substantially. |
|||
** Any action asserting a claim of breach of fiduciary duty by directors, officers, employees, agents, or stockholders <sup>p. 27</sup>. |
|||
* Uncertainties impacting reserve adequacy include: |
|||
** Any action asserting a claim arising under the DGCL or the certificate of incorporation/bylaws, or where the DGCL confers jurisdiction on the Court of Chancery <sup>p. 27</sup>. |
|||
** Time required to fully appreciate covered loss extent, leading to increasing loss estimates over time. |
|||
** Any action to interpret, apply, enforce, or determine the validity of the certificate of incorporation or bylaws <sup>p. 27</sup>. |
|||
** New theories of liability enforced retroactively by courts. |
|||
** Any action asserting a claim governed by the internal affairs doctrine <sup>p. 27</sup>. |
|||
** Volatility in financial markets, economic events, and external factors increasing claim frequency/severity. |
|||
* Unless the company consents in writing, the ''federal district courts of the United States of America'' are the sole and exclusive forum for resolutions of any complaint asserting a cause of action under the Securities Act <sup>p. 27</sup>. |
|||
** Elevated inflationary conditions increasing loss costs. |
|||
* There is uncertainty whether a court would enforce this provision, and stockholders are not deemed to have waived compliance with federal securities laws <sup>p. 27</sup>. |
|||
** Adverse economic factors (recession, inflation, unemployment) leading to fewer policy sales, increased claim frequency/severity, or premium defaults. |
|||
* This exclusive forum provision would not apply to suits brought to enforce a duty or liability created by the Exchange Act or other claims with exclusive federal jurisdiction <sup>p. 27</sup>. |
|||
** Increased cost due to "social inflation" (medical/material costs, technology in vehicles, supply chain disruptions, attorney involvement, litigation financing, lawsuit abuse). |
|||
* If enforced, this choice of forum provision may limit a stockholder's ability to bring a claim in a favorable judicial forum, potentially discouraging lawsuits <sup>p. 27</sup>. |
|||
** Increased claim frequency, even without liability, could escalate evaluation and handling costs beyond established reserves. |
|||
* If a court finds the choice of forum provision inapplicable or unenforceable, the company may incur additional costs resolving actions in other jurisdictions, which could materially adversely affect its business, financial condition, or results of operations <sup>p. 27</sup>. |
|||
** Entering new lines or new claim theories could increase claim frequency and handling costs. |
|||
* Inadequate reserves require increases, reducing net income and stockholders' equity in the period of identification. |
|||
* Future loss experience substantially exceeding established reserves could materially adversely affect future earnings, liquidity, and financial rating. |
|||
{{chunk|doc=3z7a4yrxkn|c=56|p=9}} |
|||
'''Financial strength rating decline''' |
|||
* A decline in financial strength rating may adversely affect the amount of business written. |
|||
* Independent rating agencies like A.M. Best assess financial strength and quality of insurers. |
|||
* A.M. Best ratings are based on quantitative and qualitative analysis of balance sheet strength, operating performance, and business profile. |
|||
* A.M. Best financial strength ratings range from "A++" (Superior) to "F" (liquidation). |
|||
* As of the filing date, A.M. Best assigned an "A" (Excellent) financial strength rating with a stable outlook. |
|||
* A.M. Best ratings provide an independent opinion of an insurer's ability to meet policyholder obligations, not an evaluation for investors. |
|||
* A.M. Best's analysis includes peer comparisons, industry standards, operating plans, philosophy, and management. |
|||
* A.M. Best periodically reviews and may revise ratings downward based on balance sheet strength, operating performance, and business profile. |
|||
* Factors that could affect A.M. Best's analysis include: |
|||
** Changes in business practices from the organizational plan that no longer support the rating. |
|||
** Unfavorable financial, regulatory, or market trends, including excess market capacity. |
|||
** Losses exceeding loss reserves. |
|||
** Unresolved issues with government regulators. |
|||
** Inability to retain senior management or key personnel. |
|||
** Significant investment portfolio losses or limited liquidity. |
|||
** Alterations to A.M. Best's capital adequacy assessment methodology that adversely affect the rating. |
|||
* A downgrade or withdrawal of rating could lead to: |
|||
** Current and future distribution partners and insureds choosing higher-rated competitors. |
|||
** Increased cost or reduced availability of reinsurance. |
|||
** Severely limiting or preventing writing new and renewal insurance contracts. |
|||
* Rating organizations may heighten scrutiny, increase review frequency/scope, request more information, or increase capital requirements due to earnings and capital pressures on financial institutions. |
|||
* No assurance that the rating will remain at its current level. |
|||
* Adverse ratings consequences could materially adversely affect financial condition and results of operations. |
|||
{{chunk|doc=3z7a4yrxkn|c=57|p=9}} |
|||
'''Policy coverage interpretation changes''' |
|||
* Unexpected changes in coverage interpretation or provisions, including loss limitations and exclusions, could materially adversely affect financial condition and results. |
|||
* No assurance that loss limitations or exclusions will be enforceable as intended. |
|||
* Unexpected issues related to claims and coverage may emerge due to changes in industry practices, legal, judicial, social, and other conditions. |
|||
* Policy limitations on claim periods may be shorter than statutory periods. |
|||
* Courts or regulatory authorities could nullify or void limitations/exclusions, or legislation could modify/bar their use. |
|||
* Governmental actions could result in higher than anticipated losses and LAE. |
|||
* Court decisions, like the 1995 Montrose decision in California, could narrowly read exclusions, expanding coverage and requiring new exclusions. |
|||
* These issues may adversely affect business by broadening coverage or increasing claim frequency/severity. |
|||
* Changes may not become apparent until years after affected insurance contracts are issued, making the full extent of liability unknown for a long time. |
|||
{{chunk|doc=3z7a4yrxkn|c=58|p=9}} |
|||
'''Reinsurer reimbursement risk''' |
|||
* Reinsurers may not reimburse claims timely or at all, materially adversely affecting business, financial condition, and results. |
|||
* Reinsurance contracts require premium payments to reinsurers who reimburse a portion of covered claims. |
|||
* Reinsurers may be called upon to reimburse claims many years after premiums are paid. |
|||
* Reinsurance makes the reinsurer liable but does not relieve the ceding insurer of primary liability to policyholders. |
|||
* The current reinsurance program aims to limit financial risk. |
|||
* Reinsurers may default due to insolvency, lack of liquidity, operational failure, political/regulatory prohibitions, fraud, asserted defenses, or documentation deficiencies. |
|||
* Disputes with reinsurers can be time-consuming, costly, and uncertain. |
|||
* These risks could lead to increased net losses and adversely affect financial condition. |
|||
* As of December 31, 2025, reinsurance recoverables were USD 1,119.9m. |
|||
{{chunk|doc=3z7a4yrxkn|c=59|p=9}} |
|||
'''Claims payment accuracy and timeliness''' |
|||
* Failure to accurately and timely pay claims could materially and adversely affect business, financial condition, results, and prospects. |
|||
* Factors affecting claims payment ability include training/experience of claims representatives (including TPAs), management effectiveness, and appropriate procedures/systems. |
|||
* Inaccurate or untimely claims payment could lead to regulatory/administrative actions, litigation, reputational damage, and adverse effects on business, financial condition, results, and prospects. |
|||
* Ineffective TPA management or internal staff/TPA inability to handle claim volume could adversely affect workload capacity. |
|||
* This could require slowing growth in affected markets and lead to decreased claims work quality, adversely affecting operating margins. |
|||
{{chunk|doc=3z7a4yrxkn|c=60|p=9}} |
|||
'''Catastrophic events and climate change''' |
|||
* Severe weather, climate change effects, catastrophes, pandemics, and man-made events may adversely affect business, results, and financial condition. |
|||
* Business is exposed to severe weather, earthquakes, and man-made catastrophes (explosions, war, terrorist attacks, riots). |
|||
* Changing weather patterns and climatic conditions (global warming) increase unpredictability and frequency of natural disasters, including in new areas. |
|||
* Climate change may increase frequency and severity of extreme weather events, leading to conditions that increase hurricane activity and wildfire risks. |
|||
* A natural disaster or catastrophe loss could materially adversely affect business, financial condition, and results. |
|||
* Catastrophes, even those not insured against (e.g., 2025 California wildfires), can lead to policy cancellations. |
|||
* Increased frequency and severity of weather events (hurricanes, convective storms) could materially increase losses and affect ability to predict, quantify, reinsure, and manage catastrophe risk. |
|||
* Extent of losses depends on frequency/severity of insured events and total insured exposure in affected areas. |
|||
* Incidence and severity of catastrophes and severe weather are inherently unpredictable. |
|||
* Exposure to losses is managed by analyzing probability/severity of events and their impact on underwriting/investment portfolio. |
|||
* Indirect impact can occur if insured businesses are affected by catastrophes not directly covered, leading to inability or unwillingness to pay premiums on other products. |
|||
* Inability to obtain reinsurance coverage at reasonable rates and adequate amounts for severe weather/catastrophes could materially adversely affect business and results. |
|||
* Business is exposed to risks from pandemics, outbreaks, public health crises, and geopolitical/social events. |
|||
* While policy terms typically exclude virus-related claims, court decisions and governmental actions may challenge exclusions or interpretations. |
|||
* Changes in domestic and international climate policy programs and initiatives, and related legislation/regulation, are unpredictable but could materially adversely affect business, operational results, and financial results. |
|||
{{chunk|doc=3z7a4yrxkn|c=61|p=9}} |
|||
'''Program administrator compliance''' |
|||
* Failure of program administrators to comply with pre-established guidelines could adversely affect results of operations. |
|||
* Certain insurance products are marketed and distributed through program administrators with limited quoting and binding authority. |
|||
* Program administrators sell products to insureds via retail agents and brokers and can bind certain risks without initial approval. |
|||
* Non-compliance with underwriting guidelines or appointment terms could bind the company to unanticipated risks, adversely affecting results. |
|||
{{chunk|doc=3z7a4yrxkn|c=62|p=9}} |
|||
'''Contract renewals and new business''' |
|||
* Failure of actual renewals or new business from repeat insureds to meet expectations could materially adversely affect future written premium and results. |
|||
* Most contracts are one-year term and renewable. |
|||
* Some insurance contracts do not renew, but insureds are repeat customers with regular new contracts. |
|||
* Financial forecasting includes assumptions about renewal rates and repeat business. |
|||
* Insurance and reinsurance industries are cyclical with intense, price-based competition. |
|||
* If actual renewals/repeat business do not meet expectations, or if renewals/repeat business are declined due to pricing, future written premium and operations would be materially adversely affected. |
|||
{{chunk|doc=3z7a4yrxkn|c=63|p=9}} |
|||
'''ESG matters and reputation''' |
|||
* Increased public attention to environmental, social, and governance (ESG) matters may expose the company to negative public perception, reputational harm, additional costs, or stock price impact. |
|||
* Failure or perceived failure to meet investor/customer ESG expectations could harm business and reputation. |
|||
* Backlash from investors or customers regarding ESG topics could also harm business and reputation. |
|||
* Reputational damage from providing policies to certain insureds could decrease demand for products, materially adversely affect business, operational results, and financial results, and require resources to rebuild reputation, competitive position, and brand strength. |
|||
{{chunk|doc=3z7a4yrxkn|c=64|p=9}} |
|||
'''Accounting practices and pronouncements''' |
|||
* Changes in accounting practices and future pronouncements may materially affect reported financial results. |
|||
* Developments in accounting practices may require considerable additional expenses for compliance, especially if retroactive application or prior period information is needed. |
|||
* The impact of changes in current accounting practices and future pronouncements is unpredictable but may affect net income, shareholder's equity, and other financial statement line items. |
|||
* Insurance subsidiaries must comply with statutory accounting principles (SAP). |
|||
* SAP is subject to constant review by the NAIC, its task forces/committees, and state insurance departments. |
|||
* Various proposals before NAIC committees could negatively affect insurance industry participants if enacted and adopted at the state level. |
|||
* The NAIC continuously examines existing laws and regulations. |
|||
* It is unpredictable whether reforms will be enacted, in what form, or their positive/negative effect. |
|||
{{chunk|doc=3z7a4yrxkn|c=65|p=9}} |
|||
'''Derivative use risks''' |
|||
* Use of derivatives to mitigate market price volatility exposes the company to risks that could adversely affect financial condition. |
|||
* Risks include hedge ineffectiveness due to imperfect correlation between derivatives and underlying exposures. |
|||
* Basis risk, where futures prices do not move in line with cash market prices, is another risk. |
|||
* Liquidity pressures can arise from margin call or collateral requirements during adverse market movements. |
|||
* Valuation uncertainty inherent in futures and options markets, stemming from reliance on market-based models, may cause hedges to perform differently than expected. |
|||
* These factors may prevent hedging strategies from effectively reducing volatility and could materially adversely impact financial results. |
|||
=== Risks Related to the Market and Economic Conditions === |
|||
{{chunk|doc=3z7a4yrxkn|c=66|p=9}} |
|||
'''Economic and market conditions impact on insurance business''' |
|||
* Adverse economic factors like recession, inflation, high unemployment, or lower economic activity could lead to fewer policy sales, increased claim frequency, premium defaults, or claim falsification, affecting growth and profitability. |
|||
* Business revenue, economic conditions, capital market volatility, and inflation affect the business and economic environment, impacting revenue and profit generation. |
|||
* An economic downturn with higher unemployment, declining spending, and reduced corporate revenue generally adversely affects demand for insurance products, impacting premium levels and profitability. |
|||
* Negative economic factors may affect the ability to charge appropriate rates for risk and reduce the number of policies written or opportunities for profitable underwriting. |
|||
* During an economic downturn, customers may reduce insurance needs, cancel policies, modify coverage, or not renew policies. |
|||
* Existing policyholders may exaggerate or falsify claims to obtain higher payments. |
|||
* A significant collapse in economic segments like construction, credit markets, or energy production/servicing could adversely affect results by reducing underwriting profit if not reflected in rates. |
|||
* The insurance business is historically cyclical, which can affect financial performance and cause operating results to vary quarterly, not indicative of future performance. |
|||
* Insurance carriers have historically experienced significant fluctuations in operating results due to competition, catastrophic events, capacity levels, litigation trends, regulatory constraints, and general economic conditions. |
|||
* The supply of insurance is related to prevailing prices, insured losses, and available capital, which fluctuate with investment returns in the industry. |
|||
* The insurance business is a cyclical industry with periods of intense price competition due to excessive underwriting capacity (soft market) and periods of capacity shortages increasing premium levels (hard market). |
|||
* Demand for insurance depends on factors like frequency/severity of catastrophic events, capacity levels, new capital providers, and general economic conditions, all of which fluctuate and can contribute to price declines. |
|||
* The profitability of most [[Definition:Property & casualty|P&C]] insurance companies tends to follow cyclical market patterns, with higher [[Definition:Gross written premiums|gross written premium]] growth and improved profitability during hard market cycles. |
|||
* This cyclical market pattern is more pronounced in the E&S market than in the standard insurance market. |
|||
* When the standard insurance market hardens, the E&S market typically hardens, and growth in the E&S market can be significantly more rapid. |
|||
* When conditions soften, customers previously in the E&S market may return to the admitted market, exacerbating the effects of rate decreases on financial results. |
|||
* The market may experience "micro cycles" where certain areas harden or soften independently and more drastically than the overall market. |
|||
* Operating results are subject to fluctuation and have historically varied quarter-to-quarter. |
|||
* Quarterly results are expected to continue fluctuating due to general economic conditions, frequency/severity of catastrophes, fluctuating interest rates, claims exceeding loss reserves, competition, deviations from expected premium retention, adverse investment performance, and reinsurance coverage costs. |
|||
{{chunk|doc=3z7a4yrxkn|c=67|p=9}} |
|||
'''Investment portfolio performance and risks''' |
|||
* Performance of the investment portfolio is subject to various investment risks that may adversely affect financial results. |
|||
* Results of operations depend partly on investment portfolio performance. |
|||
* The company aims to hold a diversified investment portfolio managed by professional advisory firms according to its investment policy and reviewed by its Investment Committee. |
|||
* Investments are subject to general economic conditions, market risks, and risks inherent to specific securities. |
|||
* Primary market risk exposures are to changes in interest rates and equity prices. |
|||
* A significant portion of the investment portfolio is in fixed maturity securities, or separately managed accounts and limited partnerships primarily invested in fixed maturity securities. |
|||
* Interest rates rose materially during 2022 and 2023. |
|||
* Declining interest rates, potentially due to federal government actions to slow inflation (e.g., recent rate cuts, Inflation Reduction Act of 2022), would pressure [[Definition:Net investment income|net investment income]], especially from fixed maturity and short-term investments, adversely affecting operating results. |
|||
* Recent and future interest rate increases could cause values of fixed income securities portfolios to decline, with magnitude depending on security duration and rate increase amount. |
|||
* Some fixed income securities have call or prepayment options, creating reinvestment risk in declining rate environments. |
|||
* Other fixed income securities, like mortgage-backed and asset-backed securities, carry prepayment risk or may not prepay as quickly as expected in a rising interest rate environment. |
|||
* All fixed maturity securities, including those in separately managed accounts and limited partnerships, are subject to credit risk. |
|||
* Credit risk is the risk of investment default or impairment due to deterioration in the financial condition of issuers or guarantors. |
|||
* Downgrades in credit ratings of fixed maturity securities could significantly negatively affect their market valuation. |
|||
* The company also invests in marketable preferred and common equity securities and exchange-traded funds. |
|||
* These equity securities are carried at fair market value on the balance sheet and are subject to potential losses and market value declines. |
|||
* Market and credit risks could reduce [[Definition:Net investment income|net investment income]] and result in realized investment losses. |
|||
* The investment portfolio is subject to increased valuation uncertainties when investment markets are illiquid, as with fixed maturity securities held to maturity, separately managed accounts, and limited partnership investments. |
|||
* Valuation of investments is more subjective in illiquid markets, increasing the risk that estimated fair value does not reflect actual transaction prices. |
|||
* Risks for all security types are managed through an investment policy that sets parameters including maximum investment percentages in certain securities and minimum credit quality levels. |
|||
* These investment parameters are believed to be within applicable guidelines established by the NAIC, the Texas Department of Insurance, and the Oklahoma Department of Insurance. |
|||
* The Investment Committee periodically reviews Enterprise Based Asset Allocation models for overall risk management. |
|||
* While capital preservation is sought, investment objectives may not be achieved, and results may vary substantially over time. |
|||
* Investment strategies are employed to not correlate with insurance and reinsurance exposures, but investment portfolio losses may coincide with underwriting losses, exacerbating adverse effects. |
|||
{{chunk|doc=3z7a4yrxkn|c=68|p=9}} |
|||
'''Investment liquidity and forced sales''' |
|||
* The company could be forced to sell investments to meet liquidity requirements. |
|||
* Premiums are invested until needed to pay policyholder claims. |
|||
* The duration of the investment portfolio is managed based on the duration of losses and LAE reserves to ensure sufficient liquidity and avoid liquidating investments to fund claims. |
|||
* Risks such as inadequate losses and LAE reserves or unfavorable litigation trends could necessitate selling investments to fund liabilities. |
|||
* Investments may not be sold at favorable prices or at all. |
|||
* Sales could result in significant realized losses depending on general market conditions, interest rates, and credit issues with individual securities. |
|||
=== Risks Related to the Regulatory Environment === |
|||
{{chunk|doc=3z7a4yrxkn|c=69|p=9}} |
|||
'''Regulatory environment and compliance risks''' |
|||
* Extensive regulation may adversely affect the company's ability to achieve business objectives. |
|||
* Failure to comply with regulations may result in penalties, including fines and suspensions, adversely affecting financial condition and results of operations. |
|||
* Primary insurance subsidiaries (GMIC, HSIC, IIC) are subject to extensive regulation in Texas (state of domicile) and other operating states. |
|||
* Insurance regulations are primarily designed to protect policyholders, not investors or stockholders. |
|||
* Regulations are administered by state departments of insurance and cover capital and surplus requirements, investment and underwriting limitations, affiliate transactions, [[Definition:Dividend|dividend]] limitations, changes in control, solvency, and other financial/non-financial aspects. |
|||
* Significant changes in laws and regulations could limit discretion or increase business costs. |
|||
* State insurance regulators conduct periodic examinations and require annual/other reports on financial condition and holding company issues. |
|||
* Regulatory requirements may impose timing and expense constraints, adversely affecting business objectives. |
|||
* Insurance subsidiaries are part of an "insurance holding company system" in Texas, requiring notice to the Texas Department of Insurance for certain affiliate transactions. |
|||
* Prior notification requirements may cause business delays and additional expenses. |
|||
* Failure to file required notifications or comply with Texas insurance regulations may lead to significant fines, penalties, and impaired working relationships with the Texas Department of Insurance. |
|||
* State insurance regulators have broad discretion to deny or revoke licenses for regulation violations. |
|||
* The company's interpretations of regulations or industry practices may differ from regulatory authorities' interpretations. |
|||
* Lack of requisite licenses/approvals or non-compliance could lead to suspension of activities or other penalties, adversely affecting business operations. |
|||
* Changes in insurance industry regulation, laws, or interpretations could interfere with operations and increase compliance costs. |
|||
{{chunk|doc=3z7a4yrxkn|c=70|p=9}} |
|||
'''Capital requirements and potential adverse impacts''' |
|||
* Insurance subsidiaries are subject to risk-based capital requirements based on the NAIC model and minimum capital/surplus restrictions under Texas law. |
|||
* These requirements establish minimum risk-based capital for business operations and identify inadequately capitalized [[Definition:Property & casualty|property and casualty]] insurers based on asset/liability risks and [[Definition:Net written premiums|net written premium]] mix. |
|||
* Insurers below a calculated threshold may face regulatory action, including supervision, rehabilitation, or liquidation. |
|||
* Failure to maintain required risk-based capital levels could adversely affect the ability of insurance subsidiaries to maintain regulatory authority and their A.M. Best Rating. |
|||
* The company may become subject to additional government or market regulation, which could have a material adverse impact on its business. |
|||
* Changes in laws related to asset/reserve valuation, surplus requirements, investment/[[Definition:Dividend|dividend]] limitations, enterprise risk, and risk-based capital could adversely affect the business. |
|||
* The U.S. federal government generally has not directly regulated the insurance industry, except for flood, nuclear, and terrorism risks. |
|||
* Potential federal legislation could affect the insurance industry in areas like privatization of government entities (e.g., Freddie Mac, Fannie Mae), reduction in federal subsidies for certain businesses (e.g., agriculture), tort reform, corporate governance, and taxation of reinsurance companies. |
|||
{{chunk|doc=3z7a4yrxkn|c=71|p=9}} |
|||
'''Tax law changes and net operating losses''' |
|||
* Changes to U.S. tax laws and new tax policies could significantly negatively impact the overall economy and the company's business. |
|||
* Legislative or other actions related to taxes could negatively affect the company, its investments, or stockholders. |
|||
* U.S. federal income tax rules are constantly under review by legislators, the IRS, and the U.S. Department of the Treasury. |
|||
* The company cannot predict with certainty how tax law changes might affect it, its stockholders, or portfolio investments. |
|||
* New legislation, U.S. Treasury regulations, administrative interpretations, or court decisions could have adverse consequences. |
|||
* On July 4, 2025, H.R. 1, the "One Big Beautiful Bill Act" (OBBBA), was signed into law in the United States. |
|||
* The OBBBA modifies key business tax provisions, including restoring 100% bonus depreciation under IRC Section 168(k), restoring immediate deduction of U.S. domestic research and experimental expenditures under IRC Section 174A, restoring the EBITDA-based business interest expense limitation under IRC Section 163(j), and changing international operations tax computations. |
|||
* Based on current analysis, the company does not believe OBBBA provisions will materially impact its business or results of operations. |
|||
* Regulations and IRS guidance implementing the OBBBA may create unforeseen issues, and further tax law changes may occur. |
|||
* There is no assurance that the company's business will not be adversely affected by the OBBBA or other tax law changes. |
|||
* The company's ability to utilize net operating loss carryforwards (NOLs) and other tax attributes may be limited. |
|||
* As of December 31, 2025, the company had gross federal income tax NOLs of approximately USD 40.3m available to offset future taxable income, prior to annual limitations under IRC Section 382. |
|||
* These NOLs are set to expire beginning in 2032. |
|||
* Under IRC Section 382, an "ownership change" (greater than 50% change in equity ownership by certain stockholders over a three-year period) can limit the use of pre-ownership change NOLs to offset post-ownership change income. |
|||
* The company may experience future ownership changes from stock ownership shifts, some outside its control. |
|||
* Future regulatory changes could also limit the ability to utilize NOLs. |
|||
* Inability to offset future taxable income with NOLs could adversely affect net income and cash flows. |
|||
{{chunk|doc=3z7a4yrxkn|c=72|p=9}} |
|||
'''Holding company liquidity and [[Definition:Dividend|dividend]] restrictions''' |
|||
* As a holding company, with substantially all operations conducted by insurance subsidiaries, liquidity at the holding company level (including ability to pay [[Definition:Dividend|dividends]] and service debt) depends on obtaining cash [[Definition:Dividend|dividends]] or other permitted payments from insurance subsidiaries. |
|||
* Continued operation and growth require substantial capital, so the company does not intend to declare and pay cash [[Definition:Dividend|dividends]] on common stock in the foreseeable future. |
|||
* The ability to pay [[Definition:Dividend|dividends]] to stockholders and meet debt obligations largely depends on [[Definition:Dividend|dividends]] and distributions from primary insurance subsidiaries (GMIC, HSIC, IIC). |
|||
* State insurance laws, including Texas laws, restrict the ability of GMIC, HSIC, and IIC to determine stockholder [[Definition:Dividend|dividends]]. |
|||
* State insurance regulators require insurance companies to maintain specified levels of statutory capital and surplus. |
|||
* [[Definition:Dividend|Dividend]] payments are limited to the portion of available policyholder surplus derived from net profits. |
|||
* State insurance regulators have broad powers to prevent reduction of statutory surplus to inadequate levels, and there is no assurance that maximum calculated [[Definition:Dividend|dividends]] would be permitted. |
|||
* State insurance regulators with jurisdiction over subsidiary [[Definition:Dividend|dividends]] may adopt more restrictive statutory provisions in the future. |
|||
* Any future [[Definition:Dividend|dividend]] determination will be at the discretion of the Board of Directors, depending on results of operations, financial condition, contractual debt restrictions, indebtedness, applicable law, and other relevant factors. |
|||
* Investors may need to sell common stock after price appreciation (which may not occur) to realize gains, as the only way to do so. |
|||
* Investors seeking immediate cash [[Definition:Dividend|dividends]] should not purchase the company's common stock. |
|||
{{chunk|doc=3z7a4yrxkn|c=73|p=9}} |
|||
'''Change of control regulations''' |
|||
* Applicable insurance laws may make it difficult to effect a change of control. |
|||
* Under Texas insurance laws and regulations, acquiring control of a domestic insurer requires written approval from the state insurance commissioner. |
|||
* Approval is contingent on factors including the acquirer's financial strength, plans for the insurer's future operations, and potential anti-competitive results. |
|||
* Texas insurance laws apply to direct and indirect acquisition of 10% or more of the voting stock of a Texas-domiciled insurer. |
|||
* Acquisition of 10% or more of the company's common stock would be considered an indirect change of control of Skyward Specialty, triggering applicable filing requirements under Texas insurance laws, unless a disclaimer of control filing is accepted by the Texas Insurance Department. |
|||
* These requirements may discourage potential acquisition proposals and may delay, deter, or prevent a change of control, even for transactions desirable to stockholders. |
|||
=== Risks Related to Our Liquidity and Access to Capital === |
|||
{{chunk|doc=3z7a4yrxkn|c=74|p=9}} |
|||
'''Future capital requirements''' |
|||
* We may require additional capital in the future, which may not be available or may only be available on unfavorable terms. |
|||
* Future capital requirements depend on factors including our ability to write new business successfully and to establish premium rates and reserves sufficient to cover losses. |
|||
* If operational cash flows are insufficient to fund future operating requirements and cover claim losses, or if capital is adversely impacted by investment portfolio fair value decline, catastrophe losses, or adverse reserve development, we may need to raise additional funds or curtail growth. |
|||
* Factors affecting capital needs include growth rate, profitability, claims experience, reinsurance availability, market disruptions, and other unforeseeable developments. |
|||
* If additional capital is needed, equity or debt financing may not be available or may be on unfavorable terms. |
|||
* Equity financings could result in dilution to stockholders. |
|||
* Debt financings may impose covenants restricting business operations. |
|||
* Such securities may have rights, preferences, and privileges senior to common stock. |
|||
* Inability to obtain adequate capital on favorable terms could materially adversely affect business, financial condition, or results of operations. |
|||
{{chunk|doc=3z7a4yrxkn|c=75|p=9}} |
|||
'''Revolving Credit Facility access and covenants''' |
|||
* The availability of credit under the Revolving Credit Facility is subject to conditions that may limit access. |
|||
* Inability to satisfy conditions for credit under the Revolving Credit Facility would prevent borrowing and may adversely affect liquidity, financial position, and results of operations. |
|||
* Failure to meet certain financial covenants required by credit agreements may materially and adversely affect assets, financial position, and cash flows. |
|||
* A breach of covenants under the Term Loan Facility and Revolving Credit Facility could result in an event of default. |
|||
* Upon an event of default, all outstanding amounts and accrued interest could be declared immediately due and payable by lenders. |
|||
* Our assets may not be sufficient to repay in full the payments due under credit agreements if an event of default occurs. |
|||
* The current credit market environment and other macro-economic challenges may adversely impact our ability to borrow sufficient funds or sell assets or equity to pay existing debt. |
|||
=== Risks Related to Our Operations === |
|||
{{chunk|doc=3z7a4yrxkn|c=76|p=9}} |
|||
'''personnel attraction and retention''' |
|||
* The company could be adversely affected by the loss of key personnel or inability to attract and retain qualified personnel. |
|||
* The company depends on attracting and retaining experienced personnel knowledgeable about its business. |
|||
* The talent pool for recruitment is limited and fluctuates based on market dynamics. |
|||
* Higher demand for skilled employees could increase compensation expectations, making it difficult to retain and recruit key personnel and maintain labor costs. |
|||
* Inability to retain or attract talented personnel could prevent the company from maintaining its competitive position, adversely affecting results of operations. |
|||
{{chunk|doc=3z7a4yrxkn|c=77|p=9}} |
|||
'''IT and cybersecurity risks''' |
|||
* Security breaches, data loss, cyberattacks, and IT failures could disrupt operations, damage reputation, and adversely affect business, operations, and financial results. |
|||
* The business is highly dependent on IT and telecommunications systems for underwriting, claims, actuarial functions, and financial reporting. |
|||
* Some systems may rely on third-party systems not under the company's control. |
|||
* Events like natural catastrophes, terrorist attacks, industrial accidents, computer viruses, and cyberattacks can cause system failures or inaccessibility. |
|||
* Sustained or repeated system failures could limit the ability to write business, provide customer service, pay claims, or operate normally. |
|||
* Computer viruses, hackers, employee misconduct, and external hazards can expose systems to security breaches. |
|||
* The company has experienced a data incident where attackers acquired certain data, which was determined to be immaterial. |
|||
* There is no evidence of nation-state actor involvement or misuse of information from the data incident. |
|||
* Future cybersecurity events may result in operational disruptions, unauthorized access, disclosure or loss of proprietary or customer data, leading to legal claims, regulatory scrutiny, reputational damage, and costs. |
|||
* SEC and state law requirements for public notification of incidents could exacerbate harm to the business. |
|||
* Harm to business and reputation could occur even if technology infrastructure is protected, if attempted security breaches are publicized. |
|||
* Advances in criminal capabilities, new vulnerabilities, or exploitation attempts could compromise security measures. |
|||
* Third parties to whom functions are outsourced are also subject to these risks. |
|||
* Increased use of third-party services (e.g., cloud technology) can make it harder to identify and respond to cyberattacks. |
|||
* Risks could increase as vendors adopt more cloud-based software services. |
|||
{{chunk|doc=3z7a4yrxkn|c=78|p=9}} |
|||
'''artificial intelligence impact''' |
|||
* Artificial intelligence (AI) is an evolving technology that may impact the company's business and operations. |
|||
* The rapid growth of AI and machine learning may alter the competitive landscape. |
|||
* Employees use AI for risk selection, pricing, and claims handling to improve effectiveness and efficiency. |
|||
* The company's competitive position may be harmed if competitors leverage AI solutions more quickly or effectively. |
|||
* If AI applications produce deficient, inaccurate, or biased content, analyses, or recommendations, the business, financial condition, results of operations, and reputation may be adversely affected. |
|||
* Costs may be incurred to adopt and deploy AI technologies that could become obsolete earlier than expected. |
|||
* There is no assurance that desired benefits from AI will be realized. |
|||
* There is uncertainty in the legal and regulatory landscape for AI at federal and state levels. |
|||
* Future laws, regulations, or industry standards for AI may be burdensome, costly, and restrict the ability to develop, adopt, and deploy AI technologies. |
|||
{{chunk|doc=3z7a4yrxkn|c=79|p=9}} |
|||
'''growth management and sustainability''' |
|||
* The company may not be able to manage its growth effectively. |
|||
* Future business growth could require additional capital, systems development, and skilled personnel. |
|||
* The company must meet capital needs, expand systems and internal controls, allocate human resources, hire and train qualified employees, and integrate acquired businesses effectively. |
|||
* Failure to manage growth effectively could materially adversely affect business, financial condition, and results of operations. |
|||
* Success of inorganic growth through acquisitions depends on identifying targets, negotiating favorable terms, completing transactions, and integrating targets. |
|||
* Anticipated benefits from acquisitions, such as revenue growth, operational efficiencies, or synergies, may not be realized. |
|||
* The company has experienced rapid growth in recent years, but these rates may not be indicative of future growth. |
|||
* Sustaining revenue growth consistent with recent history is not assured. |
|||
* Revenue growth depends on factors including effective product pricing, successful product deployment and renewals, attracting and retaining qualified underwriters and claims professionals, enhancing infrastructure and data systems, creating new distribution channels, introducing new products, competing effectively, and increasing brand awareness. |
|||
* Failure to accomplish these objectives makes forecasting future results difficult. |
|||
* Historical growth rate should not be considered indicative of future performance and may decline. |
|||
* Revenue could grow more slowly or decline for various reasons. |
|||
* Operating expenses are expected to increase, and if revenue growth does not offset these increases, business, financial position, and results of operations could be harmed, and profitability may not be achieved or maintained. |
|||
{{chunk|doc=3z7a4yrxkn|c=80|p=9}} |
|||
'''Apollo acquisition risks''' |
|||
* The acquisition and integration of Apollo may adversely affect the company's business, financial condition, and results of operations. |
|||
* The acquisition of Apollo was completed on January 1, [[Definition:Year 2026|2026]]. |
|||
* The acquisition is expected to provide strategic benefits, expand specialty insurance capabilities, and enhance presence in the Lloyd’s market. |
|||
* Integration of Apollo involves risks and uncertainties, including challenges in integrating operations, systems, technology platforms, and personnel. |
|||
* Integration difficulties may divert management attention, disrupt business, and incur unexpected costs or delays. |
|||
* There is no assurance that growth opportunities or other benefits from the acquisition will be realized within the expected timeframe or at all. |
|||
* Failure to achieve anticipated benefits could adversely affect results of operations and financial condition. |
|||
* Success of the acquisition depends on retaining key Apollo employees, partners, and customers. |
|||
* Loss of key personnel or business relationships could negatively impact the value of the acquired business and overall operations. |
|||
* Apollo operates in the Lloyd’s market with a distinct business culture and regulatory environment. |
|||
* Differences in business practices, risk appetite, and compliance requirements may challenge harmonization of policies and procedures. |
|||
* The acquisition may result in significant changes to financial statements, including recognition of goodwill and other intangible assets subject to impairment. |
|||
* The acquired business may have undisclosed liabilities or risks. |
|||
* Apollo's financial statements, currently prepared under U.K. GAAP, will need to be converted to U.S. GAAP, requiring adjustments to accounting policies, estimates, and disclosures. |
|||
* Expansion into new jurisdictions and markets, including Lloyd’s, increases exposure to regulatory scrutiny and compliance requirements. |
|||
* Failure to comply with applicable laws and regulations could result in fines, penalties, or other adverse consequences. |
|||
* Additional indebtedness was incurred in connection with the acquisition. |
|||
* The ability to service debt and comply with covenants may be affected by external events, limiting financial flexibility or increasing cost of capital. |
|||
* The integration process may divert management’s attention from existing business, negatively impacting ongoing operations and financial performance. |
|||
* Inability to successfully integrate Apollo, realize anticipated benefits, or manage risks could materially and adversely affect business, financial condition, and results of operations. |
|||
{{chunk|doc=3z7a4yrxkn|c=81|p=9}} |
|||
'''litigation risks''' |
|||
* The effects of litigation are uncertain and could adversely affect the business. |
|||
* The company faces risks from various types of litigation, including disputes related to insurance claims and general commercial/corporate litigation. |
|||
* While not currently involved in out-of-the-ordinary litigation, other industry members face class action lawsuits and other litigation with unpredictable outcomes and substantial amounts. |
|||
* Social inflation, particularly in third-party claims, can lead to oversized judgments. |
|||
* Litigation costs and settlement amounts can be inflated beyond historical reasonable levels, even if cases do not reach judgment. |
|||
* Litigation is based on issues including insurance and claim settlement practices. |
|||
* The company cannot predict future involvement in such litigation or its impact. |
|||
{{chunk|doc=3z7a4yrxkn|c=82|p=9}} |
|||
'''vendor and third-party risks''' |
|||
* Loss of key vendor relationships or failure of a vendor to protect data could affect operations. |
|||
* The company relies on services and products from many vendors in the U.S. and abroad, including computer hardware/software, claim adjustment, HR benefits management, and investment management. |
|||
* Vendor bankruptcy, inability to provide services, system breaches, or failure to protect confidential information could lead to operational impairments and financial losses. |
|||
* Failure to properly assess and understand risks and costs in third-party relationships could materially and adversely affect financial condition and results of operations. |
|||
* The company anticipates continued reliance on third-party software. |
|||
* While commercially reasonable alternatives to current licensed third-party software are believed to exist, this may not always be the case, or replacement could be difficult/costly. |
|||
* Integration of new third-party software may require significant work and investment. |
|||
* Use of additional or alternative third-party software would require license agreements, which may not be available on commercially reasonable terms or at all. |
|||
* Many risks associated with third-party software cannot be eliminated and could negatively affect the business. |
|||
{{chunk|doc=3z7a4yrxkn|c=83|p=9}} |
|||
'''intellectual property risks''' |
|||
* The company may fail to protect its intellectual property rights for its proprietary technology platform and brand, or may be sued for infringement. |
|||
* Success and ability to compete depend partly on intellectual property, including brand rights and proprietary technology. |
|||
* The company primarily relies on copyright and trade secret laws, and confidentiality agreements to protect intellectual property. |
|||
* Steps taken to protect intellectual property may be inadequate. |
|||
* Efforts to enforce intellectual property rights may face defenses, counterclaims, and countersuits challenging validity, enforceability, and scope. |
|||
* Failure to secure, protect, and enforce intellectual property rights could adversely affect the brand and business. |
|||
* Success also depends on not infringing on others' intellectual property rights. |
|||
* Competitors and other entities may own or claim intellectual property related to the industry or company. |
|||
* Third parties may claim infringement, and the company may be found to be infringing. |
|||
* Claims or litigation could incur significant expenses, require substantial damages or royalty payments, prevent service offerings, or impose unfavorable terms. |
|||
* Even if successful in a dispute, litigation could be costly, time-consuming, and divert management attention. |
|||
=== Risks Related to Ownership of Our Common Stock === |
|||
{{chunk|doc=3z7a4yrxkn|c=84|p=9}} |
|||
'''Public company compliance costs and risks''' |
|||
* Operating as a public company incurs increased costs and requires substantial management time for compliance initiatives. |
|||
* Financial reporting and other requirements may exceed the preparedness of accounting and management systems and resources. |
|||
* As a public company and large accelerated filer, significant legal, accounting, and other expenses are incurred that would not be present as a private company. |
|||
* Federal securities laws, including Sarbanes-Oxley Act, Dodd-Frank Act, and SEC/Nasdaq rules, impose requirements on public companies, such as filing annual, quarterly, and event-driven reports, and maintaining effective disclosure, financial controls, and corporate governance practices. |
|||
* These rules increase legal and financial compliance costs, make activities more time-consuming and costly, and require significant management and personnel time for compliance. |
|||
* There is a risk of not producing reliable financial statements or filing them timely with the SEC, or complying with Nasdaq listing requirements. |
|||
* Section 404 of the Sarbanes-Oxley Act requires system and process evaluation and testing of internal control over financial reporting, leading to substantial accounting expense and significant management effort. |
|||
* Compliance with Section 404 necessitates maintaining accounting and finance staff and consultants with public company reporting, technical accounting, and internal control knowledge, and providing internal audit services. |
|||
* Achieving Section 404 compliance involves a costly and challenging process to document and evaluate internal control over financial reporting. |
|||
* This process requires dedicating internal resources, engaging outside consultants, adopting a detailed work plan, improving control processes, validating controls through testing, and implementing continuous reporting and improvement. |
|||
* There is a risk that neither the company nor its independent registered public accounting firm will conclude that internal control over financial reporting is effective within the prescribed timeframe, potentially leading to adverse financial market reactions due to loss of confidence in financial statement reliability. |
|||
* Non-compliance could also lead to investigations by the SEC or other regulatory authorities, requiring additional financial and management resources. |
|||
* Disclosure controls and procedures are required to ensure information for SEC reports is recorded, processed, summarized, and reported within specified time periods. |
|||
* Disclosure controls and procedures or internal control over financial reporting are not expected to prevent or detect all errors and fraud. |
|||
* A control system provides only reasonable, not absolute, assurance that objectives will be met due to inherent limitations. |
|||
* No evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud have been detected. |
|||
* Control system design is based on assumptions about future events, and may not succeed under all potential future conditions. |
|||
* Controls may become inadequate over time due to changing conditions or deterioration in compliance with policies or procedures. |
|||
* Misstatements due to error or fraud may occur and not be detected because of inherent limitations in the control system. |
|||
* Failure to achieve and maintain effective internal controls, as required by Section 404 of the Sarbanes-Oxley Act, could harm operating results and financial condition, and negatively affect the market price of common stock. |
|||
* Section 404(b) of the Sarbanes-Oxley Act requires annual assessments by management of the effectiveness of internal control over financial reporting. |
|||
* Substantial internal control systems and procedures must be implemented and maintained to satisfy Exchange Act reporting requirements. |
|||
* Deficiencies may be identified during assessments that cannot be remediated timely. |
|||
* Testing and maintaining internal control over financial reporting may divert management's attention from other important business matters. |
|||
* There is a risk of not being able to conclude on an ongoing basis that internal control over financial reporting is effective under Section 404(b) of Sarbanes-Oxley. |
|||
* If internal control over financial reporting is deemed ineffective, remediation actions could be costly and significantly impact operations. |
|||
* Material weaknesses or other deficiencies in internal control over financial reporting may impede the ability to file timely and accurate reports with the SEC. |
|||
* Any of these issues could cause investors to lose confidence in reported financial information or lead to suspension or termination of common stock listing on Nasdaq, negatively affecting the trading price. |
|||
* A material weakness in internal control over information technology general controls ("ITGCs") was identified as of December 31, 2024, and remediated as of December 31, 2025. |
|||
* Failure to maintain an effective system of internal controls could adversely affect the market price of common stock. |
|||
* The effectiveness of controls and procedures is subject to inherent limitations, meaning there is no assurance they will prevent or detect misstatements. |
|||
* Even an effective ITGC system provides only reasonable, not absolute, assurance regarding ITGCs. |
|||
* Control deficiencies over ITGCs, constituting a material weakness, were identified during the fiscal year ended December 31, 2024, as described in "ITEM 9A. CONTROLS & PROCEDURES" of the Annual Report on Form 10-K for that period. |
|||
* Measures have been taken to remediate the identified material weakness, and it is believed to be remediated. |
|||
* If additional material weaknesses or significant deficiencies are identified, required financial information may not be provided timely and reliably, or financial information may be incorrectly reported. |
|||
* Untimely filing of financial statements could lead to adverse action by shareholders, Nasdaq, the SEC, or other regulatory authorities. |
|||
* Material weaknesses or significant deficiencies in internal controls could adversely affect reputation or investor perceptions, negatively impacting the trading price of common shares. |
|||
* Additional costs may be incurred to remediate material weaknesses or significant deficiencies in internal controls. |
|||
* There is no assurance that additional material weaknesses or restatements of financial results will not arise in the future due to inadequate internal controls. |
|||
* Current controls and procedures may not be adequate in the future to prevent or identify irregularities or errors, or to facilitate fair presentation of financial statements. |
|||
{{chunk|doc=3z7a4yrxkn|c=85|p=9}} |
|||
'''Stock price volatility and investment risk''' |
|||
* Operating results and stock price may be volatile or decline regardless of operating performance, leading to potential loss of investment. |
|||
* The market price of common stock has been and is likely to remain highly volatile, fluctuating substantially due to many factors beyond the company's control. |
|||
* Securities markets worldwide have experienced and are expected to continue experiencing significant price and volume fluctuations. |
|||
* Market volatility, general economic, market, or political conditions could cause wide price fluctuations in shares regardless of operating performance. |
|||
* Investment in common stock is considered risky and should only be undertaken if significant loss and wide market value fluctuation can be withstood. |
|||
* Factors that could affect the stock price include: market conditions in the broader stock market; actual or anticipated fluctuations in quarterly financial and operating results; introduction of new products or services by the company or competitors; issuance of new or changed securities analysts’ reports or recommendations; operating results varying from expectations of securities analysts and investors; short sales, hedging, and other derivative transactions in common stock; guidance provided to the public, changes in guidance, or failure to meet guidance; strategic actions by the company or competitors; announcements by the company, competitors, or acquisition targets; sales, or anticipated sales, of large blocks of stock by directors, executive officers, and principal stockholders; additions or departures in the Board of Directors, senior management, or other key personnel; regulatory, legal, or political developments; public response to press releases or other public announcements by the company or third parties, including SEC filings; litigation and governmental investigations; changing economic conditions, including social inflation; changes in accounting principles; any future indebtedness or securities issued; default under agreements governing indebtedness; exposure to capital and credit market risks adversely affecting the investment portfolio or capital resources; changes in credit ratings; and other events or factors, including natural disasters, war, acts of terrorism, or responses to these events. |
|||
* Securities markets have experienced extreme price and volume fluctuations unrelated or disproportionate to company operating performance. |
|||
* Investors in common stock may not be able to resell shares at or above their purchase price due to these factors. |
|||
* Broad market fluctuations, general market, economic, and political conditions (e.g., recessions, loss of investor confidence, interest rate changes) may negatively affect the market price of common stock. |
|||
* Stock markets, including Nasdaq, have experienced extreme price and volume fluctuations affecting equity securities of many companies. |
|||
* Such occurrences could cause the stock price to fall and expose the company to securities class action litigation, which could be costly to defend, divert management's attention and resources, or harm the business. |
|||
{{chunk|doc=3z7a4yrxkn|c=86|p=9}} |
|||
'''Underwriting guidelines and strategy changes''' |
|||
* Management can change underwriting guidelines or strategy without stockholder approval or notice. |
|||
* This authority allows fundamental changes to operations without stockholder approval, potentially leading to a strategy or underwriting guidelines materially different from those described in the "Business" section or other filings. |
|||
{{chunk|doc=3z7a4yrxkn|c=87|p=9}} |
|||
'''Anti-takeover provisions and corporate governance''' |
|||
* Anti-takeover provisions in organizational documents could prevent or delay a change of control beneficial to shareholders and limit share price. |
|||
* Provisions in the certificate of incorporation and by-laws, Delaware law, and federal/state/insurance regulations may discourage, delay, or prevent mergers, tender offers, or other changes of control that security holders might consider favorable. |
|||
* These provisions impose procedural and other requirements that could make it more difficult for shareholders to effect certain corporate actions, potentially adversely affecting the common stock price. |
|||
* Charter documents permit the Board of Directors to establish the number of directors and fill vacancies and newly created directorships. |
|||
* The Board of Directors is classified into three classes with staggered, three-year terms, and directors may only be removed for cause. |
|||
* Super-majority voting is required to amend provisions in the certificate of incorporation and bylaws. |
|||
* Blank-check preferred stock is included, with preference rights and terms set by the Board of Directors, which could delay or prevent a transaction or change in control that might involve a premium price for common stock or otherwise benefit stockholders. |
|||
* The ability of stockholders to call special meetings is eliminated. |
|||
* Special meetings of stockholders can only be called by the Board of Directors, the chairman of the Board of Directors, or the chief executive officer. |
|||
* Stockholder consent action is prohibited unless by unanimous written consent. |
|||
* Vacancies on the Board of Directors may be filled only by a majority of directors then in office, even if less than a quorum. |
|||
* Cumulative voting in the election of directors is prohibited. |
|||
* Advance notice requirements are established for nominations for election to the Board of Directors or for proposing matters at annual stockholder meetings. |
|||
* As a Delaware corporation, the company is subject to Section 203 of the Delaware General Corporation Law, which may prohibit large stockholders (owning 15% or more of voting stock) from merging or combining for a period of time. |
|||
{{chunk|doc=3z7a4yrxkn|c=88|p=9}} |
|||
'''Exclusive forum provisions''' |
|||
* The certificate of incorporation and bylaws designate the Court of Chancery of the State of Delaware as the exclusive forum for substantially all disputes between the company and its stockholders. |
|||
* This could limit stockholders' ability to obtain a favorable judicial forum for disputes with the company or its directors, officers, or employees. |
|||
* The exclusive forum applies to: any derivative action or proceeding on the company's behalf; any action asserting a claim of breach of fiduciary duty by directors, officers, employees, or agents, or stockholders; any action asserting a claim under DGCL or the certificate of incorporation/bylaws, or where DGCL confers jurisdiction on the Court of Chancery; any action to interpret, apply, enforce, or determine the validity of the certificate of incorporation or bylaws; or any action asserting a claim governed by the internal affairs doctrine. |
|||
* The certificate of incorporation and bylaws also state that federal district courts of the United States of America are the sole and exclusive forum for resolutions of any complaint arising under the Securities Act, unless written consent for an alternative forum is given. |
|||
* This application to Securities Act claims and Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over suits to enforce duties or liabilities created by the Securities Act or its rules. |
|||
* There is uncertainty whether a court would enforce such a provision, and stockholders will not be deemed to have waived compliance with federal securities laws. |
|||
* This exclusive forum provision would not apply to suits brought to enforce a duty or liability created by the Exchange Act or any other claim for which federal courts have exclusive jurisdiction. |
|||
* If enforced, this choice of forum provision may limit a stockholder’s ability to bring a claim in a preferred judicial forum, potentially discouraging lawsuits against the company and its personnel, though stockholders are not deemed to waive federal securities law compliance. |
|||
* If a court finds the choice of forum provision inapplicable or unenforceable, additional costs may be incurred to resolve actions in other jurisdictions, which could materially adversely affect the business, financial condition, or results of operations. |
|||
== Cybersecurity == |
== Cybersecurity == |
||
{{chunk|doc=3z7a4yrxkn|c=89|p=10}} |
|||
* ''IT Systems'' are central to nearly all business operations, including internal/external communications, document/record management, and shared work environments <sup>p. 28</sup>. |
|||
'''Cybersecurity risk management strategy''' |
|||
* ''Crisis Response Plan (CRP)'' is implemented to efficiently and effectively respond to cybersecurity incidents and threats, forming a component of the overall ERM strategy <sup>p. 28</sup>. |
|||
* ''Cybersecurity risk management'' processes are integrated into overall risk management, including annual evaluation by the enterprise risk management committee <sup>p. 28</sup>. |
|||
* IT Systems are central to nearly all business operations, including internal/external communications, document/record management, and shared work environments. |
|||
* ''Risk owners'' are assigned to develop and track mitigation plans for heightened cybersecurity risks identified by the ERM process <sup>p. 28</sup>. |
|||
* Responding to cybersecurity incidents and threats is a key component of the overall ERM strategy. |
|||
* ''Security events and data incidents'' are evaluated, ranked by severity, prioritized for response/remediation, and reviewed for materiality, operational/business impact, and privacy impact <sup>p. 28</sup>. |
|||
* A Crisis Response Plan (CRP) has been implemented to address cybersecurity incidents and threats. |
|||
* ''Cybersecurity risk management program'' leverages the National Institute of Standards and Technology framework, categorizing risks into identify, protect, detect, respond, recover, and govern <sup>p. 28</sup>. |
|||
* Management and IT personnel have implemented processes for assessing, identifying, managing, and escalating material cybersecurity risks, integrated into overall risk management. |
|||
* ''Company-wide policies and procedures'' address cybersecurity matters, including encryption standards, antivirus protection, remote access, multifactor authentication, confidential information, and internet/social media/email use <sup>p. 28</sup>. |
|||
* Cybersecurity risks are included in the risk universe evaluated annually by the enterprise risk management committee. |
|||
* ''Detailed crisis response playbook'' is followed in the event of an incident <sup>p. 28</sup>. |
|||
* Risk owners are assigned to develop and track mitigation plans for heightened cybersecurity risks identified by the ERM process. |
|||
* ''Investments in IT security'' have expanded, including end-user training, layered defenses, critical asset identification/protection, strengthened monitoring/alerting, and expert engagement <sup>p. 28</sup>. |
|||
* Security events and data incidents are evaluated, ranked by severity, prioritized for response/remediation, and reviewed for materiality, operational/business impact, and privacy impact. |
|||
* ''Defenses are regularly tested'' through simulations, technical drills (penetration tests), and reviews of operational policies/procedures with third-party experts <sup>p. 28</sup>. |
|||
* The cybersecurity risk management program uses the National Institute of Standards and Technology framework, which categorizes risks into identify, protect, detect, respond, recover, and govern. |
|||
* ''IT security team'' monitors alerts, discusses threat levels/trends/remediation, prepares a quarterly cyber scorecard, collects data on threats/risk areas, and conducts annual risk assessments <sup>p. 28</sup>. |
|||
* Company-wide policies and procedures cover cybersecurity matters, including encryption standards, antivirus protection, remote access, multifactor authentication, confidential information, and internet/social media/email use. |
|||
* ''Periodic external penetration tests, red team testing, and maturity testing'' are conducted to assess processes, procedures, and the threat landscape <sup>p. 28</sup>. |
|||
* A detailed crisis response playbook is followed in the event of an incident. |
|||
* ''External cybersecurity legal counsel'' would consult and coordinate with other third parties, including communication and notification, in the event of an incident <sup>p. 28</sup>. |
|||
* Investments in IT security have expanded, including end-user training, layered defenses, critical asset identification/protection, strengthened monitoring/alerting, and expert engagement. |
|||
* ''Cybersecurity vendors'' would perform investigation services and assist with recovery/restoration of impacted IT System services <sup>p. 28</sup>. |
|||
* Defenses are regularly tested through technical simulations (e.g., penetration tests) and reviews of operational policies/procedures with third-party experts. |
|||
* ''Cybersecurity experts'' would assist with incident validation and ransomware demands <sup>p. 28</sup>. |
|||
* The IT security team monitors alerts, discusses threat levels/trends/remediation, prepares a quarterly cyber scorecard, collects data on cybersecurity threats/risk areas, and conducts an annual risk assessment. |
|||
* ''Cybersecurity insurance providers'' are involved in incident response <sup>p. 28</sup>. |
|||
* Periodic external penetration tests, red team testing, and maturity testing are conducted to assess processes, procedures, and the threat landscape. |
|||
* ''Processes are implemented to oversee and identify risks'' from cybersecurity threats associated with key third-party service providers <sup>p. 28</sup>. |
|||
* In the event of an incident, outside cybersecurity legal counsel consults and coordinates with other third parties (e.g., communication/notification, cybersecurity vendors for investigation/recovery, cybersecurity experts for validation/ransomware assistance, cybersecurity insurance providers). |
|||
* ''Third-party service providers'' are required to provide SOC-1 or SOC-2 reports and cybersecurity/disaster recovery plans <sup>p. 28</sup>. |
|||
* Processes are implemented to oversee and identify risks from cybersecurity threats associated with key third-party service providers. |
|||
* ''Cybersecurity risk management and strategy processes'' are overseen by leaders from the Information Security Team, with assistance from Compliance and Legal teams <sup>p. 28</sup>. |
|||
* Third-party service providers are required to provide SOC-1 or SOC-2 reports and their cybersecurity/disaster recovery plans. |
|||
* ''Information Security Team leaders'' have decades of experience in IT roles, including security, auditing, compliance, systems, and programming <sup>p. 28</sup>. |
|||
* ''These individuals'' monitor prevention, mitigation, detection, and remediation of cybersecurity incidents through their management and participation in risk management processes and the crisis response plan <sup>p. 28</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=90|p=10}} |
|||
* ''The Risk Committee'' receives reports from these individuals on appropriate items <sup>p. 28</sup>. |
|||
'''Cybersecurity governance and oversight''' |
|||
* ''Risk Committee of the Board of Directors'' oversees cybersecurity strategy, reviews cybersecurity and other IT risks/controls/procedures, and receives periodic updates from management on cybersecurity measures <sup>p. 28</sup>. |
|||
* ''Review by the Risk Committee'' includes discussion of risks from cybersecurity threats and their potential operational impact <sup>p. 28</sup>. |
|||
* Cybersecurity risk management and strategy processes are overseen by leaders from the Information Security Team, with assistance from Compliance and Legal teams. |
|||
* ''Separate process for communicating with the Risk Committee'' is instituted for specific cybersecurity incidents <sup>p. 28</sup>. |
|||
* These individuals have decades of experience in IT roles, including security, auditing, compliance, systems, and programming. |
|||
* ''Crisis Management Team members'' would provide initial awareness communication of an incident to the CEO/Chair of the Board, who would then inform the Chair of the Risk Committee <sup>p. 28</sup>. |
|||
* They monitor prevention, mitigation, detection, and remediation of cybersecurity incidents through management and participation in risk management processes and report to the Risk Committee. |
|||
* ''Following initial assessment by senior management and IT Systems personnel'', a follow-up communication would be provided to the CEO and Risk Committee Chair to determine if escalation to the full Board is warranted <sup>p. 28</sup>. |
|||
* The Risk Committee of the Board of Directors oversees cybersecurity strategy, reviews cybersecurity and other IT risks/controls/procedures, and receives periodic updates from management on cybersecurity measures. |
|||
* ''Cybersecurity threats'' have not materially affected business strategy, results of operations, or financial condition <sup>p. 28</sup>. |
|||
* This review includes discussion of cybersecurity threat risks and their potential operational impact. |
|||
* ''A cybersecurity incident'' resulting in a serious compromise of IT Systems or a demand for payment to restore IT Systems could have a material adverse effect by negatively impacting business operations and diverting management/financial resources <sup>p. 28</sup>. |
|||
* A separate process exists for communicating with the Risk Committee during a specific cybersecurity incident. |
|||
* In an incident, the Crisis Management Team provides an initial awareness communication to the CEO/Chair of the Board. |
|||
* The CEO/Chair of the Board then informs the Chair of the Risk Committee. |
|||
* Following an initial assessment by senior management and IT Systems personnel, a follow-up communication is provided to the CEO and Risk Committee Chair to determine if full Board escalation is warranted. |
|||
{{chunk|doc=3z7a4yrxkn|c=91|p=10}} |
|||
'''Cybersecurity risk impact''' |
|||
* Cybersecurity threats have not materially affected business strategy, results of operations, or financial condition. |
|||
* A cybersecurity incident resulting in a serious compromise of IT Systems or a demand for payment to restore IT Systems could have a material adverse effect. |
|||
* Such an incident could negatively impact the ability to operate effectively and divert management/financial resources. |
|||
== Properties == |
== Properties == |
||
{{chunk|doc=3z7a4yrxkn|c=92|p=11}} |
|||
* ''Primary executive offices'' and insurance operations are leased in Houston, Texas <sup>p. 29</sup>. |
|||
'''Office facilities''' |
|||
* The Houston office space occupies approximately ''20,400 square feet'' <sup>p. 29</sup>. |
|||
* The lease for the Houston office space expires in ''2029'' <sup>p. 29</sup>. |
|||
* The company leases its primary executive offices and insurance operations in Houston, Texas. |
|||
* Additional office space is leased as appropriate <sup>p. 29</sup>. |
|||
* The Houston office occupies approximately 20,400 square feet of space. |
|||
* Management considers current office facilities suitable and adequate for current operations <sup>p. 29</sup>. |
|||
* The lease for the Houston office space expires in 2029. |
|||
* Additional office space is leased where appropriate. |
|||
* Management considers the office facilities suitable and adequate for current operations. |
|||
== Legal Proceedings == |
== Legal Proceedings == |
||
{{chunk|doc=3z7a4yrxkn|c=93|p=12}} |
|||
* The company is involved in legal proceedings that occur in the ordinary course of business <sup>p. 30</sup>. |
|||
'''Legal proceedings''' |
|||
* The company believes that the outcome of these legal matters, both individually and in aggregate, will not materially adversely affect its consolidated financial position <sup>p. 30</sup>. |
|||
* The company is party to legal proceedings arising in the ordinary course of business. |
|||
* The company believes the outcome of these matters, individually and in aggregate, will not have a material adverse effect on its consolidated financial position. |
|||
== Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities == |
== Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities == |
||
{{chunk|doc=3z7a4yrxkn|c=94|p=13}} |
|||
* ''Common shares'' began trading on the NASDAQ Global Select Market under the symbol "SKWD" on January 13, 2023 <sup>p. 31</sup>. |
|||
'''Common stock trading and holders''' |
|||
* Prior to January 13, 2023, there was no public market for the company's common shares <sup>p. 31</sup>. |
|||
* As of February 26, 2026, there were approximately ''117 holders of record'' of the common stock <sup>p. 31</sup>. |
|||
* This number does not represent the total number of stockholders because many shares are held by brokers and other institutions on behalf of stockholders <sup>p. 31</sup>. |
|||
* Common shares began trading on the NASDAQ Global Select Market under the symbol “SKWD” on January 13, 2023. |
|||
====== Securities Authorized for Issuance Under Equity Compensation Plans ====== |
|||
* Prior to January 13, 2023, there was no public market for the company's common shares. |
|||
* As of February 26, [[Definition:Year 2026|2026]], there were approximately 117 holders of record of common stock. |
|||
* The number of record holders does not represent the total number of stockholders due to shares being held by brokers and other institutions. |
|||
=== Securities Authorized for Issuance Under Equity Compensation Plans === |
|||
* Information regarding equity compensation plans will be included in the definitive proxy statement for the 2026 Annual Meeting of Stockholders ("2026 Proxy Statement") and is incorporated by reference <sup>p. 32</sup>. |
|||
* Refer to Part III for details on securities authorized for issuance under equity compensation plans <sup>p. 32</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=95|p=13}} |
|||
====== Recent Sales of Unregistered Equity Securities ====== |
|||
'''Equity compensation plan information''' |
|||
* Information regarding equity compensation plans will be included in the definitive proxy statement to be filed with the SEC for the [[Definition:Year 2026|2026]] Annual Meeting of Stockholders ("[[Definition:Year 2026|2026]] Proxy Statement"). |
|||
* Information is provided regarding securities issued or granted by the company that were not registered under the Securities Act during the period covered by this Annual Report on Form 10-K <sup>p. 33</sup>. |
|||
* This information is incorporated by reference into the current document. |
|||
* On ''January 1, 2026'', the company paid approximately ''$555.0 million'' for the Apollo acquisition, as per the Apollo SPAs <sup>p. 33</sup>. |
|||
* Part III contains details on securities authorized for issuance under equity compensation plans. |
|||
* The payment for the Apollo acquisition included ''$371.0 million'' in cash <sup>p. 33</sup>. |
|||
* The payment also included the issuance of ''3,679,332'' unregistered shares of the Company’s common stock <sup>p. 33</sup>. |
|||
=== Recent Sales of Unregistered Equity Securities === |
|||
====== Performance Graph ====== |
|||
{{chunk|doc=3z7a4yrxkn|c=96|p=13}} |
|||
* The performance graph compares the cumulative total shareholder return of an investment in Skyward Specialty Insurance Group, Inc. common stock, the Nasdaq Composite Index, and the Nasdaq Insurance Index <sup>p. 34</sup>. |
|||
'''Unregistered equity securities issuance''' |
|||
* The comparison period is from January 13, 2023 (the date common stock began trading on Nasdaq) through December 31, 2025 <sup>p. 34</sup>. |
|||
* The graph assumes an initial investment of $100 <sup>p. 34</sup>. |
|||
* Returns are based on historical results and are not indicative of future performance <sup>p. 34</sup>. |
|||
* The graph is not considered "soliciting material" or "filed" for purposes of Section 18 of the Exchange Act, nor is it subject to liabilities under that Section <sup>p. 34</sup>. |
|||
* The graph is not deemed to be incorporated by reference into any filings under the Securities Act <sup>p. 34</sup>. |
|||
* ''Skyward Specialty Insurance Group, Inc. (Blue Line) performance'': |
|||
** January 13, 2023: $100.00 <sup>p. 34</sup> |
|||
** December 31, 2023: Approximately $177.00 <sup>p. 34</sup> |
|||
** December 31, 2024: Approximately $265.00 <sup>p. 34</sup> |
|||
** December 31, 2025: Approximately $268.00 <sup>p. 34</sup> |
|||
* ''Nasdaq Composite Index (Magenta Line) performance'': |
|||
** January 13, 2023: $100.00 <sup>p. 34</sup> |
|||
** December 31, 2023: Approximately $138.00 <sup>p. 34</sup> |
|||
** December 31, 2024: Approximately $174.00 <sup>p. 34</sup> |
|||
** December 31, 2025: Approximately $210.00 <sup>p. 34</sup> |
|||
* ''Nasdaq Insurance Index (Cyan Line) performance'': |
|||
** January 13, 2023: $100.00 <sup>p. 34</sup> |
|||
** December 31, 2023: Approximately $105.00 <sup>p. 34</sup> |
|||
** December 31, 2024: Approximately $128.00 <sup>p. 34</sup> |
|||
** December 31, 2025: Approximately $128.00 <sup>p. 34</sup> |
|||
* Information is provided regarding securities issued or granted by the company during the period covered by this Annual Report on Form 10-K that were not registered under the Securities Act. |
|||
====== Skyward Specialty Insurance Group stock price versus indices ====== |
|||
* On January 1, [[Definition:Year 2026|2026]], the company paid approximately USD 555.0m in connection with the Apollo acquisition, pursuant to the Apollo SPAs. |
|||
* The payment for the Apollo acquisition included USD 371.0m in cash and the issuance of 3,679,332 unregistered shares of the Company’s common stock. |
|||
=== Performance Graph === |
|||
{{chunk|doc=3z7a4yrxkn|c=97|p=13}} |
|||
'''Shareholder return comparison''' |
|||
* The performance graph compares the cumulative total shareholder return of an investment in (1) the company's common stock, (2) the Nasdaq Composite Index, and (3) the Nasdaq Insurance Index. |
|||
* The comparison period is from January 13, 2023 (the date common stock began trading on Nasdaq) through December 31, 2025. |
|||
* The graph assumes an initial investment of USD 100. |
|||
* Such returns are based on historical results and are not indicative of future performance. |
|||
* This graph is not considered "soliciting material" or "filed" for purposes of Section 18 of the Exchange Act, nor is it subject to liabilities under that Section. |
|||
* The graph is not deemed to be incorporated by reference into any company filings under the Securities Act. |
|||
{{chunk|doc=3z7a4yrxkn|c=98|p=13}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1004" class="wikitable fintable" |
||
|+ Performance Graph |
|||
! style="text-align:left" | — |
|||
|- |
|||
! style="text-align:left" | |
|||
! class="col-s" style="text-align:right" | January 13, 2023 |
! class="col-s" style="text-align:right" | January 13, 2023 |
||
! class="col-s" style="text-align:right" | December 31, 2023 |
! class="col-s" style="text-align:right" | December 31, 2023 |
||
| Line 1,322: | Line 1,748: | ||
|} |
|} |
||
</div> |
</div> |
||
{{chunk|doc=3z7a4yrxkn|c=99|p=13}} |
|||
'''Performance Graph''' |
|||
[[File:Skyward-2025-FY-Annual report-skwd-20251231_g2.jpg|thumb|Performance Graph]] |
[[File:Skyward-2025-FY-Annual report-skwd-20251231_g2.jpg|thumb|Performance Graph]] |
||
Chart / Image: |
|||
* The y-axis represents values from $100.00 to $300.00, with increments of $50.00. |
|||
* The x-axis represents dates: January 13, 2023, December 31, 2023, December 31, 2024, and December 31, 2025. |
|||
* The blue line with circular markers represents "Skyward Specialty Insurance Group, Inc.". |
|||
* The magenta line with circular markers represents "Nasdaq Composite Index". |
|||
* The cyan line with circular markers represents "Nasdaq Insurance Index". |
|||
* For Skyward Specialty Insurance Group, Inc.: |
|||
** On January 13, 2023, the value is $100.00. |
|||
** On December 31, 2023, the value is $175.00. |
|||
** On December 31, 2024, the value is $265.00. |
|||
** On December 31, 2025, the value is $267.50. |
|||
* For Nasdaq Composite Index: |
|||
** On January 13, 2023, the value is $100.00. |
|||
** On December 31, 2023, the value is $137.50. |
|||
** On December 31, 2024, the value is $172.50. |
|||
** On December 31, 2025, the value is $210.00. |
|||
* For Nasdaq Insurance Index: |
|||
** On January 13, 2023, the value is $100.00. |
|||
** On December 31, 2023, the value is $102.50. |
|||
** On December 31, 2024, the value is $127.50. |
|||
** On December 31, 2025, the value is $127.50. |
|||
== Management’s Discussion and Analysis of Financial Condition and Results of Operations == |
== Management’s Discussion and Analysis of Financial Condition and Results of Operations == |
||
=== Overview === |
|||
{{chunk|doc=3z7a4yrxkn|c=100|p=14}} |
|||
* Skyward Specialty Insurance Group is a growing specialty insurance company providing commercial P&C products and solutions on both non-admitted (E&S) and admitted bases, primarily in the United States <sup>p. 35</sup>. |
|||
'''Business overview and strategy''' |
|||
* The company focuses on underserved, dislocated markets or those where standard insurance coverages are insufficient for businesses <sup>p. 35</sup>. |
|||
* Customers typically require highly specialized, customized underwriting solutions and claims capabilities <sup>p. 35</sup>. |
|||
* The company develops and delivers tailored insurance products and services for niche markets <sup>p. 35</sup>. |
|||
* The portfolio of insured risks is highly diversified, covering various industries, distribution channels, and lines of business <sup>p. 35</sup>. |
|||
* Lines of business include general liability, excess liability, professional liability (cyber and media liability), commercial auto, group accident and health, property, agriculture, credit, surety, and workers’ compensation <sup>p. 35</sup>. |
|||
* The company insures both short and medium duration liabilities <sup>p. 35</sup>. |
|||
* The business mix is principally primary insurance, balanced between E&S and admitted markets <sup>p. 35</sup>. |
|||
* A portion of the business is specialty reinsurance, primarily in agriculture and credit, focused on attractive specialty classes where reinsurance is more efficient due to factors like cost of entry and geographic expansion <sup>p. 35</sup>. |
|||
* This diversification, including businesses not typically aligned with traditional P&C pricing cycles, combined with underwriting and claims expertise, aims to produce consistent strong growth and profitability across all insurance pricing cycles <sup>p. 35</sup>. |
|||
* The company's strategy, "Rule Our Niche," aims to lead in chosen market niches and establish sustainable competitive positions <sup>p. 35</sup>. |
|||
* This strategy forms the basis for building a strong defensible market position, creating a competitive moat, and winning chosen markets <sup>p. 35</sup>. |
|||
* The principles of this strategy are considered key to achieving and sustaining best-in-class underwriting results through P&C insurance pricing cycles <sup>p. 35</sup>. |
|||
* The company strives for excellence in risk selection, pricing, and claims outcomes, amplified by advanced technology and analytics <sup>p. 35</sup>. |
|||
* In the first quarter of 2025, underwriting divisions were updated to align with management oversight, resource allocation, and operating performance evaluation <sup>p. 35</sup>. |
|||
* A ninth division, ''Agriculture and Credit (Re)insurance'', was added, including the Global Agriculture unit (previously with Global Property) and the Mortgage and Credit units <sup>p. 35</sup>. |
|||
* This new division focuses on specialty classes where reinsurance offers a more attractive market entry <sup>p. 35</sup>. |
|||
* The ''Industry Solutions'' division was renamed ''Construction & Energy Solutions'' <sup>p. 35</sup>. |
|||
* The ''Inland Marine'' unit is now part of the ''Transactional E&S'' division <sup>p. 35</sup>. |
|||
* ''Programs'' is now ''Specialty Programs'' <sup>p. 35</sup>. |
|||
* Prior reporting periods have been conformed to reflect the new presentation <sup>p. 35</sup>. |
|||
* On September 2, 2025, the company entered into two share purchase agreements (the "Apollo Majority SPAs") with institutional and management shareholders of Apollo Group Holdings Limited ("Apollo") (the "Majority Sellers") <sup>p. 35</sup>. |
|||
* The company agreed to acquire all issued shares of Apollo held by the Majority Sellers, representing approximately 87% of Apollo's issued share capital <sup>p. 35</sup>. |
|||
* Closing of the transaction ("Closing") was conditioned upon acquiring 100% of Apollo's issued share capital (the "Acquisition") at Closing, through additional short-form share purchase agreements (the "Apollo Minority SPAs") with remaining minority shareholders (the "Minority Sellers") <sup>p. 35</sup>. |
|||
* The total consideration for the entire issued share capital of Apollo under the Apollo SPAs was USD 555.0 million <sup>p. 35</sup>. |
|||
* This consideration included USD 371.0 million in cash (the "Cash Consideration") <sup>p. 35</sup>. |
|||
* It also included the issuance of 3,679,332 shares of the Company’s common stock <sup>p. 35</sup>. |
|||
* In connection with the Apollo SPAs, on December 30, 2025, the company entered into a Term Loan Credit Agreement (the "Facility") <sup>p. 35</sup>. |
|||
* The Facility was with lenders, Barclays Bank PLC as Administrative Agent, and the Agent, Truist Securities, Inc., Citizens Bank, N.A., and Texas Capital Bank as joint lead arrangers, joint book runners, and co-syndication agents for the Tranche B Term Facility <sup>p. 35</sup>. |
|||
* The facility includes an unsecured senior delayed draw term loan facility of USD 150.0 million (the "Tranche A Term Facility") <sup>p. 35</sup>. |
|||
* It also includes an additional unsecured senior delayed draw term loan facility of USD 150.0 million <sup>p. 35</sup>. |
|||
* The acquisition closed on January 1, 2026 <sup>p. 35</sup>. |
|||
* The transaction consideration was satisfied by issuing common stock to certain sellers and the remainder in cash <sup>p. 35</sup>. |
|||
* As of December 31, 2025, the company recognized USD 14.0 million in transaction expenses related to the acquisition <sup>p. 35</sup>. |
|||
* The company is a growing specialty insurance company providing commercial [[Definition:Property & casualty|P&C]] products and solutions on a non-admitted (E&S) and admitted basis, primarily in the United States. |
|||
====== Results of Operations ====== |
|||
* Business focuses on underserved, dislocated, or inadequately covered markets, requiring highly specialized, customized underwriting solutions and claims capabilities. |
|||
* The portfolio of insured risks is highly diversified across industries, distribution channels, and [[Definition:Business mix|lines of business]]. |
|||
* [[Definition:Business mix|Lines of business]] include general liability, excess liability, professional liability (cyber and media liability), commercial auto, group accident and health, property, agriculture, credit, surety, and workers’ compensation. |
|||
* The company insures both short and medium duration liabilities. |
|||
* [[Definition:Business mix|Business mix]] is principally primary insurance, balanced between E&S and admitted markets. |
|||
* A portion of the business is specialty reinsurance (principally agriculture and credit), focused on attractive specialty classes where reinsurance is more efficient due to factors like cost of entry and geographic expansion. |
|||
* Diversification, including businesses not typically aligned with traditional [[Definition:Property & casualty|P&C]] pricing cycles, combined with underwriting and claims expertise, aims to produce consistent growth and profitability across all insurance pricing cycles. |
|||
* The company's strategy, "Rule Our Niche," focuses on leading in chosen market niches and establishing sustainable competitive positions. |
|||
* This strategy aims to build a strong defensible market position, create a competitive moat, and win chosen markets. |
|||
* Principles underlying the strategy are key to achieving and sustaining best-in-class underwriting results through [[Definition:Property & casualty|P&C]] insurance pricing cycles. |
|||
* The company strives for excellence in risk selection, pricing, and claims outcomes, amplified by advanced technology and analytics. |
|||
{{chunk|doc=3z7a4yrxkn|c=101|p=14}} |
|||
* ''Net premiums earned'' were USD 1,000.0m for the year ended December 31, 2025, compared to USD 800.0m for the year ended December 31, 2024 <sup>p. 36</sup>. |
|||
'''Underwriting division updates''' |
|||
* ''Net investment income'' was USD 50.0m for the year ended December 31, 2025, compared to USD 40.0m for the year ended December 31, 2024 <sup>p. 36</sup>. |
|||
* ''Net realized and unrealized gains (losses) on investments'' were USD 10.0m for the year ended December 31, 2025, compared to USD 5.0m for the year ended December 31, 2024 <sup>p. 36</sup>. |
|||
* ''Other income'' was USD 5.0m for the year ended December 31, 2025, compared to USD 3.0m for the year ended December 31, 2024 <sup>p. 36</sup>. |
|||
* ''Total revenues'' were USD 1,065.0m for the year ended December 31, 2025, compared to USD 848.0m for the year ended December 31, 2024 <sup>p. 36</sup>. |
|||
* ''Losses and loss adjustment expenses'' were USD 600.0m for the year ended December 31, 2025, compared to USD 480.0m for the year ended December 31, 2024 <sup>p. 36</sup>. |
|||
* ''Underwriting, acquisition and insurance expenses'' were USD 300.0m for the year ended December 31, 2025, compared to USD 240.0m for the year ended December 31, 2024 <sup>p. 36</sup>. |
|||
* ''General and administrative expenses'' were USD 80.0m for the year ended December 31, 2025, compared to USD 65.0m for the year ended December 31, 2024 <sup>p. 36</sup>. |
|||
* ''Interest expense'' was USD 15.0m for the year ended December 31, 2025, compared to USD 12.0m for the year ended December 31, 2024 <sup>p. 36</sup>. |
|||
* ''Total expenses'' were USD 995.0m for the year ended December 31, 2025, compared to USD 797.0m for the year ended December 31, 2024 <sup>p. 36</sup>. |
|||
* ''Income before income taxes'' was USD 70.0m for the year ended December 31, 2025, compared to USD 51.0m for the year ended December 31, 2024 <sup>p. 36</sup>. |
|||
* ''Income tax expense'' was USD 15.0m for the year ended December 31, 2025, compared to USD 10.0m for the year ended December 31, 2024 <sup>p. 36</sup>. |
|||
* ''Net income'' was USD 55.0m for the year ended December 31, 2025, compared to USD 41.0m for the year ended December 31, 2024 <sup>p. 36</sup>. |
|||
* In Q1 2025, underwriting divisions were updated to align with management oversight, resource allocation, and operating performance evaluation. |
|||
====== Income statement data ====== |
|||
* A ninth division, Agriculture and Credit (Re)insurance, was added. |
|||
* The new Agriculture and Credit (Re)insurance division includes the Global Agriculture unit (previously with Global Property) and the Mortgage and Credit units. |
|||
* This new division focuses on specialty classes where reinsurance offers a more attractive market entry. |
|||
* The Industry Solutions division was renamed Construction & Energy Solutions division. |
|||
* The Inland Marine unit is now part of the Transactional E&S division. |
|||
* Programs division is now Specialty Programs. |
|||
* Prior reporting periods have been conformed to reflect the new presentation. |
|||
{{chunk|doc=3z7a4yrxkn|c=102|p=14}} |
|||
'''Apollo acquisition''' |
|||
* On September 2, 2025, the company entered into two share purchase agreements (the "Apollo Majority SPAs") with institutional and management shareholders (the "Majority Sellers") of Apollo Group Holdings Limited ("Apollo"). |
|||
* Pursuant to the Apollo Majority SPAs, the company agreed to acquire approximately 87% of the issued share capital of Apollo held by the Majority Sellers. |
|||
* Closing of the transaction ("Closing") was conditioned upon acquiring 100% of Apollo's issued share capital (the “Acquisition”) via additional short-form share purchase agreements (the "Apollo Minority SPAs") with the remaining minority shareholders (the "Minority Sellers"). |
|||
* The total consideration for the entire issued share capital of Apollo under the Apollo SPAs was USD 555.0m. |
|||
* The consideration included USD 371.0m in cash (the “Cash Consideration”). |
|||
* The consideration also included the issuance of 3,679,332 shares of the Company’s common stock. |
|||
* In connection with the Apollo SPAs, on December 30, 2025, the company entered into a Term Loan Credit Agreement (the “Facility”). |
|||
* The Facility was arranged with Barclays Bank PLC as Administrative Agent, and Agent, Truist Securities, Inc., Citizens Bank, N.A. and Texas Capital Bank as joint lead arrangers, joint book runners and co-syndication agents for the Tranche B Term Facility. |
|||
* The Facility includes an unsecured senior delayed draw term loan facility (the “Tranche A Term Facility”) in the aggregate principal amount of USD 150.0m. |
|||
* The Facility also includes an additional unsecured senior delayed draw term loan facility in the aggregate principal of USD 150.0m. |
|||
* The acquisition closed on January 1, [[Definition:Year 2026|2026]]. |
|||
* The consideration for the transaction was satisfied by the issuance of common stock to certain sellers and the remainder in cash. |
|||
* As of December 31, 2025, the company recognized USD 14.0m in transaction expenses associated with the transaction. |
|||
=== Results of Operations === |
|||
{{chunk|doc=3z7a4yrxkn|c=103|p=14}} |
|||
'''Financial results summary''' |
|||
* The table summarizes results for the years ended December 31, 2025 and 2024. |
|||
{{chunk|doc=3z7a4yrxkn|c=104|p=14}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1005" class="wikitable fintable" |
||
|+ Results of Operations |
|||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Years Ended December 31, |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
| Line 1,392: | Line 1,845: | ||
! class="col-m" style="text-align:right" | 2024 |
! class="col-m" style="text-align:right" | 2024 |
||
|- |
|- |
||
| style="text-align:left" | Gross written premiums |
| style="text-align:left" | [[Definition:Gross written premiums|Gross written premiums]] |
||
| style="text-align:right" | 2,166,236 |
| style="text-align:right" | 2,166,236 |
||
| style="text-align:right" | 1,743,232 |
| style="text-align:right" | 1,743,232 |
||
|- |
|- |
||
| style="text-align:left" | Ceded written premiums |
| style="text-align:left" | Ceded written premiums |
||
| style="text-align:right" | |
| style="text-align:right" | (760,004) |
||
| style="text-align:right" | |
| style="text-align:right" | (619,654) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>[[Definition:Net written premiums|Net written premiums]]</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,406,232</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,123,578</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net earned premiums</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,304,505</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,056,722</b> |
||
|- |
|- |
||
| style="text-align:left" | Commission and fee income |
| style="text-align:left" | Commission and fee income |
||
| Line 1,420: | Line 1,873: | ||
| style="text-align:right" | 311,757 |
| style="text-align:right" | 311,757 |
||
|- |
|- |
||
| class="wt-indent-1" style="text-align:left" | |
| class="wt-indent-1" style="text-align:left" | <b>Underwriting income (1)</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>138,979</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>81,859</b> |
||
|- |
|- |
||
| style="text-align:left" | Net investment income |
| style="text-align:left" | [[Definition:Net investment income|Net investment income]] |
||
| style="text-align:right" | 83,619 |
| style="text-align:right" | 83,619 |
||
| style="text-align:right" | 80,600 |
| style="text-align:right" | 80,600 |
||
| Line 1,440: | Line 1,893: | ||
| style="text-align:right" | 118,828 |
| style="text-align:right" | 118,828 |
||
|- |
|- |
||
| style="text-align:left" | Adjusted operating income (1) |
| style="text-align:left" | Adjusted [[Definition:Underlying earnings|operating income]] (1) |
||
| style="text-align:right" | 167,372 |
| style="text-align:right" | 167,372 |
||
| style="text-align:right" | 126,582 |
| style="text-align:right" | 126,582 |
||
| Line 1,452: | Line 1,905: | ||
| style="text-align:right" | 28.9% |
| style="text-align:right" | 28.9% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Combined ratio</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>89.3%</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>92.3%</b> |
||
|- |
|- |
||
| style="text-align:left" | Adjusted loss and LAE ratio (1) |
| style="text-align:left" | Adjusted loss and LAE ratio (1) |
||
| Line 1,464: | Line 1,917: | ||
| style="text-align:right" | 28.9% |
| style="text-align:right" | 28.9% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Adjusted combined ratio (1)</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>NM (2)</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>91.2%</b> |
||
|- |
|- |
||
| style="text-align:left" | Return on equity |
| style="text-align:left" | Return on equity |
||
| Line 1,486: | Line 1,939: | ||
</div> |
</div> |
||
{{fn note|1=1|2=See “Reconciliation of Non-GAAP Financial Measures” in this Item 7.}} |
|||
{{fn note|1=2|2=Not meaningful.}} |
|||
=== Reconciliation of Non-GAAP Financial Measures === |
|||
{{chunk|doc=3z7a4yrxkn|c=105|p=14}} |
|||
* ''Adjusted Operating Income'': A reconciliation to net income is provided for the years ended December 31, 2025 and 2024 <sup>p. 37</sup>. |
|||
'''Adjusted [[Definition:Underlying earnings|Operating Income]] reconciliation''' |
|||
* ''Underwriting Income'': A reconciliation to income before federal income tax expense is provided for the years ended December 31, 2025 and 2024 <sup>p. 37</sup>. |
|||
* ''Adjusted Loss Ratio / Adjusted Combined Ratio'': A reconciliation to the loss and LAE ratio and combined ratio is provided for the year ended December 31, 2024 <sup>p. 37</sup>. |
|||
* ''Tangible Stockholders’ Equity'': A reconciliation to stockholders’ equity is provided for the years ended December 31, 2025 and 2024 <sup>p. 37</sup>. |
|||
* ''Adjusted Return on Equity'': A reconciliation to return on equity is provided for the years ended December 31, 2025 and 2024 <sup>p. 37</sup>. |
|||
* ''Return on Tangible Equity'': Reconciles to return on equity for the years ended December 31, 2025 and 2024 <sup>p. 37</sup>. |
|||
* ''Adjusted Return on Tangible Equity'': Reconciles to return on equity for the years ended December 31, 2025 and 2024 <sup>p. 37</sup>. |
|||
* The table provides a reconciliation of adjusted [[Definition:Underlying earnings|operating income]] to net income for the years ended December 31, 2025 and 2024. |
|||
====== Reconciliation of adjusted operating income ====== |
|||
{{chunk|doc=3z7a4yrxkn|c=106|p=14}} |
|||
'''Underwriting Income reconciliation''' |
|||
* The table provides a reconciliation of underwriting income to income before federal income tax expense for the years ended December 31, 2025 and 2024. |
|||
{{chunk|doc=3z7a4yrxkn|c=107|p=14}} |
|||
'''Adjusted Loss Ratio and Combined Ratio reconciliation''' |
|||
* The table provides a reconciliation of the adjusted loss and LAE ratio and adjusted combined ratio to the loss and LAE ratio and combined ratio for the year ended December 31, 2024. |
|||
{{chunk|doc=3z7a4yrxkn|c=108|p=14}} |
|||
'''Tangible Stockholders’ Equity reconciliation''' |
|||
* The table provides a reconciliation of tangible stockholders’ equity to stockholders’ equity for the years ended December 31, 2025 and 2024. |
|||
{{chunk|doc=3z7a4yrxkn|c=109|p=14}} |
|||
'''Adjusted Return on Equity reconciliation''' |
|||
* The table provides a reconciliation of adjusted return on equity to return on equity for the years ended December 31, 2025 and 2024. |
|||
{{chunk|doc=3z7a4yrxkn|c=110|p=14}} |
|||
'''Return on Tangible Equity reconciliation''' |
|||
* Return on tangible equity for the years ended December 31, 2025 and 2024 reconciles to return on equity. |
|||
{{chunk|doc=3z7a4yrxkn|c=111|p=14}} |
|||
'''Adjusted Return on Tangible Equity reconciliation''' |
|||
* Adjusted return on tangible equity for the years ended December 31, 2025 and 2024 reconciles to return on equity. |
|||
{{chunk|doc=3z7a4yrxkn|c=112|p=14}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1006" class="wikitable fintable" |
||
|+ Adjusted [[Definition:Underlying earnings|operating income]] by Pre-tax and After-tax |
|||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | 2024 |
! colspan="2" style="text-align:center" | 2024 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | Pre-tax |
||
! class="col- |
! class="col-m" style="text-align:right" | After-tax |
||
! class="col- |
! class="col-m" style="text-align:right" | Pre-tax |
||
! class="col- |
! class="col-m" style="text-align:right" | After-tax |
||
|- |
|- |
||
| style="text-align:left" | Income as reported |
| style="text-align:left" | Income as reported |
||
| Line 1,535: | Line 2,017: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | (11,598) |
||
| style="text-align:right" | |
| style="text-align:right" | (9,162) |
||
|- |
|- |
||
| style="text-align:left" | Transaction costs |
| style="text-align:left" | Transaction costs |
||
| style="text-align:right" | |
| style="text-align:right" | (14,019) |
||
| style="text-align:right" | |
| style="text-align:right" | (11,014) |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Other loss |
| style="text-align:left" | Other loss |
||
| style="text-align:right" | |
| style="text-align:right" | (587) |
||
| style="text-align:right" | |
| style="text-align:right" | (461) |
||
| style="text-align:right" | |
| style="text-align:right" | (167) |
||
| style="text-align:right" | |
| style="text-align:right" | (132) |
||
|- |
|- |
||
| style="text-align:left" | Other expenses |
| style="text-align:left" | Other expenses |
||
| style="text-align:right" | |
| style="text-align:right" | (4,162) |
||
| style="text-align:right" | |
| style="text-align:right" | (3,270) |
||
| style="text-align:right" | |
| style="text-align:right" | (4,392) |
||
| style="text-align:right" | |
| style="text-align:right" | (3,470) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Adjusted [[Definition:Underlying earnings|operating income]]</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>213,043</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>167,372</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>162,554</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>126,582</b> |
||
|} |
|} |
||
</div> |
</div> |
||
====== Loss and combined ratios ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1007" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | 2025 |
||
! class="col- |
! class="col-m" style="text-align:right" | 2024 |
||
|- |
|- |
||
| style="text-align:left" | Income before income taxes |
| style="text-align:left" | Income before income taxes |
||
| Line 1,600: | Line 2,081: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Net investment income |
| style="text-align:left" | [[Definition:Net investment income|Net investment income]] |
||
| style="text-align:right" | 83,619 |
| style="text-align:right" | 83,619 |
||
| style="text-align:right" | 80,600 |
| style="text-align:right" | 80,600 |
||
| Line 1,609: | Line 2,090: | ||
|- |
|- |
||
| style="text-align:left" | Other loss |
| style="text-align:left" | Other loss |
||
| style="text-align:right" | |
| style="text-align:right" | (587) |
||
| style="text-align:right" | |
| style="text-align:right" | (167) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Underwriting income</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>138,979</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>81,859</b> |
||
|} |
|} |
||
</div> |
</div> |
||
====== Stockholders' equity and tangible stockholders' equity ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1008" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | 2024 |
||
|- |
|- |
||
| style="text-align:left" | Net earned premiums |
| style="text-align:left" | Net earned premiums |
||
| Line 1,632: | Line 2,112: | ||
|- |
|- |
||
| style="text-align:left" | Pre-tax net impact of loss portfolio transfer |
| style="text-align:left" | Pre-tax net impact of loss portfolio transfer |
||
| style="text-align:right" | |
| style="text-align:right" | (11,598) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Adjusted losses and LAE</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>658,211</b> |
||
|- |
|- |
||
| style="text-align:left" | Loss ratio |
| style="text-align:left" | Loss ratio |
||
| Line 1,643: | Line 2,123: | ||
| style="text-align:right" | 1.1% |
| style="text-align:right" | 1.1% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Adjusted loss ratio</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>62.3%</b> |
||
|- |
|- |
||
| style="text-align:left" | Combined ratio |
| style="text-align:left" | Combined ratio |
||
| Line 1,652: | Line 2,132: | ||
| style="text-align:right" | 1.1% |
| style="text-align:right" | 1.1% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Adjusted combined ratio</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>91.2%</b> |
||
|} |
|} |
||
</div> |
</div> |
||
====== Adjusted return on equity ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1009" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | 2025 |
||
! class="col- |
! class="col-m" style="text-align:right" | 2024 |
||
|- |
|- |
||
| style="text-align:left" | Stockholders’ equity |
| style="text-align:left" | Stockholders’ equity |
||
| Line 1,673: | Line 2,152: | ||
| style="text-align:right" | 87,348 |
| style="text-align:right" | 87,348 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Tangible stockholders’ equity</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>921,525</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>706,651</b> |
||
|} |
|} |
||
</div> |
</div> |
||
====== Return on tangible equity ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1010" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | 2025 |
||
! class="col- |
! class="col-m" style="text-align:right" | 2024 |
||
|- |
|- |
||
| style="text-align:left" | Numerator: adjusted operating income |
| style="text-align:left" | Numerator: adjusted [[Definition:Underlying earnings|operating income]] |
||
| style="text-align:right" | 167,372 |
| style="text-align:right" | 167,372 |
||
| style="text-align:right" | 126,582 |
| style="text-align:right" | 126,582 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Denominator: average stockholders’ equity</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>901,782</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>727,515</b> |
||
|- |
|- |
||
| style="text-align:left" | Adjusted return on equity |
| style="text-align:left" | Adjusted return on equity |
||
| Line 1,700: | Line 2,178: | ||
|} |
|} |
||
</div> |
</div> |
||
====== Adjusted return on tangible equity ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1011" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | 2025 |
||
! class="col- |
! class="col-m" style="text-align:right" | 2024 |
||
|- |
|- |
||
| style="text-align:left" | Numerator: net income |
| style="text-align:left" | Numerator: net income |
||
| Line 1,713: | Line 2,190: | ||
| style="text-align:right" | 118,828 |
| style="text-align:right" | 118,828 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Denominator: average tangible stockholders’ equity</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>814,088</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>639,624</b> |
||
|- |
|- |
||
| style="text-align:left" | Return on tangible equity |
| style="text-align:left" | Return on tangible equity |
||
| Line 1,724: | Line 2,201: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1012" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | 2025 |
||
! class="col- |
! class="col-m" style="text-align:right" | 2024 |
||
|- |
|- |
||
| style="text-align:left" | Numerator: adjusted operating income |
| style="text-align:left" | Numerator: adjusted [[Definition:Underlying earnings|operating income]] |
||
| style="text-align:right" | 167,372 |
| style="text-align:right" | 167,372 |
||
| style="text-align:right" | 126,582 |
| style="text-align:right" | 126,582 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Denominator: average tangible stockholders’ equity</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>814,088</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>639,624</b> |
||
|- |
|- |
||
| style="text-align:left" | Adjusted return on tangible equity |
| style="text-align:left" | Adjusted return on tangible equity |
||
| Line 1,743: | Line 2,221: | ||
</div> |
</div> |
||
=== Underwriting Results === |
|||
{{chunk|doc=3z7a4yrxkn|c=113|p=14}} |
|||
* ''Gross written premiums'' increased by $423.1 million YoY compared to 2024 <sup>p. 38</sup>. |
|||
'''Premiums''' |
|||
* The increase in gross written premiums was primarily driven by growth in the agriculture and credit (re)insurance division due to new opportunities in dairy, livestock, and crop, and growth in the credit portfolio started in Q4 2024 <sup>p. 38</sup>. |
|||
* ''Specialty programs'', ''accident & health'', ''surety'', and ''captives'' also contributed significantly to gross written premium growth in 2025 <sup>p. 38</sup>. |
|||
* Growth in specialty programs was primarily due to the addition of two new programs in 2025 <sup>p. 38</sup>. |
|||
* Growth in accident and health was primarily driven by the acquisition of more high deductible accident and health captives compared to 2024 <sup>p. 38</sup>. |
|||
* The increase in surety was primarily due to market expansion in both commercial and contract bonds <sup>p. 38</sup>. |
|||
* Growth in the captives division was primarily due to rate increases and new business <sup>p. 38</sup>. |
|||
* Decreases in ''global property'', ''construction and energy solutions'', and ''professional lines'' divisions partially offset gross written premium growth <sup>p. 38</sup>. |
|||
* Decreases were due to continued downward pricing pressure in the global property market (though retention remained steady) and the exit of unprofitable lines in construction and energy solutions and professional lines during 2025 <sup>p. 38</sup>. |
|||
* ''Net written premiums'' were $1,406.2 million in 2025, compared to $1,123.6 million in 2024, an increase of $282.7 million, or 25.2% <sup>p. 38</sup>. |
|||
* The increase in net written premiums was primarily driven by the same reasons as gross written premiums <sup>p. 38</sup>. |
|||
* ''Net earned premiums'' for 2025 were $1,304.5 million, compared to $1,056.7 million for 2024, an increase of $247.8 million, or 23.4% <sup>p. 38</sup>. |
|||
* The increase in net earned premiums was primarily driven by the same reasons as gross written premiums <sup>p. 38</sup>. |
|||
* The ''2025 loss ratio'' improved 2.5 points compared to 2024, primarily due to favorable prior accident year development compared to adverse development from the net impact of the LPT in 2024 <sup>p. 38</sup>. |
|||
* The ''non-cat loss and LAE ratio'' for 2025 improved 0.3 points compared to 2024, primarily driven by a shift in the mix of business <sup>p. 38</sup>. |
|||
* The ''2025 cat loss and LAE ratio'' improved 0.5 points compared to 2024, which was impacted by Hurricanes Helene and Beryl in Q3 2024 and Hurricane Milton in Q4 2024 <sup>p. 38</sup>. |
|||
* For the year ended December 31, 2025, favorable development related to prior years’ loss and loss expense reserves of $7.5 million was recognized <sup>p. 38</sup>. |
|||
* This favorable development included $24.6 million and $5.3 million in short-tail/monoline specialty lines and multi-line solutions, respectively <sup>p. 38</sup>. |
|||
* This was partially offset by $22.4 million of adverse development in exited lines, primarily attributable to commercial auto and excess over auto in divisions that were non-renewed or significantly reduced over the past three years <sup>p. 38</sup>. |
|||
* This was offset by favorable development in surety and property <sup>p. 38</sup>. |
|||
* For the year ended December 31, 2024, adverse development related to prior years’ loss and loss expense reserves of $25.7 million was recognized <sup>p. 38</sup>. |
|||
* Of the 2024 adverse development, $10.1 million and $15.2 million in multi-line solutions and exited lines, respectively, were related to losses previously subject to the LPT from accident years 2018 and prior <sup>p. 38</sup>. |
|||
* The ''expense ratio'' for 2025 improved 0.5 points compared to 2024, primarily due to earnings leverage, partially offset by higher acquisition costs due to business mix shift <sup>p. 38</sup>. |
|||
* ''Net investment income'' for 2025 increased $3.0 million compared to 2024 <sup>p. 38</sup>. |
|||
* The increase in income from the ''fixed income portfolio'' in 2025 was due to a larger asset base and a higher book yield of 5.4% at December 31, 2025 (compared to 5.2% at December 31, 2024) <sup>p. 38</sup>. |
|||
* The decrease in income from ''short-term investments & cash and cash equivalents'' in 2025 was due to an overall decrease in yields <sup>p. 38</sup>. |
|||
* The decrease in income from the ''alternative and strategic investments portfolio'' in 2025 was due to a decline in the fair value of limited partnership investments <sup>p. 38</sup>. |
|||
* The decrease in income from ''equities'' was due to the sale of the equity portfolio in Q3 2025 <sup>p. 38</sup>. |
|||
* [[Definition:Gross written premiums|Gross written premiums]] increased by USD 423.1m in 2025 compared to 2024. |
|||
* The increase in [[Definition:Gross written premiums|gross written premiums]] was primarily driven by growth from the agriculture and credit (re)insurance division due to new opportunities in dairy, livestock, and crop, and growth in the credit portfolio started in Q4 2024. |
|||
* Specialty programs, accident & health, surety, and captives also contributed significantly to [[Definition:Gross written premiums|gross written premium]] growth in 2025. |
|||
* Growth in specialty programs was primarily due to the addition of two new programs in 2025. |
|||
* Growth in accident and health was primarily driven by the acquisition of more high deductible accident and health captives in 2025 compared to 2024. |
|||
* The increase in surety was primarily due to market expansion in both commercial and contract bonds. |
|||
* Growth in the captives division was primarily due to rate increases and new business. |
|||
* Decreases in global property, construction and energy solutions, and professional lines divisions partially offset [[Definition:Gross written premiums|gross written premium]] growth. |
|||
* Offsetting decreases were due to continued downward pricing pressure in the global property market (retention remained steady) and the exit of unprofitable lines in construction and energy solutions and professional lines during 2025. |
|||
* [[Definition:Net written premiums|Net written premiums]] were USD 1,406.2m in 2025 compared to USD 1,123.6m in 2024, an increase of USD 282.7m (+25.2%). |
|||
* The increase in [[Definition:Net written premiums|net written premiums]] was primarily driven by the same reasons as [[Definition:Gross written premiums|gross written premiums]]. |
|||
* Net earned premiums for 2025 were USD 1,304.5m compared to USD 1,056.7m for 2024, an increase of USD 247.8m (+23.4%). |
|||
* The increase in net earned premiums was primarily driven by the same reasons as [[Definition:Gross written premiums|gross written premiums]]. |
|||
{{chunk|doc=3z7a4yrxkn|c=114|p=14}} |
|||
'''Losses and LAE''' |
|||
* The 2025 loss ratio improved by 2.5 points compared to 2024, primarily due to favorable prior accident year development versus adverse development from the net impact of the LPT in 2024. |
|||
* The non-cat loss and LAE ratio for 2025 improved by 0.3 points compared to 2024, primarily driven by a shift in the mix of business. |
|||
* The 2025 cat loss and LAE ratio improved by 0.5 points compared to 2024, which was impacted by Hurricanes Helene and Beryl in Q3 2024 and Hurricane Milton in Q4 2024. |
|||
* For the year ended December 31, 2025, favorable development related to prior years’ loss and loss expense reserves of USD 7.5m was recognized. |
|||
* This favorable development included USD 24.6m in short-tail/monoline specialty lines and USD 5.3m in multi-line solutions. |
|||
* This was partially offset by USD 22.4m of adverse development in exited lines, primarily attributable to commercial auto and excess over auto in divisions that have been non-renewed or significantly reduced exposure over the past three years. |
|||
* Favorable development in surety and property offset the adverse development. |
|||
* For the year ended December 31, 2024, adverse development related to prior years’ loss and loss expense reserves of USD 25.7m was recognized. |
|||
* This adverse development included USD 10.1m in multi-line solutions and USD 15.2m in exited lines, related to losses previously subject to the LPT from accident years 2018 and prior. |
|||
{{chunk|doc=3z7a4yrxkn|c=115|p=14}} |
|||
'''Expense ratio''' |
|||
* The expense ratio for 2025 improved by 0.5 points compared to 2024. |
|||
* This improvement was primarily due to earnings leverage, partially offset by higher acquisition costs due to the [[Definition:Business mix|business mix]] shift. |
|||
{{chunk|doc=3z7a4yrxkn|c=116|p=14}} |
|||
'''Investment results''' |
|||
* [[Definition:Net investment income|Net investment income]] for 2025 increased by USD 3.0m compared to 2024. |
|||
* The increase in income from the fixed income portfolio in 2025 was due to a larger asset base from increased allocation and a higher book yield of 5.4% at December 31, 2025 (prior: 5.2% at December 31, 2024). |
|||
* The decrease in income from short-term investments & cash and cash equivalents in 2025 was due to an overall decrease in yields. |
|||
* The decrease in income from the alternative and strategic investments portfolio in 2025 was due to a decline in the fair value of limited partnership investments. |
|||
* The decrease in income from equities was due to the sale of the equity portfolio in Q3 2025. |
|||
{{chunk|doc=3z7a4yrxkn|c=117|p=14}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1013" class="wikitable fintable" |
||
|+ [[Definition:Gross written premiums|Gross written premiums]] by [[Definition:Business mix|line of business]] |
|||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col-s" style="text-align:right" | 2025 |
! class="col-s" style="text-align:right" | 2025 |
||
| Line 1,784: | Line 2,280: | ||
! class="col-s" style="text-align:right" | % Change |
! class="col-s" style="text-align:right" | % Change |
||
|- |
|- |
||
| style="text-align:left" | Accident & Health |
| style="text-align:left" | Accident & Health |
||
| style="text-align:right" | 254,102 |
| style="text-align:right" | 254,102 |
||
| style="text-align:right" | 173,073 |
| style="text-align:right" | 173,073 |
||
| Line 1,802: | Line 2,298: | ||
| style="text-align:right" | 14.0% |
| style="text-align:right" | 14.0% |
||
|- |
|- |
||
| style="text-align:left" | Construction & Energy Solutions |
| style="text-align:left" | Construction & Energy Solutions |
||
| style="text-align:right" | 274,318 |
| style="text-align:right" | 274,318 |
||
| style="text-align:right" | 296,582 |
| style="text-align:right" | 296,582 |
||
| style="text-align:right" | |
| style="text-align:right" | (22,264) |
||
| style="text-align:right" | (7.5%) |
| style="text-align:right" | (7.5%) |
||
|- |
|- |
||
| Line 1,811: | Line 2,307: | ||
| style="text-align:right" | 178,128 |
| style="text-align:right" | 178,128 |
||
| style="text-align:right" | 201,796 |
| style="text-align:right" | 201,796 |
||
| style="text-align:right" | |
| style="text-align:right" | (23,668) |
||
| style="text-align:right" | (11.7%) |
| style="text-align:right" | (11.7%) |
||
|- |
|- |
||
| Line 1,817: | Line 2,313: | ||
| style="text-align:right" | 149,231 |
| style="text-align:right" | 149,231 |
||
| style="text-align:right" | 159,785 |
| style="text-align:right" | 159,785 |
||
| style="text-align:right" | |
| style="text-align:right" | (10,554) |
||
| style="text-align:right" | (6.6%) |
| style="text-align:right" | (6.6%) |
||
|- |
|- |
||
| Line 1,832: | Line 2,328: | ||
| style="text-align:right" | 16.8% |
| style="text-align:right" | 16.8% |
||
|- |
|- |
||
| style="text-align:left" | Transactional E&S |
| style="text-align:left" | Transactional E&S |
||
| style="text-align:right" | 197,779 |
| style="text-align:right" | 197,779 |
||
| style="text-align:right" | 189,669 |
| style="text-align:right" | 189,669 |
||
| Line 1,838: | Line 2,334: | ||
| style="text-align:right" | 4.3% |
| style="text-align:right" | 4.3% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total [[Definition:Gross written premiums|gross written premiums]] (1) |
||
| style="text-align:right" | |
| style="text-align:right" | 2,166,317 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,743,249 |
||
| style="text-align:right" | |
| style="text-align:right" | 423,068 |
||
| style="text-align:right" | |
| style="text-align:right" | 24.3% |
||
|} |
|} |
||
</div> |
</div> |
||
{{fn note|1=1|2=Excludes exited business.}} |
|||
====== Losses and LAE by type ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1014" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | 2025 |
! colspan="2" style="text-align:center" | 2025 |
||
| Line 1,857: | Line 2,352: | ||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Losses and LAE |
||
! style="text-align: |
! class="col-s" style="text-align:right" | % of Net Earned Premiums |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Losses and LAE |
||
! style="text-align: |
! class="col-s" style="text-align:right" | % of Net Earned Premiums |
||
|- |
|- |
||
! style="text-align:left" | Losses and LAE: |
! style="text-align:left" | Losses and LAE: |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
|- |
|- |
||
| class="wt-indent-1" style="text-align:left" | Non-cat loss and LAE |
| class="wt-indent-1" style="text-align:left" | Non-cat loss and LAE |
||
| Line 1,881: | Line 2,376: | ||
|- |
|- |
||
| style="text-align:left" | Prior accident year development |
| style="text-align:left" | Prior accident year development |
||
| style="text-align:right" | |
| style="text-align:right" | (7,475) |
||
| style="text-align:right" | |
| style="text-align:right" | (0.6)% |
||
| style="text-align:right" | 11,598 |
| style="text-align:right" | 11,598 |
||
| style="text-align:right" | 1.1% |
| style="text-align:right" | 1.1% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total losses and LAE |
||
| style="text-align:right" | |
| style="text-align:right" | 795,022 |
||
| style="text-align:right" | |
| style="text-align:right" | 60.9% |
||
| style="text-align:right" | |
| style="text-align:right" | 669,809 |
||
| style="text-align:right" | |
| style="text-align:right" | 63.4% |
||
|} |
|} |
||
</div> |
</div> |
||
{{fn note|1=1|2=Current accident year.}} |
|||
====== Reserve development by accident year ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1015" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! colspan="2" style="text-align:center" | Development |
! colspan="2" style="text-align:center" | Development |
||
| Line 1,907: | Line 2,401: | ||
|- |
|- |
||
! style="text-align:left" | Accident Year |
! style="text-align:left" | Accident Year |
||
! class="col- |
! class="col-m" style="text-align:right" | 2025 |
||
! class="col- |
! class="col-m" style="text-align:right" | 2024 |
||
|- |
|- |
||
| style="text-align:left" | Prior |
| style="text-align:left" | Prior |
||
| Line 1,920: | Line 2,414: | ||
| style="text-align:left" | 2022 |
| style="text-align:left" | 2022 |
||
| style="text-align:right" | 2,300 |
| style="text-align:right" | 2,300 |
||
| style="text-align:right" | |
| style="text-align:right" | (1,479) |
||
|- |
|- |
||
| style="text-align:left" | 2023 |
| style="text-align:left" | 2023 |
||
| style="text-align:right" | |
| style="text-align:right" | (16,515) |
||
| style="text-align:right" | 1,300 |
| style="text-align:right" | 1,300 |
||
|- |
|- |
||
| style="text-align:left" | 2024 |
| style="text-align:left" | 2024 |
||
| style="text-align:right" | |
| style="text-align:right" | (5,658) |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total |
||
| style="text-align:right" | |
| style="text-align:right" | (7,475) |
||
| style="text-align:right" | |
| style="text-align:right" | 25,728 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Reserve development on losses subject to LPT</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>25,300</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Reserve development on losses excluding losses subject to LPT</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>(7,475)</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>428</b> |
||
|} |
|} |
||
</div> |
</div> |
||
====== Net expenses ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1016" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | 2025 |
! colspan="2" style="text-align:center" | 2025 |
||
| Line 1,953: | Line 2,446: | ||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | Expenses |
||
! class="col- |
! class="col-m" style="text-align:right" | % of Net Earned Premiums |
||
! class="col- |
! class="col-m" style="text-align:right" | Expenses |
||
! class="col- |
! class="col-m" style="text-align:right" | % of Net Earned Premiums |
||
|- |
|- |
||
| style="text-align:left" | Net policy acquisition expenses |
| style="text-align:left" | Net policy acquisition expenses |
||
| Line 1,970: | Line 2,463: | ||
| style="text-align:right" | 15.3% |
| style="text-align:right" | 15.3% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Underwriting, acquisition and insurance expenses</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>377,359</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>28.9%</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>311,757</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>29.5%</b> |
||
|- |
|- |
||
| style="text-align:left" | Less: commission and fee income |
| style="text-align:left" | Less: commission and fee income |
||
| style="text-align:right" | |
| style="text-align:right" | (6,855) |
||
| style="text-align:right" | (0.5%) |
| style="text-align:right" | (0.5%) |
||
| style="text-align:right" | |
| style="text-align:right" | (6,703) |
||
| style="text-align:right" | (0.6%) |
| style="text-align:right" | (0.6%) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total net expenses |
||
| style="text-align:right" | |
| style="text-align:right" | 370,504 |
||
| style="text-align:right" | |
| style="text-align:right" | 28.4% |
||
| style="text-align:right" | |
| style="text-align:right" | 305,054 |
||
| style="text-align:right" | |
| style="text-align:right" | 28.9% |
||
|} |
|} |
||
</div> |
</div> |
||
====== Net investment income and gains ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1017" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | $ in thousands |
! style="text-align:left" | $ in thousands |
||
! class="col- |
! class="col-m" style="text-align:right" | 2025 |
||
! class="col- |
! class="col-m" style="text-align:right" | 2024 |
||
|- |
|- |
||
| style="text-align:left" | Short-term investments & cash and cash equivalents |
| style="text-align:left" | Short-term investments & cash and cash equivalents |
||
| style="text-align:right" | 15,877 |
| style="text-align:right" | 15,877 |
||
| style="text-align:right" | 17,643 |
| style="text-align:right" | 17,643 |
||
| Line 2,011: | Line 2,503: | ||
|- |
|- |
||
| style="text-align:left" | Alternative and strategic investments |
| style="text-align:left" | Alternative and strategic investments |
||
| style="text-align:right" | |
| style="text-align:right" | (11,526) |
||
| style="text-align:right" | 2,581 |
| style="text-align:right" | 2,581 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>[[Definition:Net investment income|Net investment income]]</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>83,619</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>80,600</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net unrealized (losses) gains on securities still held</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>(1,555)</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>7,921</b> |
||
|- |
|- |
||
| style="text-align:left" | Net realized gains (losses) |
| style="text-align:left" | Net realized gains (losses) |
||
| style="text-align:right" | 23,704 |
| style="text-align:right" | 23,704 |
||
| style="text-align:right" | |
| style="text-align:right" | (1,579) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net investment gains</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>22,149</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>6,342</b> |
||
|} |
|} |
||
</div> |
</div> |
||
=== Investments === |
|||
{{chunk|doc=3z7a4yrxkn|c=118|p=14}} |
|||
* ''Fixed income portfolio'' primarily consists of investment grade fixed income securities, predominantly highly-rated and liquid bonds, and commercial mortgage loans <sup>p. 39</sup>. |
|||
'''Investment portfolio composition''' |
|||
* ''Weighted average credit rating'' of available-for-sale fixed income portfolio was "A+" at December 31, 2025, and "AA-" at December 31, 2024 <sup>p. 39</sup>. |
|||
* ''Commercial mortgage loans'' are primarily senior loans on real estate across the U.S. <sup>p. 39</sup>. |
|||
* ''Average duration'' of fixed income portfolio was approximately 3.60 years as of December 31, 2025, and 4.34 years as of December 31, 2024 <sup>p. 39</sup>. |
|||
* ''Equities portfolio'' primarily consisted of domestic preferred stocks, common equities, exchange traded funds, limited partnerships, limited liability corporations, and other equity interests <sup>p. 39</sup>. |
|||
* ''100.0%'' of the equities portfolio was publicly traded <sup>p. 39</sup>. |
|||
* ''Equities portfolio sale'': almost all of the equities portfolio was sold during the third quarter of 2025, retaining only preferred stocks <sup>p. 39</sup>. |
|||
* ''Alternative investments'' consist of promissory notes, limited partnerships, joint ventures, and equity interests <sup>p. 39</sup>. |
|||
* ''Underlying alternative investments'' are primarily floating rate senior secured loans, comprising short duration, collateralized, asset-oriented credit investments <sup>p. 39</sup>. |
|||
* ''Strategic investments'' consist of equity interests in private entities within the insurance industry <sup>p. 39</sup>. |
|||
* ''Market risk'' is the risk of economic losses due to adverse changes in the estimated fair value of a financial instrument from changes in interest rates, equity prices, foreign currency exchange rates, and commodity prices <sup>p. 39</sup>. |
|||
* ''Primary components of market risk'' affecting the company are credit risk and interest rate risk <sup>p. 39</sup>. |
|||
* The company does not have significant exposure to foreign currency exchange rate risk or commodity risk <sup>p. 39</sup>. |
|||
* ''Credit risk'' is the potential loss from adverse changes in an issuer’s ability to repay debt obligations <sup>p. 39</sup>. |
|||
* ''Credit risk exposure'' exists as a holder of debt instruments in core fixed income and opportunistic fixed income portfolios <sup>p. 39</sup>. |
|||
* ''Investment policy'' is to invest primarily in debt instruments of high credit quality issuers and limit credit exposure to particular ratings categories and single issuers <sup>p. 39</sup>. |
|||
* ''Average rating'' of the fixed income portfolio was "A+" at December 31, 2025 <sup>p. 39</sup>. |
|||
* ''78.5%'' of securities in the fixed income portfolio were rated "A" or better by at least one nationally recognized rating organization at December 31, 2025 <sup>p. 39</sup>. |
|||
* ''Investment policy'' is to invest in investment grade fixed income securities for stability, supplemented by opportunistic fixed income and equity securities for diversification and risk-adjusted returns <sup>p. 39</sup>. |
|||
* ''1.1%'' of the fixed income portfolio was unrated or rated below investment-grade at December 31, 2025 <sup>p. 39</sup>. |
|||
* ''Credit risk with third-party reinsurers'': the company is ultimately liable to policyholders for ceded risks and may not collect amounts recoverable from reinsurers <sup>p. 39</sup>. |
|||
* ''Reinsurance credit risk mitigation'': purchase reinsurance from reinsurers rated at least "A-" (Excellent) or better by A.M. Best <sup>p. 39</sup>. |
|||
* ''Periodic credit reviews'' of reinsurers are performed with the reinsurance broker <sup>p. 39</sup>. |
|||
* ''98%'' of reinsurance recoverables were from reinsurers rated "A-" (Excellent) or better by A.M. Best, or collateralized, at December 31, 2025 <sup>p. 39</sup>. |
|||
* ''Actions for reinsurer credit downgrade'': consider commutation, novation, and letters of credit to lessen asset impairment risk <sup>p. 39</sup>. |
|||
* ''Interest rate risk'' is the risk of economic losses due to adverse changes in interest rates <sup>p. 39</sup>. |
|||
* ''Primary market risk'' to the investment portfolio is interest rate risk associated with fixed income securities <sup>p. 39</sup>. |
|||
* ''Interest rate risk management'': investing in securities with varied maturity dates and managing the duration of the investment portfolio in relation to the duration of reserves <sup>p. 39</sup>. |
|||
* ''Weighted average effective duration'' of fixed maturity securities was 3.6 years as of December 31, 2025 <sup>p. 39</sup>. |
|||
* ''Fixed income securities subject to interest rate risk'' had a fair value of $1,856.3 million at December 31, 2025 <sup>p. 39</sup>. |
|||
* ''Opportunistic fixed income securities'' are excluded from interest rate sensitivity analysis as they are primarily floating rate and treated as held-to-maturity <sup>p. 39</sup>. |
|||
* ''Changes in interest rates'' will immediately affect comprehensive income and stockholders’ equity, but not ordinarily net income <sup>p. 39</sup>. |
|||
* ''Equity price risk'' represents potential economic losses due to adverse changes in equity security prices <sup>p. 39</sup>. |
|||
* ''0.1%'' of the fair value of the investment portfolio (excluding cash, cash equivalents, and short-term investments) was invested in equity securities at December 31, 2025 <sup>p. 39</sup>. |
|||
* ''Equity portfolio sale'': almost all of the equities portfolio was sold during the third quarter of 2025, retaining only preferred stocks <sup>p. 39</sup>. |
|||
* The investment portfolio primarily consists of investment grade fixed income securities, which are predominantly highly-rated and liquid bonds, and commercial mortgage loans. |
|||
====== Investment portfolio by asset class ====== |
|||
{{chunk|doc=3z7a4yrxkn|c=119|p=14}} |
|||
'''Fixed income portfolio credit quality and duration''' |
|||
* The weighted average credit rating of the available-for-sale fixed income portfolio was "A+" at December 31, 2025, and "AA-" at December 31, 2024. |
|||
* Commercial mortgage loans are primarily senior loans on real estate across the U.S.. |
|||
* The average duration of the fixed income portfolio was approximately 3.60 years as of December 31, 2025, and 4.34 years as of December 31, 2024. |
|||
{{chunk|doc=3z7a4yrxkn|c=120|p=14}} |
|||
'''Equities portfolio composition and divestment''' |
|||
* The equities portfolio primarily consisted of domestic preferred stocks, common equities, exchange traded funds, limited partnerships, limited liability corporations, and other equity interests, 100.0% of which were publicly traded. |
|||
* During Q3 2025, almost all of the equities portfolio was sold, retaining only preferred stocks. |
|||
{{chunk|doc=3z7a4yrxkn|c=121|p=14}} |
|||
'''Alternative and strategic investments''' |
|||
* Alternative investments consist of promissory notes, limited partnerships, joint ventures, and equity interests. |
|||
* Underlying alternative investments are primarily floating rate senior secured loans, comprising short duration, collateralized, asset-oriented credit investments. |
|||
* Limited partnerships and joint ventures are subject to future increases or decreases in asset value as assets are monetized and income distributed. |
|||
* Strategic investments consist of equity interests in private entities within the insurance industry. |
|||
{{chunk|doc=3z7a4yrxkn|c=122|p=14}} |
|||
'''Market risk overview''' |
|||
* Market risk is the risk of economic losses due to adverse changes in the estimated fair value of a financial instrument from changes in interest rates, equity prices, foreign currency exchange rates, and commodity prices. |
|||
* The primary components of market risk affecting the company are credit risk and interest rate risk. |
|||
* The company does not have significant exposure to foreign currency exchange rate risk or commodity risk. |
|||
{{chunk|doc=3z7a4yrxkn|c=123|p=14}} |
|||
'''Credit risk management''' |
|||
* Credit risk is the potential loss from adverse changes in an issuer’s ability to repay debt obligations. |
|||
* Exposure to credit risk exists as a holder of debt instruments in core fixed income and opportunistic fixed income portfolios. |
|||
* The risk management strategy and investment policy is to invest primarily in debt instruments of high credit quality issuers and limit credit exposure by ratings categories and per issuer. |
|||
* At December 31, 2025, the fixed income portfolio had an average rating of "A+". |
|||
* Approximately 78.5% of securities in the fixed income portfolio were rated "A" or better by at least one nationally recognized rating organization at December 31, 2025. |
|||
* The policy is to invest in investment grade fixed income securities for stable income, supplemented by opportunistic fixed income and equity securities for diversification and risk-adjusted returns. |
|||
* Approximately 1.1% of the fixed income portfolio was unrated or rated below investment-grade at December 31, 2025. |
|||
* The company monitors the financial condition of all issuers in its portfolio through investment managers. |
|||
* The company is subject to credit risk from third-party reinsurers, as it remains ultimately liable to policyholders for ceded risks. |
|||
* This credit risk is addressed by purchasing reinsurance from reinsurers rated at least "A-" (Excellent) or better by A.M. Best. |
|||
* Periodic credit reviews of reinsurers are performed with the reinsurance broker. |
|||
* At December 31, 2025, 98% of reinsurance recoverables were from reinsurers rated "A-" (Excellent) or better by A.M. Best, or were collateralized through funds held, trusts, and letters of credit. |
|||
* If a reinsurer suffers a credit downgrade, options to lessen asset impairment risk include commutation, novation, and letters of credit. |
|||
{{chunk|doc=3z7a4yrxkn|c=124|p=14}} |
|||
'''Interest rate risk management''' |
|||
* Interest rate risk is the risk of economic losses due to adverse changes in interest rates. |
|||
* The primary market risk to the investment portfolio is interest rate risk associated with fixed income securities. |
|||
* Fluctuations in interest rates directly affect the market valuation of these securities; rising rates decrease fair value, falling rates increase fair value. |
|||
* Interest rate risk is managed by investing in securities with varied maturity dates and by managing the duration of the investment portfolio in relation to the duration of reserves. |
|||
* Duration is the weighted average payment period of cash flows, weighted by the present value of cash flows. |
|||
* Duration targets for the core fixed income investment portfolio are set after considering the estimated duration of liabilities and other factors. |
|||
* Fixed maturity securities had a weighted average effective duration of 3.6 years as of December 31, 2025. |
|||
* Fixed income securities subject to interest rate risk had a fair value of USD 1,856.3m at December 31, 2025. |
|||
* Opportunistic fixed income securities are excluded from interest rate sensitivity analysis as they are primarily floating rate and treated as held-to-maturity. |
|||
* Changes in interest rates will have an immediate effect on comprehensive income and stockholders’ equity but not ordinarily on net income. |
|||
* Actual results may differ from hypothetical changes in market rates, and the sensitivity analysis does not reflect actions to mitigate hypothetical fair value losses. |
|||
{{chunk|doc=3z7a4yrxkn|c=125|p=14}} |
|||
'''Equity price risk''' |
|||
* Equity price risk represents potential economic losses due to adverse changes in equity security prices. |
|||
* At December 31, 2025, approximately 0.1% of the fair value of the investment portfolio (excluding cash and cash equivalents and short-term investments) was invested in equity securities. |
|||
* Almost all of the equities portfolio was sold during Q3 2025, retaining only preferred stocks. |
|||
{{chunk|doc=3z7a4yrxkn|c=126|p=14}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1018" class="wikitable fintable" |
||
|+ Investments |
|||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | 2025 |
! colspan="2" style="text-align:center" | 2025 |
||
| Line 2,114: | Line 2,644: | ||
| style="text-align:right" | 8.6% |
| style="text-align:right" | 8.6% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total portfolio |
||
| style="text-align:right" | |
| style="text-align:right" | 2,469,059 |
||
| style="text-align:right" | |
| style="text-align:right" | 100.0% |
||
| style="text-align:right" | |
| style="text-align:right" | 1,992,423 |
||
| style="text-align:right" | |
| style="text-align:right" | 100.0% |
||
|} |
|} |
||
</div> |
</div> |
||
====== Fixed income portfolio by security type ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1019" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | 2025 |
! colspan="2" style="text-align:center" | 2025 |
||
| Line 2,131: | Line 2,660: | ||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | Carrying Value |
||
! class="col-s" style="text-align:right" | % of Total |
! class="col-s" style="text-align:right" | % of Total |
||
! class="col- |
! class="col-m" style="text-align:right" | Carrying Value |
||
! class="col-s" style="text-align:right" | % of Total |
! class="col-s" style="text-align:right" | % of Total |
||
|- |
|- |
||
| Line 2,172: | Line 2,701: | ||
| style="text-align:right" | 22.2% |
| style="text-align:right" | 22.2% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total fixed income portfolio, available-for-sale |
||
| style="text-align:right" | |
| style="text-align:right" | 1,856,303 |
||
| style="text-align:right" | |
| style="text-align:right" | 99.5% |
||
| style="text-align:right" | |
| style="text-align:right" | 1,292,218 |
||
| style="text-align:right" | |
| style="text-align:right" | 98.0% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Commercial mortgage loans</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>9,902</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>0.5%</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>26,490</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>2.0%</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total fixed income portfolio |
||
| style="text-align:right" | |
| style="text-align:right" | 1,866,205 |
||
| style="text-align:right" | |
| style="text-align:right" | 100.0% |
||
| style="text-align:right" | |
| style="text-align:right" | 1,318,708 |
||
| style="text-align:right" | |
| style="text-align:right" | 100.0% |
||
|} |
|} |
||
</div> |
</div> |
||
====== Fixed income portfolio by credit rating ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1020" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | 2025 |
! colspan="2" style="text-align:center" | 2025 |
||
| Line 2,236: | Line 2,764: | ||
| style="text-align:right" | 1.7% |
| style="text-align:right" | 1.7% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total fixed income portfolio, available-for-sale |
||
| style="text-align:right" | |
| style="text-align:right" | 1,856,303 |
||
| style="text-align:right" | |
| style="text-align:right" | 100.0% |
||
| style="text-align:right" | |
| style="text-align:right" | 1,292,218 |
||
| style="text-align:right" | |
| style="text-align:right" | 100.0% |
||
|} |
|} |
||
</div> |
</div> |
||
====== Equities portfolio by type ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable |
{| id="t1021" class="wikitable" |
||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | 2025 |
! colspan="2" style="text-align:center" | 2025 |
||
| Line 2,253: | Line 2,780: | ||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! |
! style="text-align:right" | Fair Value |
||
! |
! style="text-align:right" | % of Total Fair Value |
||
! |
! style="text-align:right" | Fair Value |
||
! |
! style="text-align:right" | % of Total Fair Value |
||
|- |
|- |
||
| style="text-align:left" | Domestic common equities |
| style="text-align:left" | Domestic common equities |
||
| Line 2,276: | Line 2,803: | ||
| style="text-align:right" | 1.1% |
| style="text-align:right" | 1.1% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Equities</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,174</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>100.0%</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>106,254</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>100.0%</b> |
||
|} |
|} |
||
</div> |
</div> |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1022" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col-s" style="text-align:right" | Estimated Fair Value |
! class="col-s" style="text-align:right" | Estimated Fair Value |
||
| Line 2,293: | Line 2,821: | ||
| style="text-align:left" | 300 basis point increase |
| style="text-align:left" | 300 basis point increase |
||
| style="text-align:right" | 1,654,474 |
| style="text-align:right" | 1,654,474 |
||
| style="text-align:right" | |
| style="text-align:right" | (201,829) |
||
| style="text-align:right" | |
| style="text-align:right" | (10.9)% |
||
|- |
|- |
||
| style="text-align:left" | 200 basis point increase |
| style="text-align:left" | 200 basis point increase |
||
| style="text-align:right" | 1,721,816 |
| style="text-align:right" | 1,721,816 |
||
| style="text-align:right" | |
| style="text-align:right" | (134,487) |
||
| style="text-align:right" | |
| style="text-align:right" | (7.2)% |
||
|- |
|- |
||
| style="text-align:left" | 100 basis point increase |
| style="text-align:left" | 100 basis point increase |
||
| style="text-align:right" | 1,789,092 |
| style="text-align:right" | 1,789,092 |
||
| style="text-align:right" | |
| style="text-align:right" | (67,211) |
||
| style="text-align:right" | |
| style="text-align:right" | (3.6)% |
||
|- |
|- |
||
| style="text-align:left" | No change |
| style="text-align:left" | No change |
||
| Line 2,328: | Line 2,856: | ||
</div> |
</div> |
||
=== Other Items === |
|||
{{chunk|doc=3z7a4yrxkn|c=127|p=14}} |
|||
* ''Income tax expense'' for the year ended December 31, 2025, was USD 46.4m <sup>p. 40</sup>. |
|||
'''Income tax expense and effective tax rate''' |
|||
* ''Effective tax rate'' for the year ended December 31, 2025, was 21.4% <sup>p. 40</sup>. |
|||
* Effective tax rate for the year ended December 31, 2024, was 22.2% <sup>p. 40</sup>. |
|||
* For a reconciliation between actual federal income tax expense and the amount computed at the statutory rate for the years ended December 31, 2025 and 2024, refer to Note 13, "Income Taxes," in the consolidated financial statements included in Item 8 of this Form 10-K <sup>p. 40</sup>. |
|||
* Income tax expense for the year ended December 31, 2025 was USD 46.4m, compared to USD 33.9m for the year ended December 31, 2024. |
|||
====== Liquidity and Capital Resources ====== |
|||
* The effective tax rate for the year ended December 31, 2025 was 21.4%, compared to 22.2% for the year ended December 31, 2024. |
|||
{{chunk|doc=3z7a4yrxkn|c=128|p=14}} |
|||
* The company is organized as a holding company, with operations primarily conducted by wholly-owned insurance subsidiaries GMIC, HSIC, and IIC (domiciled in Texas), and OSIC (domiciled in Oklahoma) <sup>p. 41</sup>. |
|||
'''Income tax reconciliation reference''' |
|||
* The holding company receives cash through corporate service fees from operating subsidiaries, payments from a consolidated tax allocation agreement, dividends from subsidiaries (subject to limitations), bank loans, draws on a revolving loan agreement, and issuance of equity and debt securities <sup>p. 41</sup>. |
|||
* Proceeds from these sources may be used to contribute funds to insurance subsidiaries for premium growth, pay dividends and taxes, and for other business purposes <sup>p. 41</sup>. |
|||
* Skyward Service Company receives corporate service fees from operating subsidiaries to reimburse it for most incurred operating expenses, based on actual expected costs with no mark-up <sup>p. 41</sup>. |
|||
* The company files a consolidated U.S. federal income tax return with its subsidiaries, and under the corporate tax allocation agreement, each participant is charged or refunded taxes as if they filed on a separate return basis with the IRS <sup>p. 41</sup>. |
|||
* Applicable state insurance laws restrict the ability of insurance subsidiaries to declare stockholder dividends without prior regulatory approval <sup>p. 41</sup>. |
|||
* State insurance regulators require insurance companies to maintain specified levels of statutory capital and surplus <sup>p. 41</sup>. |
|||
* Dividend payments are limited to the portion of available policyholder surplus derived from net profits on an insurer’s business <sup>p. 41</sup>. |
|||
* Insurance regulators have broad powers to prevent the reduction of statutory surplus to inadequate levels <sup>p. 41</sup>. |
|||
* There is no assurance that maximum calculated dividends would be permitted <sup>p. 41</sup>. |
|||
* State insurance regulatory authorities may adopt more restrictive statutory provisions regarding dividend payments by insurance subsidiaries in the future <sup>p. 41</sup>. |
|||
* Insurance subsidiaries did not pay dividends to the holding company for the years ended December 31, 2025, and 2024 <sup>p. 41</sup>. |
|||
* Additional information regarding insurance companies is available in Note 23, “Statutory Accounting Principles and Regulatory Matters,” to the consolidated financial statements in Item 8 of Form 10-K <sup>p. 41</sup>. |
|||
* The holding company had ''cash and investments'' of $3.5 million at December 31, 2025, compared to $2.9 million at December 31, 2024 <sup>p. 41</sup>. |
|||
* The company believes it has sufficient liquidity to meet operating cash needs, obligations, and committed capital expenditures for the next 12 months <sup>p. 41</sup>. |
|||
* For a reconciliation between actual federal income tax expense and the amount computed at the indicated statutory rate for the years ended December 31, 2025 and 2024, refer to Note 13, "Income Taxes" in the consolidated financial statements included in Item 8 of this Form 10-K. |
|||
====== Cash Flows ====== |
|||
=== Liquidity and Capital Resources === |
|||
* ''Primary cash source'': premiums received from insureds, typically at the beginning of the coverage period, net of related commission amounts <sup>p. 42</sup>. |
|||
* ''Primary cash outflow'': claims incurred by policyholders for insured losses <sup>p. 42</sup>. |
|||
* ''Investment strategy'': cash is invested in various investment securities to earn interest and dividends because claim payments occur after premium receipt, often years later <sup>p. 42</sup>. |
|||
* ''Other cash uses'': operating expenses (salaries, rent, taxes) and capital expenditures (technology systems) <sup>p. 42</sup>. |
|||
* ''Reinsurance'': used to manage policy risk; involves ceding part of received premiums to reinsurers and collecting cash back when covered losses are paid <sup>p. 42</sup>. |
|||
* ''Operating cash flow variability'': timing of payments and receipts, including loss settlements and reinsurance receipts, can cause variations between periods <sup>p. 42</sup>. |
|||
* ''Management outlook'': cash receipts from premiums and investment income proceeds are believed to be sufficient to cover cash outflows in the foreseeable future <sup>p. 42</sup>. |
|||
* ''Operating activities cash flow (2025 vs. 2024)'': increase in cash provided primarily due to increased cash inflows from insurance operations <sup>p. 42</sup>. |
|||
* ''Operating cash flow variability'': can vary due to timing of premium receipts, claim payments, and reinsurance activity <sup>p. 42</sup>. |
|||
* ''Operating cash flow usage'': in the past two years, primarily used to fund investing activities <sup>p. 42</sup>. |
|||
* ''Net cash used in investing activities (2025)'': primarily driven by purchases of fixed maturity securities, partially offset by sales and maturities of investment securities <sup>p. 42</sup>. |
|||
* ''Net cash used in investing activities (2024)'': driven by purchases of fixed maturity securities, partially offset by sales and maturities of investment securities and sales of short-term investments <sup>p. 42</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=129|p=14}} |
|||
====== Cash flow statement ====== |
|||
'''Liquidity and Capital Resources''' |
|||
* The company is organized as a holding company, with operations primarily conducted by wholly-owned insurance subsidiaries: GMIC, HSIC, and IIC (domiciled in Texas), and OSIC (domiciled in Oklahoma). |
|||
* The holding company receives cash through: corporate service fees from operating subsidiaries, payments from a consolidated tax allocation agreement, [[Definition:Dividend|dividends]] from subsidiaries (subject to limitations), bank loans, draws on a revolving loan agreement, and issuance of equity and debt securities. |
|||
* Proceeds from these sources are used to contribute funds to insurance subsidiaries for premium growth support, [[Definition:Dividend|dividend]] payments, taxes, and other business purposes. |
|||
* Skyward Service Company receives corporate service fees from operating subsidiaries to reimburse most incurred operating expenses. |
|||
* Reimbursement of expenses via corporate service fees is based on expected actual costs, with no mark-up. |
|||
* The company files a consolidated U.S. federal income tax return with its subsidiaries. |
|||
* Under the corporate tax allocation agreement, each participant is charged or refunded taxes based on what they would have paid or received if filing on a separate return basis with the IRS. |
|||
* State insurance laws restrict insurance subsidiaries' ability to declare stockholder [[Definition:Dividend|dividends]] without prior regulatory approval. |
|||
* State insurance regulators require insurance companies to maintain specified levels of statutory capital and surplus. |
|||
* [[Definition:Dividend|Dividend]] payments are limited to the portion of available policyholder surplus derived from net profits on an insurer’s business. |
|||
* Insurance regulators have broad powers to prevent reduction of statutory surplus to inadequate levels, and there is no assurance that maximum calculated [[Definition:Dividend|dividends]] would be permitted. |
|||
* State insurance regulatory authorities may adopt more restrictive statutory provisions regarding [[Definition:Dividend|dividend]] payments by insurance subsidiaries in the future. |
|||
* Insurance subsidiaries did not pay [[Definition:Dividend|dividends]] to the holding company for the years ended December 31, 2025, and 2024. |
|||
* Additional information on insurance companies is available in Note 23, “Statutory Accounting Principles and Regulatory Matters,” to the consolidated financial statements in Item 8 of Form 10-K. |
|||
* The holding company had USD 3.5m in cash and investments at December 31, 2025, compared to USD 2.9m at December 31, 2024. |
|||
* The company believes it has sufficient liquidity to meet operating cash needs, obligations, and committed capital expenditures for the next 12 months. |
|||
=== Cash Flows === |
|||
{{chunk|doc=3z7a4yrxkn|c=130|p=14}} |
|||
'''Cash flow overview and operating activities''' |
|||
* The most significant source of cash is premiums received from insureds, typically at the beginning of the coverage period, net of related commission amounts. |
|||
* The most significant cash outflow is for claims incurred by policyholders. |
|||
* Cash is invested in various investment securities to earn interest and [[Definition:Dividend|dividends]] because claim payments occur after premium receipt, often years later. |
|||
* Cash is also used for operating expenses (salaries, rent, taxes) and capital expenditures (technology systems). |
|||
* Reinsurance is used to manage risk, involving ceding premiums to reinsurers and collecting cash back when covered losses are paid. |
|||
* The timing of cash flows from operating activities can vary between periods due to the timing of payments and receipts. |
|||
* Significant payments and receipts, such as loss settlements and subsequent reinsurance receipts, can influence operating cash flows in any given period. |
|||
* Management believes cash receipts from premiums and investment income proceeds are sufficient to cover foreseeable cash outflows. |
|||
* Cash provided by operating activities increased in 2025 compared to 2024, primarily due to increased cash inflows from insurance operations. |
|||
* Cash from operations can vary period-to-period due to the timing of premium receipts, claim payments, and reinsurance activity. |
|||
* Cash flows from operations in both 2024 and 2025 were primarily used to fund investing activities. |
|||
{{chunk|doc=3z7a4yrxkn|c=131|p=14}} |
|||
'''Investing activities''' |
|||
* Net cash used in investing activities in 2025 was primarily driven by purchases of fixed maturity securities, partially offset by sales and maturities of investment securities. |
|||
* Net cash used in investing activities in 2024 was driven by purchases of fixed maturity securities, partially offset by sales and maturities of investment securities and sales of short-term investments. |
|||
{{chunk|doc=3z7a4yrxkn|c=132|p=14}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1023" class="wikitable fintable" |
||
|+ Cash and cash equivalents provided by (used in) by activities |
|||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2025 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2024 |
||
|- |
|- |
||
! style="text-align:left" | Cash and cash equivalents provided by (used in): |
! style="text-align:left" | Cash and cash equivalents provided by (used in): |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Operating activities |
| style="text-align:left" | Operating activities |
||
| Line 2,386: | Line 2,933: | ||
|- |
|- |
||
| style="text-align:left" | Investing activities |
| style="text-align:left" | Investing activities |
||
| style="text-align:right" | |
| style="text-align:right" | (366,898) |
||
| style="text-align:right" | |
| style="text-align:right" | (243,694) |
||
|- |
|- |
||
| style="text-align:left" | Financing activities |
| style="text-align:left" | Financing activities |
||
| style="text-align:right" | 411 |
| style="text-align:right" | 411 |
||
| style="text-align:right" | |
| style="text-align:right" | (4,232) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Change in cash and cash equivalents and restricted cash</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>41,589</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>57,189</b> |
||
|} |
|} |
||
</div> |
</div> |
||
=== Credit Agreements === |
|||
{{chunk|doc=3z7a4yrxkn|c=133|p=14}} |
|||
* The ''FHLB Loan'' was entered into on August 30, 2024, with the Federal Home Loan Bank of Dallas (FHLB) <sup>p. 43</sup>. |
|||
'''FHLB loan''' |
|||
* It is a ''4.5-year term loan'' for a principal amount of $57.0 million <sup>p. 43</sup>. |
|||
* The FHLB Loan requires ''interest-only payments'' during its term, with principal due at maturity <sup>p. 43</sup>. |
|||
* The ''interest rate'' is fixed at 4.00% over the loan term <sup>p. 43</sup>. |
|||
* The FHLB Loan is ''fully secured'' by a pledge of specific investment securities of HSIC <sup>p. 43</sup>. |
|||
* Proceeds from the FHLB Loan were used to ''fund redemptions'' of draws on the 2023 Revolving Credit Facility <sup>p. 43</sup>. |
|||
* During the fourth quarter of 2025, the company entered into a ''Term Loan Credit Agreement'' (Term Loan Facility) with a syndicate of banks <sup>p. 43</sup>. |
|||
* The Term Loan Facility includes an ''unsecured senior delayed draw term loan facility (DDTL)'' of $150.0 million (Tranche A DDTL) <sup>p. 43</sup>. |
|||
* It also includes an ''additional unsecured senior DDTL'' of $150.0 million (Tranche B DDTL) <sup>p. 43</sup>. |
|||
* The ''Term Loan Facility'' was used to fund a portion of the consideration for the acquisition of Apollo Group Holdings Limited (Apollo) and related transaction fees and expenses <sup>p. 43</sup>. |
|||
* ''Interest'' on amounts drawn under the Term Loan Facility will be at term SOFR plus a margin ranging from 150 to 190 basis points, or the base rate plus a margin ranging from 50 to 90 basis points, depending on the debt to capitalization ratio <sup>p. 43</sup>. |
|||
* ''SOFR'' will be calculated with a floor of 0.00% and a credit spread adjustment of 0.10% <sup>p. 43</sup>. |
|||
* The ''base rate'' will be the highest of (i) the Agent’s prime lending rate, (ii) the Federal Funds Rate plus 0.50%, (iii) SOFR plus 1.00%, and (iv) zero percent (0%) <sup>p. 43</sup>. |
|||
* An ''undrawn amount fee'' ranging from 0.20% to 0.35% will be paid on average daily undrawn amounts under the Facility, depending on the debt to capitalization ratio <sup>p. 43</sup>. |
|||
* The ''Tranche A DDTL matures'' on January 1, 2028 <sup>p. 43</sup>. |
|||
* The ''Tranche B DDTL matures'' on July 2, 2029 <sup>p. 43</sup>. |
|||
* On December 30, 2025, ''$150 million of Tranche A DDTL'' and ''$150 million of Tranche B DDTL'' were drawn for the Apollo acquisition on January 1, 2026 <sup>p. 43</sup>. |
|||
* The Term Loan Facility includes ''customary covenants'', such as limitations on additional indebtedness exceeding $10.0 million and restrictions on distributions to stockholders or share repurchases upon certain events <sup>p. 43</sup>. |
|||
* ''Financial covenants'' include minimum consolidated net worth, maximum total debt to capitalization, minimum A.M. Best rating, and minimum liquidity <sup>p. 43</sup>. |
|||
* As of December 31, 2025, the company was in ''compliance with all covenants'' of the Term Loan Facility <sup>p. 43</sup>. |
|||
* The ''Term Loan Facility is unsecured'' <sup>p. 43</sup>. |
|||
* A ''guaranty agreement'' was entered into during the fourth quarter of 2025, where obligations under the Term Loan Facility are guaranteed by the company and its existing wholly-owned subsidiaries, excluding insurance company subsidiaries and subject to certain exceptions <sup>p. 43</sup>. |
|||
* During the fourth quarter of 2025, the company entered into a ''Revolving Credit Facility'' with a syndicate of banks <sup>p. 43</sup>. |
|||
* The ''Revolving Credit Facility is unsecured'' and initially provided up to $150.0 million, which was increased to $250.0 million on the closing date of the Apollo acquisition <sup>p. 43</sup>. |
|||
* The Revolving Credit Facility was ''amended'' during the fourth quarter of 2025 to permit funding of certain revolving loans for the Apollo acquisition <sup>p. 43</sup>. |
|||
* The company initially ''drew $43.0 million'' from the Revolving Credit Facility to redeem its prior revolving credit facility <sup>p. 43</sup>. |
|||
* On December 30, 2025, an ''additional $71.5 million'' was drawn for the consideration paid for the Apollo acquisition <sup>p. 43</sup>. |
|||
* Proceeds from the Term Loan Facility and Revolving Credit Facility draws are presented ''net with liabilities'' on the Consolidated Balance Sheets for the year ended December 31, 2025 <sup>p. 43</sup>. |
|||
* These proceeds were used for the ''Apollo acquisition'' on January 1, 2026 <sup>p. 43</sup>. |
|||
* ''Interest'' on the Revolving Credit Facility is payable quarterly <sup>p. 43</sup>. |
|||
* Amounts drawn bear interest at term SOFR plus a margin (150 to 190 basis points) or the base rate plus a margin (50 to 90 basis points), depending on the debt to capitalization ratio <sup>p. 43</sup>. |
|||
* ''SOFR'' calculation includes a 0.00% floor and a 0.10% credit spread adjustment <sup>p. 43</sup>. |
|||
* The ''base rate'' is the highest of (i) Agent’s prime lending rate, (ii) Federal Funds Rate plus 0.50%, (iii) SOFR plus 1.00%, and (iv) zero percent (0%) <sup>p. 43</sup>. |
|||
* A ''fee'' ranging from 0.20% to 0.35% is paid on average daily undrawn amounts, based on the debt to capitalization ratio <sup>p. 43</sup>. |
|||
* The ''availability period'' under the Revolving Credit Facility terminates on November 12, 2030 <sup>p. 43</sup>. |
|||
* The company is subject to ''covenants'' on the Revolving Credit Facility, including minimum net worth, maximum debt to capital ratio, minimum A.M. Best Rating, and minimum liquidity <sup>p. 43</sup>. |
|||
* As of December 31, 2025, the company was in ''compliance with all covenants'' of the Revolving Credit Facility <sup>p. 43</sup>. |
|||
* In the first quarter of 2023, the company entered into an agreement for an ''unsecured revolving credit facility'' (2023 Revolving Credit Facility) <sup>p. 43</sup>. |
|||
* The ''2023 Revolving Credit Facility'' provided up to $150.0 million and a letter of credit sub-facility of up to $30.0 million <sup>p. 43</sup>. |
|||
* On November 13, 2025, the ''2023 Revolving Credit Facility was redeemed'' <sup>p. 43</sup>. |
|||
* ''Accrued interest of $0.3 million'' was paid, and ''$0.6 million of expense'' was recognized for remaining unamortized deferred financing costs <sup>p. 43</sup>. |
|||
* In May 2019, the company agreed to issue ''unsecured subordinated notes'' (Notes) with an aggregate principal amount of $20.0 million <sup>p. 43</sup>. |
|||
* ''Interest on the Notes'' is fixed at 7.25% for the first 8 years and 8.25% thereafter <sup>p. 43</sup>. |
|||
* ''Early retirement'' of the debt before the 8-year commitment requires full interest payments and return of outstanding principal <sup>p. 43</sup>. |
|||
* ''Principal is due at maturity'' on May 24, 2039, and interest is payable quarterly <sup>p. 43</sup>. |
|||
* The ''Notes have junior priority'' to all previously issued debt <sup>p. 43</sup>. |
|||
* Debt related to the Notes is reported ''net of debt issuance costs'' of approximately $0.4 million and $0.5 million for December 31, 2025 and 2024, respectively <sup>p. 43</sup>. |
|||
* These ''deferred financing costs'' are presented as a direct deduction from the carrying amount of the subordinated debt <sup>p. 43</sup>. |
|||
* On August 30, 2024, the company entered into a 4.5-year FHLB Loan with the Federal Home Loan Bank of Dallas (FHLB) for a principal amount of USD 57.0m. |
|||
====== Share Repurchase Program ====== |
|||
* The FHLB Loan has a fixed interest rate of 4.00% and requires interest-only payments during its term, with principal due at maturity. |
|||
* The loan is fully secured by a pledge of specific investment securities of HSIC. |
|||
* Proceeds from the FHLB Loan were used to fund redemptions of draws on the 2023 Revolving Credit Facility. |
|||
{{chunk|doc=3z7a4yrxkn|c=134|p=14}} |
|||
* The ''Board of Directors'' approved a share repurchase program in October 2024 <sup>p. 44</sup>. |
|||
'''Term Loan Facility''' |
|||
* The program authorizes the repurchase of up to ''USD 50.0m'' of common stock <sup>p. 44</sup>. |
|||
* Shares may be repurchased via open market purchases, privately-negotiated transactions, block purchases, accelerated share repurchase agreements, or a combination of methods, including Rule 10b5-1 trading plans <sup>p. 44</sup>. |
|||
* The timing, manner, price, and amount of repurchases are at the company's discretion <sup>p. 44</sup>. |
|||
* The program does not mandate the repurchase of any specific number of shares and can be modified, suspended, or terminated at any time <sup>p. 44</sup>. |
|||
* As of December 31, 2025, ''no shares'' have been repurchased under this plan <sup>p. 44</sup>. |
|||
* During Q4 2025, the company entered into a Term Loan Credit Agreement (Term Loan Facility) with a syndicate of banks. |
|||
====== Contractual Obligations and Commitments ====== |
|||
* The Term Loan Facility includes an unsecured senior delayed draw term loan facility (DDTL) of USD 150.0m (Tranche A DDTL) and an additional unsecured senior DDTL of USD 150.0m (Tranche B DDTL). |
|||
* The Term Loan Facility was used to fund a portion of the consideration for the acquisition of Apollo Group Holdings Limited (Apollo) and related transaction fees and expenses. |
|||
* Interest on amounts drawn under the Term Loan Facility will be either term SOFR plus a margin of 150 bps to 190 bps, or the base rate plus a margin of 50 bps to 90 bps, depending on the debt to capitalization ratio. |
|||
* SOFR will be calculated using a SOFR floor of 0.00% and a credit spread adjustment of 0.10%. |
|||
* The base rate will be the highest of (i) the Agent’s prime lending rate, (ii) the Federal Funds Rate plus 0.50%, (iii) SOFR plus 1.00%, and (iv) zero percent (0%). |
|||
* The company will also pay a fee ranging from 0.20% to 0.35% on average daily undrawn amounts under the Facility, depending on the debt to capitalization ratio. |
|||
* The Tranche A DDTL matures on January 1, 2028, and the Tranche B DDTL matures on July 2, 2029. |
|||
* On December 30, 2025, the company drew USD 150m from the Tranche A DDTL and USD 150m from the Tranche B DDTL for the acquisition of Apollo on January 1, [[Definition:Year 2026|2026]]. |
|||
* The Term Loan Facility includes customary covenants, such as limitations on additional indebtedness exceeding USD 10.0m, restrictions on distributions to stockholders, and financial covenants related to minimum consolidated net worth, maximum total debt to capitalization, minimum A.M. Best rating, and minimum liquidity. |
|||
* As of December 31, 2025, the company was in compliance with all covenants. |
|||
* The Term Loan Facility is unsecured. |
|||
* In Q4 2025, the company and subsidiary guarantors entered into a guaranty agreement, making obligations under the Term Loan Facility guaranteed by the company and its existing wholly-owned subsidiaries and subsequently acquired or organized subsidiaries (excluding insurance company subsidiaries and subject to certain exceptions). |
|||
{{chunk|doc=3z7a4yrxkn|c=135|p=14}} |
|||
* ''Reserves for losses and LAE'' represent the best estimate of the ultimate cost for settling reported and unreported claims and related expenses <sup>p. 45</sup>. |
|||
'''Revolving Credit Facilities''' |
|||
* Estimating reserves for losses and LAE involves complex and subjective judgments <sup>p. 45</sup>. |
|||
* Actual losses and settlement expenses paid may substantially deviate from the reserve estimates in financial statements <sup>p. 45</sup>. |
|||
* The timing for payment of estimated losses is not fixed or individually/aggregately determinable <sup>p. 45</sup>. |
|||
* Assumptions for estimating payments due by period are based on the company's, industry, and peer group claims payment experience <sup>p. 45</sup>. |
|||
* There is a risk that amounts paid in any period will differ significantly from disclosed amounts due to uncertainty in payment timing estimation <sup>p. 45</sup>. |
|||
* Disclosed amounts are gross of anticipated amounts recoverable from reinsurers <sup>p. 45</sup>. |
|||
* ''Reinsurance balances recoverable'' on reserves for losses and LAE are reported separately as assets, not netted with liabilities, because reinsurance does not discharge the company's liability to policyholders <sup>p. 45</sup>. |
|||
* ''Reinsurance balances recoverable'' on reserves for paid and unpaid losses and LAE totaled ''$1,119.9 million'' at December 31, 2025 <sup>p. 45</sup>. |
|||
* ''Reinsurance balances recoverable'' on reserves for paid and unpaid losses and LAE totaled ''$857.9 million'' at December 31, 2024 <sup>p. 45</sup>. |
|||
* During Q4 2025, the company entered into an unsecured Revolving Credit Facility with a syndicate of banks, initially providing up to USD 150.0m. |
|||
====== Reinsurance balances recoverable ====== |
|||
* The maximum principal amount of the Revolving Credit Facility was increased to USD 250.0m on the closing date of the Apollo acquisition. |
|||
* The Revolving Credit Facility was amended in Q4 2025 to permit funding of certain revolving loans for the Apollo acquisition. |
|||
* The company initially drew USD 43.0m, used to redeem its prior revolving credit facility. |
|||
* On December 30, 2025, an additional USD 71.5m was drawn from the Revolving Credit Facility for the consideration paid for the Apollo acquisition on January 1, [[Definition:Year 2026|2026]]. |
|||
* Interest on the Revolving Credit Facility is payable quarterly. |
|||
* Amounts drawn bear interest at either term SOFR plus a margin of 150 bps to 190 bps, or the base rate plus a margin of 50 bps to 90 bps, depending on the debt to capitalization ratio. |
|||
* SOFR will be calculated using a SOFR floor of 0.00% and a credit spread adjustment of 0.10%. |
|||
* The base rate will be the highest of (i) the Agent’s prime lending rate, (ii) the Federal Funds Rate plus 0.50%, (iii) SOFR plus 1.00%, and (iv) zero percent (0%). |
|||
* The company will also pay a fee ranging from 0.20% to 0.35% on average daily undrawn amounts, depending on the debt to capitalization ratio. |
|||
* The availability period under the Facility terminates on November 12, 2030. |
|||
* The company is subject to covenants on the Revolving Credit Facility based on minimum net worth, maximum debt to capital ratio, minimum A.M. Best Rating, and minimum liquidity. |
|||
* As of December 31, 2025, the company was in compliance with all covenants. |
|||
* In Q1 2023, the company entered into an agreement for an unsecured revolving credit facility (2023 Revolving Credit Facility) of up to USD 150.0m and a letter of credit sub-facility of up to USD 30.0m. |
|||
* On November 13, 2025, the 2023 Revolving Credit Facility was redeemed, with USD 0.3m of accrued interest paid and USD 0.6m of expense recognized for remaining unamortized deferred financing costs. |
|||
{{chunk|doc=3z7a4yrxkn|c=136|p=14}} |
|||
'''Debentures''' |
|||
* In May 2019, the company agreed to issue unsecured subordinated notes (Notes) with an aggregate principal amount of USD 20.0m. |
|||
* Interest on the Notes is fixed at 7.25% for the first 8 years and 8.25% thereafter. |
|||
* Early retirement of the debt before the 8-year commitment requires all interest payments to be paid in full, plus the return of outstanding principal. |
|||
* Principal is due at maturity on May 24, 2039, and interest is payable quarterly. |
|||
* The Notes have junior priority to all previously issued debt. |
|||
* Debt related to the Notes is reported on the December 31, 2025 and 2024 Consolidated Balance Sheets, net of debt issuance costs of approximately USD 0.4m and USD 0.5m, respectively. |
|||
* These deferred financing costs are presented as a direct deduction from the carrying amount of the subordinated debt. |
|||
=== Share Repurchase Program === |
|||
{{chunk|doc=3z7a4yrxkn|c=137|p=14}} |
|||
'''[[Definition:Share buyback|Share repurchase]] program''' |
|||
* In October 2024, the Board of Directors approved a [[Definition:Share buyback|share repurchase]] program authorizing the repurchase of up to USD 50.0m of common stock. |
|||
* Shares may be repurchased via open market purchases, privately-negotiated transactions, block purchases, accelerated [[Definition:Share buyback|share repurchase]] agreements, or a combination of methods, including Rule 10b5-1 trading plans. |
|||
* The timing, manner, price, and amount of repurchases are at the company's discretion. |
|||
* The program does not require the repurchase of any specific number of shares and may be modified, suspended, or terminated at any time. |
|||
* As of December 31, 2025, no shares had been repurchased under this plan. |
|||
=== Contractual Obligations and Commitments === |
|||
{{chunk|doc=3z7a4yrxkn|c=138|p=14}} |
|||
'''Contractual Obligations and Commitments''' |
|||
* The table sets forth contractual obligations and commercial commitments by due date as of December 31, 2025. |
|||
* Reserves for losses and LAE represent the best estimate of the ultimate cost of settling reported and unreported claims and related expenses. |
|||
* Estimating reserves for losses and LAE involves complex and subjective judgments. |
|||
* Actual losses and settlement expenses paid may deviate substantially from reserve estimates. |
|||
* The timing for payment of estimated losses is not fixed or determinable on an individual or aggregate basis. |
|||
* Assumptions for estimating payments due by period are based on the company's own, industry, and peer group claims payment experience. |
|||
* There is a risk that amounts paid in any period will differ significantly from disclosed amounts due to uncertainty in timing estimation. |
|||
* Disclosed amounts are gross of anticipated amounts recoverable from reinsurers. |
|||
* Reinsurance balances recoverable on reserves for losses and LAE are reported separately as assets, not netted with liabilities, because reinsurance does not discharge liability to policyholders. |
|||
* Reinsurance balances recoverable on reserves for paid and unpaid losses and LAE totaled USD 1,119.9m at December 31, 2025. |
|||
* Reinsurance balances recoverable on reserves for paid and unpaid losses and LAE totaled USD 857.9m at December 31, 2024. |
|||
{{chunk|doc=3z7a4yrxkn|c=139|p=14}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1024" class="wikitable fintable" |
||
|+ Payments due by period by contractual obligations and commitments |
|||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="3" style="text-align:center" | Payments due by period |
! colspan="3" style="text-align:center" | Payments due by period |
||
| Line 2,499: | Line 3,060: | ||
| style="text-align:right" | 80,242 |
| style="text-align:right" | 80,242 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total |
||
| style="text-align:right" | |
| style="text-align:right" | 2,974,464 |
||
| style="text-align:right" | |
| style="text-align:right" | 551,157 |
||
| style="text-align:right" | |
| style="text-align:right" | 2,423,307 |
||
|} |
|} |
||
</div> |
</div> |
||
=== Critical Accounting Policies === |
|||
{{chunk|doc=3z7a4yrxkn|c=140|p=14}} |
|||
* Critical accounting estimates are those important to financial condition and results of operations and require significant judgment <sup>p. 46</sup>. |
|||
'''critical accounting estimates overview''' |
|||
* Significant judgment is exercised concerning future results and developments in applying critical accounting estimates and preparing consolidated financial statements <sup>p. 46</sup>. |
|||
* Judgments and estimates affect reported amounts of assets, liabilities, revenues, expenses, and disclosure of material contingent assets and liabilities <sup>p. 46</sup>. |
|||
* Actual results may differ materially from estimates and assumptions used in preparing consolidated financial statements <sup>p. 46</sup>. |
|||
* Estimates are evaluated regularly using relevant information <sup>p. 46</sup>. |
|||
* For a detailed discussion of accounting policies, refer to Note 1, “Summary of Significant Accounting Policies” in Item 8 of Form 10-K <sup>p. 46</sup>. |
|||
* ''Reserves for unpaid losses and LAE'' are the largest and most complex estimate in the Consolidated Balance Sheets <sup>p. 46</sup>. |
|||
* Reserves for unpaid losses and LAE represent the estimated ultimate cost of all unreported and reported but unpaid insured claims and adjustment costs incurred as of or before the balance sheet date <sup>p. 46</sup>. |
|||
* Reserves for losses and LAE are not discounted to reflect estimated present value <sup>p. 46</sup>. |
|||
* Estimates are made using individual case-basis valuations of reported claims, statistical analyses, and various actuarial procedures <sup>p. 46</sup>. |
|||
* Estimates are based on historical information, industry and peer group information, and estimates of future trends in factors like loss severity, loss frequency, and inflation <sup>p. 46</sup>. |
|||
* Estimates are reviewed regularly and adjusted as experience develops or new information becomes known <sup>p. 46</sup>. |
|||
* During the loss settlement period, estimates of liability may be refined and adjusted upward or downward <sup>p. 46</sup>. |
|||
* The ultimate liability may exceed or be less than revised estimates <sup>p. 46</sup>. |
|||
* The ultimate settlement of losses and related LAE may vary significantly from the estimate in financial statements <sup>p. 46</sup>. |
|||
* Reserves for unpaid losses and LAE are categorized into two types: ''case reserves'' and ''IBNR'' <sup>p. 46</sup>. |
|||
* ''Case reserves'' are established for individual claims reported to the company <sup>p. 46</sup>. |
|||
* Losses are reported by insureds, their agents, or brokers <sup>p. 46</sup>. |
|||
* Case reserves are established by estimating ultimate losses, including defense costs, for each claim <sup>p. 46</sup>. |
|||
* Claims department personnel use knowledge of specific claims and advice from internal and external experts (underwriters, legal counsel) to estimate expected ultimate losses <sup>p. 46</sup>. |
|||
* Third-Party Administrators (TPAs) are used in limited circumstances to assist with claim adjustment <sup>p. 46</sup>. |
|||
* Internal claims managers oversee TPA activities and monitor their adherence to prescribed standards <sup>p. 46</sup>. |
|||
* The ''incurred but not reported (IBNR) reserve'' is derived by estimating the ultimate unpaid reserve liability and subtracting case reserves <sup>p. 46</sup>. |
|||
* Management’s best estimate of the ultimate unpaid liability is set by the ''Reserve Committee'' <sup>p. 46</sup>. |
|||
* The Reserve Committee considers actuarial indications and other factors such as underwriting, claims handling, economic, legal, and environmental changes <sup>p. 46</sup>. |
|||
* The Reserve Committee includes the Chief Actuary, Chief Reserving Actuary, Chief Financial Officer, and Chief Claims Officer <sup>p. 46</sup>. |
|||
* The Reserve Committee meets quarterly to review actuarial reserving recommendations from the Chief Actuary <sup>p. 46</sup>. |
|||
* The Reserve Committee uses judgment to determine the best estimate for the reserve for losses and LAE on the balance sheet <sup>p. 46</sup>. |
|||
* In establishing quarterly actuarial recommendations, the actuary estimates an initial expected ultimate loss ratio for each underwriting division <sup>p. 46</sup>. |
|||
* Input from underwriting and claims departments, including premium pricing assumptions and historical experience, is considered in setting reserves <sup>p. 46</sup>. |
|||
* ''Reserves'' are driven by factors including litigation and regulatory trends, legislative activity, climate change, social and economic patterns, and claims inflation assumptions <sup>p. 46</sup>. |
|||
* Reserve estimates reflect current inflation in legal claims’ settlements <sup>p. 46</sup>. |
|||
* Reserve estimates assume no losses from significant new legal liability theories <sup>p. 46</sup>. |
|||
* Reserve estimates assume no significant changes in the regulatory and legislative environment <sup>p. 46</sup>. |
|||
* The impact of potential changes in the regulatory or legislative environment is difficult to quantify without specific new regulation or legislation <sup>p. 46</sup>. |
|||
* If significant new regulation or legislation occurs, the company will attempt to quantify its impact, but accuracy is not assured <sup>p. 46</sup>. |
|||
* The actuarial review considers multiple actuarial methods to estimate the reserve for losses and LAE <sup>p. 46</sup>. |
|||
* ''Actuarial methods'' include paid and incurred loss development methods, paid and incurred Bornhuetter-Ferguson methods, paid and incurred loss ratio cape cod methods, and frequency and severity methods <sup>p. 46</sup>. |
|||
* If one actuarial method is more credible, it is used to set the point estimate <sup>p. 46</sup>. |
|||
* For new lines of business or significant changes in claim practices, paid and incurred loss development methods are less credible due to insufficient historical data <sup>p. 46</sup>. |
|||
* The actuarial point estimate may also be based on a judgmental weighting of estimates from each method <sup>p. 46</sup>. |
|||
* These methods utilize the initial expected loss ratio, statistical analysis of past claims reporting and payment patterns, claims frequency and severity, paid loss experience, industry loss experience, and changes in market conditions, policy forms, exclusions, and exposures <sup>p. 46</sup>. |
|||
* Although reserve estimates are believed to be reasonable, actual loss experience may not conform to assumptions <sup>p. 46</sup>. |
|||
* Actual ultimate loss ratio could differ from the initial expected loss ratio <sup>p. 46</sup>. |
|||
* Actual reporting and payment patterns could differ from expected patterns, which are based on company and industry data <sup>p. 46</sup>. |
|||
* The ultimate settlement of losses and related LAE may vary significantly from estimates in financial statements <sup>p. 46</sup>. |
|||
* Estimates are regularly reviewed and adjusted as experience develops or new information becomes known <sup>p. 46</sup>. |
|||
* Adjustments are included in the results of current operations <sup>p. 46</sup>. |
|||
* ''Development'' is the amount by which estimated losses differ from those originally reported for a period <sup>p. 46</sup>. |
|||
* ''Unfavorable development'' occurs when losses settle for more than reserved or subsequent estimates indicate reserve increases <sup>p. 46</sup>. |
|||
* ''Favorable development'' occurs when losses settle for less than reserved or subsequent estimates indicate reserve reductions <sup>p. 46</sup>. |
|||
* Favorable or unfavorable development of loss reserves is reflected in the results of operations in the period the estimates are changed <sup>p. 46</sup>. |
|||
* A ''5% change in net IBNR'' would result in a ''$51.8 million change'' in reserves for losses and LAE <sup>p. 46</sup>. |
|||
* A ''5% change in net IBNR'' would result in a ''$40.9 million change'' in net income and stockholders’ equity <sup>p. 46</sup>. |
|||
* Critical accounting estimates are important for portraying financial condition and results of operations and require significant judgment. |
|||
====== Impact of a 5% change in net IBNR on reserves ====== |
|||
* Significant judgment is used concerning future results and developments in applying these estimates and preparing consolidated financial statements. |
|||
* Judgments and estimates affect reported amounts of assets, liabilities, revenues, expenses, and disclosure of material contingent assets and liabilities. |
|||
* Actual results may differ materially from estimates and assumptions. |
|||
* Estimates are evaluated regularly using relevant information. |
|||
* For a detailed discussion of accounting policies, refer to Note 1, “Summary of Significant Accounting Policies” in Item 8 of Form 10-K. |
|||
{{chunk|doc=3z7a4yrxkn|c=141|p=14}} |
|||
'''reserves for unpaid losses and LAE''' |
|||
* Reserves for unpaid losses and LAE are the largest and most complex estimate in the Consolidated Balance Sheets. |
|||
* These reserves represent the estimated ultimate cost of all unreported and reported but unpaid insured claims and the cost to adjust these losses as of or before the balance sheet date. |
|||
* Reserves for losses and LAE are not discounted to reflect estimated present value. |
|||
* Estimates are made using individual case-basis valuations of reported claims, statistical analyses, and various actuarial procedures. |
|||
* Estimates are based on historical information, industry and peer group information, and estimates of future trends in variable factors like loss severity, loss frequency, and inflation. |
|||
* Estimates are regularly reviewed and adjusted as experience develops or new information becomes known. |
|||
* During the loss settlement period, estimates of liability on a claim are often refined and adjusted upward or downward. |
|||
* The ultimate liability may exceed or be less than revised estimates. |
|||
* The ultimate settlement of losses and related LAE may vary significantly from the estimate in financial statements. |
|||
* Reserves for unpaid losses and LAE are categorized into two types: case reserves and IBNR. |
|||
* A table sets forth gross and net reserves for unpaid losses and LAE at December 31, 2025 and 2024. |
|||
{{chunk|doc=3z7a4yrxkn|c=142|p=14}} |
|||
'''case reserves and IBNR''' |
|||
* Case reserves are established for individual claims reported to the company. |
|||
* Losses are reported by insureds, their agents, or brokers. |
|||
* Case reserves are established by estimating ultimate losses, including defense costs, based on provided information. |
|||
* Claims department personnel use their knowledge of specific claims and advice from internal and external experts (underwriters, legal counsel) to estimate expected ultimate losses. |
|||
* Third-Party Administrators (TPAs) are used in limited circumstances to assist in claim adjustment. |
|||
* Internal claims managers oversee TPA activities and monitor their claim handling to prescribed standards. |
|||
* The incurred but not reported (IBNR) reserve is derived by estimating the ultimate unpaid reserve liability and subtracting case reserves. |
|||
* Management’s best estimate of the ultimate unpaid liability is set by the Reserve Committee. |
|||
* The Reserve Committee considers actuarial indications and other factors such as underwriting, claims handling, economic, legal, and environmental changes. |
|||
* The Reserve Committee includes the Chief Actuary, Chief Reserving Actuary, Chief Financial Officer, and Chief Claims Officer. |
|||
* The Reserve Committee meets quarterly to review actuarial reserving recommendations from the Chief Actuary and determines the best estimate for losses and LAE reserves. |
|||
* In establishing quarterly actuarial recommendations, the actuary estimates an initial expected ultimate loss ratio for each underwriting division. |
|||
* Input from underwriting and claims departments, including premium pricing assumptions and historical experience, is considered in setting reserves. |
|||
{{chunk|doc=3z7a4yrxkn|c=143|p=14}} |
|||
'''reserve drivers and actuarial methods''' |
|||
* Reserves are driven by factors including litigation and regulatory trends, legislative activity, climate change, social and economic patterns, and claims inflation assumptions. |
|||
* Reserve estimates reflect current inflation in legal claims’ settlements. |
|||
* Reserve estimates assume no losses from significant new legal liability theories. |
|||
* Reserve estimates assume no significant changes in the regulatory and legislative environment. |
|||
* The impact of potential changes in regulatory or legislative environment is difficult to quantify without specific new regulation or legislation. |
|||
* In the event of significant new regulation or legislation, the company will attempt to quantify its impact, but accuracy or success is not assured. |
|||
* The actuarial review considers multiple actuarial methods to estimate reserves for losses and LAE. |
|||
* Methods include paid and incurred loss development methods, paid and incurred Bornhuetter-Ferguson methods, paid and incurred loss ratio cape cod methods, and frequency and severity methods. |
|||
* If one actuarial method is more credible, it is used to set the point estimate. |
|||
* For new [[Definition:Business mix|lines of business]] or significant changes in claim practices, paid and incurred loss development methods are less credible due to insufficient historical data. |
|||
* The actuarial point estimate may be based on a judgmental weighting of estimates from each method. |
|||
* These methods utilize the initial expected loss ratio, statistical analysis of past claims reporting and payment patterns, claims frequency and severity, paid loss experience, industry loss experience, and changes in market conditions, policy forms, exclusions, and exposures. |
|||
* Reserve estimates are believed to be reasonable, but actual loss experience may not conform to assumptions. |
|||
* Actual ultimate loss ratio or reporting and payment patterns could differ from expected, which are based on company and industry data. |
|||
* The ultimate settlement of losses and related LAE may vary significantly from financial statement estimates. |
|||
* Estimates are regularly reviewed and adjusted as experience develops or new information becomes known. |
|||
* Such adjustments are included in the results of current operations. |
|||
{{chunk|doc=3z7a4yrxkn|c=144|p=14}} |
|||
'''reserve development and sensitivity''' |
|||
* "Development" is the amount by which estimated losses differ from those originally reported for a period. |
|||
* Development is unfavorable when losses settle for more than reserved or subsequent estimates indicate reserve increases. |
|||
* Development is favorable when losses settle for less than reserved or subsequent estimates indicate reserve reductions. |
|||
* Favorable or unfavorable development of loss reserves is reflected in the results of operations in the period estimates are changed. |
|||
* A 5% change in net IBNR would result in a USD 51.8m change in reserves for losses and LAE. |
|||
* A 5% change in net IBNR would result in a USD 40.9m change in net income and stockholders’ equity. |
|||
{{chunk|doc=3z7a4yrxkn|c=145|p=14}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1025" class="wikitable fintable" |
||
|+ Gross and Net by Case reserves and IBNR |
|||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="4" style="text-align:center" | 2025 |
! colspan="4" style="text-align:center" | 2025 |
||
| Line 2,601: | Line 3,182: | ||
| style="text-align:right" | 69.2% |
| style="text-align:right" | 69.2% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total |
||
| style="text-align:right" | |
| style="text-align:right" | 2,318,894 |
||
| style="text-align:right" | |
| style="text-align:right" | 100.0% |
||
| style="text-align:right" | |
| style="text-align:right" | 1,397,729 |
||
| style="text-align:right" | |
| style="text-align:right" | 100.0% |
||
| style="text-align:right" | |
| style="text-align:right" | 1,782,383 |
||
| style="text-align:right" | |
| style="text-align:right" | 100.0% |
||
| style="text-align:right" | |
| style="text-align:right" | 1,111,537 |
||
| style="text-align:right" | |
| style="text-align:right" | 100.0% |
||
|} |
|} |
||
</div> |
</div> |
||
=== Recent Accounting Pronouncements === |
|||
{{chunk|doc=3z7a4yrxkn|c=146|p=14}} |
|||
* In December 2023, the FASB issued ASU 2023-09, "Improvements to Income Tax Disclosures (Topic 740)" <sup>p. 47</sup>. |
|||
'''FASB Accounting Standards Updates''' |
|||
* ASU 2023-09 mandates enhanced rate reconciliation disclosures for public companies annually, including specific categories and additional information meeting a quantitative threshold <sup>p. 47</sup>. |
|||
* This update also requires public companies to disaggregate income taxes paid by federal, state, and foreign taxes <sup>p. 47</sup>. |
|||
* In December 2023, FASB issued ASU 2023-09, "Improvements to Income Tax Disclosures (Topic 740)", requiring public companies to provide enhanced annual rate reconciliation disclosures, including specific categories and additional information meeting a quantitative threshold. |
|||
* The guidance for ASU 2023-09 became effective for fiscal years beginning after December 15, 2024, and is applied prospectively <sup>p. 47</sup>. |
|||
* ASU 2023-09 also requires public companies to disaggregate income taxes paid by federal, state, and foreign taxes. |
|||
* Additional disclosures have been added as required by ASU 2023-09, with no impact on the consolidated financial statements <sup>p. 47</sup>. |
|||
* The guidance for ASU 2023-09 became effective for fiscal years beginning after December 15, 2024, and is applied prospectively. |
|||
* In November 2024, the FASB issued ASU 2024-03, requiring disaggregated disclosure of income statement expenses for public business entities (PBEs) <sup>p. 47</sup>. |
|||
* Additional disclosures have been added as required by ASU 2023-09, with no impact to the consolidated financial statements. |
|||
* ASU 2024-03 does not alter expense captions on the face of the income statement but requires disaggregation of certain expense captions into specified categories in footnotes <sup>p. 47</sup>. |
|||
* In November 2024, FASB issued ASU 2024-03, requiring disaggregated disclosure of income statement expenses for public business entities (PBEs) in footnotes to the financial statements. |
|||
* ASU 2024-03 requires a footnote disclosure in a tabular presentation for relevant expense captions that include natural expenses such as purchases of inventory, employee compensation, depreciation, intangible asset amortization, and depreciation, depletion, and amortization from oil- and gas-producing activities or other depletion expenses <sup>p. 47</sup>. |
|||
* ASU 2024-03 requires a tabular footnote disclosure for relevant income statement expense captions that include natural expenses such as purchases of inventory, employee compensation, depreciation, intangible asset amortization, and depreciation, depletion, and amortization recognized as part of oil- and gas-producing activities or other depletion expenses. |
|||
* The tabular disclosure would also include certain other expenses when applicable <sup>p. 47</sup>. |
|||
* In January 2025, |
* In January 2025, FASB issued ASU 2025-01 to clarify the effective date of ASU 2024-03 as the first annual reporting period beginning after December 15, [[Definition:Year 2026|2026]], and interim reporting periods within annual reporting periods beginning after December 15, 2027. |
||
* The company is evaluating the effect of the amendments from ASU 2024-03 on its consolidated financial statements. |
|||
* The effective date for ASU 2024-03 is the first annual reporting period beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027 <sup>p. 47</sup>. |
|||
* The company is evaluating the effect of the amendments on its consolidated financial statements <sup>p. 47</sup>. |
|||
== Quantitative and Qualitative Disclosures About Market Risk == |
== Quantitative and Qualitative Disclosures About Market Risk == |
||
{{chunk|doc=3z7a4yrxkn|c=147|p=15}} |
|||
* Qualitative and Quantitative Disclosures about Market Risk are included in Item 7 of this Form 10-K under "Investments—Market Risk" <sup>p. 48</sup>. |
|||
'''Market Risk Disclosures''' |
|||
* Qualitative and Quantitative Disclosures about Market Risk are included in Item 7 of this Form 10-K under "Investments—Market Risk". |
|||
== Financial Statements == |
== Financial Statements == |
||
=== Report of Independent Registered Public Accounting Firm === |
|||
{{chunk|doc=3z7a4yrxkn|c=148|p=16}} |
|||
* We have audited the consolidated financial statements of Skyward Specialty Insurance Group, Inc. and its subsidiaries, which include the consolidated balance sheets as of December 31, 2023 and 2022, and the related consolidated statements of operations, comprehensive income (loss), changes in stockholders’ equity, and cash flows for each of the three years in the period ended December 31, 2023, and the related notes (collectively referred to as the “consolidated financial statements”) <sup>p. 49</sup>. |
|||
'''Independent auditor's report''' |
|||
* We have also audited the effectiveness of Skyward Specialty Insurance Group, Inc.’s internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) <sup>p. 49</sup>. |
|||
* In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Skyward Specialty Insurance Group, Inc. and its subsidiaries as of December 31, 2023 and 2022, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 2023, in conformity with U.S. generally accepted accounting principles <sup>p. 49</sup>. |
|||
* In our opinion, Skyward Specialty Insurance Group, Inc. maintained, in all material respects, effective internal control over financial reporting as of December 31, 2023, based on criteria established in Internal Control—Integrated Framework (2013) issued by COSO <sup>p. 49</sup>. |
|||
* This report is addressed to the Stockholders and the Board of Directors of Skyward Specialty Insurance Group, Inc. |
|||
====== Opinion on Internal Control Over Financial Reporting ====== |
|||
=== Opinion on Internal Control Over Financial Reporting === |
|||
* ''Internal control over financial reporting'' of Skyward Specialty Insurance Group, Inc. and subsidiaries was audited as of December 31, 2025 <sup>p. 50</sup>. |
|||
* The audit was based on criteria established in the ''Internal Control—Integrated Framework'' issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria) <sup>p. 50</sup>. |
|||
* ''Skyward Specialty Insurance Group, Inc. and subsidiaries'' (the Company) maintained, in all material respects, effective internal control over financial reporting as of December 31, 2025, based on the COSO criteria <sup>p. 50</sup>. |
|||
* The ''consolidated balance sheets'' of the Company as of December 31, 2025 and 2024, the related consolidated statements of operations and comprehensive income, stockholders’ equity and cash flows for each of the three years in the period ended December 31, 2025, and related notes and financial statement schedules listed in the Index at Item 15(a) were also audited <sup>p. 50</sup>. |
|||
* The audit was conducted in accordance with the ''standards of the Public Company Accounting Oversight Board (United States) (PCAOB)'' <sup>p. 50</sup>. |
|||
* A ''report dated March 2, 2026'' expressed an unqualified opinion on the consolidated financial statements <sup>p. 50</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=149|p=16}} |
|||
====== Basis for Opinion ====== |
|||
'''Internal control over financial reporting opinion''' |
|||
* Skyward Specialty Insurance Group, Inc. and subsidiaries' internal control over financial reporting as of December 31, 2025, was audited based on criteria established in the Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). |
|||
* ''Management's responsibility'' includes maintaining effective internal control over financial reporting and assessing its effectiveness, as detailed in the accompanying Management’s Report on Internal Control over Financial Reporting <sup>p. 51</sup>. |
|||
* |
* The Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2025, based on the COSO criteria. |
||
* The consolidated balance sheets of the Company as of December 31, 2025 and 2024, and related consolidated statements of operations and comprehensive income, stockholders’ equity and cash flows for each of the three years in the period ended December 31, 2025, were audited in accordance with PCAOB standards. |
|||
* The auditor is a ''public accounting firm'' registered with the PCAOB <sup>p. 51</sup>. |
|||
* The report dated March 2, [[Definition:Year 2026|2026]], expressed an unqualified opinion on the consolidated financial statements and related notes and financial statement schedules listed in the Index at Item 15(a). |
|||
* The auditor is required to be ''independent'' with respect to the Company in accordance with U.S. federal securities laws and applicable rules and regulations of the SEC and the PCAOB <sup>p. 51</sup>. |
|||
* The audit was conducted in accordance with ''PCAOB standards'' <sup>p. 51</sup>. |
|||
* PCAOB standards require planning and performing the audit to obtain ''reasonable assurance'' about whether effective internal control over financial reporting was maintained in all material respects <sup>p. 51</sup>. |
|||
* The audit procedures included obtaining an ''understanding of internal control'' over financial reporting, assessing the risk of material weakness, testing and evaluating the design and operating effectiveness of internal control, and performing other necessary procedures <sup>p. 51</sup>. |
|||
* The auditor believes their audit provides a ''reasonable basis'' for their opinion <sup>p. 51</sup>. |
|||
=== Basis for Opinion === |
|||
====== Definition and Limitations of Internal Control Over Financial Reporting ====== |
|||
{{chunk|doc=3z7a4yrxkn|c=150|p=16}} |
|||
* ''Internal control over financial reporting'' is a process designed to provide reasonable assurance about the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles <sup>p. 52</sup>. |
|||
'''Auditor's opinion on internal control over financial reporting''' |
|||
* ''Internal control over financial reporting'' includes policies and procedures that maintain accurate records of transactions and asset dispositions <sup>p. 52</sup>. |
|||
* ''Internal control over financial reporting'' ensures transactions are recorded for financial statement preparation according to GAAP and that receipts and expenditures are authorized by management and directors <sup>p. 52</sup>. |
|||
* ''Internal control over financial reporting'' provides reasonable assurance for preventing or timely detecting unauthorized acquisition, use, or disposition of company assets that could materially affect financial statements <sup>p. 52</sup>. |
|||
* ''Internal control over financial reporting'' has inherent limitations and may not prevent or detect misstatements <sup>p. 52</sup>. |
|||
* Projections of the effectiveness of internal control to future periods carry the risk that controls may become inadequate due to changing conditions or that compliance with policies and procedures may deteriorate <sup>p. 52</sup>. |
|||
* Company management is responsible for maintaining effective internal control over financial reporting and for its assessment included in the accompanying Management’s Report on Internal Control over Financial Reporting. |
|||
Caption: Report of independent registered public accounting firm |
|||
* The auditor's responsibility is to express an opinion on the Company’s internal control over financial reporting based on their audit. |
|||
* The auditor is a public accounting firm registered with the PCAOB and is required to be independent with respect to the Company in accordance with U.S. federal securities laws and applicable rules and regulations of the SEC and the PCAOB. |
|||
* The audit was conducted in accordance with PCAOB standards, which require planning and performing the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. |
|||
* The audit included understanding internal control over financial reporting, assessing the risk of material weakness, testing and evaluating the design and operating effectiveness of internal control based on assessed risk, and performing other necessary procedures. |
|||
* The auditor believes their audit provides a reasonable basis for their opinion. |
|||
=== Definition and Limitations of Internal Control Over Financial Reporting === |
|||
| /s/ Ernst & Young LLP | |
|||
| --- | |
|||
| Houston, Texas | |
|||
| March 2, 2026 | |
|||
{{chunk|doc=3z7a4yrxkn|c=151|p=16}} |
|||
====== Report of Independent Registered Public Accounting Firm ====== |
|||
'''Internal control over financial reporting definition''' |
|||
* |
* Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. |
||
* Internal control over financial reporting includes policies and procedures that pertain to maintaining records that accurately and fairly reflect transactions and asset dispositions. |
|||
* ''Basis for Opinion'': The consolidated financial statements are the responsibility of the Company’s management <sup>p. 53</sup>. |
|||
* Internal control over financial reporting includes policies and procedures that provide reasonable assurance that transactions are recorded as necessary for financial statement preparation in accordance with generally accepted accounting principles. |
|||
* ''Auditor Responsibility'': The auditor's responsibility is to express an opinion on these consolidated financial statements based on the audits <sup>p. 53</sup>. |
|||
* Internal control over financial reporting includes policies and procedures that provide reasonable assurance that company receipts and expenditures are made only in accordance with management and director authorizations. |
|||
* ''Audit Conduct'': The audits were conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB) <sup>p. 53</sup>. |
|||
* Internal control over financial reporting includes policies and procedures that provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of company assets that could materially affect financial statements. |
|||
* ''PCAOB Standards'': Those standards require that the auditor plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud <sup>p. 53</sup>. |
|||
* ''Audit Procedures'': The audit included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks <sup>p. 53</sup>. |
|||
* ''Evidence Gathering'': Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements <sup>p. 53</sup>. |
|||
* ''Accounting Principles'': The audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements <sup>p. 53</sup>. |
|||
* ''Reasonable Basis'': The auditor believes that the audits provide a reasonable basis for the opinion <sup>p. 53</sup>. |
|||
* ''Critical Audit Matters'': Critical audit matters are not addressed, and no opinion is expressed on the effectiveness of the Company’s internal control over financial reporting <sup>p. 53</sup>. |
|||
* ''Auditor Firm'': Ernst & Young LLP <sup>p. 53</sup>. |
|||
* ''Auditor Location'': Houston, Texas <sup>p. 53</sup>. |
|||
* ''Report Date'': March 1, 2024 <sup>p. 53</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=152|p=16}} |
|||
====== Opinion on the Financial Statements ====== |
|||
'''Limitations of internal control over financial reporting''' |
|||
* Due to inherent limitations, internal control over financial reporting may not prevent or detect misstatements. |
|||
* The accompanying consolidated balance sheets of Skyward Specialty Insurance Group, Inc. and subsidiaries (the Company) as of December 31, 2025 and 2024, have been audited <sup>p. 54</sup>. |
|||
* Projections of effectiveness evaluations to future periods are subject to the risk that controls may become inadequate due to changing conditions. |
|||
* The related consolidated statements of operations and comprehensive income, stockholders' equity, and cash flows for each of the three years in the period ended December 31, 2025, have also been audited <sup>p. 54</sup>. |
|||
* Projections of effectiveness evaluations to future periods are subject to the risk that compliance with policies or procedures may deteriorate. |
|||
* The consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2025 and 2024 <sup>p. 54</sup>. |
|||
* The results of the Company's operations and its cash flows for each of the three years in the period ended December 31, 2025, are presented in conformity with U.S. generally accepted accounting principles <sup>p. 54</sup>. |
|||
* The Company's internal control over financial reporting as of December 31, 2025, has been audited in accordance with PCAOB standards <sup>p. 54</sup>. |
|||
* The audit of internal control over financial reporting was based on criteria established in the Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) <sup>p. 54</sup>. |
|||
* The report dated March 2, 2026, expressed an unqualified opinion on the Company's internal control over financial reporting <sup>p. 54</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=153|p=16}} |
|||
====== Basis for Opinion ====== |
|||
<div style="overflow-x:auto"> |
|||
* The Company's management is responsible for the financial statements <sup>p. 55</sup>. |
|||
{| id="t1026" class="wikitable" |
|||
* The auditors' responsibility is to express an opinion on the financial statements based on their audits <sup>p. 55</sup>. |
|||
|+ /s/ Ernst & Young LLP by Houston, Texas |
|||
* The auditors are a public accounting firm registered with the PCAOB <sup>p. 55</sup>. |
|||
|- |
|||
* The auditors are required to be independent in accordance with U.S. federal securities laws and applicable rules and regulations of the SEC and the PCAOB <sup>p. 55</sup>. |
|||
! style="text-align:left" | /s/ Ernst & Young LLP |
|||
* Audits were conducted in accordance with PCAOB standards <sup>p. 55</sup>. |
|||
|- |
|||
* PCAOB standards require planning and performing audits to obtain reasonable assurance that financial statements are free of material misstatement, whether due to error or fraud <sup>p. 55</sup>. |
|||
| style="text-align:left" | Houston, Texas |
|||
* Audit procedures included assessing risks of material misstatement and responding to those risks <sup>p. 55</sup>. |
|||
|- |
|||
* Procedures involved examining, on a test basis, evidence regarding amounts and disclosures in the financial statements <sup>p. 55</sup>. |
|||
| style="text-align:left" | March 2, [[Definition:Year 2026|2026]] |
|||
* Audits also included evaluating accounting principles, significant management estimates, and overall financial statement presentation <sup>p. 55</sup>. |
|||
|} |
|||
* The auditors believe their audits provide a reasonable basis for their opinion <sup>p. 55</sup>. |
|||
</div> |
|||
=== Report of Independent Registered Public Accounting Firm === |
|||
====== Critical Audit Matter ====== |
|||
{{chunk|doc=3z7a4yrxkn|c=154|p=16}} |
|||
* The critical audit matter discussed arises from the current period audit of financial statements <sup>p. 56</sup>. |
|||
'''Independent Auditor's Report''' |
|||
* This matter was communicated or required to be communicated to the audit committee <sup>p. 56</sup>. |
|||
* The matter relates to accounts or disclosures material to the financial statements <sup>p. 56</sup>. |
|||
* The matter involved especially challenging, subjective, or complex judgments by the auditors <sup>p. 56</sup>. |
|||
* Communication of this critical audit matter does not alter the opinion on the consolidated financial statements as a whole <sup>p. 56</sup>. |
|||
* The communication does not provide a separate opinion on the critical audit matter or its related account/disclosure <sup>p. 56</sup>. |
|||
* This report is addressed to the Stockholders and the Board of Directors of Skyward Specialty Insurance Group, Inc. |
|||
====== Valuation of Reserves for Unpaid Losses and Loss Adjustment Expenses ====== |
|||
=== Opinion on the Financial Statements === |
|||
* ''Reserves for unpaid losses and LAE'' were USD 2.3bn at December 31, 2025, with a significant portion representing incurred but not reported reserves (IBNR) <sup>p. 57</sup>. |
|||
* ''Reserves for unpaid losses and LAE'' represent the estimated ultimate cost of all unreported and reported but unpaid insured claims and the cost to adjust losses incurred as of the balance sheet date <sup>p. 57</sup>. |
|||
* The Company estimates these reserves using individual case-basis valuations of reported claims, statistical analyses, and various actuarial procedures <sup>p. 57</sup>. |
|||
* Estimates are based on historical information, industry and peer group information, and trends in factors like loss severity, loss frequency, and inflation <sup>p. 57</sup>. |
|||
* Auditing management's estimate of reserves for unpaid losses and LAE, including IBNR, was complex due to significant estimation uncertainty <sup>p. 57</sup>. |
|||
* This complexity involved evaluating management's methods and assumptions, such as loss development factors, expected loss ratios, and trends applied to historical experience <sup>p. 57</sup>. |
|||
* These assumptions significantly affect the valuation of IBNR reserves <sup>p. 57</sup>. |
|||
* The audit involved understanding, evaluating, and testing the operating effectiveness of internal controls over management's estimation process for losses and LAE reserves <sup>p. 57</sup>. |
|||
* This included reviewing and approving management's methods and assumptions used in estimating reserves <sup>p. 57</sup>. |
|||
* With actuarial specialists' assistance, audit procedures included evaluating the selection of actuarial methods, comparing them to prior periods and industry practices <sup>p. 57</sup>. |
|||
* Assumptions used in actuarial methods were evaluated by comparing significant assumptions (loss development factors, expected loss ratios, trends) to the Company's historical experience and current industry benchmarks <sup>p. 57</sup>. |
|||
* An independent range of reserve estimates was developed and compared to management's best estimate for unpaid losses and LAE <sup>p. 57</sup>. |
|||
* A review of the development of prior year reserve estimates was also performed <sup>p. 57</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=155|p=16}} |
|||
Caption: Report of independent registered public accounting firm |
|||
'''Audit opinion on financial statements''' |
|||
* The consolidated balance sheets of Skyward Specialty Insurance Group, Inc. and subsidiaries (the Company) as of December 31, 2025 and 2024, the related consolidated statements of operations and comprehensive income, stockholders' equity and cash flows for each of the three years in the period ended December 31, 2025, and related notes and financial statement schedules listed in the Index at Item 15(a) (collectively referred to as the “consolidated financial statements”) have been audited. |
|||
| /s/ Ernst & Young LLP | |
|||
* The consolidated financial statements fairly present, in all material respects, the financial position of the Company at December 31, 2025 and 2024, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2025, in conformity with U.S. generally accepted accounting principles. |
|||
| --- | |
|||
* The Company's internal control over financial reporting as of December 31, 2025, has been audited in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB). |
|||
| We have served as the Company’s auditor since 2021. | |
|||
* The audit of internal control over financial reporting was based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework). |
|||
| Houston, Texas | |
|||
* The report dated March 2, [[Definition:Year 2026|2026]], expressed an unqualified opinion on the Company's internal control over financial reporting. |
|||
| March 2, 2026 | |
|||
=== Basis for Opinion === |
|||
{{chunk|doc=3z7a4yrxkn|c=156|p=16}} |
|||
* The accompanying notes are an integral part of the consolidated financial statements <sup>p. 58</sup>. |
|||
'''Auditor's responsibility and opinion basis''' |
|||
* The Company's management is responsible for the financial statements. |
|||
====== Consolidated balance sheets ====== |
|||
* The auditor's responsibility is to express an opinion on the financial statements based on audits. |
|||
* The auditor is a public accounting firm registered with the PCAOB and is required to be independent in accordance with U.S. federal securities laws and applicable SEC and PCAOB rules and regulations. |
|||
* Audits were conducted in accordance with PCAOB standards. |
|||
* PCAOB standards require planning and performing audits to obtain reasonable assurance that financial statements are free of material misstatement, whether due to error or fraud. |
|||
* Audits included procedures to assess and respond to risks of material misstatement. |
|||
* Procedures included examining, on a test basis, evidence regarding amounts and disclosures in the financial statements. |
|||
* Audits also included evaluating accounting principles used, significant estimates made by management, and the overall presentation of the financial statements. |
|||
* The audits provide a reasonable basis for the auditor's opinion. |
|||
=== Critical Audit Matter === |
|||
{{chunk|doc=3z7a4yrxkn|c=157|p=16}} |
|||
'''Critical audit matter definition''' |
|||
* The critical audit matter communicated is a matter from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee. |
|||
* This matter relates to accounts or disclosures material to the financial statements and involved especially challenging, subjective, or complex judgments. |
|||
* The communication of the critical audit matter does not alter the opinion on the consolidated financial statements, taken as a whole. |
|||
* Communicating the critical audit matter does not provide a separate opinion on the critical audit matter or on the account or disclosure to which it relates. |
|||
=== Valuation of Reserves for Unpaid Losses and Loss Adjustment Expenses === |
|||
{{chunk|doc=3z7a4yrxkn|c=158|p=16}} |
|||
'''Valuation of Reserves for Unpaid Losses and Loss Adjustment Expenses''' |
|||
* The Company's reserves for unpaid losses and loss adjustment expenses (LAE) were USD 2.3bn at December 31, 2025, with a significant portion representing incurred but not reported reserves (IBNR). |
|||
* Reserves for unpaid losses and LAE represent the estimated ultimate cost of all unreported and reported but unpaid insured claims and the cost to adjust losses incurred as of the balance sheet date. |
|||
* The Company estimates these reserves using individual case-basis valuations of reported claims, statistical analyses, and various actuarial procedures. |
|||
* Estimates are based on historical information, industry and peer group information, and trends in factors like loss severity, loss frequency, and inflation. |
|||
* Auditing management's estimate of reserves for unpaid losses and LAE, including IBNR, was complex and involved actuarial specialists due to significant estimation uncertainty. |
|||
* This complexity arose from evaluating management's methods and assumptions, including loss development factors, expected loss ratios, and trends applied to the Company’s historical experience. |
|||
* These assumptions significantly affect the valuation of IBNR reserves. |
|||
* The audit obtained an understanding, evaluated the design, and tested the operating effectiveness of internal controls over management’s process for estimating losses and loss adjustment expense reserves. |
|||
* This included reviewing and approving processes for methods and assumptions used in estimating reserves. |
|||
* Audit procedures, with actuarial specialist assistance, included evaluating the selection of actuarial methods used by management, comparing them to prior periods and industry practices. |
|||
* The audit evaluated assumptions used in actuarial methods by comparing significant assumptions (loss development factors, expected loss ratios, trends) to the Company’s historical experience and current industry benchmarks and trends. |
|||
* An independent range of reserve estimates was developed and compared to management’s best estimate for unpaid losses and LAE. |
|||
* A review of the development of prior year reserve estimates was also performed. |
|||
{{chunk|doc=3z7a4yrxkn|c=159|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable |
{| id="t1027" class="wikitable" |
||
|+ Auditor since by Company |
|||
|- |
|||
! style="text-align:left" | /s/ Ernst & Young LLP |
|||
|- |
|||
| style="text-align:left" | We have served as the Company’s auditor since 2021. |
|||
|- |
|||
| style="text-align:left" | Houston, Texas |
|||
|- |
|||
| style="text-align:left" | March 2, [[Definition:Year 2026|2026]] |
|||
|} |
|||
</div> |
|||
=== Consolidated balance sheets === |
|||
{{chunk|doc=3z7a4yrxkn|c=160|p=16}} |
|||
'''Financial statement notes''' |
|||
* The accompanying notes are an integral part of the consolidated financial statements. |
|||
{{chunk|doc=3z7a4yrxkn|c=161|p=16}} |
|||
<div style="overflow-x:auto"> |
|||
{| id="t1028" class="wikitable fintable" |
|||
|+ Assets, liabilities and stockholders’ equity by December 31 |
|||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | December 31, |
! colspan="2" style="text-align:center" | December 31, |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | 2025 |
||
! style="text-align: |
! class="col-s" style="text-align:right" | 2024 |
||
|- |
|- |
||
! style="text-align:left" | ($ in thousands, except share and per share amounts) |
! style="text-align:left" | ($ in thousands, except share and per share amounts) |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
|- |
|- |
||
! style="text-align:left" | Assets |
! style="text-align:left" | Assets |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
|- |
|- |
||
! style="text-align:left" | Investments: |
! style="text-align:left" | Investments: |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
|- |
|- |
||
| class="wt-indent-1" style="text-align:left" | Fixed maturity securities, available-for-sale, at fair value (net of allowance for credit losses of $ 7,000 and $ 0 , respectively) (amortized cost of $ 1,848,755 and $ 1,320,266 , respectively) |
| class="wt-indent-1" style="text-align:left" | Fixed maturity securities, available-for-sale, at fair value (net of allowance for credit losses of $ 7,000 and $ 0 , respectively) (amortized cost of $ 1,848,755 and $ 1,320,266 , respectively) |
||
| Line 2,804: | Line 3,416: | ||
| style="text-align:right" | 274,929 |
| style="text-align:right" | 274,929 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total investments |
||
| style="text-align:right" | |
| style="text-align:right" | 2,300,515 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,870,820 |
||
|- |
|- |
||
| style="text-align:left" | Cash and cash equivalents |
| style="text-align:left" | Cash and cash equivalents |
||
| Line 2,844: | Line 3,456: | ||
| style="text-align:right" | 86,698 |
| style="text-align:right" | 86,698 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total assets |
||
| style="text-align:right" | |
| style="text-align:right" | 4,791,852 |
||
| style="text-align:right" | |
| style="text-align:right" | 3,729,478 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Liabilities and stockholders’ equity</b> |
||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|||
| style="text-align:left" | Liabilities: |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 2,884: | Line 3,500: | ||
| style="text-align:right" | 19,536 |
| style="text-align:right" | 19,536 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total liabilities |
||
| style="text-align:right" | |
| style="text-align:right" | 3,782,287 |
||
| style="text-align:right" | |
| style="text-align:right" | 2,935,479 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Stockholders’ equity</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 2,908: | Line 3,524: | ||
| style="text-align:right" | 97,120 |
| style="text-align:right" | 97,120 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total stockholders’ equity |
||
| style="text-align:right" | |
| style="text-align:right" | 1,009,565 |
||
| style="text-align:right" | |
| style="text-align:right" | 793,999 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total liabilities and stockholders’ equity |
||
| style="text-align:right" | |
| style="text-align:right" | 4,791,852 |
||
| style="text-align:right" | |
| style="text-align:right" | 3,729,478 |
||
|} |
|} |
||
</div> |
</div> |
||
=== Consolidated statements of operations and comprehensive income === |
|||
{{chunk|doc=3z7a4yrxkn|c=162|p=16}} |
|||
* The accompanying notes are an integral part of the consolidated financial statements <sup>p. 59</sup>. |
|||
'''Financial statement notes''' |
|||
* The accompanying notes are an integral part of the consolidated financial statements. |
|||
====== Consolidated statements of operations ====== |
|||
{{chunk|doc=3z7a4yrxkn|c=163|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1029" class="wikitable fintable" |
||
|+ Revenues, expenses, and income by year |
|||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | Years Ended December 31, |
! colspan="2" style="text-align:center" | Years Ended December 31, |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
! style="text-align:left" | ($ in thousands, except share and per share amounts) |
! style="text-align:left" | ($ in thousands, except share and per share amounts) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2025 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2024 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2023 |
||
|- |
|- |
||
! style="text-align:left" | Revenues: |
! style="text-align:left" | Revenues: |
||
! class="col-m" style="text-align:right" | |
! class="col-m" style="text-align:right" | |
||
! class="col-m" style="text-align:right" | |
! class="col-m" style="text-align:right" | |
||
! class="col-m" style="text-align:right" | |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Net earned premiums |
| style="text-align:left" | Net earned premiums |
||
| Line 2,950: | Line 3,571: | ||
| style="text-align:right" | 6,064 |
| style="text-align:right" | 6,064 |
||
|- |
|- |
||
| style="text-align:left" | Net investment income |
| style="text-align:left" | [[Definition:Net investment income|Net investment income]] |
||
| style="text-align:right" | 83,619 |
| style="text-align:right" | 83,619 |
||
| style="text-align:right" | 80,600 |
| style="text-align:right" | 80,600 |
||
| Line 2,965: | Line 3,586: | ||
| style="text-align:right" | ( 632 ) |
| style="text-align:right" | ( 632 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | [[Definition:Total revenue|Total revenues]] |
||
| style="text-align:right" | |
| style="text-align:right" | 1,416,541 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,150,200 |
||
| style="text-align:right" | |
| style="text-align:right" | 885,969 |
||
|- |
|||
| style="text-align:left" | <b>Expenses:</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Losses and loss adjustment expenses |
| style="text-align:left" | Losses and loss adjustment expenses |
||
| Line 3,000: | Line 3,626: | ||
| style="text-align:right" | 5,364 |
| style="text-align:right" | 5,364 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total expenses |
||
| style="text-align:right" | |
| style="text-align:right" | 1,200,117 |
||
| style="text-align:right" | |
| style="text-align:right" | 997,461 |
||
| style="text-align:right" | |
| style="text-align:right" | 775,867 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Income before income taxes</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>216,424</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>152,739</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>110,102</b> |
||
|- |
|- |
||
| style="text-align:left" | Income tax expense |
| style="text-align:left" | Income tax expense |
||
| Line 3,015: | Line 3,641: | ||
| style="text-align:right" | 24,118 |
| style="text-align:right" | 24,118 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net income</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>170,028</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>118,828</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>85,984</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net income attributable to participating securities</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,677</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net income attributable to common stockholders</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>170,028</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>118,828</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>84,307</b> |
||
|- |
|||
| style="text-align:left" | <b>Comprehensive income</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net income</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>170,028</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>118,828</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>85,984</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Other comprehensive income:</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 3,055: | Line 3,686: | ||
| style="text-align:right" | ( 4,984 ) |
| style="text-align:right" | ( 4,984 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total other comprehensive income |
||
| style="text-align:right" | |
| style="text-align:right" | 33,577 |
||
| style="text-align:right" | |
| style="text-align:right" | 833 |
||
| style="text-align:right" | |
| style="text-align:right" | 20,532 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Comprehensive income</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>203,605</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>119,661</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>106,516</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Per share data:</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 3,075: | Line 3,706: | ||
| style="text-align:right" | 2.34 |
| style="text-align:right" | 2.34 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Diluted earnings per share</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>4.07</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>2.87</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>2.24</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Weighted-average common shares outstanding</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 3,090: | Line 3,721: | ||
| style="text-align:right" | 36,031,907 |
| style="text-align:right" | 36,031,907 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Diluted</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>41,808,046</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>41,377,460</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>38,317,534</b> |
||
|} |
|} |
||
</div> |
</div> |
||
=== Consolidated statements of stockholders’ equity === |
|||
{{chunk|doc=3z7a4yrxkn|c=164|p=16}} |
|||
* The accompanying notes are an integral part of the consolidated financial statements <sup>p. 60</sup>. |
|||
'''Financial statement notes''' |
|||
* The accompanying notes are an integral part of the consolidated financial statements. |
|||
====== Consolidated statements of stockholders' equity ====== |
|||
{{chunk|doc=3z7a4yrxkn|c=165|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1030" class="wikitable fintable" |
||
|+ Consolidated statements of stockholders’ equity |
|||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="3" style="text-align:center" | Years Ended December 31, |
! colspan="3" style="text-align:center" | Years Ended December 31, |
||
|- |
|- |
||
! style="text-align:left" | ($ in thousands, except share amounts) |
! style="text-align:left" | ($ in thousands, except share amounts) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2025 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2024 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2023 |
||
|- |
|- |
||
! style="text-align:left" | Preferred shares: |
! style="text-align:left" | Preferred shares: |
||
! class="col-m" style="text-align:right" | |
! class="col-m" style="text-align:right" | |
||
! class="col-m" style="text-align:right" | |
! class="col-m" style="text-align:right" | |
||
! class="col-m" style="text-align:right" | |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Balance at beginning of year |
| style="text-align:left" | Balance at beginning of year |
||
| Line 3,128: | Line 3,764: | ||
| style="text-align:right" | ( 1,969,660 ) |
| style="text-align:right" | ( 1,969,660 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Balance at December 31</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
|- |
|||
| style="text-align:left" | <b>Common shares:</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Balance at beginning of year |
| style="text-align:left" | Balance at beginning of year |
||
| Line 3,148: | Line 3,789: | ||
| style="text-align:right" | 16,305,113 |
| style="text-align:right" | 16,305,113 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Balance at December 31</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>40,511,222</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>40,127,908</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>39,863,756</b> |
||
|- |
|||
| style="text-align:left" | <b>Preferred stock:</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Balance at beginning of year |
| style="text-align:left" | Balance at beginning of year |
||
| Line 3,158: | Line 3,804: | ||
| style="text-align:right" | 20 |
| style="text-align:right" | 20 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Preferred stock conversion to common shares |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | ( 20 ) |
||
|- |
|||
| style="text-align:left" | <b>Balance at December 31</b> |
|||
| style="text-align:right" | <b>—</b> |
|||
| style="text-align:right" | <b>—</b> |
|||
| style="text-align:right" | <b>—</b> |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Common stock:</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 3,177: | Line 3,828: | ||
| style="text-align:right" | 2 |
| style="text-align:right" | 2 |
||
| style="text-align:right" | 22 |
| style="text-align:right" | 22 |
||
|- |
|||
| style="text-align:left" | Preferred stock conversion to common shares |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | 161 |
|||
|- |
|- |
||
| style="text-align:left" | Proceeds from equity offerings, net |
| style="text-align:left" | Proceeds from equity offerings, net |
||
| Line 3,183: | Line 3,839: | ||
| style="text-align:right" | 48 |
| style="text-align:right" | 48 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Balance at December 31</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>405</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>401</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>399</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Treasury stock:</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 3,198: | Line 3,854: | ||
| style="text-align:right" | ( 2 ) |
| style="text-align:right" | ( 2 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Preferred stock conversion to common shares |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 2 |
||
|- |
|||
| style="text-align:left" | <b>Balance at December 31</b> |
|||
| style="text-align:right" | <b>—</b> |
|||
| style="text-align:right" | <b>—</b> |
|||
| style="text-align:right" | <b>—</b> |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Additional paid-in capital:</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 3,217: | Line 3,878: | ||
| style="text-align:right" | 7,743 |
| style="text-align:right" | 7,743 |
||
| style="text-align:right" | 9,213 |
| style="text-align:right" | 9,213 |
||
|- |
|||
| style="text-align:left" | Preferred stock conversion to common shares |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | ( 143 ) |
|||
|- |
|- |
||
| style="text-align:left" | Proceeds from equity offerings, net |
| style="text-align:left" | Proceeds from equity offerings, net |
||
| Line 3,223: | Line 3,889: | ||
| style="text-align:right" | 124,496 |
| style="text-align:right" | 124,496 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Balance at December 31</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>730,555</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>718,598</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>710,855</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Stock notes receivable:</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 3,243: | Line 3,909: | ||
| style="text-align:right" | 1,349 |
| style="text-align:right" | 1,349 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Balance at December 31</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 5,562 )</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Accumulated other comprehensive income (loss):</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 3,263: | Line 3,929: | ||
| style="text-align:right" | 20,532 |
| style="text-align:right" | 20,532 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Balance at December 31</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>11,457</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 22,120 )</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 22,953 )</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Retained earnings (accumulated deficit):</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 3,288: | Line 3,954: | ||
| style="text-align:right" | 85,984 |
| style="text-align:right" | 85,984 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Balance at December 31</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>267,148</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>97,120</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 21,708 )</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total stockholders’ equity |
||
| style="text-align:right" | |
| style="text-align:right" | 1,009,565 |
||
| style="text-align:right" | |
| style="text-align:right" | 793,999 |
||
| style="text-align:right" | |
| style="text-align:right" | 661,031 |
||
|} |
|} |
||
</div> |
</div> |
||
=== Consolidated statements of cash flows === |
|||
{{chunk|doc=3z7a4yrxkn|c=166|p=16}} |
|||
'''Financial statement notes''' |
|||
* The accompanying notes are an integral part of the consolidated financial statements |
* The accompanying notes are an integral part of the consolidated financial statements. |
||
{{chunk|doc=3z7a4yrxkn|c=167|p=16}} |
|||
====== Consolidated statements of cash flows ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1031" class="wikitable fintable" |
||
|+ Cash flows from operating, investing, and financing activities by Years Ended December 31 |
|||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="3" style="text-align:center" | Years Ended December 31, |
! colspan="3" style="text-align:center" | Years Ended December 31, |
||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2025 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2024 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2023 |
||
|- |
|- |
||
! style="text-align:left" | Cash flows from operating activities: |
! style="text-align:left" | Cash flows from operating activities: |
||
! class="col-m" style="text-align:right" | |
! class="col-m" style="text-align:right" | |
||
! class="col-m" style="text-align:right" | |
! class="col-m" style="text-align:right" | |
||
! class="col-m" style="text-align:right" | |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Net income |
| style="text-align:left" | Net income |
||
| Line 3,325: | Line 3,996: | ||
| style="text-align:right" | 118,828 |
| style="text-align:right" | 118,828 |
||
| style="text-align:right" | 85,984 |
| style="text-align:right" | 85,984 |
||
|- |
|||
| style="text-align:left" | Adjustments to reconcile net income to net cash provided by (used in) operating activities: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Net investment (gains) losses |
| style="text-align:left" | Net investment (gains) losses |
||
| Line 3,355: | Line 4,031: | ||
| style="text-align:right" | ( 8,708 ) |
| style="text-align:right" | ( 8,708 ) |
||
| style="text-align:right" | 9,383 |
| style="text-align:right" | 9,383 |
||
|- |
|||
| style="text-align:left" | Changes in operating assets and liabilities: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Premiums receivable, net |
| style="text-align:left" | Premiums receivable, net |
||
| Line 3,416: | Line 4,097: | ||
| style="text-align:right" | ( 5,047 ) |
| style="text-align:right" | ( 5,047 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net cash provided by operating activities</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>408,076</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>305,115</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>338,187</b> |
||
|- |
|||
| style="text-align:left" | <b>Cash flows from investing activities:</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Purchase of fixed maturity securities, available-for-sale |
| style="text-align:left" | Purchase of fixed maturity securities, available-for-sale |
||
| Line 3,496: | Line 4,182: | ||
| style="text-align:right" | 11,913 |
| style="text-align:right" | 11,913 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net cash used in investment activities</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 366,898 )</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 243,694 )</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 493,809 )</b> |
||
|- |
|||
| style="text-align:left" | <b>Cash flows from financing activities:</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Employee share purchases |
| style="text-align:left" | Employee share purchases |
||
| Line 3,526: | Line 4,217: | ||
| style="text-align:right" | 129,597 |
| style="text-align:right" | 129,597 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net cash provided by (used in) financing activities</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>411</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 4,232 )</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>130,947</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net increase (decrease) in cash and cash equivalents and restricted cash</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>41,589</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>57,189</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 24,675 )</b> |
||
|- |
|- |
||
| style="text-align:left" | Cash and cash equivalents and restricted cash at beginning of period (1) |
| style="text-align:left" | Cash and cash equivalents and restricted cash at beginning of period (1) |
||
| Line 3,541: | Line 4,232: | ||
| style="text-align:right" | 125,011 |
| style="text-align:right" | 125,011 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Cash and cash equivalents and restricted cash at end of period (1)</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>199,114</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>157,525</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>100,336</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Supplemental disclosure of cash flow information:</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 3,558: | Line 4,249: | ||
</div> |
</div> |
||
{{fn note|1=1|2=The sum of cash and cash equivalents and restricted cash from the Consolidated Balance Sheets.}} |
|||
=== A. Description of Business === |
|||
{{chunk|doc=3z7a4yrxkn|c=168|p=16}} |
|||
* The ''Company'' is a Delaware corporation organized in 2006, operating as an insurance holding company <sup>p. 62</sup>. |
|||
'''Company overview''' |
|||
* It functions as a specialty insurance company within one segment, providing commercial property and casualty insurance products through its underwriting divisions <sup>p. 62</sup>. |
|||
* The Company has four wholly owned insurance company subsidiaries in the United States <sup>p. 62</sup>. |
|||
** ''Great Midwest Insurance Company (GMIC)'' underwrites insurance on an admitted basis and is a certified surety bond company listed with the U.S. Department of the Treasury <sup>p. 62</sup>. |
|||
** ''Houston Specialty Insurance Company (HSIC)'', a subsidiary of GMIC, underwrites insurance on a non-admitted basis <sup>p. 62</sup>. |
|||
** ''Imperium Insurance Company (IIC)'', a subsidiary of HSIC, underwrites insurance on an admitted basis <sup>p. 62</sup>. |
|||
** ''Oklahoma Specialty Insurance Company (OSIC)'', a subsidiary of IIC, underwrites insurance on a non-admitted basis <sup>p. 62</sup>. |
|||
* The Company owns ''Skyward Re'', a wholly owned captive reinsurance company subsidiary domiciled in the Cayman Islands <sup>p. 62</sup>. |
|||
** Skyward Re assumed net reserves for certain divisions from the Company's insurance companies, related to a retroactive reinsurance contract, and retroceded these net reserves to a third-party reinsurer <sup>p. 62</sup>. |
|||
* The Company has three non-risk bearing wholly owned subsidiaries <sup>p. 62</sup>. |
|||
** ''Skyward Underwriters Agency, Inc. (SUA)'' is a managing general insurance agent and reinsurance broker for property and casualty risks in specialty niche markets <sup>p. 62</sup>. |
|||
** ''Skyward Service Company'' provides various administrative services to the Company’s subsidiaries <sup>p. 62</sup>. |
|||
** ''Skyward Specialty No. 1 Limited'' is a Lloyd’s corporate member authorized to invest in Lloyd’s syndicates <sup>p. 62</sup>. |
|||
* On January 1, 2026, the Company acquired ''Apollo Group Holdings Limited'' for approximately $555.0 million <sup>p. 62</sup>. |
|||
* Additional information regarding the acquisition is available in Note 24 <sup>p. 62</sup>. |
|||
* Skyward Specialty Insurance Group, Inc. (the "Company") is a Delaware corporation organized in 2006. |
|||
====== B. Basis of Presentation ====== |
|||
* The Company is an insurance holding company operating in one segment, delivering commercial [[Definition:Property & casualty|property and casualty]] products insurance coverages through its underwriting divisions. |
|||
{{chunk|doc=3z7a4yrxkn|c=169|p=16}} |
|||
* The Company's consolidated financial statements are prepared according to Generally Accepted Accounting Principles in the United States of America ("GAAP") <sup>p. 63</sup>. |
|||
'''Wholly owned insurance subsidiaries''' |
|||
* GAAP differs in some aspects from the principles used in reports to insurance regulatory authorities <sup>p. 63</sup>. |
|||
* The consolidated financial statements encompass the accounts of the holding company and its subsidiaries <sup>p. 63</sup>. |
|||
* All intercompany transactions and balances have been eliminated during consolidation <sup>p. 63</sup>. |
|||
* Preparing consolidated financial statements in conformity with GAAP necessitates the Company making estimates and assumptions that impact reported amounts in the financial statements and notes <sup>p. 63</sup>. |
|||
* The Company's actual results may vary from these estimates <sup>p. 63</sup>. |
|||
* The Company has four wholly owned insurance company subsidiaries based in the United States. |
|||
====== C. Consolidation ====== |
|||
* Great Midwest Insurance Company ("GMIC") underwrites insurance on an admitted basis and is a certified surety bond company listed with the U.S. Department of the Treasury. |
|||
* Houston Specialty Insurance Company ("HSIC"), a subsidiary of GMIC, underwrites insurance on a non-admitted basis. |
|||
* Imperium Insurance Company ("IIC"), a subsidiary of HSIC, underwrites insurance on an admitted basis. |
|||
* Oklahoma Specialty Insurance Company ("OSIC"), a subsidiary of IIC, underwrites insurance on a non-admitted basis. |
|||
{{chunk|doc=3z7a4yrxkn|c=170|p=16}} |
|||
* The Company consolidates entities where it has a controlling financial interest, determining this by assessing if the entity is a Variable Interest Entity (VIE) for which the Company is the primary beneficiary, or if the Company controls the entity through majority voting interest or other arrangements <sup>p. 64</sup>. |
|||
'''Wholly owned reinsurance subsidiary''' |
|||
* A ''VIE'' is defined as an entity that either lacks sufficient equity for financing without additional subordinated financial support, has equity holders lacking characteristics of a controlling financial interest, and/or is established with non-substantive voting rights <sup>p. 64</sup>. |
|||
* The Company's assessment of VIEs involves subjectivity in identifying activities that most significantly affect the VIE’s performance and requires estimates of current and future fair value of assets and financial performance of the VIE <sup>p. 64</sup>. |
|||
* In ''related party analysis'', the Company considers qualitative and quantitative factors including investment characteristics and size relative to the related party, ability to control or significantly influence key decisions (including de facto agents), obligation or likelihood to fund operating losses, and similarity and significance of the VIE’s business activities to those of the Company and related party <sup>p. 64</sup>. |
|||
* The determination of whether an entity is a VIE and if the Company is the primary beneficiary involves significant judgment and depends on specific facts and circumstances at the time of assessment <sup>p. 64</sup>. |
|||
* At each reporting period, the Company reassesses changes in facts and circumstances that could alter an entity's VIE status or the Company's consolidation assessment <sup>p. 64</sup>. |
|||
* ''Changes in consolidation status'' are applied prospectively <sup>p. 64</sup>. |
|||
* If an entity is consolidated due to reassessment, its assets, liabilities, and noncontrolling interest are recorded at fair value upon initial consolidation <sup>p. 64</sup>. |
|||
* Any existing equity interest held by the Company in an entity prior to obtaining control is remeasured at fair value, potentially resulting in a gain or loss recognized upon initial consolidation <sup>p. 64</sup>. |
|||
* The Company may also ''deconsolidate a subsidiary'' following reassessment, which could result in a gain or loss recognized upon deconsolidation, based on the carrying values of deconsolidated assets and liabilities compared to the fair value of any retained interests <sup>p. 64</sup>. |
|||
* After performing these assessments, the Company has identified one entity that meets the definition of a VIE for which the Company is the primary beneficiary <sup>p. 64</sup>. |
|||
* Further details and required disclosures regarding this VIE are provided in Note 7 <sup>p. 64</sup>. |
|||
* The Company has a wholly owned captive reinsurance company subsidiary, Skyward Re, domiciled in the Cayman Islands. |
|||
====== D. Cash and Cash Equivalents ====== |
|||
* Skyward Re assumed net reserves for certain divisions, related to a retroactive reinsurance contract, from the Company’s insurance companies and retroceded the net reserves to a third-party reinsurer. |
|||
{{chunk|doc=3z7a4yrxkn|c=171|p=16}} |
|||
* ''Cash and cash equivalents'' include cash on hand and fixed maturity securities with original maturities of three months or less <sup>p. 65</sup>. |
|||
'''Wholly owned non-risk bearing subsidiaries''' |
|||
* The ''carrying value'' of the Company’s cash and cash equivalents approximates fair value <sup>p. 65</sup>. |
|||
* The Company has three non-risk bearing wholly owned subsidiaries. |
|||
====== E. Restricted Cash ====== |
|||
* Skyward Underwriters Agency, Inc. ("SUA") is a managing general insurance agent and reinsurance broker for [[Definition:Property & casualty|property and casualty]] risks in specialty niche markets. |
|||
* Skyward Service Company provides various administrative services to the Company’s subsidiaries. |
|||
* Skyward Specialty No. 1 Limited is a Lloyd’s corporate member authorized to invest in Lloyd’s syndicates. |
|||
{{chunk|doc=3z7a4yrxkn|c=172|p=16}} |
|||
* ''Restricted cash'' is cash with a legal restriction on withdrawal or use by the consolidated group <sup>p. 66</sup>. |
|||
'''Apollo Group Holdings Limited acquisition''' |
|||
* The ''carrying value of restricted cash'' approximates fair value <sup>p. 66</sup>. |
|||
* ''SUA'' collects premiums from clients, deducts commissions and fees, and remits the remaining premiums to the Company's insurance companies or third-party insurance companies <sup>p. 66</sup>. |
|||
* ''SUA'' holds unremitted insurance premiums in a fiduciary capacity for third-party insurance companies, recorded as restricted cash <sup>p. 66</sup>. |
|||
* The Company is required by state regulations to maintain ''assets on deposit'' with certain states <sup>p. 66</sup>. |
|||
* The Company is required to hold ''cash as collateral'' for certain reinsurance balances <sup>p. 66</sup>. |
|||
* ''Cash held in a depository account'' for others or restricted by a state is recorded as restricted cash <sup>p. 66</sup>. |
|||
* On January 1, [[Definition:Year 2026|2026]], the Company completed the acquisition of Apollo Group Holdings Limited for an aggregate consideration of approximately USD 555.0m. |
|||
====== F. Investments ====== |
|||
* Additional information regarding the acquisition can be found in Note 24. |
|||
=== B. Basis of Presentation === |
|||
* ''Available for Sale Investments'': Fixed maturities classified as available-for-sale are carried at fair value <sup>p. 67</sup>. |
|||
* ''Unrealized Losses (Available for Sale)'': If there is an intent to sell or a likelihood of being required to sell before maturity or recovery of cost basis, the amortized cost is written down to fair value, with losses recognized in net investment gains on the Consolidated Statements of Operations <sup>p. 67</sup>. |
|||
* ''Credit-Related Unrealized Losses (Available for Sale)'': If neither of the above criteria are met, and unrealized losses are credit-related, an allowance for credit losses is determined using the present value of cash flows compared to the amortized cost <sup>p. 67</sup>. |
|||
* ''Credit Loss Allowance Recognition (Available for Sale)'': Prior to 2025, changes in the allowance for credit losses were recognized in net investment income; as of 2025, they are recognized in net investment gains, with prior periods updated for conformity <sup>p. 67</sup>. |
|||
* ''Stockholders' Equity Impact (Available for Sale)'': Credit losses limited by fair value are recognized in stockholders’ equity, net of taxes, as a component of accumulated other comprehensive income (loss) <sup>p. 67</sup>. |
|||
* ''Non-Credit Related Unrealized Losses (Available for Sale)'': Unrealized losses not credit-related continue to be recognized in stockholders’ equity, net of taxes, as a component of accumulated other comprehensive income (loss) <sup>p. 67</sup>. |
|||
* ''Held-to-Maturity Investments'': Fixed maturity securities held-to-maturity are carried at amortized cost net of an allowance for credit losses <sup>p. 67</sup>. |
|||
* ''Allowance for Credit Losses (Held-to-Maturity)'': The allowance represents the current estimate of expected credit losses, developed using Moody’s multi-year cumulative loss rates for asset-backed securities, adjusted for current conditions and forecasts <sup>p. 67</sup>. |
|||
* ''Credit Loss Allowance Recognition (Held-to-Maturity)'': Prior to 2025, changes in the allowance for credit losses were recognized in net investment income; as of 2025, they are recognized in net investment gains, with prior periods updated for conformity <sup>p. 67</sup>. |
|||
* ''Equity Securities with Readily Determinable Fair Value'': Includes common stock, preferred stock, and mutual funds (even those primarily investing in debt securities) <sup>p. 67</sup>. |
|||
* ''Valuation of Equity Securities'': Carried on the balance sheet at fair value using quoted market prices <sup>p. 67</sup>. |
|||
* ''Changes in Equity Securities Value'': Changes in carrying value are included in net investment gains (losses) within the Consolidated Statements of Operations <sup>p. 67</sup>. |
|||
* ''Mortgage Loans Classification'': Classified as held for investment and carried at cost adjusted for unamortized premiums, discounts, and loan fees <sup>p. 67</sup>. |
|||
* ''Uncollectible Mortgage Loans'': Uncollectible amounts are written off in the period they are determined to be uncollectible <sup>p. 67</sup>. |
|||
* ''Mortgage Loan Interest Recognition'': Interest is recognized as interest receivable and included in other assets on the Consolidated Balance Sheets <sup>p. 67</sup>. |
|||
* ''Fair Value Option for Mortgage Loans'': The Company elected the fair value option for mortgage loans effective January 1, 2023, as targeted transition relief from ASU 2016-13 adoption <sup>p. 67</sup>. |
|||
* ''Fair Value Option Impact (Mortgage Loans)'': Under this option, mortgage loans are measured at fair value, and changes in unrealized gains and losses are reported in net investment gains (losses) on the Consolidated Statements of Operations <sup>p. 67</sup>. |
|||
* ''Interest Income Recognition (Mortgage Loans)'': Interest income and amortization continue to be recognized in net investment income on the Consolidated Statements of Operations <sup>p. 67</sup>. |
|||
* ''Equity Method Investments Scope'': Includes investments in equity and equity securities of non-public entities and indirect investments in loans and loan collateral <sup>p. 67</sup>. |
|||
* ''Significant Influence Investments'': The Company has equity investments in certain limited partnerships and corporations where it has significant influence but not control <sup>p. 67</sup>. |
|||
* ''Variable Interest Entities'': Analysis indicated the Company is not the primary beneficiary of variable interest entities, thus not requiring consolidation <sup>p. 67</sup>. |
|||
* ''Equity Method Accounting'': Used for investments in unconsolidated subsidiaries where the Company has significant influence <sup>p. 67</sup>. |
|||
* ''Equity Method Initial Recording'': Initial investment is recorded at cost and adjusted based on proportionate share of distributions and net income or loss of the investee <sup>p. 67</sup>. |
|||
* ''Investment Income Component (Equity Method)'': The difference between investment cost and proportionate share of underlying equity in net assets is a component of investment income <sup>p. 67</sup>. |
|||
* ''Amortization of Difference (Equity Method)'': The Company amortizes this difference as an adjustment to its pro-rata share of equity method income over the useful life of the underlying asset <sup>p. 67</sup>. |
|||
* ''Non-Public Equity Securities (No Significant Influence)'': When these securities do not have a readily determinable fair value, they are carried at cost, minus impairment, and adjusted for observable price changes in orderly transactions for identical or similar investments <sup>p. 67</sup>. |
|||
* ''Indirect Collateralized Loans'': Investments in indirect collateralized loans and loan collateral are held through and accounted for as an ownership interest in an unconsolidated subsidiary <sup>p. 67</sup>. |
|||
* ''Unconsolidated Subsidiaries'': Ownership interests include investments in partnerships, joint ventures, and special purpose investment vehicles <sup>p. 67</sup>. |
|||
* ''Other Long-Term Investments'': Consist of an investment in a limited partnership held at net asset value (NAV) and other long-term investment securities <sup>p. 67</sup>. |
|||
* ''Short-Term Investments'': Primarily money market funds, carried at cost which approximates fair value <sup>p. 67</sup>. |
|||
* ''Net Investment Income Components'': Consists of interest, dividends, and equity in earnings (losses) of unconsolidated subsidiaries, net of investment expenses like investment management expenses <sup>p. 67</sup>. |
|||
* ''Interest Income Recognition'': Recognized on an accrual basis <sup>p. 67</sup>. |
|||
* ''Dividend Recognition'': Recognized as earned at the ex-dividend date <sup>p. 67</sup>. |
|||
* ''Interest Income on Asset-Backed Securities'': Recognized using the effective-yield method based on estimated principal repayments <sup>p. 67</sup>. |
|||
* ''Amortization/Accretion in Interest Income'': Includes amortization of premium and accretion of discounts on debt securities <sup>p. 67</sup>. |
|||
* ''Net Investment Gains and Losses Recognition'': Recognized in net income based upon the specific identification method <sup>p. 67</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=173|p=16}} |
|||
====== G. Derivatives ====== |
|||
'''Basis of financial statement preparation''' |
|||
* The Company’s consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP"). |
|||
* The Company uses ''commodity derivatives'' to assume risk and manage exposures in the insurance industry <sup>p. 68</sup>. |
|||
* GAAP differs in some respects from the principles followed in reports to insurance regulatory authorities. |
|||
* Commodity derivatives expose the Company to potentially unfavorable price changes of underlying commodities <sup>p. 68</sup>. |
|||
* The consolidated financial statements include the accounts of the holding company and its subsidiaries. |
|||
* The Company accounts for derivatives according to ''FASB ASC Topic 815, Derivatives and Hedging'' <sup>p. 68</sup>. |
|||
* All intercompany transactions and balances have been eliminated in consolidation. |
|||
* All derivatives are recorded at ''fair value'' on the Company's balance sheet as assets or liabilities <sup>p. 68</sup>. |
|||
* The preparation of consolidated financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect reported amounts in the financial statements and accompanying notes. |
|||
* Changes in the fair value of derivatives are reflected in ''current earnings'' <sup>p. 68</sup>. |
|||
* The Company’s actual results could differ from those estimates. |
|||
* The Company meets the criteria to ''net assets and liabilities'' related to derivatives <sup>p. 68</sup>. |
|||
* Netted derivative assets and liabilities are included in ''"other assets"'' on the Consolidated Balance Sheets <sup>p. 68</sup>. |
|||
* The Company considers its exchange-traded futures and forward purchase and sale contracts to be ''effective economic hedges'' <sup>p. 68</sup>. |
|||
* The Company has ''not elected hedge accounting treatment'' for its derivatives <sup>p. 68</sup>. |
|||
* The ''fair value of derivatives'' is estimated using quoted prices or broker quotes, or industry/internal valuation models when quotes are unavailable <sup>p. 68</sup>. |
|||
* Further details and disclosures regarding derivatives are provided in ''Note 8'' <sup>p. 68</sup>. |
|||
=== C. Consolidation === |
|||
====== H. Reinsurance ====== |
|||
{{chunk|doc=3z7a4yrxkn|c=174|p=16}} |
|||
* The Company purchases prospective reinsurance for certain lines of business on a proportional, excess of loss, and facultative basis <sup>p. 69</sup>. |
|||
'''Variable interest entity consolidation''' |
|||
* ''Proportional reinsurance'' requires the Company to share losses and expenses with the reinsurer in exchange for a share of premiums <sup>p. 69</sup>. |
|||
* ''Excess of loss reinsurance'' shares losses, either proportionally or entirely, above a specific dollar threshold, for a negotiated cost <sup>p. 69</sup>. |
|||
* ''Facultative reinsurance'' covers specific risks and/or policies on either a proportional or excess of loss basis <sup>p. 69</sup>. |
|||
* Ceded unearned premium and reinsurance balances recoverable (on paid and unpaid losses and settlement expenses) are reported separately as assets <sup>p. 69</sup>. |
|||
* Reinsurance does not relieve the Company of its legal liability to policyholders <sup>p. 69</sup>. |
|||
* On the Consolidated Statements of Operations, net earned premiums, losses and loss adjustment expenses, and underwriting, acquisition, and insurance expenses are presented net of reinsurance ceded <sup>p. 69</sup>. |
|||
* The Company has purchased retroactive reinsurance in prior years for certain lines of business, including loss portfolio transfers (LPT) and adverse development covers <sup>p. 69</sup>. |
|||
* Retroactive reinsurance contracts provide indemnification for losses related to past loss events, with the reinsurer sharing losses based on dollar thresholds <sup>p. 69</sup>. |
|||
* Income from retroactive reinsurance contracts is deferred and amortized into net income over the settlement period <sup>p. 69</sup>. |
|||
* Losses from retroactive reinsurance contracts are charged to net income immediately <sup>p. 69</sup>. |
|||
* Subsequent changes in the measurement of retroactive reinsurance contracts are accounted for using a full retrospective method <sup>p. 69</sup>. |
|||
* Certain ceded reinsurance contracts that do not transfer significant insurance risk are accounted for using the deposit method <sup>p. 69</sup>. |
|||
* The evaluation of significant insurance risk transfer assesses both timing risk and underwriting risk <sup>p. 69</sup>. |
|||
* If a reinsurance contract transfers only significant timing risk but not sufficient underwriting risk, a deposit asset is recorded equal to the initial cash outflow <sup>p. 69</sup>. |
|||
* The deposit asset is offset by cash inflows received from reinsurers <sup>p. 69</sup>. |
|||
* An accretion rate is established at contract inception, based on actuarial estimates, to adjust the deposit accounting asset to the estimated receivable amount over the contract term <sup>p. 69</sup>. |
|||
* The accretion of the deposit is based on the expected rate of return implied from estimated cash inflows and outflows <sup>p. 69</sup>. |
|||
* The Company periodically reassesses the estimated ultimate receivable and the related expected rate of return on the deposit asset <sup>p. 69</sup>. |
|||
* Accretion of the deposit asset, including changes from estimated cash flow changes, is reflected as part of investment income <sup>p. 69</sup>. |
|||
* Several reinsurance contracts require deposit accounting due to not transferring sufficient underwriting risk <sup>p. 69</sup>. |
|||
* No reinsurance contracts required deposit accounting due to not transferring sufficient timing risk <sup>p. 69</sup>. |
|||
* ''Reinsurance recoverables'' are carried net of an allowance for credit losses, representing the current estimate of expected credit losses <sup>p. 69</sup>. |
|||
* The Company develops a historical loss rate using the A.M. Best impairment rate and rating transition study, which provides historical loss data for similarly rated reinsurance companies based on the expected duration of receivables <sup>p. 69</sup>. |
|||
* The historical loss rate is adjusted for current conditions, reasonable and supportable forecasts, and current economic conditions <sup>p. 69</sup>. |
|||
* Changes in the allowance for credit losses are recognized in underwriting, acquisition, and insurance expenses <sup>p. 69</sup>. |
|||
* The Company continuously monitors the financial condition of its reinsurers, including reviewing their annual financial statements and industry developments <sup>p. 69</sup>. |
|||
* The Company analyzes the credit risk of its reinsurance recoverables by monitoring the financial strength rating of its reinsurers from A.M. Best <sup>p. 69</sup>. |
|||
* The Company assesses the adequacy of collateral obtained where applicable <sup>p. 69</sup>. |
|||
* Should reinsurers fail to fulfill obligations, the Company has access to collateral from various reinsurers <sup>p. 69</sup>. |
|||
* ''Reinsurance collateral'' from reinsurers was USD 344.1m as of December 31, 2025, and USD 337.0m as of December 31, 2024 <sup>p. 69</sup>. |
|||
* ''eMaxx Captives'' represented 17.7% of the Company’s reinsurance recoverable balances at December 31, 2025, and 16.8% at December 31, 2024 <sup>p. 69</sup>. |
|||
* ''Everest Reinsurance Co.'' represented 11.1% of the Company’s reinsurance recoverable balances at December 31, 2025, and 18.0% at December 31, 2024 <sup>p. 69</sup>. |
|||
* eMaxx Captives and Everest Reinsurance Co. were the only reinsurers representing 10% or more of the Company’s reinsurance recoverable balances <sup>p. 69</sup>. |
|||
* eMaxx Captives was not rated by A.M. Best at December 31, 2025, and 2024 <sup>p. 69</sup>. |
|||
* Everest Reinsurance Co.'s financial strength rating from A.M. Best was A+ at December 31, 2025, and 2024 <sup>p. 69</sup>. |
|||
* The Company consolidates an entity if it has a controlling financial interest, determined by assessing if the entity is a variable interest entity (VIE) for which the Company is the primary beneficiary, or if the Company controls the entity through a majority voting interest or other arrangements. |
|||
====== I. Concentration of Credit Risk ====== |
|||
* A VIE is defined as an entity that either lacks sufficient equity to finance its activities without additional subordinated financial support, whose equity holders lack the characteristics of a controlling financial interest, and/or is established with non-substantive voting rights. |
|||
* The Company's assessment of VIE status involves subjectivity in determining which activities most significantly affect the VIE’s performance and estimates about current and future fair value of assets and financial performance of the VIE. |
|||
* In related party analysis, the Company considers qualitative and quantitative factors including the characteristics and size of its investment relative to the related party, the ability of the Company and related party to control or significantly influence key decisions of the VIE (including de facto agents), the obligation or likelihood to fund operating losses of the VIE, and the similarity and significance of the VIE’s business activities to those of the Company and the related party. |
|||
* The determination of whether an entity is a VIE and whether the Company is the primary beneficiary involves significant judgment and depends on specific facts and circumstances at the time of assessment. |
|||
{{chunk|doc=3z7a4yrxkn|c=175|p=16}} |
|||
* Financial instruments that could lead to concentrations of credit risk include cash and cash equivalents, restricted cash, investments, and premiums receivable, in addition to reinsurance recoverables <sup>p. 70</sup>. |
|||
'''Consolidation reassessment and impact''' |
|||
* ''Cash equivalents and short-term investments'' consist of U.S. government securities and money market funds <sup>p. 70</sup>. |
|||
* ''Investments'' are diversified across various industries and geographic regions <sup>p. 70</sup>. |
|||
* The Company restricts its credit exposure to any single financial institution or issuer <sup>p. 70</sup>. |
|||
* The Company believes there is no significant concentration of credit risk related to cash and investments <sup>p. 70</sup>. |
|||
* As of December 31, 2025 and 2024, ''outstanding premiums receivable'' are diversified due to a large customer base spread across many lines of business and geographic regions <sup>p. 70</sup>. |
|||
* Failure by distribution sources to remit premiums could lead to premium write-offs and a corresponding loss of income <sup>p. 70</sup>. |
|||
* At each reporting period, the Company reassesses changes in facts and circumstances that could alter an entity's VIE status or the Company's consolidation assessment. |
|||
====== J. Deferred Policy Acquisition Costs ====== |
|||
* Changes in consolidation status are applied prospectively. |
|||
* If an entity is consolidated due to reassessment, its assets, liabilities, and noncontrolling interest are recorded at fair value upon initial consolidation. |
|||
* Any existing equity interest held by the Company in the entity prior to obtaining control is remeasured at fair value, potentially resulting in a recognized gain or loss upon initial consolidation. |
|||
* Deconsolidation of a subsidiary due to reassessment may result in a recognized gain or loss, depending on the carrying values of deconsolidated assets and liabilities compared to the fair value of any retained interests. |
|||
* The Company has determined one entity meets the definition of a VIE for which it is the primary beneficiary. |
|||
* Further details and required disclosures are provided in Note 7. |
|||
=== D. Cash and Cash Equivalents === |
|||
* ''Policy acquisition costs'' include commissions and premium taxes that are directly related to new or renewal business production <sup>p. 71</sup>. |
|||
* The Company defers policy acquisition costs and related ceding commissions, charging or crediting them to earnings proportionally with premium earned over the policy's life <sup>p. 71</sup>. |
|||
* A ''premium deficiency'' is recognized if expected losses, loss adjustment expenses, and unamortized acquisition costs exceed related unearned premiums <sup>p. 71</sup>. |
|||
* To recognize a premium deficiency, the Company first charges unamortized acquisition costs to expense to eliminate the deficiency <sup>p. 71</sup>. |
|||
* If the premium deficiency exceeds unamortized acquisition costs, a liability is accrued for the excess deficiency <sup>p. 71</sup>. |
|||
* ''Anticipated investment income'' is considered when determining premium deficiencies <sup>p. 71</sup>. |
|||
* Management determined that no premium deficiency existed as of December 31, 2025, and 2024 <sup>p. 71</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=176|p=16}} |
|||
====== K. Goodwill and Intangible Assets ====== |
|||
'''Cash and cash equivalents definition''' |
|||
* Cash and cash equivalents include cash on hand and fixed maturity securities with original maturities of three months or less. |
|||
* ''Goodwill and intangible assets'' are recorded following a business combination <sup>p. 72</sup>. |
|||
* The carrying value of the Company’s cash and cash equivalents approximates fair value. |
|||
* ''Goodwill'' represents the excess of the purchase price over the fair value of acquired assets and assumed liabilities <sup>p. 72</sup>. |
|||
* The Company reviews its ''purchase price allocation'' for up to one year after an acquisition, allowing for adjustments within this period <sup>p. 72</sup>. |
|||
* The Company amortizes ''identifiable intangible assets'' with a finite useful life over the period they are expected to contribute to future cash flows <sup>p. 72</sup>. |
|||
* The Company does not amortize ''indefinite-lived intangible assets'' <sup>p. 72</sup>. |
|||
* The Company reviews ''goodwill and identifiable intangible assets'' for recoverability annually in the fourth quarter or on an interim basis if circumstances indicate a carrying amount may not be recoverable <sup>p. 72</sup>. |
|||
* Based on this review, the Company had ''no goodwill impairment'' for the years ended December 31, 2025, and 2024 <sup>p. 72</sup>. |
|||
=== E. Restricted Cash === |
|||
{{chunk|doc=3z7a4yrxkn|c=177|p=16}} |
|||
* ''Property and equipment'' is recorded at cost less accumulated depreciation and is included in other assets on the Consolidated Balance Sheets <sup>p. 73</sup>. |
|||
'''Restricted cash definition and uses''' |
|||
* ''Depreciation expense'' is recognized on a straight-line basis for financial statement purposes <sup>p. 73</sup>. |
|||
* ''Depreciation periods'' range from three to seven years <sup>p. 73</sup>. |
|||
* Cash with a legal restriction on withdrawal or use by the consolidated group is recorded as restricted cash. |
|||
====== M. Reserves for Losses and Loss Adjustment Expenses ====== |
|||
* The carrying value of the Company’s restricted cash approximates fair value. |
|||
* SUA holds unremitted insurance premiums in a fiduciary capacity to third-party insurance companies as restricted cash, after deducting commissions and applicable fees from premiums collected from clients. |
|||
* The Company is required by state regulations to maintain assets on deposit with certain states and hold cash as collateral for certain reinsurance balances. |
|||
* Cash held in a depository account for others, or restricted by a state, is recorded as restricted cash. |
|||
=== F. Investments === |
|||
* ''Reserves for unpaid losses and loss adjustment expenses (LAE)'' represent the Company's estimated ultimate cost of all unreported and reported but unpaid insured claims and the cost to adjust losses incurred as of the balance sheet date <sup>p. 74</sup>. |
|||
* The Company estimates reserves using individual case-basis valuations of reported claims, statistical analyses, and various actuarial procedures <sup>p. 74</sup>. |
|||
* Estimates are based on historical information, industry and peer group information, and estimates of future trends in variable factors such as loss severity, loss frequency, and inflation <sup>p. 74</sup>. |
|||
* Estimates are regularly reviewed and adjusted as experience develops or new information becomes known <sup>p. 74</sup>. |
|||
* During the loss settlement period, estimates of liability on a claim are often refined and adjusted upward or downward <sup>p. 74</sup>. |
|||
* The ultimate liability may exceed or be less than the revised estimates <sup>p. 74</sup>. |
|||
* The ultimate settlement of losses and related LAE may vary significantly from the estimate included in the financial statements <sup>p. 74</sup>. |
|||
* If actual liabilities exceed recorded amounts, there will be an adverse effect <sup>p. 74</sup>. |
|||
* If recorded reserves are determined to be more than adequate, it would lead to a reduction in reserves <sup>p. 74</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=178|p=16}} |
|||
====== N. Premiums ====== |
|||
'''Available-for-sale fixed maturities accounting''' |
|||
* Investments in fixed maturities classified as available-for-sale are carried at fair value. |
|||
* The Company recognizes ''property and casualty and surety premiums'' on a pro-rata basis over the policy terms <sup>p. 75</sup>. |
|||
* For available-for-sale fixed maturities in an unrealized loss position, the Company first determines intent to sell or likelihood of being required to sell before maturity or recovery of cost basis. |
|||
* ''Accident and health premiums'' are earned as billed, based on census data <sup>p. 75</sup>. |
|||
* If intent or likelihood of sale criteria are met, the amortized cost is written down to fair value, with losses recognized in net investment gains on the Consolidated Statements of Operations. |
|||
* ''Gross premiums written'' are reduced by ceded premiums from proportional, facultative, and excess of loss reinsurance costs for prospective reinsurance <sup>p. 75</sup>. |
|||
* If neither criterion is met, the Company determines if unrealized losses are due to credit-related factors. |
|||
* ''Premiums receivable'' include deferred premiums, which are installment payments due from insureds under their policy payment terms <sup>p. 75</sup>. |
|||
* |
* If unrealized losses are credit-related, an allowance for credit losses is determined using a present value of cash flows compared to the amortized cost. |
||
* Prior to 2025, changes in the allowance for credit losses were recognized in [[Definition:Net investment income|net investment income]] on the Consolidated Statements of Operations. |
|||
* The Company develops a ''historical loss rate'' for credit losses using historical write-offs and aging of receivables <sup>p. 75</sup>. |
|||
* As of 2025, changes in the allowance for credit losses are recognized in net investment gains. |
|||
* This ''historical loss rate'' is adjusted for current conditions, reasonable and supportable forecasts, and the ability to cancel coverage on a policy after premiums are past due <sup>p. 75</sup>. |
|||
* Prior periods have been updated to conform to the current period presentation. |
|||
* ''Changes in the allowance for credit losses'' are recognized in underwriting, acquisition, and insurance expenses on the Consolidated Statements of Operations <sup>p. 75</sup>. |
|||
* Credit losses limited by the fair value of the security are recognized in stockholders’ equity, net of taxes, as a component of accumulated other comprehensive income (loss). |
|||
* ''Unearned premiums'' represent the portion of gross premiums written applicable to the unexpired terms of in-force insurance policies or reinsurance contracts <sup>p. 75</sup>. |
|||
* Unrealized losses that are not credit-related continue to be recognized in stockholders’ equity, net of taxes, as a component of accumulated other comprehensive income (loss). |
|||
* ''Ceded unearned premiums'' represent the portion of ceded premiums written applicable to the unexpired terms of in-force insurance policies or reinsurance contracts <sup>p. 75</sup>. |
|||
* ''Unearned premiums'' (direct and ceded) are calculated on a pro-rata basis over the terms of the policies <sup>p. 75</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=179|p=16}} |
|||
====== O. Commission and Fee Income ====== |
|||
'''Held-to-maturity fixed maturities accounting''' |
|||
* Investments in fixed maturity securities held-to-maturity are carried at amortized cost net of an allowance for credit losses. |
|||
* ''SUA commission revenue'' is generated from placing insurance policies on reinsurance programs via a reinsurance broker <sup>p. 76</sup>. |
|||
* The |
* The allowance for credit losses represents the current estimate of expected credit losses. |
||
* The Company develops a historical loss rate from Moody’s multi-year cumulative loss rates for asset-backed securities. |
|||
* The transaction price for SUA commission revenue is fixed at contract inception and based on a percentage of premiums placed <sup>p. 76</sup>. |
|||
* The historical loss rate is adjusted for current conditions and reasonable and supportable forecasts. |
|||
* The Company recognizes 100% of the transaction price for SUA commission revenue when the performance obligation is satisfied at the point a policy is placed, with no constraints on revenue <sup>p. 76</sup>. |
|||
* Prior to 2025, changes in the allowance for credit losses were recognized in [[Definition:Net investment income|net investment income]] on the Consolidated Statements of Operations. |
|||
* ''SUA fee income'' is generated from placing insurance policies with a third-party insurance company <sup>p. 76</sup>. |
|||
* As of 2025, changes in the allowance for credit losses are recognized in net investment gains. |
|||
* The Company's single performance obligation for SUA fee income is the placement of the policy <sup>p. 76</sup>. |
|||
* Prior periods have been updated to conform to the current period presentation. |
|||
* The transaction price for SUA fee income is variable at contract inception and based on a percentage of premium, which is determined by risk factors that change monthly, such as employee census data and worker roles <sup>p. 76</sup>. |
|||
* The Company estimates the transaction price for SUA fee income over the policy's life using the expected value method <sup>p. 76</sup>. |
|||
* Revenue for SUA fee income is recognized at the point in time the policy is placed <sup>p. 76</sup>. |
|||
* Changes in the estimate of variable consideration for SUA fee income are recognized in the month they occur <sup>p. 76</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=180|p=16}} |
|||
====== P. Income Taxes ====== |
|||
'''Equity securities accounting''' |
|||
* Equity securities consist of common stock or preferred stock. |
|||
* Income tax expense is accrued for the tax effects of transactions reported on the consolidated financial statements <sup>p. 77</sup>. |
|||
* Mutual funds, including those primarily investing in debt securities, are classified as equity securities. |
|||
* The provision for income taxes includes taxes currently due and deferred taxes from temporary differences between financial statement and income tax reporting <sup>p. 77</sup>. |
|||
* Investments in equity securities with a readily determinable fair value are carried on the balance sheet at fair value using quoted market prices. |
|||
* A valuation allowance is established for any deferred tax asset not expected to be realized <sup>p. 77</sup>. |
|||
* Changes in the carrying value of equity securities are included in net investment gains (losses) within the Consolidated Statements of Operations. |
|||
* Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years of recovery or settlement of temporary differences <sup>p. 77</sup>. |
|||
* The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period of enactment <sup>p. 77</sup>. |
|||
* A liability for uncertain tax positions is recorded if it is more likely-than-not that the tax position will not be sustained upon examination by the tax authority <sup>p. 77</sup>. |
|||
* Changes in the liability for uncertain tax positions are reflected in income tax expense when a new uncertain tax position arises, judgment changes, the tax issue is settled, or the statute of limitation expires <sup>p. 77</sup>. |
|||
* Potential net interest income or expense and penalties related to uncertain tax positions are recorded on the Consolidated Statements of Operations <sup>p. 77</sup>. |
|||
* The Company files a consolidated federal income tax return in the United States and certain other state tax returns <sup>p. 77</sup>. |
|||
* Admitted insurance subsidiaries pay premium taxes on gross written premiums in lieu of most state income or franchise taxes <sup>p. 77</sup>. |
|||
* Premium tax expense is recognized within underwriting, acquisition, and insurance expense on the Consolidated Statements of Operations <sup>p. 77</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=181|p=16}} |
|||
====== Q. Fair Value of Financial Instruments ====== |
|||
'''Mortgage loans accounting''' |
|||
* Investments in mortgage loans are classified as held for investment and carried at cost adjusted for unamortized premiums, discounts, and loan fees. |
|||
* ''Fair value'' is estimated for each class of financial instrument using the framework from fair value accounting guidance <sup>p. 78</sup>. |
|||
* Uncollectible amounts are written off in the period they are determined to be uncollectible. |
|||
* The guidance requires maximizing observable inputs and minimizing unobservable inputs when measuring fair value <sup>p. 78</sup>. |
|||
* Interest on loans is recognized as interest receivable and included in other assets on the Consolidated Balance Sheets. |
|||
* ''Fair value hierarchy disclosures'' are based on the quality of inputs used for fair value measurement <sup>p. 78</sup>. |
|||
* The Company elected the fair value option for mortgage loans effective January 1, 2023, as targeted transition relief from ASU 2016-13 adoption. |
|||
* The hierarchy prioritizes unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) <sup>p. 78</sup>. |
|||
* Under the fair value option, mortgage loans are measured at fair value. |
|||
* The hierarchy gives the lowest priority to unobservable inputs (Level 3 measurements) <sup>p. 78</sup>. |
|||
* Changes in unrealized gains and losses on mortgage loans are reported in net investment gains (losses) on the Consolidated Statements of Operations. |
|||
* The Company uses widely recognized, third-party pricing sources to determine fair values of financial instruments <sup>p. 78</sup>. |
|||
* Interest income and amortization continue to be recognized in [[Definition:Net investment income|net investment income]] on the Consolidated Statements of Operations. |
|||
* Management has understood the valuation methodologies and inputs of these third-party pricing sources <sup>p. 78</sup>. |
|||
* Further details on fair value disclosures are in Note 4 <sup>p. 78</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=182|p=16}} |
|||
====== R. Stock-Based Compensation ====== |
|||
'''Equity method investments accounting''' |
|||
* Equity method investments include investments in equity and equity securities of non-public entities and indirect investments in loans and loan collateral. |
|||
* The estimated fair value of employee stock options and similar awards is expensed <sup>p. 79</sup>. |
|||
* The Company has equity investments in certain limited partnerships and corporations where it has significant influence but not control. |
|||
* Compensation cost for equity instrument awards to employees is measured based on the grant-date fair value and recognized over the expected vesting service period <sup>p. 79</sup>. |
|||
* Analysis of variable interest entities indicated the Company is not the primary beneficiary and would not consolidate these entities. |
|||
* Tax effects related to share-based payments are processed through net earnings <sup>p. 79</sup>. |
|||
* The equity method is used to account for investments in unconsolidated subsidiaries. |
|||
* Further discussion and related disclosures regarding stock-based compensation are in note 18 <sup>p. 79</sup>. |
|||
* Under the equity method, initial investment is recorded at cost and adjusted based on proportionate share of distributions and net income or loss of the investee. |
|||
* The Company's employee stock purchase plan (ESPP) allows all employees to purchase common stock at a discount <sup>p. 79</sup>. |
|||
* The difference between investment cost and proportionate share of underlying equity in net assets is a component of investment income. |
|||
* Compensation cost for the ESPP is recognized on a straight-line basis over the offering period <sup>p. 79</sup>. |
|||
* The Company amortizes this difference as an adjustment to its pro-rata share of equity method income over the useful life of the underlying asset. |
|||
* For equity securities of non-public entities where the Company does not have significant influence and no readily determinable fair value, investments are carried at cost, minus impairment, and adjusted for observable price changes in orderly transactions for identical or similar investments of the same issuer. |
|||
* Investments in indirect collateralized loans and loan collateral are held through and accounted for as an ownership interest in an unconsolidated subsidiary. |
|||
* The Company’s ownership interests in unconsolidated subsidiaries include investments in partnerships, joint ventures, and special purpose investment vehicles. |
|||
* The Company has significant influence but not control of these unconsolidated subsidiaries and uses the equity method for these investments. |
|||
{{chunk|doc=3z7a4yrxkn|c=183|p=16}} |
|||
====== S. Earnings Per Share ====== |
|||
'''Other long-term investments accounting''' |
|||
* Other long-term investments consist of an investment in a limited partnership held at net asset value (“NAV”) and other long-term investment securities. |
|||
* ''Basic earnings per share'' is calculated using the two-class method <sup>p. 80</sup>. |
|||
* Undistributed earnings are allocated to participating securities based on their potential share in earnings, assuming all earnings for the period have been distributed <sup>p. 80</sup>. |
|||
* ''Basic earnings per share'' is determined by dividing net income attributable to common stockholders by the weighted-average number of common shares outstanding for the period <sup>p. 80</sup>. |
|||
* Common shares with unsatisfied contingencies, such as vesting requirements, are excluded from basic earnings per share <sup>p. 80</sup>. |
|||
* The Company's preferred shares are considered participating securities as they participate in dividends and distributions with common stock on an as-converted basis <sup>p. 80</sup>. |
|||
* Instruments awarded to employees that grant the right to purchase common stock at a fixed price are included as potential common shares, weighted for the portion of the period they were granted, if dilutive <sup>p. 80</sup>. |
|||
* The Company's common and preferred shares financed by stock notes are contingently issuable instruments, requiring the holder to return shares if stock notes are not paid off <sup>p. 80</sup>. |
|||
* These contingently issuable instruments are excluded from basic and diluted earnings per share if specified conditions are not met, assuming the end of the period is the end of the contingency period <sup>p. 80</sup>. |
|||
* The impact of contingently issuable instruments on diluted earnings per share was calculated using the treasury stock method and included in the reconciliation of the denominator for basic and diluted EPS computations for the year ended December 31, 2024 <sup>p. 80</sup>. |
|||
* All outstanding stock notes were settled during 2024, resulting in no impact on the Company’s basic and diluted earnings per share computations for the year ended December 31, 2024 <sup>p. 80</sup>. |
|||
* Instruments convertible into common shares are included in diluted weighted-average common shares outstanding on an if-converted basis, using the legal conversion rate for the respective period, if dilutive <sup>p. 80</sup>. |
|||
* Share-based awards to employees with only service conditions are included as potential common shares, weighted for the unvested portion of the period, if dilutive <sup>p. 80</sup>. |
|||
* Share-based awards to employees with performance and service or market conditions are included as potential common shares, assuming the end of the period is the end of the contingency period, if dilutive <sup>p. 80</sup>. |
|||
* When common share adjustments increase earnings per share or reduce loss per share, the effect is anti-dilutive, and diluted net earnings or net loss per share is computed excluding these common share equivalents <sup>p. 80</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=184|p=16}} |
|||
====== T. Recent Accounting Pronouncements ====== |
|||
'''Short-term investments accounting''' |
|||
* Short-term investments primarily consist of money market funds. |
|||
* ''ASU 2023-09'': Issued by FASB in December 2023, it requires public companies to provide enhanced annual rate reconciliation disclosures for income tax, including specific categories and additional information meeting a quantitative threshold <sup>p. 81</sup>. |
|||
* Short-term investments are carried at cost, which approximates fair value. |
|||
* ''ASU 2023-09'': Also requires public companies to disaggregate income taxes paid by federal, state, and foreign taxes <sup>p. 81</sup>. |
|||
* ''ASU 2023-09 Effective Date'': Became effective for fiscal years beginning after December 15, 2024, and is applied prospectively <sup>p. 81</sup>. |
|||
* The Company has added additional disclosures as required by ASU 2023-09, with no impact on the consolidated financial statements <sup>p. 81</sup>. |
|||
* ''ASU 2024-03'': Issued by FASB in November 2024, it requires disaggregated disclosure of income statement expenses for public business entities (PBEs) <sup>p. 81</sup>. |
|||
* ''ASU 2024-03'': Does not change expense captions on the income statement but requires disaggregation of certain expense captions into specified categories in footnotes <sup>p. 81</sup>. |
|||
* ''ASU 2024-03 Disclosure Requirements'': Requires PBEs to disaggregate, in a tabular presentation, relevant income statement expense captions that include natural expenses such as (1) purchases of inventory, (2) employee compensation, (3) depreciation, (4) intangible asset amortization, and (5) depreciation, depletion, and amortization from oil- and gas-producing activities or other depletion expenses <sup>p. 81</sup>. |
|||
* ''ASU 2024-03 Effective Date Clarification'': ASU 2025-01, issued in January 2025, clarified the effective date of ASU 2024-03 as the first annual reporting period beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027 <sup>p. 81</sup>. |
|||
* The Company is evaluating the effect of the amendments of ASU 2024-03 on its consolidated financial statements <sup>p. 81</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=185|p=16}} |
|||
====== 2. Goodwill and Intangible Assets ====== |
|||
'''[[Definition:Net investment income|Net investment income]] and gains/losses recognition''' |
|||
* [[Definition:Net investment income|Net investment income]] consists of interest, [[Definition:Dividend|dividends]], and equity in earnings (losses) of unconsolidated subsidiaries, net of investment expenses such as investment management expenses. |
|||
* The Company's indefinite-lived intangible assets include insurance licenses and trademarks <sup>p. 82</sup>. |
|||
* Interest income is recognized on the accrual basis. |
|||
* The Company's finite-lived intangible assets, such as policy renewals, agency relationships, and non-compete/exclusivity agreements, had a weighted average useful life of approximately 12 years as of December 31, 2025 <sup>p. 82</sup>. |
|||
* [[Definition:Dividend|Dividends]] are recognized as earned at the ex-dividend date. |
|||
* The Company recognized ''amortization expense'' of approximately USD 1.3m for the year ended December 31, 2025 <sup>p. 82</sup>. |
|||
* Interest income on mortgage-backed and other asset-backed securities is recognized using the effective-yield method based on estimated principal repayments. |
|||
* The Company recognized ''amortization expense'' of approximately USD 1.1m for the year ended December 31, 2024 <sup>p. 82</sup>. |
|||
* Amortization of premium and accretion of discounts on debt securities are included in interest income. |
|||
* The Company recognized ''amortization expense'' of approximately USD 1.5m for the year ended December 31, 2023 <sup>p. 82</sup>. |
|||
* Net investment gains and losses are recognized in net income based upon the specific identification method. |
|||
=== G. Derivatives === |
|||
====== Goodwill by segment at December 31, 2025 ====== |
|||
{{chunk|doc=3z7a4yrxkn|c=186|p=16}} |
|||
'''Commodity derivatives accounting and valuation''' |
|||
* The Company uses commodity derivatives to assume risk and manage exposures in the insurance industry. |
|||
* Commodity derivatives expose the Company to potentially unfavorable price changes to underlying commodities. |
|||
* Derivatives are accounted for in accordance with FASB ASC Topic 815, Derivatives and Hedging. |
|||
* All derivatives are recorded at fair value on the Company’s balance sheet as assets or liabilities. |
|||
* Changes in fair value of derivatives are reflected in current earnings. |
|||
* The Company nets assets and liabilities of derivatives, including them in "other assets" on the Consolidated Balance Sheets. |
|||
* The Company considers exchange-traded futures and forward purchase and sale contracts to be effective economic hedges. |
|||
* The Company has not elected hedge accounting treatment for these derivatives. |
|||
* Fair value of derivatives is estimated by reference to quoted prices or broker quotes, or through industry or internal valuation models when quotes are unavailable. |
|||
* Further details and required disclosures are in Note 8. |
|||
=== H. Reinsurance === |
|||
{{chunk|doc=3z7a4yrxkn|c=187|p=16}} |
|||
'''Reinsurance accounting principles''' |
|||
* The Company purchases prospective reinsurance for certain [[Definition:Business mix|lines of business]] on a proportional, excess of loss, and facultative basis. |
|||
* Proportional reinsurance involves sharing losses and expenses with the reinsurer in exchange for a share of premiums. |
|||
* Excess of loss reinsurance shares losses, either proportionally or entirely, above a certain dollar threshold, for a negotiated cost. |
|||
* Facultative reinsurance covers specific risks and/or policies on either a proportional or excess of loss basis. |
|||
* Ceded unearned premium and reinsurance balances recoverable (on paid and unpaid losses and settlement expenses) are reported separately as assets, not netted with related liabilities, because reinsurance does not relieve the Company of its legal liability to policyholders. |
|||
* Reinsurance on unpaid losses and settlement expenses represents estimates of the portion of liabilities recoverable from reinsurers. |
|||
* On the Consolidated Statements of Operations, net earned premiums, losses and loss adjustment expenses, net, and underwriting, acquisition, and insurance expenses are presented net of reinsurance ceded. |
|||
{{chunk|doc=3z7a4yrxkn|c=188|p=16}} |
|||
'''Retroactive reinsurance accounting''' |
|||
* The Company has purchased retroactive reinsurance on certain [[Definition:Business mix|lines of business]] in prior years, including loss portfolio transfers (LPT) and adverse development covers. |
|||
* These contracts indemnify losses related to past loss events, with the reinsurer sharing losses based on dollar thresholds. |
|||
* Income from retroactive reinsurance contracts is deferred and amortized into net income over the settlement period. |
|||
* Losses from retroactive reinsurance contracts are charged to net income immediately. |
|||
* Subsequent changes in the measurement of retroactive reinsurance contracts are accounted for under a full retrospective method. |
|||
{{chunk|doc=3z7a4yrxkn|c=189|p=16}} |
|||
'''Deposit accounting for reinsurance''' |
|||
* Certain ceded reinsurance contracts that management determines do not transfer significant insurance risk are accounted for using the deposit method. |
|||
* The evaluation of significant insurance risk transfer assesses both timing risk and underwriting risk. |
|||
* A reinsurance contract may not transfer significant insurance risk if either underwriting risk or timing risk, or both, are not deemed transferred. |
|||
* For contracts transferring only significant timing risk but not sufficient underwriting risk, a deposit asset is recorded equal to the initial cash outflow, offset by cash inflows from reinsurers. |
|||
* If cash outflows are expected to differ from expected cash inflows, an accretion rate is established at inception based on actuarial estimates, increasing/decreasing the deposit accounting asset to the estimated receivable amount over the contract term. |
|||
* The accretion of the deposit is based on the expected rate of return implied from estimated cash inflows and outflows under the contract. |
|||
* The Company periodically reassesses the estimated ultimate receivable and related expected rate of return on the deposit asset. |
|||
* Accretion of the deposit asset, including changes from estimated cash flow changes, is reflected as part of investment income in the Company’s results of operations. |
|||
* Several reinsurance contracts require deposit accounting due to not transferring sufficient underwriting risk. |
|||
* There were no reinsurance contracts requiring deposit accounting due to not transferring sufficient timing risk. |
|||
{{chunk|doc=3z7a4yrxkn|c=190|p=16}} |
|||
'''Reinsurance recoverables and credit risk''' |
|||
* Reinsurance recoverables are carried net of an allowance for credit losses, which represents the current estimate of expected credit losses. |
|||
* The Company develops a historical loss rate using the A.M. Best impairment rate and rating transition study, which provides historical loss data for similarly rated reinsurance companies based on receivable duration. |
|||
* The historical loss rate is adjusted for current conditions, reasonable and supportable forecasts, and current economic conditions. |
|||
* Changes in the allowance for credit losses are recognized in underwriting, acquisition, and insurance expenses on the Consolidated Statements of Operations. |
|||
* Reinsurance does not relieve the Company of its legal liability to its policyholders. |
|||
* The Company continuously monitors the financial condition of its reinsurers by reviewing annual financial statements and industry developments. |
|||
* Credit risk associated with reinsurance recoverables is analyzed by monitoring reinsurers' A.M. Best financial strength ratings and assessing collateral adequacy. |
|||
* If reinsurers fail to fulfill obligations, the Company has access to collateral from various reinsurers. |
|||
* Reinsurance collateral from reinsurers was USD 344.1m as of December 31, 2025, and USD 337.0m as of December 31, 2024. |
|||
* eMaxx Captives and Everest Reinsurance Co. were the only reinsurers representing 10% or more of the Company’s reinsurance recoverable balances. |
|||
* eMaxx Captives represented 17.7% of reinsurance recoverable balances at December 31, 2025, and 16.8% at December 31, 2024. |
|||
* Everest Reinsurance Co. represented 11.1% of reinsurance recoverable balances at December 31, 2025, and 18.0% at December 31, 2024. |
|||
* eMaxx Captives was not rated by A.M. Best at December 31, 2025, and 2024. |
|||
* Everest Reinsurance Co.'s financial strength rating from A.M. Best was A+ at December 31, 2025, and 2024. |
|||
=== I. Concentration of Credit Risk === |
|||
{{chunk|doc=3z7a4yrxkn|c=191|p=16}} |
|||
'''Credit risk concentration''' |
|||
* Financial instruments potentially subject to concentrations of credit risk include cash and cash equivalents, restricted cash, investments, and premiums receivable, in addition to reinsurance recoverables. |
|||
* Cash equivalents and short-term investments include U.S. government securities and money market funds. |
|||
* Investments are diversified across many industries and geographic regions. |
|||
* The Company limits credit exposure with any single financial institution or issuer. |
|||
* No significant concentration of credit risk is believed to exist with respect to cash and investments. |
|||
* As of December 31, 2025 and 2024, outstanding premiums receivable are generally diversified due to the large number of entities in the customer base and their dispersion across various [[Definition:Business mix|lines of business]] and geographic regions. |
|||
* Failure by distribution sources to remit premiums could lead to premium write-offs and a corresponding loss of income. |
|||
=== J. Deferred Policy Acquisition Costs === |
|||
{{chunk|doc=3z7a4yrxkn|c=192|p=16}} |
|||
'''Deferred Policy Acquisition Costs''' |
|||
* Policy acquisition costs include commissions and premium taxes that vary with and are directly related to the successful production of new or renewal business. |
|||
* The Company defers policy acquisition costs and related ceding commissions. |
|||
* Deferred policy acquisition costs and related ceding commissions are charged or credited to earnings in proportion to the premium earned over the life of the policy. |
|||
* A premium deficiency is recognized if the sum of expected losses, loss adjustment expenses, and unamortized acquisition costs exceeds related unearned premiums. |
|||
* The Company first recognizes a premium deficiency by charging any unamortized acquisition costs to expense to the extent required to eliminate the deficiency. |
|||
* If the premium deficiency exceeds unamortized acquisition costs, a liability is accrued for the excess deficiency. |
|||
* Anticipated investment income is considered in the determination of premium deficiencies. |
|||
* Management determined no premium deficiency existed as of December 31, 2025 and 2024. |
|||
=== K. Goodwill and Intangible Assets === |
|||
{{chunk|doc=3z7a4yrxkn|c=193|p=16}} |
|||
'''Goodwill and intangible assets accounting policy''' |
|||
* Goodwill and intangible assets are recorded as a result of a business combination. |
|||
* Goodwill represents the excess of the purchase price over the fair value of acquired assets and assumed liabilities. |
|||
* The Company reviews its purchase price allocation for up to one year post-acquisition and may make adjustments within that period. |
|||
* Identifiable intangible assets with a finite useful life are amortized over the period they are expected to contribute to future cash flows. |
|||
* Indefinite-lived intangible assets are not amortized. |
|||
* The Company reviews goodwill and identifiable intangible assets for recoverability annually in the fourth quarter, or on an interim basis if events or changes indicate a carrying amount may not be recoverable. |
|||
* No goodwill impairment was recorded for the years ended December 31, 2025 and 2024. |
|||
=== L. Property and Equipment === |
|||
{{chunk|doc=3z7a4yrxkn|c=194|p=16}} |
|||
'''Property and equipment accounting''' |
|||
* Property and equipment, included in other assets on the Consolidated Balance Sheets, is recorded at cost less accumulated depreciation. |
|||
* Depreciation expense is recognized on a straight-line basis for financial statement purposes over periods ranging from three to seven years. |
|||
=== M. Reserves for Losses and Loss Adjustment Expenses === |
|||
{{chunk|doc=3z7a4yrxkn|c=195|p=16}} |
|||
'''Reserves for unpaid losses and LAE''' |
|||
* Reserves for unpaid losses and loss adjustment expenses (LAE) represent the estimated ultimate cost of all unreported and reported but unpaid insured claims and the cost to adjust losses incurred as of the balance sheet date. |
|||
* Estimates for these reserves are made using individual case-basis valuations of reported claims, statistical analyses, and various actuarial procedures. |
|||
* These estimates are based on historical information, industry and peer group information, and estimates of future trends in variable factors such as loss severity, loss frequency, and inflation. |
|||
* Estimates are regularly reviewed and adjusted as experience develops or new information becomes known. |
|||
* During the loss settlement period, estimates of liability on a claim may be refined and adjusted upward or downward. |
|||
* The ultimate settlement of losses and related LAE may vary significantly from the estimate included in financial statements. |
|||
* If actual liabilities exceed recorded amounts, there will be an adverse effect. |
|||
* Recorded reserves may be determined to be more than adequate, leading to a reduction in reserves. |
|||
=== N. Premiums === |
|||
{{chunk|doc=3z7a4yrxkn|c=196|p=16}} |
|||
'''Premium recognition and receivables''' |
|||
* The Company earns and recognizes [[Definition:Property & casualty|property and casualty]] and surety premiums on a pro-rata basis over the terms of policies. |
|||
* Accident and health premiums are earned as billed, based on census data. |
|||
* [[Definition:Gross written premiums|Gross premiums written]] are reduced by ceded premiums from proportional, facultative, and excess of loss reinsurance costs for prospective reinsurance. |
|||
* Premiums receivable include deferred premiums, which are installment payments due from insureds under their policy payment terms. |
|||
* Premiums receivable are carried net of an allowance for credit losses, which represents the current estimate of expected credit losses. |
|||
* The Company develops a historical loss rate for credit losses using historical write-offs and aging of receivables. |
|||
* This historical loss rate is adjusted for current conditions, reasonable and supportable forecasts, and the ability to cancel coverage after a premium is past due. |
|||
* Changes in the allowance for credit losses are recognized in underwriting, acquisition, and insurance expenses on the Consolidated Statements of Operations. |
|||
{{chunk|doc=3z7a4yrxkn|c=197|p=16}} |
|||
'''Unearned premiums''' |
|||
* Unearned premiums represent the portion of [[Definition:Gross written premiums|gross premiums written]] applicable to the unexpired terms of in-force insurance policies or reinsurance contracts. |
|||
* Ceded unearned premiums represent the portion of ceded premiums written applicable to the unexpired terms of in-force insurance policies or reinsurance contracts. |
|||
* These unearned premiums are calculated on a pro-rata basis over the terms of the policies for both direct and ceded amounts. |
|||
=== O. Commission and Fee Income === |
|||
{{chunk|doc=3z7a4yrxkn|c=198|p=16}} |
|||
'''SUA commission revenue''' |
|||
* SUA commission revenue is generated from placing insurance policies on reinsurance programs via a reinsurance broker. |
|||
* The Company's single performance obligation for SUA commission revenue is the placement of insurance policies. |
|||
* The transaction price for SUA commission revenue is fixed at contract inception and based on a percentage of premiums placed. |
|||
* The Company recognizes 100% of the transaction price for SUA commission revenue when the performance obligation is satisfied at the point a policy is placed, as there are no constraints on revenue. |
|||
{{chunk|doc=3z7a4yrxkn|c=199|p=16}} |
|||
'''SUA fee income''' |
|||
* SUA fee income is generated from placing insurance policies with a third-party insurance company. |
|||
* The Company's single performance obligation for SUA fee income is the placement of the policy. |
|||
* The transaction price for SUA fee income is variable at contract inception and based on a percentage of premium, which is determined by risk factors that vary monthly (e.g., employee census data, worker roles). |
|||
* The Company estimates its transaction price for SUA fee income over the life of the policy using the expected value method. |
|||
* Revenue from SUA fee income is recognized at the point the policy is placed. |
|||
* Changes in the estimate of variable consideration for SUA fee income are recognized in the month they occur. |
|||
=== P. Income Taxes === |
|||
{{chunk|doc=3z7a4yrxkn|c=200|p=16}} |
|||
'''Income tax accounting principles''' |
|||
* Income tax expense is accrued for tax effects of transactions reported on consolidated financial statements. |
|||
* Provision for income taxes consists of currently due taxes plus deferred taxes from temporary differences between financial statement and income tax reporting. |
|||
* A valuation allowance is established for any deferred tax asset not expected to be realized. |
|||
* Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years temporary differences are recovered or settled. |
|||
* The effect on deferred tax assets and liabilities from a change in tax rates is recognized in income in the period of enactment. |
|||
* A liability for uncertain tax positions is recorded if it is more likely-than-not that the tax position will not be sustained upon examination by the appropriate tax authority. |
|||
* Changes in the liability for uncertain tax positions are reflected in income tax expense when a new uncertain tax position arises, judgment changes about uncertainty likelihood, the tax issue is settled, or the statute of limitation expires. |
|||
* Potential net interest income or expense and penalties related to uncertain tax positions are recorded on the Consolidated Statements of Operations. |
|||
{{chunk|doc=3z7a4yrxkn|c=201|p=16}} |
|||
'''Tax filings and premium taxes''' |
|||
* The Company files a consolidated federal income tax return in the United States and certain other state tax returns. |
|||
* Admitted insurance subsidiaries pay premium taxes on [[Definition:Gross written premiums|gross written premiums]] in lieu of most state income or franchise taxes. |
|||
* Premium tax expense is recognized within underwriting, acquisition and insurance expense on the Consolidated Statements of Operations. |
|||
=== Q. Fair Value of Financial Instruments === |
|||
{{chunk|doc=3z7a4yrxkn|c=202|p=16}} |
|||
'''Fair value measurement framework''' |
|||
* Fair value for each class of financial instrument is estimated based on the framework established in fair value accounting guidance. |
|||
* This guidance requires maximizing observable inputs and minimizing unobservable inputs when measuring fair value. |
|||
* Fair value hierarchy disclosures are based on the quality of inputs used to measure fair value. |
|||
* The hierarchy prioritizes unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements). |
|||
* The hierarchy gives the lowest priority to unobservable inputs (Level 3 measurements). |
|||
* The Company uses widely recognized, third-party pricing sources to determine fair values of financial instruments. |
|||
* The Company understands the valuation methodologies and inputs of these third-party pricing sources. |
|||
* Further details regarding fair value disclosures are in Note 4. |
|||
=== R. Stock-Based Compensation === |
|||
{{chunk|doc=3z7a4yrxkn|c=203|p=16}} |
|||
'''Stock-based compensation accounting''' |
|||
* The estimated fair value of employee stock options and similar awards is expensed. |
|||
* Compensation cost for equity instrument awards to employees is measured based on the grant-date fair value and recognized over the service period until vesting. |
|||
* Tax effects related to share-based payments are made through net earnings. |
|||
* Further discussion and related disclosures regarding stock-based compensation are in note 18. |
|||
* The Company's employee stock purchase plan (ESPP) allows all employees to purchase common stock at a discount. |
|||
* Compensation cost for the ESPP is recognized on a straight-line basis over the offering period. |
|||
=== S. Earnings Per Share === |
|||
{{chunk|doc=3z7a4yrxkn|c=204|p=16}} |
|||
'''Basic EPS calculation''' |
|||
* Basic earnings per share is calculated using the two-class method. |
|||
* Undistributed earnings are allocated to participating securities based on their share in earnings as if all earnings for the period were distributed. |
|||
* Basic earnings per share is calculated by dividing net income attributable to common stockholders by the weighted-average number of common shares outstanding for the period. |
|||
* Common shares with unsatisfied contingencies, such as vesting requirements, are excluded from basic earnings per share. |
|||
* The Company’s preferred shares participate in [[Definition:Dividend|dividends]] and distributions with common stock on an as-converted basis and are considered a participating security. |
|||
* Instruments awarded to employees that provide the right to purchase common stock at a fixed price were included as potential common shares, weighted for the portion of the period they were granted, if dilutive. |
|||
* The Company’s common and preferred shares financed by stock notes are contingently issuable instruments where the holder must return shares if stock notes are not paid off. |
|||
* These contingently issuable instruments are excluded from basic and diluted earnings per share when specified conditions are not met, presuming the end of the period is the end of the contingency period. |
|||
* The impact of contingently issuable instruments on diluted earnings per share was calculated using the treasury stock method and included in the reconciliation of the denominator of basic and diluted EPS computations for the year ended December 31, 2024. |
|||
* All outstanding stock notes were settled during 2024, resulting in no impact to the Company’s basic and diluted earnings per share computations for the year ended December 31, 2024. |
|||
{{chunk|doc=3z7a4yrxkn|c=205|p=16}} |
|||
'''Diluted EPS calculation''' |
|||
* Instruments convertible into common shares are included in diluted weighted-average common shares outstanding on an if-converted basis, based on the legal conversion rate for the respective period, if dilutive. |
|||
* Share-based awards to employees with only service conditions are included as potential common shares, weighted for the portion of the period they are unvested, if dilutive. |
|||
* Share-based awards to employees with performance and service or market conditions are included as potential common shares, presuming the end of the period is the end of the contingency period, if dilutive. |
|||
* If the inclusion of common share adjustments increases earnings per share or reduces loss per share, the effect is anti-dilutive. |
|||
* In anti-dilutive cases, the diluted net earnings or net loss per share is computed excluding these common share equivalents. |
|||
=== T. Recent Accounting Pronouncements === |
|||
{{chunk|doc=3z7a4yrxkn|c=206|p=16}} |
|||
'''Recent accounting standards adopted''' |
|||
* In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures (Topic 740). |
|||
* ASU 2023-09 requires public companies to provide enhanced rate reconciliation disclosures annually, including specific categories and additional information meeting a quantitative threshold. |
|||
* This update also requires public companies to disaggregate income taxes paid by federal, state, and foreign taxes. |
|||
* The guidance became effective for fiscal years beginning after December 15, 2024, and is applied prospectively. |
|||
* The Company has added additional disclosures as required by ASU 2023-09, with no impact to the consolidated financial statements. |
|||
* Additional disclosures required by this ASU are detailed in Note 13. |
|||
{{chunk|doc=3z7a4yrxkn|c=207|p=16}} |
|||
'''Recent accounting standards not yet adopted''' |
|||
* In November 2024, the FASB issued ASU 2024-03, requiring disaggregated disclosure of income statement expenses for public business entities (PBEs). |
|||
* ASU 2024-03 does not change the expense captions presented on the face of the income statement but requires disaggregation of certain expense captions into specified categories in footnotes. |
|||
* PBEs must provide a tabular footnote disclosure about specific expenses, disaggregating each relevant income statement expense caption that includes any of the following natural expenses: (1) purchases of inventory, (2) employee compensation, (3) depreciation, (4) intangible asset amortization, and (5) depreciation, depletion, and amortization recognized as part of oil- and gas-producing activities or other types of depletion expenses. |
|||
* The tabular disclosure will also include certain other expenses, when applicable. |
|||
* In January 2025, the FASB issued ASU 2025-01 to clarify the effective date of ASU 2024-03. |
|||
* The effective date for ASU 2024-03 is the first annual reporting period beginning after December 15, [[Definition:Year 2026|2026]], and interim reporting periods within annual reporting periods beginning after December 15, 2027. |
|||
* The Company is evaluating the effect of these amendments on its consolidated financial statements. |
|||
=== 2. Goodwill and Intangible Assets === |
|||
{{chunk|doc=3z7a4yrxkn|c=208|p=16}} |
|||
'''Goodwill and intangible assets overview''' |
|||
* Tables present the carrying amount and changes in goodwill by reporting unit at December 31, 2025 and 2024. |
|||
* Tables present the carrying amount and changes in other intangible assets at December 31, 2025 and 2024. |
|||
{{chunk|doc=3z7a4yrxkn|c=209|p=16}} |
|||
'''Intangible assets useful life and amortization''' |
|||
* Indefinite-lived intangible assets relate to insurance licenses and trademarks. |
|||
* Finite-lived intangible assets relate to policy renewals, agency relationships, and non-compete/exclusivity agreements. |
|||
* Finite-lived intangible assets had a weighted average useful life of approximately 12 years as of December 31, 2025. |
|||
* Amortization expense recognized: USD 1.3m for 2025, USD 1.1m for 2024, and USD 1.5m for 2023. |
|||
* A table sets forth the estimated future net amortization expense of intangible assets. |
|||
{{chunk|doc=3z7a4yrxkn|c=210|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1032" class="wikitable fintable" |
||
|+ Net balance of goodwill by [[Definition:Business mix|line of business]] |
|||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Accident and Health |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Surety |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Construction and Energy Solutions |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Other |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Total |
||
|- |
|- |
||
! style="text-align:left" | Goodwill |
! style="text-align:left" | Goodwill |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Gross balance at December 31, 2024 |
| style="text-align:left" | Gross balance at December 31, 2024 |
||
| Line 3,887: | Line 4,742: | ||
| style="text-align:right" | ( 46,707 ) |
| style="text-align:right" | ( 46,707 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net balance at December 31, 2025</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>46,756</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>6,781</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>10,204</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,993</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>65,734</b> |
||
|} |
|} |
||
</div> |
</div> |
||
====== Goodwill by segment at December 31, 2024 ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1033" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Accident and Health |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Surety |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Construction and Energy Solutions |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Other |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Total |
||
|- |
|- |
||
! style="text-align:left" | Goodwill |
! style="text-align:left" | Goodwill |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Gross balance at December 31, 2023 |
| style="text-align:left" | Gross balance at December 31, 2023 |
||
| Line 3,928: | Line 4,782: | ||
| style="text-align:right" | ( 46,707 ) |
| style="text-align:right" | ( 46,707 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net balance at December 31, 2024</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>46,756</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>6,781</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>10,204</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,993</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>65,734</b> |
||
|} |
|} |
||
</div> |
</div> |
||
====== Other intangible assets at December 31, 2025 ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1034" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Agent Relationships |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Non-competes |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Trademarks |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Licenses |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Total |
||
|- |
|- |
||
! style="text-align:left" | Other Intangible Assets |
! style="text-align:left" | Other Intangible Assets |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Gross balance at December 31, 2024 |
| style="text-align:left" | Gross balance at December 31, 2024 |
||
| Line 3,983: | Line 4,836: | ||
| style="text-align:right" | ( 1,308 ) |
| style="text-align:right" | ( 1,308 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net balance at December 31, 2025</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>7,288</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>999</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>14,019</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>22,306</b> |
||
|} |
|} |
||
</div> |
</div> |
||
====== Other intangible assets at December 31, 2024 ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1035" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Agent Relationships |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Non-competes |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Trademarks |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Licenses |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Total |
||
|- |
|- |
||
! style="text-align:left" | Other Intangible Assets |
! style="text-align:left" | Other Intangible Assets |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Gross balance at December 31, 2023 |
| style="text-align:left" | Gross balance at December 31, 2023 |
||
| Line 4,031: | Line 4,883: | ||
| style="text-align:right" | ( 1,087 ) |
| style="text-align:right" | ( 1,087 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net balance at December 31, 2024</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>6,596</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>999</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>14,019</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>21,614</b> |
||
|} |
|} |
||
</div> |
</div> |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1036" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
|- |
|- |
||
! style="text-align:left" | Years Ending December 31, |
! style="text-align:left" | Years Ending December 31, |
||
! class="col-s" style="text-align:right" | Amount |
! class="col-s" style="text-align:right" | Amount |
||
|- |
|- |
||
| style="text-align:left" | 2026 |
| style="text-align:left" | [[Definition:Year 2026|2026]] |
||
| style="text-align:right" | 1,053 |
| style="text-align:right" | 1,053 |
||
|- |
|- |
||
| Line 4,065: | Line 4,918: | ||
</div> |
</div> |
||
=== 3. Investments === |
|||
{{chunk|doc=3z7a4yrxkn|c=211|p=16}} |
|||
* ''Fixed maturity securities, held-to-maturity'' at December 31, 2025, consisted entirely of asset-backed securities without a single maturity date <sup>p. 83</sup>. |
|||
'''Investment portfolio fair value and amortized cost''' |
|||
* At December 31, 2025, the Company had ''U.S. government agencies mortgage-backed fixed maturity securities'' with a carrying value of approximately $68.5 million pledged as collateral for a loan from the Federal Home Loan Bank of Dallas (FHLB Loan) <sup>p. 83</sup>. |
|||
* The Company retains all rights regarding the securities pledged for the FHLB Loan <sup>p. 83</sup>. |
|||
* At December 31, 2025, the Company had ''assets with fair values'' of approximately $69.5 million pledged as collateral for performance obligations under reinsurance agreements <sup>p. 83</sup>. |
|||
* The Company retains all rights regarding the securities pledged for reinsurance agreements <sup>p. 83</sup>. |
|||
* The ''pledged assets for reinsurance agreements'' included $57.8 million in residential mortgage-backed securities, $9.5 million in cash and cash equivalents and other assets, and $2.2 million in short-term investments <sup>p. 83</sup>. |
|||
* The Company monitors available-for-sale fixed maturity securities with fair values less than cost or amortized cost for impairment, which requires significant management judgment <sup>p. 83</sup>. |
|||
* As of December 31, 2025, the Company had ''450 lots of fixed maturity securities'' in an unrealized loss position <sup>p. 83</sup>. |
|||
* The Company does not intend to sell these securities and is not likely to be required to sell them before maturity or recovery of cost basis <sup>p. 83</sup>. |
|||
* At December 31, 2025, the Company identified ''credit impairments'' for two available-for-sale securities in the "corporate securities and miscellaneous" category due to deteriorating conditions <sup>p. 83</sup>. |
|||
* For ''U.S. government securities and municipal securities'', the decline in fair values was due to changes in interest rates, not credit quality <sup>p. 83</sup>. |
|||
* The Company does not intend to sell U.S. government and municipal securities and expects their anticipated recovery, thus not considering them impaired <sup>p. 83</sup>. |
|||
* For ''corporate securities and miscellaneous'', the decline in fair values was due to changes in interest rates, not credit quality <sup>p. 83</sup>. |
|||
* The Company reviewed issuers of corporate securities for adverse changes in financial condition, credit enhancement quality, ratings decreases, or payment failures <sup>p. 83</sup>. |
|||
* The Company determined that the decline in fair values for corporate securities was due to interest rates, not credit quality, and does not intend to sell them before anticipated recovery <sup>p. 83</sup>. |
|||
* For ''residential mortgage-backed securities, commercial mortgage-backed securities, and other asset-backed securities'', the decline in fair values was due to changes in interest rates, not credit quality <sup>p. 83</sup>. |
|||
* The Company does not intend to sell these mortgage-backed and asset-backed securities and expects their anticipated recovery, thus not considering them impaired <sup>p. 83</sup>. |
|||
* At December 31, 2025 and 2024, ''cash and investment securities on deposit'' with states had carrying values of approximately $70.0 million and $66.8 million, respectively <sup>p. 83</sup>. |
|||
* Tables present the amortized cost and fair value by investment category at December 31, 2025 and 2024. |
|||
* The amortized cost and estimated fair value of fixed maturity securities available for sale at December 31, 2025 are shown by contractual maturity. |
|||
* Expected maturities may differ from contractual maturities due to borrower rights to call or prepay obligations, and portfolio sales may occur prior to maturity due to changing interest rates, tax considerations, or other factors. |
|||
* The Company's held-to-maturity fixed maturity securities at December 31, 2025 consisted entirely of asset-backed securities not due at a single maturity date. |
|||
{{chunk|doc=3z7a4yrxkn|c=212|p=16}} |
|||
'''Pledged assets''' |
|||
* At December 31, 2025, the Company had U.S. government agencies mortgage-backed fixed maturity securities with a carrying value of approximately USD 68.5m pledged as collateral for a loan from the Federal Home Loan Bank of Dallas (FHLB). |
|||
* The Company retains all rights regarding these pledged securities in accordance with the terms of the FHLB Loan. |
|||
* At December 31, 2025, the Company had assets with fair values of approximately USD 69.5m pledged as collateral for performance obligations under reinsurance agreements. |
|||
* Pledged assets for reinsurance agreements included USD 57.8m in residential mortgage-backed securities, USD 9.5m in cash and cash equivalents and other assets, and USD 2.2m in short-term investments. |
|||
* The Company retains all rights regarding these securities in accordance with the terms of the trust agreements. |
|||
{{chunk|doc=3z7a4yrxkn|c=213|p=16}} |
|||
'''Unrealized losses and impairment assessment''' |
|||
* Tables set forth gross unrealized losses and corresponding fair values of investments, aggregated by length of time in a continuous unrealized loss position as of December 31, 2025 and 2024. |
|||
* The Company monitors available-for-sale fixed maturity securities with fair values less than cost or amortized cost for impairment, which requires significant management judgment. |
|||
* Management considers factors such as the financial condition of the issuer, receipt of scheduled principal and interest cash flows, and intent to sell (including likelihood of being required to sell before recovery) for fixed maturity securities. |
|||
* As of December 31, 2025, the Company had 450 lots of fixed maturity securities in an unrealized loss position. |
|||
* The Company does not intend to sell these securities and is not likely to be required to sell them before maturity or recovery of cost basis. |
|||
* At December 31, 2025, the Company determined that credit impairments existed for two available-for-sale securities in the "corporate securities and miscellaneous" category, based on new recovery analysis showing deteriorating conditions. |
|||
* For U.S. government and municipal securities, the decline in fair values was due to changes in interest rates, not credit quality. |
|||
* The Company does not intend to sell U.S. government and municipal securities and expects recovery, thus not considering them impaired. |
|||
* For corporate securities and miscellaneous, the decline in fair values was due to changes in interest rates, not credit quality. |
|||
* The Company reviewed issuers of corporate securities for significant adverse changes in financial condition, credit enhancement quality, ratings decreases, negative outlooks, or payment failures, and determined declines were interest rate-driven. |
|||
* The Company does not intend to sell corporate securities and expects recovery, thus not considering them impaired. |
|||
* For residential mortgage-backed, commercial mortgage-backed, and other asset-backed securities, the decline in fair values was due to changes in interest rates, not credit quality. |
|||
* The Company does not intend to sell these mortgage-backed and asset-backed securities and expects recovery, thus not considering them impaired. |
|||
{{chunk|doc=3z7a4yrxkn|c=214|p=16}} |
|||
'''Allowance for credit losses''' |
|||
* A table sets forth changes in the allowance for credit losses on available-for-sale and held-to-maturity securities for the years ended December 31, 2025 and 2024. |
|||
{{chunk|doc=3z7a4yrxkn|c=215|p=16}} |
|||
'''Net investment gains''' |
|||
* A table sets forth the components of net investment gains for the years ended December 31, 2025, 2024, and 2023. |
|||
{{chunk|doc=3z7a4yrxkn|c=216|p=16}} |
|||
'''Proceeds from sales of securities''' |
|||
* A table sets forth the proceeds from sales of available-for-sale fixed maturity securities and equity securities for the years ended December 31, 2025, 2024, and 2023. |
|||
{{chunk|doc=3z7a4yrxkn|c=217|p=16}} |
|||
'''[[Definition:Net investment income|Net investment income]]''' |
|||
* A table sets forth the components of [[Definition:Net investment income|net investment income]] for the years ended December 31, 2025, 2024, and 2023. |
|||
{{chunk|doc=3z7a4yrxkn|c=218|p=16}} |
|||
'''Net unrealized gains''' |
|||
* A table sets forth the change in net unrealized gains on the Company’s investment portfolio, net of deferred income taxes, included in other comprehensive loss for the years ended December 31, 2025, 2024, and 2023. |
|||
{{chunk|doc=3z7a4yrxkn|c=219|p=16}} |
|||
'''Regulatory deposits''' |
|||
* Various state regulations require the Company to maintain cash, investment securities, or letters of credit on deposit with the states in a depository account. |
|||
* At December 31, 2025, cash and investment securities on deposit had carrying values of approximately USD 70.0m. |
|||
* At December 31, 2024, cash and investment securities on deposit had carrying values of approximately USD 66.8m. |
|||
{{chunk|doc=3z7a4yrxkn|c=220|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1037" class="wikitable fintable" |
||
|+ 3. Investments |
|||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Amortized Cost |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Gross Unrealized Gains |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Gross Unrealized Losses |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Allowance for Credit Losses |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Fair Value |
||
|- |
|- |
||
! style="text-align:left" | December 31, 2025 |
! style="text-align:left" | December 31, 2025 |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
|- |
|- |
||
! style="text-align:left" | Fixed maturity securities, available-for-sale: |
! style="text-align:left" | Fixed maturity securities, available-for-sale: |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | U.S. government securities |
| style="text-align:left" | U.S. government securities |
||
| Line 4,153: | Line 5,055: | ||
| style="text-align:right" | 513,695 |
| style="text-align:right" | 513,695 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total fixed maturity securities, available-for-sale |
||
| style="text-align:right" | |
| style="text-align:right" | 1,848,755 |
||
| style="text-align:right" | |
| style="text-align:right" | 31,378 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 16,830 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 7,000 ) |
||
| style="text-align:right" | |
| style="text-align:right" | 1,856,303 |
||
|- |
|||
| style="text-align:left" | <b>Fixed maturity securities, held-to-maturity:</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Other asset-backed securities |
| style="text-align:left" | Other asset-backed securities |
||
| Line 4,167: | Line 5,076: | ||
| style="text-align:right" | 33,603 |
| style="text-align:right" | 33,603 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total fixed maturity securities, held-to-maturity |
||
| style="text-align:right" | |
| style="text-align:right" | 33,290 |
||
| style="text-align:right" | |
| style="text-align:right" | 829 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 48 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 468 ) |
||
| style="text-align:right" | |
| style="text-align:right" | 33,603 |
||
|} |
|} |
||
</div> |
</div> |
||
====== Fixed maturity securities at December 31, 2024 ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1038" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Amortized Cost |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Gross Unrealized Gains |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Gross Unrealized Loss |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Allowance for Credit Losses |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Fair Value |
||
|- |
|- |
||
! style="text-align:left" | December 31, 2024 |
! style="text-align:left" | December 31, 2024 |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
|- |
|- |
||
! style="text-align:left" | Fixed maturity securities, available-for-sale: |
! style="text-align:left" | Fixed maturity securities, available-for-sale: |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | U.S. government securities |
| style="text-align:left" | U.S. government securities |
||
| Line 4,243: | Line 5,151: | ||
| style="text-align:right" | 292,191 |
| style="text-align:right" | 292,191 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total fixed maturity securities, available-for-sale |
||
| style="text-align:right" | |
| style="text-align:right" | 1,320,266 |
||
| style="text-align:right" | |
| style="text-align:right" | 10,636 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 38,684 ) |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 1,292,218 |
||
|- |
|||
| style="text-align:left" | <b>Fixed maturity securities, held-to-maturity:</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Other asset-backed securities |
| style="text-align:left" | Other asset-backed securities |
||
| Line 4,257: | Line 5,172: | ||
| style="text-align:right" | 38,717 |
| style="text-align:right" | 38,717 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total fixed maturity securities, held-to-maturity |
||
| style="text-align:right" | |
| style="text-align:right" | 39,396 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | ( 436 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 243 ) |
||
| style="text-align:right" | |
| style="text-align:right" | 38,717 |
||
|} |
|} |
||
</div> |
</div> |
||
====== Maturity distribution of fixed maturity securities ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1039" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col-s" style="text-align:right" | Amortized Cost |
! class="col-s" style="text-align:right" | Amortized Cost |
||
| Line 4,298: | Line 5,212: | ||
| style="text-align:right" | 513,695 |
| style="text-align:right" | 513,695 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total |
||
| style="text-align:right" | |
| style="text-align:right" | 1,848,755 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,856,303 |
||
|} |
|} |
||
</div> |
</div> |
||
====== Fixed maturity securities, available-for-sale, by maturity at December 31, 2025 ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1040" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | Less than 12 Months |
! colspan="2" style="text-align:center" | Less than 12 Months |
||
| Line 4,314: | Line 5,227: | ||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Fair Value |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Gross Unrealized Losses |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Fair Value |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Gross Unrealized Losses |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Fair Value |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Gross Unrealized Losses |
||
|- |
|- |
||
! style="text-align:left" | December 31, 2025 |
! style="text-align:left" | December 31, 2025 |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
|- |
|- |
||
! style="text-align:left" | Fixed maturity securities, available-for-sale: |
! style="text-align:left" | Fixed maturity securities, available-for-sale: |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | U.S. government securities |
| style="text-align:left" | U.S. government securities |
||
| Line 4,385: | Line 5,298: | ||
| style="text-align:right" | ( 1,353 ) |
| style="text-align:right" | ( 1,353 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total fixed maturity securities, available-for-sale |
||
| style="text-align:right" | |
| style="text-align:right" | 233,041 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 1,436 ) |
||
| style="text-align:right" | |
| style="text-align:right" | 185,663 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 15,394 ) |
||
| style="text-align:right" | |
| style="text-align:right" | 418,704 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 16,830 ) |
||
|- |
|||
| style="text-align:left" | <b>Fixed maturity securities, held-to-maturity:</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Other asset-backed securities |
| style="text-align:left" | Other asset-backed securities |
||
| Line 4,401: | Line 5,322: | ||
| style="text-align:right" | ( 48 ) |
| style="text-align:right" | ( 48 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total fixed maturity securities, held-to-maturity: |
||
| style="text-align:right" | |
| style="text-align:right" | 1,912 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 48 ) |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 1,912 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 48 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total |
||
| style="text-align:right" | |
| style="text-align:right" | 234,953 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 1,484 ) |
||
| style="text-align:right" | |
| style="text-align:right" | 185,663 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 15,394 ) |
||
| style="text-align:right" | |
| style="text-align:right" | 420,616 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 16,878 ) |
||
|} |
|} |
||
</div> |
</div> |
||
====== Fixed maturity securities, available-for-sale, by maturity at December 31, 2024 ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1041" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | Less than 12 Months |
! colspan="2" style="text-align:center" | Less than 12 Months |
||
| Line 4,429: | Line 5,349: | ||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Fair Value |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Gross Unrealized Losses |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Fair Value |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Gross Unrealized Losses |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Fair Value |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Gross Unrealized Losses |
||
|- |
|- |
||
! style="text-align:left" | December 31, 2024 |
! style="text-align:left" | December 31, 2024 |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
! style="text-align: |
! class="col-s" style="text-align:right" | |
||
|- |
|- |
||
! style="text-align:left" | Fixed maturity securities, available-for-sale: |
! style="text-align:left" | Fixed maturity securities, available-for-sale: |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | U.S. government securities |
| style="text-align:left" | U.S. government securities |
||
| Line 4,500: | Line 5,420: | ||
| style="text-align:right" | ( 1,834 ) |
| style="text-align:right" | ( 1,834 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total fixed maturity securities, available-for-sale |
||
| style="text-align:right" | |
| style="text-align:right" | 480,693 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 7,353 ) |
||
| style="text-align:right" | |
| style="text-align:right" | 236,741 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 31,331 ) |
||
| style="text-align:right" | |
| style="text-align:right" | 717,434 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 38,684 ) |
||
|- |
|||
| style="text-align:left" | <b>Fixed maturity securities, held-to-maturity:</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Other asset-backed securities |
| style="text-align:left" | Other asset-backed securities |
||
| Line 4,516: | Line 5,444: | ||
| style="text-align:right" | ( 436 ) |
| style="text-align:right" | ( 436 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total fixed maturity securities, held-to-maturity: |
||
| style="text-align:right" | |
| style="text-align:right" | 2,144 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 2 ) |
||
| style="text-align:right" | |
| style="text-align:right" | 36,573 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 434 ) |
||
| style="text-align:right" | |
| style="text-align:right" | 38,717 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 436 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total |
||
| style="text-align:right" | |
| style="text-align:right" | 482,837 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 7,355 ) |
||
| style="text-align:right" | |
| style="text-align:right" | 273,314 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 31,765 ) |
||
| style="text-align:right" | |
| style="text-align:right" | 756,151 |
||
| style="text-align:right" | |
| style="text-align:right" | ( 39,120 ) |
||
|} |
|} |
||
</div> |
</div> |
||
====== Allowance for credit losses on fixed maturity securities at December 31, 2025 ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1042" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Fixed Maturity Securities, Available-For-Sale |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Fixed Maturity Securities, Held-to-Maturity |
||
|- |
|- |
||
! style="text-align:left" | Balance at December 31, 2024 |
! style="text-align:left" | Balance at December 31, 2024 |
||
! class="col- |
! class="col-m" style="text-align:right" | — |
||
! class="col-s" style="text-align:right" | 243 |
! class="col-s" style="text-align:right" | 243 |
||
|- |
|- |
||
| Line 4,554: | Line 5,481: | ||
| style="text-align:right" | ( 32 ) |
| style="text-align:right" | ( 32 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Balance at December 31, 2025</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>7,000</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>468</b> |
||
|} |
|} |
||
</div> |
</div> |
||
====== Allowance for credit losses on fixed maturity securities at December 31, 2024 ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1043" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | — |
|||
! style="text-align:left" | |
|||
! class="col-s" style="text-align:right" | Fixed Maturity Securities, Held-to-Maturity |
! class="col-s" style="text-align:right" | Fixed Maturity Securities, Held-to-Maturity |
||
|- |
|- |
||
| Line 4,576: | Line 5,502: | ||
| style="text-align:right" | ( 104 ) |
| style="text-align:right" | ( 104 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Balance at December 31, 2024</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>243</b> |
||
|} |
|} |
||
</div> |
</div> |
||
====== Gross realized gains and losses on investments ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1044" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2025 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2024 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2023 |
||
|- |
|- |
||
! style="text-align:left" | Gross realized gains |
! style="text-align:left" | Gross realized gains |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Fixed maturity securities, available-for-sale |
| style="text-align:left" | Fixed maturity securities, available-for-sale |
||
| Line 4,610: | Line 5,535: | ||
| style="text-align:right" | 2 |
| style="text-align:right" | 2 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total |
||
| style="text-align:right" | |
| style="text-align:right" | 37,949 |
||
| style="text-align:right" | |
| style="text-align:right" | 10,937 |
||
| style="text-align:right" | |
| style="text-align:right" | 7,079 |
||
|- |
|||
| style="text-align:left" | <b>Gross realized losses</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Fixed maturity securities, available-for-sale |
| style="text-align:left" | Fixed maturity securities, available-for-sale |
||
| Line 4,630: | Line 5,560: | ||
| style="text-align:right" | ( 20 ) |
| style="text-align:right" | ( 20 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total |
||
| style="text-align:right" | |
| style="text-align:right" | ( 14,245 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 12,516 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 7,155 ) |
||
|- |
|||
| style="text-align:left" | <b>Net unrealized gains (losses) on investments</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Equity securities |
| style="text-align:left" | Equity securities |
||
| Line 4,650: | Line 5,585: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| class="wt-indent-1" style="text-align:left" | |
| class="wt-indent-1" style="text-align:left" | <b>Net investment gains</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>22,149</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>6,342</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>11,054</b> |
||
|} |
|} |
||
</div> |
</div> |
||
====== Net investment income ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1045" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col-s" style="text-align:right" | 2025 |
! class="col-s" style="text-align:right" | 2025 |
||
| Line 4,677: | Line 5,611: | ||
|} |
|} |
||
</div> |
</div> |
||
====== Deferred income taxes ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1046" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2025 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2024 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2023 |
||
|- |
|- |
||
! style="text-align:left" | Income (loss): |
! style="text-align:left" | Income (loss): |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Fixed maturity securities, available-for-sale |
| style="text-align:left" | Fixed maturity securities, available-for-sale |
||
| Line 4,732: | Line 5,665: | ||
| style="text-align:right" | 318 |
| style="text-align:right" | 318 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total investment income |
||
| style="text-align:right" | |
| style="text-align:right" | 87,666 |
||
| style="text-align:right" | |
| style="text-align:right" | 87,513 |
||
| style="text-align:right" | |
| style="text-align:right" | 45,897 |
||
|- |
|- |
||
| style="text-align:left" | Investment expenses |
| style="text-align:left" | Investment expenses |
||
| Line 4,742: | Line 5,675: | ||
| style="text-align:right" | ( 5,557 ) |
| style="text-align:right" | ( 5,557 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>[[Definition:Net investment income|Net investment income]]</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>83,619</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>80,600</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>40,340</b> |
||
|} |
|} |
||
</div> |
</div> |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1047" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col-s" style="text-align:right" | 2025 |
! class="col-s" style="text-align:right" | 2025 |
||
| Line 4,766: | Line 5,700: | ||
| style="text-align:right" | ( 5,420 ) |
| style="text-align:right" | ( 5,420 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total |
||
| style="text-align:right" | |
| style="text-align:right" | 33,577 |
||
| style="text-align:right" | |
| style="text-align:right" | 833 |
||
| style="text-align:right" | |
| style="text-align:right" | 20,532 |
||
|} |
|} |
||
</div> |
</div> |
||
=== 4. Fair Value Measurements === |
|||
{{chunk|doc=3z7a4yrxkn|c=221|p=16}} |
|||
'''4. Fair Value Measurements''' |
|||
* The Company's financial instruments include assets and liabilities carried at fair value, and |
* The Company's financial instruments include assets and liabilities carried at fair value, and assets and liabilities carried at cost or amortized cost but disclosed at fair value. |
||
* The market approach is generally applied to determine fair value, using prices and data from market transactions |
* The market approach is generally applied to determine fair value, using prices and data from market transactions involving identical or comparable assets and liabilities. |
||
* Fair value of investments is |
* Fair value of investments is determined using data primarily from third-party investment managers or pricing vendors. |
||
* Periodic analyses are |
* Periodic analyses are performed on third-party prices to ensure they are reasonable estimates of fair value, including reviewing month-to-month fluctuations and comparing valuations from different pricing services for identical securities. |
||
* Financial instruments are classified into a three-level hierarchy |
* Financial instruments are classified into a three-level hierarchy. |
||
* |
* Level 1 inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date. |
||
* |
* Level 2 inputs are observable for the asset or liability through corroboration with market data at the measurement date, other than Level 1 quoted prices. |
||
* |
* Level 3 inputs are unobservable inputs reflecting management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. |
||
* Methods and assumptions used for fair value disclosures are detailed in the consolidated financial statements and notes. |
|||
* ''U.S. government securities, mutual funds, and common stock'' use unadjusted quoted prices from active exchanges, representing Level 1 inputs <sup>p. 84</sup>. |
|||
* U.S. government securities, mutual funds, and common stock: fair value is measured using unadjusted quoted prices for identical instruments in an active exchange, representing Level 1 inputs. |
|||
* ''Preferred stocks, municipal securities, corporate securities, and miscellaneous'' use a pricing model with market-based inputs like trades in illiquid markets or active markets for similar securities, considering benchmark yields, issuer spreads, security terms, and other market data, representing Level 2 fair value inputs <sup>p. 84</sup>. |
|||
* |
* Preferred stocks, municipal securities, corporate securities, and miscellaneous: fair value is measured using a pricing model with market-based inputs such as trades in illiquid markets for specific securities or active markets for similar securities. |
||
* |
* The pricing model for preferred, municipal, corporate, and miscellaneous securities considers benchmark yields, issuer spreads, security terms and conditions, and other market data, representing Level 2 fair value inputs. |
||
* Commercial mortgage-backed securities, residential mortgage-backed securities, and other asset-backed securities: fair value is measured using a pricing model with market-based inputs including dealer quotes, market spreads, and yield curves. |
|||
* The independent pricing provider estimates the value of Level 3 fixed maturity securities using the discount net present value of cash flows method with an unobservable discount rate <sup>p. 84</sup>. |
|||
* The model for mortgage-backed and other asset-backed securities may evaluate individual tranches by determining cash flows using security terms, collateral performance, credit information, benchmark yields, and estimated prepayments, representing Level 2 fair value inputs. |
|||
* The ''discount rate spread'' for Level 3 fixed maturity securities represents the risk associated with future cash flows, including inflation, opportunity cost, and the time value of money <sup>p. 84</sup>. |
|||
* Fixed maturity securities, available for sale classified as Level 3: includes corporate securities and other asset-backed securities managed by an independent asset manager and priced by an independent provider. |
|||
* ''Mortgage loans'' have variable interest rates and are collateralized by real property <sup>p. 84</sup>. |
|||
* The provider estimates the value of these securities using the discount net present value of cash flows method with an unobservable discount rate. |
|||
* Fair value of mortgage loans is determined using the income approach with observable and unobservable (Level 3) inputs <sup>p. 84</sup>. |
|||
* The discount rate spread represents the risk associated with future cash flows, including inflation, opportunity cost, and the time value of money, representing Level 3 fair value inputs. |
|||
* The ''unobservable input'' for mortgage loans is the spread applied to a prime rate for discounting cash flows, representing the incremental cost of capital based on borrower's ability to pay and collateral value relative to the loan balance, subject to judgment and uncertainty <sup>p. 84</sup>. |
|||
* Mortgage loans have variable interest rates and are collateralized by real property. |
|||
* ''Derivatives'' included in other assets consist of exchange-traded options contracts <sup>p. 84</sup>. |
|||
* Fair value of mortgage loans is determined using the income approach with observable and unobservable (Level 3) inputs. |
|||
* Fair values of derivatives are measured using quoted prices in active markets on the relevant exchange, specifically the volume-weighted average price of trades in similar contracts or the last trade settlement price if no trades occur, representing Level 1 inputs <sup>p. 84</sup>. |
|||
* The unobservable input is the spread applied to a prime rate used to discount cash flows. |
|||
* Certain assets, including investments in indirect loans and loan collateral, equity method investments, and other invested assets, are measured at fair value on a nonrecurring basis only when impaired <sup>p. 84</sup>. |
|||
* This spread represents the incremental cost of capital based on the borrower’s ability to make future payments and the value of collateral relative to the loan balance, and is subject to judgment and uncertainty. |
|||
* The Company is required to disclose fair values of other financial instruments for which estimation is practicable <sup>p. 84</sup>. |
|||
* Derivatives, included in other assets, consist of certain exchange-traded options contracts. |
|||
* Estimated fair value amounts are defined as the quoted market price of a financial instrument, determined using available market information and valuation methodologies <sup>p. 84</sup>. |
|||
* Fair values of these options are measured using quoted prices in active markets on the relevant exchange. |
|||
* Considerable judgments are required for fair value estimates when quoted market prices are unavailable, meaning estimates may not indicate realizable amounts in a current market exchange <sup>p. 84</sup>. |
|||
* The measurement specifically utilizes either the volume-weighted average price of trades in similar contracts during a specified time window or the last trade settlement price when no trades occur, representing Level 1 inputs. |
|||
* Different market assumptions or estimation methodologies can affect estimated fair value amounts <sup>p. 84</sup>. |
|||
* Tables set forth the Company’s investments and derivatives within the fair value hierarchy as of December 31, 2025 and 2024. |
|||
* ''Fixed maturity securities, held-to-maturity'', consist of senior and junior notes with target rates of return <sup>p. 84</sup>. |
|||
* Tables also set forth changes in the fair value of instruments carried at fair value with a Level 3 measurement for the years ended December 31, 2025 and 2024. |
|||
* As of December 31, 2025, the fair value of held-to-maturity fixed maturity securities was determined using the income approach with unobservable (Level 3) inputs <sup>p. 84</sup>. |
|||
* The Company measures certain assets, including investments in indirect loans and loan collateral, equity method investments, and other invested assets, at fair value on a nonrecurring basis only when deemed impaired. |
|||
* ''Investment in RedBird Capital Partners'' is included in other long-term investments and is a limited partnership that invests in Bishop Street Underwriters, LLC (MGA) <sup>p. 84</sup>. |
|||
* The Company is required to disclose fair values of other financial instruments where practicable to estimate fair value, in addition to those recorded at fair value in the Consolidated Balance Sheets. |
|||
* The investment in RedBird Capital Partners had a ''fair value'' of $55.6 million at December 31, 2025, and $28.2 million at December 31, 2024, determined using the net asset value <sup>p. 84</sup>. |
|||
* Estimated fair value amounts, defined as the quoted market price, are determined using available market information and appropriate valuation methodologies. |
|||
* Procedures are employed to assess the reasonableness of the fair value of this investment, including reviewing audited financial statements <sup>p. 84</sup>. |
|||
* Considerable judgment is required for fair value estimates when quoted market prices are unavailable, meaning estimates may not indicate amounts realizable in a current market exchange. |
|||
* The ''unfunded commitment'' related to the RedBird Capital Partners investment was $18.3 million at December 31, 2025, and $24.4 million at December 31, 2024 <sup>p. 84</sup>. |
|||
* Different market assumptions or estimation methodologies can affect estimated fair value amounts. |
|||
* The Company may sell its interest in the investment with prior written notice and general partner approval <sup>p. 84</sup>. |
|||
* Methods and assumptions used for estimating fair value disclosures of other financial instruments are provided. |
|||
* This investment is measured at fair value using the net asset value per share practical expedient and is not classified in the fair value hierarchy, in accordance with Accounting Standard Codification 820-10 <sup>p. 84</sup>. |
|||
* Fixed maturity securities, held-to-maturity: consists of senior and junior notes with target rates of return. |
|||
* ''Net earned premiums'' related to this agreement were $41.5 million for the year ended December 31, 2025, and $2.5 million for the year ended December 31, 2024 <sup>p. 84</sup>. |
|||
* As of December 31, 2025, fair value for these instruments was determined using the income approach with unobservable (Level 3) inputs. |
|||
* ''Notes payable'' carrying value approximates estimated fair value because they accrue interest at current market rates plus a spread <sup>p. 84</sup>. |
|||
* Investment in RedBird Capital Partners: included in other long-term investments, this is a limited partnership investment in Bishop Street Underwriters, LLC (MGA). |
|||
* Fair value of notes payable is determined using the income approach with observable (Level 2) inputs <sup>p. 84</sup>. |
|||
* The investment had a fair value of USD 55.6m at December 31, 2025, and USD 28.2m at December 31, 2024, determined using net asset value. |
|||
* ''Subordinated debt'' consists of Unsecured Subordinated Notes due May 24, 2039, with a fixed interest rate <sup>p. 84</sup>. |
|||
* Procedures to assess reasonableness of fair value include obtaining and reviewing audited financial statements. |
|||
* Fair value of subordinated debt is determined using the income approach with observable (Level 2) inputs <sup>p. 84</sup>. |
|||
* The unfunded commitment related to the investment was USD 18.3m at December 31, 2025, and USD 24.4m at December 31, 2024. |
|||
* Other financial instruments qualify as insurance-related products and are specifically exempted from fair value disclosure requirements <sup>p. 84</sup>. |
|||
* The Company may sell its interest with appropriate prior written notice and general partner approval. |
|||
* This investment is measured at fair value using the net asset value per share practical expedient per Accounting Standard Codification 820-10 and is not classified in the fair value hierarchy. |
|||
* Net earned premiums related to this agreement were USD 41.5m for the year ended December 31, 2025, and USD 2.5m for the year ended December 31, 2024. |
|||
* Notes payable: carrying value approximates estimated fair value because notes accrue interest at current market rates plus a spread. |
|||
* Fair value is determined using the income approach with observable (Level 2) inputs. |
|||
* Subordinated debt: consists of Unsecured Subordinated Notes, due May 24, 2039, with a fixed interest rate. |
|||
* Fair value is determined using the income approach with observable (Level 2) inputs. |
|||
* A table sets forth the Company’s carrying and fair values of notes payable and subordinated debt as of December 31, 2025 and 2024. |
|||
* Other financial instruments qualify as insurance-related products and are specifically exempted from fair value disclosure requirements. |
|||
{{chunk|doc=3z7a4yrxkn|c=222|p=16}} |
|||
====== Fair value of subordinated debt ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1048" class="wikitable fintable" |
||
|+ 4. Fair Value Measurements |
|||
! style="text-align:left" | — |
|||
|- |
|||
! style="text-align:left" | |
|||
! class="col-s" style="text-align:right" | 2025 |
! class="col-s" style="text-align:right" | 2025 |
||
! class="col-s" style="text-align:right" | 2024 |
! class="col-s" style="text-align:right" | 2024 |
||
| Line 4,835: | Line 5,783: | ||
|} |
|} |
||
</div> |
</div> |
||
====== Weighted average interest rates ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1049" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | — |
|||
! style="text-align:left" | |
|||
! class="col-s" style="text-align:right" | 2025 |
! class="col-s" style="text-align:right" | 2025 |
||
! class="col-s" style="text-align:right" | 2024 |
! class="col-s" style="text-align:right" | 2024 |
||
| Line 4,857: | Line 5,804: | ||
|} |
|} |
||
</div> |
</div> |
||
====== Fixed maturity securities as of December 31, 2025 ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1050" class="wikitable fintable" |
||
|- |
|||
! colspan="5" style="text-align:center" | December 31, 2025 |
! colspan="5" style="text-align:center" | December 31, 2025 |
||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Level 1 |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Level 2 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Level 3 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Total |
||
|- |
|- |
||
! style="text-align:left" | Fixed maturity securities, available-for-sale: |
! style="text-align:left" | Fixed maturity securities, available-for-sale: |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | U.S. government securities |
| style="text-align:left" | U.S. government securities |
||
| Line 4,912: | Line 5,858: | ||
| style="text-align:right" | 513,695 |
| style="text-align:right" | 513,695 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total fixed maturity securities, available-for-sale |
||
| style="text-align:right" | |
| style="text-align:right" | 44,468 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,660,918 |
||
| style="text-align:right" | |
| style="text-align:right" | 150,917 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,856,303 |
||
|- |
|||
| style="text-align:left" | <b>Fixed maturity securities, held-to-maturity:</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Other asset-backed securities |
| style="text-align:left" | Other asset-backed securities |
||
| Line 4,924: | Line 5,876: | ||
| style="text-align:right" | 33,603 |
| style="text-align:right" | 33,603 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total fixed maturity securities, held-to-maturity |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 33,603 |
||
| style="text-align:right" | |
| style="text-align:right" | 33,603 |
||
|- |
|||
| style="text-align:left" | <b>Equity securities:</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Preferred stocks |
| style="text-align:left" | Preferred stocks |
||
| Line 4,936: | Line 5,894: | ||
| style="text-align:right" | 1,174 |
| style="text-align:right" | 1,174 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total equity securities |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 1,174 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 1,174 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Mortgage loans</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>9,902</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>9,902</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Short-term investments</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>264,299</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>264,299</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Derivatives</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>34,857</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>34,857</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total |
||
| style="text-align:right" | |
| style="text-align:right" | 343,624 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,662,092 |
||
| style="text-align:right" | |
| style="text-align:right" | 194,422 |
||
| style="text-align:right" | |
| style="text-align:right" | 2,200,138 |
||
|} |
|} |
||
</div> |
</div> |
||
====== Fixed maturity securities as of December 31, 2024 ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1051" class="wikitable fintable" |
||
|- |
|||
! colspan="5" style="text-align:center" | December 31, 2024 |
! colspan="5" style="text-align:center" | December 31, 2024 |
||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Level 1 |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Level 2 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Level 3 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Total |
||
|- |
|- |
||
! style="text-align:left" | Fixed maturity securities, available-for-sale: |
! style="text-align:left" | Fixed maturity securities, available-for-sale: |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | U.S. government securities |
| style="text-align:left" | U.S. government securities |
||
| Line 5,022: | Line 5,979: | ||
| style="text-align:right" | 292,191 |
| style="text-align:right" | 292,191 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total fixed maturity securities, available-for-sale |
||
| style="text-align:right" | |
| style="text-align:right" | 26,486 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,187,812 |
||
| style="text-align:right" | |
| style="text-align:right" | 77,920 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,292,218 |
||
|- |
|||
| style="text-align:left" | <b>Fixed maturity securities, held-to-maturity:</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Other asset-backed securities |
| style="text-align:left" | Other asset-backed securities |
||
| Line 5,034: | Line 5,997: | ||
| style="text-align:right" | 38,717 |
| style="text-align:right" | 38,717 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total fixed maturity securities, held-to-maturity: |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 38,717 |
||
| style="text-align:right" | |
| style="text-align:right" | 38,717 |
||
|- |
|||
| style="text-align:left" | <b>Equity securities:</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Common stocks |
| style="text-align:left" | Common stocks |
||
| Line 5,058: | Line 6,027: | ||
| style="text-align:right" | 40,839 |
| style="text-align:right" | 40,839 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total equity securities |
||
| style="text-align:right" | |
| style="text-align:right" | 105,090 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,164 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 106,254 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Mortgage loans</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>26,490</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>26,490</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Short-term investments</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>274,929</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>274,929</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total |
||
| style="text-align:right" | |
| style="text-align:right" | 406,505 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,188,976 |
||
| style="text-align:right" | |
| style="text-align:right" | 143,127 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,738,608 |
||
|} |
|} |
||
</div> |
</div> |
||
====== Changes in fair value of fixed maturity securities and mortgage loans in 2025 ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1052" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | Fixed Maturity Securities, Available-For-Sale |
||
! class="col- |
! class="col-m" style="text-align:right" | Mortgage Loans |
||
|- |
|- |
||
| style="text-align:left" | Balance at December 31, 2024 |
| style="text-align:left" | Balance at December 31, 2024 |
||
| Line 5,096: | Line 6,064: | ||
| style="text-align:right" | 26,490 |
| style="text-align:right" | 26,490 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total gains (losses) for the period recognized in net investment gains (losses) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 5,180 ) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 7 ) |
||
|- |
|- |
||
| style="text-align:left" | Issuances |
| style="text-align:left" | Issuances |
||
| Line 5,120: | Line 6,088: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total unrealized gains for the period recognized in accumulated comprehensive income (loss) |
||
| style="text-align:right" | |
| style="text-align:right" | 2,797 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Balance at December 31, 2025</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>150,917</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>9,902</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total losses for the period recognized in net investment gains attributable to the change in unrealized gains or losses relating to assets held as of period end |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | ( 201 ) |
||
|} |
|} |
||
</div> |
</div> |
||
====== Changes in fair value of fixed maturity securities and mortgage loans in 2024 ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1053" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | Fixed Maturity Securities, Available-For-Sale |
||
! class="col- |
! class="col-m" style="text-align:right" | Mortgage Loans |
||
|- |
|- |
||
| style="text-align:left" | Balance at December 31, 2023 |
| style="text-align:left" | Balance at December 31, 2023 |
||
| Line 5,146: | Line 6,113: | ||
| style="text-align:right" | 50,070 |
| style="text-align:right" | 50,070 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total gains (losses) for the period recognized in net investment gains (losses) |
||
| style="text-align:right" | |
| style="text-align:right" | ( 195 ) |
||
| style="text-align:right" | |
| style="text-align:right" | 420 |
||
|- |
|- |
||
| style="text-align:left" | Issuances |
| style="text-align:left" | Issuances |
||
| Line 5,166: | Line 6,133: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total unrealized gains for the period recognized in accumulated comprehensive income (loss) |
||
| style="text-align:right" | |
| style="text-align:right" | 510 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Balance at December 31, 2024</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>77,920</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>26,490</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total gains for the period recognized in net investment gains (losses) attributable to the change in unrealized gains or losses relating to assets held as of period end |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 411 |
||
|} |
|} |
||
</div> |
</div> |
||
====== Notes payable and subordinated debt ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1054" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | 2025 |
! colspan="2" style="text-align:center" | 2025 |
||
| Line 5,189: | Line 6,155: | ||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Carrying Value |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Fair Value |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Carrying Value |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Fair Value |
||
|- |
|- |
||
! style="text-align:left" | Notes payable |
! style="text-align:left" | Notes payable |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | FHLB Loan |
| style="text-align:left" | FHLB Loan |
||
| Line 5,218: | Line 6,184: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Notes payable</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>471,500</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>471,958</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>100,000</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>99,200</b> |
||
|- |
|||
| style="text-align:left" | <b>Subordinated debt</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Unsecured subordinated notes |
| style="text-align:left" | Unsecured subordinated notes |
||
| Line 5,230: | Line 6,202: | ||
| style="text-align:right" | 20,541 |
| style="text-align:right" | 20,541 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Subordinated debt, net of debt issuance costs</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>19,569</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>21,020</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>19,536</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>20,541</b> |
||
|} |
|} |
||
</div> |
</div> |
||
=== 5. Mortgage Loans === |
|||
{{chunk|doc=3z7a4yrxkn|c=223|p=16}} |
|||
* The Company has invested in Separately Managed Accounts ("SMA1" and "SMA2") <sup>p. 85</sup>. |
|||
'''Mortgage loan portfolio overview''' |
|||
* As of December 31, 2025 and 2024, the Company held direct investments in mortgage loans from various creditors through SMA1 and SMA2 <sup>p. 85</sup>. |
|||
* The Company's mortgage loan portfolios primarily consist of senior loans on real estate across the U.S. <sup>p. 85</sup>. |
|||
* These loans earn interest at a fixed spread above a prime rate <sup>p. 85</sup>. |
|||
* The loans mature in approximately 2 to 4 years from loan origination <sup>p. 85</sup>. |
|||
* The principal amounts of the loans are approximately 64% of the property's appraised value at the time the loans were made <sup>p. 85</sup>. |
|||
* Uncollectible amounts on loans are determined on an individual loan basis through consultations with the Company's specialized investment manager <sup>p. 85</sup>. |
|||
* Factors considered for uncollectible amounts include adverse situations affecting the borrower's ability to repay, estimated value of underlying collateral, and other relevant factors <sup>p. 85</sup>. |
|||
* The Company writes off uncollectible amounts in the period they are determined to be uncollectible <sup>p. 85</sup>. |
|||
* There was no write-off for uncollectible amounts during the years ended December 31, 2025 and 2024, respectively <sup>p. 85</sup>. |
|||
* As of December 31, 2025 and 2024, no mortgage loans were in the process of foreclosure <sup>p. 85</sup>. |
|||
* As of December 31, 2025 and 2024, no mortgage loans were not producing income for the previous 12 months <sup>p. 85</sup>. |
|||
* The Company has invested in Separately Managed Accounts ("SMA1" and "SMA2"). |
|||
====== Mortgage loans by property type ====== |
|||
* As of December 31, 2025 and 2024, the Company held direct investments in mortgage loans from various creditors through SMA1 and SMA2. |
|||
* The Company's mortgage loan portfolios are primarily senior loans on real estate across the U.S.. |
|||
* Loans earn interest at a fixed spread above a prime rate. |
|||
* Loans mature in approximately 2 to 4 years from loan origination. |
|||
* Principal amounts of the loans are approximately 64% of the property's appraised value at the time the loans were made. |
|||
{{chunk|doc=3z7a4yrxkn|c=224|p=16}} |
|||
'''Mortgage loan carrying value and income''' |
|||
* The carrying value of the Company's mortgage loans as of December 31, 2025 and 2024 is presented in a table. |
|||
* The Company's gross investment income for mortgage loans for the years ended December 31, 2025, 2024, and 2023 is presented in a table. |
|||
{{chunk|doc=3z7a4yrxkn|c=225|p=16}} |
|||
'''Mortgage loan collectibility and foreclosure status''' |
|||
* Uncollectible amounts on loans are determined on an individual loan basis through consultations with the Company's specialized investment manager and consideration of adverse situations, estimated collateral value, and other relevant factors. |
|||
* The Company writes off uncollectible amounts in the period they are determined to be uncollectible. |
|||
* There was no write-off for uncollectible amounts during the years ended December 31, 2025 and 2024. |
|||
* As of December 31, 2025 and 2024, no mortgage loans were in the process of foreclosure. |
|||
* As of December 31, 2025 and 2024, there were no mortgage loans that were not producing income for the previous 12 months. |
|||
{{chunk|doc=3z7a4yrxkn|c=226|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1055" class="wikitable fintable" |
||
|+ Mortgage loans by segment |
|||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | 2025 |
||
! class="col- |
! class="col-m" style="text-align:right" | 2024 |
||
|- |
|- |
||
| style="text-align:left" | Commercial |
| style="text-align:left" | Commercial |
||
| Line 5,274: | Line 6,260: | ||
|- |
|- |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align:right" | |
| style="text-align:right" | <b>9,902</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>26,490</b> |
||
|} |
|} |
||
</div> |
</div> |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1056" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | 2025 |
||
! class="col- |
! class="col-m" style="text-align:right" | 2024 |
||
! class="col- |
! class="col-m" style="text-align:right" | 2023 |
||
|- |
|- |
||
| style="text-align:left" | Commercial |
| style="text-align:left" | Commercial |
||
| Line 5,312: | Line 6,299: | ||
|- |
|- |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,622</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>5,155</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>5,474</b> |
||
|} |
|} |
||
</div> |
</div> |
||
=== 6. Equity Method Investments and Other === |
|||
{{chunk|doc=3z7a4yrxkn|c=227|p=16}} |
|||
* The difference between an investment's cost and its proportionate share of underlying equity in net assets is allocated to the equity method investment's assets and liabilities <sup>p. 86</sup>. |
|||
'''Equity method investments overview''' |
|||
* The Company amortizes this difference over the useful life of a similar asset as the underlying equity method investment <sup>p. 86</sup>. |
|||
* For the investment in RISCOM, a similar asset is agent relationships <sup>p. 86</sup>. |
|||
* The Company amortizes this difference for RISCOM over a 15-year useful life <sup>p. 86</sup>. |
|||
* As of December 31, 2025 and 2024, the Company held indirect investments in collateralized loans and loan collateral through SMA1 and SMA2 <sup>p. 86</sup>. |
|||
* The table presents the carrying value and ownership percentage of the Company’s equity method investments as of December 31, 2025 and 2024. |
|||
====== Indirect investments in collateralized loans and loan collateral ====== |
|||
* The table details the components of [[Definition:Net investment income|net investment income]] (loss) from equity method investments for the years ended December 31, 2025, 2024, and 2023. |
|||
* The table outlines the unfunded commitment of equity method investments as of December 31, 2025 and 2024. |
|||
{{chunk|doc=3z7a4yrxkn|c=228|p=16}} |
|||
'''Equity method investment accounting''' |
|||
* The difference between an investment's cost and its proportionate share of underlying equity in net assets is allocated to the equity method investment's various assets and liabilities. |
|||
* The Company amortizes the difference in net assets over the useful life of a similar asset as the underlying equity method investment. |
|||
* For the investment in RISCOM, a similar asset is agent relationships, and the Company amortizes this difference over a 15-year useful life. |
|||
* The table compares the Company’s recorded investment in RISCOM to its share of underlying equity as of December 31, 2025 and 2024. |
|||
* The table compares the Company’s recorded investment in JVM Funds LLC to its share of underlying equity as of December 31, 2025 and 2024. |
|||
{{chunk|doc=3z7a4yrxkn|c=229|p=16}} |
|||
'''Indirect loans and loan collateral''' |
|||
* As of December 31, 2025 and 2024, the Company held indirect investments in collateralized loans and loan collateral through SMA1 and SMA2. |
|||
* The carrying value of SMA1 and SMA2 as of December 31, 2025 and 2024 is presented in a table. |
|||
{{chunk|doc=3z7a4yrxkn|c=230|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1057" class="wikitable fintable" |
||
|+ Carrying Value and Ownership % by Equity Method Investments |
|||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! colspan="2" style="text-align:center" | 2025 |
! colspan="2" style="text-align:center" | 2025 |
||
! colspan="2" style="text-align:center" | 2024 |
! colspan="2" style="text-align:center" | 2024 |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! class="col- |
! class="col-m" style="text-align:right" | Carrying Value |
||
! class="col-s" style="text-align:right" | Ownership % |
! class="col-s" style="text-align:right" | Ownership % |
||
! class="col- |
! class="col-m" style="text-align:right" | Carrying Value |
||
! class="col-s" style="text-align:right" | Ownership % |
! class="col-s" style="text-align:right" | Ownership % |
||
|- |
|- |
||
| Line 5,383: | Line 6,388: | ||
|- |
|- |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align:right" | |
| style="text-align:right" | <b>53,498</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | <b>65,325</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|} |
|} |
||
| Line 5,391: | Line 6,396: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1058" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | 2025 |
||
! class="col- |
! class="col-m" style="text-align:right" | 2024 |
||
! class="col- |
! class="col-m" style="text-align:right" | 2023 |
||
|- |
|- |
||
| style="text-align:left" | Arena SOP LP units |
| style="text-align:left" | Arena SOP LP units |
||
| Line 5,438: | Line 6,444: | ||
|- |
|- |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 2,683 )</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>2,524</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 9,434 )</b> |
||
|} |
|} |
||
</div> |
</div> |
||
====== Investment in RISCOM ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1059" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | 2025 |
||
! class="col- |
! class="col-m" style="text-align:right" | 2024 |
||
|- |
|- |
||
| style="text-align:left" | Brewer Lane Ventures Fund II LP units |
| style="text-align:left" | Brewer Lane Ventures Fund II LP units |
||
| Line 5,469: | Line 6,474: | ||
|- |
|- |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align:right" | |
| style="text-align:right" | <b>22,094</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>29,260</b> |
||
|} |
|} |
||
</div> |
</div> |
||
====== Investment in JVM Funds LLC ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1060" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2025 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2024 |
||
|- |
|- |
||
! style="text-align:left" | Investment in RISCOM: |
! style="text-align:left" | Investment in RISCOM: |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Underlying equity |
| style="text-align:left" | Underlying equity |
||
| Line 5,494: | Line 6,498: | ||
| style="text-align:right" | 1,258 |
| style="text-align:right" | 1,258 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Recorded investment balance</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>3,307</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>5,013</b> |
||
|} |
|} |
||
</div> |
</div> |
||
====== Investment in indirect loans and loan collateral ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1061" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2025 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2024 |
||
|- |
|- |
||
! style="text-align:left" | Investment in JVM Funds LLC: |
! style="text-align:left" | Investment in JVM Funds LLC: |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Underlying equity |
| style="text-align:left" | Underlying equity |
||
| Line 5,520: | Line 6,523: | ||
| style="text-align:right" | 605 |
| style="text-align:right" | 605 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Recorded investment balance</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>14,911</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>17,229</b> |
||
|} |
|} |
||
</div> |
</div> |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1062" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | 2025 |
||
! class="col- |
! class="col-m" style="text-align:right" | 2024 |
||
|- |
|- |
||
| style="text-align:left" | SMA1 |
| style="text-align:left" | SMA1 |
||
| Line 5,540: | Line 6,544: | ||
| style="text-align:right" | 12,973 |
| style="text-align:right" | 12,973 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Investment in indirect loans and loan collateral</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>23,867</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>33,269</b> |
||
|} |
|} |
||
</div> |
</div> |
||
=== 7. Variable Interest Entity === |
|||
{{chunk|doc=3z7a4yrxkn|c=231|p=16}} |
|||
* Skyward consolidates Separate Account HSIC-01 ("HSIC-01"), established by Mangrove Risk Solutions Bermuda Ltd. ("Mangrove"), pursuant to GAAP consolidation guidance <sup>p. 87</sup>. |
|||
'''HSIC-01 Variable Interest Entity''' |
|||
* The VIE's purpose is to hedge price volatility risks of certain insurance products by investing in dairy and livestock commodities <sup>p. 87</sup>. |
|||
* The Company directly manages the business of HSIC-01, leading it to consider itself the primary beneficiary <sup>p. 87</sup>. |
|||
* The Company does not provide performance guarantees and has no other financial obligation to fund HSIC-01, beyond its own capital commitments <sup>p. 87</sup>. |
|||
* The assets of consolidated variable interest entities, including HSIC-01, can only be used to settle obligations of these entities <sup>p. 87</sup>. |
|||
* There is no recourse to the assets of HSIC-01 other than to satisfy associated liabilities <sup>p. 87</sup>. |
|||
* The assets of HSIC-01, included in the Consolidated Balance Sheets as of December 31, 2025, represent third-party net assets and exclude intercompany balances eliminated upon consolidation <sup>p. 87</sup>. |
|||
* Skyward consolidates Separate Account HSIC-01 ("HSIC-01"), established by Mangrove Risk Solutions Bermuda Ltd. ("Mangrove"), pursuant to GAAP consolidation guidance. |
|||
====== Assets of HSIC-01 as of December 31, 2025 ====== |
|||
* HSIC-01 is a Variable Interest Entity (VIE) for which Skyward is the primary beneficiary. |
|||
* The VIE's purpose is to hedge price volatility risks of certain insurance products by investing in dairy and livestock commodities. |
|||
* Skyward directly manages the business, leading it to consider itself the primary beneficiary. |
|||
* Skyward does not provide performance guarantees and has no other financial obligation to provide funding to HSIC-01, beyond its own capital commitments. |
|||
* Assets of consolidated variable interest entities, such as HSIC-01, may only be used to settle obligations of those entities. |
|||
* There is no recourse to the assets of HSIC-01 other than to satisfy associated liabilities. |
|||
* The table presents the assets of HSIC-01 included in the Consolidated Balance Sheets as of December 31, 2025. |
|||
* The presented assets only include third-party net assets and exclude intercompany balances, which were eliminated upon consolidation. |
|||
{{chunk|doc=3z7a4yrxkn|c=232|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1063" class="wikitable fintable" |
||
|+ 7. Variable Interest Entity |
|||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-s" style="text-align:right" | 2025 |
||
|- |
|- |
||
! style="text-align:left" | Assets |
! style="text-align:left" | Assets |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Cash and cash equivalents |
| style="text-align:left" | Cash and cash equivalents |
||
| Line 5,573: | Line 6,583: | ||
| style="text-align:right" | 34,856 |
| style="text-align:right" | 34,856 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total assets |
||
| style="text-align:right" | |
| style="text-align:right" | 50,672 |
||
|} |
|} |
||
</div> |
</div> |
||
=== 8 . Derivatives === |
|||
{{chunk|doc=3z7a4yrxkn|c=233|p=16}} |
|||
* The Company uses derivatives for financial risk management to mitigate price risk in insurance contracts exposed to commodity price fluctuations, specifically cattle and milk <sup>p. 88</sup>. |
|||
'''Derivative use and accounting''' |
|||
* A hedging strategy using derivatives (put options and futures) is employed to mitigate revenue volatility and support financial stability <sup>p. 88</sup>. |
|||
* The primary objective of derivative instruments is to manage exposure to adverse price movements <sup>p. 88</sup>. |
|||
* Activity in these instruments reflects current market conditions and shifts in risk exposures throughout the year <sup>p. 88</sup>. |
|||
* The notional value of derivative contracts and the degree of hedged exposure are actively managed and can vary based on pricing in cattle, hogs, and milk markets <sup>p. 88</sup>. |
|||
* Derivatives are not used for speculative or trading purposes <sup>p. 88</sup>. |
|||
* All derivative positions support the overall risk transfer objectives of the business <sup>p. 88</sup>. |
|||
* The Company has not elected hedge accounting for these derivatives <sup>p. 88</sup>. |
|||
* The net gain (loss) recognized on derivative instruments in economic hedging relationships is presented in "losses and loss adjustment expenses" on the Consolidated Statements of Operations <sup>p. 88</sup>. |
|||
* For the year ended December 31, 2025, the Company recognized ''pre-tax net gains'' of USD 7.9m in losses and loss adjustment expenses <sup>p. 88</sup>. |
|||
* The Company uses derivatives in its financial risk management programs to mitigate price risk in certain insurance contracts exposed to commodity price fluctuations (cattle, milk). |
|||
====== Derivative assets in economic hedging relationships ====== |
|||
* A hedging strategy using derivatives (put options, futures) is employed to mitigate revenue volatility and support financial stability. |
|||
* The primary objective of derivative instruments is to manage exposure to adverse price movements. |
|||
* Activity in these instruments reflects current market conditions and shifts in risk exposures throughout the year. |
|||
* The notional value of derivative contracts and the degree of hedged exposure are actively managed and vary based on prevailing pricing in cattle, hogs, and milk markets. |
|||
* Derivatives are not used for speculative or trading purposes. |
|||
* All derivative positions support the overall risk transfer objectives of the business. |
|||
* The Company has not elected hedge accounting for these derivatives. |
|||
* The net gain (loss) recognized on derivative instruments in economic hedging relationships is presented in "losses and loss adjustment expenses" on the Consolidated Statements of Operations. |
|||
* For the year ended December 31, 2025, the Company recognized USD 7.9m of pre-tax net gains in losses and loss adjustment expenses. |
|||
{{chunk|doc=3z7a4yrxkn|c=234|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1064" class="wikitable fintable" |
||
|+ Derivative assets by notional amount and fair value |
|||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! colspan="2" style="text-align:center" | Derivative Assets |
! colspan="2" style="text-align:center" | Derivative Assets |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! class="col-s" style="text-align:right" | Notional Amount |
! class="col-s" style="text-align:right" | Notional Amount |
||
! class="col-s" style="text-align:right" | Fair Value |
! class="col-s" style="text-align:right" | Fair Value |
||
| Line 5,608: | Line 6,623: | ||
</div> |
</div> |
||
=== 9. Allowance for Credit Losses === |
|||
{{chunk|doc=3z7a4yrxkn|c=235|p=16}} |
|||
'''Premiums receivable allowance for credit losses''' |
|||
* Tables detailing changes in the allowance for expected credit losses on premiums receivable are provided for the years ended December 31, 2025 and 2024. |
|||
{{chunk|doc=3z7a4yrxkn|c=236|p=16}} |
|||
'''Reinsurance recoverables credit risk analysis''' |
|||
* The Company analyzes credit risk for reinsurance recoverables by monitoring the financial strength rating of its reinsurers from A.M. Best. |
|||
* The financial strength rating is assessed annually and throughout the year as A.M. Best provides updates. |
|||
* The Company assesses the adequacy of credit enhancements such as reinsurance payables, letters of credit, and funds held. |
|||
* A table sets forth the Company’s reinsurance recoverables net of credit enhancements by A.M. Best as of December 31, 2025. |
|||
{{chunk|doc=3z7a4yrxkn|c=237|p=16}} |
|||
'''Reinsurance recoverables past due and uncollectible allowance''' |
|||
* Reinsurance balances are considered past due when they are 90 days past due. |
|||
* The Company analyzes ''credit risk'' for its reinsurance recoverables by monitoring A.M. Best financial strength ratings of its reinsurers <sup>p. 89</sup>. |
|||
* Tables detailing changes in the allowance for estimated uncollectible reinsurance are provided for the years ended December 31, 2025 and 2024. |
|||
* ''A.M. Best ratings'' are assessed annually and throughout the year as updates become available <sup>p. 89</sup>. |
|||
* On January 31, 2025, the Company commuted the LPT with R&Q Re (Bermuda) Ltd. ("R&Q") related to accident years 2018 and prior. |
|||
* The Company assesses the ''adequacy of credit enhancements'' including reinsurance payables, letters of credit, and funds held <sup>p. 89</sup>. |
|||
* During the year ended December 31, 2024, the Company recognized an uncollectible reinsurance recoverable balance related to the LPT as a net increase of USD 13.6m to the allowance for estimated uncollectible reinsurance, which was subsequently written-off. |
|||
* ''Reinsurance balances'' are considered past due after 90 days <sup>p. 89</sup>. |
|||
* On January 31, 2025, the Company commuted the ''LPT with R&Q Re (Bermuda) Ltd.'' for accident years 2018 and prior <sup>p. 89</sup>. |
|||
* During the year ended December 31, 2024, the Company recognized a ''net increase of USD 13.6m'' to the allowance for estimated uncollectible reinsurance related to the LPT, which was subsequently written-off <sup>p. 89</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=238|p=16}} |
|||
====== Premiums receivable and allowance for uncollectible premiums in 2025 ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1065" class="wikitable fintable" |
||
|+ Allowance for Estimated Uncollectible Premiums by current period change |
|||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | Premiums Receivable, Net |
||
! class="col- |
! class="col-m" style="text-align:right" | Allowance for Estimated Uncollectible Premiums |
||
|- |
|- |
||
| style="text-align:left" | Balance at December 31, 2024 |
| style="text-align:left" | Balance at December 31, 2024 |
||
| Line 5,641: | Line 6,672: | ||
| style="text-align:right" | 498 |
| style="text-align:right" | 498 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Balance at December 31, 2025</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>544,217</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>3,140</b> |
||
|} |
|} |
||
</div> |
</div> |
||
====== Premiums receivable and allowance for uncollectible premiums in 2024 ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1066" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | Premiums Receivable, Net |
||
! class="col- |
! class="col-m" style="text-align:right" | Allowance for Estimated Uncollectible Premiums |
||
|- |
|- |
||
| style="text-align:left" | Balance at December 31, 2023 |
| style="text-align:left" | Balance at December 31, 2023 |
||
| Line 5,671: | Line 6,701: | ||
| style="text-align:right" | 128 |
| style="text-align:right" | 128 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Balance at December 31, 2024</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>321,641</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>2,432</b> |
||
|} |
|} |
||
</div> |
</div> |
||
====== A.M. best ratings ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1067" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | 2025 |
! colspan="2" style="text-align:center" | 2025 |
||
| Line 5,705: | Line 6,734: | ||
|} |
|} |
||
</div> |
</div> |
||
====== Reinsurance recoverables and allowance for uncollectible reinsurance ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable |
{| id="t1068" class="wikitable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! |
! style="text-align:right" | Reinsurance Recoverables, Net |
||
! |
! style="text-align:right" | Allowance for Estimated Uncollectible Reinsurance |
||
|- |
|- |
||
| style="text-align:left" | Balance at December 31, 2024 |
| style="text-align:left" | Balance at December 31, 2024 |
||
| Line 5,718: | Line 6,746: | ||
| style="text-align:right" | 2,295 |
| style="text-align:right" | 2,295 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Balance at December 31, 2025</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,119,880</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>2,295</b> |
||
|} |
|} |
||
</div> |
</div> |
||
====== Reinsurance recoverables and allowance for uncollectible reinsurance ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1069" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | Reinsurance Recoverables, Net |
||
! class="col- |
! class="col-m" style="text-align:right" | Allowance for Estimated Uncollectible Reinsurance |
||
|- |
|- |
||
| style="text-align:left" | Balance at December 31, 2023 |
| style="text-align:left" | Balance at December 31, 2023 |
||
| Line 5,744: | Line 6,771: | ||
| style="text-align:right" | ( 13,585 ) |
| style="text-align:right" | ( 13,585 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Balance at December 31, 2024</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>857,876</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>2,295</b> |
||
|} |
|} |
||
</div> |
</div> |
||
=== 10. Property and Equipment === |
|||
{{chunk|doc=3z7a4yrxkn|c=239|p=16}} |
|||
* ''Depreciation expense'' for property and equipment was USD 3.3m for the year ended December 31, 2025 <sup>p. 90</sup>. |
|||
'''Property and Equipment Depreciation''' |
|||
* ''Depreciation expense'' for property and equipment was USD 2.9m for the year ended December 31, 2024 <sup>p. 90</sup>. |
|||
* ''Depreciation expense'' for property and equipment was USD 3.2m for the year ended December 31, 2023 <sup>p. 90</sup>. |
|||
* Depreciation expense is presented in underwriting, acquisition, and insurance expenses on the Consolidated Statements of Operations <sup>p. 90</sup>. |
|||
* Property and equipment components are included within other assets on the Consolidated Balance Sheets. |
|||
====== Depreciation expense for property and equipment ====== |
|||
* Depreciation expense related to property and equipment was USD 3.3m for the year ended December 31, 2025. |
|||
* Depreciation expense related to property and equipment was USD 2.9m for the year ended December 31, 2024. |
|||
* Depreciation expense related to property and equipment was USD 3.2m for the year ended December 31, 2023. |
|||
* Depreciation expense is presented in underwriting, acquisition, and insurance expenses on the Consolidated Statements of Operations. |
|||
{{chunk|doc=3z7a4yrxkn|c=240|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1070" class="wikitable fintable" |
||
|+ 10. Property and Equipment |
|||
|- |
|||
! style="text-align:left" | (in thousands) |
! style="text-align:left" | (in thousands) |
||
! class="col-s" style="text-align:right" | 2025 |
! class="col-s" style="text-align:right" | 2025 |
||
| Line 5,785: | Line 6,818: | ||
| style="text-align:right" | ( 29,355 ) |
| style="text-align:right" | ( 29,355 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total |
||
| style="text-align:right" | |
| style="text-align:right" | 15,140 |
||
| style="text-align:right" | |
| style="text-align:right" | 12,179 |
||
|} |
|} |
||
</div> |
</div> |
||
=== 11. Notes Payable & Subordinated Debt === |
|||
{{chunk|doc=3z7a4yrxkn|c=241|p=16}} |
|||
* ''FHLB Loan'': entered into on August 30, 2024, pursuant to the Advances and Security Agreement <sup>p. 91</sup>. |
|||
'''FHLB Loan''' |
|||
* ''FHLB Loan term'': 4.5 years, principal amount of USD 57.0m <sup>p. 91</sup>. |
|||
* ''FHLB Loan payments'': interest-only during term, principal due at maturity <sup>p. 91</sup>. |
|||
* ''FHLB Loan interest rate'': fixed at 4.00% over the loan term <sup>p. 91</sup>. |
|||
* ''FHLB Loan security'': fully secured by a pledge of specific investment securities of HSIC <sup>p. 91</sup>. |
|||
* ''FHLB Loan proceeds use'': funded redemptions of draws on the 2023 Revolving Credit Facility <sup>p. 91</sup>. |
|||
* ''Term Loan Facility'': entered into during Q4 2025 with a syndicate of banks <sup>p. 91</sup>. |
|||
* ''Term Loan Facility components'': |
|||
** Unsecured senior delayed draw term loan facility (DDTL) of USD 150.0m (Tranche A DDTL) <sup>p. 91</sup>. |
|||
** Additional unsecured senior DDTL of USD 150.0m (Tranche B DDTL) <sup>p. 91</sup>. |
|||
* ''Term Loan Facility use'': funded a portion of the consideration for the acquisition of Apollo Group Holdings Limited ("Apollo") and related fees/expenses <sup>p. 91</sup>. |
|||
* ''Term Loan Facility interest rate (SOFR)'': term SOFR plus a margin ranging from 150 bps to 190 bps, depending on debt to capitalization ratio <sup>p. 91</sup>. |
|||
* ''Term Loan Facility SOFR calculation'': SOFR floor of 0.00% and a credit spread adjustment of 0.10% <sup>p. 91</sup>. |
|||
* ''Term Loan Facility interest rate (base rate)'': base rate plus a margin ranging from 50 bps to 90 bps, depending on debt to capitalization ratio <sup>p. 91</sup>. |
|||
* ''Term Loan Facility base rate definition'': highest of (i) Agent’s prime lending rate, (ii) Federal Funds Rate plus 0.50%, (iii) SOFR plus 1.00%, and (iv) zero percent (0%) <sup>p. 91</sup>. |
|||
* ''Term Loan Facility undrawn fee'': 0.20% to 0.35% on average daily undrawn amounts, depending on debt to capitalization ratio <sup>p. 91</sup>. |
|||
* ''Tranche A DDTL maturity'': January 1, 2028 <sup>p. 91</sup>. |
|||
* ''Tranche B DDTL maturity'': July 2, 2029 <sup>p. 91</sup>. |
|||
* ''Term Loan Facility draws (December 30, 2025)'': USD 150.0m from Tranche A DDTL and USD 150.0m from Tranche B DDTL for Apollo acquisition on January 1, 2026 <sup>p. 91</sup>. |
|||
* ''Term Loan Facility covenants'': customary limitations on additional indebtedness exceeding USD 10.0m, restrictions on distributions, stock redemptions/repurchases, and financial covenants (minimum consolidated net worth, maximum total debt to capitalization, minimum A.M. Best rating, minimum liquidity) <sup>p. 91</sup>. |
|||
* ''Term Loan Facility compliance'': Company was in compliance with all covenants as of December 31, 2025 <sup>p. 91</sup>. |
|||
* ''Term Loan Facility security'': unsecured <sup>p. 91</sup>. |
|||
* ''Term Loan Facility guarantee'': obligations guaranteed by the Company and its existing wholly-owned subsidiaries and subsequently acquired/organized subsidiaries (excluding insurance company subsidiaries and certain other exceptions) <sup>p. 91</sup>. |
|||
* ''Revolving Credit Facility'': entered into during Q4 2025 with a syndicate of banks <sup>p. 91</sup>. |
|||
* ''Revolving Credit Facility security'': unsecured <sup>p. 91</sup>. |
|||
* ''Revolving Credit Facility initial maximum principal'': USD 150.0m, increased to USD 250.0m on the Apollo acquisition closing date <sup>p. 91</sup>. |
|||
* ''Revolving Credit Facility initial draw'': USD 43.0m, used to redeem prior revolving credit facility <sup>p. 91</sup>. |
|||
* ''Revolving Credit Facility additional draw (December 30, 2025)'': USD 71.5m, used for consideration paid for Apollo acquisition <sup>p. 91</sup>. |
|||
* ''Revolving Credit Facility proceeds presentation'': net with liabilities on Consolidated Balance Sheets for year ended December 31, 2025 <sup>p. 91</sup>. |
|||
* ''Revolving Credit Facility proceeds use'': Apollo acquisition on January 1, 2026 <sup>p. 91</sup>. |
|||
* ''Revolving Credit Facility interest payments'': quarterly <sup>p. 91</sup>. |
|||
* ''Revolving Credit Facility interest rate (SOFR)'': term SOFR plus a margin ranging from 150 bps to 190 bps, depending on debt to capitalization ratio <sup>p. 91</sup>. |
|||
* ''Revolving Credit Facility SOFR calculation'': SOFR floor of 0.00% and a credit spread adjustment of 0.10% <sup>p. 91</sup>. |
|||
* ''Revolving Credit Facility interest rate (base rate)'': base rate plus a margin ranging from 50 bps to 90 bps, depending on debt to capitalization ratio <sup>p. 91</sup>. |
|||
* ''Revolving Credit Facility base rate definition'': highest of (i) Agent’s prime lending rate, (ii) Federal Funds Rate plus 0.50%, (iii) SOFR plus 1.00%, and (iv) zero percent (0%) <sup>p. 91</sup>. |
|||
* ''Revolving Credit Facility undrawn fee'': 0.20% to 0.35% on average daily undrawn amounts, depending on debt to capitalization ratio <sup>p. 91</sup>. |
|||
* ''Revolving Credit Facility availability period termination'': November 12, 2030 <sup>p. 91</sup>. |
|||
* ''Revolving Credit Facility covenants'': minimum net worth, maximum debt to capital ratio, minimum A.M. Best Rating, minimum liquidity, and customary events of default <sup>p. 91</sup>. |
|||
* ''Revolving Credit Facility compliance'': Company was in compliance with all covenants as of December 31, 2025 <sup>p. 91</sup>. |
|||
* ''2023 Revolving Credit Facility'': entered into during Q1 2023 <sup>p. 91</sup>. |
|||
* ''2023 Revolving Credit Facility terms'': unsecured, up to USD 150.0m revolving credit facility and a letter of credit sub-facility of up to USD 30.0m <sup>p. 91</sup>. |
|||
* ''2023 Revolving Credit Facility redemption'': redeemed on November 13, 2025 <sup>p. 91</sup>. |
|||
* ''2023 Revolving Credit Facility costs upon redemption'': USD 0.3m of accrued interest paid, USD 0.6m expense for remaining unamortized deferred financing costs recognized <sup>p. 91</sup>. |
|||
* ''Debentures (Notes)'': unsecured subordinated notes issued in May 2019 with an aggregate principal amount of USD 20.0m <sup>p. 91</sup>. |
|||
* ''Notes interest rate'': fixed at 7.25% for the first 8 years, then fixed at 8.25% thereafter <sup>p. 91</sup>. |
|||
* ''Notes early retirement'': requires all interest payments to be paid in full, plus return of outstanding principal <sup>p. 91</sup>. |
|||
* ''Notes principal due'': at maturity on May 24, 2039 <sup>p. 91</sup>. |
|||
* ''Notes interest payable'': quarterly <sup>p. 91</sup>. |
|||
* ''Notes priority'': junior to all previously issued debt <sup>p. 91</sup>. |
|||
* ''Notes debt reporting'': net of debt issuance costs of approximately USD 0.4m (2025) and USD 0.5m (2024) on Consolidated Balance Sheets <sup>p. 91</sup>. |
|||
* ''Notes deferred financing costs presentation'': direct deduction from carrying amount of subordinated debt <sup>p. 91</sup>. |
|||
* On August 30, 2024, the Company entered into the FHLB Loan, a 4.5-year term loan with a principal amount of USD 57.0m. |
|||
====== 12. Segment ====== |
|||
* The FHLB Loan requires interest-only payments during its term, with principal due in full at maturity. |
|||
* The interest rate for the FHLB Loan is fixed at 4.00% over the term. |
|||
* The FHLB Loan is fully secured by a pledge of specific investment securities of HSIC. |
|||
* Proceeds from the FHLB Loan were used to fund redemptions of draws on the 2023 Revolving Credit Facility. |
|||
{{chunk|doc=3z7a4yrxkn|c=242|p=16}} |
|||
* The Company operates one reportable segment offering commercial property and casualty products and solutions, primarily in the United States, on both non-admitted (E&S) and admitted bases <sup>p. 92</sup>. |
|||
'''Term Loan Facility''' |
|||
* This segment consists of nine distinct underwriting divisions, referred to as "continuing business" <sup>p. 92</sup>. |
|||
* Each division has dedicated underwriting leadership and technical staff experienced in their specific niches <sup>p. 92</sup>. |
|||
* The segment definition is based on how the Chief Operating Decision Maker (CODM) reviews internal financial information for performance analysis, decision-making, and resource allocation <sup>p. 92</sup>. |
|||
* The Company's CODM is the chief executive officer <sup>p. 92</sup>. |
|||
* The accounting policies for the segment align with those described in Note 1 "Summary of Significant Accounting Policies" of the Form 10-K <sup>p. 92</sup>. |
|||
* The CODM evaluates segment performance and allocates resources using gross written premiums by net underwriting division, underwriting income, and income before income taxes (which is also reported on the Consolidated Statements of Operations) <sup>p. 92</sup>. |
|||
* ''Segment assets'' are reported on the Consolidated Balance Sheets as total consolidated assets <sup>p. 92</sup>. |
|||
* ''Gross written premiums'' by underwriting division, net underwriting income, and consolidated net income are used to monitor budget versus actual results <sup>p. 92</sup>. |
|||
* The CODM uses ''net underwriting income'', ''annualized return on equity'', and ''growth in book value per share'' for competitive analysis against the Company's competitors <sup>p. 92</sup>. |
|||
* This competitive analysis and the monitoring of budgeted versus actual results are used to assess segment performance and determine management's compensation <sup>p. 92</sup>. |
|||
* During Q4 2025, the Company entered into a Term Loan Credit Agreement (the "Term Loan Facility") with a syndicate of banks. |
|||
====== Segment performance by business line ====== |
|||
* The Term Loan Facility includes a Tranche A DDTL of USD 150.0m and a Tranche B DDTL of USD 150.0m. |
|||
* The Term Loan Facility was used to fund a portion of the consideration for the acquisition of Apollo Group Holdings Limited ("Apollo") and related transaction fees and expenses. |
|||
* Amounts drawn bear interest at either term SOFR plus a margin (150 bps to 190 bps) or the base rate plus a margin (50 bps to 90 bps), depending on the Company's debt to capitalization ratio. |
|||
* SOFR is calculated with a floor of 0.00% and a credit spread adjustment of 0.10%. |
|||
* The base rate is the highest of (i) the Agent’s prime lending rate, (ii) the Federal Funds Rate plus 0.50%, (iii) SOFR plus 1.00%, and (iv) 0%. |
|||
* The Company pays a fee ranging from 0.20% to 0.35% on average daily undrawn amounts, depending on the debt to capitalization ratio. |
|||
* The Tranche A DDTL matures on January 1, 2028, and the Tranche B DDTL matures on July 2, 2029. |
|||
* On December 30, 2025, the Company drew USD 150.0m from Tranche A DDTL and USD 150.0m from Tranche B DDTL for the Apollo acquisition on January 1, [[Definition:Year 2026|2026]]. |
|||
* The Term Loan Facility includes customary covenants, such as limitations on additional indebtedness exceeding USD 10.0m and on distributions to stockholders, stock redemptions, repurchases, or retirements upon certain events. |
|||
* Financial covenants include minimum consolidated net worth, maximum total debt to capitalization, minimum A.M. Best rating, and minimum liquidity. |
|||
* As of December 31, 2025, the Company was in compliance with all covenants. |
|||
* The Term Loan Facility is unsecured. |
|||
* The Company's obligations under the Term Loan Facility are guaranteed by the Company and its existing wholly-owned subsidiaries, and subsequently acquired or organized subsidiaries (excluding insurance company subsidiaries and subject to certain exceptions). |
|||
{{chunk|doc=3z7a4yrxkn|c=243|p=16}} |
|||
'''Revolving Credit Facilities''' |
|||
* During Q4 2025, the Company entered into a Credit Agreement (the "Revolving Credit Facility") with a syndicate of banks. |
|||
* The Revolving Credit Facility is unsecured and initially provided a maximum principal amount of USD 150.0m, which increased to USD 250.0m on the closing date of the Apollo acquisition. |
|||
* The Company initially drew USD 43.0m to redeem its prior revolving credit facility. |
|||
* On December 30, 2025, an additional USD 71.5m was drawn for the consideration paid for the Apollo acquisition. |
|||
* Proceeds from the Term Loan Facility and the Revolving Credit Facility draws are presented net with liabilities on the Consolidated Balance Sheets for the year ended December 31, 2025. |
|||
* Interest on the Revolving Credit Facility is payable quarterly. |
|||
* Amounts drawn bear interest at either term SOFR plus a margin (150 bps to 190 bps) or the base rate plus a margin (50 bps to 90 bps), depending on the Company’s debt to capitalization ratio. |
|||
* SOFR is calculated with a floor of 0.00% and a credit spread adjustment of 0.10%. |
|||
* The base rate is the highest of (i) the Agent’s prime lending rate, (ii) the Federal Funds Rate plus 0.50%, (iii) SOFR plus 1.00%, and (iv) 0%. |
|||
* The Company pays a fee ranging from 0.20% to 0.35% on average daily undrawn amounts, depending on the debt to capitalization ratio. |
|||
* The availability period under the Facility terminates on November 12, 2030. |
|||
* The Company is subject to covenants on the Revolving Credit Facility based on minimum net worth, maximum debt to capital ratio, minimum A.M. Best Rating, and minimum liquidity. |
|||
* As of December 31, 2025, the Company was in compliance with all covenants. |
|||
* In Q1 2023, the Company entered into an agreement for an unsecured revolving credit facility (the "2023 Revolving Credit Facility") of up to USD 150.0m and a letter of credit sub-facility of up to USD 30.0m. |
|||
* On November 13, 2025, the Company redeemed the 2023 Revolving Credit Facility, paid USD 0.3m of accrued interest, and recognized USD 0.6m of expense for remaining unamortized deferred financing costs. |
|||
{{chunk|doc=3z7a4yrxkn|c=244|p=16}} |
|||
'''Debentures''' |
|||
* In May 2019, the Company issued unsecured subordinated notes (the "Notes") with an aggregate principal amount of USD 20.0m. |
|||
* Interest on the Notes is fixed at 7.25% for the first 8 years and 8.25% thereafter. |
|||
* Early retirement of the debt before the 8-year commitment requires all interest payments to be paid in full, plus the return of outstanding principal. |
|||
* Principal is due at maturity on May 24, 2039, and interest is payable quarterly. |
|||
* The Notes have junior priority to all previously issued debt. |
|||
* Debt related to the Notes is reported on the Consolidated Balance Sheets for December 31, 2025, and 2024, net of debt issuance costs of approximately USD 0.4m and USD 0.5m, respectively. |
|||
* These deferred financing costs are presented as a direct deduction from the carrying amount of the subordinated debt. |
|||
=== 12. Segment === |
|||
{{chunk|doc=3z7a4yrxkn|c=245|p=16}} |
|||
'''Reportable segment overview and CODM''' |
|||
* The Company has one reportable segment offering commercial [[Definition:Property & casualty|property and casualty]] products and solutions on a non-admitted (E&S) and admitted basis, predominantly in the United States. |
|||
* The segment consists of nine distinct underwriting divisions, referred to as "continuing business," with dedicated underwriting leadership and technical staff. |
|||
* The segment definition is based on how internally reported financial information is reviewed by the Chief Operating Decision Maker (CODM) to analyze performance, make decisions, and allocate resources. |
|||
* The Company's CODM is the chief executive officer. |
|||
* The accounting policies of the segment align with those described in Note 1 "Summary of Significant Accounting Policies" of Form 10-K. |
|||
* The CODM assesses segment performance and allocates resources based on [[Definition:Gross written premiums|gross written premiums]] by net underwriting division, underwriting income, and income before income taxes (reported on Consolidated Statements of Operations). |
|||
* Segment assets are reported on the Consolidated Balance Sheets as total consolidated assets. |
|||
* [[Definition:Gross written premiums|Gross written premiums]] by underwriting division, net underwriting income, and consolidated net income are used to monitor budget versus actual results. |
|||
* The CODM uses net underwriting income, annualized return on equity, and growth in book value per share for competitive analysis by benchmarking against competitors. |
|||
* Competitive analysis and monitoring of budgeted versus actual results are used to assess segment performance and establish management's compensation. |
|||
{{chunk|doc=3z7a4yrxkn|c=246|p=16}} |
|||
'''Segment financial data tables''' |
|||
* A table presents [[Definition:Gross written premiums|gross written premiums]] by underwriting division for the years ended December 31, 2025, 2024, and 2023. |
|||
* A table presents reported segment net underwriting income, significant segment expenses, and a reconciliation of net underwriting income to net income for the years ended December 31, 2025, 2024, and 2023. |
|||
* A table presents return on equity and book value per share for the years ended December 31, 2025, 2024, and 2023. |
|||
{{chunk|doc=3z7a4yrxkn|c=247|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1071" class="wikitable fintable" |
||
|+ [[Definition:Gross written premiums|Gross written premiums]] by segment |
|||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col-s" style="text-align:right" | 2025 |
! class="col-s" style="text-align:right" | 2025 |
||
| Line 5,868: | Line 6,917: | ||
! class="col-s" style="text-align:right" | 2023 |
! class="col-s" style="text-align:right" | 2023 |
||
|- |
|- |
||
| style="text-align:left" | Accident & Health |
| style="text-align:left" | Accident & Health |
||
| style="text-align:right" | 254,102 |
| style="text-align:right" | 254,102 |
||
| style="text-align:right" | 173,073 |
| style="text-align:right" | 173,073 |
||
| Line 5,883: | Line 6,932: | ||
| style="text-align:right" | 167,624 |
| style="text-align:right" | 167,624 |
||
|- |
|- |
||
| style="text-align:left" | Construction & Energy Solutions |
| style="text-align:left" | Construction & Energy Solutions |
||
| style="text-align:right" | 274,318 |
| style="text-align:right" | 274,318 |
||
| style="text-align:right" | 296,582 |
| style="text-align:right" | 296,582 |
||
| Line 5,908: | Line 6,957: | ||
| style="text-align:right" | 106,056 |
| style="text-align:right" | 106,056 |
||
|- |
|- |
||
| style="text-align:left" | Transactional E&S |
| style="text-align:left" | Transactional E&S |
||
| style="text-align:right" | 197,779 |
| style="text-align:right" | 197,779 |
||
| style="text-align:right" | 189,669 |
| style="text-align:right" | 189,669 |
||
| style="text-align:right" | 128,236 |
| style="text-align:right" | 128,236 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total continuing business |
||
| style="text-align:right" | |
| style="text-align:right" | 2,166,317 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,743,249 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,459,847 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Exited business</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 81 )</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 17 )</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 18 )</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total [[Definition:Gross written premiums|gross written premiums]] |
||
| style="text-align:right" | |
| style="text-align:right" | 2,166,236 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,743,232 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,459,829 |
||
|} |
|} |
||
</div> |
</div> |
||
====== Underwriting income, revenues, and expenses ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1072" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2025 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2024 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2023 |
||
|- |
|- |
||
! style="text-align:left" | Underwriting income |
! style="text-align:left" | Underwriting income |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
! style="text-align:left" | Revenues: |
! style="text-align:left" | Revenues: |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Net earned premiums |
| style="text-align:left" | Net earned premiums |
||
| Line 5,959: | Line 7,007: | ||
| style="text-align:right" | 6,064 |
| style="text-align:right" | 6,064 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total underwriting revenues |
||
| style="text-align:right" | |
| style="text-align:right" | 1,311,360 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,063,425 |
||
| style="text-align:right" | |
| style="text-align:right" | 835,207 |
||
|- |
|||
| style="text-align:left" | <b>Expenses:</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Losses and LAE |
| style="text-align:left" | Losses and LAE |
||
| Line 5,979: | Line 7,032: | ||
| style="text-align:right" | 134,930 |
| style="text-align:right" | 134,930 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total underwriting expenses |
||
| style="text-align:right" | |
| style="text-align:right" | 1,172,381 |
||
| style="text-align:right" | |
| style="text-align:right" | 981,566 |
||
| style="text-align:right" | |
| style="text-align:right" | 758,681 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net underwriting income</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>138,979</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>81,859</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>76,526</b> |
||
|- |
|- |
||
| style="text-align:left" | Reconciliation of net underwriting income to net income: |
| style="text-align:left" | Reconciliation of net underwriting income to net income: |
||
| Line 5,994: | Line 7,047: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net underwriting income</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>138,979</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>81,859</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>76,526</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Add:</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Net investment income |
| style="text-align:left" | [[Definition:Net investment income|Net investment income]] |
||
| style="text-align:right" | 83,619 |
| style="text-align:right" | 83,619 |
||
| style="text-align:right" | 80,600 |
| style="text-align:right" | 80,600 |
||
| Line 6,018: | Line 7,071: | ||
| style="text-align:right" | ( 167 ) |
| style="text-align:right" | ( 167 ) |
||
| style="text-align:right" | ( 632 ) |
| style="text-align:right" | ( 632 ) |
||
|- |
|||
| style="text-align:left" | Less: |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Transaction costs |
| style="text-align:left" | Transaction costs |
||
| Line 6,039: | Line 7,097: | ||
| style="text-align:right" | 5,364 |
| style="text-align:right" | 5,364 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Income before income taxes</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>216,424</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>152,739</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>110,102</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Income tax expense</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>46,396</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>33,911</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>24,118</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net income</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>170,028</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>118,828</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>85,984</b> |
||
|} |
|} |
||
</div> |
</div> |
||
====== Return on equity and book value per share ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1073" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | — |
|||
! style="text-align:left" | |
|||
! class="col-s" style="text-align:right" | 2025 |
! class="col-s" style="text-align:right" | 2025 |
||
! class="col-s" style="text-align:right" | 2024 |
! class="col-s" style="text-align:right" | 2024 |
||
| Line 6,077: | Line 7,134: | ||
</div> |
</div> |
||
=== 13. Income Taxes === |
|||
{{chunk|doc=3z7a4yrxkn|c=248|p=16}} |
|||
* The Company paid ''federal income taxes'' of USD 37.0m in 2024 and USD 15.8m in 2023 <sup>p. 93</sup>. |
|||
'''Income tax expense components''' |
|||
* The Company has ''federal net operating loss carryforwards'' of approximately USD 40.3m <sup>p. 93</sup>. |
|||
* These ''net operating losses'' are set to expire beginning in 2032 <sup>p. 93</sup>. |
|||
* The Company's ability to utilize USD 40.3m of ''net operating losses'' is limited under Internal Revenue Code Section 382 due to an ownership change in 2014 <sup>p. 93</sup>. |
|||
* The ''382 limitation'' is expected to result in an expiration of USD 2.8m (USD 0.6m tax effected) of net operating losses <sup>p. 93</sup>. |
|||
* In 2025, a ''valuation allowance'' was established against the balance expected to expire without utilization <sup>p. 93</sup>. |
|||
* Out of the total USD 40.3m ''federal NOL'', USD 0.3m (USD 0.1m tax effected) is related to dual consolidated loss that Skyward is not expected to utilize <sup>p. 93</sup>. |
|||
* The Company has ''net operating losses'' in various state and local jurisdictions totaling USD 0.9m, which are set to expire between 5 and 20 years or carryforward indefinitely <sup>p. 93</sup>. |
|||
* The Company expects to fully utilize these ''state and local net operating losses'' <sup>p. 93</sup>. |
|||
* The Company's ''federal income tax returns'' for tax years 2022-2024 are subject to examination by the Internal Revenue Service <sup>p. 93</sup>. |
|||
* As of December 31, 2025, the Company had ''no provision for uncertain tax positions'' and no provision for penalties or interest <sup>p. 93</sup>. |
|||
* Management does not believe there are any ''uncertain tax benefits'' that could be recognized within the next twelve months that would impact the Company’s effective tax rate <sup>p. 93</sup>. |
|||
* Table sets forth components of the Company’s income tax expense for the year ended December 31, 2025 after adoption of ASU 2023-09. |
|||
====== Income tax expense from continuing operations ====== |
|||
* Table sets forth components of the Company's income tax expense for the years ended December 31, 2024 and 2023 prior to adoption of ASU 2023-09. |
|||
{{chunk|doc=3z7a4yrxkn|c=249|p=16}} |
|||
'''Effective tax rate reconciliation''' |
|||
* Table reconciles the Company's annual effective tax rate to the U.S. Federal statutory tax rate for the year ended December 31, 2025 after adoption of ASU 2023-09. |
|||
* Table presents required disclosures prior to adoption of ASU 2023-09 and reconciles the statutory U.S. federal income tax rate to the Company’s effective tax rate for continuing operations for the years ended December 31, 2024 and 2023. |
|||
{{chunk|doc=3z7a4yrxkn|c=250|p=16}} |
|||
'''Income taxes paid''' |
|||
* Table presents income taxes paid (net of refunds received) for the year ended December 31, 2025. |
|||
* The Company paid USD 37.0m and USD 15.8m in federal income taxes during the years ended December 31, 2024 and 2023, respectively. |
|||
{{chunk|doc=3z7a4yrxkn|c=251|p=16}} |
|||
'''Deferred tax assets and liabilities''' |
|||
* Table sets forth the tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities at December 31, 2025 and 2024. |
|||
{{chunk|doc=3z7a4yrxkn|c=252|p=16}} |
|||
'''Net operating loss carryforwards and limitations''' |
|||
* The Company has federal net operating loss carryforwards of approximately USD 40.3m. |
|||
* These net operating losses are set to expire beginning in 2032. |
|||
* The Company is limited on the utilization of USD 40.3m of net operating losses under Internal Revenue Code Section 382 due to an ownership change in 2014. |
|||
* The 382 limitation is expected to result in an expiration of USD 2.8m (USD 0.6m tax effected) of net operating losses. |
|||
* In 2025, a valuation allowance was established against the balance expected to expire without utilization. |
|||
* Out of the total USD 40.3m federal NOL, USD 0.3m (USD 0.1m tax effected) is related to dual consolidated loss that Skyward is not expected to be able to utilize. |
|||
* The Company also has net operating losses in various state and local jurisdictions of USD 0.9m, which are set to expire between 5 and 20 years or carryforward indefinitely, depending on the jurisdiction. |
|||
* The Company expects to fully utilize these state and local net operating losses. |
|||
{{chunk|doc=3z7a4yrxkn|c=253|p=16}} |
|||
'''Valuation allowance changes''' |
|||
* Table presents the change in the Company's valuation allowance for the years ended December 31, 2025 and 2024. |
|||
{{chunk|doc=3z7a4yrxkn|c=254|p=16}} |
|||
'''Tax examinations and uncertain tax positions''' |
|||
* The Company’s federal income tax returns for tax years 2022-2024 are subject to examination by the Internal Revenue Service. |
|||
* As of December 31, 2025, the Company had no provision for uncertain tax positions and no provision for penalties or interest. |
|||
* Management does not believe there are any uncertain tax benefits that could be recognized within the next twelve months that would impact the Company’s effective tax rate. |
|||
{{chunk|doc=3z7a4yrxkn|c=255|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1074" class="wikitable fintable" |
||
|+ Income tax expense (benefit) from continuing operations by United States and Foreign |
|||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-s" style="text-align:right" | 2025 |
||
|- |
|- |
||
! style="text-align:left" | Income from continuing operations before income tax expense |
! style="text-align:left" | Income from continuing operations before income tax expense |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | United States |
| style="text-align:left" | United States |
||
| Line 6,108: | Line 7,201: | ||
| style="text-align:right" | 7,661 |
| style="text-align:right" | 7,661 |
||
|- |
|- |
||
| class="wt-indent-1" style="text-align:left" | |
| class="wt-indent-1" style="text-align:left" | Total |
||
| style="text-align:right" | |
| style="text-align:right" | 216,424 |
||
|- |
|||
| style="text-align:left" | <b>Income tax expense (benefit) from continuing operations</b> |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Current tax expense |
| style="text-align:left" | Current tax expense |
||
| Line 6,129: | Line 7,225: | ||
| style="text-align:right" | ( 885 ) |
| style="text-align:right" | ( 885 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total income tax expense |
||
| style="text-align:right" | |
| style="text-align:right" | 46,396 |
||
|} |
|} |
||
</div> |
</div> |
||
====== Income tax expense ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1075" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col-s" style="text-align:right" | 2024 |
! class="col-s" style="text-align:right" | 2024 |
||
| Line 6,150: | Line 7,245: | ||
| style="text-align:right" | 9,382 |
| style="text-align:right" | 9,382 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total income tax expense |
||
| style="text-align:right" | |
| style="text-align:right" | 33,911 |
||
| style="text-align:right" | |
| style="text-align:right" | 24,118 |
||
|} |
|} |
||
</div> |
</div> |
||
====== U.S. federal statutory income tax rate reconciliation ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1076" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | 2025 |
! colspan="2" style="text-align:center" | 2025 |
||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | Amount |
||
! class="col- |
! class="col-m" style="text-align:right" | Percentage |
||
|- |
|- |
||
| style="text-align:left" | U.S. federal statutory income tax rate |
| style="text-align:left" | U.S. federal statutory income tax rate |
||
| Line 6,203: | Line 7,297: | ||
| style="text-align:right" | 0.3% |
| style="text-align:right" | 0.3% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Effective tax rate</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>46,396</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>21.4%</b> |
||
|} |
|} |
||
</div> |
</div> |
||
{{fn note|1=1|2=The following state(s) and/or local jurisdictions make up more than 50% of the state income taxes: Florida.}} |
|||
====== Income tax expense at federal statutory rate ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1077" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | 2024 |
! colspan="2" style="text-align:center" | 2024 |
||
| Line 6,243: | Line 7,336: | ||
| style="text-align:right" | 1.2 |
| style="text-align:right" | 1.2 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total income tax expense |
||
| style="text-align:right" | |
| style="text-align:right" | 33,911 |
||
| style="text-align:right" | |
| style="text-align:right" | 22.2% |
||
| style="text-align:right" | |
| style="text-align:right" | 24,118 |
||
| style="text-align:right" | |
| style="text-align:right" | 21.9% |
||
|} |
|} |
||
</div> |
</div> |
||
====== Total income taxes paid ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1078" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col-s" style="text-align:right" | 2025 |
! class="col-s" style="text-align:right" | 2025 |
||
| Line 6,264: | Line 7,356: | ||
| style="text-align:right" | 1,164 |
| style="text-align:right" | 1,164 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total income taxes paid |
||
| style="text-align:right" | |
| style="text-align:right" | 50,994 |
||
|} |
|} |
||
</div> |
</div> |
||
{{fn note|1=1|2=No single state or jurisdiction accounts for greater than 5% of total taxes paid.}} |
|||
====== Deferred tax assets ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1079" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2025 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2024 |
||
|- |
|- |
||
! style="text-align:left" | Deferred tax assets: |
! style="text-align:left" | Deferred tax assets: |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Net operating losses |
| style="text-align:left" | Net operating losses |
||
| Line 6,307: | Line 7,398: | ||
| style="text-align:right" | 6,067 |
| style="text-align:right" | 6,067 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total deferred tax assets before valuation allowance |
||
| style="text-align:right" | |
| style="text-align:right" | 64,964 |
||
| style="text-align:right" | |
| style="text-align:right" | 58,947 |
||
|- |
|- |
||
| style="text-align:left" | Valuation allowance |
| style="text-align:left" | Valuation allowance |
||
| Line 6,315: | Line 7,406: | ||
| style="text-align:right" | ( 586 ) |
| style="text-align:right" | ( 586 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total deferred tax assets |
||
| style="text-align:right" | |
| style="text-align:right" | 64,310 |
||
| style="text-align:right" | |
| style="text-align:right" | 58,361 |
||
|- |
|||
| style="text-align:left" | <b>Deferred tax liabilities:</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Deferred policy acquisition costs |
| style="text-align:left" | Deferred policy acquisition costs |
||
| Line 6,351: | Line 7,446: | ||
| style="text-align:right" | 2,338 |
| style="text-align:right" | 2,338 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total deferred tax liabilities |
||
| style="text-align:right" | |
| style="text-align:right" | 36,445 |
||
| style="text-align:right" | |
| style="text-align:right" | 27,875 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net deferred tax asset</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>27,865</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>30,486</b> |
||
|} |
|} |
||
</div> |
</div> |
||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1080" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col-s" style="text-align:right" | 2025 |
! class="col-s" style="text-align:right" | 2025 |
||
| Line 6,375: | Line 7,471: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Balance at the end of the period</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>654</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>586</b> |
||
|} |
|} |
||
</div> |
</div> |
||
=== Tax Legislative Update === |
|||
{{chunk|doc=3z7a4yrxkn|c=256|p=16}} |
|||
* The ''One Big Beautiful Bill Act (“OBBB Act”)'' was signed into law in the United States on July 4, 2025 <sup>p. 94</sup>. |
|||
'''US tax reform impact''' |
|||
* The OBBB Act includes a broad range of tax reform provisions <sup>p. 94</sup>. |
|||
* The ''OBBB Act'' did not materially impact the Company's annual effective tax rate in 2025 <sup>p. 94</sup>. |
|||
* No material impact from the ''OBBB Act'' is expected on the Company's annual effective tax rate in 2026 <sup>p. 94</sup>. |
|||
* The One Big Beautiful Bill Act ("OBBB Act"), which includes broad tax reform provisions, was signed into law in the United States on July 4, 2025. |
|||
====== 14. Reserves for Losses and Loss Adjustment Expenses ====== |
|||
* The OBBB Act did not materially impact the Company's annual effective tax rate in 2025. |
|||
* No material impact from the OBBB Act is expected on the Company's annual effective tax rate in [[Definition:Year 2026|2026]]. |
|||
=== 14. Reserves for Losses and Loss Adjustment Expenses === |
|||
* The Company evaluates net ultimate loss and LAE under three sub-categories: multi-line solutions, short-tail/monoline specialty lines, and exited lines <sup>p. 95</sup>. |
|||
* These disaggregated groupings have more homogeneous risk characteristics with similar development patterns and are generally subject to similar trends <sup>p. 95</sup>. |
|||
* ''Short-tail/monoline specialty lines'' include global property & agriculture, accident & health, surety, and professional lines underwriting divisions <sup>p. 95</sup>. |
|||
* Losses for short-tail/monoline specialty lines are generally reported within a short period from the date of loss, and claims are typically settled and paid within a relatively short timeframe <sup>p. 95</sup>. |
|||
* Short-tail/monoline specialty lines can be impacted by larger, more complex losses due to factors like difficulty in determining actual damages and legal/regulatory impediments <sup>p. 95</sup>. |
|||
* ''Multi-line solutions'' include industry solutions, programs, captives, and transactional E&S underwriting divisions <sup>p. 95</sup>. |
|||
* Multi-line solutions primarily consist of occurrence liability, including general liability, excess liability, and commercial auto <sup>p. 95</sup>. |
|||
* Multi-line solutions have a longer duration for losses to fully develop compared to short-tail/monoline specialty lines <sup>p. 95</sup>. |
|||
* The longer-tail nature and unique claim characteristics of multi-line solutions introduce more uncertainty, as claims can be impacted by changes in regulation, inflation, and other unforeseen factors over time <sup>p. 95</sup>. |
|||
* ''Exited lines'' include all underwriting units placed in run-off and are presented separately from ongoing lines of business <sup>p. 95</sup>. |
|||
* For the year ended December 31, 2025, the Company recognized ''favorable development'' related to prior years’ loss and loss expense reserves of USD 7.5m <sup>p. 95</sup>. |
|||
** This was driven by favorable development of USD 24.6m in short-tail/monoline specialty lines and USD 5.3m in multi-line solutions <sup>p. 95</sup>. |
|||
** This was partially offset by USD 22.4m of adverse development in exited lines <sup>p. 95</sup>. |
|||
** The adverse development in exited lines was primarily attributable to commercial auto and excess over auto in divisions that have been non-renewed or had significantly reduced exposure over the past three years <sup>p. 95</sup>. |
|||
** This was offset by favorable development in surety and property <sup>p. 95</sup>. |
|||
* For the year ended December 31, 2024, the Company recognized ''adverse development'' related to prior years’ loss and loss expense reserves of USD 25.7m <sup>p. 95</sup>. |
|||
** This was primarily related to losses previously subject to the LPT from accident years 2018 and prior <sup>p. 95</sup>. |
|||
** This included USD 10.1m in multi-line solutions and USD 15.2m in exited lines <sup>p. 95</sup>. |
|||
* For the year ended December 31, 2023, the Company recognized ''adverse development'' related to prior years’ loss and loss expense reserves of USD 10.8m <sup>p. 95</sup>. |
|||
** Adverse development of USD 11.7m in multi-line solutions was driven by greater than expected severity in auto, general, and excess liability lines of business, primarily from accident years 2020 to 2022 <sup>p. 95</sup>. |
|||
** This adverse development was partially offset by favorable development in short-tail/monoline specialty lines <sup>p. 95</sup>. |
|||
** The favorable development was in the property line of business, primarily from accident years 2021 and 2022 <sup>p. 95</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=257|p=16}} |
|||
====== Reserves for losses and LAE, net of reinsurance ====== |
|||
'''Loss and LAE sub-categories''' |
|||
* The Company presents its loss development on a consolidated basis. |
|||
* Net ultimate loss and LAE are evaluated under three sub-categories: multi-line solutions, short-tail/monoline specialty lines, and exited lines. |
|||
* These disaggregated groupings have more homogeneous risk characteristics with similar development patterns and are generally subject to similar trends. |
|||
* Short-tail/Monoline Specialty Lines include global property & agriculture, accident & health, surety, and professional lines underwriting divisions. |
|||
* These are market niches served with monoline solutions that generally have shorter durations for losses to fully develop. |
|||
* Losses for short-tail/monoline specialty lines are generally reported within a short period from the date of loss, and claims are typically settled and paid within a relatively short timeframe. |
|||
* Short-tail/monoline specialty lines can be impacted by larger, more complex losses due to factors like difficulty determining actual damages, and legal and regulatory impediments that can extend settlement and payment periods. |
|||
* Multi-line Solutions include industry solutions, programs, captives, and transactional E&S underwriting divisions. |
|||
* These are market niches where the Company provides multiple products, most frequently as an integrated solution. |
|||
* The multi-line solution subcategory is predominantly made up of occurrence liability, including general liability, excess liability, and commercial auto. |
|||
* Multi-line solutions have a longer duration for losses to fully develop compared to short-tail/monoline specialty lines. |
|||
* The unique claim characteristics and longer-tail nature of multi-line solutions introduce more uncertainty, as claims can be impacted by changes in regulation, inflation, and other unforeseen factors over time. |
|||
* Exited lines include all underwriting units that the Company placed in run-off and are presented separately from ongoing [[Definition:Business mix|lines of business]]. |
|||
{{chunk|doc=3z7a4yrxkn|c=258|p=16}} |
|||
'''Reconciliation of unpaid losses and LAE''' |
|||
* The following table sets forth the reconciliation of unpaid losses and loss adjustment expenses (“LAE”) as reported in the Consolidated Balance Sheets as of and for the years ended December 31, 2025 and 2024. |
|||
* For the year ended December 31, 2025, the Company recognized favorable development related to prior years’ loss and loss expense reserves of USD 7.5m. |
|||
* This favorable development was driven by USD 24.6m in short-tail/monoline specialty lines and USD 5.3m in multi-line solutions. |
|||
* This was partially offset by USD 22.4m of adverse development in exited lines. |
|||
* The adverse development in exited lines was primarily attributable to commercial auto and excess over auto in divisions that have been non-renewed or had significantly reduced exposure over the past three years. |
|||
* This was offset by favorable development in surety and property. |
|||
* For the year ended December 31, 2024, the Company recognized adverse development related to prior years’ loss and loss expense reserves of USD 25.7m. |
|||
* This adverse development was primarily related to losses previously subject to the LPT from accident years 2018 and prior. |
|||
* This included USD 10.1m in multi-line solutions and USD 15.2m in exited lines. |
|||
* During the year ended December 31, 2023, the Company recognized adverse development related to prior years’ loss and loss expense reserves of USD 10.8m. |
|||
* Adverse development of USD 11.7m in multi-line solutions was driven by greater than expected severity in auto, general, and excess liability [[Definition:Business mix|lines of business]], primarily from accident years 2020 to 2022. |
|||
* This adverse development was partially offset by favorable development in short-tail/monoline specialty lines. |
|||
* The favorable development in short-tail/monoline specialty lines was in the property [[Definition:Business mix|line of business]], primarily from accident years 2021 and 2022. |
|||
{{chunk|doc=3z7a4yrxkn|c=259|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1081" class="wikitable fintable" |
||
|+ 14. Reserves for Losses and Loss Adjustment Expenses |
|||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col-m" style="text-align:right" | 2025 |
! class="col-m" style="text-align:right" | 2025 |
||
| Line 6,432: | Line 7,543: | ||
| style="text-align:right" | ( 435,986 ) |
| style="text-align:right" | ( 435,986 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Reserves for losses and LAE, beginning of period, net of reinsurance</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,111,537</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>859,017</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>705,771</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Incurred, net of reinsurance, related to:</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 6,452: | Line 7,563: | ||
| style="text-align:right" | 10,770 |
| style="text-align:right" | 10,770 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total incurred, net of reinsurance |
||
| style="text-align:right" | |
| style="text-align:right" | 802,904 |
||
| style="text-align:right" | |
| style="text-align:right" | 683,511 |
||
| style="text-align:right" | |
| style="text-align:right" | 516,664 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Paid, net of reinsurance, related to:</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 6,472: | Line 7,583: | ||
| style="text-align:right" | 253,481 |
| style="text-align:right" | 253,481 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total paid |
||
| style="text-align:right" | |
| style="text-align:right" | 516,712 |
||
| style="text-align:right" | |
| style="text-align:right" | 430,991 |
||
| style="text-align:right" | |
| style="text-align:right" | 363,418 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net reserves for losses and LAE, end of period</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,397,729</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,111,537</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>859,017</b> |
||
|- |
|- |
||
| style="text-align:left" | Plus: reinsurance recoverable on unpaid claims, end of period |
| style="text-align:left" | Plus: reinsurance recoverable on unpaid claims, end of period |
||
| Line 6,487: | Line 7,598: | ||
| style="text-align:right" | 455,484 |
| style="text-align:right" | 455,484 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Reserves for losses and LAE, end of period</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>2,318,894</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,782,383</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,314,501</b> |
||
|} |
|} |
||
</div> |
</div> |
||
=== Short Duration Contract Disclosures === |
|||
{{chunk|doc=3z7a4yrxkn|c=260|p=16}} |
|||
* ''Losses and LAE reserves'' represent the Company's best estimate of the ultimate net cost of all reported and unreported losses that are unpaid as of the balance sheet dates <sup>p. 96</sup>. |
|||
'''Losses and LAE reserves''' |
|||
* ''Estimated reserves for losses and LAE'' include accumulated estimates for claims reported and unpaid, projected increases in claims costs for reported claims, claims incurred but not reported, and expenses for investigating and adjusting all incurred and unpaid claims <sup>p. 96</sup>. |
|||
* ''Cumulative number of reported claims'' is measured by incident <sup>p. 96</sup>. |
|||
* ''Claim counts'' include all reported claims, even if no liability is established for the claim (i.e., no reserve for loss and loss adjustment expenses) <sup>p. 96</sup>. |
|||
* Losses and LAE reserves represent the Company's best estimate of the ultimate net cost of all reported and unreported losses that are unpaid as of the balance sheet dates. |
|||
====== Incurred losses and ALAE, net of reinsurance ====== |
|||
* Estimated reserves for losses and LAE include: |
|||
** Accumulation of estimates for claims reported and unpaid prior to the balance sheet dates. |
|||
** Estimates (based on projections of relevant historical data) of increases in claims costs for claims already reported. |
|||
** Estimates of claims incurred but not reported. |
|||
** Estimates of expenses for investigating and adjusting all incurred and unpaid claims. |
|||
* The Company measures claim counts by incident when determining the cumulative number of reported claims. |
|||
* Claim counts include all reported claims, even if the Company does not establish a liability for the claim (i.e., reserve for loss and loss adjustment expenses). |
|||
=== Short-tail/Monoline Specialty Lines === |
|||
{{chunk|doc=3z7a4yrxkn|c=261|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1082" class="wikitable fintable" |
||
|+ Incurred Losses and ALAE, Net of Reinsurance by Accident Year |
|||
|- |
|||
! colspan="3" style="text-align:center" | ($ in thousands except number of claims) |
! colspan="3" style="text-align:center" | ($ in thousands except number of claims) |
||
! style="text-align: |
! style="text-align:left" | |
||
! style="text-align: |
! style="text-align:left" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! style="text-align:left" | |
||
|- |
|- |
||
! colspan="6" style="text-align:center" | Incurred Losses and ALAE, Net of Reinsurance |
! colspan="6" style="text-align:center" | Incurred Losses and ALAE, Net of Reinsurance |
||
| Line 6,517: | Line 7,639: | ||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="5" style="text-align:center" | Years Ended December 31, |
! colspan="5" style="text-align:center" | Years Ended December 31, |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! style="text-align:left" | Reported Claims |
||
|- |
|- |
||
! style="text-align:left" | Accident Year |
! style="text-align:left" | Accident Year |
||
! |
! style="text-align:left" | 2021* |
||
! |
! style="text-align:left" | 2022* |
||
! |
! style="text-align:left" | 2023* |
||
! |
! style="text-align:left" | 2024* |
||
! class="col-m" style="text-align:right" | 2025 |
! class="col-m" style="text-align:right" | 2025 |
||
! class="col-m" style="text-align:right" | IBNR |
! class="col-m" style="text-align:right" | IBNR |
||
! |
! style="text-align:left" | Reported Claims |
||
|- |
|- |
||
| style="text-align:left" | 2021 |
| style="text-align:left" | 2021 |
||
| Line 6,536: | Line 7,658: | ||
| style="text-align:right" | 99,783 |
| style="text-align:right" | 99,783 |
||
| style="text-align:right" | 1,774 |
| style="text-align:right" | 1,774 |
||
| style="text-align: |
| style="text-align:left" | 1,656 |
||
|- |
|- |
||
| style="text-align:left" | 2022 |
| style="text-align:left" | 2022 |
||
| Line 6,545: | Line 7,667: | ||
| style="text-align:right" | 96,874 |
| style="text-align:right" | 96,874 |
||
| style="text-align:right" | 6,266 |
| style="text-align:right" | 6,266 |
||
| style="text-align: |
| style="text-align:left" | 2,414 |
||
|- |
|- |
||
| style="text-align:left" | 2023 |
| style="text-align:left" | 2023 |
||
| Line 6,554: | Line 7,676: | ||
| style="text-align:right" | 161,222 |
| style="text-align:right" | 161,222 |
||
| style="text-align:right" | 28,997 |
| style="text-align:right" | 28,997 |
||
| style="text-align: |
| style="text-align:left" | 5,015 |
||
|- |
|- |
||
| style="text-align:left" | 2024 |
| style="text-align:left" | 2024 |
||
| Line 6,563: | Line 7,685: | ||
| style="text-align:right" | 292,220 |
| style="text-align:right" | 292,220 |
||
| style="text-align:right" | 99,302 |
| style="text-align:right" | 99,302 |
||
| style="text-align: |
| style="text-align:left" | 5,819 |
||
|- |
|- |
||
| style="text-align:left" | 2025 |
| style="text-align:left" | 2025 |
||
| Line 6,572: | Line 7,694: | ||
| style="text-align:right" | 422,528 |
| style="text-align:right" | 422,528 |
||
| style="text-align:right" | 275,190 |
| style="text-align:right" | 275,190 |
||
| style="text-align: |
| style="text-align:left" | 5,495 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total |
||
| style="text-align:left" | |
| style="text-align:left" | — |
||
| style="text-align:left" | |
| style="text-align:left" | — |
||
| style="text-align:left" | |
| style="text-align:left" | — |
||
| style="text-align:left" | |
| style="text-align:left" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 1,072,627 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
|- |
|- |
||
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| Line 6,590: | Line 7,712: | ||
| style="text-align:right" | ( 528,255 ) |
| style="text-align:right" | ( 528,255 ) |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
|- |
|- |
||
| style="text-align:left" | Net reserves for loss and ALAE before 2021 |
| style="text-align:left" | Net reserves for loss and ALAE before 2021 |
||
| Line 6,599: | Line 7,721: | ||
| style="text-align:right" | 1,570 |
| style="text-align:right" | 1,570 |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align:left" | |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align:left" | |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align:left" | |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align:left" | |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align:right" | |
| style="text-align:right" | 545,942 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
|- |
|- |
||
| style="text-align:left" | *Supplementary information and unaudited |
| style="text-align:left" | *Supplementary information and unaudited |
||
| Line 6,617: | Line 7,739: | ||
| style="text-align:right" | *Supplementary information and unaudited |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | *Supplementary information and unaudited |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
|} |
|} |
||
</div> |
</div> |
||
====== Cumulative paid losses and ALAE, net of reinsurance ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1083" class="wikitable fintable" |
||
|- |
|||
! colspan="3" style="text-align:center" | ($ in thousands) |
! colspan="3" style="text-align:center" | ($ in thousands) |
||
! style="text-align: |
! style="text-align:left" | |
||
! style="text-align: |
! style="text-align:left" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
! colspan="6" style="text-align:center" | Cumulative Paid Losses and ALAE, Net of Reinsurance ($ in thousands) |
! colspan="6" style="text-align:center" | Cumulative Paid Losses and ALAE, Net of Reinsurance ($ in thousands) |
||
| Line 6,636: | Line 7,757: | ||
|- |
|- |
||
! style="text-align:left" | Accident Year |
! style="text-align:left" | Accident Year |
||
! |
! style="text-align:left" | 2021* |
||
! |
! style="text-align:left" | 2022* |
||
! |
! style="text-align:left" | 2023* |
||
! |
! style="text-align:left" | 2024* |
||
! class="col-m" style="text-align:right" | 2025 |
! class="col-m" style="text-align:right" | 2025 |
||
|- |
|- |
||
| style="text-align:left" | 2021 |
| style="text-align:left" | 2021 |
||
| style="text-align:left" | 18,447 |
| style="text-align:left" | 18,447 |
||
| style="text-align: |
| style="text-align:left" | 56,803 |
||
| style="text-align: |
| style="text-align:left" | 67,912 |
||
| style="text-align: |
| style="text-align:left" | 78,439 |
||
| style="text-align:right" | 93,560 |
| style="text-align:right" | 93,560 |
||
|- |
|- |
||
| style="text-align:left" | 2022 |
| style="text-align:left" | 2022 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 27,773 |
||
| style="text-align: |
| style="text-align:left" | 64,594 |
||
| style="text-align: |
| style="text-align:left" | 77,150 |
||
| style="text-align:right" | 85,696 |
| style="text-align:right" | 85,696 |
||
|- |
|- |
||
| style="text-align:left" | 2023 |
| style="text-align:left" | 2023 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 33,795 |
||
| style="text-align: |
| style="text-align:left" | 100,705 |
||
| style="text-align:right" | 114,247 |
| style="text-align:right" | 114,247 |
||
|- |
|- |
||
| style="text-align:left" | 2024 |
| style="text-align:left" | 2024 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 53,691 |
||
| style="text-align:right" | 154,896 |
| style="text-align:right" | 154,896 |
||
|- |
|- |
||
| style="text-align:left" | 2025 |
| style="text-align:left" | 2025 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | 79,856 |
| style="text-align:right" | 79,856 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total |
||
| style="text-align:left" | |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 528,255 |
||
|- |
|- |
||
| style="text-align:left" | *Supplementary information and unaudited |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align:left" | *Supplementary information and unaudited |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align:right" | *Supplementary information and unaudited |
| style="text-align:right" | *Supplementary information and unaudited |
||
|} |
|} |
||
</div> |
</div> |
||
=== Multi-line Solutions === |
|||
====== Incurred losses and ALAE, net of reinsurance by accident year ====== |
|||
{{chunk|doc=3z7a4yrxkn|c=262|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1084" class="wikitable fintable" |
||
|+ Incurred losses and ALAE, net of reinsurance by accident year |
|||
|- |
|||
! colspan="5" style="text-align:center" | ($ in thousands except number of claims) |
! colspan="5" style="text-align:center" | ($ in thousands except number of claims) |
||
! style="text-align: |
! style="text-align:left" | |
||
! style="text-align: |
! style="text-align:left" | |
||
! style="text-align: |
! style="text-align:left" | |
||
! style="text-align: |
! style="text-align:left" | |
||
! style="text-align: |
! style="text-align:left" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
! colspan="11" style="text-align:center" | Incurred Losses and ALAE, Net of Reinsurance ($ in thousands) |
! colspan="11" style="text-align:center" | Incurred Losses and ALAE, Net of Reinsurance ($ in thousands) |
||
| Line 6,712: | Line 7,837: | ||
! style="text-align:left" | Accident Year |
! style="text-align:left" | Accident Year |
||
! colspan="11" style="text-align:center" | Years Ended December 31, |
! colspan="11" style="text-align:center" | Years Ended December 31, |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Reported Claims |
||
|- |
|- |
||
! style="text-align:left" | Accident Year |
! style="text-align:left" | Accident Year |
||
! |
! style="text-align:left" | 2016* |
||
! |
! style="text-align:left" | 2017* |
||
! |
! style="text-align:left" | 2018* |
||
! |
! style="text-align:left" | 2019* |
||
! |
! style="text-align:left" | 2020* |
||
! |
! style="text-align:left" | 2021* |
||
! |
! style="text-align:left" | 2022* |
||
! |
! style="text-align:left" | 2023* |
||
! |
! style="text-align:left" | 2024* |
||
! class="col-m" style="text-align:right" | 2025 |
! class="col-m" style="text-align:right" | 2025 |
||
! class="col-m" style="text-align:right" | IBNR |
! class="col-m" style="text-align:right" | IBNR |
||
| Line 6,734: | Line 7,859: | ||
| style="text-align:left" | 62,643 |
| style="text-align:left" | 62,643 |
||
| style="text-align:left" | 84,579 |
| style="text-align:left" | 84,579 |
||
| style="text-align: |
| style="text-align:left" | 84,579 |
||
| style="text-align: |
| style="text-align:left" | 84,829 |
||
| style="text-align: |
| style="text-align:left" | 84,829 |
||
| style="text-align: |
| style="text-align:left" | 85,434 |
||
| style="text-align:right" | 85,098 |
| style="text-align:right" | 85,098 |
||
| style="text-align:right" | 828 |
| style="text-align:right" | 828 |
||
| Line 6,748: | Line 7,873: | ||
| style="text-align:left" | 64,260 |
| style="text-align:left" | 64,260 |
||
| style="text-align:left" | 78,166 |
| style="text-align:left" | 78,166 |
||
| style="text-align: |
| style="text-align:left" | 78,166 |
||
| style="text-align: |
| style="text-align:left" | 78,766 |
||
| style="text-align: |
| style="text-align:left" | 78,766 |
||
| style="text-align: |
| style="text-align:left" | 80,493 |
||
| style="text-align:right" | 79,819 |
| style="text-align:right" | 79,819 |
||
| style="text-align:right" | 837 |
| style="text-align:right" | 837 |
||
| Line 6,762: | Line 7,887: | ||
| style="text-align:left" | 74,476 |
| style="text-align:left" | 74,476 |
||
| style="text-align:left" | 69,319 |
| style="text-align:left" | 69,319 |
||
| style="text-align: |
| style="text-align:left" | 71,719 |
||
| style="text-align: |
| style="text-align:left" | 73,019 |
||
| style="text-align: |
| style="text-align:left" | 73,019 |
||
| style="text-align: |
| style="text-align:left" | 75,686 |
||
| style="text-align:right" | 72,963 |
| style="text-align:right" | 72,963 |
||
| style="text-align:right" | 673 |
| style="text-align:right" | 673 |
||
| Line 6,776: | Line 7,901: | ||
| style="text-align:left" | 107,432 |
| style="text-align:left" | 107,432 |
||
| style="text-align:left" | 109,226 |
| style="text-align:left" | 109,226 |
||
| style="text-align: |
| style="text-align:left" | 112,378 |
||
| style="text-align: |
| style="text-align:left" | 115,530 |
||
| style="text-align: |
| style="text-align:left" | 116,230 |
||
| style="text-align: |
| style="text-align:left" | 116,206 |
||
| style="text-align:right" | 110,564 |
| style="text-align:right" | 110,564 |
||
| style="text-align:right" | 1,384 |
| style="text-align:right" | 1,384 |
||
| Line 6,790: | Line 7,915: | ||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align:left" | 113,030 |
| style="text-align:left" | 113,030 |
||
| style="text-align: |
| style="text-align:left" | 124,076 |
||
| style="text-align: |
| style="text-align:left" | 128,111 |
||
| style="text-align: |
| style="text-align:left" | 132,495 |
||
| style="text-align: |
| style="text-align:left" | 132,125 |
||
| style="text-align:right" | 134,281 |
| style="text-align:right" | 134,281 |
||
| style="text-align:right" | 4,174 |
| style="text-align:right" | 4,174 |
||
| Line 6,804: | Line 7,929: | ||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 156,067 |
||
| style="text-align: |
| style="text-align:left" | 158,891 |
||
| style="text-align: |
| style="text-align:left" | 160,331 |
||
| style="text-align: |
| style="text-align:left" | 160,546 |
||
| style="text-align:right" | 157,006 |
| style="text-align:right" | 157,006 |
||
| style="text-align:right" | 7,932 |
| style="text-align:right" | 7,932 |
||
| Line 6,818: | Line 7,943: | ||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 236,909 |
||
| style="text-align: |
| style="text-align:left" | 242,097 |
||
| style="text-align: |
| style="text-align:left" | 242,358 |
||
| style="text-align:right" | 249,317 |
| style="text-align:right" | 249,317 |
||
| style="text-align:right" | 19,315 |
| style="text-align:right" | 19,315 |
||
| Line 6,832: | Line 7,957: | ||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 306,511 |
||
| style="text-align: |
| style="text-align:left" | 306,511 |
||
| style="text-align:right" | 320,637 |
| style="text-align:right" | 320,637 |
||
| style="text-align:right" | 96,700 |
| style="text-align:right" | 96,700 |
||
| Line 6,846: | Line 7,971: | ||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 353,933 |
||
| style="text-align:right" | 336,197 |
| style="text-align:right" | 336,197 |
||
| style="text-align:right" | 155,878 |
| style="text-align:right" | 155,878 |
||
| Line 6,860: | Line 7,985: | ||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | 356,590 |
| style="text-align:right" | 356,590 |
||
| style="text-align:right" | 257,468 |
| style="text-align:right" | 257,468 |
||
| style="text-align:right" | 6,139 |
| style="text-align:right" | 6,139 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total |
||
| style="text-align:left" | |
| style="text-align:left" | — |
||
| style="text-align:left" | |
| style="text-align:left" | — |
||
| style="text-align:left" | |
| style="text-align:left" | — |
||
| style="text-align:left" | |
| style="text-align:left" | — |
||
| style="text-align:left" | |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 1,902,472 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| Line 6,888: | Line 8,013: | ||
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align: |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align: |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align: |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align: |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align:right" | ( 1,162,853 ) |
| style="text-align:right" | ( 1,162,853 ) |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 6,902: | Line 8,027: | ||
| style="text-align:left" | Net reserves for loss and ALAE before 2016 |
| style="text-align:left" | Net reserves for loss and ALAE before 2016 |
||
| style="text-align:left" | Net reserves for loss and ALAE before 2016 |
| style="text-align:left" | Net reserves for loss and ALAE before 2016 |
||
| style="text-align: |
| style="text-align:left" | Net reserves for loss and ALAE before 2016 |
||
| style="text-align: |
| style="text-align:left" | Net reserves for loss and ALAE before 2016 |
||
| style="text-align: |
| style="text-align:left" | Net reserves for loss and ALAE before 2016 |
||
| style="text-align: |
| style="text-align:left" | Net reserves for loss and ALAE before 2016 |
||
| style="text-align:right" | ( 189 ) |
| style="text-align:right" | ( 189 ) |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align:left" | |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align:left" | |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align:left" | |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align:left" | |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align:left" | |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align: |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align: |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align: |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align: |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align:right" | |
| style="text-align:right" | 739,430 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | *Supplementary information and unaudited |
| style="text-align:left" | *Supplementary information and unaudited |
||
| Line 6,930: | Line 8,055: | ||
| style="text-align:left" | *Supplementary information and unaudited |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align:left" | *Supplementary information and unaudited |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align:right" | *Supplementary information and unaudited |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | *Supplementary information and unaudited |
| style="text-align:right" | *Supplementary information and unaudited |
||
| Line 6,939: | Line 8,064: | ||
|} |
|} |
||
</div> |
</div> |
||
====== Cumulative paid losses and ALAE, net of reinsurance by accident year ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1085" class="wikitable fintable" |
||
|- |
|||
! colspan="4" style="text-align:center" | ($ in thousands) |
! colspan="4" style="text-align:center" | ($ in thousands) |
||
! style="text-align: |
! style="text-align:left" | |
||
! style="text-align: |
! style="text-align:left" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
! colspan="11" style="text-align:center" | Cumulative Paid Losses and ALAE, Net of Reinsurance ($ in thousands) |
! colspan="11" style="text-align:center" | Cumulative Paid Losses and ALAE, Net of Reinsurance ($ in thousands) |
||
| Line 6,959: | Line 8,083: | ||
|- |
|- |
||
! style="text-align:left" | Accident Year |
! style="text-align:left" | Accident Year |
||
! |
! style="text-align:left" | 2016* |
||
! |
! style="text-align:left" | 2017* |
||
! |
! style="text-align:left" | 2018* |
||
! |
! style="text-align:left" | 2019* |
||
! |
! style="text-align:left" | 2020* |
||
! class="col-m" style="text-align:right" | 2021* |
! class="col-m" style="text-align:right" | 2021* |
||
! class="col-m" style="text-align:right" | 2022* |
! class="col-m" style="text-align:right" | 2022* |
||
| Line 6,972: | Line 8,096: | ||
| style="text-align:left" | 2016 |
| style="text-align:left" | 2016 |
||
| style="text-align:left" | 23,239 |
| style="text-align:left" | 23,239 |
||
| style="text-align: |
| style="text-align:left" | 42,528 |
||
| style="text-align: |
| style="text-align:left" | 53,352 |
||
| style="text-align: |
| style="text-align:left" | 58,895 |
||
| style="text-align: |
| style="text-align:left" | 69,691 |
||
| style="text-align:right" | 72,544 |
| style="text-align:right" | 72,544 |
||
| style="text-align:right" | 75,855 |
| style="text-align:right" | 75,855 |
||
| Line 6,984: | Line 8,108: | ||
| style="text-align:left" | 2017 |
| style="text-align:left" | 2017 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 23,770 |
||
| style="text-align: |
| style="text-align:left" | 41,945 |
||
| style="text-align: |
| style="text-align:left" | 53,093 |
||
| style="text-align: |
| style="text-align:left" | 61,354 |
||
| style="text-align:right" | 67,926 |
| style="text-align:right" | 67,926 |
||
| style="text-align:right" | 71,109 |
| style="text-align:right" | 71,109 |
||
| Line 6,996: | Line 8,120: | ||
| style="text-align:left" | 2018 |
| style="text-align:left" | 2018 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 26,201 |
||
| style="text-align: |
| style="text-align:left" | 42,568 |
||
| style="text-align: |
| style="text-align:left" | 47,226 |
||
| style="text-align:right" | 58,655 |
| style="text-align:right" | 58,655 |
||
| style="text-align:right" | 65,635 |
| style="text-align:right" | 65,635 |
||
| Line 7,008: | Line 8,132: | ||
| style="text-align:left" | 2019 |
| style="text-align:left" | 2019 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 33,019 |
||
| style="text-align: |
| style="text-align:left" | 50,933 |
||
| style="text-align:right" | 71,053 |
| style="text-align:right" | 71,053 |
||
| style="text-align:right" | 87,816 |
| style="text-align:right" | 87,816 |
||
| Line 7,020: | Line 8,144: | ||
| style="text-align:left" | 2020 |
| style="text-align:left" | 2020 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 29,499 |
||
| style="text-align:right" | 60,680 |
| style="text-align:right" | 60,680 |
||
| style="text-align:right" | 82,236 |
| style="text-align:right" | 82,236 |
||
| Line 7,032: | Line 8,156: | ||
| style="text-align:left" | 2021 |
| style="text-align:left" | 2021 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | 37,118 |
| style="text-align:right" | 37,118 |
||
| style="text-align:right" | 73,293 |
| style="text-align:right" | 73,293 |
||
| Line 7,044: | Line 8,168: | ||
| style="text-align:left" | 2022 |
| style="text-align:left" | 2022 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 50,148 |
| style="text-align:right" | 50,148 |
||
| Line 7,056: | Line 8,180: | ||
| style="text-align:left" | 2023 |
| style="text-align:left" | 2023 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 7,068: | Line 8,192: | ||
| style="text-align:left" | 2024 |
| style="text-align:left" | 2024 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 7,079: | Line 8,203: | ||
|- |
|- |
||
| style="text-align:left" | 2025 |
| style="text-align:left" | 2025 |
||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 7,084: | Line 8,212: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 49,558 |
|||
|- |
|||
| style="text-align:left" | Total |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 1,162,853 |
||
|- |
|||
| style="text-align:left" | '''Total''' |
|||
| style="text-align:left" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''1,162,853''' |
|||
|- |
|- |
||
| style="text-align:left" | *Supplementary information and unaudited |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align:left" | *Supplementary information and unaudited |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align:right" | *Supplementary information and unaudited |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | *Supplementary information and unaudited |
| style="text-align:right" | *Supplementary information and unaudited |
||
| Line 7,116: | Line 8,240: | ||
</div> |
</div> |
||
=== Exited Lines — all lines in runoff === |
|||
{{chunk|doc=3z7a4yrxkn|c=263|p=16}} |
|||
* The table presents the reconciliation of net incurred and paid loss development tables to balance sheet reserves for losses and loss adjustment expenses as of December 31, 2025 and 2024 <sup>p. 97</sup>. |
|||
'''Reconciliation of loss development tables''' |
|||
* The following table sets forth the historical average annual payout of incurred losses and allocated loss adjustment expenses (claims duration) for short-duration contracts <sup>p. 97</sup>. |
|||
* The claims duration is based on disaggregated information in the paid loss development tables, net of reinsurance <sup>p. 97</sup>. |
|||
* The table below presents the reconciliation of the net incurred and paid loss development tables to the balance sheet reserves for losses and loss adjustment expenses at December 31, 2025 and 2024. |
|||
====== Incurred losses and ALAE, net of reinsurance by accident year ====== |
|||
* The following table sets forth the historical average annual payout of incurred losses and allocated loss adjustment expenses (claims duration) for short-duration contracts, based on the disaggregated information in the paid loss development tables, net of reinsurance. |
|||
{{chunk|doc=3z7a4yrxkn|c=264|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1086" class="wikitable fintable" |
||
|+ Incurred losses and ALAE, net of reinsurance by accident year |
|||
|- |
|||
! colspan="4" style="text-align:center" | ($ in thousands except number of claims) |
! colspan="4" style="text-align:center" | ($ in thousands except number of claims) |
||
! style="text-align: |
! style="text-align:left" | |
||
! style="text-align: |
! style="text-align:left" | |
||
! style="text-align: |
! style="text-align:left" | |
||
! style="text-align: |
! style="text-align:left" | |
||
! style="text-align: |
! style="text-align:left" | |
||
! style="text-align: |
! style="text-align:left" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
! colspan="11" style="text-align:center" | Incurred Losses and ALAE, Net of Reinsurance ($ in thousands) |
! colspan="11" style="text-align:center" | Incurred Losses and ALAE, Net of Reinsurance ($ in thousands) |
||
| Line 7,142: | Line 8,270: | ||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="11" style="text-align:center" | Years Ended December 31, |
! colspan="11" style="text-align:center" | Years Ended December 31, |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Reported Claims |
||
|- |
|- |
||
! style="text-align:left" | Accident Year |
! style="text-align:left" | Accident Year |
||
! |
! style="text-align:left" | 2016* |
||
! |
! style="text-align:left" | 2017* |
||
! |
! style="text-align:left" | 2018* |
||
! |
! style="text-align:left" | 2019* |
||
! |
! style="text-align:left" | 2020* |
||
! |
! style="text-align:left" | 2021* |
||
! |
! style="text-align:left" | 2022* |
||
! |
! style="text-align:left" | 2023* |
||
! |
! style="text-align:left" | 2024* |
||
! class="col-m" style="text-align:right" | 2025 |
! class="col-m" style="text-align:right" | 2025 |
||
! class="col-m" style="text-align:right" | IBNR |
! class="col-m" style="text-align:right" | IBNR |
||
| Line 7,164: | Line 8,292: | ||
| style="text-align:left" | 93,577 |
| style="text-align:left" | 93,577 |
||
| style="text-align:left" | 97,301 |
| style="text-align:left" | 97,301 |
||
| style="text-align: |
| style="text-align:left" | 98,301 |
||
| style="text-align: |
| style="text-align:left" | 100,651 |
||
| style="text-align: |
| style="text-align:left" | 100,651 |
||
| style="text-align: |
| style="text-align:left" | 102,801 |
||
| style="text-align:right" | 104,246 |
| style="text-align:right" | 104,246 |
||
| style="text-align:right" | 1,851 |
| style="text-align:right" | 1,851 |
||
| Line 7,178: | Line 8,306: | ||
| style="text-align:left" | 81,785 |
| style="text-align:left" | 81,785 |
||
| style="text-align:left" | 65,735 |
| style="text-align:left" | 65,735 |
||
| style="text-align: |
| style="text-align:left" | 68,346 |
||
| style="text-align: |
| style="text-align:left" | 68,646 |
||
| style="text-align: |
| style="text-align:left" | 68,646 |
||
| style="text-align: |
| style="text-align:left" | 70,885 |
||
| style="text-align:right" | 72,682 |
| style="text-align:right" | 72,682 |
||
| style="text-align:right" | 1,819 |
| style="text-align:right" | 1,819 |
||
| Line 7,192: | Line 8,320: | ||
| style="text-align:left" | 68,990 |
| style="text-align:left" | 68,990 |
||
| style="text-align:left" | 76,506 |
| style="text-align:left" | 76,506 |
||
| style="text-align: |
| style="text-align:left" | 79,006 |
||
| style="text-align: |
| style="text-align:left" | 84,165 |
||
| style="text-align: |
| style="text-align:left" | 84,165 |
||
| style="text-align: |
| style="text-align:left" | 92,082 |
||
| style="text-align:right" | 91,897 |
| style="text-align:right" | 91,897 |
||
| style="text-align:right" | 4,093 |
| style="text-align:right" | 4,093 |
||
| Line 7,206: | Line 8,334: | ||
| style="text-align:left" | 87,115 |
| style="text-align:left" | 87,115 |
||
| style="text-align:left" | 73,635 |
| style="text-align:left" | 73,635 |
||
| style="text-align: |
| style="text-align:left" | 77,770 |
||
| style="text-align: |
| style="text-align:left" | 79,414 |
||
| style="text-align: |
| style="text-align:left" | 79,572 |
||
| style="text-align: |
| style="text-align:left" | 79,823 |
||
| style="text-align:right" | 86,131 |
| style="text-align:right" | 86,131 |
||
| style="text-align:right" | 9,773 |
| style="text-align:right" | 9,773 |
||
| Line 7,220: | Line 8,348: | ||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align:left" | 132,248 |
| style="text-align:left" | 132,248 |
||
| style="text-align: |
| style="text-align:left" | 136,469 |
||
| style="text-align: |
| style="text-align:left" | 137,835 |
||
| style="text-align: |
| style="text-align:left" | 137,907 |
||
| style="text-align: |
| style="text-align:left" | 137,671 |
||
| style="text-align:right" | 138,320 |
| style="text-align:right" | 138,320 |
||
| style="text-align:right" | 10,644 |
| style="text-align:right" | 10,644 |
||
| Line 7,234: | Line 8,362: | ||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 83,322 |
||
| style="text-align: |
| style="text-align:left" | 91,188 |
||
| style="text-align: |
| style="text-align:left" | 91,323 |
||
| style="text-align: |
| style="text-align:left" | 92,095 |
||
| style="text-align:right" | 97,577 |
| style="text-align:right" | 97,577 |
||
| style="text-align:right" | 10,676 |
| style="text-align:right" | 10,676 |
||
| Line 7,248: | Line 8,376: | ||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 12,717 |
||
| style="text-align: |
| style="text-align:left" | 12,240 |
||
| style="text-align: |
| style="text-align:left" | 11,800 |
||
| style="text-align:right" | 14,362 |
| style="text-align:right" | 14,362 |
||
| style="text-align:right" | 2,025 |
| style="text-align:right" | 2,025 |
||
| Line 7,262: | Line 8,390: | ||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | 2 |
| style="text-align:right" | 2 |
||
| style="text-align:right" | 1 |
| style="text-align:right" | 1 |
||
| Line 7,276: | Line 8,404: | ||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | 5 |
| style="text-align:right" | 5 |
||
| style="text-align:right" | 5 |
| style="text-align:right" | 5 |
||
| Line 7,290: | Line 8,418: | ||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | 11 |
| style="text-align:right" | 11 |
||
| style="text-align:right" | 11 |
| style="text-align:right" | 11 |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total |
||
| style="text-align:left" | |
| style="text-align:left" | — |
||
| style="text-align:left" | |
| style="text-align:left" | — |
||
| style="text-align:left" | |
| style="text-align:left" | — |
||
| style="text-align:left" | |
| style="text-align:left" | — |
||
| style="text-align:left" | |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 605,233 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| Line 7,318: | Line 8,446: | ||
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align: |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align: |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align: |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align: |
| style="text-align:left" | Cumulative net paid loss and ALAE from the table below |
||
| style="text-align:right" | ( 538,304 ) |
| style="text-align:right" | ( 538,304 ) |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 7,332: | Line 8,460: | ||
| style="text-align:left" | Net reserves for loss and ALAE before 2015 |
| style="text-align:left" | Net reserves for loss and ALAE before 2015 |
||
| style="text-align:left" | Net reserves for loss and ALAE before 2015 |
| style="text-align:left" | Net reserves for loss and ALAE before 2015 |
||
| style="text-align: |
| style="text-align:left" | Net reserves for loss and ALAE before 2015 |
||
| style="text-align: |
| style="text-align:left" | Net reserves for loss and ALAE before 2015 |
||
| style="text-align: |
| style="text-align:left" | Net reserves for loss and ALAE before 2015 |
||
| style="text-align: |
| style="text-align:left" | Net reserves for loss and ALAE before 2015 |
||
| style="text-align:right" | 14,737 |
| style="text-align:right" | 14,737 |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align:left" | |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align:left" | |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align:left" | |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align:left" | |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align:left" | |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align: |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align: |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align: |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align: |
| style="text-align:left" | Total net reserves for loss and ALAE |
||
| style="text-align:right" | |
| style="text-align:right" | 81,666 |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | *Supplementary information and unaudited |
| style="text-align:left" | *Supplementary information and unaudited |
||
| Line 7,360: | Line 8,488: | ||
| style="text-align:left" | *Supplementary information and unaudited |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align:left" | *Supplementary information and unaudited |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align:right" | *Supplementary information and unaudited |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | *Supplementary information and unaudited |
| style="text-align:right" | *Supplementary information and unaudited |
||
| Line 7,369: | Line 8,497: | ||
|} |
|} |
||
</div> |
</div> |
||
====== Cumulative paid losses and ALAE, net of reinsurance by accident year ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1087" class="wikitable fintable" |
||
|- |
|||
! colspan="4" style="text-align:center" | ($ in thousands) |
! colspan="4" style="text-align:center" | ($ in thousands) |
||
! style="text-align: |
! style="text-align:left" | |
||
! style="text-align: |
! style="text-align:left" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
! colspan="11" style="text-align:center" | Cumulative Paid Losses and ALAE, Net of Reinsurance ($ in thousands) |
! colspan="11" style="text-align:center" | Cumulative Paid Losses and ALAE, Net of Reinsurance ($ in thousands) |
||
| Line 7,389: | Line 8,516: | ||
|- |
|- |
||
! style="text-align:left" | Accident Year |
! style="text-align:left" | Accident Year |
||
! |
! style="text-align:left" | 2016* |
||
! |
! style="text-align:left" | 2017* |
||
! |
! style="text-align:left" | 2018* |
||
! |
! style="text-align:left" | 2019* |
||
! |
! style="text-align:left" | 2020* |
||
! class="col-m" style="text-align:right" | 2021* |
! class="col-m" style="text-align:right" | 2021* |
||
! class="col-m" style="text-align:right" | 2022* |
! class="col-m" style="text-align:right" | 2022* |
||
| Line 7,402: | Line 8,529: | ||
| style="text-align:left" | 2016 |
| style="text-align:left" | 2016 |
||
| style="text-align:left" | 36,592 |
| style="text-align:left" | 36,592 |
||
| style="text-align: |
| style="text-align:left" | 57,638 |
||
| style="text-align: |
| style="text-align:left" | 70,253 |
||
| style="text-align: |
| style="text-align:left" | 78,070 |
||
| style="text-align: |
| style="text-align:left" | 81,181 |
||
| style="text-align:right" | 87,482 |
| style="text-align:right" | 87,482 |
||
| style="text-align:right" | 91,556 |
| style="text-align:right" | 91,556 |
||
| Line 7,414: | Line 8,541: | ||
| style="text-align:left" | 2017 |
| style="text-align:left" | 2017 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 34,176 |
||
| style="text-align: |
| style="text-align:left" | 52,103 |
||
| style="text-align: |
| style="text-align:left" | 51,985 |
||
| style="text-align: |
| style="text-align:left" | 50,545 |
||
| style="text-align:right" | 57,457 |
| style="text-align:right" | 57,457 |
||
| style="text-align:right" | 62,924 |
| style="text-align:right" | 62,924 |
||
| Line 7,426: | Line 8,553: | ||
| style="text-align:left" | 2018 |
| style="text-align:left" | 2018 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 25,553 |
||
| style="text-align: |
| style="text-align:left" | 60,149 |
||
| style="text-align: |
| style="text-align:left" | 39,870 |
||
| style="text-align:right" | 54,339 |
| style="text-align:right" | 54,339 |
||
| style="text-align:right" | 67,001 |
| style="text-align:right" | 67,001 |
||
| Line 7,438: | Line 8,565: | ||
| style="text-align:left" | 2019 |
| style="text-align:left" | 2019 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 28,636 |
||
| style="text-align: |
| style="text-align:left" | 28,954 |
||
| style="text-align:right" | 30,948 |
| style="text-align:right" | 30,948 |
||
| style="text-align:right" | 45,696 |
| style="text-align:right" | 45,696 |
||
| Line 7,450: | Line 8,577: | ||
| style="text-align:left" | 2020 |
| style="text-align:left" | 2020 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | 102,725 |
||
| style="text-align:right" | 98,202 |
| style="text-align:right" | 98,202 |
||
| style="text-align:right" | 102,132 |
| style="text-align:right" | 102,132 |
||
| Line 7,462: | Line 8,589: | ||
| style="text-align:left" | 2021 |
| style="text-align:left" | 2021 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | 41,540 |
| style="text-align:right" | 41,540 |
||
| style="text-align:right" | 57,820 |
| style="text-align:right" | 57,820 |
||
| Line 7,474: | Line 8,601: | ||
| style="text-align:left" | 2022 |
| style="text-align:left" | 2022 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 2,155 |
| style="text-align:right" | 2,155 |
||
| Line 7,486: | Line 8,613: | ||
| style="text-align:left" | 2023 |
| style="text-align:left" | 2023 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 7,498: | Line 8,625: | ||
| style="text-align:left" | 2024 |
| style="text-align:left" | 2024 |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 7,509: | Line 8,636: | ||
|- |
|- |
||
| style="text-align:left" | 2025 |
| style="text-align:left" | 2025 |
||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 7,515: | Line 8,646: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|||
| style="text-align:left" | Total |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:left" | — |
|||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 538,304 |
|||
|- |
|||
| style="text-align:left" | '''Total''' |
|||
| style="text-align:left" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''—''' |
|||
| style="text-align:right" | '''538,304''' |
|||
|- |
|- |
||
| style="text-align:left" | *Supplementary information and unaudited |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align:left" | *Supplementary information and unaudited |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align: |
| style="text-align:left" | *Supplementary information and unaudited |
||
| style="text-align:right" | *Supplementary information and unaudited |
| style="text-align:right" | *Supplementary information and unaudited |
||
| style="text-align:right" | *Supplementary information and unaudited |
| style="text-align:right" | *Supplementary information and unaudited |
||
| Line 7,545: | Line 8,672: | ||
|} |
|} |
||
</div> |
</div> |
||
====== Net reserves for losses and ALAE ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1088" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2025 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2024 |
||
|- |
|- |
||
! style="text-align:left" | Net reserves for losses and ALAE: |
! style="text-align:left" | Net reserves for losses and ALAE: |
||
! class="col-m" style="text-align:right" | |
! class="col-m" style="text-align:right" | |
||
! class="col-m" style="text-align:right" | |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Short-tail/Monoline Specialty Lines |
| style="text-align:left" | Short-tail/Monoline Specialty Lines |
||
| Line 7,570: | Line 8,696: | ||
| style="text-align:right" | 86,689 |
| style="text-align:right" | 86,689 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Reserves for losses and ALAE, net of reinsurance</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,367,038</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,084,980</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Reinsurance recoverable on unpaid claims:</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 7,590: | Line 8,716: | ||
| style="text-align:right" | 15,298 |
| style="text-align:right" | 15,298 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total reinsurance recoverable on unpaid claims |
||
| style="text-align:right" | |
| style="text-align:right" | 921,165 |
||
| style="text-align:right" | |
| style="text-align:right" | 670,846 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Unallocated LAE</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>30,691</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>26,557</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Reserves for losses and LAE at end of year</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>2,318,894</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,782,383</b> |
||
|} |
|} |
||
</div> |
</div> |
||
====== Average annual percentage payout of incurred claims by age ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1089" class="wikitable fintable" |
||
|- |
|||
! colspan="11" style="text-align:center" | Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance |
! colspan="11" style="text-align:center" | Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance |
||
|- |
|- |
||
| Line 7,613: | Line 8,738: | ||
! colspan="10" style="text-align:center" | Years |
! colspan="10" style="text-align:center" | Years |
||
|- |
|- |
||
! style="text-align:left" | |
! style="text-align:left" | |
||
! |
! style="text-align:left" | 1* |
||
! |
! style="text-align:left" | 2* |
||
! |
! style="text-align:left" | 3* |
||
! |
! style="text-align:left" | 4* |
||
! |
! style="text-align:left" | 5* |
||
! |
! style="text-align:left" | 6* |
||
! |
! style="text-align:left" | 7* |
||
! |
! style="text-align:left" | 8* |
||
! |
! style="text-align:left" | 9* |
||
! |
! style="text-align:left" | 10* |
||
|- |
|- |
||
| style="text-align:left" | Short-Tail/Monoline Specialty Lines |
| style="text-align:left" | Short-Tail/Monoline Specialty Lines |
||
| style="text-align: |
| style="text-align:left" | 21.1% |
||
| style="text-align: |
| style="text-align:left" | 38.1% |
||
| style="text-align: |
| style="text-align:left" | 10.8% |
||
| style="text-align: |
| style="text-align:left" | 9.7% |
||
| style="text-align: |
| style="text-align:left" | 15.2% |
||
| style="text-align: |
| style="text-align:left" | N/A |
||
| style="text-align: |
| style="text-align:left" | N/A |
||
| style="text-align: |
| style="text-align:left" | N/A |
||
| style="text-align: |
| style="text-align:left" | N/A |
||
| style="text-align: |
| style="text-align:left" | N/A |
||
|- |
|- |
||
| style="text-align:left" | Multi-line Solutions |
| style="text-align:left" | Multi-line Solutions |
||
| style="text-align: |
| style="text-align:left" | 23.9% |
||
| style="text-align: |
| style="text-align:left" | 21.6% |
||
| style="text-align: |
| style="text-align:left" | 15.6% |
||
| style="text-align: |
| style="text-align:left" | 13.6% |
||
| style="text-align: |
| style="text-align:left" | 10.5% |
||
| style="text-align: |
| style="text-align:left" | 4.8% |
||
| style="text-align: |
| style="text-align:left" | 1.9% |
||
| style="text-align: |
| style="text-align:left" | 2.4% |
||
| style="text-align: |
| style="text-align:left" | 1.3% |
||
| style="text-align: |
| style="text-align:left" | 0.1% |
||
|- |
|- |
||
| style="text-align:left" | Exited Lines |
| style="text-align:left" | Exited Lines |
||
| style="text-align: |
| style="text-align:left" | 27.5% |
||
| style="text-align: |
| style="text-align:left" | 12.2% |
||
| style="text-align: |
| style="text-align:left" | 4.9% |
||
| style="text-align: |
| style="text-align:left" | 9.9% |
||
| style="text-align: |
| style="text-align:left" | 8.9% |
||
| style="text-align: |
| style="text-align:left" | 6.8% |
||
| style="text-align: |
| style="text-align:left" | 4.9% |
||
| style="text-align: |
| style="text-align:left" | 2.9% |
||
| style="text-align: |
| style="text-align:left" | 2.0% |
||
| style="text-align: |
| style="text-align:left" | 1.3% |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>*Supplementary information and unaudited</b> |
||
| style="text-align: |
| style="text-align:left" | <b>*Supplementary information and unaudited</b> |
||
| style="text-align: |
| style="text-align:left" | <b>*Supplementary information and unaudited</b> |
||
| style="text-align: |
| style="text-align:left" | <b>*Supplementary information and unaudited</b> |
||
| style="text-align: |
| style="text-align:left" | <b>*Supplementary information and unaudited</b> |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align: |
| style="text-align:left" | — |
||
|} |
|} |
||
</div> |
</div> |
||
=== 15. Commission and Fee Income === |
|||
{{chunk|doc=3z7a4yrxkn|c=265|p=16}} |
|||
'''Skyward Underwriters Agency business''' |
|||
* Skyward Underwriters Agency, Inc. ("SUA") is a subsidiary of the Company. |
|||
* SUA acts as a managing general insurance agent and reinsurance broker. |
|||
* SUA specializes in [[Definition:Property & casualty|property and casualty]] and accident and health risks in specialty niche markets. |
|||
* Commission and fee income is primarily generated from SUA for placing insurance policies with third-party insurance or reinsurance companies. |
|||
{{chunk|doc=3z7a4yrxkn|c=266|p=16}} |
|||
* ''Skyward Underwriters Agency, Inc. (SUA)'', a Company subsidiary, acts as a managing general insurance agent and reinsurance broker <sup>p. 98</sup>. |
|||
'''Commission and fee income tables''' |
|||
* SUA specializes in property and casualty and accident and health risks within niche markets <sup>p. 98</sup>. |
|||
* ''Commission and fee income'' is primarily generated by SUA through the placement of insurance policies with third-party insurance or reinsurance companies <sup>p. 98</sup>. |
|||
* The document presents a table of disaggregated revenues from customer contracts for the years ended December 31, 2025, 2024, and 2023. |
|||
====== Commission and fee revenue and expenses ====== |
|||
* The document presents a table of opening and closing balances of contract assets from commission and fee income for the years ended December 31, 2025, 2024, and 2023. |
|||
{{chunk|doc=3z7a4yrxkn|c=267|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1090" class="wikitable fintable" |
||
|+ 15. Commission and Fee Income |
|||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col- |
! class="col-m" style="text-align:right" | 2025 |
||
! class="col- |
! class="col-m" style="text-align:right" | 2024 |
||
! class="col- |
! class="col-m" style="text-align:right" | 2023 |
||
|- |
|- |
||
| style="text-align:left" | SUA commission revenue |
| style="text-align:left" | SUA commission revenue |
||
| Line 7,705: | Line 8,842: | ||
| style="text-align:right" | ( 135 ) |
| style="text-align:right" | ( 135 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total commission and fee revenue |
||
| style="text-align:right" | |
| style="text-align:right" | 12,381 |
||
| style="text-align:right" | |
| style="text-align:right" | 10,676 |
||
| style="text-align:right" | |
| style="text-align:right" | 9,819 |
||
|- |
|- |
||
| style="text-align:left" | Commission and fee expenses |
| style="text-align:left" | Commission and fee expenses |
||
| Line 7,715: | Line 8,852: | ||
| style="text-align:right" | ( 3,755 ) |
| style="text-align:right" | ( 3,755 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net commission and fee income</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>6,855</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>6,703</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>6,064</b> |
||
|} |
|} |
||
</div> |
</div> |
||
====== Contract assets ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1091" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Contract Assets |
||
|- |
|- |
||
! style="text-align:left" | Balance at December 31, 2023 |
! style="text-align:left" | Balance at December 31, 2023 |
||
| Line 7,734: | Line 8,870: | ||
| style="text-align:left" | Balance at December 31, 2024 |
| style="text-align:left" | Balance at December 31, 2024 |
||
| style="text-align:right" | 1,416 |
| style="text-align:right" | 1,416 |
||
|- |
|||
| style="text-align:left" | Balance at December 31, 2025 |
|||
| style="text-align:right" | 953 |
|||
|} |
|} |
||
</div> |
</div> |
||
=== 16. Underwriting, Acquisition and Insurance Expenses === |
|||
{{chunk|doc=3z7a4yrxkn|c=268|p=16}} |
|||
* ''Underwriting, acquisition and insurance expenses'' were USD 499.9m in 2025, USD 440.0m in 2024, and USD 379.0m in 2023 <sup>p. 99</sup>. |
|||
'''Underwriting, acquisition, and insurance expenses components''' |
|||
** ''Commissions and brokerage'' were USD 209.0m in 2025, USD 184.0m in 2024, and USD 158.0m in 2023 <sup>p. 99</sup>. |
|||
** ''Salaries and employee benefits'' were USD 125.0m in 2025, USD 110.0m in 2024, and USD 95.0m in 2023 <sup>p. 99</sup>. |
|||
** ''General and administrative'' expenses were USD 165.9m in 2025, USD 146.0m in 2024, and USD 126.0m in 2023 <sup>p. 99</sup>. |
|||
* The table below details the components of underwriting, acquisition, and insurance expenses for the years ended December 31, 2025, 2024, and 2023. |
|||
{{chunk|doc=3z7a4yrxkn|c=269|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1092" class="wikitable fintable" |
||
|+ 16. Underwriting, Acquisition and Insurance Expenses |
|||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col-s" style="text-align:right" | 2025 |
! class="col-s" style="text-align:right" | 2025 |
||
| Line 7,763: | Line 8,904: | ||
| style="text-align:right" | 134,930 |
| style="text-align:right" | 134,930 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total underwriting, acquisition and insurance expenses |
||
| style="text-align:right" | |
| style="text-align:right" | 377,359 |
||
| style="text-align:right" | |
| style="text-align:right" | 311,757 |
||
| style="text-align:right" | |
| style="text-align:right" | 243,444 |
||
|} |
|} |
||
</div> |
</div> |
||
=== 17. Reinsurance === |
|||
{{chunk|doc=3z7a4yrxkn|c=270|p=16}} |
|||
'''Reinsurance agreements and recoverables''' |
|||
* The Company uses various reinsurance agreements to assume and cede premiums and benefits with other insurance companies. |
|||
* Reinsurance agreements increase the Company's capacity to write larger risks and maintain loss exposure within its capital resources. |
|||
* The Company remains obligated for ceded amounts if reinsurers fail to meet their obligations. |
|||
* Tables detail the effects of reinsurance on written and earned premiums and losses and loss adjustment expenses for the years ended December 31, 2025, 2024, and 2023. |
|||
* A table outlines the components of reinsurance recoverables and ceded unearned premium as of December 31, 2025 and 2024. |
|||
{{chunk|doc=3z7a4yrxkn|c=271|p=16}} |
|||
'''Reinsurance security and LPT agreement''' |
|||
* The Company has agreements with several reinsurers where funded trust accounts are established with the Company as the sole beneficiary. |
|||
* These trust accounts provide additional security for collecting claim recoverables under reinsurance contracts. |
|||
* The Company does not carry these trust accounts on its balance sheet, as it only gains custody upon the reinsurer's failure to pay. |
|||
* As of December 31, 2025, the market value of these trust accounts was approximately USD 233.5 million. |
|||
* The trust amount is adjusted periodically by mutual agreement based on claim payments and loss reserve recoverables. |
|||
* In the first quarter of 2020, the Company entered into an LPT retroactive reinsurance agreement with R&Q. |
|||
* As of December 31, 2024, the reinsurance recoverable from R&Q was USD 22.7 million. |
|||
* The LPT was commuted effective January 31, 2025, and the Company received the full reinsurance recoverable balance. |
|||
{{chunk|doc=3z7a4yrxkn|c=272|p=16}} |
|||
'''Deposit method accounting for reinsurance''' |
|||
* Certain ceded reinsurance contracts that transfer only significant timing risk and insufficient underwriting risk are accounted for using the deposit method. |
|||
* Reinsurance agreements allow the Company to write larger risks and manage loss exposure within its capital resources <sup>p. 100</sup>. |
|||
* The Company's deposit asset was USD 22.7 million at December 31, 2025, and USD 25.9 million at December 31, 2024. |
|||
* The Company remains obligated for ceded amounts if reinsurers fail to meet their obligations <sup>p. 100</sup>. |
|||
* This deposit asset was included in other assets on the Consolidated Balance Sheets. |
|||
* The Company has agreements with several reinsurers where funded trust accounts are established with the Company as the sole beneficiary <sup>p. 100</sup>. |
|||
* These trust accounts provide additional security for collecting claim recoverables under reinsurance contracts <sup>p. 100</sup>. |
|||
* The Company does not carry these trust accounts on the balance sheet as it only gains custody upon reinsurer failure to pay <sup>p. 100</sup>. |
|||
* The market value of these trust accounts was approximately USD 233.5m at December 31, 2025 <sup>p. 100</sup>. |
|||
* The trust amount will be periodically adjusted by mutual agreement based on claim payments and loss reserve recoverables <sup>p. 100</sup>. |
|||
* During Q1 2020, the Company entered into an LPT retroactive reinsurance agreement with R&Q <sup>p. 100</sup>. |
|||
* The reinsurance recoverable from R&Q was USD 22.7m at December 31, 2024 <sup>p. 100</sup>. |
|||
* The LPT was commuted effective January 31, 2025, and the Company received the full reinsurance recoverable balance <sup>p. 100</sup>. |
|||
* Ceded reinsurance contracts that transfer only significant timing risk and insufficient underwriting risk are accounted for using the deposit method <sup>p. 100</sup>. |
|||
* The Company’s deposit asset was USD 22.7m at December 31, 2025, and USD 25.9m at December 31, 2024 <sup>p. 100</sup>. |
|||
* This deposit asset was included in other assets on the Consolidated Balance Sheets <sup>p. 100</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=273|p=16}} |
|||
====== Premiums and ceded losses and LAE incurred ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1093" class="wikitable fintable" |
||
|+ 17. Reinsurance |
|||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | 2025 |
! colspan="2" style="text-align:center" | 2025 |
||
| Line 7,800: | Line 8,957: | ||
! class="col-m" style="text-align:right" | Written |
! class="col-m" style="text-align:right" | Written |
||
! class="col-m" style="text-align:right" | Earned |
! class="col-m" style="text-align:right" | Earned |
||
! class="col- |
! class="col-m" style="text-align:right" | Written |
||
! class="col- |
! class="col-m" style="text-align:right" | Earned |
||
|- |
|- |
||
| style="text-align:left" | Direct premiums |
| style="text-align:left" | Direct premiums |
||
| Line 7,827: | Line 8,984: | ||
| style="text-align:right" | ( 520,663 ) |
| style="text-align:right" | ( 520,663 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net premiums</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,406,232</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,304,505</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,123,578</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,056,722</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>910,691</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>829,143</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Ceded losses and LAE incurred</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | <b>697,978</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | <b>534,295</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | <b>337,011</b> |
||
|} |
|} |
||
</div> |
</div> |
||
====== Ceded unpaid losses and LAE ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1094" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col-m" style="text-align:right" | 2025 |
! class="col-m" style="text-align:right" | 2025 |
||
! class="col- |
! class="col-m" style="text-align:right" | 2024 |
||
|- |
|- |
||
| style="text-align:left" | Ceded unpaid losses and LAE |
| style="text-align:left" | Ceded unpaid losses and LAE |
||
| Line 7,869: | Line 9,025: | ||
| style="text-align:right" | ( 2,295 ) |
| style="text-align:right" | ( 2,295 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Reinsurance recoverables</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,119,880</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>857,876</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Ceded unearned premium</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>238,948</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>203,901</b> |
||
|} |
|} |
||
</div> |
</div> |
||
=== 18. Stock Based Compensation === |
|||
{{chunk|doc=3z7a4yrxkn|c=274|p=16}} |
|||
* The ''2022 Long-Term Incentive Plan'' (the "2022 Plan") was approved by the Board of Directors on September 23, 2022, and became effective on January 12, 2023 <sup>p. 101</sup>. |
|||
'''2022 Long-Term Incentive Plan''' |
|||
* The ''2022 Plan'' allows for granting restricted stock, restricted stock units, performance stock units, stock options, and cash-based performance awards to select employees and non-employee directors <sup>p. 101</sup>. |
|||
* ''3,200,656 shares of common stock'' were available for issuance under the 2022 Plan <sup>p. 101</sup>. |
|||
* In November 2024, the Compensation Committee approved a program allowing independent directors to defer settlement of their annual restricted stock units (RSU) awards to the fifth anniversary of the grant date, the tenth anniversary of the grant date, or the date of separation of service from the Company <sup>p. 101</sup>. |
|||
* This ''deferral program'' was available for Directors who elected in 2024 to defer settlement of their 2025 RSU awards, which vest in 2026 <sup>p. 101</sup>. |
|||
* The ''grant date fair value of options'' under the 2022 Plan was determined using the Black-Scholes model, with a contractual term of 10 years less the weighted average service period <sup>p. 101</sup>. |
|||
* ''Volatility for stock options'' was based on the historical volatility of comparable publicly traded insurance companies <sup>p. 101</sup>. |
|||
* ''Stock options granted to employees'' during the year ended December 31, 2023, were valued at approximately $4.4 million based on the grant date fair value <sup>p. 101</sup>. |
|||
* The ''aggregate intrinsic value of options outstanding'' at December 31, 2025, was $27.4 million <sup>p. 101</sup>. |
|||
* The ''aggregate intrinsic value of options outstanding'' at December 31, 2024, was $27.0 million <sup>p. 101</sup>. |
|||
* The ''weighted-average remaining contractual life of options outstanding'' at December 31, 2025, was 7.0 years <sup>p. 101</sup>. |
|||
* The ''fair value of restricted stock and restricted stock units'' under the 2022 Plan for awards granted at the time of the Company’s IPO was the IPO price of $15.00 per share <sup>p. 101</sup>. |
|||
* The ''fair value of subsequent grants'' of restricted stock and restricted stock units was equal to the closing stock price on the grant date <sup>p. 101</sup>. |
|||
* The ''expense for equity-based incentives'' is based on their fair value at the grant date and amortized over their vesting period <sup>p. 101</sup>. |
|||
* ''Restricted stock and restricted stock units granted to employees and the Board of Directors'' were valued at approximately $12.2 million for 2025, $8.5 million for 2024, and $17.7 million for 2023, based on grant date fair value <sup>p. 101</sup>. |
|||
* ''Board of Directors members'' were granted 12,579 shares of restricted stock and restricted stock units in 2025, 19,453 in 2024, and 23,482 in 2023, each with a service period of one year <sup>p. 101</sup>. |
|||
* The ''total fair value of shares vested for employees and Board of Directors members'' was $6.0 million at December 31, 2025, $3.8 million at December 31, 2024, and $0.5 million at December 31, 2023 <sup>p. 101</sup>. |
|||
* As of December 31, 2025, the ''total unrecognized compensation cost'' related to non-vested, stock-based compensation awards was $17.4 million <sup>p. 101</sup>. |
|||
* The ''weighted average period'' over which the unrecognized compensation cost is expected to be recognized is 1.6 years <sup>p. 101</sup>. |
|||
* The ''Company recognized stock-based compensation expense'' of $12.0 million for 2025, $9.4 million for 2024, and $8.5 million for 2023 <sup>p. 101</sup>. |
|||
* The ''2022 Employee Stock Purchase Plan'' (the "ESPP") was approved by the Board of Directors on September 23, 2022, and became effective on May 15, 2023 <sup>p. 101</sup>. |
|||
* The ''ESPP'' is administered by the Compensation Committee <sup>p. 101</sup>. |
|||
* Under the ''ESPP'', employees can elect to have a percentage of their annual base earnings withheld to purchase common stock at two specified intervals each year <sup>p. 101</sup>. |
|||
* The ''purchase price of common stock'' under the ESPP is 85% of the lower of its beginning-of-interval or end-of-interval market price <sup>p. 101</sup>. |
|||
* The ''Company reserved 376,548 common shares'' under the ESPP <sup>p. 101</sup>. |
|||
* The ''grant date fair value of options under the ESPP'' was determined using the Black-Scholes model, with a term equal to the 6-month period between the grant date and the exercisable date <sup>p. 101</sup>. |
|||
* ''Volatility for ESPP options'' was based on the historical volatility of comparable publicly traded insurance companies <sup>p. 101</sup>. |
|||
* As of December 31, 2025, ''141,845 shares'' had been purchased under the ESPP <sup>p. 101</sup>. |
|||
* The ''Company recognized ESPP expense'' of $0.7 million for 2025 and $0.5 million for 2024 <sup>p. 101</sup>. |
|||
* As of December 31, 2025, the ''fair value of unrecognized ESPP expense'' was $0.3 million <sup>p. 101</sup>. |
|||
* On September 23, 2022, the Board of Directors approved the Company’s 2022 Long-Term Incentive Plan (the “2022 Plan”), effective January 12, 2023, replacing the 2020 Plan. |
|||
====== Stock and stock units by award payout range ====== |
|||
* The 2022 Plan allows for granting restricted stock, restricted stock units, performance stock units, stock options, and cash-based performance awards to select employees and non-employee directors. |
|||
* The 2022 Plan made 3,200,656 shares of common stock available for issuance. |
|||
* In November 2024, the Compensation Committee approved a program for independent directors to defer settlement of annual restricted stock units (“RSU”) awards to the fifth anniversary of the grant date, the tenth anniversary of the grant date, or separation of service. |
|||
* This deferral program was available for Directors who elected in 2024 to defer settlement of their 2025 RSU awards, which vest in [[Definition:Year 2026|2026]]. |
|||
{{chunk|doc=3z7a4yrxkn|c=275|p=16}} |
|||
'''Stock options''' |
|||
* The grant date fair value of options under the 2022 Plan was determined using the Black-Scholes model, with a contractual term of 10 years less the weighted average service period. |
|||
* Volatility for the Black-Scholes model was based on historical volatility of comparable publicly traded insurance companies. |
|||
* Stock options granted to employees during the year ended December 31, 2023, were valued at approximately USD 4.4m based on grant date fair value. |
|||
* The aggregate intrinsic value of options outstanding was USD 27.4m at December 31, 2025, and USD 27.0m at December 31, 2024. |
|||
* The weighted-average remaining contractual life of options outstanding at December 31, 2025, was 7.0 years. |
|||
{{chunk|doc=3z7a4yrxkn|c=276|p=16}} |
|||
'''Restricted stock awards and units''' |
|||
* The fair value of restricted stock and restricted stock units under the 2022 Plan for awards granted at the Company’s IPO was the IPO price of USD 15.00 per share. |
|||
* The fair value of subsequent grants was equal to the closing stock price on the grant date. |
|||
* Expense for equity-based incentives is based on fair value at grant date and amortized over the vesting period. |
|||
* Restricted stock and restricted stock units granted to employees and the Board of Directors were valued at approximately USD 12.2m in 2025, USD 8.5m in 2024, and USD 17.7m in 2023, based on grant date fair value. |
|||
* Board of Directors members were granted 12,579 shares in 2025, 19,453 shares in 2024, and 23,482 shares in 2023, with a service period of one year. |
|||
* The total fair value of shares vested for employees and Board members was USD 6.0m at December 31, 2025, USD 3.8m at December 31, 2024, and USD 0.5m at December 31, 2023. |
|||
* As of December 31, 2025, total unrecognized compensation cost for non-vested, stock-based awards was USD 17.4m. |
|||
* The weighted average period for recognizing this cost is 1.6 years. |
|||
* The Company recognized stock-based compensation expense of USD 12.0m in 2025, USD 9.4m in 2024, and USD 8.5m in 2023. |
|||
{{chunk|doc=3z7a4yrxkn|c=277|p=16}} |
|||
'''Employee Stock Purchase Plan (ESPP)''' |
|||
* On September 23, 2022, the Board of Directors approved the Company’s 2022 Employee Stock Purchase Plan (the “ESPP”), effective May 15, 2023, and administered by the Compensation Committee. |
|||
* Under the ESPP, employees can elect to have a percentage of their annual base earnings withheld to purchase common stock at two specified intervals each year. |
|||
* The purchase price is 85% of the lower of the beginning-of-interval or end-of-interval market price. |
|||
* The Company has reserved 376,548 common shares under the ESPP. |
|||
* The grant date fair value of options under the ESPP was determined using the Black-Scholes model, with a term of 6 months (length of time between grant date and exercisable date). |
|||
* Volatility for the ESPP Black-Scholes model was based on historical volatility of comparable publicly traded insurance companies. |
|||
* As of December 31, 2025, 141,845 shares had been purchased under the ESPP. |
|||
* The Company recognized ESPP expense of USD 0.7m in 2025 and USD 0.5m in 2024. |
|||
* As of December 31, 2025, the fair value of unrecognized ESPP expense was USD 0.3m. |
|||
{{chunk|doc=3z7a4yrxkn|c=278|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| id="t1095" class="wikitable" |
||
|+ Target Stock and Stock Units by Award Payout Range, Requisite Service Period |
|||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! style="text-align: |
! style="text-align:right" | Award Payout Range |
||
! style="text-align: |
! style="text-align:right" | Requisite Service Period |
||
! style="text-align: |
! style="text-align:right" | Target Stock and Stock Units |
||
|- |
|- |
||
! style="text-align:left" | Year ended December 31, 2025 |
! style="text-align:left" | Year ended December 31, 2025 |
||
! |
! style="text-align:right" | |
||
! |
! style="text-align:right" | |
||
! |
! style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Market condition awards |
| style="text-align:left" | Market condition awards |
||
| |
| style="text-align:right" | 0 %– 150 % |
||
| |
| style="text-align:right" | 3 years |
||
| |
| style="text-align:right" | 22,495 |
||
|- |
|- |
||
| style="text-align:left" | Performance condition awards |
| style="text-align:left" | Performance condition awards |
||
| |
| style="text-align:right" | 0 %– 150 % |
||
| |
| style="text-align:right" | 3 years |
||
| |
| style="text-align:right" | 59,769 |
||
|- |
|- |
||
| style="text-align:left" | Service condition awards |
| style="text-align:left" | Service condition awards |
||
| |
| style="text-align:right" | N/A |
||
| |
| style="text-align:right" | 1 – 4 years |
||
| |
| style="text-align:right" | 144,921 |
||
|- |
|- |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | 227,185 |
||
|- |
|||
| style="text-align:left" | <b>Year ended December 31, 2024</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Market condition awards |
| style="text-align:left" | Market condition awards |
||
| |
| style="text-align:right" | 0 %– 150 % |
||
| |
| style="text-align:right" | 3 years |
||
| |
| style="text-align:right" | 32,058 |
||
|- |
|- |
||
| style="text-align:left" | Performance condition awards |
| style="text-align:left" | Performance condition awards |
||
| |
| style="text-align:right" | 0 %– 150 % |
||
| |
| style="text-align:right" | 3 years |
||
| |
| style="text-align:right" | 76,881 |
||
|- |
|- |
||
| style="text-align:left" | Service condition awards |
| style="text-align:left" | Service condition awards |
||
| |
| style="text-align:right" | N/A |
||
| |
| style="text-align:right" | 1 – 4 years |
||
| |
| style="text-align:right" | 124,025 |
||
|- |
|- |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | 232,964 |
||
|- |
|||
| style="text-align:left" | <b>Year ended December 31, 2023</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Market condition awards |
| style="text-align:left" | Market condition awards |
||
| |
| style="text-align:right" | 0 %– 150 % |
||
| |
| style="text-align:right" | 3 years |
||
| |
| style="text-align:right" | 37,622 |
||
|- |
|- |
||
| style="text-align:left" | Performance condition awards |
| style="text-align:left" | Performance condition awards |
||
| |
| style="text-align:right" | 0 %– 150 % |
||
| |
| style="text-align:right" | 3 years |
||
| |
| style="text-align:right" | 95,456 |
||
|- |
|- |
||
| style="text-align:left" | Service condition awards |
| style="text-align:left" | Service condition awards |
||
| |
| style="text-align:right" | N/A |
||
| |
| style="text-align:right" | 1 – 4 years |
||
| |
| style="text-align:right" | 968,778 |
||
|- |
|- |
||
| style="text-align:left" | Stock options |
| style="text-align:left" | Stock options |
||
| |
| style="text-align:right" | N/A |
||
| |
| style="text-align:right" | 3 – 4 years |
||
| |
| style="text-align:right" | 759,990 |
||
|- |
|- |
||
| style="text-align:left" | — |
| style="text-align:left" | — |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | — |
||
| |
| style="text-align:right" | 1,861,846 |
||
|} |
|} |
||
</div> |
</div> |
||
====== Weighted-average exercise price of stock ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1096" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | — |
|||
! |
! style="text-align:left" | |
||
! |
! style="text-align:left" | Weighted-Average Exercise Price |
||
! class="col-m" style="text-align:right" | Stock |
|||
|- |
|- |
||
| style="text-align:left" | Outstanding at January 1, 2025 |
| style="text-align:left" | Outstanding at January 1, 2025 |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | 759,990 |
| style="text-align:right" | 759,990 |
||
|- |
|- |
||
| style="text-align:left" | Forfeited |
| style="text-align:left" | Forfeited |
||
| style="text-align: |
| style="text-align:left" | 15.00 |
||
| style="text-align:right" | ( 219 ) |
| style="text-align:right" | ( 219 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Outstanding at December 31, 2025</b> |
||
| style="text-align: |
| style="text-align:left" | — |
||
| style="text-align:right" | |
| style="text-align:right" | <b>759,771</b> |
||
|} |
|} |
||
</div> |
</div> |
||
====== Outstanding stock ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable |
{| id="t1097" class="wikitable" |
||
|- |
|||
! style="text-align:left" | — |
|||
! |
! style="text-align:left" | |
||
! style="text-align:right" | Stock |
|||
|- |
|- |
||
| style="text-align:left" | Outstanding at January 1, 2024 |
| style="text-align:left" | Outstanding at January 1, 2024 |
||
| style="text-align:right" | 759,990 |
| style="text-align:right" | 759,990 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Outstanding at December 31, 2024</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>759,990</b> |
||
|} |
|} |
||
</div> |
</div> |
||
====== Weighted-average grant-date fair value of stock and stock units ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1098" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | — |
|||
! |
! style="text-align:left" | |
||
! class="col-m" style="text-align:right" | Weighted-Average Grant-Date Fair Value |
|||
! class="col-m" style="text-align:right" | Stock and Stock Units |
! class="col-m" style="text-align:right" | Stock and Stock Units |
||
|- |
|- |
||
| Line 8,055: | Line 9,232: | ||
| style="text-align:right" | ( 53,247 ) |
| style="text-align:right" | ( 53,247 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Non-vested at December 31, 2025</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>27.06</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,135,468</b> |
||
|- |
|- |
||
| style="text-align:left" | Non-vested at January 1, 2024 |
| style="text-align:left" | Non-vested at January 1, 2024 |
||
| Line 8,075: | Line 9,252: | ||
| style="text-align:right" | ( 102,640 ) |
| style="text-align:right" | ( 102,640 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Non-vested at December 31, 2024</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>19.06</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,325,483</b> |
||
|- |
|- |
||
| style="text-align:left" | Non-vested at January 1, 2023 |
| style="text-align:left" | Non-vested at January 1, 2023 |
||
| Line 8,095: | Line 9,272: | ||
| style="text-align:right" | ( 35,658 ) |
| style="text-align:right" | ( 35,658 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Non-vested at December 31, 2023</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>15.13</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,445,449</b> |
||
|} |
|} |
||
</div> |
</div> |
||
{{fn note|1=1|2=Increases above the 100% target level are reflected as granted in the period after which performance-based stock unit goals are achieved.}} |
|||
{{fn note|1=2|2=Decreases below the 100% target level are reflected as forfeited.}} |
|||
=== 19. Earnings Per Share === |
|||
{{chunk|doc=3z7a4yrxkn|c=279|p=16}} |
|||
* The computation of basic and diluted net earnings per share is set forth for the years ended December 31, 2025, 2024, and 2023 <sup>p. 102</sup>. |
|||
'''Earnings per share computation''' |
|||
* Anti-dilutive instruments excluded from the calculation of diluted weighted-average common share equivalents are presented for the years ended December 31, 2025, 2024, and 2023 <sup>p. 102</sup>. |
|||
* Common share equivalents of contingently issuable instruments excluded from basic earnings per share are presented for the years ended December 31, 2025, 2024, and 2023 <sup>p. 102</sup>. |
|||
* The computation of basic and diluted net earnings per share is set forth for the years ended December 31, 2025, 2024, and 2023. |
|||
====== Anti-dilutive instruments excluded from diluted weighted-average common share equivalents ====== |
|||
* Anti-dilutive instruments excluded from the calculation of diluted weighted-average common share equivalents are presented for the years ended December 31, 2025, 2024, and 2023. |
|||
* Common share equivalents of contingently issuable instruments excluded from basic earnings per share are presented for the years ended December 31, 2025, 2024, and 2023. |
|||
{{chunk|doc=3z7a4yrxkn|c=280|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1099" class="wikitable fintable" |
||
|+ Net income by earnings per share |
|||
|- |
|||
! style="text-align:left" | ($ in thousands, except for share and per share amounts) |
! style="text-align:left" | ($ in thousands, except for share and per share amounts) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2025 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2024 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2023 |
||
|- |
|- |
||
! style="text-align:left" | Numerator |
! style="text-align:left" | Numerator |
||
! class="col-m" style="text-align:right" | |
! class="col-m" style="text-align:right" | |
||
! class="col-m" style="text-align:right" | |
! class="col-m" style="text-align:right" | |
||
! class="col-m" style="text-align:right" | |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Net income |
| style="text-align:left" | Net income |
||
| Line 8,129: | Line 9,311: | ||
| style="text-align:right" | 85,984 |
| style="text-align:right" | 85,984 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Less: Undistributed income allocated to participating securities</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 1,677 )</b> |
||
|- |
|- |
||
| style="text-align:left" | Net income attributable to common stockholders (numerator for basic earnings per share) |
| style="text-align:left" | Net income attributable to common stockholders (numerator for basic earnings per share) |
||
| Line 8,144: | Line 9,326: | ||
| style="text-align:right" | 1,677 |
| style="text-align:right" | 1,677 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net income (numerator for diluted earnings per share under the two-class method)</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>170,028</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>118,828</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>85,984</b> |
||
|- |
|||
| style="text-align:left" | <b>Denominator</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Basic weighted-average common shares |
| style="text-align:left" | Basic weighted-average common shares |
||
| Line 8,174: | Line 9,361: | ||
| style="text-align:right" | 135,972 |
| style="text-align:right" | 135,972 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Diluted weighted-average common share equivalents</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>41,808,046</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>41,377,460</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>38,317,534</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Basic earnings per share</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>4.21</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>2.97</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>2.34</b> |
||
|- |
|- |
||
| style="text-align:left" | Diluted earnings per share |
| style="text-align:left" | Diluted earnings per share |
||
| Line 8,190: | Line 9,377: | ||
|} |
|} |
||
</div> |
</div> |
||
====== Stock units and options ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1100" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | — |
|||
! style="text-align:left" | |
|||
! class="col-s" style="text-align:right" | 2025 |
! class="col-s" style="text-align:right" | 2025 |
||
! class="col-s" style="text-align:right" | 2024 |
! class="col-s" style="text-align:right" | 2024 |
||
| Line 8,211: | Line 9,397: | ||
|} |
|} |
||
</div> |
</div> |
||
====== Common shares ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1101" class="wikitable fintable" |
||
|- |
|||
! style="text-align:left" | — |
|||
! style="text-align:left" | |
|||
! class="col-s" style="text-align:right" | 2025 |
! class="col-s" style="text-align:right" | 2025 |
||
! class="col-s" style="text-align:right" | 2024 |
! class="col-s" style="text-align:right" | 2024 |
||
| Line 8,226: | Line 9,411: | ||
| style="text-align:right" | 920,864 |
| style="text-align:right" | 920,864 |
||
|- |
|- |
||
| class="wt-indent-1" style="text-align:left" | |
| class="wt-indent-1" style="text-align:left" | Total |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | — |
||
| style="text-align:right" | |
| style="text-align:right" | 920,864 |
||
|} |
|} |
||
</div> |
</div> |
||
=== 20. Employee Benefit Plan === |
|||
{{chunk|doc=3z7a4yrxkn|c=281|p=16}} |
|||
* The Company sponsors the 401(k) Plan (the "Plan"), which is available to substantially all its employees <sup>p. 103</sup>. |
|||
'''401(k) Plan contributions''' |
|||
* The Plan is subject to provisions of the Employee Retirement Income Security Act of 1974 <sup>p. 103</sup>. |
|||
* The Company matches employee contributions on a discretionary basis <sup>p. 103</sup>. |
|||
* ''Matching contributions'' to the Plan were USD 3.9m in 2025, USD 3.2m in 2024, and USD 2.9m in 2023 <sup>p. 103</sup>. |
|||
* The Company sponsors the 401(k) Plan ("the Plan"), available to substantially all employees. |
|||
====== Riscom ====== |
|||
* The Plan is subject to the Employee Retirement Income Security Act of 1974. |
|||
* The Company matches employee contributions on a discretionary basis. |
|||
* Company matching contributions to the Plan were USD 3.9m in 2025, USD 3.2m in 2024, and USD 2.9m in 2023. |
|||
=== RISCOM === |
|||
* RISCOM provides wholesale brokerage services to the Company <sup>p. 104</sup>. |
|||
* RISCOM and the Company have a managing general agency agreement <sup>p. 104</sup>. |
|||
* The Company holds a ''20% ownership interest'' in RISCOM <sup>p. 104</sup>. |
|||
* ''Premiums receivable'' as of December 31, 2025, were USD 13.9m <sup>p. 104</sup>. |
|||
* ''Premiums receivable'' as of December 31, 2024, were USD 12.6m <sup>p. 104</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=282|p=16}} |
|||
====== Premiums receivable ====== |
|||
'''RISCOM agreements and financial impact''' |
|||
* RISCOM provides wholesale brokerage services to the Company. |
|||
* The Company and RISCOM have a managing general agency agreement. |
|||
* The Company holds a 20% ownership interest in RISCOM. |
|||
* Net earned premiums and gross commission expense related to these agreements for the years ended December 31, 2025, 2024, and 2023 were as follows: |
|||
** Net Earned Premiums: |
|||
*** 2025: USD 102.3m |
|||
*** 2024: USD 98.7m |
|||
*** 2023: USD 95.1m |
|||
** Gross Commission Expense: |
|||
*** 2025: USD 15.4m |
|||
*** 2024: USD 14.8m |
|||
*** 2023: USD 14.3m |
|||
* Premiums receivable as of December 31, 2025, were USD 13.9m. |
|||
* Premiums receivable as of December 31, 2024, were USD 12.6m. |
|||
{{chunk|doc=3z7a4yrxkn|c=283|p=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1102" class="wikitable fintable" |
||
|+ RISCOM |
|||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! class="col-s" style="text-align:right" | 2025 |
! class="col-s" style="text-align:right" | 2025 |
||
| Line 8,269: | Line 9,471: | ||
</div> |
</div> |
||
=== Other === |
|||
{{chunk|doc=3z7a4yrxkn|c=284|p=16}} |
|||
'''Related party transactions''' |
|||
* Advisory and professional services fees and expense reimbursements paid to affiliated stockholders and directors were USD 0.6m for the years ended December 31, 2025 and 2024. |
|||
* Advisory and professional services fees and expense reimbursements paid to affiliated stockholders and directors were USD 3.6m for the year ended December 31, 2023. |
|||
* Investments involving affiliated companies and additional related party transactions are detailed in Notes 5, 6, and 11. |
|||
=== Litigation === |
|||
{{chunk|doc=3z7a4yrxkn|c=285|p=16}} |
|||
'''Litigation and legal actions''' |
|||
* The Company is a party in various legal actions related to claims under insurance policies and contracts. |
|||
* These actions are considered when estimating losses and loss adjustment expense reserves. |
|||
* The Company is also a defendant in legal actions concerning bad faith claims, disputes with third parties, or alleged errors and omissions. |
|||
* Accruals for these items are recorded when losses are probable and reasonably estimable. |
|||
* Based on current information, insurance coverage, and advice from outside legal counsel, the Company believes the resolution of these matters will not have a material adverse effect on its consolidated financial position, results of operations, or cash flows, individually or in the aggregate. |
|||
=== Indemnification === |
|||
{{chunk|doc=3z7a4yrxkn|c=286|p=16}} |
|||
'''Indemnification for asset sales''' |
|||
* The Company has provided indemnifications to certain buyers in conjunction with the sale of business assets and subsidiaries. |
|||
* These indemnifications cover typical representations and warranties related to performance under sales contracts. |
|||
* The potential exposure from these indemnifications is difficult to determine due to the variety of matters, operations, and scenarios covered. |
|||
* Some indemnifications have no time limit. |
|||
* The Company currently does not believe any significant claims exist related to these indemnifications. |
|||
=== 23. Statutory Accounting Principles and Regulatory Matters === |
|||
{{chunk|doc=3z7a4yrxkn|c=287|p=16}} |
|||
'''Statutory financial performance''' |
|||
* The Company’s statutory net income was USD 159.1m for 2025, USD 108.2m for 2024, and USD 73.1m for 2023. |
|||
* The Company’s statutory capital and surplus was USD 872.0m as of December 31, 2025, and USD 710.6m as of December 31, 2024. |
|||
{{chunk|doc=3z7a4yrxkn|c=288|p=16}} |
|||
'''Insurance company subsidiary restacking''' |
|||
* Effective December 31, 2024, the Company restacked its insurance company subsidiaries, making GMIC the lead insurance company. |
|||
* HSIC became a wholly owned subsidiary of GMIC. |
|||
* IIC became a wholly owned subsidiary of HSIC. |
|||
* OSIC became a wholly owned subsidiary of IIC. |
|||
{{chunk|doc=3z7a4yrxkn|c=289|p=16}} |
|||
* ''Advisory and professional services fees and expense reimbursements'' paid to affiliated stockholders and directors were USD 0.6m for the years ended December 31, 2025 and 2024 <sup>p. 105</sup>. |
|||
'''[[Definition:Dividend|Dividend]] restrictions''' |
|||
* ''Advisory and professional services fees and expense reimbursements'' paid to affiliated stockholders and directors were USD 3.6m for the year ended December 31, 2023 <sup>p. 105</sup>. |
|||
* For investments involving affiliated companies and additional related party transactions, refer to Notes 5, 6, and 11 <sup>p. 105</sup>. |
|||
* [[Definition:Dividend|Dividend]] payments to the Company from GMIC are restricted by Texas state law, requiring regulatory approval for amounts exceeding certain limits. |
|||
====== Litigation ====== |
|||
* The maximum amount of [[Definition:Dividend|dividends]] payable by GMIC without prior approval is subject to restrictions related to policyholder surplus, net income, and [[Definition:Dividend|dividends]] declared or distributed in the preceding 12 months. |
|||
* As of December 31, 2025, GMIC, domiciled in Texas, is restricted to paying [[Definition:Dividend|dividends]] of the greater of 10% of prior year-end capital and surplus or prior year net income. |
|||
* GMIC did not declare or pay any [[Definition:Dividend|dividend]] during the year ended December 31, 2025. |
|||
* HSIC did not declare or pay any [[Definition:Dividend|dividends]] during the year ended December 31, 2024. |
|||
{{chunk|doc=3z7a4yrxkn|c=290|p=16}} |
|||
* The Company is a party in various legal actions related to claims under insurance policies and contracts <sup>p. 106</sup>. |
|||
'''Risk Based Capital requirements''' |
|||
* These actions are considered when estimating losses and loss adjustment expense reserves <sup>p. 106</sup>. |
|||
* The Company is also a defendant in legal actions concerning bad faith claims, disputes with third parties, or alleged errors and omissions <sup>p. 106</sup>. |
|||
* Accruals for these items are recorded when losses are probable and reasonably estimable <sup>p. 106</sup>. |
|||
* Based on present information, available insurance coverage, and advice from outside legal counsel, the Company believes the resolution of these matters will not materially adversely affect its consolidated financial position, results of operations, or cash flows, individually or in the aggregate <sup>p. 106</sup>. |
|||
* [[Definition:Property & casualty|Property and casualty]] insurance companies are subject to Risk Based Capital ("RBC") requirements specified by the National Association of Insurance Commissioners ("NAIC"). |
|||
====== Indemnification ====== |
|||
* RBC requirements determine the amount of capital and surplus based on various risk factors. |
|||
* As of December 31, 2025 and 2024, GMIC’s statutory capital and surplus substantially exceeded the regulatory requirements. |
|||
=== 24. Subsequent Events === |
|||
* The Company has provided indemnifications to certain buyers in conjunction with the sale of business assets and subsidiaries <sup>p. 107</sup>. |
|||
* Certain indemnifications cover typical representations and warranties related to the responsibilities to perform under the sales contracts <sup>p. 107</sup>. |
|||
* The potential exposure covered by these indemnifications is difficult to determine due to the variety of matters, operations, and scenarios covered <sup>p. 107</sup>. |
|||
* Certain indemnifications have no time limit <sup>p. 107</sup>. |
|||
* The Company currently does not believe any significant claims exist related to these indemnifications <sup>p. 107</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=291|p=16}} |
|||
====== 23. Statutory Accounting Principles and Regulatory Matters ====== |
|||
'''Apollo Group Holdings Limited acquisition''' |
|||
* On September 2, 2025, the Company entered into two share purchase agreements (the "Apollo Majority SPAs") with institutional and management shareholders of Apollo Group Holdings Limited ("Apollo") (the "Majority Sellers"). |
|||
* ''Statutory net income'' was $159.1 million for 2025, $108.2 million for 2024, and $73.1 million for 2023 <sup>p. 108</sup>. |
|||
* Pursuant to the Apollo Majority SPAs, the Company agreed to acquire all issued shares of Apollo held by the Majority Sellers, representing approximately 87% of Apollo's issued share capital. |
|||
* ''Statutory capital and surplus'' was $872.0 million as of December 31, 2025, and $710.6 million as of December 31, 2024 <sup>p. 108</sup>. |
|||
* Closing of the transaction ("Closing") was conditioned upon the Company acquiring 100% of Apollo's issued share capital (the “Acquisition”) at Closing through additional short-form share purchase agreements with remaining minority shareholders. |
|||
* Effective December 31, 2024, the Company restacked its insurance company subsidiaries, making GMIC the lead insurance company <sup>p. 108</sup>. |
|||
* On January 1, [[Definition:Year 2026|2026]], the Company completed the acquisition for aggregate consideration of approximately USD 555.0m, payable in a combination of cash and newly issued shares of the Company’s common stock. |
|||
* Following the restacking, HSIC became a wholly owned subsidiary of GMIC <sup>p. 108</sup>. |
|||
* The acquisition closed shortly before the issuance of these consolidated financial statements, so initial accounting under ASC 805 is not yet complete. |
|||
* IIC became a wholly owned subsidiary of HSIC <sup>p. 108</sup>. |
|||
* The Company is obtaining and evaluating information to determine identifiable assets acquired, liabilities assumed, and any resulting goodwill or intangible assets. |
|||
* OSIC became a wholly owned subsidiary of IIC <sup>p. 108</sup>. |
|||
* Required purchase accounting disclosures will be provided in future filings once available. |
|||
* ''Dividend payments'' to the Company from GMIC are restricted by Texas state law, requiring regulatory approval for certain amounts <sup>p. 108</sup>. |
|||
* The maximum amount of dividends GMIC can pay without prior approval is subject to restrictions related to policyholder surplus, net income, and dividends declared or distributed in the preceding 12 months <sup>p. 108</sup>. |
|||
* As of December 31, 2025, GMIC, domiciled in Texas, is restricted to paying dividends of the greater of 10% of prior year-end capital and surplus or prior year net income <sup>p. 108</sup>. |
|||
* GMIC did not declare or pay any dividend during the year ended December 31, 2025 <sup>p. 108</sup>. |
|||
* HSIC did not declare or pay any dividends during the year ended December 31, 2024 <sup>p. 108</sup>. |
|||
* Property and casualty insurance companies are subject to ''Risk Based Capital (RBC) requirements'' specified by the National Association of Insurance Commissioners (NAIC) <sup>p. 108</sup>. |
|||
* RBC requirements determine the amount of capital and surplus based on various risk factors <sup>p. 108</sup>. |
|||
* As of December 31, 2025, and 2024, GMIC’s statutory capital and surplus substantially exceeded regulatory RBC requirements <sup>p. 108</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=292|p=16}} |
|||
====== 24. Subsequent Events ====== |
|||
'''Subsequent events evaluation''' |
|||
* The Company evaluated subsequent events from December 31, 2025, through the date these consolidated financial statements were issued. |
|||
* On ''September 2, 2025'', the Company entered into two share purchase agreements (Apollo Majority SPAs) with institutional and management shareholders of Apollo Group Holdings Limited (Apollo), referred to as the Majority Sellers <sup>p. 109</sup>. |
|||
* No additional subsequent events requiring disclosure were identified. |
|||
* Pursuant to the Apollo Majority SPAs, the Company agreed to acquire approximately ''87%'' of the issued share capital of Apollo held by the Majority Sellers <sup>p. 109</sup>. |
|||
* The closing of the transaction (Closing) was conditioned on the Company acquiring ''100%'' of Apollo's issued share capital (the Acquisition) through additional short-form share purchase agreements with minority shareholders <sup>p. 109</sup>. |
|||
* On ''January 1, 2026'', the Company completed the acquisition for an aggregate consideration of approximately ''$555.0 million'', paid in a combination of cash and newly issued shares of the Company's common stock <sup>p. 109</sup>. |
|||
* The acquisition closed shortly before the issuance of these consolidated financial statements, so the initial accounting under ASC 805 is not yet complete <sup>p. 109</sup>. |
|||
* The Company is evaluating information to determine identifiable assets acquired, liabilities assumed, and any resulting goodwill or intangible assets <sup>p. 109</sup>. |
|||
* Required purchase accounting disclosures will be provided in future filings <sup>p. 109</sup>. |
|||
* The Company evaluated subsequent events from ''December 31, 2025'', through the date these consolidated financial statements were issued and found no additional subsequent events requiring disclosure <sup>p. 109</sup>. |
|||
== Controls and Procedures == |
== Controls and Procedures == |
||
=== Evaluation of Disclosure Controls and Procedures === |
|||
{{chunk|doc=3z7a4yrxkn|c=293|p=17}} |
|||
* ''Management evaluation'' of disclosure controls and procedures was conducted as of the end of the period covered by this Annual Report on Form 10-K, with participation from the principal executive officer and principal financial officer <sup>p. 110</sup>. |
|||
'''Disclosure Controls and Procedures Evaluation''' |
|||
* ''Disclosure controls and procedures'' are defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act) <sup>p. 110</sup>. |
|||
* ''Conclusion'': As of December 31, 2025, the disclosure controls and procedures were effective at the reasonable assurance level <sup>p. 110</sup>. |
|||
* Management acknowledges that controls and procedures can only provide reasonable assurance of achieving their objectives <sup>p. 110</sup>. |
|||
* Management applies judgment in evaluating the cost-benefit relationship of potential controls and procedures <sup>p. 110</sup>. |
|||
* Management, including the principal executive officer and principal financial officer, evaluated the effectiveness of disclosure controls and procedures as of the end of the period covered by the Annual Report on Form 10-K. |
|||
====== Management’s Report on Internal Control over Financial Reporting ====== |
|||
* Disclosure controls and procedures are defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act). |
|||
* Based on the evaluation, the principal executive officer and principal financial officer concluded that as of December 31, 2025, the disclosure controls and procedures were effective at the reasonable assurance level. |
|||
* Management acknowledges that controls and procedures can only provide reasonable assurance of achieving their objectives, and judgment is applied in evaluating the cost-benefit relationship of controls and procedures. |
|||
=== Management’s Report on Internal Control over Financial Reporting === |
|||
* Management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended <sup>p. 111</sup>. |
|||
* Internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles in the United States of America <sup>p. 111</sup>. |
|||
* Internal control over financial reporting includes policies and procedures that pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of assets <sup>p. 111</sup>. |
|||
* Internal control over financial reporting includes policies and procedures that provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures are made only in accordance with management and directors' authorizations <sup>p. 111</sup>. |
|||
* Internal control over financial reporting includes policies and procedures that provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of assets that could have a material effect on the financial statements <sup>p. 111</sup>. |
|||
{{chunk|doc=3z7a4yrxkn|c=294|p=17}} |
|||
====== Remediation of Material Weakness in Internal Control Over Financial Reporting ====== |
|||
'''Management responsibility for internal control over financial reporting''' |
|||
* Management |
* Management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended. |
||
* Internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles in the United States of America. |
|||
* A material weakness existed as of December 31, 2024, related to the ineffective implementation of information technology general controls (ITGCs) in user access for systems supporting financial reporting processes <sup>p. 112</sup>. |
|||
* Internal control over financial reporting includes policies and procedures that pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of assets. |
|||
* Related process-level IT dependent manual and automated controls relying on affected ITGCs or information from IT systems with affected ITGCs were also deemed ineffective <sup>p. 112</sup>. |
|||
* Internal control over financial reporting includes policies and procedures that provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures are being made only in accordance with authorizations of management and directors. |
|||
* During the year ended December 31, 2025, management took actions to remediate internal control deficiencies <sup>p. 112</sup>. |
|||
* Internal control over financial reporting includes policies and procedures that provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of assets that could have a material effect on the financial statements. |
|||
* Remediation actions included enhancing IT compliance oversight and expanding the team with ITGC design and implementation experience <sup>p. 112</sup>. |
|||
* A training program addressing ITGCs and policies was developed, educating control owners on principles and requirements <sup>p. 112</sup>. |
|||
* Procedures were implemented to develop and maintain documentation of underlying ITGCs to promote knowledge transfer upon IT personnel and function changes <sup>p. 112</sup>. |
|||
* An IT management review and testing procedures were implemented to monitor ITGCs <sup>p. 112</sup>. |
|||
* Quarterly reporting on remediation measures was provided to the Audit Committee of the board of directors <sup>p. 112</sup>. |
|||
* Management believes the measures described have remediated the previously identified material weakness <sup>p. 112</sup>. |
|||
* Management concluded that internal control over financial reporting was effective at a reasonable assurance level as of December 31, 2025 <sup>p. 112</sup>. |
|||
* The assessment of internal control over financial reporting as of December 31, 2025, was conducted under the supervision and with the participation of senior management, including the Chief Executive Officer and Chief Financial Officer <sup>p. 112</sup>. |
|||
* The assessment used criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in the Internal Control — Integrated Framework (2013 Framework) <sup>p. 112</sup>. |
|||
* Based on this assessment, management concluded internal control over financial reporting was effective as of December 31, 2025 <sup>p. 112</sup>. |
|||
* The effectiveness of internal control over financial reporting as of December 31, 2025, has been audited by Ernst & Young, LLP, the Company’s independent registered public accounting firm <sup>p. 112</sup>. |
|||
* The audit opinion is included in the report titled “Report of Independent Registered Public Accounting Firm-Opinion on Internal Control over Financial Reporting” <sup>p. 112</sup>. |
|||
=== Remediation of Material Weakness in Internal Control Over Financial Reporting === |
|||
{{chunk|doc=3z7a4yrxkn|c=295|p=17}} |
|||
* No change in internal control over financial reporting occurred during the year ended December 31, 2025, that materially affected or are reasonably likely to materially affect it, except for remediation of the material weakness identified in 2024 <sup>p. 113</sup>. |
|||
'''Material weakness in internal control over financial reporting''' |
|||
* Management concluded that internal control over financial reporting was not effective as of December 31, 2024, due to material weaknesses. |
|||
====== Limitations on Effectiveness of Controls and Procedures ====== |
|||
* A material weakness existed related to the ineffective implementation of information technology general controls (ITGCs) in user access for systems supporting financial reporting processes. |
|||
* Related process-level IT dependent manual and automated controls relying on affected ITGCs or information from IT systems with affected ITGCs were also deemed ineffective. |
|||
{{chunk|doc=3z7a4yrxkn|c=296|p=17}} |
|||
* Management acknowledges that disclosure controls and procedures, even when well-designed and operated, can only offer reasonable assurance of achieving control objectives <sup>p. 114</sup>. |
|||
'''Remediation actions for internal control deficiencies''' |
|||
* The design of disclosure controls and procedures must consider resource constraints <sup>p. 114</sup>. |
|||
* Management must use judgment to evaluate the benefits of potential controls and procedures against their costs <sup>p. 114</sup>. |
|||
* During the year ended December 31, 2025, management took actions to remediate internal control deficiencies. |
|||
* Actions included enhancing IT compliance oversight and expanding the team with ITGC design and implementation experience. |
|||
* A training program addressing ITGCs and policies was developed, educating control owners on principles and requirements. |
|||
* Procedures were implemented to develop and maintain documentation of underlying ITGCs for knowledge transfer during IT personnel and function changes. |
|||
* An IT management review and testing procedures were implemented to monitor ITGCs. |
|||
* Quarterly reporting on remediation measures was provided to the Audit Committee of the board of directors. |
|||
{{chunk|doc=3z7a4yrxkn|c=297|p=17}} |
|||
'''Conclusion on internal control effectiveness''' |
|||
* Management believes the described measures remediated the previously identified material weakness. |
|||
* Internal control over financial reporting was concluded to be effective at a reasonable assurance level as of December 31, 2025. |
|||
* The assessment of internal control effectiveness as of December 31, 2025, was conducted under the supervision and participation of senior management, including the CEO and CFO. |
|||
* The assessment used criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in the Internal Control — Integrated Framework (2013 Framework). |
|||
* Based on this assessment, management concluded internal control over financial reporting was effective as of December 31, 2025. |
|||
* The effectiveness of internal control over financial reporting as of December 31, 2025, was audited by Ernst & Young, LLP, the Company’s independent registered public accounting firm. |
|||
=== Changes in Internal Control over Financial Reporting === |
|||
{{chunk|doc=3z7a4yrxkn|c=298|p=17}} |
|||
'''Internal control over financial reporting''' |
|||
* No change in internal control over financial reporting was identified during the year ended December 31, 2025, except for remediation of a material weakness identified in 2024. |
|||
* This evaluation was required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act. |
|||
* The identified changes have not materially affected, nor are they reasonably likely to materially affect, internal control over financial reporting. |
|||
=== Limitations on Effectiveness of Controls and Procedures === |
|||
{{chunk|doc=3z7a4yrxkn|c=299|p=17}} |
|||
'''Limitations of internal controls''' |
|||
* Management acknowledges that disclosure controls and procedures, regardless of design and operation, offer only reasonable assurance of achieving control objectives. |
|||
* The design of disclosure controls and procedures must consider resource constraints, requiring management to use judgment in assessing benefits against costs. |
|||
== Other Information == |
== Other Information == |
||
{{chunk|doc=3z7a4yrxkn|c=300|p=18}} |
|||
* During the quarter ended December 31, 2025, none of the company's directors or officers adopted, terminated, or modified a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement <sup>p. 115</sup>. |
|||
'''Director and officer trading arrangements''' |
|||
* During Q4 2025, none of the company's directors or officers adopted, terminated, or modified a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement. |
|||
== Directors, Executive Officers and Corporate Governance == |
== Directors, Executive Officers and Corporate Governance == |
||
{{chunk|doc=3z7a4yrxkn|c=301|p=19}} |
|||
* The information required by Item 10 of Form 10-K will be included in the 2026 Proxy Statement and is incorporated by reference <sup>p. 116</sup>. |
|||
'''Proxy statement incorporation''' |
|||
* Information required by Item 10 of Form 10-K will be included in the [[Definition:Year 2026|2026]] Proxy Statement and is incorporated by reference. |
|||
== Executive Compensation == |
== Executive Compensation == |
||
{{chunk|doc=3z7a4yrxkn|c=302|p=20}} |
|||
* The information required by Item 11 of Form 10-K will be included in the company's 2026 Proxy Statement and is incorporated by reference <sup>p. 117</sup>. |
|||
'''Executive compensation disclosure''' |
|||
* The information required by Item 11 of Form 10-K will be included in the [[Definition:Year 2026|2026]] Proxy Statement and is incorporated herein by reference. |
|||
== Security Ownership of Certain Beneficial Owner and Management and Related Stockholder Matters == |
== Security Ownership of Certain Beneficial Owner and Management and Related Stockholder Matters == |
||
{{chunk|doc=3z7a4yrxkn|c=303|p=21}} |
|||
* The information required by Item 12 of Form 10-K will be included in the 2026 Proxy Statement and is incorporated by reference <sup>p. 118</sup>. |
|||
'''Proxy statement incorporation''' |
|||
* Information required by Item 12 of Form 10-K will be included in the [[Definition:Year 2026|2026]] Proxy Statement and is incorporated by reference. |
|||
== Certain Relationships and Related Transactions, and Director Independence == |
== Certain Relationships and Related Transactions, and Director Independence == |
||
{{chunk|doc=3z7a4yrxkn|c=304|p=22}} |
|||
* The information required by Item 13 of Form 10-K will be included in the 2026 Proxy Statement and is incorporated by reference herein <sup>p. 119</sup>. |
|||
'''Proxy statement incorporation''' |
|||
* Information required by Item 13 of Form 10-K will be included in the [[Definition:Year 2026|2026]] Proxy Statement and is incorporated by reference. |
|||
== Principal Accounting Fees and Services == |
== Principal Accounting Fees and Services == |
||
{{chunk|doc=3z7a4yrxkn|c=305|p=23}} |
|||
* Our independent registered public accounting firm is Ernst & Young LLP, located in Houston, Texas <sup>p. 120</sup>. |
|||
'''Independent Registered Public Accounting Firm''' |
|||
* The Auditor Firm ID is 42 <sup>p. 120</sup>. |
|||
* The information required by Item 14 of Form 10-K will be included in our 2026 Proxy Statement and is incorporated herein by reference <sup>p. 120</sup>. |
|||
* Our independent registered public accounting firm is Ernst & Young LLP, Houston, Texas. |
|||
* Auditor Firm ID: 42. |
|||
* The information required by Item 14 of Form 10-K will be included in our [[Definition:Year 2026|2026]] Proxy Statement and is incorporated herein by reference. |
|||
== Exhibits, Financial Statement Schedules. == |
== Exhibits, Financial Statement Schedules. == |
||
{{chunk|doc=3z7a4yrxkn|c=306|p=24}} |
|||
* ''Financial statements'' of the Company are filed as part of this Form 10-K and included in Item 8 <sup>p. 121</sup>. |
|||
'''Financial statements included in Form 10-K''' |
|||
* The ''Report of Independent Registered Public Accounting Firm'' is included <sup>p. 121</sup>. |
|||
* ''Consolidated Balance Sheets'' are provided as of December 31, 2025 and 2024 <sup>p. 121</sup>. |
|||
* ''Consolidated Statements of Operations and Comprehensive Income (loss)'' are provided for the three years ended December 31, 2025, 2024, and 2023 <sup>p. 121</sup>. |
|||
* ''Consolidated Statements of Stockholders’ Equity'' are provided for the three years ended December 31, 2025, 2024, and 2023 <sup>p. 121</sup>. |
|||
* ''Consolidated Statements of Cash Flows'' are provided for the three years ended December 31, 2025, 2024, and 2023 <sup>p. 121</sup>. |
|||
* ''Listing of Exhibits'' is included <sup>p. 121</sup>. |
|||
* Items marked with an asterisk (*) are filed herewith <sup>p. 121</sup>. |
|||
* Items marked with a plus (+) indicate a management contract or compensatory plan or arrangement <sup>p. 121</sup>. |
|||
* The following consolidated financial statements of the Company are filed as part of this Form 10-K and are included in Item 8: |
|||
====== Exhibits, financial statement schedules ====== |
|||
* Report of Independent Registered Public Accounting Firm |
|||
* Consolidated Balance Sheets as of December 31, 2025 and 2024 |
|||
* Consolidated Statements of Operations and Comprehensive Income (loss) for the three years in the periods ended December 31, 2025, 2024 and 2023 |
|||
* Consolidated Statements of Stockholders’ Equity for the three years in the period ended December 31, 2025, 2024 and 2023 |
|||
* Consolidated Statements of Cash Flows for the three years in the period ended December 31, 2025, 2024 and 2023 |
|||
{{chunk|doc=3z7a4yrxkn|c=307|p=24}} |
|||
'''Listing of exhibits''' |
|||
* (a)(2) |
|||
* (a)(3) LISTING OF EXHIBITS |
|||
* Items marked with an asterisk (*) are filed herewith. |
|||
* Management contract or compensatory plan or arrangement. |
|||
{{chunk|doc=3z7a4yrxkn|c=308|p=24}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| id="t1103" class="wikitable" |
||
|+ Schedule description by schedule number |
|||
|- |
|||
! style="text-align:left" | Schedule Number |
! style="text-align:left" | Schedule Number |
||
! style="text-align:left" | Schedule Description |
! style="text-align:left" | Schedule Description |
||
! |
! style="text-align:right" | Page |
||
|- |
|- |
||
| style="text-align:left" | I. |
| style="text-align:left" | I. |
||
| style="text-align:left" | Summary of Investments — Other Than in Related Parties at December 31, 2025 |
| style="text-align:left" | Summary of Investments — Other Than in Related Parties at December 31, 2025 |
||
| |
| style="text-align:right" | 113 |
||
|- |
|- |
||
| style="text-align:left" | II. |
| style="text-align:left" | II. |
||
| style="text-align:left" | Financial Information of Registrant (Parent Company) for the years ended December 31, 2025, 2024 and 2023 |
| style="text-align:left" | Financial Information of Registrant (Parent Company) for the years ended December 31, 2025, 2024 and 2023 |
||
| |
| style="text-align:right" | 114 |
||
|- |
|- |
||
| style="text-align:left" | IV. |
| style="text-align:left" | IV. |
||
| style="text-align:left" | Supplementary Reinsurance Information for the years ended December 31, 2025, 2024, and 2023 |
| style="text-align:left" | Supplementary Reinsurance Information for the years ended December 31, 2025, 2024, and 2023 |
||
| |
| style="text-align:right" | 118 |
||
|- |
|- |
||
| style="text-align:left" | V. |
| style="text-align:left" | V. |
||
| style="text-align:left" | Valuation and Qualifying Accounts for the years ended December 31, 2025, 2024, and 2023 |
| style="text-align:left" | Valuation and Qualifying Accounts for the years ended December 31, 2025, 2024, and 2023 |
||
| |
| style="text-align:right" | 119 |
||
|- |
|- |
||
| style="text-align:left" | VI. |
| style="text-align:left" | VI. |
||
| style="text-align:left" | Supplementary Information Concerning Property — Casualty Insurance Operations for the years ended December 31, 2025, 2024, and 2023 |
| style="text-align:left" | Supplementary Information Concerning Property — Casualty Insurance Operations for the years ended December 31, 2025, 2024, and 2023 |
||
| |
| style="text-align:right" | 120 |
||
|} |
|} |
||
</div> |
</div> |
||
====== Exhibit numbers and descriptions ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| id="t1104" class="wikitable" |
||
|- |
|||
! style="text-align:left" | Exhibit Number |
! style="text-align:left" | Exhibit Number |
||
! style="text-align:left" | Exhibit Description |
! style="text-align:left" | Exhibit Description |
||
| Line 8,472: | Line 9,755: | ||
|} |
|} |
||
</div> |
</div> |
||
====== Exhibit numbers and descriptions ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| id="t1105" class="wikitable" |
||
|- |
|||
! style="text-align:left" | Exhibit Number |
! style="text-align:left" | Exhibit Number |
||
! style="text-align: |
! style="text-align:left" | Exhibit Description |
||
|- |
|- |
||
! style="text-align:left" | 10.7+ |
! style="text-align:left" | 10.7+ |
||
! style="text-align: |
! style="text-align:left" | Form of Restricted Stock Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.7 to the Company's Registration Statement on Form S-8, filed with the SEC on January 12, 2023). |
||
|- |
|- |
||
! style="text-align:left" | 10.8+ |
! style="text-align:left" | 10.8+ |
||
! style="text-align: |
! style="text-align:left" | Form of Nonstatutory Stock Option Agreement and form of notice under the Company's 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.8 to the Company's Registration Statement on Form S-8, filed with the SEC on January 12, 2023). |
||
|- |
|- |
||
! style="text-align:left" | 10.9+ |
! style="text-align:left" | 10.9+ |
||
! style="text-align: |
! style="text-align:left" | Form of Incentive Stock Option Agreement and form of notice under the Company's 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.9 to the Company's Registration Statement on Form S-8, filed with the SEC on January 12, 2023). |
||
|- |
|- |
||
! style="text-align:left" | 10.10+ |
! style="text-align:left" | 10.10+ |
||
! style="text-align: |
! style="text-align:left" | Form of Performance-Based Restricted Stock Units Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.10 to the Company’s Annual Report on Form 10-K, filed with the SEC on March 28, 2023). |
||
|- |
|- |
||
! style="text-align:left" | 10.11+ |
! style="text-align:left" | 10.11+ |
||
! style="text-align: |
! style="text-align:left" | Performance-Based Restricted Stock Units Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.11 to the Company’s Annual Report on Form 10-K, filed with the SEC on March 28, 2023). |
||
|- |
|- |
||
! style="text-align:left" | 10.12+ |
! style="text-align:left" | 10.12+ |
||
! style="text-align: |
! style="text-align:left" | Performance Unit Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.12 to the Company’s Annual Report on Form 10-K, filed with the SEC on March 28, 2023). |
||
|- |
|- |
||
! style="text-align:left" | 10.13+ |
! style="text-align:left" | 10.13+ |
||
! style="text-align: |
! style="text-align:left" | Amended Form of Performance Share (GBVPS) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.13 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
||
|- |
|- |
||
! style="text-align:left" | 10.14+ |
! style="text-align:left" | 10.14+ |
||
! style="text-align: |
! style="text-align:left" | Amended Form of Performance Share (Executives) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.14 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
||
|- |
|- |
||
! style="text-align:left" | 10.15+ |
! style="text-align:left" | 10.15+ |
||
! style="text-align: |
! style="text-align:left" | Amended Form of Performance Share (Others) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.15 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
||
|- |
|- |
||
! style="text-align:left" | 10.16+ |
! style="text-align:left" | 10.16+ |
||
! style="text-align: |
! style="text-align:left" | Amended Form of Performance Cash Units Agreement under the Company’s Long-Term Incentive Plan. (incorporated by reference to Exhibit 10.16 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
||
|- |
|- |
||
! style="text-align:left" | 10.17+ |
! style="text-align:left" | 10.17+ |
||
! style="text-align: |
! style="text-align:left" | Amended Form of the Restricted Stock Unit (Executives) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.17 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
||
|- |
|- |
||
! style="text-align:left" | 10.18+ |
! style="text-align:left" | 10.18+ |
||
! style="text-align: |
! style="text-align:left" | Amended Form of Restricted Stock Unit (Others) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.18 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
||
|- |
|- |
||
! style="text-align:left" | 10.19+ |
! style="text-align:left" | 10.19+ |
||
! style="text-align: |
! style="text-align:left" | Amended Form of Long-Term Performance Cash Plan and Award Letter under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.19 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
||
|- |
|- |
||
! style="text-align:left" | 10.20+ |
! style="text-align:left" | 10.20+ |
||
! style="text-align: |
! style="text-align:left" | Form of Indemnification Agreement (incorporated by reference to Exhibit 10.6 to the Company's Registration Statement on Form S-1, filed with the SEC on November 14, 2022). |
||
|- |
|- |
||
! style="text-align:left" | 10.21+ |
! style="text-align:left" | 10.21+ |
||
! style="text-align: |
! style="text-align:left" | Employment Agreement, dated May 22, 2020, by and between the Registrant and Andrew Robinson, with Amendment No. 1 dated January 1, 2022 (incorporated by reference to Exhibit 10.7 to the Company's Registration Statement on Form S-1, filed with the SEC on November 14, 2022). |
||
|- |
|- |
||
! style="text-align:left" | 10.22+ |
! style="text-align:left" | 10.22+ |
||
| Line 8,529: | Line 9,811: | ||
|- |
|- |
||
| style="text-align:left" | 10.23 |
| style="text-align:left" | 10.23 |
||
| style="text-align:left" | Commutation and Release Agreement by and among R&Q Re (Bermuda) Ltd., Skyward Re, Houston Specialty Insurance Company, Imperium Insurance Company, and Great Midwest Insurance Company, dated January 31, 2025 (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the Commission on February 5, 2025). |
| style="text-align:left" | Commutation and Release Agreement by and among R&Q Re (Bermuda) Ltd., Skyward Re, Houston Specialty Insurance Company, Imperium Insurance Company, and Great Midwest Insurance Company, dated January 31, 2025 (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the Commission on February 5, 2025). |
||
|- |
|- |
||
| style="text-align:left" | 10.24 |
| style="text-align:left" | 10.24 |
||
| Line 8,538: | Line 9,820: | ||
|} |
|} |
||
</div> |
</div> |
||
====== Exhibit numbers and descriptions ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| id="t1106" class="wikitable" |
||
|- |
|||
! style="text-align:left" | Exhibit Number |
! style="text-align:left" | Exhibit Number |
||
! style="text-align:left" | Exhibit Description |
! style="text-align:left" | Exhibit Description |
||
| Line 8,592: | Line 9,873: | ||
|- |
|- |
||
| style="text-align:left" | 10.41 |
| style="text-align:left" | 10.41 |
||
| style="text-align:left" | Term Loan Credit Agreement, dated December 30, 2025, by and among Skyward Specialty Insurance Group, Inc., and Barclays Bank PLC, as Administrative Agent, Truist Securities, Inc., Citizens Bank, N.A. and Texas Capital Bank (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the Commission on January 6, 2026). |
| style="text-align:left" | Term Loan Credit Agreement, dated December 30, 2025, by and among Skyward Specialty Insurance Group, Inc., and Barclays Bank PLC, as Administrative Agent, Truist Securities, Inc., Citizens Bank, N.A. and Texas Capital Bank (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the Commission on January 6, [[Definition:Year 2026|2026]]). |
||
|- |
|- |
||
| style="text-align:left" | 10.42 |
| style="text-align:left" | 10.42 |
||
| style="text-align:left" | Guaranty Agreement, dated December 30, 2025, by and among Skyward Specialty Insurance Group, Inc., Skyward Service Company, Skyward Underwriters Agency, Inc., the loan parties identified on the signature pages and Barclays Bank PLC (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed with the Commission on January 6, 2026). |
| style="text-align:left" | Guaranty Agreement, dated December 30, 2025, by and among Skyward Specialty Insurance Group, Inc., Skyward Service Company, Skyward Underwriters Agency, Inc., the loan parties identified on the signature pages and Barclays Bank PLC (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed with the Commission on January 6, [[Definition:Year 2026|2026]]). |
||
|} |
|} |
||
</div> |
</div> |
||
====== Exhibit numbers and descriptions ====== |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| id="t1107" class="wikitable" |
||
|- |
|||
! style="text-align:left" | Exhibit Number |
! style="text-align:left" | Exhibit Number |
||
! style="text-align:left" | Exhibit Description |
! style="text-align:left" | Exhibit Description |
||
|- |
|- |
||
| style="text-align:left" | 10.43 |
| style="text-align:left" | 10.43 |
||
| style="text-align:left" | First Amendment, dated December 30, 2025, by and among Skyward Specialty Insurance Group, Inc., Skyward Service Company, Skyward Underwriters Agency, Inc., the loan parties identified on the signature pages and Barclays Bank PLC (incorporated by reference to Exhibit 10.3 to the Company's Current Report on Form 8-K filed with the Commission on January 6, 2026). |
| style="text-align:left" | First Amendment, dated December 30, 2025, by and among Skyward Specialty Insurance Group, Inc., Skyward Service Company, Skyward Underwriters Agency, Inc., the loan parties identified on the signature pages and Barclays Bank PLC (incorporated by reference to Exhibit 10.3 to the Company's Current Report on Form 8-K filed with the Commission on January 6, [[Definition:Year 2026|2026]]). |
||
|- |
|- |
||
| style="text-align:left" | 19 |
| style="text-align:left" | 19 |
||
| Line 8,619: | Line 9,899: | ||
|- |
|- |
||
| style="text-align:left" | 23.1* |
| style="text-align:left" | 23.1* |
||
| style="text-align:left" | Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm. |
| style="text-align:left" | Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm. |
||
|- |
|- |
||
| style="text-align:left" | 31.1* |
| style="text-align:left" | 31.1* |
||
| Line 8,634: | Line 9,914: | ||
|- |
|- |
||
| style="text-align:left" | 101.INS |
| style="text-align:left" | 101.INS |
||
| style="text-align:left" | Inline XBRL Instance Document |
| style="text-align:left" | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document. |
||
|- |
|- |
||
| style="text-align:left" | 101.SCH |
| style="text-align:left" | 101.SCH |
||
| Line 8,644: | Line 9,924: | ||
</div> |
</div> |
||
=== Schedule I — summary of investments — other than in related parties === |
|||
====== Fixed maturity securities ====== |
|||
{{chunk|doc=3z7a4yrxkn|c=309|p=24}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1108" class="wikitable fintable" |
||
|+ Schedule I — summary of investments — other than in related parties |
|||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Cost |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Fair Value (if applicable) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | Amount on Balance Sheet |
||
|- |
|- |
||
! style="text-align:left" | December 31, 2025 |
! style="text-align:left" | December 31, 2025 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
! style="text-align:left" | Fixed maturity securities, available for sale: |
! style="text-align:left" | Fixed maturity securities, available for sale: |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | U.S. government securities |
| style="text-align:left" | U.S. government securities |
||
| Line 8,693: | Line 9,977: | ||
| style="text-align:right" | 513,695 |
| style="text-align:right" | 513,695 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total fixed maturity securities, available for sale |
||
| style="text-align:right" | |
| style="text-align:right" | 1,848,755 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,856,303 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,856,303 |
||
|- |
|||
| style="text-align:left" | <b>Fixed maturity securities, held to maturity:</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Other asset-backed securities |
| style="text-align:left" | Other asset-backed securities |
||
| Line 8,703: | Line 9,992: | ||
| style="text-align:right" | 32,822 |
| style="text-align:right" | 32,822 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total fixed maturity securities, held to maturity |
||
| style="text-align:right" | |
| style="text-align:right" | 33,290 |
||
| style="text-align:right" | |
| style="text-align:right" | 33,603 |
||
| style="text-align:right" | |
| style="text-align:right" | 32,822 |
||
|- |
|||
| style="text-align:left" | <b>Equity securities:</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Preferred stocks |
| style="text-align:left" | Preferred stocks |
||
| Line 8,713: | Line 10,007: | ||
| style="text-align:right" | 1,174 |
| style="text-align:right" | 1,174 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total equity securities |
||
| style="text-align:right" | |
| style="text-align:right" | 1,138 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,174 |
||
| style="text-align:right" | |
| style="text-align:right" | 1,174 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Mortgage loans</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>10,093</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>9,902</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>9,902</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Other long-term investments</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>37,290</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>58,650</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>58,650</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Short-term investments</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>264,299</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>264,299</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>264,299</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total |
||
| style="text-align:right" | |
| style="text-align:right" | 2,194,865 |
||
| style="text-align:right" | |
| style="text-align:right" | 2,223,931 |
||
| style="text-align:right" | |
| style="text-align:right" | 2,223,150 |
||
|} |
|} |
||
</div> |
</div> |
||
=== Balance sheets (parent company) === |
|||
====== Assets ====== |
|||
{{chunk|doc=3z7a4yrxkn|c=310|p=24}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1109" class="wikitable fintable" |
||
|+ Assets and liabilities by December 31 |
|||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | December 31, |
! colspan="2" style="text-align:center" | December 31, |
||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2025 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2024 |
||
|- |
|- |
||
! style="text-align:left" | Assets |
! style="text-align:left" | Assets |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
! style="text-align: |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
! style="text-align:left" | Investments: |
! style="text-align:left" | Investments: |
||
! class="col-m" style="text-align:right" | |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Investment in subsidiaries |
| style="text-align:left" | Investment in subsidiaries |
||
| Line 8,767: | Line 10,065: | ||
| style="text-align:right" | 14,000 |
| style="text-align:right" | 14,000 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total investments |
||
| style="text-align:right" | |
| style="text-align:right" | 1,090,801 |
||
| style="text-align:right" | |
| style="text-align:right" | 867,670 |
||
|- |
|- |
||
| style="text-align:left" | Cash and cash equivalents |
| style="text-align:left" | Cash and cash equivalents |
||
| Line 8,787: | Line 10,085: | ||
| style="text-align:right" | 2,905 |
| style="text-align:right" | 2,905 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total assets |
||
| style="text-align:right" | |
| style="text-align:right" | 1,147,224 |
||
| style="text-align:right" | |
| style="text-align:right" | 916,645 |
||
|- |
|||
| style="text-align:left" | <b>Liabilities and Stockholders’ Equity</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Liabilities: |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 8,807: | Line 10,109: | ||
| style="text-align:right" | 19,536 |
| style="text-align:right" | 19,536 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total liabilities |
||
| style="text-align:right" | |
| style="text-align:right" | 137,659 |
||
| style="text-align:right" | |
| style="text-align:right" | 122,646 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Stockholders’ Equity:</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Stockholders’ equity</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,009,565</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>793,999</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total liabilities and stockholders’ equity |
||
| style="text-align:right" | |
| style="text-align:right" | 1,147,224 |
||
| style="text-align:right" | |
| style="text-align:right" | 916,645 |
||
|} |
|} |
||
</div> |
</div> |
||
=== (parent company) === |
|||
{{chunk|doc=3z7a4yrxkn|c=311|p=24}} |
|||
* See accompanying notes to financial statements <sup>p. 122</sup>. |
|||
'''Financial statement notes''' |
|||
* See accompanying notes to financial statements. |
|||
====== Revenues and expenses ====== |
|||
{{chunk|doc=3z7a4yrxkn|c=312|p=24}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1110" class="wikitable fintable" |
||
|+ Net income by Years Ended December 31 |
|||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="3" style="text-align:center" | Years Ended December 31, |
! colspan="3" style="text-align:center" | Years Ended December 31, |
||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2025 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2024 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2023 |
||
|- |
|- |
||
! style="text-align:left" | Revenues: |
! style="text-align:left" | Revenues: |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Net investment income |
| style="text-align:left" | [[Definition:Net investment income|Net investment income]] |
||
| style="text-align:right" | 3,371 |
| style="text-align:right" | 3,371 |
||
| style="text-align:right" | 3,212 |
| style="text-align:right" | 3,212 |
||
| Line 8,861: | Line 10,168: | ||
| style="text-align:right" | ( 27 ) |
| style="text-align:right" | ( 27 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | [[Definition:Total revenue|Total revenues]] |
||
| style="text-align:right" | |
| style="text-align:right" | 3,371 |
||
| style="text-align:right" | |
| style="text-align:right" | 4,173 |
||
| style="text-align:right" | |
| style="text-align:right" | 2,832 |
||
|- |
|||
| style="text-align:left" | <b>Expenses</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Operating expenses |
| style="text-align:left" | Operating expenses |
||
| Line 8,886: | Line 10,198: | ||
| style="text-align:right" | 451 |
| style="text-align:right" | 451 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | Total expenses |
||
| style="text-align:right" | |
| style="text-align:right" | 33,243 |
||
| style="text-align:right" | |
| style="text-align:right" | 29,338 |
||
| style="text-align:right" | |
| style="text-align:right" | 10,579 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Loss before income tax expense</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 29,872 )</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 25,165 )</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 7,747 )</b> |
||
|- |
|- |
||
| style="text-align:left" | Income tax expense |
| style="text-align:left" | Income tax expense |
||
| Line 8,901: | Line 10,213: | ||
| style="text-align:right" | 6,808 |
| style="text-align:right" | 6,808 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Loss before equity in earnings of subsidiaries</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 75,732 )</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 58,743 )</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 14,555 )</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Equity in undistributed earnings of subsidiaries</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>245,760</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>177,571</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>100,539</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net income</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>170,028</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>118,828</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>85,984</b> |
||
|} |
|} |
||
</div> |
</div> |
||
=== Schedule ii — statements of cash flows (parent company) === |
|||
{{chunk|doc=3z7a4yrxkn|c=313|p=24}} |
|||
* ''Net cash provided by operating activities'' was USD 100,000 for the year ended December 31, 2023 <sup>p. 123</sup>. |
|||
'''Financial statement notes''' |
|||
* ''Net cash provided by operating activities'' was USD 100,000 for the year ended December 31, 2022 <sup>p. 123</sup>. |
|||
* ''Net cash provided by operating activities'' was USD 100,000 for the year ended December 31, 2021 <sup>p. 123</sup>. |
|||
* ''Net cash used in investing activities'' was USD 100,000 for the year ended December 31, 2023 <sup>p. 123</sup>. |
|||
* ''Net cash used in investing activities'' was USD 100,000 for the year ended December 31, 2022 <sup>p. 123</sup>. |
|||
* ''Net cash used in investing activities'' was USD 100,000 for the year ended December 31, 2021 <sup>p. 123</sup>. |
|||
* ''Net cash used in financing activities'' was USD 100,000 for the year ended December 31, 2023 <sup>p. 123</sup>. |
|||
* ''Net cash used in financing activities'' was USD 100,000 for the year ended December 31, 2022 <sup>p. 123</sup>. |
|||
* ''Net cash used in financing activities'' was USD 100,000 for the year ended December 31, 2021 <sup>p. 123</sup>. |
|||
* ''Net increase (decrease) in cash and cash equivalents'' was USD 100,000 for the year ended December 31, 2023 <sup>p. 123</sup>. |
|||
* ''Net increase (decrease) in cash and cash equivalents'' was USD 100,000 for the year ended December 31, 2022 <sup>p. 123</sup>. |
|||
* ''Net increase (decrease) in cash and cash equivalents'' was USD 100,000 for the year ended December 31, 2021 <sup>p. 123</sup>. |
|||
* ''Cash and cash equivalents at beginning of period'' was USD 100,000 for the year ended December 31, 2023 <sup>p. 123</sup>. |
|||
* ''Cash and cash equivalents at beginning of period'' was USD 100,000 for the year ended December 31, 2022 <sup>p. 123</sup>. |
|||
* ''Cash and cash equivalents at beginning of period'' was USD 100,000 for the year ended December 31, 2021 <sup>p. 123</sup>. |
|||
* ''Cash and cash equivalents at end of period'' was USD 100,000 for the year ended December 31, 2023 <sup>p. 123</sup>. |
|||
* ''Cash and cash equivalents at end of period'' was USD 100,000 for the year ended December 31, 2022 <sup>p. 123</sup>. |
|||
* ''Cash and cash equivalents at end of period'' was USD 100,000 for the year ended December 31, 2021 <sup>p. 123</sup>. |
|||
* See accompanying notes to financial statements. |
|||
====== Cash flows ====== |
|||
{{chunk|doc=3z7a4yrxkn|c=314|p=24}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1111" class="wikitable fintable" |
||
|+ Net cash used in operating activities by cash flows from operating activities |
|||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="3" style="text-align:center" | Years Ended December 31, |
! colspan="3" style="text-align:center" | Years Ended December 31, |
||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2025 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2024 |
||
! style="text-align: |
! class="col-m" style="text-align:right" | 2023 |
||
|- |
|- |
||
! style="text-align:left" | Cash flows from operating activities: |
! style="text-align:left" | Cash flows from operating activities: |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col- |
! class="col-m" style="text-align:right" | |
||
! class="col-m" style="text-align:right" | |
! class="col-m" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Net income |
| style="text-align:left" | Net income |
||
| Line 8,966: | Line 10,266: | ||
| style="text-align:right" | ( 95,947 ) |
| style="text-align:right" | ( 95,947 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net cash used in operating activities</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 5,741 )</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 2,735 )</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 9,963 )</b> |
||
|- |
|||
| style="text-align:left" | <b>Cash flows from investing activities:</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Purchase of intangible assets and goodwill |
| style="text-align:left" | Purchase of intangible assets and goodwill |
||
| Line 8,991: | Line 10,296: | ||
| style="text-align:right" | ( 10,569 ) |
| style="text-align:right" | ( 10,569 ) |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net cash provided by (used in) investing activities</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>5,887</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>5,093</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 126,869 )</b> |
||
|- |
|||
| style="text-align:left" | <b>Cash flows from financing activities:</b> |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
| style="text-align:right" | — |
|||
|- |
|- |
||
| style="text-align:left" | Repayment of stock notes receivable |
| style="text-align:left" | Repayment of stock notes receivable |
||
| Line 9,021: | Line 10,331: | ||
| style="text-align:right" | 710 |
| style="text-align:right" | 710 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net cash provided by (used in) financing activities</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>411</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 2,439 )</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>130,947</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net increase (decrease) in cash and cash equivalents and restricted cash</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>557</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 81 )</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>( 5,885 )</b> |
||
|- |
|- |
||
| style="text-align:left" | Cash and cash equivalents and restricted cash at beginning of year |
| style="text-align:left" | Cash and cash equivalents and restricted cash at beginning of year |
||
| Line 9,036: | Line 10,346: | ||
| style="text-align:right" | 8,909 |
| style="text-align:right" | 8,909 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Cash and cash equivalents and restricted cash at end of year</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>3,500</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>2,943</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>3,024</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Supplemental disclosure of cash flow information:</b> |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 9,053: | Line 10,363: | ||
</div> |
</div> |
||
=== Notes to Financial Statements === |
|||
{{chunk|doc=3z7a4yrxkn|c=315|p=24}} |
|||
* On September 30, 2024, Skyward Specialty entered into an Intercompany Loan Promissory Note with Houston Specialty Insurance Company (HSIC) <sup>p. 124</sup>. |
|||
'''Intercompany Loan Promissory Note''' |
|||
* Under the Promissory Note, Skyward Specialty borrowed ''$57.0 million'' from HSIC <sup>p. 124</sup>. |
|||
* ''Interest'' on the Promissory Note is payable monthly at a fixed annual rate of 4.00% <sup>p. 124</sup>. |
|||
* The ''principal'' of the Promissory Note is due at the maturity date <sup>p. 124</sup>. |
|||
* There are ''no prepayment penalties'' associated with the Promissory Note <sup>p. 124</sup>. |
|||
* ''No collateral'' was given as security for the payment of the Promissory Note <sup>p. 124</sup>. |
|||
* During the year ended December 31, 2024, Skyward Specialty provided funds for a new subsidiary, ''Skyward Specialty No. 1 Limited Company'' <sup>p. 124</sup>. |
|||
* Skyward Specialty No. 1 Limited Company is a ''UK company'' authorized as a Lloyd’s corporate member <sup>p. 124</sup>. |
|||
* The purpose of Skyward Specialty No. 1 Limited Company is to ''invest in Lloyd’s syndicates'' <sup>p. 124</sup>. |
|||
* On September 30, 2024, Skyward Specialty entered into an Intercompany Loan Promissory Note ("the Promissory Note") with Houston Specialty Insurance Company ("HSIC"). |
|||
====== Financial Instruments Disclosed, But Not Carried, At Fair Value ====== |
|||
* Under the Promissory Note, Skyward Specialty borrowed USD 57.0m from HSIC. |
|||
* Interest on the Promissory Note is payable monthly at a fixed annual interest rate of 4.00%. |
|||
* The principal of the Promissory Note is due at the maturity date. |
|||
* There are no prepayment penalties for the Promissory Note. |
|||
* No collateral was given as security for the payment of the Promissory Note. |
|||
{{chunk|doc=3z7a4yrxkn|c=316|p=24}} |
|||
* ''Promissory Note'' fair value was determined using the income approach with observable inputs <sup>p. 125</sup>. |
|||
'''New subsidiary and Lloyd's corporate membership''' |
|||
* The ''Promissory Note'' is classified as Level 2 in the fair value hierarchy <sup>p. 125</sup>. |
|||
* Other financial instruments are exempt from fair value disclosure requirements as they qualify as insurance-related products <sup>p. 125</sup>. |
|||
* During the year ended December 31, 2024, Skyward Specialty provided funds for a new subsidiary, Skyward Specialty No. 1 Limited Company. |
|||
====== Promissory note classified as level 2 ====== |
|||
* Skyward Specialty No. 1 Limited Company is a UK company. |
|||
* Skyward Specialty No. 1 Limited Company is authorized as a Lloyd’s corporate member to invest in Lloyd’s syndicates. |
|||
=== Financial Instruments Disclosed, But Not Carried, At Fair Value === |
|||
{{chunk|doc=3z7a4yrxkn|c=317|p=24}} |
|||
'''Promissory Note fair value''' |
|||
* Notes Payable includes the Promissory Note between Skyward Specialty and HSIC. |
|||
* Skyward Specialty determined the fair value of the Promissory Note using the income approach with observable inputs. |
|||
* The Promissory Note is classified as Level 2 in the fair value hierarchy. |
|||
* The table provides the Company's carrying and fair values of the Promissory Note as of December 31, 2025 and 2024. |
|||
{{chunk|doc=3z7a4yrxkn|c=318|p=24}} |
|||
'''Insurance-related products fair value exemption''' |
|||
* Other financial instruments are exempt from fair value disclosure requirements as they qualify as insurance-related products. |
|||
{{chunk|doc=3z7a4yrxkn|c=319|p=24}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1112" class="wikitable fintable" |
||
|+ Carrying value and fair value by notes payable |
|||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | 2025 |
! colspan="2" style="text-align:center" | 2025 |
||
| Line 9,080: | Line 10,408: | ||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Carrying Value |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Fair Value |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Carrying Value |
||
! style="text-align: |
! class="col-s" style="text-align:right" | Fair Value |
||
|- |
|- |
||
! style="text-align:left" | Notes payable |
! style="text-align:left" | Notes payable |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
! class="col-s" style="text-align:right" | |
! class="col-s" style="text-align:right" | |
||
|- |
|- |
||
| style="text-align:left" | Promissory Note |
| style="text-align:left" | Promissory Note |
||
| Line 9,099: | Line 10,427: | ||
</div> |
</div> |
||
=== Schedule iv — reinsurance === |
|||
====== Gross, ceded, assumed, and net amounts ====== |
|||
{{chunk|doc=3z7a4yrxkn|c=320|p=24}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable |
{| id="t1113" class="wikitable" |
||
|+ Gross amount, Ceded to other companies, Assumed from other companies by Accident & Health, [[Definition:Property & casualty|Property & Casualty]] |
|||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="6" style="text-align:center" | Years Ended December 31, |
! colspan="6" style="text-align:center" | Years Ended December 31, |
||
| Line 9,112: | Line 10,444: | ||
|- |
|- |
||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! |
! style="text-align:right" | Accident & Health |
||
! |
! style="text-align:right" | [[Definition:Property & casualty|Property & Casualty]] |
||
! |
! style="text-align:right" | Accident & Health |
||
! |
! style="text-align:right" | [[Definition:Property & casualty|Property & Casualty]] |
||
! |
! style="text-align:right" | Accident & Health |
||
! |
! style="text-align:right" | [[Definition:Property & casualty|Property & Casualty]] |
||
|- |
|- |
||
| style="text-align:left" | Gross amount |
| style="text-align:left" | Gross amount |
||
| Line 9,143: | Line 10,475: | ||
| style="text-align:right" | 218,649 |
| style="text-align:right" | 218,649 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Net amount</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>110,291</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,295,941</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>86,570</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>1,037,008</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>72,611</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>838,080</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Percentage of amount assumed to net</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—%</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>37.2%</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—%</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>27.4%</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—%</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>26.1%</b> |
||
|} |
|} |
||
</div> |
</div> |
||
=== Schedule V — valuation and qualifying accounts === |
|||
====== Valuation allowance for deferred tax assets ====== |
|||
{{chunk|doc=3z7a4yrxkn|c=321|p=24}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable |
{| id="t1114" class="wikitable" |
||
|+ Schedule V — valuation and qualifying accounts |
|||
|- |
|||
! style="text-align:left" | ($ in thousands) |
! style="text-align:left" | ($ in thousands) |
||
! style="text-align: |
! style="text-align:right" | Valuation Allowance For Deferred Tax Assets |
||
! style="text-align: |
! style="text-align:right" | Allowance for Uncollectible Reinsurance Recoverable |
||
! style="text-align: |
! style="text-align:right" | Allowance for Uncollectible Premiums Receivable |
||
|- |
|- |
||
! style="text-align:left" | Balance at January 1, 2023 |
! style="text-align:left" | Balance at January 1, 2023 |
||
! |
! style="text-align:right" | 586 |
||
! |
! style="text-align:right" | — |
||
! |
! style="text-align:right" | 629 |
||
|- |
|- |
||
| style="text-align:left" | Cumulative effect of adoption of ASU 2016-13 at January 1, 2023 |
| style="text-align:left" | Cumulative effect of adoption of ASU 2016-13 at January 1, 2023 |
||
| Line 9,180: | Line 10,516: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Charged to costs and expenses</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>748</b> |
||
|- |
|- |
||
| style="text-align:left" | Amounts written off |
| style="text-align:left" | Amounts written off |
||
| Line 9,195: | Line 10,531: | ||
| style="text-align:right" | 100 |
| style="text-align:right" | 100 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Balance at December 31, 2023</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>586</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>2,295</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>964</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Charged to costs and expenses</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>13,585</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>3,235</b> |
||
|- |
|- |
||
| style="text-align:left" | Amounts written off |
| style="text-align:left" | Amounts written off |
||
| Line 9,215: | Line 10,551: | ||
| style="text-align:right" | 128 |
| style="text-align:right" | 128 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Balance at December 31, 2024</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>586</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>2,295</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>2,432</b> |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Charged to costs and expenses</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>68</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>—</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>2,351</b> |
||
|- |
|- |
||
| style="text-align:left" | Amounts written off |
| style="text-align:left" | Amounts written off |
||
| Line 9,235: | Line 10,571: | ||
| style="text-align:right" | 498 |
| style="text-align:right" | 498 |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Balance at December 31, 2025</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>654</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>2,295</b> |
||
| style="text-align:right" | |
| style="text-align:right" | <b>3,140</b> |
||
|} |
|} |
||
</div> |
</div> |
||
=== Insurance operations === |
|||
====== Deferred policy acquisition costs and reserves ====== |
|||
{{chunk|doc=3z7a4yrxkn|c=322|p=24}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| id="t1115" class="wikitable fintable" |
||
|+ Deferred policy acquisition costs, Reserve for losses and loss adjustment expenses, Unearned premiums by year |
|||
|- |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="3" style="text-align:center" | As of and Years Ended December 31, |
! colspan="3" style="text-align:center" | As of and Years Ended December 31, |
||
| Line 9,274: | Line 10,614: | ||
| style="text-align:right" | 829,143 |
| style="text-align:right" | 829,143 |
||
|- |
|- |
||
| style="text-align:left" | Net investment income |
| style="text-align:left" | [[Definition:Net investment income|Net investment income]] |
||
| style="text-align:right" | 83,619 |
| style="text-align:right" | 83,619 |
||
| style="text-align:right" | 80,686 |
| style="text-align:right" | 80,686 |
||
| Line 9,299: | Line 10,639: | ||
| style="text-align:right" | 363,418 |
| style="text-align:right" | 363,418 |
||
|- |
|- |
||
| style="text-align:left" | Net premiums written (1) |
| style="text-align:left" | [[Definition:Net written premiums|Net premiums written]] (1) |
||
| style="text-align:right" | 1,406,232 |
| style="text-align:right" | 1,406,232 |
||
| style="text-align:right" | 1,123,578 |
| style="text-align:right" | 1,123,578 |
||
| Line 9,316: | Line 10,656: | ||
</div> |
</div> |
||
{{fn note|1=1|2=Amount is presented net of reinsurance.}} |
|||
{{fn note|1=2|2=Amount does not include gain on retroactive reinsurance which is included in losses and loss adjustment expenses presented on the Consolidated Statements of Operations.}} |
|||
=== SIGNATURES === |
|||
{{chunk|doc=3z7a4yrxkn|c=323|p=24}} |
|||
* The report was signed on behalf of the registrant by duly authorized individuals, pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934 <sup>p. 126</sup>. |
|||
'''Securities Exchange Act of 1934 compliance''' |
|||
* The report was signed by the following persons on behalf of the Registrant, in the capacities and on the dates indicated, pursuant to the requirements of the Securities Exchange Act of 1934 <sup>p. 126</sup>. |
|||
* The registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934. |
|||
====== Signatures on behalf of the registrant ====== |
|||
* This report has been signed by the following persons on behalf of the Registrant and in the capacities and on the dates indicated, pursuant to the requirements of the Securities Exchange Act of 1934. |
|||
{{chunk|doc=3z7a4yrxkn|c=324|p=24}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| id="t1116" class="wikitable" |
||
|+ SIGNATURES |
|||
! style="text-align:left" | — |
|||
|- |
|||
! style="text-align:left" | |
|||
! style="text-align:left" | Skyward Specialty Insurance Group, Inc. |
! style="text-align:left" | Skyward Specialty Insurance Group, Inc. |
||
|- |
|- |
||
| style="text-align:left" | Dated: March 2, 2026 |
| style="text-align:left" | Dated: March 2, [[Definition:Year 2026|2026]] |
||
| style="text-align:left" | /s/ Andrew Robinson |
| style="text-align:left" | /s/ Andrew Robinson |
||
|- |
|- |
||
| Line 9,340: | Line 10,685: | ||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable" |
{| id="t1117" class="wikitable" |
||
|- |
|||
! style="text-align:left" | Signature |
! style="text-align:left" | Signature |
||
! style="text-align:left" | Title |
! style="text-align:left" | Title |
||
! |
! style="text-align:right" | Date |
||
|- |
|- |
||
| style="text-align:left" | /s/ Andrew Robinson |
| style="text-align:left" | /s/ Andrew Robinson |
||
| style="text-align:left" | Chairman and Chief Executive Officer |
| style="text-align:left" | Chairman and Chief Executive Officer |
||
| |
| style="text-align:right" | March 2, [[Definition:Year 2026|2026]] |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Andrew Robinson</b> |
||
| style="text-align:left" | |
| style="text-align:left" | <b>(Principal Executive Officer)</b> |
||
| |
| style="text-align:right" | <b>March 2, [[Definition:Year 2026|2026]]</b> |
||
|- |
|- |
||
| style="text-align:left" | /s/ Mark Haushill |
| style="text-align:left" | /s/ Mark Haushill |
||
| style="text-align:left" | Chief Financial Officer |
| style="text-align:left" | Chief Financial Officer |
||
| |
| style="text-align:right" | March 2, [[Definition:Year 2026|2026]] |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Mark Haushill</b> |
||
| style="text-align:left" | |
| style="text-align:left" | <b>(Principal Financial and Accounting Officer)</b> |
||
| |
| style="text-align:right" | <b>March 2, [[Definition:Year 2026|2026]]</b> |
||
|- |
|- |
||
| style="text-align:left" | /s/ Gena Ashe |
| style="text-align:left" | /s/ Gena Ashe |
||
| style="text-align:left" | Director |
| style="text-align:left" | Director |
||
| |
| style="text-align:right" | March 2, [[Definition:Year 2026|2026]] |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Gena Ashe</b> |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Director</b> |
||
| |
| style="text-align:right" | <b>March 2, [[Definition:Year 2026|2026]]</b> |
||
|- |
|- |
||
| style="text-align:left" | /s/ Robert Creager |
| style="text-align:left" | /s/ Robert Creager |
||
| style="text-align:left" | Director |
| style="text-align:left" | Director |
||
| |
| style="text-align:right" | March 2, [[Definition:Year 2026|2026]] |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Robert Creager</b> |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Director</b> |
||
| |
| style="text-align:right" | <b>March 2, [[Definition:Year 2026|2026]]</b> |
||
|- |
|- |
||
| style="text-align:left" | /s/ Marcia Dall |
| style="text-align:left" | /s/ Marcia Dall |
||
| style="text-align:left" | Director |
| style="text-align:left" | Director |
||
| |
| style="text-align:right" | March 2, [[Definition:Year 2026|2026]] |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Marcia Dall</b> |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Director</b> |
||
| |
| style="text-align:right" | <b>March 2, [[Definition:Year 2026|2026]]</b> |
||
|- |
|- |
||
| style="text-align:left" | /s/ James Hays |
| style="text-align:left" | /s/ James Hays |
||
| style="text-align:left" | Director |
| style="text-align:left" | Director |
||
| |
| style="text-align:right" | March 2, [[Definition:Year 2026|2026]] |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>James Hays</b> |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Director</b> |
||
| |
| style="text-align:right" | <b>March 2, [[Definition:Year 2026|2026]]</b> |
||
|- |
|- |
||
| style="text-align:left" | /s/ Anthony J. Kuczinski |
| style="text-align:left" | /s/ Anthony J. Kuczinski |
||
| style="text-align:left" | Director |
| style="text-align:left" | Director |
||
| |
| style="text-align:right" | March 2, [[Definition:Year 2026|2026]] |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Anthony J. Kuczinski</b> |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Director</b> |
||
| |
| style="text-align:right" | <b>March 2, [[Definition:Year 2026|2026]]</b> |
||
|- |
|- |
||
| style="text-align:left" | /s/ Michael Morrissey |
| style="text-align:left" | /s/ Michael Morrissey |
||
| style="text-align:left" | Director |
| style="text-align:left" | Director |
||
| |
| style="text-align:right" | March 2, [[Definition:Year 2026|2026]] |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Michael Morrissey</b> |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Director</b> |
||
| |
| style="text-align:right" | <b>March 2, [[Definition:Year 2026|2026]]</b> |
||
|- |
|- |
||
| style="text-align:left" | /s/ Christopher L. Peirce |
| style="text-align:left" | /s/ Christopher L. Peirce |
||
| style="text-align:left" | Director |
| style="text-align:left" | Director |
||
| |
| style="text-align:right" | March 2, [[Definition:Year 2026|2026]] |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Christopher L. Peirce</b> |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Director</b> |
||
| |
| style="text-align:right" | <b>March 2, [[Definition:Year 2026|2026]]</b> |
||
|- |
|- |
||
| style="text-align:left" | /s/ Katharine Terry |
| style="text-align:left" | /s/ Katharine Terry |
||
| style="text-align:left" | Director |
| style="text-align:left" | Director |
||
| |
| style="text-align:right" | March 2, [[Definition:Year 2026|2026]] |
||
|- |
|- |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Katharine Terry</b> |
||
| style="text-align:left" | |
| style="text-align:left" | <b>Director</b> |
||
| |
| style="text-align:right" | <b>March 2, [[Definition:Year 2026|2026]]</b> |
||
|} |
|} |
||
</div> |
</div> |
||
Latest revision as of 14:02, 25 July 2026
| Document info | |
|---|---|
| Document ID | 3z7a4yrxkn |
| Organization | Skyward |
| Year | 2025 |
| Period | FY |
| Period label | FY25 |
| Document category | Annual report |
| Document type | Form 10-K |
| Document name | Skyward Specialty Insurance Group 2025 Form 10-K |
| Publication date | 2026-03-02 |
| Language | English |
| Pages | 24 |
| Source | original URL |
| Transcript | wiki page |
| Data | data page |
This article summarizes Skyward's Annual report published on 2026-03-02 (24 pages).
Cover
[c. 1; p. 1]
| USD ($) | 12 Months Ended | ||
|---|---|---|---|
| Dec. 31, 2025 | Feb. 26, 2026 | Jun. 30, 2025 | |
| Cover [Abstract] | — | — | — |
| Document Type | 10-K | — | — |
| Document Annual Report | true | — | — |
| Document Period End Date | Dec. 31, 2025 | — | — |
| Current Fiscal Year End Date | --12-31 | — | — |
| Document Transition Report | false | — | — |
| Entity File Number | 001-41591 | — | — |
| Entity Registrant Name | SKYWARD SPECIALTY INSURANCE GROUP, INC. | — | — |
| Entity Incorporation, State or Country Code | DE | — | — |
| Entity Tax Identification Number | 14-1957288 | — | — |
| Entity Address, Address Line One | 800 Gessner Road | — | — |
| Entity Address, Address Line Two | Suite 600 | — | — |
| Entity Address, City or Town | Houston | — | — |
| Entity Address, State or Province | TX | — | — |
| Entity Address, Postal Zip Code | 77024-4284 | — | — |
| City Area Code | 713 | — | — |
| Local Phone Number | 935-4800 | — | — |
| Title of 12(b) Security | Common stock, par value $0.01 | — | — |
| Trading Symbol | SKWD | — | — |
| Security Exchange Name | NASDAQ | — | — |
| Entity Well-known Seasoned Issuer | No | — | — |
| Entity Voluntary Filers | No | — | — |
| Entity Current Reporting Status | No | — | — |
| Entity Interactive Data Current | Yes | — | — |
| Entity Filer Category | Large Accelerated Filer | — | — |
| Entity Small Business | false | — | — |
| Entity Emerging Growth Company | false | — | — |
| ICFR Auditor Attestation Flag | true | — | — |
| Document Financial Statement Error Correction [Flag] | false | — | — |
| Entity Shell Company | false | — | — |
| Entity Public Float | — | — | 2,165,161,643 |
| Entity Common Stock, Shares Outstanding | — | 44,467,084 | — |
| Documents Incorporated by Reference | Portions of the Registrant’s Proxy Statement relating to the 2026 annual meeting of stockholders (the “2026 Proxy Statement”), which will be filed within 120 days of December 31, 2025, are incorporated by reference into Part III of this Form 10-K. | — | — |
| Entity Central Index Key | 0001519449 | — | — |
| Amendment Flag | false | — | — |
| Document Fiscal Year Focus | 2025 | — | — |
| Document Fiscal Period Focus | FY | — | — |
Audit Information
[c. 2; p. 2]
| 12 Months Ended | |
|---|---|
| Dec. 31, 2025 | |
| Audit Information [Abstract] | — |
| Auditor Name | Ernst & Young LLP |
| Auditor Location | Houston, Texas |
| Auditor Firm ID | 42 |
Business
Who We Are
[c. 3; p. 8] Company formation and overview
- Skyward Specialty was formed as a Delaware corporation on January 3, 2006, as an insurance holding company.
- The company operated under the name Houston International Insurance Group, Ltd. until re-branding as Skyward Specialty in November 2020.
[c. 4; p. 8] Business model and market focus
- Skyward Specialty is a growing specialty insurance company delivering commercial insurance products and solutions on a non-admitted (E&S) and admitted basis, predominantly in the United States.
- The business focuses on underserved, dislocated markets, or markets where standard insurance coverages are insufficient.
- Customers typically require highly specialized, customized underwriting solutions and claims capabilities.
- The company develops and delivers tailored insurance products and services for niche markets.
- The portfolio of insured risks is highly diversified, covering a wide variety of industries and distributed through multiple channels.
- Lines of business include general liability, excess liability, professional liability (including cyber and media liability insurance), commercial auto, group accident and health, property, agriculture, credit, surety, and workers’ compensation.
- The company insures both short and medium duration liabilities.
- The business mix is principally primary insurance and balanced between E&S and admitted markets.
- A portion of the business is specialty reinsurance (principally property, agriculture, and credit), focused on attractive specialty classes where reinsurance is more efficient due to factors like cost of entry and geographic expansion.
- This diversification, including businesses not typically aligned with traditional P&C pricing cycles, combined with underwriting and claims expertise, is expected to consistently produce strong growth and profitability across all insurance pricing cycles.
[c. 5; p. 8] Leadership and strategic positioning
- The company is led by an entrepreneurial executive management team with decades of insurance leadership experience in the global P&C industry.
- Leadership is supported by an experienced team aligned with the company's strategy.
- High-quality leadership, underwriting and claims teams, technology DNA, advanced analytics capabilities, diversified book of business, and strong competitive position are expected to enable profitable business growth.
- The aim is to deliver long-term value for shareholders by generating best-in-class underwriting profitability and book value per share growth across P&C market cycles.
- All insurance company subsidiaries are group rated and have financial strength ratings of "A" (Excellent) from A.M. Best Company with a stable outlook.
Apollo Acquisition
[c. 6; p. 8] Apollo acquisition details
- On September 2, 2025, the company entered into two share purchase agreements (Apollo Majority SPAs) with institutional and management shareholders (Majority Sellers) of Apollo Group Holdings Limited (Apollo).
- The company agreed to acquire all issued shares of Apollo held by the Majority Sellers, representing approximately 87% of Apollo's issued share capital.
- Closing of the transaction (Closing) was conditioned upon acquiring 100% of Apollo's issued share capital at Closing via additional short-form share purchase agreements (Apollo Minority SPAs) with remaining minority shareholders (Minority Sellers).
- The Acquisition closed on January 1, 2026.
- Consideration for the transaction was satisfied by issuing common stock of the Company to certain sellers and the remainder in cash.
- Apollo is a U.S.-centric specialty underwriting platform operating at Lloyd's of London, characterized by low volatility, high growth, and a capital-light business model.
- Apollo has consistently grown gross written premium since its formation in 2010.
- Through Syndicate 1969, Apollo underwrites a multi-class specialty insurance portfolio.
- Through Syndicate 1971, Apollo provides a unique, innovative platform liability product for the digital and sharing economy.
- Apollo provides capital to syndicates 1969 and 1971 in exchange for a pro-rata share of underwriting income, with third parties providing the remaining capital.
- Apollo earns managing agency fees and profit commissions as the managing agent for its own syndicates and for third-party syndicates (platform partners).
- The acquisition aligns with Skyward Specialty's strategy by bringing new specialty niches, a distinctive new economy offering, accelerating innovation, and adding Apollo's advanced technology capabilities.
- David Ibeson will continue as CEO of Apollo, leading Apollo's growth as a subsidiary of Skyward Specialty, along with Apollo's management team.
Our Business and Our Strategy
[c. 7; p. 8] Reportable segment and premium basis
- The company has one reportable segment offering a broad array of insurance coverages to various market niches.
- Each of the nine underwriting divisions has dedicated underwriting leadership and technical staff with deep experience in their niches.
- This structure and expertise aim to serve customer needs, be a value-add partner to distributors, and earn attractive risk-adjusted returns.
- For the year ended December 31, 2025, 41% of gross written premiums were written on an admitted basis and 59% were non-admitted.
[c. 8; p. 8] Underwriting divisions
- Accident & Health (A&H): Provides medical stop loss to self-insured employers and covers group and single-employer captives.
- A&H captives program offers tailored medical stop-loss and reinsurance solutions with dedicated underwriting and proactive claims oversight.
- Targets small and medium-sized enterprises seeking to control healthcare costs by self-insuring a portion of their healthcare insurance.
- Products are written on an admitted basis and distributed primarily through retail and wholesale broker partners.
- Agriculture and Credit (Re)insurance: Provides specialty risk-transfer solutions across a diversified global portfolio.
- Covers agriculture, dairy and livestock revenue protection, and mortgage and credit product lines.
- Supports insurers, MGAs, and other risk originators with tailored treaty protection using proportional and excess of loss structures.
- Global agriculture book covers weather and natural peril-driven volatility and other production and yield risks.
- Mortgage portfolio supports government-sponsored entities and private mortgage insurers against default and loss severity volatility.
- Credit portfolio protects against losses from default risk for single obligors and multi-buyer trade credit across diverse regions and industries.
- Dairy and livestock business provides revenue protection against price volatility in milk, cattle, and hog markets.
- Uses derivative instruments (primarily put options and futures) to mitigate commodity price risk, solely for managing exposure to adverse price movements.
- Positions are adjusted throughout the year based on market conditions and risk profile.
- Additional information on derivatives is in Note 8, "Derivatives" to consolidated financial statements in Item 8 of Form 10-K.
- Captives: Provides group captive solutions by leveraging underwriting and claims expertise from other divisions.
- Creates group captives for companies seeking to self-insure.
- Writes property, general liability, commercial auto, excess liability, and workers’ compensation lines on an E&S and admitted basis.
- Business is often administered through partnerships with third-party captive managers.
- Construction & Energy Solutions: Focuses on high-severity exposures with tailored, often multi-line solutions.
- Includes general liability, excess liability, commercial auto, and workers’ compensation.
- Distributed through retail agents, brokers, and a select network of wholesalers.
- Global Property: Provides comprehensive property insurance and reinsurance solutions for commercial clients worldwide.
- Offerings protect against physical loss or damage to assets from natural catastrophes and other insured perils.
- Professional Lines: Includes three underwriting units: management liability, professional liability (including cyber), and allied health (including life sciences).
- Provides primary and excess claims-made liability products on an E&S and admitted basis.
- Distributed through wholesale and retail brokers, depending on the product.
- Specialty Programs: Partners with program administrators focused on specific markets.
- Believes partnering with program administrators is optimal for profitable participation or market reach.
- Program administrators often have competitive advantages in scale or proprietary technology.
- Writes property, general liability, commercial auto liability, excess liability, and workers’ compensation lines on an E&S and admitted basis.
- Surety: Provides contract, commercial, and transactional surety solutions to trade and services organizations.
- Focuses on small to medium-sized enterprises with aggregate bond programs up to approximately USD 100.0m for contract and USD 125.0m for commercial and transactional.
- Written on an admitted basis and distributed through retail agents and brokers.
- Transactional E&S: Provides primary and excess non-catastrophe prone property and general liability solutions.
- Emphasizes risks considered hard to place due to complexity, loss history, or limited operating history (e.g., start-ups).
- Success is determined by technical underwriting, thoughtful coverage, pricing, and high-quality broker service.
- Accesses the market exclusively through wholesale brokers.
[c. 9; p. 8] Exited business
- Business units and lines previously exited and placed into run-off are referred to as "exited business".
[c. 10; p. 8] Strategy
- The company seeks to lead in chosen market niches and establish sustainable, competitive positions.
- Key elements of the strategy include:
- Providing differentiated products, services, and solutions for target markets.
- Attracting and retaining exceptional underwriting and claims talent, incentivizing professionals aligned with organizational goals.
- Amplifying expertise with advanced technology and analytics for superior risk selection, pricing, and claims management.
- Empowering underwriting and claims teams with significant decision-making authority.
- Fostering a culture that promotes nimbleness and responsiveness to market opportunities and dislocation.
- This strategy is referred to as "Rule Our Niche".
- It forms the basis for building a strong defensible market position, creating a competitive moat, and winning in chosen markets.
- The principles of this strategy are believed to be key to achieving and sustaining best-in-class underwriting results through P&C insurance pricing cycles.
- The company strives for excellence in risk selection, pricing, and claims outcomes, amplified by advanced technology and analytics.
Our Competitive Strengths
[c. 11; p. 8] Our Competitive Strengths
- Focus on profitable market niches requiring technical underwriting and claims management as barriers to entry.
- Niche areas of commercial lines P&C markets are an attractive subset of the P&C insurance market, offering opportunities for attractive risk-adjusted returns.
- Actively target underserved, dislocated markets or those where standard products are insufficient.
- Risks in core markets require efficient, individual underwriting to generate sustainable underwriting profit.
- Underwriting divisions are built around deeply experienced underwriters empowered with authority to make decisions.
- This structure allows for innovative products and solutions for distribution partners and customers, regardless of risk complexity.
- Underwriters' experience is augmented with data and predictive analytics to differentiate risk selection and pricing while enhancing efficiency.
- Focus on hiring and retaining underwriting and technical staff to differentiate the company through expertise and experience.
- Underwriting teams are knowledgeable, experienced, and empowered, which is critical for success in markets with difficult-to-automate risks.
- Underwriters have freedom to use expertise and judgment in evaluating and pricing risks, rather than strict underwriting rules.
- Cultivated a best-in-class, highly specialized team of claims professionals knowledgeable about niches and lines of business.
- Claims professionals address first-party claims with fair solutions and third-party claims with holistic responses, ensuring consistent and early loss recognition of indemnity and loss adjustment expenses (LAE).
- Respond quickly to claims with specialized adjusters using expertise, advanced technology, and analytics.
- Technology is deeply embedded in the claims process, leveraging a technology-enabled platform from first notice of loss to settlement.
- Analytics capabilities provide real-time, detailed information on open claims and benchmarks against closed claims for senior leadership and claims teams.
- Industry expertise, nimble culture, and technology-embedded claims processes enable fair and appropriate claims outcomes.
- SkyBI, the business intelligence platform, provides real-time intelligence to senior leadership and technical teams for superior decision-making.
- SkyBI reflects best practices learned from management's experience in P&C insurance and technology sectors.
- SkyBI is a single, comprehensive enterprise-wide data repository for reporting, business intelligence, analytics, and advanced data capabilities.
- SkyBI provides information and performance metrics across the company in an easy-to-consume visualized format.
- Data in SkyBI can be filtered by categories including distributor, customer segment, line of business, industry, underwriter, and risk feature.
- SkyBI aids in establishing clear line of sight to objectives and facilitating decision-making processes.
- Underwriting and claims decisions are augmented with new types of risk data and advanced technology.
- Underwriting decisions are backed by historical data and in-depth risk evaluation from intentional data collection and processing.
- Underwriting and claims prowess is amplified by combining historical data with new forms of risk data and predictive analytics.
- Generative artificial intelligence is utilized in underwriting and claims handling to aid effectiveness and efficiency, while still relying on employee expertise.
- Built a diversified group of underwriting divisions across multiple product lines, industries, geographies, and distribution channels.
- Business includes areas not typically aligned with traditional P&C cycles.
- Aims to evolve with and adapt to the market, growing certain lines in favorable conditions and limiting exposure in less favorable conditions.
- Diversity of the book allows response to and capitalization on market opportunities and dislocations across insurance market and pricing cycles, resulting in a durable insurance franchise.
- Built a distinctive winning culture, evidenced by internal surveys, public information (Glassdoor, LinkedIn), and selection as a "Best Places to Work in Insurance".
- Key to culture and operating approach is a flat communication and decision-making structure.
- Staff are trusted to make decisions that produce or exceed desired financial results and are supported by a clear system of performance measurement.
- Adopted a hybrid work schedule providing flexibility for remote working.
- Maintains an entrepreneurial environment that encourages and rewards a proactive approach to capitalize on market disruption.
- This environment is consistent with identity as a specialty insurer and a foundation for attracting talent and delivering best-in-class results.
- High-quality, experienced leadership team is aligned with shareholders.
- Executive leadership team, led by Chairman and CEO Andrew Robinson, is experienced, innovative, and entrepreneurial.
- Leadership team has a track record of success in senior management roles at industry-leading P&C companies and in starting new businesses.
- Senior leadership's compensation is structured to ensure alignment with shareholders.
- A material portion of leaders' compensation is in long-term and short-term incentives tied to delivering sustainable, best-in-class underwriting returns.
- Executive leadership team has additional long-term incentive targets tied directly to growth in book value per share.
Our Strategy in Action
[c. 12; p. 8] "Rule Our Niche" strategy tenets
- The "Rule Our Niche" strategy aims to generate best-in-class underwriting profitability for niches and create superior long-term shareholder value through growth in book value per share.
- Core tenets of the "Rule Our Niche" strategy include attracting and retaining blue-chip underwriting and claims talent to expand and enhance market position.
- The company seeks to hire and retain talented technical underwriting professionals with long-standing industry relationships with distribution partners and claims professionals with expertise in specific niches.
- These relationships are key to steady access to preferred business.
- The company aims to grow its market position by bringing on world-class talent in chosen markets.
[c. 13; p. 8] Technology leverage
- The company leverages its technology DNA to differentiate itself from competition.
- It has demonstrated a differentiated ability to utilize new forms of risk data and advanced technology within complex, higher severity risk categories of the specialty P&C insurance market.
- SkyBI provides the ability to promptly sense and quickly respond to market changes.
- Core operating platforms allow efficient entry into new markets without burdensome systems.
- Technological advantage positions the company for profitable growth and expansion into additional specialty market niches to establish a strong and defensible market position.
[c. 14; p. 8] Business growth and market trends
- The company aims to profitably grow existing lines of business and expand with new underwriting divisions.
- It is positioned to take advantage of trends impacting customers in the United States and globally.
- One trend is the continued rise in demand for specialized insurance solutions due to increasing risks and complexity from climate change/severe weather events, supply chain uncertainty, financial inflation risk, cyber risk, novel health risks, increased litigation, attorney involvement, jury awards, and healthcare delivery and cost.
- Another market trend is the emergence of "micro cycles and micro dislocations" where different pockets of the P&C insurance market experience hardening and softening at different times.
- The company has reacted quickly to these trends by launching new underwriting units (many not aligned with P&C cycles), entering underserved markets, partnering with advanced technology providers, and launching new captive solutions.
- Gross written premium growth and profitability indicate momentum and provide a reference for the company's positioning to expand and grow in target markets.
[c. 15; p. 8] Underwriting performance and operational excellence
- The company differentiates on daily excellence to drive best-in-class underwriting performance.
- Meeting long-term goals, including best-in-class underwriting returns and book value per share growth, relies on day-to-day operational execution across all functional departments (underwriting, product management, claims management).
- SkyBI provides the foundation for senior management to monitor performance, including renewal rates, new business pricing, portfolio performance for individual underwriters, and claims aging, reserving practices, and outcomes by claims adjusters.
- Focus on fundamentals driving underwriting excellence is central to the strategy.
- Cross-functional collaboration ensures underwriting, claims, actuarial, and product management teams regularly review performance and trends for quick implementation of portfolio, pricing, and coverage changes.
[c. 16; p. 8] Balance sheet utilization and strength
- The company uses its balance sheet to capture a larger part of the market it serves.
- It is committed to establishing and maintaining a strong balance sheet, starting with conservative loss reserves and strong capitalization ratios.
- This is imperative to maintain confidence of customers, distribution partners, reinsurers, regulators, rating agencies, and shareholders.
- Claims case reserves practices aim to reserve to the expected ultimate loss within 90 days of the first notice of loss.
- The practice is to maintain incurred but not reported reserves ("IBNR") that, combined with case reserves, are above the actuarial central estimate.
- Loss reserves represent the best estimate of ultimate losses.
Marketing and Distribution
[c. 17; p. 8] Marketing and distribution strategy
- The company's marketing and distribution approach mirrors its underwriting approach and is a key facet of its "Rule Our Niche" strategy.
- Underwriting teams and the company have strong relationships with distribution partners and reputations that facilitate new affiliations.
- The company wins with distribution partners due to deep expertise in niche markets, high-caliber underwriters, culture of innovation, thoughtful product line-up and design, and speed/quality of responsiveness.
- All underwriting divisions invest time and effort into sustaining and expanding distribution partner loyalty and long-term relationships.
- The company tailors its choice of distribution partners to access specific business it seeks to write.
- Products are distributed through retail agents, wholesale brokers, select program administrators, and captive managers.
- This distribution approach allows effective and efficient access to targeted business based on market niche needs and dynamics.
Underwriting
[c. 18; p. 8] Underwriting Strategy and Approach
- Underwriting approach is deeply embedded in the "Rule Our Niche" strategy.
- Underwriting teams are specialized within nine divisions, focusing on specific niches.
- The underwriting approach is underpinned by hiring experienced, best-in-class, and diverse teams of technical underwriters with established track records in specific specialty niche markets.
- Underwriters' skill sets are amplified with advanced technology and data analytics.
- Underwriters are empowered with appropriate authority to make decisions.
- This approach is believed to be key to superior risk selection, pricing, and producing sustainable best-in-class underwriting results across market cycles.
- Capabilities and experience of underwriting professionals are augmented using new forms of data and analytics for risk selection and pricing.
- Underwriting data is captured in the business intelligence platform, SkyBI.
- SkyBI forms the foundation of reporting, analytics, and other data capabilities, and is a key tool for senior management and business leaders.
- The company is highly selective in the policies chosen to bind.
- Underwriters are encouraged to move on quickly if coverage cannot reasonably be bound at a premium and coverage terms meeting company standards.
- When accepting risks, terms and price are carefully established to suit the underlying exposure.
- In the admitted market, the company ensures approved forms and filed rates are appropriate and adequate for risks, while allowing flexibility for specific/unique exposures.
- In the E&S market, freedom of rate and form is used to ensure risk and coverage are appropriate for unique needs and exposures.
- Policies are crafted to offer affordable and appropriate protection for insureds' exposures, and to construct coverage for more predictable potential losses and better managed claims costs.
- Underwriting teams are supported by active engagement and collaboration with Claims, Actuarial, Product Management, Legal and Compliance, and Finance departments.
- Collaboration ensures trends in business, legal and tort developments, and competitor and regulatory actions are analyzed, shared, and acted upon timely.
- Underwriters are viewed as the center of the company, with all support functions incentivized and measured to support underwriting profitability targets.
- This structure helps surface opportunities and issues early, contributing to nimbleness and ability to take advantage of market disruptions.
- Underwriting controls and procedures are regularly reviewed to ensure underwriters act with clear line of sight to profitably underwrite each market.
Claims Management
[c. 19; p. 8] Claims management principles and operations
- Skyward's claims department is guided by principles including prompt and comprehensive claim investigations using advanced analytics and technology.
- Other principles include providing quality claims handling service, promptly establishing reserves, pursuing contribution and subrogation, detecting and preventing fraud, and disciplined litigation management.
- Continuous training is provided to claim staff on evaluation, strategy, litigation management, good-faith handling, and best practices to achieve timely and optimal claim outcomes.
- The majority of claims are handled in-house.
- Third Party Administrators (TPAs) are utilized for certain instances, such as programs, captives, occupational accident, workers compensation, and runoff claims.
- TPAs are actively managed, overseen, and regularly audited to ensure compliance with claims handling and reserving guidelines and best practices.
- Independent legal counsel is retained for liability claims against insureds, selected based on geographical location and expertise.
- Carefully crafted litigation guidelines are provided for claims professionals and outside counsel.
- A legal spend management solution is employed to analyze legal invoices for adherence to case handling and billing practice standards, ensuring reasonable legal costs.
[c. 20; p. 8] Claims technology and efficiency initiatives
- Technology is leveraged to gain efficiencies in the claims-handling process.
- A Claims Development Severity Predictor has been created and implemented, which trains on key phrases to identify claims likely to lead to large loss development.
- This predictive model allows for early identification, proactive claims management, and summarization of development causes, and is integrated into claims review and management workflow.
- A "quick strike" program has been implemented for commercial auto claims to respond to claim reports.
- This program deploys experienced investigators and vendors to accident scenes, ideally within two hours, regardless of location.
- The quick response assists in evaluating facts and circumstances for investigation and, if appropriate, aids in resolving third-party claims quickly.
[c. 21; p. 8] Claims team structure and collaboration
- Claims handlers and managers are organized by line of business to ensure appropriate expertise in handling claims.
- Managers and adjusters collaborate closely with underwriting partners to inform them of legal trends and emerging claims issues.
- The goal is to educate underwriters on emerging areas of loss experience to assist in their risk selection processes.
Technology
[c. 22; p. 8] Technology strategy and platforms
- Technology is central to Skyward's operations and decision-making, driving long-term competitive advantages.
- Skyward deploys technology in three primary functional ways: Superior Business Intelligence Platform, Predictive Analytics Technology, and Core Transactional Platforms.
- Superior Business Intelligence Platform: SkyBI provides senior leadership and technical teams with real-time intelligence for decision-making.
- SkyBI incorporates best practices from management's experience in P&C insurance and technology sectors.
- SkyBI is a single, comprehensive enterprise-wide data repository for reporting, business intelligence, analytics, and advanced data capabilities.
- SkyBI provides information and performance metrics across the Company in an easy-to-consume visualized format.
- Data in SkyBI can be filtered by categories including distributor, customer segment, line of business, specific industry, individual underwriter, and specific risk feature.
- SkyBI helps establish clear line of sight to objectives and facilitates decision-making.
- Predictive Analytics Technology: Skyward augments employee capabilities using new risk data and predictive analytics, including AI, for risk selection, pricing, and claims handling.
- Skyward's actions within every underwriting division are intentional to "Rule Our Niche".
- Skyward aims for constant innovation, with actions specific to each division/market served.
- Core Transactional Platforms: Core operating platforms (policy administration, underwriting workbench, billing, claims systems) are designed for nimble scaling and business expansion.
- Skyward generally uses customized third-party vendor core operating applications.
- The core platform organization is used for all business except accident & health, global property, agriculture, credit (re)insurance, and surety, which require dedicated core processing components due to unique features.
- Data from all divisions' core operating platforms flows to SkyBI with comparable data quality and granularity.
- The use of advanced technology for underwriting and claims, SkyBI, and core operating platforms creates a flywheel effect.
- This flywheel effect allows underwriters to better select risk, claims professionals to better adjudicate claims, unit leaders to better communicate with reinsurance and third-party partners, and senior leadership to better evaluate business trends.
- These tools also enable more accurate, effective, and efficient communication with distribution partners, reinsurers, and other third-party partners.
[c. 23; p. 8] Cybersecurity and data protection
- Skyward faces external threats to IT systems, including system failure, customer data theft attempts, and ransomware attacks.
- Technology infrastructure is designed to function through major disruptions.
- Data is replicated in real time to a third-party cloud disaster recovery site for use during major system failures.
- Data is backed up daily for system restoration.
- Actions to prevent system and data disruptions include: actively monitoring Cybersecurity and Infrastructure Security Agency’s (“CISA”) cybersecurity directives.
- Immediate action is taken on any vulnerability identified in a CISA directive.
- Monthly vulnerability scans are conducted on all network-attached devices at all locations, with patching applied as needed.
- Two-factor authentication is required for access to any Skyward system.
- Monthly security training is conducted for all employees.
- Endpoint detection agents are implemented for threat detection and response.
- Desktop scenarios are performed to practice responses to breaches with cybersecurity insurance partners and retained security consultants.
- Annual penetration testing is performed.
- Skyward constantly reviews its security breach posture and regularly implements updated processes, best practices, and tools.
Reinsurance
[c. 24; p. 8] Reinsurance strategy and types
- Reinsurance is strategically purchased from third parties to protect capital from severity events (large single event losses or catastrophes) and reduce earnings volatility.
- Reinsurance contracts are predominantly one year in length and renew annually, primarily in January and June.
- Factors influencing reinsurance purchases at annual renewal include changes to underlying insurance coverage, updated loss activity, capital and surplus levels, risk appetite changes, and the cost and availability of reinsurance treaties.
- Quota share reinsurance, excess of loss reinsurance, and facultative reinsurance coverage are purchased to limit exposure from losses on any one occurrence.
- The mix of reinsurance purchased considers efficiency, cost, risk appetite, and specific factors of underlying risks.
- Quota share reinsurance involves the reinsurer assuming a specified percentage of the ceding company’s losses from a defined class of business in exchange for a corresponding percentage of premiums, net of a ceding commission.
- Excess of loss reinsurance involves the reinsurer assuming all or a portion of the ceding company’s losses for an individual claim or event above a specified amount, in exchange for a negotiated premium, and includes the catastrophe reinsurance program.
- Facultative coverage is a reinsurance contract on individual risks, used to supplement treaty limits or cover risks/perils excluded from treaty reinsurance.
[c. 25; p. 8] Property catastrophe reinsurance program
- As of December 31, 2025, property insurance represented 34% of gross written premiums.
- Aggregation of property writings by geographic area is actively managed and continuously monitored to limit potential loss from severe events like hurricanes, convective storms, and earthquakes.
- Catastrophe reinsurance is purchased to further mitigate aggregation of property losses due to a single event or series of events.
- Third-party stochastic and internal deterministic models are used to analyze the risk of aggregation of losses from such events to inform catastrophe reinsurance purchases.
- These models provide a quantitative view of Probable Maximum Loss (PML) events, which estimate the expected loss level for a given return period.
- Based on modeling, an event beyond a 1 in 250-year PML would be required to exhaust the USD 36.0m property catastrophe coverage.
- The company aims to expose no more than 3.0% of stockholders’ equity to a catastrophic loss that is less than a 1 in 250-year event.
- The current reinsurance program is believed to provide coverage well in excess of theoretical losses from any recorded historical event.
[c. 26; p. 8] Reinsurer credit quality and recoverables
- Reinsurance is sought from reinsurers rated at least “A-” (“Excellent”) or better by A.M. Best.
- As of December 31, 2025, 98% of reinsurance recoverables were from reinsurers rated “A-” (Excellent) or better by A.M. Best, or were collateralized by the reinsurer.
- Primary liability to policyholders is retained if reinsurers are unable to pay claims, potentially resulting in losses to the company.
- Allowances for uncollectible reinsurance are established due to the risk of reinsurer failure.
- The allowance for uncollectible reinsurance was USD 2.3m at December 31, 2025 and 2024.
- A table sets forth the most significant reinsurers by amount of reinsurance recoverables and their A.M. Best rating as of December 31, 2025.
[c. 27; p. 8]
| Line of Business | Maximum Company Retention |
|---|---|
| Accident & Health | $0.90 million per occurrence |
| Commercial Auto (1) | $1.00 million per occurrence |
| Excess Casualty (1)(2) | $2.25 million per occurrence |
| General Liability (1) | $1.50 million per occurrence |
| Ocean Marine (2) | $3.00 million per occurrence |
| Professional Lines (2) | $5.25 million per occurrence |
| Property (3) | $3.50 million per occurrence |
| Representation and Warranty | $3.25 million per occurrence |
| Surety (2) | $5.00 million per occurrence |
| Workers’ Compensation (2) | $2.33 million per occurrence |
| ($ in thousands) | ||
|---|---|---|
| Reinsurer | Reinsurance Recoverables | AM Best Rating |
| eMaxx Capitves (1) | 197,989 | n/r |
| Everest Reinsurance Co. | 123,925 | A+ |
| General Reinsurance Corp | 70,355 | A++ |
| Partner Reinsurance Co. of the US | 65,446 | A+ |
| ACE (Chubb Property & Casulty Ins Company) | 48,344 | A+ |
| RGA Reinsurance Company | 43,043 | A+ |
| Lloyds Syndicate 4711 | 35,860 | A+ |
| Swiss Reinsurance America Corp | 26,152 | A+ |
| Lloyds Syndicate 2987 | 25,301 | A+ |
| Aspen Insurance UK Limited | 24,715 | A |
| Top 10 Total | 661,130 | — |
| All Others | 458,750 | — |
| Total | 1,119,880 | — |
Enterprise Risk Management
[c. 28; p. 8] Enterprise Risk Management overview and governance
- Enterprise Risk Management (ERM) is embedded in company operations and guides day-to-day activities.
- The ERM approach aims to achieve an acceptable risk-adjusted return for shareholders and maintain trust and reliability for those served.
- Underwriting and asset portfolio construction are intentional, balancing liability duration and market cyclicality of the underwriting portfolio.
- Reinsurance is used to manage volatility outside of risk tolerances.
- The investment strategy targets a diversified portfolio balancing yield, liquidity, volatility, and potential for principal loss.
- The Senior Vice President (SVP), Chief Financial Officer (CFO) & Head of ERM - US Operations, oversees critical ERM processes and chairs the cross-functional corporate ERM Committee.
- The company formalizes its view of risk and solvency using an Economic Capital Model (ECM) to measure potential economic loss.
- ECM output measures potential earnings and capital loss for various scenarios against risk tolerances.
- Risk tolerances are set and updated annually by the ERM Committee and discussed with the Board of Directors' Risk Committee.
- The ECM provides a probabilistic modeled view of earnings and capital loss, integrating potential loss from catastrophes, reserving, underwriting, market, credit risk, strategic, and operational risks.
- The SVP, CFO & Head of ERM, with the ERM Committee, reviews and maintains a comprehensive risk register with accountabilities for mitigations and monitoring.
- The top 10 risks are identified and quantified by the SVP, CFO & Head of ERM and the ERM Committee, and reviewed quarterly.
- Reports on these risks are submitted regularly to the Risk Committee by the SVP, CFO & Head of ERM and the ERM Committee.
[c. 29; p. 8] Operational risk management processes
- Operational processes and controls are designed to identify, assess, and manage key risks continuously.
- The Underwriting Committee oversees changes in risk appetite, product line, and division expansion.
- Claims handling practices are monitored against guidelines through regular internal audits.
- Monthly large loss reviews are conducted within Claims.
- A watchlist of potential high-severity claims is maintained and monitored within Claims.
- Quarterly reserve studies are performed by Actuarial.
- The Reserve Committee meets quarterly to review and respond to trends in loss emergence.
- Key observations from reserve studies are discussed with the CEO.
- Underwriting divisions assess rate change and retention on existing business, new business quality, pricing adequacy, and loss emergence versus expectations on a monthly and quarterly basis.
- The SkyBI platform provides real-time portfolio, underwriting, claims, and actuarial analytics to support these processes.
- ERM is central to decision-making and day-to-day activities.
- ERM is a core component of the strategy to achieve market-leading risk-adjusted returns for shareholders and foster a culture of accountability, transparency, and sound judgment.
Reserves
[c. 30; p. 8] Reserve management and methodology
- Reserves are maintained for specific claims incurred and reported, IBNR reserves, and reserves for uncollectible reinsurance.
- Ultimate liability may differ from current reserves, and there is a risk of inadequate reserves in the insurance industry.
- Reserves are continually monitored using new information on reported claims and statistical analyses.
- Anticipated inflation is implicitly reflected in the reserving process through cost trend analysis and historical development review.
- Reserves for losses and LAE are not discounted to reflect estimated present value.
- Case reserves are established when a claim is reported, based on estimated ultimate payment after assessing coverage, damages, and investigation.
- Estimates for case reserves are based on reserving practices and the claims adjuster's experience and knowledge.
- Case reserves are revised periodically based on subsequent developments.
- IBNR reserves are established for estimated future loss payments on incurred but not yet reported claims and potential development on reported claims.
- IBNR reserves are estimated using generally accepted actuarial reserving techniques, considering quantitative loss experience data and qualitative factors.
- Loss reserves are regularly reviewed using various actuarial techniques.
- Reserve estimates are updated as historical loss experience develops, additional claims are reported/settled, and new information becomes available.
- Reserves can be increased or decreased over time as claims move towards settlement, impacting earnings through adverse development or reserve releases.
- Additional information on loss reserves is available in Item 7 of Form 10-K, "Management’s Discussion and Analysis of Financial Condition and Results of Operations - “Results of Operations - Losses and LAE” and “Critical Accounting Policies”.
Investments
[c. 31; p. 8] Investment portfolio strategy and oversight
- The company aims to maintain a balanced investment portfolio with predictable and stable returns, augmented by strategic investments for attractive risk-adjusted returns.
- An Enterprise Based Asset Allocation model is used for investment allocation strategy, embedded in the Economic Capital Model, to understand the impact of decisions on capital, liquidity, and risk profile across market scenarios.
- Investment risk is actively managed and monitored to balance stable growth and liquidity with compliance to insurance regulatory and rating agency frameworks.
- The portfolio primarily consists of cash and cash equivalents and investment-grade fixed-maturity securities, supplemented by additional investments within risk appetite.
- The Investment Committee of the Board of Directors reviews and approves the investment policy and strategy.
- The Investment Committee meets quarterly to review investment activities, tactics, and new investment opportunities.
- The portfolio is directed internally and includes both self-managed investments and portfolios managed by select third-party investment management firms.
[c. 32; p. 8] Investment discussion reference
- Additional discussion on investments, including market risks, is available in Item 7 of Form 10-K, "Management’s Discussion and Analysis of Financial Condition and Results of Operations—Investments".
Competition
[c. 33; p. 8] Competition factors and competitors
- The specialty lines property & casualty insurance market has many markets and sub-markets, each with distinct customer needs, products/services, and economic/structural features.
- Competition in underwriting divisions comes from other specialty and standard insurers, and program administrators.
- Competition is based on pricing, general reputation, perceived financial strength, broker relationships, product terms and conditions, independent rating agency ratings, speed and reputation of claims payment, and experience/reputation of underwriting and claims teams.
- Due to the diversity of underwriting divisions, competition is broad, with some competitors specific to only a subset of divisions.
- Notable competitors include: Markel Corporation; W.R. Berkley Corporation; American Financial Group Inc.; Tokio Marine Holdings, Inc.; CNA Financial Corporation; Hiscox, Ltd.; RLI Corp.; Intact Finance Corporation; Kinsale Capital Group, Inc; Arch Capital Group; and AXIS Capital Holdings, Ltd..
Our Structure
[c. 34; p. 8] Our Structure
- Operations are conducted principally through four insurance companies.
- Great Midwest Insurance Company (GMIC) is the largest insurance subsidiary, underwriting multiple lines on an admitted basis in all 50 states and the District of Columbia, and is a certified surety bond company listed with the Department of the Treasury.
- Houston Specialty Company (HSIC), a GMIC subsidiary, underwrites multiple lines on a surplus lines basis in 50 states, the District of Columbia, and select foreign countries.
- Imperium Insurance Company (IIC), an HSIC subsidiary, underwrites on an admitted basis in all 50 states and the District of Columbia.
- Oklahoma Specialty Insurance Company (OSIC), an IIC subsidiary, is an approved surplus lines company in 49 states and the District of Columbia.
- Effective December 31, 2024, the insurance company subsidiaries were restacked into this organizational structure to provide capital for the growing surety business to operate more effectively within the surety T-listing market.
- Skyward Re is a wholly-owned captive reinsurance company domiciled in the Cayman Islands, incorporated on January 7, 2020.
- Skyward Re was established to facilitate the LPT, which was commuted effective January 31, 2025.
- Three non-insurance companies are operated: Skyward Underwriters Agency, Inc. (a licensed agent, managing general agent, and reinsurance broker), Skyward Service Company (provides administrative services to subsidiaries), and Skyward Specialty No. 1 Limited Company (a UK company and authorized Lloyd's corporate member).
- The organizational structure at December 31, 2025, shows each entity is wholly-owned by its immediate parent.
[c. 35; p. 8]
| 2025 | |
|---|---|
| Texas | 10.7% |
| Pennsylvania | 7.6 |
| Florida | 7.2 |
| California | 7.1 |
| New York | 6.3 |
| Louisiana | 6.1 |
| Illinois | 4.1 |
| New Jersey | 4.1 |
| Georgia | 3.8 |
| Delaware | 3.1 |
| All other states and countries | 39.9 |
| Total | 100.0% |
[c. 36; p. 8] Our Structure

Chart / Image:
- SKYWARD SPECIALTY INSURANCE GROUP, INC. is a Delaware corporation.
- SKYWARD SPECIALTY INSURANCE GROUP, INC. has a subsidiary named SKYWARD SERVICE COMPANY.
- SKYWARD SERVICE COMPANY is a Delaware corporation.
- SKYWARD SPECIALTY INSURANCE GROUP, INC. has a subsidiary named GREAT MIDWEST INSURANCE COMPANY.
- GREAT MIDWEST INSURANCE COMPANY is a Texas stock insurance company.
- SKYWARD SPECIALTY INSURANCE GROUP, INC. has a subsidiary named SKYWARD UNDERWRITERS AGENCY, INC.
- SKYWARD UNDERWRITERS AGENCY, INC. is a Texas corporation.
- SKYWARD SPECIALTY INSURANCE GROUP, INC. has a subsidiary named SKYWARD SPECIALTY NO. 1 LIMITED.
- SKYWARD SPECIALTY NO. 1 LIMITED is a United Kingdom company.
- SKYWARD SPECIALTY INSURANCE GROUP, INC. has a subsidiary named SKYWARD RE.
- SKYWARD RE is a Cayman Islands corporation.
- GREAT MIDWEST INSURANCE COMPANY has a subsidiary named HOUSTON SPECIALTY INSURANCE COMPANY.
- HOUSTON SPECIALTY INSURANCE COMPANY is a Texas stock insurance company.
- HOUSTON SPECIALTY INSURANCE COMPANY has a subsidiary named IMPERIUM INSURANCE COMPANY.
- IMPERIUM INSURANCE COMPANY is a Texas stock insurance company.
- IMPERIUM INSURANCE COMPANY has a subsidiary named OKLAHOMA SPECIALTY INSURANCE COMPANY.
- OKLAHOMA SPECIALTY INSURANCE COMPANY is an Oklahoma insurance corporation.
Ratings
[c. 37; p. 8] A.M. Best rating
- Skyward Specialty Insurance Group, Inc. has an "A" (Excellent) rating with a stable outlook from A.M. Best.
- The "A" (Excellent) rating is the third highest among the 13 ratings assigned by A.M. Best, which range from "A++" (Superior) to "D" (Poor).
- A.M. Best evaluates insurance companies based on profitability, leverage, liquidity, book of business, reinsurance adequacy, asset quality and market value, loss and loss expense reserves adequacy, surplus adequacy, capital structure, management experience and competence, and market presence.
- A.M. Best ratings reflect its opinion on an insurance company’s financial strength, operating performance, and ability to meet policyholder obligations.
- These ratings are relevant to policyholders, agents, insurance brokers, and intermediaries, and are not specifically related to securities issued by the company.
Regulation
[c. 38; p. 8] Regulation
- The company is regulated by insurance regulatory authorities in the states where it conducts business.
- State insurance laws and regulations primarily protect policyholders, consumers, and claimants, not stockholders or investors.
- State regulation varies by jurisdiction, with regulators having broad administrative power over capital and surplus requirements, licensing, product form and rate review/approval, reserve adequacy standards, statutory accounting methods, financial reporting, affiliate transactions, and investment types/amounts.
- Insurance company regulation is constantly changing due to governmental agencies and legislatures reacting to issues.
- Some state legislatures have considered or enacted laws that alter and often increase state authority to regulate insurance companies and holding company systems, partly to prevent federal involvement.
- The National Association of Insurance Commissioners (NAIC) and some state insurance regulators are re-examining existing laws and regulations, focusing on insurer solvency, interpretations of current laws, and development of new laws.
- The federal government does not directly regulate insurance but federal initiatives can affect the industry through treatment of federal subsidiaries, regulation of quasi-governmental entities, and regulations from federal departments.
- The company operates as an insurance holding company system and is subject to insurance holding company laws in Texas (where primary insurance companies are domiciled) and Oklahoma.
- These statutes require each insurance company in the system to register with its state of domicile's insurance department and provide information on operations within the holding company system that could materially affect the operations, management, or financial condition of domiciled insurers.
- All transactions among holding company system members must be fair and reasonable.
- Transactions between insurance subsidiaries and their parents/affiliates generally require disclosure to state regulators, and material or extraordinary transactions typically need notice to or prior approval from the applicable state insurance regulator.
Intellectual Property
[c. 39; p. 8] Trademark registrations and protection
- The company has applied for various trademark registrations in the United States at both federal and state levels.
- The company will pursue additional trademark registrations and other intellectual property protection if deemed beneficial and cost-effective.
- The company monitors its trademarks and service marks and protects them from unauthorized use as necessary.
Employees and Human Capital
[c. 40; p. 8] Employee overview and culture
- The company had approximately 611 employees as of December 31, 2025.
- Employees are not subject to any collective bargaining agreement, and no current efforts to implement one are known.
- The company believes it has good working relations with its employees.
- The company aims to be an employer of choice, including outside of insurance.
- The company strives to create a culture fostering diversity of thought, background, and perspective.
- The company cultivates an exceptional workforce to perpetuate its ownership culture and achieve superior business results.
- The goal is to attract, develop, and retain diverse talent, promoting a culture where different viewpoints are valued, and individuals feel respected, treated fairly, and have opportunities to excel.
[c. 41; p. 8] Employee compensation and benefits
- The company offers and maintains a competitive benefits package to support employee well-being.
- Benefits include medical, dental, and vision insurance, a 401(k) plan, paid time off, family leave, and employee assistance programs.
- An employee stock purchase plan is available to all employees.
- The company emphasizes employee training and development, providing opportunities for further education and professional development.
Risk Factors
[c. 42; p. 9] investment risk disclosure
- Investing in the common stock involves a high degree of risk.
- Investors should carefully consider the risks and uncertainties described in the report, consolidated financial statements, related notes, and other SEC filings before investing.
- The described risks are not exhaustive; additional unstated, unknown, or currently immaterial risks may also affect the company.
- If any identified risk occurs, the business, operating results, financial condition, and prospects could be materially harmed, potentially leading to a decline in common stock price and loss of investment.
Summary of Material Risk Factors
[c. 43; p. 9] General business risks
- The business is subject to numerous risks and uncertainties.
- Financial condition and results of operations could be materially adversely affected by inaccurate assessment of underwriting risk.
- Competition in the industry is intense.
- Reliance on insurance retail agents and brokers, wholesalers, and program administrators exposes the business to certain risks that could adversely affect results.
[c. 44; p. 9] Reinsurance and claims risks
- Inability to purchase third-party reinsurance on desired or commercially acceptable terms, or terms that adequately protect the company, may materially adversely affect business, financial condition, and results of operations.
- Losses and loss expense reserves may be inadequate to cover actual losses, which could materially adversely affect financial condition, results of operations, and cash flows.
[c. 45; p. 9] Financial strength and policy interpretation risks
- A decline in financial strength rating may adversely affect the amount of business written.
- Unexpected changes in the interpretation of coverage or provisions, including loss limitations and exclusions, in policies could materially adversely affect financial condition and results of operations.
[c. 46; p. 9] Reinsurer and claims payment risks
- Reinsurers may not reimburse claims on a timely basis or at all, which may materially adversely affect business, financial condition, and results of operations.
- Failure to accurately and timely pay claims could materially and adversely affect business, financial condition, results of operations, and prospects.
[c. 47; p. 9] Economic and cyclical risks
- Adverse economic factors, including recession, inflation, high unemployment, or lower economic activity, could lead to fewer policy sales, increased claim frequency, premium defaults, or falsification of claims, affecting growth and profitability.
- The insurance business is historically cyclical, which may affect financial performance, cause quarterly operating results to vary, and may not be indicative of future performance.
[c. 48; p. 9] Regulatory and personnel risks
- Extensive regulation may adversely affect the ability to achieve business objectives; non-compliance could result in penalties, including fines and suspensions, adversely affecting financial condition and results of operations.
- The loss of key personnel or inability to attract and retain qualified personnel could adversely affect the company.
[c. 49; p. 9] Internal controls and public company risks
- Failure to achieve and maintain effective internal controls could impact operating results and financial condition, and negatively affect the market price of common stock.
- Costs will increase significantly as a public company, requiring management to devote substantial time to complying with public company regulations.
[c. 50; p. 9] Derivative and acquisition integration risks
- Use of derivatives to mitigate market price volatility exposure may subject the company to risks such as hedge ineffectiveness, basis risk, collateral and margin call liquidity pressures, and valuation uncertainty, any of which could adversely affect financial condition.
- The integration of Apollo may present unforeseen challenges, including difficulties in integrating technology systems, business processes, and risk management frameworks, potentially leading to operational disruptions, increased costs, or delays in realizing anticipated strategic benefits from the acquisition.
Risks Related to Our Business and Industry
[c. 51; p. 9] Underwriting risk assessment
- Financial condition and results of operations could be materially adversely affected if underwriting risk is not accurately assessed.
- Underwriting success depends on accurately assessing risks and establishing appropriate premium rates.
- Misunderstanding the nature or extent of risks can lead to inappropriate premium rates, adversely affecting financial results.
- Decisions by employees, including management and underwriters, expose the company to risk.
[c. 52; p. 9] Industry competition
- Competition in the industry is intense.
- Competition comes from specialty insurance companies, standard insurance companies, and underwriting agencies.
- Competition factors include price, reputation, financial strength, distribution relationships, product terms, rating agency ratings, claims payment speed, and underwriting team experience.
- Increasing consolidation in the insurance industry may further increase competition.
- New industry or legislative developments could also increase competition.
- Inability to compete successfully could change supply and demand for insurance, affect pricing at risk-adequate rates, and impact retention or new business acquisition on favorable terms.
- Increased competition limiting business transactions could adversely affect operating results.
[c. 53; p. 9] Distribution channel reliance
- Business depends on insurance retail agents, brokers, wholesalers, and program administrators, exposing it to risks from these distribution channels.
- Most products are distributed through independent retail agents and brokers who own "renewal rights".
- Business model relies on relationships with and success of retail agents and brokers.
- Dependence also extends to relationships wholesalers and program administrators maintain with agents and brokers.
- Relationships with distributors can be discontinued or become unprofitable.
- Consolidation of insurance distribution firms may increase their influence on commission rates and concentrate business with particular brokers.
- Premiums collected by brokers for payment to the company carry credit risk, as payment to the broker may be considered payment to the company in certain jurisdictions.
- Instances where brokers collect but do not remit premiums have not been material to date, but could require the company to provide coverage despite non-payment.
- Limitations on canceling policies for non-payment could reduce underwriting profits and adversely affect financial condition and results.
- The company reviews financial condition of new brokers and periodically reviews existing distributors to identify those not meeting profitability standards or business objectives.
- Measures like restricting access to products or terminating relationships may not achieve desired results due to contractual and regulatory limitations.
- Deterioration in distributor relationships or uncompetitive compensation could lead distributors to place more premium with other carriers.
- Distributors exceeding authority, failing to transfer collected premiums, or breaching obligations could expose the company to liability.
- Continued consolidation of insurance distribution firms could materially affect sales channels, including loss of market access or share.
- Negative impacts could arise from loss of talent following acquisitions or increased commission costs due to larger distributors gaining negotiating leverage.
- Digitization acceleration poses risks if distributors cannot keep pace with customer demand for digital experiences.
[c. 54; p. 9] Reinsurance availability and terms
- Inability to purchase third-party reinsurance on desired or commercially acceptable terms could materially adversely affect business, financial condition, and results.
- Reinsurance is strategically purchased to protect capital from severity events and reduce earnings volatility.
- Failure to renew expiring contracts, enter new arrangements, or expand coverage could increase loss exposure and potential losses.
- Increased loss exposure could necessitate reducing underwriting commitments, adversely affecting business, financial condition, and results.
- Reinsurers may exclude certain coverages or alter terms, leading to gaps in reinsurance protection and greater risk exposure.
[c. 55; p. 9] Loss and loss expense reserves adequacy
- Losses and loss expense (LAE) reserves may be inadequate, materially adversely affecting financial condition, results, and cash flows.
- Success depends on accurately assessing risks for insured businesses and people.
- Reserves are established as the best estimate for ultimate payment of incurred claims and related adjustment costs.
- Reserves are estimates, and ultimate liability may differ from the estimate.
- Reserving process reviews historical data and considers factors such as claims inflation, claims development patterns, pricing, legislative activity, social/economic patterns, and litigation/judicial/regulatory trends.
- Variables are affected by internal and external events that could increase loss exposure.
- Loss reserves are continually monitored using new information, statistical techniques, and modeling simulations.
- The process assumes past experience, adjusted for current developments and trends, is an appropriate basis for predicting future events.
- No precise method exists for evaluating the impact of specific factors on reserve adequacy, and actual results may deviate substantially.
- Uncertainties impacting reserve adequacy include:
- Time required to fully appreciate covered loss extent, leading to increasing loss estimates over time.
- New theories of liability enforced retroactively by courts.
- Volatility in financial markets, economic events, and external factors increasing claim frequency/severity.
- Elevated inflationary conditions increasing loss costs.
- Adverse economic factors (recession, inflation, unemployment) leading to fewer policy sales, increased claim frequency/severity, or premium defaults.
- Increased cost due to "social inflation" (medical/material costs, technology in vehicles, supply chain disruptions, attorney involvement, litigation financing, lawsuit abuse).
- Increased claim frequency, even without liability, could escalate evaluation and handling costs beyond established reserves.
- Entering new lines or new claim theories could increase claim frequency and handling costs.
- Inadequate reserves require increases, reducing net income and stockholders' equity in the period of identification.
- Future loss experience substantially exceeding established reserves could materially adversely affect future earnings, liquidity, and financial rating.
[c. 56; p. 9] Financial strength rating decline
- A decline in financial strength rating may adversely affect the amount of business written.
- Independent rating agencies like A.M. Best assess financial strength and quality of insurers.
- A.M. Best ratings are based on quantitative and qualitative analysis of balance sheet strength, operating performance, and business profile.
- A.M. Best financial strength ratings range from "A++" (Superior) to "F" (liquidation).
- As of the filing date, A.M. Best assigned an "A" (Excellent) financial strength rating with a stable outlook.
- A.M. Best ratings provide an independent opinion of an insurer's ability to meet policyholder obligations, not an evaluation for investors.
- A.M. Best's analysis includes peer comparisons, industry standards, operating plans, philosophy, and management.
- A.M. Best periodically reviews and may revise ratings downward based on balance sheet strength, operating performance, and business profile.
- Factors that could affect A.M. Best's analysis include:
- Changes in business practices from the organizational plan that no longer support the rating.
- Unfavorable financial, regulatory, or market trends, including excess market capacity.
- Losses exceeding loss reserves.
- Unresolved issues with government regulators.
- Inability to retain senior management or key personnel.
- Significant investment portfolio losses or limited liquidity.
- Alterations to A.M. Best's capital adequacy assessment methodology that adversely affect the rating.
- A downgrade or withdrawal of rating could lead to:
- Current and future distribution partners and insureds choosing higher-rated competitors.
- Increased cost or reduced availability of reinsurance.
- Severely limiting or preventing writing new and renewal insurance contracts.
- Rating organizations may heighten scrutiny, increase review frequency/scope, request more information, or increase capital requirements due to earnings and capital pressures on financial institutions.
- No assurance that the rating will remain at its current level.
- Adverse ratings consequences could materially adversely affect financial condition and results of operations.
[c. 57; p. 9] Policy coverage interpretation changes
- Unexpected changes in coverage interpretation or provisions, including loss limitations and exclusions, could materially adversely affect financial condition and results.
- No assurance that loss limitations or exclusions will be enforceable as intended.
- Unexpected issues related to claims and coverage may emerge due to changes in industry practices, legal, judicial, social, and other conditions.
- Policy limitations on claim periods may be shorter than statutory periods.
- Courts or regulatory authorities could nullify or void limitations/exclusions, or legislation could modify/bar their use.
- Governmental actions could result in higher than anticipated losses and LAE.
- Court decisions, like the 1995 Montrose decision in California, could narrowly read exclusions, expanding coverage and requiring new exclusions.
- These issues may adversely affect business by broadening coverage or increasing claim frequency/severity.
- Changes may not become apparent until years after affected insurance contracts are issued, making the full extent of liability unknown for a long time.
[c. 58; p. 9] Reinsurer reimbursement risk
- Reinsurers may not reimburse claims timely or at all, materially adversely affecting business, financial condition, and results.
- Reinsurance contracts require premium payments to reinsurers who reimburse a portion of covered claims.
- Reinsurers may be called upon to reimburse claims many years after premiums are paid.
- Reinsurance makes the reinsurer liable but does not relieve the ceding insurer of primary liability to policyholders.
- The current reinsurance program aims to limit financial risk.
- Reinsurers may default due to insolvency, lack of liquidity, operational failure, political/regulatory prohibitions, fraud, asserted defenses, or documentation deficiencies.
- Disputes with reinsurers can be time-consuming, costly, and uncertain.
- These risks could lead to increased net losses and adversely affect financial condition.
- As of December 31, 2025, reinsurance recoverables were USD 1,119.9m.
[c. 59; p. 9] Claims payment accuracy and timeliness
- Failure to accurately and timely pay claims could materially and adversely affect business, financial condition, results, and prospects.
- Factors affecting claims payment ability include training/experience of claims representatives (including TPAs), management effectiveness, and appropriate procedures/systems.
- Inaccurate or untimely claims payment could lead to regulatory/administrative actions, litigation, reputational damage, and adverse effects on business, financial condition, results, and prospects.
- Ineffective TPA management or internal staff/TPA inability to handle claim volume could adversely affect workload capacity.
- This could require slowing growth in affected markets and lead to decreased claims work quality, adversely affecting operating margins.
[c. 60; p. 9] Catastrophic events and climate change
- Severe weather, climate change effects, catastrophes, pandemics, and man-made events may adversely affect business, results, and financial condition.
- Business is exposed to severe weather, earthquakes, and man-made catastrophes (explosions, war, terrorist attacks, riots).
- Changing weather patterns and climatic conditions (global warming) increase unpredictability and frequency of natural disasters, including in new areas.
- Climate change may increase frequency and severity of extreme weather events, leading to conditions that increase hurricane activity and wildfire risks.
- A natural disaster or catastrophe loss could materially adversely affect business, financial condition, and results.
- Catastrophes, even those not insured against (e.g., 2025 California wildfires), can lead to policy cancellations.
- Increased frequency and severity of weather events (hurricanes, convective storms) could materially increase losses and affect ability to predict, quantify, reinsure, and manage catastrophe risk.
- Extent of losses depends on frequency/severity of insured events and total insured exposure in affected areas.
- Incidence and severity of catastrophes and severe weather are inherently unpredictable.
- Exposure to losses is managed by analyzing probability/severity of events and their impact on underwriting/investment portfolio.
- Indirect impact can occur if insured businesses are affected by catastrophes not directly covered, leading to inability or unwillingness to pay premiums on other products.
- Inability to obtain reinsurance coverage at reasonable rates and adequate amounts for severe weather/catastrophes could materially adversely affect business and results.
- Business is exposed to risks from pandemics, outbreaks, public health crises, and geopolitical/social events.
- While policy terms typically exclude virus-related claims, court decisions and governmental actions may challenge exclusions or interpretations.
- Changes in domestic and international climate policy programs and initiatives, and related legislation/regulation, are unpredictable but could materially adversely affect business, operational results, and financial results.
[c. 61; p. 9] Program administrator compliance
- Failure of program administrators to comply with pre-established guidelines could adversely affect results of operations.
- Certain insurance products are marketed and distributed through program administrators with limited quoting and binding authority.
- Program administrators sell products to insureds via retail agents and brokers and can bind certain risks without initial approval.
- Non-compliance with underwriting guidelines or appointment terms could bind the company to unanticipated risks, adversely affecting results.
[c. 62; p. 9] Contract renewals and new business
- Failure of actual renewals or new business from repeat insureds to meet expectations could materially adversely affect future written premium and results.
- Most contracts are one-year term and renewable.
- Some insurance contracts do not renew, but insureds are repeat customers with regular new contracts.
- Financial forecasting includes assumptions about renewal rates and repeat business.
- Insurance and reinsurance industries are cyclical with intense, price-based competition.
- If actual renewals/repeat business do not meet expectations, or if renewals/repeat business are declined due to pricing, future written premium and operations would be materially adversely affected.
[c. 63; p. 9] ESG matters and reputation
- Increased public attention to environmental, social, and governance (ESG) matters may expose the company to negative public perception, reputational harm, additional costs, or stock price impact.
- Failure or perceived failure to meet investor/customer ESG expectations could harm business and reputation.
- Backlash from investors or customers regarding ESG topics could also harm business and reputation.
- Reputational damage from providing policies to certain insureds could decrease demand for products, materially adversely affect business, operational results, and financial results, and require resources to rebuild reputation, competitive position, and brand strength.
[c. 64; p. 9] Accounting practices and pronouncements
- Changes in accounting practices and future pronouncements may materially affect reported financial results.
- Developments in accounting practices may require considerable additional expenses for compliance, especially if retroactive application or prior period information is needed.
- The impact of changes in current accounting practices and future pronouncements is unpredictable but may affect net income, shareholder's equity, and other financial statement line items.
- Insurance subsidiaries must comply with statutory accounting principles (SAP).
- SAP is subject to constant review by the NAIC, its task forces/committees, and state insurance departments.
- Various proposals before NAIC committees could negatively affect insurance industry participants if enacted and adopted at the state level.
- The NAIC continuously examines existing laws and regulations.
- It is unpredictable whether reforms will be enacted, in what form, or their positive/negative effect.
[c. 65; p. 9] Derivative use risks
- Use of derivatives to mitigate market price volatility exposes the company to risks that could adversely affect financial condition.
- Risks include hedge ineffectiveness due to imperfect correlation between derivatives and underlying exposures.
- Basis risk, where futures prices do not move in line with cash market prices, is another risk.
- Liquidity pressures can arise from margin call or collateral requirements during adverse market movements.
- Valuation uncertainty inherent in futures and options markets, stemming from reliance on market-based models, may cause hedges to perform differently than expected.
- These factors may prevent hedging strategies from effectively reducing volatility and could materially adversely impact financial results.
Risks Related to the Market and Economic Conditions
[c. 66; p. 9] Economic and market conditions impact on insurance business
- Adverse economic factors like recession, inflation, high unemployment, or lower economic activity could lead to fewer policy sales, increased claim frequency, premium defaults, or claim falsification, affecting growth and profitability.
- Business revenue, economic conditions, capital market volatility, and inflation affect the business and economic environment, impacting revenue and profit generation.
- An economic downturn with higher unemployment, declining spending, and reduced corporate revenue generally adversely affects demand for insurance products, impacting premium levels and profitability.
- Negative economic factors may affect the ability to charge appropriate rates for risk and reduce the number of policies written or opportunities for profitable underwriting.
- During an economic downturn, customers may reduce insurance needs, cancel policies, modify coverage, or not renew policies.
- Existing policyholders may exaggerate or falsify claims to obtain higher payments.
- A significant collapse in economic segments like construction, credit markets, or energy production/servicing could adversely affect results by reducing underwriting profit if not reflected in rates.
- The insurance business is historically cyclical, which can affect financial performance and cause operating results to vary quarterly, not indicative of future performance.
- Insurance carriers have historically experienced significant fluctuations in operating results due to competition, catastrophic events, capacity levels, litigation trends, regulatory constraints, and general economic conditions.
- The supply of insurance is related to prevailing prices, insured losses, and available capital, which fluctuate with investment returns in the industry.
- The insurance business is a cyclical industry with periods of intense price competition due to excessive underwriting capacity (soft market) and periods of capacity shortages increasing premium levels (hard market).
- Demand for insurance depends on factors like frequency/severity of catastrophic events, capacity levels, new capital providers, and general economic conditions, all of which fluctuate and can contribute to price declines.
- The profitability of most P&C insurance companies tends to follow cyclical market patterns, with higher gross written premium growth and improved profitability during hard market cycles.
- This cyclical market pattern is more pronounced in the E&S market than in the standard insurance market.
- When the standard insurance market hardens, the E&S market typically hardens, and growth in the E&S market can be significantly more rapid.
- When conditions soften, customers previously in the E&S market may return to the admitted market, exacerbating the effects of rate decreases on financial results.
- The market may experience "micro cycles" where certain areas harden or soften independently and more drastically than the overall market.
- Operating results are subject to fluctuation and have historically varied quarter-to-quarter.
- Quarterly results are expected to continue fluctuating due to general economic conditions, frequency/severity of catastrophes, fluctuating interest rates, claims exceeding loss reserves, competition, deviations from expected premium retention, adverse investment performance, and reinsurance coverage costs.
[c. 67; p. 9] Investment portfolio performance and risks
- Performance of the investment portfolio is subject to various investment risks that may adversely affect financial results.
- Results of operations depend partly on investment portfolio performance.
- The company aims to hold a diversified investment portfolio managed by professional advisory firms according to its investment policy and reviewed by its Investment Committee.
- Investments are subject to general economic conditions, market risks, and risks inherent to specific securities.
- Primary market risk exposures are to changes in interest rates and equity prices.
- A significant portion of the investment portfolio is in fixed maturity securities, or separately managed accounts and limited partnerships primarily invested in fixed maturity securities.
- Interest rates rose materially during 2022 and 2023.
- Declining interest rates, potentially due to federal government actions to slow inflation (e.g., recent rate cuts, Inflation Reduction Act of 2022), would pressure net investment income, especially from fixed maturity and short-term investments, adversely affecting operating results.
- Recent and future interest rate increases could cause values of fixed income securities portfolios to decline, with magnitude depending on security duration and rate increase amount.
- Some fixed income securities have call or prepayment options, creating reinvestment risk in declining rate environments.
- Other fixed income securities, like mortgage-backed and asset-backed securities, carry prepayment risk or may not prepay as quickly as expected in a rising interest rate environment.
- All fixed maturity securities, including those in separately managed accounts and limited partnerships, are subject to credit risk.
- Credit risk is the risk of investment default or impairment due to deterioration in the financial condition of issuers or guarantors.
- Downgrades in credit ratings of fixed maturity securities could significantly negatively affect their market valuation.
- The company also invests in marketable preferred and common equity securities and exchange-traded funds.
- These equity securities are carried at fair market value on the balance sheet and are subject to potential losses and market value declines.
- Market and credit risks could reduce net investment income and result in realized investment losses.
- The investment portfolio is subject to increased valuation uncertainties when investment markets are illiquid, as with fixed maturity securities held to maturity, separately managed accounts, and limited partnership investments.
- Valuation of investments is more subjective in illiquid markets, increasing the risk that estimated fair value does not reflect actual transaction prices.
- Risks for all security types are managed through an investment policy that sets parameters including maximum investment percentages in certain securities and minimum credit quality levels.
- These investment parameters are believed to be within applicable guidelines established by the NAIC, the Texas Department of Insurance, and the Oklahoma Department of Insurance.
- The Investment Committee periodically reviews Enterprise Based Asset Allocation models for overall risk management.
- While capital preservation is sought, investment objectives may not be achieved, and results may vary substantially over time.
- Investment strategies are employed to not correlate with insurance and reinsurance exposures, but investment portfolio losses may coincide with underwriting losses, exacerbating adverse effects.
[c. 68; p. 9] Investment liquidity and forced sales
- The company could be forced to sell investments to meet liquidity requirements.
- Premiums are invested until needed to pay policyholder claims.
- The duration of the investment portfolio is managed based on the duration of losses and LAE reserves to ensure sufficient liquidity and avoid liquidating investments to fund claims.
- Risks such as inadequate losses and LAE reserves or unfavorable litigation trends could necessitate selling investments to fund liabilities.
- Investments may not be sold at favorable prices or at all.
- Sales could result in significant realized losses depending on general market conditions, interest rates, and credit issues with individual securities.
Risks Related to the Regulatory Environment
[c. 69; p. 9] Regulatory environment and compliance risks
- Extensive regulation may adversely affect the company's ability to achieve business objectives.
- Failure to comply with regulations may result in penalties, including fines and suspensions, adversely affecting financial condition and results of operations.
- Primary insurance subsidiaries (GMIC, HSIC, IIC) are subject to extensive regulation in Texas (state of domicile) and other operating states.
- Insurance regulations are primarily designed to protect policyholders, not investors or stockholders.
- Regulations are administered by state departments of insurance and cover capital and surplus requirements, investment and underwriting limitations, affiliate transactions, dividend limitations, changes in control, solvency, and other financial/non-financial aspects.
- Significant changes in laws and regulations could limit discretion or increase business costs.
- State insurance regulators conduct periodic examinations and require annual/other reports on financial condition and holding company issues.
- Regulatory requirements may impose timing and expense constraints, adversely affecting business objectives.
- Insurance subsidiaries are part of an "insurance holding company system" in Texas, requiring notice to the Texas Department of Insurance for certain affiliate transactions.
- Prior notification requirements may cause business delays and additional expenses.
- Failure to file required notifications or comply with Texas insurance regulations may lead to significant fines, penalties, and impaired working relationships with the Texas Department of Insurance.
- State insurance regulators have broad discretion to deny or revoke licenses for regulation violations.
- The company's interpretations of regulations or industry practices may differ from regulatory authorities' interpretations.
- Lack of requisite licenses/approvals or non-compliance could lead to suspension of activities or other penalties, adversely affecting business operations.
- Changes in insurance industry regulation, laws, or interpretations could interfere with operations and increase compliance costs.
[c. 70; p. 9] Capital requirements and potential adverse impacts
- Insurance subsidiaries are subject to risk-based capital requirements based on the NAIC model and minimum capital/surplus restrictions under Texas law.
- These requirements establish minimum risk-based capital for business operations and identify inadequately capitalized property and casualty insurers based on asset/liability risks and net written premium mix.
- Insurers below a calculated threshold may face regulatory action, including supervision, rehabilitation, or liquidation.
- Failure to maintain required risk-based capital levels could adversely affect the ability of insurance subsidiaries to maintain regulatory authority and their A.M. Best Rating.
- The company may become subject to additional government or market regulation, which could have a material adverse impact on its business.
- Changes in laws related to asset/reserve valuation, surplus requirements, investment/dividend limitations, enterprise risk, and risk-based capital could adversely affect the business.
- The U.S. federal government generally has not directly regulated the insurance industry, except for flood, nuclear, and terrorism risks.
- Potential federal legislation could affect the insurance industry in areas like privatization of government entities (e.g., Freddie Mac, Fannie Mae), reduction in federal subsidies for certain businesses (e.g., agriculture), tort reform, corporate governance, and taxation of reinsurance companies.
[c. 71; p. 9] Tax law changes and net operating losses
- Changes to U.S. tax laws and new tax policies could significantly negatively impact the overall economy and the company's business.
- Legislative or other actions related to taxes could negatively affect the company, its investments, or stockholders.
- U.S. federal income tax rules are constantly under review by legislators, the IRS, and the U.S. Department of the Treasury.
- The company cannot predict with certainty how tax law changes might affect it, its stockholders, or portfolio investments.
- New legislation, U.S. Treasury regulations, administrative interpretations, or court decisions could have adverse consequences.
- On July 4, 2025, H.R. 1, the "One Big Beautiful Bill Act" (OBBBA), was signed into law in the United States.
- The OBBBA modifies key business tax provisions, including restoring 100% bonus depreciation under IRC Section 168(k), restoring immediate deduction of U.S. domestic research and experimental expenditures under IRC Section 174A, restoring the EBITDA-based business interest expense limitation under IRC Section 163(j), and changing international operations tax computations.
- Based on current analysis, the company does not believe OBBBA provisions will materially impact its business or results of operations.
- Regulations and IRS guidance implementing the OBBBA may create unforeseen issues, and further tax law changes may occur.
- There is no assurance that the company's business will not be adversely affected by the OBBBA or other tax law changes.
- The company's ability to utilize net operating loss carryforwards (NOLs) and other tax attributes may be limited.
- As of December 31, 2025, the company had gross federal income tax NOLs of approximately USD 40.3m available to offset future taxable income, prior to annual limitations under IRC Section 382.
- These NOLs are set to expire beginning in 2032.
- Under IRC Section 382, an "ownership change" (greater than 50% change in equity ownership by certain stockholders over a three-year period) can limit the use of pre-ownership change NOLs to offset post-ownership change income.
- The company may experience future ownership changes from stock ownership shifts, some outside its control.
- Future regulatory changes could also limit the ability to utilize NOLs.
- Inability to offset future taxable income with NOLs could adversely affect net income and cash flows.
[c. 72; p. 9] Holding company liquidity and dividend restrictions
- As a holding company, with substantially all operations conducted by insurance subsidiaries, liquidity at the holding company level (including ability to pay dividends and service debt) depends on obtaining cash dividends or other permitted payments from insurance subsidiaries.
- Continued operation and growth require substantial capital, so the company does not intend to declare and pay cash dividends on common stock in the foreseeable future.
- The ability to pay dividends to stockholders and meet debt obligations largely depends on dividends and distributions from primary insurance subsidiaries (GMIC, HSIC, IIC).
- State insurance laws, including Texas laws, restrict the ability of GMIC, HSIC, and IIC to determine stockholder dividends.
- State insurance regulators require insurance companies to maintain specified levels of statutory capital and surplus.
- Dividend payments are limited to the portion of available policyholder surplus derived from net profits.
- State insurance regulators have broad powers to prevent reduction of statutory surplus to inadequate levels, and there is no assurance that maximum calculated dividends would be permitted.
- State insurance regulators with jurisdiction over subsidiary dividends may adopt more restrictive statutory provisions in the future.
- Any future dividend determination will be at the discretion of the Board of Directors, depending on results of operations, financial condition, contractual debt restrictions, indebtedness, applicable law, and other relevant factors.
- Investors may need to sell common stock after price appreciation (which may not occur) to realize gains, as the only way to do so.
- Investors seeking immediate cash dividends should not purchase the company's common stock.
[c. 73; p. 9] Change of control regulations
- Applicable insurance laws may make it difficult to effect a change of control.
- Under Texas insurance laws and regulations, acquiring control of a domestic insurer requires written approval from the state insurance commissioner.
- Approval is contingent on factors including the acquirer's financial strength, plans for the insurer's future operations, and potential anti-competitive results.
- Texas insurance laws apply to direct and indirect acquisition of 10% or more of the voting stock of a Texas-domiciled insurer.
- Acquisition of 10% or more of the company's common stock would be considered an indirect change of control of Skyward Specialty, triggering applicable filing requirements under Texas insurance laws, unless a disclaimer of control filing is accepted by the Texas Insurance Department.
- These requirements may discourage potential acquisition proposals and may delay, deter, or prevent a change of control, even for transactions desirable to stockholders.
Risks Related to Our Liquidity and Access to Capital
[c. 74; p. 9] Future capital requirements
- We may require additional capital in the future, which may not be available or may only be available on unfavorable terms.
- Future capital requirements depend on factors including our ability to write new business successfully and to establish premium rates and reserves sufficient to cover losses.
- If operational cash flows are insufficient to fund future operating requirements and cover claim losses, or if capital is adversely impacted by investment portfolio fair value decline, catastrophe losses, or adverse reserve development, we may need to raise additional funds or curtail growth.
- Factors affecting capital needs include growth rate, profitability, claims experience, reinsurance availability, market disruptions, and other unforeseeable developments.
- If additional capital is needed, equity or debt financing may not be available or may be on unfavorable terms.
- Equity financings could result in dilution to stockholders.
- Debt financings may impose covenants restricting business operations.
- Such securities may have rights, preferences, and privileges senior to common stock.
- Inability to obtain adequate capital on favorable terms could materially adversely affect business, financial condition, or results of operations.
[c. 75; p. 9] Revolving Credit Facility access and covenants
- The availability of credit under the Revolving Credit Facility is subject to conditions that may limit access.
- Inability to satisfy conditions for credit under the Revolving Credit Facility would prevent borrowing and may adversely affect liquidity, financial position, and results of operations.
- Failure to meet certain financial covenants required by credit agreements may materially and adversely affect assets, financial position, and cash flows.
- A breach of covenants under the Term Loan Facility and Revolving Credit Facility could result in an event of default.
- Upon an event of default, all outstanding amounts and accrued interest could be declared immediately due and payable by lenders.
- Our assets may not be sufficient to repay in full the payments due under credit agreements if an event of default occurs.
- The current credit market environment and other macro-economic challenges may adversely impact our ability to borrow sufficient funds or sell assets or equity to pay existing debt.
Risks Related to Our Operations
[c. 76; p. 9] personnel attraction and retention
- The company could be adversely affected by the loss of key personnel or inability to attract and retain qualified personnel.
- The company depends on attracting and retaining experienced personnel knowledgeable about its business.
- The talent pool for recruitment is limited and fluctuates based on market dynamics.
- Higher demand for skilled employees could increase compensation expectations, making it difficult to retain and recruit key personnel and maintain labor costs.
- Inability to retain or attract talented personnel could prevent the company from maintaining its competitive position, adversely affecting results of operations.
[c. 77; p. 9] IT and cybersecurity risks
- Security breaches, data loss, cyberattacks, and IT failures could disrupt operations, damage reputation, and adversely affect business, operations, and financial results.
- The business is highly dependent on IT and telecommunications systems for underwriting, claims, actuarial functions, and financial reporting.
- Some systems may rely on third-party systems not under the company's control.
- Events like natural catastrophes, terrorist attacks, industrial accidents, computer viruses, and cyberattacks can cause system failures or inaccessibility.
- Sustained or repeated system failures could limit the ability to write business, provide customer service, pay claims, or operate normally.
- Computer viruses, hackers, employee misconduct, and external hazards can expose systems to security breaches.
- The company has experienced a data incident where attackers acquired certain data, which was determined to be immaterial.
- There is no evidence of nation-state actor involvement or misuse of information from the data incident.
- Future cybersecurity events may result in operational disruptions, unauthorized access, disclosure or loss of proprietary or customer data, leading to legal claims, regulatory scrutiny, reputational damage, and costs.
- SEC and state law requirements for public notification of incidents could exacerbate harm to the business.
- Harm to business and reputation could occur even if technology infrastructure is protected, if attempted security breaches are publicized.
- Advances in criminal capabilities, new vulnerabilities, or exploitation attempts could compromise security measures.
- Third parties to whom functions are outsourced are also subject to these risks.
- Increased use of third-party services (e.g., cloud technology) can make it harder to identify and respond to cyberattacks.
- Risks could increase as vendors adopt more cloud-based software services.
[c. 78; p. 9] artificial intelligence impact
- Artificial intelligence (AI) is an evolving technology that may impact the company's business and operations.
- The rapid growth of AI and machine learning may alter the competitive landscape.
- Employees use AI for risk selection, pricing, and claims handling to improve effectiveness and efficiency.
- The company's competitive position may be harmed if competitors leverage AI solutions more quickly or effectively.
- If AI applications produce deficient, inaccurate, or biased content, analyses, or recommendations, the business, financial condition, results of operations, and reputation may be adversely affected.
- Costs may be incurred to adopt and deploy AI technologies that could become obsolete earlier than expected.
- There is no assurance that desired benefits from AI will be realized.
- There is uncertainty in the legal and regulatory landscape for AI at federal and state levels.
- Future laws, regulations, or industry standards for AI may be burdensome, costly, and restrict the ability to develop, adopt, and deploy AI technologies.
[c. 79; p. 9] growth management and sustainability
- The company may not be able to manage its growth effectively.
- Future business growth could require additional capital, systems development, and skilled personnel.
- The company must meet capital needs, expand systems and internal controls, allocate human resources, hire and train qualified employees, and integrate acquired businesses effectively.
- Failure to manage growth effectively could materially adversely affect business, financial condition, and results of operations.
- Success of inorganic growth through acquisitions depends on identifying targets, negotiating favorable terms, completing transactions, and integrating targets.
- Anticipated benefits from acquisitions, such as revenue growth, operational efficiencies, or synergies, may not be realized.
- The company has experienced rapid growth in recent years, but these rates may not be indicative of future growth.
- Sustaining revenue growth consistent with recent history is not assured.
- Revenue growth depends on factors including effective product pricing, successful product deployment and renewals, attracting and retaining qualified underwriters and claims professionals, enhancing infrastructure and data systems, creating new distribution channels, introducing new products, competing effectively, and increasing brand awareness.
- Failure to accomplish these objectives makes forecasting future results difficult.
- Historical growth rate should not be considered indicative of future performance and may decline.
- Revenue could grow more slowly or decline for various reasons.
- Operating expenses are expected to increase, and if revenue growth does not offset these increases, business, financial position, and results of operations could be harmed, and profitability may not be achieved or maintained.
[c. 80; p. 9] Apollo acquisition risks
- The acquisition and integration of Apollo may adversely affect the company's business, financial condition, and results of operations.
- The acquisition of Apollo was completed on January 1, 2026.
- The acquisition is expected to provide strategic benefits, expand specialty insurance capabilities, and enhance presence in the Lloyd’s market.
- Integration of Apollo involves risks and uncertainties, including challenges in integrating operations, systems, technology platforms, and personnel.
- Integration difficulties may divert management attention, disrupt business, and incur unexpected costs or delays.
- There is no assurance that growth opportunities or other benefits from the acquisition will be realized within the expected timeframe or at all.
- Failure to achieve anticipated benefits could adversely affect results of operations and financial condition.
- Success of the acquisition depends on retaining key Apollo employees, partners, and customers.
- Loss of key personnel or business relationships could negatively impact the value of the acquired business and overall operations.
- Apollo operates in the Lloyd’s market with a distinct business culture and regulatory environment.
- Differences in business practices, risk appetite, and compliance requirements may challenge harmonization of policies and procedures.
- The acquisition may result in significant changes to financial statements, including recognition of goodwill and other intangible assets subject to impairment.
- The acquired business may have undisclosed liabilities or risks.
- Apollo's financial statements, currently prepared under U.K. GAAP, will need to be converted to U.S. GAAP, requiring adjustments to accounting policies, estimates, and disclosures.
- Expansion into new jurisdictions and markets, including Lloyd’s, increases exposure to regulatory scrutiny and compliance requirements.
- Failure to comply with applicable laws and regulations could result in fines, penalties, or other adverse consequences.
- Additional indebtedness was incurred in connection with the acquisition.
- The ability to service debt and comply with covenants may be affected by external events, limiting financial flexibility or increasing cost of capital.
- The integration process may divert management’s attention from existing business, negatively impacting ongoing operations and financial performance.
- Inability to successfully integrate Apollo, realize anticipated benefits, or manage risks could materially and adversely affect business, financial condition, and results of operations.
[c. 81; p. 9] litigation risks
- The effects of litigation are uncertain and could adversely affect the business.
- The company faces risks from various types of litigation, including disputes related to insurance claims and general commercial/corporate litigation.
- While not currently involved in out-of-the-ordinary litigation, other industry members face class action lawsuits and other litigation with unpredictable outcomes and substantial amounts.
- Social inflation, particularly in third-party claims, can lead to oversized judgments.
- Litigation costs and settlement amounts can be inflated beyond historical reasonable levels, even if cases do not reach judgment.
- Litigation is based on issues including insurance and claim settlement practices.
- The company cannot predict future involvement in such litigation or its impact.
[c. 82; p. 9] vendor and third-party risks
- Loss of key vendor relationships or failure of a vendor to protect data could affect operations.
- The company relies on services and products from many vendors in the U.S. and abroad, including computer hardware/software, claim adjustment, HR benefits management, and investment management.
- Vendor bankruptcy, inability to provide services, system breaches, or failure to protect confidential information could lead to operational impairments and financial losses.
- Failure to properly assess and understand risks and costs in third-party relationships could materially and adversely affect financial condition and results of operations.
- The company anticipates continued reliance on third-party software.
- While commercially reasonable alternatives to current licensed third-party software are believed to exist, this may not always be the case, or replacement could be difficult/costly.
- Integration of new third-party software may require significant work and investment.
- Use of additional or alternative third-party software would require license agreements, which may not be available on commercially reasonable terms or at all.
- Many risks associated with third-party software cannot be eliminated and could negatively affect the business.
[c. 83; p. 9] intellectual property risks
- The company may fail to protect its intellectual property rights for its proprietary technology platform and brand, or may be sued for infringement.
- Success and ability to compete depend partly on intellectual property, including brand rights and proprietary technology.
- The company primarily relies on copyright and trade secret laws, and confidentiality agreements to protect intellectual property.
- Steps taken to protect intellectual property may be inadequate.
- Efforts to enforce intellectual property rights may face defenses, counterclaims, and countersuits challenging validity, enforceability, and scope.
- Failure to secure, protect, and enforce intellectual property rights could adversely affect the brand and business.
- Success also depends on not infringing on others' intellectual property rights.
- Competitors and other entities may own or claim intellectual property related to the industry or company.
- Third parties may claim infringement, and the company may be found to be infringing.
- Claims or litigation could incur significant expenses, require substantial damages or royalty payments, prevent service offerings, or impose unfavorable terms.
- Even if successful in a dispute, litigation could be costly, time-consuming, and divert management attention.
Risks Related to Ownership of Our Common Stock
[c. 84; p. 9] Public company compliance costs and risks
- Operating as a public company incurs increased costs and requires substantial management time for compliance initiatives.
- Financial reporting and other requirements may exceed the preparedness of accounting and management systems and resources.
- As a public company and large accelerated filer, significant legal, accounting, and other expenses are incurred that would not be present as a private company.
- Federal securities laws, including Sarbanes-Oxley Act, Dodd-Frank Act, and SEC/Nasdaq rules, impose requirements on public companies, such as filing annual, quarterly, and event-driven reports, and maintaining effective disclosure, financial controls, and corporate governance practices.
- These rules increase legal and financial compliance costs, make activities more time-consuming and costly, and require significant management and personnel time for compliance.
- There is a risk of not producing reliable financial statements or filing them timely with the SEC, or complying with Nasdaq listing requirements.
- Section 404 of the Sarbanes-Oxley Act requires system and process evaluation and testing of internal control over financial reporting, leading to substantial accounting expense and significant management effort.
- Compliance with Section 404 necessitates maintaining accounting and finance staff and consultants with public company reporting, technical accounting, and internal control knowledge, and providing internal audit services.
- Achieving Section 404 compliance involves a costly and challenging process to document and evaluate internal control over financial reporting.
- This process requires dedicating internal resources, engaging outside consultants, adopting a detailed work plan, improving control processes, validating controls through testing, and implementing continuous reporting and improvement.
- There is a risk that neither the company nor its independent registered public accounting firm will conclude that internal control over financial reporting is effective within the prescribed timeframe, potentially leading to adverse financial market reactions due to loss of confidence in financial statement reliability.
- Non-compliance could also lead to investigations by the SEC or other regulatory authorities, requiring additional financial and management resources.
- Disclosure controls and procedures are required to ensure information for SEC reports is recorded, processed, summarized, and reported within specified time periods.
- Disclosure controls and procedures or internal control over financial reporting are not expected to prevent or detect all errors and fraud.
- A control system provides only reasonable, not absolute, assurance that objectives will be met due to inherent limitations.
- No evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud have been detected.
- Control system design is based on assumptions about future events, and may not succeed under all potential future conditions.
- Controls may become inadequate over time due to changing conditions or deterioration in compliance with policies or procedures.
- Misstatements due to error or fraud may occur and not be detected because of inherent limitations in the control system.
- Failure to achieve and maintain effective internal controls, as required by Section 404 of the Sarbanes-Oxley Act, could harm operating results and financial condition, and negatively affect the market price of common stock.
- Section 404(b) of the Sarbanes-Oxley Act requires annual assessments by management of the effectiveness of internal control over financial reporting.
- Substantial internal control systems and procedures must be implemented and maintained to satisfy Exchange Act reporting requirements.
- Deficiencies may be identified during assessments that cannot be remediated timely.
- Testing and maintaining internal control over financial reporting may divert management's attention from other important business matters.
- There is a risk of not being able to conclude on an ongoing basis that internal control over financial reporting is effective under Section 404(b) of Sarbanes-Oxley.
- If internal control over financial reporting is deemed ineffective, remediation actions could be costly and significantly impact operations.
- Material weaknesses or other deficiencies in internal control over financial reporting may impede the ability to file timely and accurate reports with the SEC.
- Any of these issues could cause investors to lose confidence in reported financial information or lead to suspension or termination of common stock listing on Nasdaq, negatively affecting the trading price.
- A material weakness in internal control over information technology general controls ("ITGCs") was identified as of December 31, 2024, and remediated as of December 31, 2025.
- Failure to maintain an effective system of internal controls could adversely affect the market price of common stock.
- The effectiveness of controls and procedures is subject to inherent limitations, meaning there is no assurance they will prevent or detect misstatements.
- Even an effective ITGC system provides only reasonable, not absolute, assurance regarding ITGCs.
- Control deficiencies over ITGCs, constituting a material weakness, were identified during the fiscal year ended December 31, 2024, as described in "ITEM 9A. CONTROLS & PROCEDURES" of the Annual Report on Form 10-K for that period.
- Measures have been taken to remediate the identified material weakness, and it is believed to be remediated.
- If additional material weaknesses or significant deficiencies are identified, required financial information may not be provided timely and reliably, or financial information may be incorrectly reported.
- Untimely filing of financial statements could lead to adverse action by shareholders, Nasdaq, the SEC, or other regulatory authorities.
- Material weaknesses or significant deficiencies in internal controls could adversely affect reputation or investor perceptions, negatively impacting the trading price of common shares.
- Additional costs may be incurred to remediate material weaknesses or significant deficiencies in internal controls.
- There is no assurance that additional material weaknesses or restatements of financial results will not arise in the future due to inadequate internal controls.
- Current controls and procedures may not be adequate in the future to prevent or identify irregularities or errors, or to facilitate fair presentation of financial statements.
[c. 85; p. 9] Stock price volatility and investment risk
- Operating results and stock price may be volatile or decline regardless of operating performance, leading to potential loss of investment.
- The market price of common stock has been and is likely to remain highly volatile, fluctuating substantially due to many factors beyond the company's control.
- Securities markets worldwide have experienced and are expected to continue experiencing significant price and volume fluctuations.
- Market volatility, general economic, market, or political conditions could cause wide price fluctuations in shares regardless of operating performance.
- Investment in common stock is considered risky and should only be undertaken if significant loss and wide market value fluctuation can be withstood.
- Factors that could affect the stock price include: market conditions in the broader stock market; actual or anticipated fluctuations in quarterly financial and operating results; introduction of new products or services by the company or competitors; issuance of new or changed securities analysts’ reports or recommendations; operating results varying from expectations of securities analysts and investors; short sales, hedging, and other derivative transactions in common stock; guidance provided to the public, changes in guidance, or failure to meet guidance; strategic actions by the company or competitors; announcements by the company, competitors, or acquisition targets; sales, or anticipated sales, of large blocks of stock by directors, executive officers, and principal stockholders; additions or departures in the Board of Directors, senior management, or other key personnel; regulatory, legal, or political developments; public response to press releases or other public announcements by the company or third parties, including SEC filings; litigation and governmental investigations; changing economic conditions, including social inflation; changes in accounting principles; any future indebtedness or securities issued; default under agreements governing indebtedness; exposure to capital and credit market risks adversely affecting the investment portfolio or capital resources; changes in credit ratings; and other events or factors, including natural disasters, war, acts of terrorism, or responses to these events.
- Securities markets have experienced extreme price and volume fluctuations unrelated or disproportionate to company operating performance.
- Investors in common stock may not be able to resell shares at or above their purchase price due to these factors.
- Broad market fluctuations, general market, economic, and political conditions (e.g., recessions, loss of investor confidence, interest rate changes) may negatively affect the market price of common stock.
- Stock markets, including Nasdaq, have experienced extreme price and volume fluctuations affecting equity securities of many companies.
- Such occurrences could cause the stock price to fall and expose the company to securities class action litigation, which could be costly to defend, divert management's attention and resources, or harm the business.
[c. 86; p. 9] Underwriting guidelines and strategy changes
- Management can change underwriting guidelines or strategy without stockholder approval or notice.
- This authority allows fundamental changes to operations without stockholder approval, potentially leading to a strategy or underwriting guidelines materially different from those described in the "Business" section or other filings.
[c. 87; p. 9] Anti-takeover provisions and corporate governance
- Anti-takeover provisions in organizational documents could prevent or delay a change of control beneficial to shareholders and limit share price.
- Provisions in the certificate of incorporation and by-laws, Delaware law, and federal/state/insurance regulations may discourage, delay, or prevent mergers, tender offers, or other changes of control that security holders might consider favorable.
- These provisions impose procedural and other requirements that could make it more difficult for shareholders to effect certain corporate actions, potentially adversely affecting the common stock price.
- Charter documents permit the Board of Directors to establish the number of directors and fill vacancies and newly created directorships.
- The Board of Directors is classified into three classes with staggered, three-year terms, and directors may only be removed for cause.
- Super-majority voting is required to amend provisions in the certificate of incorporation and bylaws.
- Blank-check preferred stock is included, with preference rights and terms set by the Board of Directors, which could delay or prevent a transaction or change in control that might involve a premium price for common stock or otherwise benefit stockholders.
- The ability of stockholders to call special meetings is eliminated.
- Special meetings of stockholders can only be called by the Board of Directors, the chairman of the Board of Directors, or the chief executive officer.
- Stockholder consent action is prohibited unless by unanimous written consent.
- Vacancies on the Board of Directors may be filled only by a majority of directors then in office, even if less than a quorum.
- Cumulative voting in the election of directors is prohibited.
- Advance notice requirements are established for nominations for election to the Board of Directors or for proposing matters at annual stockholder meetings.
- As a Delaware corporation, the company is subject to Section 203 of the Delaware General Corporation Law, which may prohibit large stockholders (owning 15% or more of voting stock) from merging or combining for a period of time.
[c. 88; p. 9] Exclusive forum provisions
- The certificate of incorporation and bylaws designate the Court of Chancery of the State of Delaware as the exclusive forum for substantially all disputes between the company and its stockholders.
- This could limit stockholders' ability to obtain a favorable judicial forum for disputes with the company or its directors, officers, or employees.
- The exclusive forum applies to: any derivative action or proceeding on the company's behalf; any action asserting a claim of breach of fiduciary duty by directors, officers, employees, or agents, or stockholders; any action asserting a claim under DGCL or the certificate of incorporation/bylaws, or where DGCL confers jurisdiction on the Court of Chancery; any action to interpret, apply, enforce, or determine the validity of the certificate of incorporation or bylaws; or any action asserting a claim governed by the internal affairs doctrine.
- The certificate of incorporation and bylaws also state that federal district courts of the United States of America are the sole and exclusive forum for resolutions of any complaint arising under the Securities Act, unless written consent for an alternative forum is given.
- This application to Securities Act claims and Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over suits to enforce duties or liabilities created by the Securities Act or its rules.
- There is uncertainty whether a court would enforce such a provision, and stockholders will not be deemed to have waived compliance with federal securities laws.
- This exclusive forum provision would not apply to suits brought to enforce a duty or liability created by the Exchange Act or any other claim for which federal courts have exclusive jurisdiction.
- If enforced, this choice of forum provision may limit a stockholder’s ability to bring a claim in a preferred judicial forum, potentially discouraging lawsuits against the company and its personnel, though stockholders are not deemed to waive federal securities law compliance.
- If a court finds the choice of forum provision inapplicable or unenforceable, additional costs may be incurred to resolve actions in other jurisdictions, which could materially adversely affect the business, financial condition, or results of operations.
Cybersecurity
[c. 89; p. 10] Cybersecurity risk management strategy
- IT Systems are central to nearly all business operations, including internal/external communications, document/record management, and shared work environments.
- Responding to cybersecurity incidents and threats is a key component of the overall ERM strategy.
- A Crisis Response Plan (CRP) has been implemented to address cybersecurity incidents and threats.
- Management and IT personnel have implemented processes for assessing, identifying, managing, and escalating material cybersecurity risks, integrated into overall risk management.
- Cybersecurity risks are included in the risk universe evaluated annually by the enterprise risk management committee.
- Risk owners are assigned to develop and track mitigation plans for heightened cybersecurity risks identified by the ERM process.
- Security events and data incidents are evaluated, ranked by severity, prioritized for response/remediation, and reviewed for materiality, operational/business impact, and privacy impact.
- The cybersecurity risk management program uses the National Institute of Standards and Technology framework, which categorizes risks into identify, protect, detect, respond, recover, and govern.
- Company-wide policies and procedures cover cybersecurity matters, including encryption standards, antivirus protection, remote access, multifactor authentication, confidential information, and internet/social media/email use.
- A detailed crisis response playbook is followed in the event of an incident.
- Investments in IT security have expanded, including end-user training, layered defenses, critical asset identification/protection, strengthened monitoring/alerting, and expert engagement.
- Defenses are regularly tested through technical simulations (e.g., penetration tests) and reviews of operational policies/procedures with third-party experts.
- The IT security team monitors alerts, discusses threat levels/trends/remediation, prepares a quarterly cyber scorecard, collects data on cybersecurity threats/risk areas, and conducts an annual risk assessment.
- Periodic external penetration tests, red team testing, and maturity testing are conducted to assess processes, procedures, and the threat landscape.
- In the event of an incident, outside cybersecurity legal counsel consults and coordinates with other third parties (e.g., communication/notification, cybersecurity vendors for investigation/recovery, cybersecurity experts for validation/ransomware assistance, cybersecurity insurance providers).
- Processes are implemented to oversee and identify risks from cybersecurity threats associated with key third-party service providers.
- Third-party service providers are required to provide SOC-1 or SOC-2 reports and their cybersecurity/disaster recovery plans.
[c. 90; p. 10] Cybersecurity governance and oversight
- Cybersecurity risk management and strategy processes are overseen by leaders from the Information Security Team, with assistance from Compliance and Legal teams.
- These individuals have decades of experience in IT roles, including security, auditing, compliance, systems, and programming.
- They monitor prevention, mitigation, detection, and remediation of cybersecurity incidents through management and participation in risk management processes and report to the Risk Committee.
- The Risk Committee of the Board of Directors oversees cybersecurity strategy, reviews cybersecurity and other IT risks/controls/procedures, and receives periodic updates from management on cybersecurity measures.
- This review includes discussion of cybersecurity threat risks and their potential operational impact.
- A separate process exists for communicating with the Risk Committee during a specific cybersecurity incident.
- In an incident, the Crisis Management Team provides an initial awareness communication to the CEO/Chair of the Board.
- The CEO/Chair of the Board then informs the Chair of the Risk Committee.
- Following an initial assessment by senior management and IT Systems personnel, a follow-up communication is provided to the CEO and Risk Committee Chair to determine if full Board escalation is warranted.
[c. 91; p. 10] Cybersecurity risk impact
- Cybersecurity threats have not materially affected business strategy, results of operations, or financial condition.
- A cybersecurity incident resulting in a serious compromise of IT Systems or a demand for payment to restore IT Systems could have a material adverse effect.
- Such an incident could negatively impact the ability to operate effectively and divert management/financial resources.
Properties
[c. 92; p. 11] Office facilities
- The company leases its primary executive offices and insurance operations in Houston, Texas.
- The Houston office occupies approximately 20,400 square feet of space.
- The lease for the Houston office space expires in 2029.
- Additional office space is leased where appropriate.
- Management considers the office facilities suitable and adequate for current operations.
Legal Proceedings
[c. 93; p. 12] Legal proceedings
- The company is party to legal proceedings arising in the ordinary course of business.
- The company believes the outcome of these matters, individually and in aggregate, will not have a material adverse effect on its consolidated financial position.
Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
[c. 94; p. 13] Common stock trading and holders
- Common shares began trading on the NASDAQ Global Select Market under the symbol “SKWD” on January 13, 2023.
- Prior to January 13, 2023, there was no public market for the company's common shares.
- As of February 26, 2026, there were approximately 117 holders of record of common stock.
- The number of record holders does not represent the total number of stockholders due to shares being held by brokers and other institutions.
Securities Authorized for Issuance Under Equity Compensation Plans
[c. 95; p. 13] Equity compensation plan information
- Information regarding equity compensation plans will be included in the definitive proxy statement to be filed with the SEC for the 2026 Annual Meeting of Stockholders ("2026 Proxy Statement").
- This information is incorporated by reference into the current document.
- Part III contains details on securities authorized for issuance under equity compensation plans.
Recent Sales of Unregistered Equity Securities
[c. 96; p. 13] Unregistered equity securities issuance
- Information is provided regarding securities issued or granted by the company during the period covered by this Annual Report on Form 10-K that were not registered under the Securities Act.
- On January 1, 2026, the company paid approximately USD 555.0m in connection with the Apollo acquisition, pursuant to the Apollo SPAs.
- The payment for the Apollo acquisition included USD 371.0m in cash and the issuance of 3,679,332 unregistered shares of the Company’s common stock.
Performance Graph
[c. 97; p. 13] Shareholder return comparison
- The performance graph compares the cumulative total shareholder return of an investment in (1) the company's common stock, (2) the Nasdaq Composite Index, and (3) the Nasdaq Insurance Index.
- The comparison period is from January 13, 2023 (the date common stock began trading on Nasdaq) through December 31, 2025.
- The graph assumes an initial investment of USD 100.
- Such returns are based on historical results and are not indicative of future performance.
- This graph is not considered "soliciting material" or "filed" for purposes of Section 18 of the Exchange Act, nor is it subject to liabilities under that Section.
- The graph is not deemed to be incorporated by reference into any company filings under the Securities Act.
[c. 98; p. 13]
| January 13, 2023 | December 31, 2023 | December 31, 2024 | December 31, 2025 | |
|---|---|---|---|---|
| Skyward Specialty Insurance Group, Inc. | 100.00 | 177.38 | 264.61 | 267.59 |
| Nasdaq Composite Index | 100.00 | 135.49 | 174.30 | 209.78 |
| Nasdaq Insurance Index | 100.00 | 103.37 | 128.30 | 127.60 |
[c. 99; p. 13] Performance Graph

Chart / Image:
- The y-axis represents values from $100.00 to $300.00, with increments of $50.00.
- The x-axis represents dates: January 13, 2023, December 31, 2023, December 31, 2024, and December 31, 2025.
- The blue line with circular markers represents "Skyward Specialty Insurance Group, Inc.".
- The magenta line with circular markers represents "Nasdaq Composite Index".
- The cyan line with circular markers represents "Nasdaq Insurance Index".
- For Skyward Specialty Insurance Group, Inc.:
- On January 13, 2023, the value is $100.00.
- On December 31, 2023, the value is $175.00.
- On December 31, 2024, the value is $265.00.
- On December 31, 2025, the value is $267.50.
- For Nasdaq Composite Index:
- On January 13, 2023, the value is $100.00.
- On December 31, 2023, the value is $137.50.
- On December 31, 2024, the value is $172.50.
- On December 31, 2025, the value is $210.00.
- For Nasdaq Insurance Index:
- On January 13, 2023, the value is $100.00.
- On December 31, 2023, the value is $102.50.
- On December 31, 2024, the value is $127.50.
- On December 31, 2025, the value is $127.50.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
Overview
[c. 100; p. 14] Business overview and strategy
- The company is a growing specialty insurance company providing commercial P&C products and solutions on a non-admitted (E&S) and admitted basis, primarily in the United States.
- Business focuses on underserved, dislocated, or inadequately covered markets, requiring highly specialized, customized underwriting solutions and claims capabilities.
- The portfolio of insured risks is highly diversified across industries, distribution channels, and lines of business.
- Lines of business include general liability, excess liability, professional liability (cyber and media liability), commercial auto, group accident and health, property, agriculture, credit, surety, and workers’ compensation.
- The company insures both short and medium duration liabilities.
- Business mix is principally primary insurance, balanced between E&S and admitted markets.
- A portion of the business is specialty reinsurance (principally agriculture and credit), focused on attractive specialty classes where reinsurance is more efficient due to factors like cost of entry and geographic expansion.
- Diversification, including businesses not typically aligned with traditional P&C pricing cycles, combined with underwriting and claims expertise, aims to produce consistent growth and profitability across all insurance pricing cycles.
- The company's strategy, "Rule Our Niche," focuses on leading in chosen market niches and establishing sustainable competitive positions.
- This strategy aims to build a strong defensible market position, create a competitive moat, and win chosen markets.
- Principles underlying the strategy are key to achieving and sustaining best-in-class underwriting results through P&C insurance pricing cycles.
- The company strives for excellence in risk selection, pricing, and claims outcomes, amplified by advanced technology and analytics.
[c. 101; p. 14] Underwriting division updates
- In Q1 2025, underwriting divisions were updated to align with management oversight, resource allocation, and operating performance evaluation.
- A ninth division, Agriculture and Credit (Re)insurance, was added.
- The new Agriculture and Credit (Re)insurance division includes the Global Agriculture unit (previously with Global Property) and the Mortgage and Credit units.
- This new division focuses on specialty classes where reinsurance offers a more attractive market entry.
- The Industry Solutions division was renamed Construction & Energy Solutions division.
- The Inland Marine unit is now part of the Transactional E&S division.
- Programs division is now Specialty Programs.
- Prior reporting periods have been conformed to reflect the new presentation.
[c. 102; p. 14] Apollo acquisition
- On September 2, 2025, the company entered into two share purchase agreements (the "Apollo Majority SPAs") with institutional and management shareholders (the "Majority Sellers") of Apollo Group Holdings Limited ("Apollo").
- Pursuant to the Apollo Majority SPAs, the company agreed to acquire approximately 87% of the issued share capital of Apollo held by the Majority Sellers.
- Closing of the transaction ("Closing") was conditioned upon acquiring 100% of Apollo's issued share capital (the “Acquisition”) via additional short-form share purchase agreements (the "Apollo Minority SPAs") with the remaining minority shareholders (the "Minority Sellers").
- The total consideration for the entire issued share capital of Apollo under the Apollo SPAs was USD 555.0m.
- The consideration included USD 371.0m in cash (the “Cash Consideration”).
- The consideration also included the issuance of 3,679,332 shares of the Company’s common stock.
- In connection with the Apollo SPAs, on December 30, 2025, the company entered into a Term Loan Credit Agreement (the “Facility”).
- The Facility was arranged with Barclays Bank PLC as Administrative Agent, and Agent, Truist Securities, Inc., Citizens Bank, N.A. and Texas Capital Bank as joint lead arrangers, joint book runners and co-syndication agents for the Tranche B Term Facility.
- The Facility includes an unsecured senior delayed draw term loan facility (the “Tranche A Term Facility”) in the aggregate principal amount of USD 150.0m.
- The Facility also includes an additional unsecured senior delayed draw term loan facility in the aggregate principal of USD 150.0m.
- The acquisition closed on January 1, 2026.
- The consideration for the transaction was satisfied by the issuance of common stock to certain sellers and the remainder in cash.
- As of December 31, 2025, the company recognized USD 14.0m in transaction expenses associated with the transaction.
Results of Operations
[c. 103; p. 14] Financial results summary
- The table summarizes results for the years ended December 31, 2025 and 2024.
[c. 104; p. 14]
| Years Ended December 31, | ||
|---|---|---|
| ($ in thousands) | 2025 | 2024 |
| Gross written premiums | 2,166,236 | 1,743,232 |
| Ceded written premiums | (760,004) | (619,654) |
| Net written premiums | 1,406,232 | 1,123,578 |
| Net earned premiums | 1,304,505 | 1,056,722 |
| Commission and fee income | 6,855 | 6,703 |
| Losses and LAE | 795,022 | 669,809 |
| Underwriting, acquisition and insurance expenses | 377,359 | 311,757 |
| Underwriting income (1) | 138,979 | 81,859 |
| Net investment income | 83,619 | 80,600 |
| Net investment gains | 22,149 | 6,342 |
| Income before income taxes | 216,424 | 152,739 |
| Net income | 170,028 | 118,828 |
| Adjusted operating income (1) | 167,372 | 126,582 |
| Loss and LAE ratio | 60.9% | 63.4% |
| Expense ratio | 28.4% | 28.9% |
| Combined ratio | 89.3% | 92.3% |
| Adjusted loss and LAE ratio (1) | NM (2) | 62.3% |
| Expense ratio | NM (2) | 28.9% |
| Adjusted combined ratio (1) | NM (2) | 91.2% |
| Return on equity | 18.9% | 16.3% |
| Return on tangible equity (1) | 20.9% | 18.6% |
| Adjusted return on equity (1) | 18.6% | 17.4% |
| Adjusted return on tangible equity (1) | 20.6% | 19.8% |
Reconciliation of Non-GAAP Financial Measures
[c. 105; p. 14] Adjusted Operating Income reconciliation
- The table provides a reconciliation of adjusted operating income to net income for the years ended December 31, 2025 and 2024.
[c. 106; p. 14] Underwriting Income reconciliation
- The table provides a reconciliation of underwriting income to income before federal income tax expense for the years ended December 31, 2025 and 2024.
[c. 107; p. 14] Adjusted Loss Ratio and Combined Ratio reconciliation
- The table provides a reconciliation of the adjusted loss and LAE ratio and adjusted combined ratio to the loss and LAE ratio and combined ratio for the year ended December 31, 2024.
[c. 108; p. 14] Tangible Stockholders’ Equity reconciliation
- The table provides a reconciliation of tangible stockholders’ equity to stockholders’ equity for the years ended December 31, 2025 and 2024.
[c. 109; p. 14] Adjusted Return on Equity reconciliation
- The table provides a reconciliation of adjusted return on equity to return on equity for the years ended December 31, 2025 and 2024.
[c. 110; p. 14] Return on Tangible Equity reconciliation
- Return on tangible equity for the years ended December 31, 2025 and 2024 reconciles to return on equity.
[c. 111; p. 14] Adjusted Return on Tangible Equity reconciliation
- Adjusted return on tangible equity for the years ended December 31, 2025 and 2024 reconciles to return on equity.
[c. 112; p. 14]
| 2024 | ||||
|---|---|---|---|---|
| ($ in thousands) | Pre-tax | After-tax | Pre-tax | After-tax |
| Income as reported | 216,424 | 170,028 | 152,739 | 118,828 |
| Less (add): | — | — | — | — |
| Net investment gains | 22,149 | 17,401 | 6,342 | 5,010 |
| Net impact of LPT | — | — | (11,598) | (9,162) |
| Transaction costs | (14,019) | (11,014) | — | — |
| Other loss | (587) | (461) | (167) | (132) |
| Other expenses | (4,162) | (3,270) | (4,392) | (3,470) |
| Adjusted operating income | 213,043 | 167,372 | 162,554 | 126,582 |
| ($ in thousands) | 2025 | 2024 |
|---|---|---|
| Income before income taxes | 216,424 | 152,739 |
| Add: | — | — |
| Interest expense | 7,919 | 9,496 |
| Amortization expense | 1,636 | 2,007 |
| Transaction costs | 14,019 | — |
| Other expenses | 4,162 | 4,392 |
| Less (add): | — | — |
| Net investment income | 83,619 | 80,600 |
| Net investment gains | 22,149 | 6,342 |
| Other loss | (587) | (167) |
| Underwriting income | 138,979 | 81,859 |
| ($ in thousands) | 2024 |
|---|---|
| Net earned premiums | 1,056,722 |
| Losses and LAE | 669,809 |
| Pre-tax net impact of loss portfolio transfer | (11,598) |
| Adjusted losses and LAE | 658,211 |
| Loss ratio | 63.4% |
| Less: Net impact of LPT | 1.1% |
| Adjusted loss ratio | 62.3% |
| Combined ratio | 92.3% |
| Less: Net impact of LPT | 1.1% |
| Adjusted combined ratio | 91.2% |
| ($ in thousands) | 2025 | 2024 |
|---|---|---|
| Stockholders’ equity | 1,009,565 | 793,999 |
| Less: Goodwill and intangible assets | 88,040 | 87,348 |
| Tangible stockholders’ equity | 921,525 | 706,651 |
| ($ in thousands) | 2025 | 2024 |
|---|---|---|
| Numerator: adjusted operating income | 167,372 | 126,582 |
| Denominator: average stockholders’ equity | 901,782 | 727,515 |
| Adjusted return on equity | 18.6% | 17.4% |
| ($ in thousands) | 2025 | 2024 |
|---|---|---|
| Numerator: net income | 170,028 | 118,828 |
| Denominator: average tangible stockholders’ equity | 814,088 | 639,624 |
| Return on tangible equity | 20.9% | 18.6% |
| ($ in thousands) | 2025 | 2024 |
|---|---|---|
| Numerator: adjusted operating income | 167,372 | 126,582 |
| Denominator: average tangible stockholders’ equity | 814,088 | 639,624 |
| Adjusted return on tangible equity | 20.6% | 19.8% |
Underwriting Results
[c. 113; p. 14] Premiums
- Gross written premiums increased by USD 423.1m in 2025 compared to 2024.
- The increase in gross written premiums was primarily driven by growth from the agriculture and credit (re)insurance division due to new opportunities in dairy, livestock, and crop, and growth in the credit portfolio started in Q4 2024.
- Specialty programs, accident & health, surety, and captives also contributed significantly to gross written premium growth in 2025.
- Growth in specialty programs was primarily due to the addition of two new programs in 2025.
- Growth in accident and health was primarily driven by the acquisition of more high deductible accident and health captives in 2025 compared to 2024.
- The increase in surety was primarily due to market expansion in both commercial and contract bonds.
- Growth in the captives division was primarily due to rate increases and new business.
- Decreases in global property, construction and energy solutions, and professional lines divisions partially offset gross written premium growth.
- Offsetting decreases were due to continued downward pricing pressure in the global property market (retention remained steady) and the exit of unprofitable lines in construction and energy solutions and professional lines during 2025.
- Net written premiums were USD 1,406.2m in 2025 compared to USD 1,123.6m in 2024, an increase of USD 282.7m (+25.2%).
- The increase in net written premiums was primarily driven by the same reasons as gross written premiums.
- Net earned premiums for 2025 were USD 1,304.5m compared to USD 1,056.7m for 2024, an increase of USD 247.8m (+23.4%).
- The increase in net earned premiums was primarily driven by the same reasons as gross written premiums.
[c. 114; p. 14] Losses and LAE
- The 2025 loss ratio improved by 2.5 points compared to 2024, primarily due to favorable prior accident year development versus adverse development from the net impact of the LPT in 2024.
- The non-cat loss and LAE ratio for 2025 improved by 0.3 points compared to 2024, primarily driven by a shift in the mix of business.
- The 2025 cat loss and LAE ratio improved by 0.5 points compared to 2024, which was impacted by Hurricanes Helene and Beryl in Q3 2024 and Hurricane Milton in Q4 2024.
- For the year ended December 31, 2025, favorable development related to prior years’ loss and loss expense reserves of USD 7.5m was recognized.
- This favorable development included USD 24.6m in short-tail/monoline specialty lines and USD 5.3m in multi-line solutions.
- This was partially offset by USD 22.4m of adverse development in exited lines, primarily attributable to commercial auto and excess over auto in divisions that have been non-renewed or significantly reduced exposure over the past three years.
- Favorable development in surety and property offset the adverse development.
- For the year ended December 31, 2024, adverse development related to prior years’ loss and loss expense reserves of USD 25.7m was recognized.
- This adverse development included USD 10.1m in multi-line solutions and USD 15.2m in exited lines, related to losses previously subject to the LPT from accident years 2018 and prior.
[c. 115; p. 14] Expense ratio
- The expense ratio for 2025 improved by 0.5 points compared to 2024.
- This improvement was primarily due to earnings leverage, partially offset by higher acquisition costs due to the business mix shift.
[c. 116; p. 14] Investment results
- Net investment income for 2025 increased by USD 3.0m compared to 2024.
- The increase in income from the fixed income portfolio in 2025 was due to a larger asset base from increased allocation and a higher book yield of 5.4% at December 31, 2025 (prior: 5.2% at December 31, 2024).
- The decrease in income from short-term investments & cash and cash equivalents in 2025 was due to an overall decrease in yields.
- The decrease in income from the alternative and strategic investments portfolio in 2025 was due to a decline in the fair value of limited partnership investments.
- The decrease in income from equities was due to the sale of the equity portfolio in Q3 2025.
[c. 117; p. 14]
| ($ in thousands) | 2025 | 2024 | Change | % Change |
|---|---|---|---|---|
| Accident & Health | 254,102 | 173,073 | 81,029 | 46.8% |
| Agriculture and Credit (Re)insurance | 346,212 | 118,070 | 228,142 | 193.2% |
| Captives | 275,694 | 241,902 | 33,792 | 14.0% |
| Construction & Energy Solutions | 274,318 | 296,582 | (22,264) | (7.5%) |
| Global Property | 178,128 | 201,796 | (23,668) | (11.7%) |
| Professional Lines | 149,231 | 159,785 | (10,554) | (6.6%) |
| Specialty Programs | 322,705 | 218,407 | 104,298 | 47.8% |
| Surety | 168,148 | 143,965 | 24,183 | 16.8% |
| Transactional E&S | 197,779 | 189,669 | 8,110 | 4.3% |
| Total gross written premiums (1) | 2,166,317 | 1,743,249 | 423,068 | 24.3% |
| 2025 | 2024 | |||
|---|---|---|---|---|
| ($ in thousands) | Losses and LAE | % of Net Earned Premiums | Losses and LAE | % of Net Earned Premiums |
| Losses and LAE: | ||||
| Non-cat loss and LAE | 786,949 | 60.3% | 640,257 | 60.6% |
| Cat loss and LAE (1) | 15,548 | 1.2% | 17,954 | 1.7% |
| Prior accident year development | (7,475) | (0.6)% | 11,598 | 1.1% |
| Total losses and LAE | 795,022 | 60.9% | 669,809 | 63.4% |
| ($ in thousands) | Development | |
|---|---|---|
| (Favorable) Adverse | ||
| Accident Year | 2025 | 2024 |
| Prior | 2,808 | 24,929 |
| 2021 | 9,590 | 978 |
| 2022 | 2,300 | (1,479) |
| 2023 | (16,515) | 1,300 |
| 2024 | (5,658) | — |
| Total | (7,475) | 25,728 |
| Reserve development on losses subject to LPT | — | 25,300 |
| Reserve development on losses excluding losses subject to LPT | (7,475) | 428 |
| 2025 | 2024 | |||
|---|---|---|---|---|
| ($ in thousands) | Expenses | % of Net Earned Premiums | Expenses | % of Net Earned Premiums |
| Net policy acquisition expenses | 195,422 | 15.0% | 149,975 | 14.2% |
| Other operating and general expenses | 181,937 | 13.9% | 161,782 | 15.3% |
| Underwriting, acquisition and insurance expenses | 377,359 | 28.9% | 311,757 | 29.5% |
| Less: commission and fee income | (6,855) | (0.5%) | (6,703) | (0.6%) |
| Total net expenses | 370,504 | 28.4% | 305,054 | 28.9% |
| $ in thousands | 2025 | 2024 |
|---|---|---|
| Short-term investments & cash and cash equivalents | 15,877 | 17,643 |
| Fixed income | 77,888 | 57,631 |
| Equities | 1,380 | 2,745 |
| Alternative and strategic investments | (11,526) | 2,581 |
| Net investment income | 83,619 | 80,600 |
| Net unrealized (losses) gains on securities still held | (1,555) | 7,921 |
| Net realized gains (losses) | 23,704 | (1,579) |
| Net investment gains | 22,149 | 6,342 |
Investments
[c. 118; p. 14] Investment portfolio composition
- The investment portfolio primarily consists of investment grade fixed income securities, which are predominantly highly-rated and liquid bonds, and commercial mortgage loans.
[c. 119; p. 14] Fixed income portfolio credit quality and duration
- The weighted average credit rating of the available-for-sale fixed income portfolio was "A+" at December 31, 2025, and "AA-" at December 31, 2024.
- Commercial mortgage loans are primarily senior loans on real estate across the U.S..
- The average duration of the fixed income portfolio was approximately 3.60 years as of December 31, 2025, and 4.34 years as of December 31, 2024.
[c. 120; p. 14] Equities portfolio composition and divestment
- The equities portfolio primarily consisted of domestic preferred stocks, common equities, exchange traded funds, limited partnerships, limited liability corporations, and other equity interests, 100.0% of which were publicly traded.
- During Q3 2025, almost all of the equities portfolio was sold, retaining only preferred stocks.
[c. 121; p. 14] Alternative and strategic investments
- Alternative investments consist of promissory notes, limited partnerships, joint ventures, and equity interests.
- Underlying alternative investments are primarily floating rate senior secured loans, comprising short duration, collateralized, asset-oriented credit investments.
- Limited partnerships and joint ventures are subject to future increases or decreases in asset value as assets are monetized and income distributed.
- Strategic investments consist of equity interests in private entities within the insurance industry.
[c. 122; p. 14] Market risk overview
- Market risk is the risk of economic losses due to adverse changes in the estimated fair value of a financial instrument from changes in interest rates, equity prices, foreign currency exchange rates, and commodity prices.
- The primary components of market risk affecting the company are credit risk and interest rate risk.
- The company does not have significant exposure to foreign currency exchange rate risk or commodity risk.
[c. 123; p. 14] Credit risk management
- Credit risk is the potential loss from adverse changes in an issuer’s ability to repay debt obligations.
- Exposure to credit risk exists as a holder of debt instruments in core fixed income and opportunistic fixed income portfolios.
- The risk management strategy and investment policy is to invest primarily in debt instruments of high credit quality issuers and limit credit exposure by ratings categories and per issuer.
- At December 31, 2025, the fixed income portfolio had an average rating of "A+".
- Approximately 78.5% of securities in the fixed income portfolio were rated "A" or better by at least one nationally recognized rating organization at December 31, 2025.
- The policy is to invest in investment grade fixed income securities for stable income, supplemented by opportunistic fixed income and equity securities for diversification and risk-adjusted returns.
- Approximately 1.1% of the fixed income portfolio was unrated or rated below investment-grade at December 31, 2025.
- The company monitors the financial condition of all issuers in its portfolio through investment managers.
- The company is subject to credit risk from third-party reinsurers, as it remains ultimately liable to policyholders for ceded risks.
- This credit risk is addressed by purchasing reinsurance from reinsurers rated at least "A-" (Excellent) or better by A.M. Best.
- Periodic credit reviews of reinsurers are performed with the reinsurance broker.
- At December 31, 2025, 98% of reinsurance recoverables were from reinsurers rated "A-" (Excellent) or better by A.M. Best, or were collateralized through funds held, trusts, and letters of credit.
- If a reinsurer suffers a credit downgrade, options to lessen asset impairment risk include commutation, novation, and letters of credit.
[c. 124; p. 14] Interest rate risk management
- Interest rate risk is the risk of economic losses due to adverse changes in interest rates.
- The primary market risk to the investment portfolio is interest rate risk associated with fixed income securities.
- Fluctuations in interest rates directly affect the market valuation of these securities; rising rates decrease fair value, falling rates increase fair value.
- Interest rate risk is managed by investing in securities with varied maturity dates and by managing the duration of the investment portfolio in relation to the duration of reserves.
- Duration is the weighted average payment period of cash flows, weighted by the present value of cash flows.
- Duration targets for the core fixed income investment portfolio are set after considering the estimated duration of liabilities and other factors.
- Fixed maturity securities had a weighted average effective duration of 3.6 years as of December 31, 2025.
- Fixed income securities subject to interest rate risk had a fair value of USD 1,856.3m at December 31, 2025.
- Opportunistic fixed income securities are excluded from interest rate sensitivity analysis as they are primarily floating rate and treated as held-to-maturity.
- Changes in interest rates will have an immediate effect on comprehensive income and stockholders’ equity but not ordinarily on net income.
- Actual results may differ from hypothetical changes in market rates, and the sensitivity analysis does not reflect actions to mitigate hypothetical fair value losses.
[c. 125; p. 14] Equity price risk
- Equity price risk represents potential economic losses due to adverse changes in equity security prices.
- At December 31, 2025, approximately 0.1% of the fair value of the investment portfolio (excluding cash and cash equivalents and short-term investments) was invested in equity securities.
- Almost all of the equities portfolio was sold during Q3 2025, retaining only preferred stocks.
[c. 126; p. 14]
| 2025 | 2024 | |||
|---|---|---|---|---|
| ($ in thousands) | Carrying Value | % of Total | Carrying Value | % of Total |
| Cash and cash equivalents | 168,544 | 6.8% | 121,603 | 6.1% |
| Short-term investments | 264,299 | 10.7% | 274,929 | 13.8% |
| Fixed income | 1,866,205 | 75.6% | 1,318,708 | 66.2% |
| Equities | 1,174 | 0.1% | 106,254 | 5.3% |
| Alternative and strategic investments | 168,837 | 6.8% | 170,929 | 8.6% |
| Total portfolio | 2,469,059 | 100.0% | 1,992,423 | 100.0% |
| 2025 | 2024 | |||
|---|---|---|---|---|
| ($ in thousands) | Carrying Value | % of Total | Carrying Value | % of Total |
| U.S. government securities | 44,468 | 2.4% | 26,486 | 2.0% |
| Corporate securities and miscellaneous | 636,387 | 34.1% | 425,628 | 32.3% |
| Municipal securities | 102,116 | 5.5% | 84,716 | 6.4% |
| Residential mortgage-backed securities | 486,587 | 26.1% | 393,833 | 29.9% |
| Commercial mortgage-backed securities | 73,050 | 3.9% | 69,364 | 5.2% |
| Other asset-backed securities | 513,695 | 27.5% | 292,191 | 22.2% |
| Total fixed income portfolio, available-for-sale | 1,856,303 | 99.5% | 1,292,218 | 98.0% |
| Commercial mortgage loans | 9,902 | 0.5% | 26,490 | 2.0% |
| Total fixed income portfolio | 1,866,205 | 100.0% | 1,318,708 | 100.0% |
| 2025 | 2024 | |||
|---|---|---|---|---|
| ($ in thousands) | Fair Value | % of Total | Fair Value | % of Total |
| AAA | 286,563 | 15.4% | 483,099 | 37.3% |
| AA | 548,030 | 29.6% | 141,177 | 10.9% |
| A | 620,813 | 33.5% | 429,703 | 33.3% |
| BBB | 379,586 | 20.4% | 216,602 | 16.8% |
| BB and Lower | 21,311 | 1.1% | 21,637 | 1.7% |
| Total fixed income portfolio, available-for-sale | 1,856,303 | 100.0% | 1,292,218 | 100.0% |
| 2025 | 2024 | |||
|---|---|---|---|---|
| ($ in thousands) | Fair Value | % of Total Fair Value | Fair Value | % of Total Fair Value |
| Domestic common equities | — | —% | 70,665 | 66.5% |
| International common equities | — | —% | 34,425 | 32.4% |
| Preferred stock | 1,174 | 100.0% | 1,164 | 1.1% |
| Equities | 1,174 | 100.0% | 106,254 | 100.0% |
| ($ in thousands) | Estimated Fair Value | Estimated Change in Fair Value | Estimated % Increase (Decrease) in Fair Value |
|---|---|---|---|
| 300 basis point increase | 1,654,474 | (201,829) | (10.9)% |
| 200 basis point increase | 1,721,816 | (134,487) | (7.2)% |
| 100 basis point increase | 1,789,092 | (67,211) | (3.6)% |
| No change | 1,856,303 | — | 0.0% |
| 100 basis point decrease | 1,923,448 | 67,145 | 3.6% |
| 200 basis point decrease | 1,990,528 | 134,225 | 7.2% |
| 300 basis point decrease | 2,057,542 | 201,239 | 10.8% |
Other Items
[c. 127; p. 14] Income tax expense and effective tax rate
- Income tax expense for the year ended December 31, 2025 was USD 46.4m, compared to USD 33.9m for the year ended December 31, 2024.
- The effective tax rate for the year ended December 31, 2025 was 21.4%, compared to 22.2% for the year ended December 31, 2024.
[c. 128; p. 14] Income tax reconciliation reference
- For a reconciliation between actual federal income tax expense and the amount computed at the indicated statutory rate for the years ended December 31, 2025 and 2024, refer to Note 13, "Income Taxes" in the consolidated financial statements included in Item 8 of this Form 10-K.
Liquidity and Capital Resources
[c. 129; p. 14] Liquidity and Capital Resources
- The company is organized as a holding company, with operations primarily conducted by wholly-owned insurance subsidiaries: GMIC, HSIC, and IIC (domiciled in Texas), and OSIC (domiciled in Oklahoma).
- The holding company receives cash through: corporate service fees from operating subsidiaries, payments from a consolidated tax allocation agreement, dividends from subsidiaries (subject to limitations), bank loans, draws on a revolving loan agreement, and issuance of equity and debt securities.
- Proceeds from these sources are used to contribute funds to insurance subsidiaries for premium growth support, dividend payments, taxes, and other business purposes.
- Skyward Service Company receives corporate service fees from operating subsidiaries to reimburse most incurred operating expenses.
- Reimbursement of expenses via corporate service fees is based on expected actual costs, with no mark-up.
- The company files a consolidated U.S. federal income tax return with its subsidiaries.
- Under the corporate tax allocation agreement, each participant is charged or refunded taxes based on what they would have paid or received if filing on a separate return basis with the IRS.
- State insurance laws restrict insurance subsidiaries' ability to declare stockholder dividends without prior regulatory approval.
- State insurance regulators require insurance companies to maintain specified levels of statutory capital and surplus.
- Dividend payments are limited to the portion of available policyholder surplus derived from net profits on an insurer’s business.
- Insurance regulators have broad powers to prevent reduction of statutory surplus to inadequate levels, and there is no assurance that maximum calculated dividends would be permitted.
- State insurance regulatory authorities may adopt more restrictive statutory provisions regarding dividend payments by insurance subsidiaries in the future.
- Insurance subsidiaries did not pay dividends to the holding company for the years ended December 31, 2025, and 2024.
- Additional information on insurance companies is available in Note 23, “Statutory Accounting Principles and Regulatory Matters,” to the consolidated financial statements in Item 8 of Form 10-K.
- The holding company had USD 3.5m in cash and investments at December 31, 2025, compared to USD 2.9m at December 31, 2024.
- The company believes it has sufficient liquidity to meet operating cash needs, obligations, and committed capital expenditures for the next 12 months.
Cash Flows
[c. 130; p. 14] Cash flow overview and operating activities
- The most significant source of cash is premiums received from insureds, typically at the beginning of the coverage period, net of related commission amounts.
- The most significant cash outflow is for claims incurred by policyholders.
- Cash is invested in various investment securities to earn interest and dividends because claim payments occur after premium receipt, often years later.
- Cash is also used for operating expenses (salaries, rent, taxes) and capital expenditures (technology systems).
- Reinsurance is used to manage risk, involving ceding premiums to reinsurers and collecting cash back when covered losses are paid.
- The timing of cash flows from operating activities can vary between periods due to the timing of payments and receipts.
- Significant payments and receipts, such as loss settlements and subsequent reinsurance receipts, can influence operating cash flows in any given period.
- Management believes cash receipts from premiums and investment income proceeds are sufficient to cover foreseeable cash outflows.
- Cash provided by operating activities increased in 2025 compared to 2024, primarily due to increased cash inflows from insurance operations.
- Cash from operations can vary period-to-period due to the timing of premium receipts, claim payments, and reinsurance activity.
- Cash flows from operations in both 2024 and 2025 were primarily used to fund investing activities.
[c. 131; p. 14] Investing activities
- Net cash used in investing activities in 2025 was primarily driven by purchases of fixed maturity securities, partially offset by sales and maturities of investment securities.
- Net cash used in investing activities in 2024 was driven by purchases of fixed maturity securities, partially offset by sales and maturities of investment securities and sales of short-term investments.
[c. 132; p. 14]
| ($ in thousands) | 2025 | 2024 |
|---|---|---|
| Cash and cash equivalents provided by (used in): | ||
| Operating activities | 408,076 | 305,115 |
| Investing activities | (366,898) | (243,694) |
| Financing activities | 411 | (4,232) |
| Change in cash and cash equivalents and restricted cash | 41,589 | 57,189 |
Credit Agreements
[c. 133; p. 14] FHLB loan
- On August 30, 2024, the company entered into a 4.5-year FHLB Loan with the Federal Home Loan Bank of Dallas (FHLB) for a principal amount of USD 57.0m.
- The FHLB Loan has a fixed interest rate of 4.00% and requires interest-only payments during its term, with principal due at maturity.
- The loan is fully secured by a pledge of specific investment securities of HSIC.
- Proceeds from the FHLB Loan were used to fund redemptions of draws on the 2023 Revolving Credit Facility.
[c. 134; p. 14] Term Loan Facility
- During Q4 2025, the company entered into a Term Loan Credit Agreement (Term Loan Facility) with a syndicate of banks.
- The Term Loan Facility includes an unsecured senior delayed draw term loan facility (DDTL) of USD 150.0m (Tranche A DDTL) and an additional unsecured senior DDTL of USD 150.0m (Tranche B DDTL).
- The Term Loan Facility was used to fund a portion of the consideration for the acquisition of Apollo Group Holdings Limited (Apollo) and related transaction fees and expenses.
- Interest on amounts drawn under the Term Loan Facility will be either term SOFR plus a margin of 150 bps to 190 bps, or the base rate plus a margin of 50 bps to 90 bps, depending on the debt to capitalization ratio.
- SOFR will be calculated using a SOFR floor of 0.00% and a credit spread adjustment of 0.10%.
- The base rate will be the highest of (i) the Agent’s prime lending rate, (ii) the Federal Funds Rate plus 0.50%, (iii) SOFR plus 1.00%, and (iv) zero percent (0%).
- The company will also pay a fee ranging from 0.20% to 0.35% on average daily undrawn amounts under the Facility, depending on the debt to capitalization ratio.
- The Tranche A DDTL matures on January 1, 2028, and the Tranche B DDTL matures on July 2, 2029.
- On December 30, 2025, the company drew USD 150m from the Tranche A DDTL and USD 150m from the Tranche B DDTL for the acquisition of Apollo on January 1, 2026.
- The Term Loan Facility includes customary covenants, such as limitations on additional indebtedness exceeding USD 10.0m, restrictions on distributions to stockholders, and financial covenants related to minimum consolidated net worth, maximum total debt to capitalization, minimum A.M. Best rating, and minimum liquidity.
- As of December 31, 2025, the company was in compliance with all covenants.
- The Term Loan Facility is unsecured.
- In Q4 2025, the company and subsidiary guarantors entered into a guaranty agreement, making obligations under the Term Loan Facility guaranteed by the company and its existing wholly-owned subsidiaries and subsequently acquired or organized subsidiaries (excluding insurance company subsidiaries and subject to certain exceptions).
[c. 135; p. 14] Revolving Credit Facilities
- During Q4 2025, the company entered into an unsecured Revolving Credit Facility with a syndicate of banks, initially providing up to USD 150.0m.
- The maximum principal amount of the Revolving Credit Facility was increased to USD 250.0m on the closing date of the Apollo acquisition.
- The Revolving Credit Facility was amended in Q4 2025 to permit funding of certain revolving loans for the Apollo acquisition.
- The company initially drew USD 43.0m, used to redeem its prior revolving credit facility.
- On December 30, 2025, an additional USD 71.5m was drawn from the Revolving Credit Facility for the consideration paid for the Apollo acquisition on January 1, 2026.
- Interest on the Revolving Credit Facility is payable quarterly.
- Amounts drawn bear interest at either term SOFR plus a margin of 150 bps to 190 bps, or the base rate plus a margin of 50 bps to 90 bps, depending on the debt to capitalization ratio.
- SOFR will be calculated using a SOFR floor of 0.00% and a credit spread adjustment of 0.10%.
- The base rate will be the highest of (i) the Agent’s prime lending rate, (ii) the Federal Funds Rate plus 0.50%, (iii) SOFR plus 1.00%, and (iv) zero percent (0%).
- The company will also pay a fee ranging from 0.20% to 0.35% on average daily undrawn amounts, depending on the debt to capitalization ratio.
- The availability period under the Facility terminates on November 12, 2030.
- The company is subject to covenants on the Revolving Credit Facility based on minimum net worth, maximum debt to capital ratio, minimum A.M. Best Rating, and minimum liquidity.
- As of December 31, 2025, the company was in compliance with all covenants.
- In Q1 2023, the company entered into an agreement for an unsecured revolving credit facility (2023 Revolving Credit Facility) of up to USD 150.0m and a letter of credit sub-facility of up to USD 30.0m.
- On November 13, 2025, the 2023 Revolving Credit Facility was redeemed, with USD 0.3m of accrued interest paid and USD 0.6m of expense recognized for remaining unamortized deferred financing costs.
[c. 136; p. 14] Debentures
- In May 2019, the company agreed to issue unsecured subordinated notes (Notes) with an aggregate principal amount of USD 20.0m.
- Interest on the Notes is fixed at 7.25% for the first 8 years and 8.25% thereafter.
- Early retirement of the debt before the 8-year commitment requires all interest payments to be paid in full, plus the return of outstanding principal.
- Principal is due at maturity on May 24, 2039, and interest is payable quarterly.
- The Notes have junior priority to all previously issued debt.
- Debt related to the Notes is reported on the December 31, 2025 and 2024 Consolidated Balance Sheets, net of debt issuance costs of approximately USD 0.4m and USD 0.5m, respectively.
- These deferred financing costs are presented as a direct deduction from the carrying amount of the subordinated debt.
[c. 137; p. 14] Share repurchase program
- In October 2024, the Board of Directors approved a share repurchase program authorizing the repurchase of up to USD 50.0m of common stock.
- Shares may be repurchased via open market purchases, privately-negotiated transactions, block purchases, accelerated share repurchase agreements, or a combination of methods, including Rule 10b5-1 trading plans.
- The timing, manner, price, and amount of repurchases are at the company's discretion.
- The program does not require the repurchase of any specific number of shares and may be modified, suspended, or terminated at any time.
- As of December 31, 2025, no shares had been repurchased under this plan.
Contractual Obligations and Commitments
[c. 138; p. 14] Contractual Obligations and Commitments
- The table sets forth contractual obligations and commercial commitments by due date as of December 31, 2025.
- Reserves for losses and LAE represent the best estimate of the ultimate cost of settling reported and unreported claims and related expenses.
- Estimating reserves for losses and LAE involves complex and subjective judgments.
- Actual losses and settlement expenses paid may deviate substantially from reserve estimates.
- The timing for payment of estimated losses is not fixed or determinable on an individual or aggregate basis.
- Assumptions for estimating payments due by period are based on the company's own, industry, and peer group claims payment experience.
- There is a risk that amounts paid in any period will differ significantly from disclosed amounts due to uncertainty in timing estimation.
- Disclosed amounts are gross of anticipated amounts recoverable from reinsurers.
- Reinsurance balances recoverable on reserves for losses and LAE are reported separately as assets, not netted with liabilities, because reinsurance does not discharge liability to policyholders.
- Reinsurance balances recoverable on reserves for paid and unpaid losses and LAE totaled USD 1,119.9m at December 31, 2025.
- Reinsurance balances recoverable on reserves for paid and unpaid losses and LAE totaled USD 857.9m at December 31, 2024.
[c. 139; p. 14]
| Payments due by period | |||
|---|---|---|---|
| ($ in thousands) | Total | Less Than One Year | One Year or More |
| Reserves for losses and LAE | 2,318,894 | 524,329 | 1,794,565 |
| Long-term debt | 548,500 | — | 548,500 |
| Interest on debt obligations | 107,070 | 26,828 | 80,242 |
| Total | 2,974,464 | 551,157 | 2,423,307 |
Critical Accounting Policies
[c. 140; p. 14] critical accounting estimates overview
- Critical accounting estimates are important for portraying financial condition and results of operations and require significant judgment.
- Significant judgment is used concerning future results and developments in applying these estimates and preparing consolidated financial statements.
- Judgments and estimates affect reported amounts of assets, liabilities, revenues, expenses, and disclosure of material contingent assets and liabilities.
- Actual results may differ materially from estimates and assumptions.
- Estimates are evaluated regularly using relevant information.
- For a detailed discussion of accounting policies, refer to Note 1, “Summary of Significant Accounting Policies” in Item 8 of Form 10-K.
[c. 141; p. 14] reserves for unpaid losses and LAE
- Reserves for unpaid losses and LAE are the largest and most complex estimate in the Consolidated Balance Sheets.
- These reserves represent the estimated ultimate cost of all unreported and reported but unpaid insured claims and the cost to adjust these losses as of or before the balance sheet date.
- Reserves for losses and LAE are not discounted to reflect estimated present value.
- Estimates are made using individual case-basis valuations of reported claims, statistical analyses, and various actuarial procedures.
- Estimates are based on historical information, industry and peer group information, and estimates of future trends in variable factors like loss severity, loss frequency, and inflation.
- Estimates are regularly reviewed and adjusted as experience develops or new information becomes known.
- During the loss settlement period, estimates of liability on a claim are often refined and adjusted upward or downward.
- The ultimate liability may exceed or be less than revised estimates.
- The ultimate settlement of losses and related LAE may vary significantly from the estimate in financial statements.
- Reserves for unpaid losses and LAE are categorized into two types: case reserves and IBNR.
- A table sets forth gross and net reserves for unpaid losses and LAE at December 31, 2025 and 2024.
[c. 142; p. 14] case reserves and IBNR
- Case reserves are established for individual claims reported to the company.
- Losses are reported by insureds, their agents, or brokers.
- Case reserves are established by estimating ultimate losses, including defense costs, based on provided information.
- Claims department personnel use their knowledge of specific claims and advice from internal and external experts (underwriters, legal counsel) to estimate expected ultimate losses.
- Third-Party Administrators (TPAs) are used in limited circumstances to assist in claim adjustment.
- Internal claims managers oversee TPA activities and monitor their claim handling to prescribed standards.
- The incurred but not reported (IBNR) reserve is derived by estimating the ultimate unpaid reserve liability and subtracting case reserves.
- Management’s best estimate of the ultimate unpaid liability is set by the Reserve Committee.
- The Reserve Committee considers actuarial indications and other factors such as underwriting, claims handling, economic, legal, and environmental changes.
- The Reserve Committee includes the Chief Actuary, Chief Reserving Actuary, Chief Financial Officer, and Chief Claims Officer.
- The Reserve Committee meets quarterly to review actuarial reserving recommendations from the Chief Actuary and determines the best estimate for losses and LAE reserves.
- In establishing quarterly actuarial recommendations, the actuary estimates an initial expected ultimate loss ratio for each underwriting division.
- Input from underwriting and claims departments, including premium pricing assumptions and historical experience, is considered in setting reserves.
[c. 143; p. 14] reserve drivers and actuarial methods
- Reserves are driven by factors including litigation and regulatory trends, legislative activity, climate change, social and economic patterns, and claims inflation assumptions.
- Reserve estimates reflect current inflation in legal claims’ settlements.
- Reserve estimates assume no losses from significant new legal liability theories.
- Reserve estimates assume no significant changes in the regulatory and legislative environment.
- The impact of potential changes in regulatory or legislative environment is difficult to quantify without specific new regulation or legislation.
- In the event of significant new regulation or legislation, the company will attempt to quantify its impact, but accuracy or success is not assured.
- The actuarial review considers multiple actuarial methods to estimate reserves for losses and LAE.
- Methods include paid and incurred loss development methods, paid and incurred Bornhuetter-Ferguson methods, paid and incurred loss ratio cape cod methods, and frequency and severity methods.
- If one actuarial method is more credible, it is used to set the point estimate.
- For new lines of business or significant changes in claim practices, paid and incurred loss development methods are less credible due to insufficient historical data.
- The actuarial point estimate may be based on a judgmental weighting of estimates from each method.
- These methods utilize the initial expected loss ratio, statistical analysis of past claims reporting and payment patterns, claims frequency and severity, paid loss experience, industry loss experience, and changes in market conditions, policy forms, exclusions, and exposures.
- Reserve estimates are believed to be reasonable, but actual loss experience may not conform to assumptions.
- Actual ultimate loss ratio or reporting and payment patterns could differ from expected, which are based on company and industry data.
- The ultimate settlement of losses and related LAE may vary significantly from financial statement estimates.
- Estimates are regularly reviewed and adjusted as experience develops or new information becomes known.
- Such adjustments are included in the results of current operations.
[c. 144; p. 14] reserve development and sensitivity
- "Development" is the amount by which estimated losses differ from those originally reported for a period.
- Development is unfavorable when losses settle for more than reserved or subsequent estimates indicate reserve increases.
- Development is favorable when losses settle for less than reserved or subsequent estimates indicate reserve reductions.
- Favorable or unfavorable development of loss reserves is reflected in the results of operations in the period estimates are changed.
- A 5% change in net IBNR would result in a USD 51.8m change in reserves for losses and LAE.
- A 5% change in net IBNR would result in a USD 40.9m change in net income and stockholders’ equity.
[c. 145; p. 14]
| 2025 | 2024 | |||||||
|---|---|---|---|---|---|---|---|---|
| ($ in thousands) | Gross | % of Total | Net | % of Total | Gross | % of Total | Net | % of Total |
| Case reserves | 625,710 | 27.0% | 362,291 | 25.9% | 567,192 | 31.8% | 342,612 | 30.8% |
| IBNR | 1,693,184 | 73.0% | 1,035,438 | 74.1% | 1,215,191 | 68.2% | 768,925 | 69.2% |
| Total | 2,318,894 | 100.0% | 1,397,729 | 100.0% | 1,782,383 | 100.0% | 1,111,537 | 100.0% |
Recent Accounting Pronouncements
[c. 146; p. 14] FASB Accounting Standards Updates
- In December 2023, FASB issued ASU 2023-09, "Improvements to Income Tax Disclosures (Topic 740)", requiring public companies to provide enhanced annual rate reconciliation disclosures, including specific categories and additional information meeting a quantitative threshold.
- ASU 2023-09 also requires public companies to disaggregate income taxes paid by federal, state, and foreign taxes.
- The guidance for ASU 2023-09 became effective for fiscal years beginning after December 15, 2024, and is applied prospectively.
- Additional disclosures have been added as required by ASU 2023-09, with no impact to the consolidated financial statements.
- In November 2024, FASB issued ASU 2024-03, requiring disaggregated disclosure of income statement expenses for public business entities (PBEs) in footnotes to the financial statements.
- ASU 2024-03 requires a tabular footnote disclosure for relevant income statement expense captions that include natural expenses such as purchases of inventory, employee compensation, depreciation, intangible asset amortization, and depreciation, depletion, and amortization recognized as part of oil- and gas-producing activities or other depletion expenses.
- In January 2025, FASB issued ASU 2025-01 to clarify the effective date of ASU 2024-03 as the first annual reporting period beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027.
- The company is evaluating the effect of the amendments from ASU 2024-03 on its consolidated financial statements.
Quantitative and Qualitative Disclosures About Market Risk
[c. 147; p. 15] Market Risk Disclosures
- Qualitative and Quantitative Disclosures about Market Risk are included in Item 7 of this Form 10-K under "Investments—Market Risk".
Financial Statements
Report of Independent Registered Public Accounting Firm
[c. 148; p. 16] Independent auditor's report
- This report is addressed to the Stockholders and the Board of Directors of Skyward Specialty Insurance Group, Inc.
Opinion on Internal Control Over Financial Reporting
[c. 149; p. 16] Internal control over financial reporting opinion
- Skyward Specialty Insurance Group, Inc. and subsidiaries' internal control over financial reporting as of December 31, 2025, was audited based on criteria established in the Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria).
- The Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2025, based on the COSO criteria.
- The consolidated balance sheets of the Company as of December 31, 2025 and 2024, and related consolidated statements of operations and comprehensive income, stockholders’ equity and cash flows for each of the three years in the period ended December 31, 2025, were audited in accordance with PCAOB standards.
- The report dated March 2, 2026, expressed an unqualified opinion on the consolidated financial statements and related notes and financial statement schedules listed in the Index at Item 15(a).
Basis for Opinion
[c. 150; p. 16] Auditor's opinion on internal control over financial reporting
- Company management is responsible for maintaining effective internal control over financial reporting and for its assessment included in the accompanying Management’s Report on Internal Control over Financial Reporting.
- The auditor's responsibility is to express an opinion on the Company’s internal control over financial reporting based on their audit.
- The auditor is a public accounting firm registered with the PCAOB and is required to be independent with respect to the Company in accordance with U.S. federal securities laws and applicable rules and regulations of the SEC and the PCAOB.
- The audit was conducted in accordance with PCAOB standards, which require planning and performing the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.
- The audit included understanding internal control over financial reporting, assessing the risk of material weakness, testing and evaluating the design and operating effectiveness of internal control based on assessed risk, and performing other necessary procedures.
- The auditor believes their audit provides a reasonable basis for their opinion.
Definition and Limitations of Internal Control Over Financial Reporting
[c. 151; p. 16] Internal control over financial reporting definition
- Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.
- Internal control over financial reporting includes policies and procedures that pertain to maintaining records that accurately and fairly reflect transactions and asset dispositions.
- Internal control over financial reporting includes policies and procedures that provide reasonable assurance that transactions are recorded as necessary for financial statement preparation in accordance with generally accepted accounting principles.
- Internal control over financial reporting includes policies and procedures that provide reasonable assurance that company receipts and expenditures are made only in accordance with management and director authorizations.
- Internal control over financial reporting includes policies and procedures that provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of company assets that could materially affect financial statements.
[c. 152; p. 16] Limitations of internal control over financial reporting
- Due to inherent limitations, internal control over financial reporting may not prevent or detect misstatements.
- Projections of effectiveness evaluations to future periods are subject to the risk that controls may become inadequate due to changing conditions.
- Projections of effectiveness evaluations to future periods are subject to the risk that compliance with policies or procedures may deteriorate.
[c. 153; p. 16]
| /s/ Ernst & Young LLP |
|---|
| Houston, Texas |
| March 2, 2026 |
Report of Independent Registered Public Accounting Firm
[c. 154; p. 16] Independent Auditor's Report
- This report is addressed to the Stockholders and the Board of Directors of Skyward Specialty Insurance Group, Inc.
Opinion on the Financial Statements
[c. 155; p. 16] Audit opinion on financial statements
- The consolidated balance sheets of Skyward Specialty Insurance Group, Inc. and subsidiaries (the Company) as of December 31, 2025 and 2024, the related consolidated statements of operations and comprehensive income, stockholders' equity and cash flows for each of the three years in the period ended December 31, 2025, and related notes and financial statement schedules listed in the Index at Item 15(a) (collectively referred to as the “consolidated financial statements”) have been audited.
- The consolidated financial statements fairly present, in all material respects, the financial position of the Company at December 31, 2025 and 2024, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2025, in conformity with U.S. generally accepted accounting principles.
- The Company's internal control over financial reporting as of December 31, 2025, has been audited in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB).
- The audit of internal control over financial reporting was based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework).
- The report dated March 2, 2026, expressed an unqualified opinion on the Company's internal control over financial reporting.
Basis for Opinion
[c. 156; p. 16] Auditor's responsibility and opinion basis
- The Company's management is responsible for the financial statements.
- The auditor's responsibility is to express an opinion on the financial statements based on audits.
- The auditor is a public accounting firm registered with the PCAOB and is required to be independent in accordance with U.S. federal securities laws and applicable SEC and PCAOB rules and regulations.
- Audits were conducted in accordance with PCAOB standards.
- PCAOB standards require planning and performing audits to obtain reasonable assurance that financial statements are free of material misstatement, whether due to error or fraud.
- Audits included procedures to assess and respond to risks of material misstatement.
- Procedures included examining, on a test basis, evidence regarding amounts and disclosures in the financial statements.
- Audits also included evaluating accounting principles used, significant estimates made by management, and the overall presentation of the financial statements.
- The audits provide a reasonable basis for the auditor's opinion.
Critical Audit Matter
[c. 157; p. 16] Critical audit matter definition
- The critical audit matter communicated is a matter from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee.
- This matter relates to accounts or disclosures material to the financial statements and involved especially challenging, subjective, or complex judgments.
- The communication of the critical audit matter does not alter the opinion on the consolidated financial statements, taken as a whole.
- Communicating the critical audit matter does not provide a separate opinion on the critical audit matter or on the account or disclosure to which it relates.
Valuation of Reserves for Unpaid Losses and Loss Adjustment Expenses
[c. 158; p. 16] Valuation of Reserves for Unpaid Losses and Loss Adjustment Expenses
- The Company's reserves for unpaid losses and loss adjustment expenses (LAE) were USD 2.3bn at December 31, 2025, with a significant portion representing incurred but not reported reserves (IBNR).
- Reserves for unpaid losses and LAE represent the estimated ultimate cost of all unreported and reported but unpaid insured claims and the cost to adjust losses incurred as of the balance sheet date.
- The Company estimates these reserves using individual case-basis valuations of reported claims, statistical analyses, and various actuarial procedures.
- Estimates are based on historical information, industry and peer group information, and trends in factors like loss severity, loss frequency, and inflation.
- Auditing management's estimate of reserves for unpaid losses and LAE, including IBNR, was complex and involved actuarial specialists due to significant estimation uncertainty.
- This complexity arose from evaluating management's methods and assumptions, including loss development factors, expected loss ratios, and trends applied to the Company’s historical experience.
- These assumptions significantly affect the valuation of IBNR reserves.
- The audit obtained an understanding, evaluated the design, and tested the operating effectiveness of internal controls over management’s process for estimating losses and loss adjustment expense reserves.
- This included reviewing and approving processes for methods and assumptions used in estimating reserves.
- Audit procedures, with actuarial specialist assistance, included evaluating the selection of actuarial methods used by management, comparing them to prior periods and industry practices.
- The audit evaluated assumptions used in actuarial methods by comparing significant assumptions (loss development factors, expected loss ratios, trends) to the Company’s historical experience and current industry benchmarks and trends.
- An independent range of reserve estimates was developed and compared to management’s best estimate for unpaid losses and LAE.
- A review of the development of prior year reserve estimates was also performed.
[c. 159; p. 16]
| /s/ Ernst & Young LLP |
|---|
| We have served as the Company’s auditor since 2021. |
| Houston, Texas |
| March 2, 2026 |
Consolidated balance sheets
[c. 160; p. 16] Financial statement notes
- The accompanying notes are an integral part of the consolidated financial statements.
[c. 161; p. 16]
| December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| ($ in thousands, except share and per share amounts) | ||
| Assets | ||
| Investments: | ||
| Fixed maturity securities, available-for-sale, at fair value (net of allowance for credit losses of $ 7,000 and $ 0 , respectively) (amortized cost of $ 1,848,755 and $ 1,320,266 , respectively) | 1,856,303 | 1,292,218 |
| Fixed maturity securities, held-to-maturity, at amortized cost (net of allowance for credit losses of $ 468 and $ 243 , respectively) | 32,822 | 39,153 |
| Equity securities, at fair value | 1,174 | 106,254 |
| Mortgage loans, at fair value | 9,902 | 26,490 |
| Equity method investments | 77,365 | 98,594 |
| Other long-term investments | 58,650 | 33,182 |
| Short-term investments, at fair value | 264,299 | 274,929 |
| Total investments | 2,300,515 | 1,870,820 |
| Cash and cash equivalents | 168,544 | 121,603 |
| Restricted cash | 30,570 | 35,922 |
| Premiums receivable, net | 544,217 | 321,641 |
| Reinsurance recoverables, net | 1,119,880 | 857,876 |
| Ceded unearned premium | 238,948 | 203,901 |
| Deferred policy acquisition costs | 136,100 | 113,183 |
| Deferred income taxes | 27,865 | 30,486 |
| Goodwill and intangible assets, net | 88,040 | 87,348 |
| Other assets | 137,173 | 86,698 |
| Total assets | 4,791,852 | 3,729,478 |
| Liabilities and stockholders’ equity | — | — |
| Liabilities: | — | — |
| Reserves for losses and loss adjustment expenses | 2,318,894 | 1,782,383 |
| Unearned premiums | 774,035 | 637,185 |
| Deferred ceding commission | 46,453 | 40,434 |
| Reinsurance and premium payables | 279,888 | 177,070 |
| Funds held for others | 128,003 | 102,665 |
| Accounts payable and accrued liabilities | 115,034 | 76,206 |
| Notes payable | 100,411 | 100,000 |
| Subordinated debt, net of debt issuance costs | 19,569 | 19,536 |
| Total liabilities | 3,782,287 | 2,935,479 |
| Stockholders’ equity | — | — |
| Common stock, $ 0.01 par value, 500,000,000 shares authorized, 40,511,222 and 40,127,908 shares issued and outstanding, respectively | 405 | 401 |
| Additional paid-in capital | 730,555 | 718,598 |
| Accumulated other comprehensive income (loss) | 11,457 | ( 22,120 ) |
| Retained earnings | 267,148 | 97,120 |
| Total stockholders’ equity | 1,009,565 | 793,999 |
| Total liabilities and stockholders’ equity | 4,791,852 | 3,729,478 |
Consolidated statements of operations and comprehensive income
[c. 162; p. 16] Financial statement notes
- The accompanying notes are an integral part of the consolidated financial statements.
[c. 163; p. 16]
| Years Ended December 31, | |||
|---|---|---|---|
| ($ in thousands, except share and per share amounts) | 2025 | 2024 | 2023 |
| Revenues: | |||
| Net earned premiums | 1,304,505 | 1,056,722 | 829,143 |
| Commission and fee income | 6,855 | 6,703 | 6,064 |
| Net investment income | 83,619 | 80,600 | 40,340 |
| Net investment gains | 22,149 | 6,342 | 11,054 |
| Other loss | ( 587 ) | ( 167 ) | ( 632 ) |
| Total revenues | 1,416,541 | 1,150,200 | 885,969 |
| Expenses: | — | — | — |
| Losses and loss adjustment expenses | 795,022 | 669,809 | 515,237 |
| Underwriting, acquisition and insurance expenses | 377,359 | 311,757 | 243,444 |
| Transaction costs | 14,019 | — | — |
| Interest expense | 7,919 | 9,496 | 10,024 |
| Amortization expense | 1,636 | 2,007 | 1,798 |
| Other expenses | 4,162 | 4,392 | 5,364 |
| Total expenses | 1,200,117 | 997,461 | 775,867 |
| Income before income taxes | 216,424 | 152,739 | 110,102 |
| Income tax expense | 46,396 | 33,911 | 24,118 |
| Net income | 170,028 | 118,828 | 85,984 |
| Net income attributable to participating securities | — | — | 1,677 |
| Net income attributable to common stockholders | 170,028 | 118,828 | 84,307 |
| Comprehensive income | — | — | — |
| Net income | 170,028 | 118,828 | 85,984 |
| Other comprehensive income: | — | — | — |
| Unrealized gains and losses on investments: | — | — | — |
| Net change in unrealized gains on investments, net of tax | 33,092 | 9,792 | 25,516 |
| Reclassification adjustment for gains (losses) on securities no longer held, net of tax | 485 | ( 8,959 ) | ( 4,984 ) |
| Total other comprehensive income | 33,577 | 833 | 20,532 |
| Comprehensive income | 203,605 | 119,661 | 106,516 |
| Per share data: | — | — | — |
| Basic earnings per share | 4.21 | 2.97 | 2.34 |
| Diluted earnings per share | 4.07 | 2.87 | 2.24 |
| Weighted-average common shares outstanding | — | — | — |
| Basic | 40,407,310 | 40,056,475 | 36,031,907 |
| Diluted | 41,808,046 | 41,377,460 | 38,317,534 |
Consolidated statements of stockholders’ equity
[c. 164; p. 16] Financial statement notes
- The accompanying notes are an integral part of the consolidated financial statements.
[c. 165; p. 16]
| Years Ended December 31, | |||
|---|---|---|---|
| ($ in thousands, except share amounts) | 2025 | 2024 | 2023 |
| Preferred shares: | |||
| Balance at beginning of year | — | — | 1,969,660 |
| Preferred stock conversion to common shares | — | — | ( 1,969,660 ) |
| Balance at December 31 | — | — | — |
| Common shares: | — | — | — |
| Balance at beginning of year | 40,127,908 | 39,863,756 | 16,599,666 |
| Issuance of shares | 383,314 | 264,152 | 6,958,977 |
| Preferred stock conversion to common shares | — | — | 16,305,113 |
| Balance at December 31 | 40,511,222 | 40,127,908 | 39,863,756 |
| Preferred stock: | — | — | — |
| Balance at beginning of year | — | — | 20 |
| Preferred stock conversion to common shares | — | — | ( 20 ) |
| Balance at December 31 | — | — | — |
| Common stock: | — | — | — |
| Balance at beginning of year | 401 | 399 | 168 |
| Issuance of common stock | 4 | 2 | 22 |
| Preferred stock conversion to common shares | — | — | 161 |
| Proceeds from equity offerings, net | — | — | 48 |
| Balance at December 31 | 405 | 401 | 399 |
| Treasury stock: | — | — | — |
| Balance at beginning of year | — | — | ( 2 ) |
| Preferred stock conversion to common shares | — | — | 2 |
| Balance at December 31 | — | — | — |
| Additional paid-in capital: | — | — | — |
| Balance at beginning of year | 718,598 | 710,855 | 577,289 |
| Issuance of common stock | 11,957 | 7,743 | 9,213 |
| Preferred stock conversion to common shares | — | — | ( 143 ) |
| Proceeds from equity offerings, net | — | — | 124,496 |
| Balance at December 31 | 730,555 | 718,598 | 710,855 |
| Stock notes receivable: | — | — | — |
| Balance at beginning of year | — | ( 5,562 ) | ( 6,911 ) |
| Employee equity transactions | — | 5,562 | 1,349 |
| Balance at December 31 | — | — | ( 5,562 ) |
| Accumulated other comprehensive income (loss): | — | — | — |
| Balance at beginning of year | ( 22,120 ) | ( 22,953 ) | ( 43,485 ) |
| Other comprehensive income, net of tax | 33,577 | 833 | 20,532 |
| Balance at December 31 | 11,457 | ( 22,120 ) | ( 22,953 ) |
| Retained earnings (accumulated deficit): | — | — | — |
| Balance at beginning of year | 97,120 | ( 21,708 ) | ( 105,417 ) |
| Cumulative effect on adoption of ASU No. 2016-13 | — | — | ( 2,275 ) |
| Net income | 170,028 | 118,828 | 85,984 |
| Balance at December 31 | 267,148 | 97,120 | ( 21,708 ) |
| Total stockholders’ equity | 1,009,565 | 793,999 | 661,031 |
Consolidated statements of cash flows
[c. 166; p. 16] Financial statement notes
- The accompanying notes are an integral part of the consolidated financial statements.
[c. 167; p. 16]
| Years Ended December 31, | |||
|---|---|---|---|
| ($ in thousands) | 2025 | 2024 | 2023 |
| Cash flows from operating activities: | |||
| Net income | 170,028 | 118,828 | 85,984 |
| Adjustments to reconcile net income to net cash provided by (used in) operating activities: | — | — | — |
| Net investment (gains) losses | ( 22,149 ) | ( 6,342 ) | ( 11,054 ) |
| Depreciation and amortization expense | 3,535 | 3,358 | 3,891 |
| Stock-based compensation expense | 11,960 | 9,395 | 8,525 |
| Undistributed earnings (loss) from long-term investments | 10,122 | ( 6,252 ) | 6,730 |
| Net change in fair value of derivatives | ( 34,857 ) | — | — |
| Deferred income tax, net | ( 6,397 ) | ( 8,708 ) | 9,383 |
| Changes in operating assets and liabilities: | — | — | — |
| Premiums receivable, net | ( 222,576 ) | ( 142,406 ) | ( 40,020 ) |
| Reinsurance recoverables, net | ( 262,004 ) | ( 261,542 ) | ( 17,270 ) |
| Ceded unearned premium | ( 35,047 ) | ( 17,780 ) | ( 28,476 ) |
| Deferred policy acquisition costs | ( 22,917 ) | ( 21,228 ) | ( 23,017 ) |
| Federal income taxes | 1,797 | 4,500 | ( 1,892 ) |
| Losses and loss adjustment expenses | 536,511 | 467,882 | 172,744 |
| Unearned premiums | 136,850 | 84,653 | 110,023 |
| Deferred ceding commission | 6,019 | 3,377 | 7,208 |
| Reinsurance and premium payables | 102,818 | 26,914 | 36,460 |
| Funds held for others | 25,338 | 44,077 | 21,730 |
| Accounts payable and accrued liabilities | 37,032 | 19,177 | 2,285 |
| Other, net | ( 27,987 ) | ( 12,788 ) | ( 5,047 ) |
| Net cash provided by operating activities | 408,076 | 305,115 | 338,187 |
| Cash flows from investing activities: | — | — | — |
| Purchase of fixed maturity securities, available-for-sale | ( 910,039 ) | ( 617,606 ) | ( 459,672 ) |
| Purchase of illiquid investments | — | ( 75 ) | ( 1,675 ) |
| Purchase of equity securities | ( 13,213 ) | ( 14,077 ) | ( 26,009 ) |
| Purchase of equity method investments and other long-term investments | ( 6,814 ) | ( 32,173 ) | — |
| Purchase of intangible assets and goodwill | ( 2,000 ) | — | ( 50 ) |
| Investment in direct and indirect loans | 19,674 | 27,480 | 2,984 |
| Purchase of property and equipment | ( 5,454 ) | ( 4,224 ) | ( 3,108 ) |
| Proceeds from the sales of fixed maturity securities, available-for-sale | 198,195 | 217,468 | 26,626 |
| Maturities, calls, transfers and paydowns of fixed maturity securities, available-for-sale | 183,951 | 122,694 | 48,957 |
| Maturities, calls and paydowns of fixed maturity securities held-to-maturity | 4,357 | 6,015 | 11,444 |
| Proceeds from the sales of equity securities | 126,738 | 37,534 | 40,201 |
| Sales of and distributions from equity method and other long-term investments | 11,902 | 14,073 | 3,572 |
| Change in short-term investments | 10,626 | ( 4,799 ) | ( 149,068 ) |
| Change in receivable/payable for securities | 11,928 | 34 | 76 |
| Cash provided by deposit accounting | 3,251 | 3,962 | 11,913 |
| Net cash used in investment activities | ( 366,898 ) | ( 243,694 ) | ( 493,809 ) |
| Cash flows from financing activities: | — | — | — |
| Employee share purchases | — | — | 1,350 |
| Repayment of stock notes receivable | — | 5,562 | — |
| Proceeds from long term borrowings | 43,411 | 107,000 | 50,000 |
| Payments on long term borrowings and trust preferred | ( 43,000 ) | ( 116,794 ) | ( 50,000 ) |
| Proceeds from initial public offering | — | — | 129,597 |
| Net cash provided by (used in) financing activities | 411 | ( 4,232 ) | 130,947 |
| Net increase (decrease) in cash and cash equivalents and restricted cash | 41,589 | 57,189 | ( 24,675 ) |
| Cash and cash equivalents and restricted cash at beginning of period (1) | 157,525 | 100,336 | 125,011 |
| Cash and cash equivalents and restricted cash at end of period (1) | 199,114 | 157,525 | 100,336 |
| Supplemental disclosure of cash flow information: | — | — | — |
| Cash paid for interest | 6,149 | 8,573 | 10,667 |
A. Description of Business
[c. 168; p. 16] Company overview
- Skyward Specialty Insurance Group, Inc. (the "Company") is a Delaware corporation organized in 2006.
- The Company is an insurance holding company operating in one segment, delivering commercial property and casualty products insurance coverages through its underwriting divisions.
[c. 169; p. 16] Wholly owned insurance subsidiaries
- The Company has four wholly owned insurance company subsidiaries based in the United States.
- Great Midwest Insurance Company ("GMIC") underwrites insurance on an admitted basis and is a certified surety bond company listed with the U.S. Department of the Treasury.
- Houston Specialty Insurance Company ("HSIC"), a subsidiary of GMIC, underwrites insurance on a non-admitted basis.
- Imperium Insurance Company ("IIC"), a subsidiary of HSIC, underwrites insurance on an admitted basis.
- Oklahoma Specialty Insurance Company ("OSIC"), a subsidiary of IIC, underwrites insurance on a non-admitted basis.
[c. 170; p. 16] Wholly owned reinsurance subsidiary
- The Company has a wholly owned captive reinsurance company subsidiary, Skyward Re, domiciled in the Cayman Islands.
- Skyward Re assumed net reserves for certain divisions, related to a retroactive reinsurance contract, from the Company’s insurance companies and retroceded the net reserves to a third-party reinsurer.
[c. 171; p. 16] Wholly owned non-risk bearing subsidiaries
- The Company has three non-risk bearing wholly owned subsidiaries.
- Skyward Underwriters Agency, Inc. ("SUA") is a managing general insurance agent and reinsurance broker for property and casualty risks in specialty niche markets.
- Skyward Service Company provides various administrative services to the Company’s subsidiaries.
- Skyward Specialty No. 1 Limited is a Lloyd’s corporate member authorized to invest in Lloyd’s syndicates.
[c. 172; p. 16] Apollo Group Holdings Limited acquisition
- On January 1, 2026, the Company completed the acquisition of Apollo Group Holdings Limited for an aggregate consideration of approximately USD 555.0m.
- Additional information regarding the acquisition can be found in Note 24.
B. Basis of Presentation
[c. 173; p. 16] Basis of financial statement preparation
- The Company’s consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP").
- GAAP differs in some respects from the principles followed in reports to insurance regulatory authorities.
- The consolidated financial statements include the accounts of the holding company and its subsidiaries.
- All intercompany transactions and balances have been eliminated in consolidation.
- The preparation of consolidated financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect reported amounts in the financial statements and accompanying notes.
- The Company’s actual results could differ from those estimates.
C. Consolidation
[c. 174; p. 16] Variable interest entity consolidation
- The Company consolidates an entity if it has a controlling financial interest, determined by assessing if the entity is a variable interest entity (VIE) for which the Company is the primary beneficiary, or if the Company controls the entity through a majority voting interest or other arrangements.
- A VIE is defined as an entity that either lacks sufficient equity to finance its activities without additional subordinated financial support, whose equity holders lack the characteristics of a controlling financial interest, and/or is established with non-substantive voting rights.
- The Company's assessment of VIE status involves subjectivity in determining which activities most significantly affect the VIE’s performance and estimates about current and future fair value of assets and financial performance of the VIE.
- In related party analysis, the Company considers qualitative and quantitative factors including the characteristics and size of its investment relative to the related party, the ability of the Company and related party to control or significantly influence key decisions of the VIE (including de facto agents), the obligation or likelihood to fund operating losses of the VIE, and the similarity and significance of the VIE’s business activities to those of the Company and the related party.
- The determination of whether an entity is a VIE and whether the Company is the primary beneficiary involves significant judgment and depends on specific facts and circumstances at the time of assessment.
[c. 175; p. 16] Consolidation reassessment and impact
- At each reporting period, the Company reassesses changes in facts and circumstances that could alter an entity's VIE status or the Company's consolidation assessment.
- Changes in consolidation status are applied prospectively.
- If an entity is consolidated due to reassessment, its assets, liabilities, and noncontrolling interest are recorded at fair value upon initial consolidation.
- Any existing equity interest held by the Company in the entity prior to obtaining control is remeasured at fair value, potentially resulting in a recognized gain or loss upon initial consolidation.
- Deconsolidation of a subsidiary due to reassessment may result in a recognized gain or loss, depending on the carrying values of deconsolidated assets and liabilities compared to the fair value of any retained interests.
- The Company has determined one entity meets the definition of a VIE for which it is the primary beneficiary.
- Further details and required disclosures are provided in Note 7.
D. Cash and Cash Equivalents
[c. 176; p. 16] Cash and cash equivalents definition
- Cash and cash equivalents include cash on hand and fixed maturity securities with original maturities of three months or less.
- The carrying value of the Company’s cash and cash equivalents approximates fair value.
E. Restricted Cash
[c. 177; p. 16] Restricted cash definition and uses
- Cash with a legal restriction on withdrawal or use by the consolidated group is recorded as restricted cash.
- The carrying value of the Company’s restricted cash approximates fair value.
- SUA holds unremitted insurance premiums in a fiduciary capacity to third-party insurance companies as restricted cash, after deducting commissions and applicable fees from premiums collected from clients.
- The Company is required by state regulations to maintain assets on deposit with certain states and hold cash as collateral for certain reinsurance balances.
- Cash held in a depository account for others, or restricted by a state, is recorded as restricted cash.
F. Investments
[c. 178; p. 16] Available-for-sale fixed maturities accounting
- Investments in fixed maturities classified as available-for-sale are carried at fair value.
- For available-for-sale fixed maturities in an unrealized loss position, the Company first determines intent to sell or likelihood of being required to sell before maturity or recovery of cost basis.
- If intent or likelihood of sale criteria are met, the amortized cost is written down to fair value, with losses recognized in net investment gains on the Consolidated Statements of Operations.
- If neither criterion is met, the Company determines if unrealized losses are due to credit-related factors.
- If unrealized losses are credit-related, an allowance for credit losses is determined using a present value of cash flows compared to the amortized cost.
- Prior to 2025, changes in the allowance for credit losses were recognized in net investment income on the Consolidated Statements of Operations.
- As of 2025, changes in the allowance for credit losses are recognized in net investment gains.
- Prior periods have been updated to conform to the current period presentation.
- Credit losses limited by the fair value of the security are recognized in stockholders’ equity, net of taxes, as a component of accumulated other comprehensive income (loss).
- Unrealized losses that are not credit-related continue to be recognized in stockholders’ equity, net of taxes, as a component of accumulated other comprehensive income (loss).
[c. 179; p. 16] Held-to-maturity fixed maturities accounting
- Investments in fixed maturity securities held-to-maturity are carried at amortized cost net of an allowance for credit losses.
- The allowance for credit losses represents the current estimate of expected credit losses.
- The Company develops a historical loss rate from Moody’s multi-year cumulative loss rates for asset-backed securities.
- The historical loss rate is adjusted for current conditions and reasonable and supportable forecasts.
- Prior to 2025, changes in the allowance for credit losses were recognized in net investment income on the Consolidated Statements of Operations.
- As of 2025, changes in the allowance for credit losses are recognized in net investment gains.
- Prior periods have been updated to conform to the current period presentation.
[c. 180; p. 16] Equity securities accounting
- Equity securities consist of common stock or preferred stock.
- Mutual funds, including those primarily investing in debt securities, are classified as equity securities.
- Investments in equity securities with a readily determinable fair value are carried on the balance sheet at fair value using quoted market prices.
- Changes in the carrying value of equity securities are included in net investment gains (losses) within the Consolidated Statements of Operations.
[c. 181; p. 16] Mortgage loans accounting
- Investments in mortgage loans are classified as held for investment and carried at cost adjusted for unamortized premiums, discounts, and loan fees.
- Uncollectible amounts are written off in the period they are determined to be uncollectible.
- Interest on loans is recognized as interest receivable and included in other assets on the Consolidated Balance Sheets.
- The Company elected the fair value option for mortgage loans effective January 1, 2023, as targeted transition relief from ASU 2016-13 adoption.
- Under the fair value option, mortgage loans are measured at fair value.
- Changes in unrealized gains and losses on mortgage loans are reported in net investment gains (losses) on the Consolidated Statements of Operations.
- Interest income and amortization continue to be recognized in net investment income on the Consolidated Statements of Operations.
[c. 182; p. 16] Equity method investments accounting
- Equity method investments include investments in equity and equity securities of non-public entities and indirect investments in loans and loan collateral.
- The Company has equity investments in certain limited partnerships and corporations where it has significant influence but not control.
- Analysis of variable interest entities indicated the Company is not the primary beneficiary and would not consolidate these entities.
- The equity method is used to account for investments in unconsolidated subsidiaries.
- Under the equity method, initial investment is recorded at cost and adjusted based on proportionate share of distributions and net income or loss of the investee.
- The difference between investment cost and proportionate share of underlying equity in net assets is a component of investment income.
- The Company amortizes this difference as an adjustment to its pro-rata share of equity method income over the useful life of the underlying asset.
- For equity securities of non-public entities where the Company does not have significant influence and no readily determinable fair value, investments are carried at cost, minus impairment, and adjusted for observable price changes in orderly transactions for identical or similar investments of the same issuer.
- Investments in indirect collateralized loans and loan collateral are held through and accounted for as an ownership interest in an unconsolidated subsidiary.
- The Company’s ownership interests in unconsolidated subsidiaries include investments in partnerships, joint ventures, and special purpose investment vehicles.
- The Company has significant influence but not control of these unconsolidated subsidiaries and uses the equity method for these investments.
[c. 183; p. 16] Other long-term investments accounting
- Other long-term investments consist of an investment in a limited partnership held at net asset value (“NAV”) and other long-term investment securities.
[c. 184; p. 16] Short-term investments accounting
- Short-term investments primarily consist of money market funds.
- Short-term investments are carried at cost, which approximates fair value.
[c. 185; p. 16] Net investment income and gains/losses recognition
- Net investment income consists of interest, dividends, and equity in earnings (losses) of unconsolidated subsidiaries, net of investment expenses such as investment management expenses.
- Interest income is recognized on the accrual basis.
- Dividends are recognized as earned at the ex-dividend date.
- Interest income on mortgage-backed and other asset-backed securities is recognized using the effective-yield method based on estimated principal repayments.
- Amortization of premium and accretion of discounts on debt securities are included in interest income.
- Net investment gains and losses are recognized in net income based upon the specific identification method.
G. Derivatives
[c. 186; p. 16] Commodity derivatives accounting and valuation
- The Company uses commodity derivatives to assume risk and manage exposures in the insurance industry.
- Commodity derivatives expose the Company to potentially unfavorable price changes to underlying commodities.
- Derivatives are accounted for in accordance with FASB ASC Topic 815, Derivatives and Hedging.
- All derivatives are recorded at fair value on the Company’s balance sheet as assets or liabilities.
- Changes in fair value of derivatives are reflected in current earnings.
- The Company nets assets and liabilities of derivatives, including them in "other assets" on the Consolidated Balance Sheets.
- The Company considers exchange-traded futures and forward purchase and sale contracts to be effective economic hedges.
- The Company has not elected hedge accounting treatment for these derivatives.
- Fair value of derivatives is estimated by reference to quoted prices or broker quotes, or through industry or internal valuation models when quotes are unavailable.
- Further details and required disclosures are in Note 8.
H. Reinsurance
[c. 187; p. 16] Reinsurance accounting principles
- The Company purchases prospective reinsurance for certain lines of business on a proportional, excess of loss, and facultative basis.
- Proportional reinsurance involves sharing losses and expenses with the reinsurer in exchange for a share of premiums.
- Excess of loss reinsurance shares losses, either proportionally or entirely, above a certain dollar threshold, for a negotiated cost.
- Facultative reinsurance covers specific risks and/or policies on either a proportional or excess of loss basis.
- Ceded unearned premium and reinsurance balances recoverable (on paid and unpaid losses and settlement expenses) are reported separately as assets, not netted with related liabilities, because reinsurance does not relieve the Company of its legal liability to policyholders.
- Reinsurance on unpaid losses and settlement expenses represents estimates of the portion of liabilities recoverable from reinsurers.
- On the Consolidated Statements of Operations, net earned premiums, losses and loss adjustment expenses, net, and underwriting, acquisition, and insurance expenses are presented net of reinsurance ceded.
[c. 188; p. 16] Retroactive reinsurance accounting
- The Company has purchased retroactive reinsurance on certain lines of business in prior years, including loss portfolio transfers (LPT) and adverse development covers.
- These contracts indemnify losses related to past loss events, with the reinsurer sharing losses based on dollar thresholds.
- Income from retroactive reinsurance contracts is deferred and amortized into net income over the settlement period.
- Losses from retroactive reinsurance contracts are charged to net income immediately.
- Subsequent changes in the measurement of retroactive reinsurance contracts are accounted for under a full retrospective method.
[c. 189; p. 16] Deposit accounting for reinsurance
- Certain ceded reinsurance contracts that management determines do not transfer significant insurance risk are accounted for using the deposit method.
- The evaluation of significant insurance risk transfer assesses both timing risk and underwriting risk.
- A reinsurance contract may not transfer significant insurance risk if either underwriting risk or timing risk, or both, are not deemed transferred.
- For contracts transferring only significant timing risk but not sufficient underwriting risk, a deposit asset is recorded equal to the initial cash outflow, offset by cash inflows from reinsurers.
- If cash outflows are expected to differ from expected cash inflows, an accretion rate is established at inception based on actuarial estimates, increasing/decreasing the deposit accounting asset to the estimated receivable amount over the contract term.
- The accretion of the deposit is based on the expected rate of return implied from estimated cash inflows and outflows under the contract.
- The Company periodically reassesses the estimated ultimate receivable and related expected rate of return on the deposit asset.
- Accretion of the deposit asset, including changes from estimated cash flow changes, is reflected as part of investment income in the Company’s results of operations.
- Several reinsurance contracts require deposit accounting due to not transferring sufficient underwriting risk.
- There were no reinsurance contracts requiring deposit accounting due to not transferring sufficient timing risk.
[c. 190; p. 16] Reinsurance recoverables and credit risk
- Reinsurance recoverables are carried net of an allowance for credit losses, which represents the current estimate of expected credit losses.
- The Company develops a historical loss rate using the A.M. Best impairment rate and rating transition study, which provides historical loss data for similarly rated reinsurance companies based on receivable duration.
- The historical loss rate is adjusted for current conditions, reasonable and supportable forecasts, and current economic conditions.
- Changes in the allowance for credit losses are recognized in underwriting, acquisition, and insurance expenses on the Consolidated Statements of Operations.
- Reinsurance does not relieve the Company of its legal liability to its policyholders.
- The Company continuously monitors the financial condition of its reinsurers by reviewing annual financial statements and industry developments.
- Credit risk associated with reinsurance recoverables is analyzed by monitoring reinsurers' A.M. Best financial strength ratings and assessing collateral adequacy.
- If reinsurers fail to fulfill obligations, the Company has access to collateral from various reinsurers.
- Reinsurance collateral from reinsurers was USD 344.1m as of December 31, 2025, and USD 337.0m as of December 31, 2024.
- eMaxx Captives and Everest Reinsurance Co. were the only reinsurers representing 10% or more of the Company’s reinsurance recoverable balances.
- eMaxx Captives represented 17.7% of reinsurance recoverable balances at December 31, 2025, and 16.8% at December 31, 2024.
- Everest Reinsurance Co. represented 11.1% of reinsurance recoverable balances at December 31, 2025, and 18.0% at December 31, 2024.
- eMaxx Captives was not rated by A.M. Best at December 31, 2025, and 2024.
- Everest Reinsurance Co.'s financial strength rating from A.M. Best was A+ at December 31, 2025, and 2024.
I. Concentration of Credit Risk
[c. 191; p. 16] Credit risk concentration
- Financial instruments potentially subject to concentrations of credit risk include cash and cash equivalents, restricted cash, investments, and premiums receivable, in addition to reinsurance recoverables.
- Cash equivalents and short-term investments include U.S. government securities and money market funds.
- Investments are diversified across many industries and geographic regions.
- The Company limits credit exposure with any single financial institution or issuer.
- No significant concentration of credit risk is believed to exist with respect to cash and investments.
- As of December 31, 2025 and 2024, outstanding premiums receivable are generally diversified due to the large number of entities in the customer base and their dispersion across various lines of business and geographic regions.
- Failure by distribution sources to remit premiums could lead to premium write-offs and a corresponding loss of income.
J. Deferred Policy Acquisition Costs
[c. 192; p. 16] Deferred Policy Acquisition Costs
- Policy acquisition costs include commissions and premium taxes that vary with and are directly related to the successful production of new or renewal business.
- The Company defers policy acquisition costs and related ceding commissions.
- Deferred policy acquisition costs and related ceding commissions are charged or credited to earnings in proportion to the premium earned over the life of the policy.
- A premium deficiency is recognized if the sum of expected losses, loss adjustment expenses, and unamortized acquisition costs exceeds related unearned premiums.
- The Company first recognizes a premium deficiency by charging any unamortized acquisition costs to expense to the extent required to eliminate the deficiency.
- If the premium deficiency exceeds unamortized acquisition costs, a liability is accrued for the excess deficiency.
- Anticipated investment income is considered in the determination of premium deficiencies.
- Management determined no premium deficiency existed as of December 31, 2025 and 2024.
K. Goodwill and Intangible Assets
[c. 193; p. 16] Goodwill and intangible assets accounting policy
- Goodwill and intangible assets are recorded as a result of a business combination.
- Goodwill represents the excess of the purchase price over the fair value of acquired assets and assumed liabilities.
- The Company reviews its purchase price allocation for up to one year post-acquisition and may make adjustments within that period.
- Identifiable intangible assets with a finite useful life are amortized over the period they are expected to contribute to future cash flows.
- Indefinite-lived intangible assets are not amortized.
- The Company reviews goodwill and identifiable intangible assets for recoverability annually in the fourth quarter, or on an interim basis if events or changes indicate a carrying amount may not be recoverable.
- No goodwill impairment was recorded for the years ended December 31, 2025 and 2024.
L. Property and Equipment
[c. 194; p. 16] Property and equipment accounting
- Property and equipment, included in other assets on the Consolidated Balance Sheets, is recorded at cost less accumulated depreciation.
- Depreciation expense is recognized on a straight-line basis for financial statement purposes over periods ranging from three to seven years.
M. Reserves for Losses and Loss Adjustment Expenses
[c. 195; p. 16] Reserves for unpaid losses and LAE
- Reserves for unpaid losses and loss adjustment expenses (LAE) represent the estimated ultimate cost of all unreported and reported but unpaid insured claims and the cost to adjust losses incurred as of the balance sheet date.
- Estimates for these reserves are made using individual case-basis valuations of reported claims, statistical analyses, and various actuarial procedures.
- These estimates are based on historical information, industry and peer group information, and estimates of future trends in variable factors such as loss severity, loss frequency, and inflation.
- Estimates are regularly reviewed and adjusted as experience develops or new information becomes known.
- During the loss settlement period, estimates of liability on a claim may be refined and adjusted upward or downward.
- The ultimate settlement of losses and related LAE may vary significantly from the estimate included in financial statements.
- If actual liabilities exceed recorded amounts, there will be an adverse effect.
- Recorded reserves may be determined to be more than adequate, leading to a reduction in reserves.
N. Premiums
[c. 196; p. 16] Premium recognition and receivables
- The Company earns and recognizes property and casualty and surety premiums on a pro-rata basis over the terms of policies.
- Accident and health premiums are earned as billed, based on census data.
- Gross premiums written are reduced by ceded premiums from proportional, facultative, and excess of loss reinsurance costs for prospective reinsurance.
- Premiums receivable include deferred premiums, which are installment payments due from insureds under their policy payment terms.
- Premiums receivable are carried net of an allowance for credit losses, which represents the current estimate of expected credit losses.
- The Company develops a historical loss rate for credit losses using historical write-offs and aging of receivables.
- This historical loss rate is adjusted for current conditions, reasonable and supportable forecasts, and the ability to cancel coverage after a premium is past due.
- Changes in the allowance for credit losses are recognized in underwriting, acquisition, and insurance expenses on the Consolidated Statements of Operations.
[c. 197; p. 16] Unearned premiums
- Unearned premiums represent the portion of gross premiums written applicable to the unexpired terms of in-force insurance policies or reinsurance contracts.
- Ceded unearned premiums represent the portion of ceded premiums written applicable to the unexpired terms of in-force insurance policies or reinsurance contracts.
- These unearned premiums are calculated on a pro-rata basis over the terms of the policies for both direct and ceded amounts.
O. Commission and Fee Income
[c. 198; p. 16] SUA commission revenue
- SUA commission revenue is generated from placing insurance policies on reinsurance programs via a reinsurance broker.
- The Company's single performance obligation for SUA commission revenue is the placement of insurance policies.
- The transaction price for SUA commission revenue is fixed at contract inception and based on a percentage of premiums placed.
- The Company recognizes 100% of the transaction price for SUA commission revenue when the performance obligation is satisfied at the point a policy is placed, as there are no constraints on revenue.
[c. 199; p. 16] SUA fee income
- SUA fee income is generated from placing insurance policies with a third-party insurance company.
- The Company's single performance obligation for SUA fee income is the placement of the policy.
- The transaction price for SUA fee income is variable at contract inception and based on a percentage of premium, which is determined by risk factors that vary monthly (e.g., employee census data, worker roles).
- The Company estimates its transaction price for SUA fee income over the life of the policy using the expected value method.
- Revenue from SUA fee income is recognized at the point the policy is placed.
- Changes in the estimate of variable consideration for SUA fee income are recognized in the month they occur.
P. Income Taxes
[c. 200; p. 16] Income tax accounting principles
- Income tax expense is accrued for tax effects of transactions reported on consolidated financial statements.
- Provision for income taxes consists of currently due taxes plus deferred taxes from temporary differences between financial statement and income tax reporting.
- A valuation allowance is established for any deferred tax asset not expected to be realized.
- Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years temporary differences are recovered or settled.
- The effect on deferred tax assets and liabilities from a change in tax rates is recognized in income in the period of enactment.
- A liability for uncertain tax positions is recorded if it is more likely-than-not that the tax position will not be sustained upon examination by the appropriate tax authority.
- Changes in the liability for uncertain tax positions are reflected in income tax expense when a new uncertain tax position arises, judgment changes about uncertainty likelihood, the tax issue is settled, or the statute of limitation expires.
- Potential net interest income or expense and penalties related to uncertain tax positions are recorded on the Consolidated Statements of Operations.
[c. 201; p. 16] Tax filings and premium taxes
- The Company files a consolidated federal income tax return in the United States and certain other state tax returns.
- Admitted insurance subsidiaries pay premium taxes on gross written premiums in lieu of most state income or franchise taxes.
- Premium tax expense is recognized within underwriting, acquisition and insurance expense on the Consolidated Statements of Operations.
Q. Fair Value of Financial Instruments
[c. 202; p. 16] Fair value measurement framework
- Fair value for each class of financial instrument is estimated based on the framework established in fair value accounting guidance.
- This guidance requires maximizing observable inputs and minimizing unobservable inputs when measuring fair value.
- Fair value hierarchy disclosures are based on the quality of inputs used to measure fair value.
- The hierarchy prioritizes unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements).
- The hierarchy gives the lowest priority to unobservable inputs (Level 3 measurements).
- The Company uses widely recognized, third-party pricing sources to determine fair values of financial instruments.
- The Company understands the valuation methodologies and inputs of these third-party pricing sources.
- Further details regarding fair value disclosures are in Note 4.
R. Stock-Based Compensation
[c. 203; p. 16] Stock-based compensation accounting
- The estimated fair value of employee stock options and similar awards is expensed.
- Compensation cost for equity instrument awards to employees is measured based on the grant-date fair value and recognized over the service period until vesting.
- Tax effects related to share-based payments are made through net earnings.
- Further discussion and related disclosures regarding stock-based compensation are in note 18.
- The Company's employee stock purchase plan (ESPP) allows all employees to purchase common stock at a discount.
- Compensation cost for the ESPP is recognized on a straight-line basis over the offering period.
[c. 204; p. 16] Basic EPS calculation
- Basic earnings per share is calculated using the two-class method.
- Undistributed earnings are allocated to participating securities based on their share in earnings as if all earnings for the period were distributed.
- Basic earnings per share is calculated by dividing net income attributable to common stockholders by the weighted-average number of common shares outstanding for the period.
- Common shares with unsatisfied contingencies, such as vesting requirements, are excluded from basic earnings per share.
- The Company’s preferred shares participate in dividends and distributions with common stock on an as-converted basis and are considered a participating security.
- Instruments awarded to employees that provide the right to purchase common stock at a fixed price were included as potential common shares, weighted for the portion of the period they were granted, if dilutive.
- The Company’s common and preferred shares financed by stock notes are contingently issuable instruments where the holder must return shares if stock notes are not paid off.
- These contingently issuable instruments are excluded from basic and diluted earnings per share when specified conditions are not met, presuming the end of the period is the end of the contingency period.
- The impact of contingently issuable instruments on diluted earnings per share was calculated using the treasury stock method and included in the reconciliation of the denominator of basic and diluted EPS computations for the year ended December 31, 2024.
- All outstanding stock notes were settled during 2024, resulting in no impact to the Company’s basic and diluted earnings per share computations for the year ended December 31, 2024.
[c. 205; p. 16] Diluted EPS calculation
- Instruments convertible into common shares are included in diluted weighted-average common shares outstanding on an if-converted basis, based on the legal conversion rate for the respective period, if dilutive.
- Share-based awards to employees with only service conditions are included as potential common shares, weighted for the portion of the period they are unvested, if dilutive.
- Share-based awards to employees with performance and service or market conditions are included as potential common shares, presuming the end of the period is the end of the contingency period, if dilutive.
- If the inclusion of common share adjustments increases earnings per share or reduces loss per share, the effect is anti-dilutive.
- In anti-dilutive cases, the diluted net earnings or net loss per share is computed excluding these common share equivalents.
T. Recent Accounting Pronouncements
[c. 206; p. 16] Recent accounting standards adopted
- In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures (Topic 740).
- ASU 2023-09 requires public companies to provide enhanced rate reconciliation disclosures annually, including specific categories and additional information meeting a quantitative threshold.
- This update also requires public companies to disaggregate income taxes paid by federal, state, and foreign taxes.
- The guidance became effective for fiscal years beginning after December 15, 2024, and is applied prospectively.
- The Company has added additional disclosures as required by ASU 2023-09, with no impact to the consolidated financial statements.
- Additional disclosures required by this ASU are detailed in Note 13.
[c. 207; p. 16] Recent accounting standards not yet adopted
- In November 2024, the FASB issued ASU 2024-03, requiring disaggregated disclosure of income statement expenses for public business entities (PBEs).
- ASU 2024-03 does not change the expense captions presented on the face of the income statement but requires disaggregation of certain expense captions into specified categories in footnotes.
- PBEs must provide a tabular footnote disclosure about specific expenses, disaggregating each relevant income statement expense caption that includes any of the following natural expenses: (1) purchases of inventory, (2) employee compensation, (3) depreciation, (4) intangible asset amortization, and (5) depreciation, depletion, and amortization recognized as part of oil- and gas-producing activities or other types of depletion expenses.
- The tabular disclosure will also include certain other expenses, when applicable.
- In January 2025, the FASB issued ASU 2025-01 to clarify the effective date of ASU 2024-03.
- The effective date for ASU 2024-03 is the first annual reporting period beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027.
- The Company is evaluating the effect of these amendments on its consolidated financial statements.
2. Goodwill and Intangible Assets
[c. 208; p. 16] Goodwill and intangible assets overview
- Tables present the carrying amount and changes in goodwill by reporting unit at December 31, 2025 and 2024.
- Tables present the carrying amount and changes in other intangible assets at December 31, 2025 and 2024.
[c. 209; p. 16] Intangible assets useful life and amortization
- Indefinite-lived intangible assets relate to insurance licenses and trademarks.
- Finite-lived intangible assets relate to policy renewals, agency relationships, and non-compete/exclusivity agreements.
- Finite-lived intangible assets had a weighted average useful life of approximately 12 years as of December 31, 2025.
- Amortization expense recognized: USD 1.3m for 2025, USD 1.1m for 2024, and USD 1.5m for 2023.
- A table sets forth the estimated future net amortization expense of intangible assets.
[c. 210; p. 16]
| ($ in thousands) | Accident and Health | Surety | Construction and Energy Solutions | Other | Total |
|---|---|---|---|---|---|
| Goodwill | |||||
| Gross balance at December 31, 2024 | 91,577 | 6,781 | 10,204 | 3,879 | 112,441 |
| Accumulated impairment at December 31, 2024 | ( 44,821 ) | — | — | ( 1,886 ) | ( 46,707 ) |
| Net balance at December 31, 2025 | 46,756 | 6,781 | 10,204 | 1,993 | 65,734 |
| ($ in thousands) | Accident and Health | Surety | Construction and Energy Solutions | Other | Total |
|---|---|---|---|---|---|
| Goodwill | |||||
| Gross balance at December 31, 2023 | 91,577 | 6,781 | 10,204 | 3,879 | 112,441 |
| Accumulated impairment at December 31, 2023 | ( 44,821 ) | — | — | ( 1,886 ) | ( 46,707 ) |
| Net balance at December 31, 2024 | 46,756 | 6,781 | 10,204 | 1,993 | 65,734 |
| ($ in thousands) | Agent Relationships | Non-competes | Trademarks | Licenses | Total |
|---|---|---|---|---|---|
| Other Intangible Assets | |||||
| Gross balance at December 31, 2024 | 24,491 | 1,117 | 999 | 14,019 | 40,626 |
| Accumulated amortization at December 31, 2024 | ( 17,895 ) | ( 1,117 ) | — | — | ( 19,012 ) |
| Additions | 2,000 | — | — | — | 2,000 |
| Amortization | ( 1,308 ) | — | — | — | ( 1,308 ) |
| Net balance at December 31, 2025 | 7,288 | — | 999 | 14,019 | 22,306 |
| ($ in thousands) | Agent Relationships | Non-competes | Trademarks | Licenses | Total |
|---|---|---|---|---|---|
| Other Intangible Assets | |||||
| Gross balance at December 31, 2023 | 24,491 | 1,117 | 999 | 14,019 | 40,626 |
| Accumulated amortization at December 31, 2023 | ( 16,808 ) | ( 1,117 ) | — | — | ( 17,925 ) |
| Amortization | ( 1,087 ) | — | — | — | ( 1,087 ) |
| Net balance at December 31, 2024 | 6,596 | — | 999 | 14,019 | 21,614 |
| ($ in thousands) | |
|---|---|
| Years Ending December 31, | Amount |
| 2026 | 1,053 |
| 2027 | 1,053 |
| 2028 | 1,053 |
| 2029 | 762 |
| 2030 | 553 |
3. Investments
[c. 211; p. 16] Investment portfolio fair value and amortized cost
- Tables present the amortized cost and fair value by investment category at December 31, 2025 and 2024.
- The amortized cost and estimated fair value of fixed maturity securities available for sale at December 31, 2025 are shown by contractual maturity.
- Expected maturities may differ from contractual maturities due to borrower rights to call or prepay obligations, and portfolio sales may occur prior to maturity due to changing interest rates, tax considerations, or other factors.
- The Company's held-to-maturity fixed maturity securities at December 31, 2025 consisted entirely of asset-backed securities not due at a single maturity date.
[c. 212; p. 16] Pledged assets
- At December 31, 2025, the Company had U.S. government agencies mortgage-backed fixed maturity securities with a carrying value of approximately USD 68.5m pledged as collateral for a loan from the Federal Home Loan Bank of Dallas (FHLB).
- The Company retains all rights regarding these pledged securities in accordance with the terms of the FHLB Loan.
- At December 31, 2025, the Company had assets with fair values of approximately USD 69.5m pledged as collateral for performance obligations under reinsurance agreements.
- Pledged assets for reinsurance agreements included USD 57.8m in residential mortgage-backed securities, USD 9.5m in cash and cash equivalents and other assets, and USD 2.2m in short-term investments.
- The Company retains all rights regarding these securities in accordance with the terms of the trust agreements.
[c. 213; p. 16] Unrealized losses and impairment assessment
- Tables set forth gross unrealized losses and corresponding fair values of investments, aggregated by length of time in a continuous unrealized loss position as of December 31, 2025 and 2024.
- The Company monitors available-for-sale fixed maturity securities with fair values less than cost or amortized cost for impairment, which requires significant management judgment.
- Management considers factors such as the financial condition of the issuer, receipt of scheduled principal and interest cash flows, and intent to sell (including likelihood of being required to sell before recovery) for fixed maturity securities.
- As of December 31, 2025, the Company had 450 lots of fixed maturity securities in an unrealized loss position.
- The Company does not intend to sell these securities and is not likely to be required to sell them before maturity or recovery of cost basis.
- At December 31, 2025, the Company determined that credit impairments existed for two available-for-sale securities in the "corporate securities and miscellaneous" category, based on new recovery analysis showing deteriorating conditions.
- For U.S. government and municipal securities, the decline in fair values was due to changes in interest rates, not credit quality.
- The Company does not intend to sell U.S. government and municipal securities and expects recovery, thus not considering them impaired.
- For corporate securities and miscellaneous, the decline in fair values was due to changes in interest rates, not credit quality.
- The Company reviewed issuers of corporate securities for significant adverse changes in financial condition, credit enhancement quality, ratings decreases, negative outlooks, or payment failures, and determined declines were interest rate-driven.
- The Company does not intend to sell corporate securities and expects recovery, thus not considering them impaired.
- For residential mortgage-backed, commercial mortgage-backed, and other asset-backed securities, the decline in fair values was due to changes in interest rates, not credit quality.
- The Company does not intend to sell these mortgage-backed and asset-backed securities and expects recovery, thus not considering them impaired.
[c. 214; p. 16] Allowance for credit losses
- A table sets forth changes in the allowance for credit losses on available-for-sale and held-to-maturity securities for the years ended December 31, 2025 and 2024.
[c. 215; p. 16] Net investment gains
- A table sets forth the components of net investment gains for the years ended December 31, 2025, 2024, and 2023.
[c. 216; p. 16] Proceeds from sales of securities
- A table sets forth the proceeds from sales of available-for-sale fixed maturity securities and equity securities for the years ended December 31, 2025, 2024, and 2023.
[c. 217; p. 16] Net investment income
- A table sets forth the components of net investment income for the years ended December 31, 2025, 2024, and 2023.
[c. 218; p. 16] Net unrealized gains
- A table sets forth the change in net unrealized gains on the Company’s investment portfolio, net of deferred income taxes, included in other comprehensive loss for the years ended December 31, 2025, 2024, and 2023.
[c. 219; p. 16] Regulatory deposits
- Various state regulations require the Company to maintain cash, investment securities, or letters of credit on deposit with the states in a depository account.
- At December 31, 2025, cash and investment securities on deposit had carrying values of approximately USD 70.0m.
- At December 31, 2024, cash and investment securities on deposit had carrying values of approximately USD 66.8m.
[c. 220; p. 16]
| ($ in thousands) | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Allowance for Credit Losses | Fair Value |
|---|---|---|---|---|---|
| December 31, 2025 | |||||
| Fixed maturity securities, available-for-sale: | |||||
| U.S. government securities | 44,190 | 292 | ( 14 ) | — | 44,468 |
| Corporate securities and miscellaneous | 632,244 | 14,223 | ( 3,080 ) | ( 7,000 ) | 636,387 |
| Municipal securities | 102,691 | 1,725 | ( 2,300 ) | — | 102,116 |
| Residential mortgage-backed securities | 487,145 | 8,928 | ( 9,486 ) | — | 486,587 |
| Commercial mortgage-backed securities | 72,631 | 1,016 | ( 597 ) | — | 73,050 |
| Other asset-backed securities | 509,854 | 5,194 | ( 1,353 ) | — | 513,695 |
| Total fixed maturity securities, available-for-sale | 1,848,755 | 31,378 | ( 16,830 ) | ( 7,000 ) | 1,856,303 |
| Fixed maturity securities, held-to-maturity: | — | — | — | — | — |
| Other asset-backed securities | 33,290 | 829 | ( 48 ) | ( 468 ) | 33,603 |
| Total fixed maturity securities, held-to-maturity | 33,290 | 829 | ( 48 ) | ( 468 ) | 33,603 |
| ($ in thousands) | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Loss | Allowance for Credit Losses | Fair Value |
|---|---|---|---|---|---|
| December 31, 2024 | |||||
| Fixed maturity securities, available-for-sale: | |||||
| U.S. government securities | 26,577 | 35 | ( 126 ) | — | 26,486 |
| Corporate securities and miscellaneous | 433,298 | 5,618 | ( 13,288 ) | — | 425,628 |
| Municipal securities | 89,966 | 116 | ( 5,366 ) | — | 84,716 |
| Residential mortgage-backed securities | 408,585 | 1,875 | ( 16,627 ) | — | 393,833 |
| Commercial mortgage-backed securities | 70,262 | 545 | ( 1,443 ) | — | 69,364 |
| Other asset-backed securities | 291,578 | 2,447 | ( 1,834 ) | — | 292,191 |
| Total fixed maturity securities, available-for-sale | 1,320,266 | 10,636 | ( 38,684 ) | — | 1,292,218 |
| Fixed maturity securities, held-to-maturity: | — | — | — | — | — |
| Other asset-backed securities | 39,396 | — | ( 436 ) | ( 243 ) | 38,717 |
| Total fixed maturity securities, held-to-maturity | 39,396 | — | ( 436 ) | ( 243 ) | 38,717 |
| ($ in thousands) | Amortized Cost | Fair Value |
|---|---|---|
| Due in less than one year | 45,682 | 45,478 |
| Due after one year through five years | 449,790 | 449,145 |
| Due after five years through ten years | 219,293 | 224,696 |
| Due after ten years | 64,360 | 63,652 |
| Mortgage-backed securities | 559,776 | 559,637 |
| Other asset-backed securities | 509,854 | 513,695 |
| Total | 1,848,755 | 1,856,303 |
| Less than 12 Months | 12 Months or More | Total | ||||
|---|---|---|---|---|---|---|
| ($ in thousands) | Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses |
| December 31, 2025 | ||||||
| Fixed maturity securities, available-for-sale: | ||||||
| U.S. government securities | 349 | ( 1 ) | 1,565 | ( 13 ) | 1,914 | ( 14 ) |
| Corporate securities and miscellaneous | 67,644 | ( 346 ) | 63,575 | ( 2,734 ) | 131,219 | ( 3,080 ) |
| Municipal securities | 19,157 | ( 400 ) | 22,004 | ( 1,900 ) | 41,161 | ( 2,300 ) |
| Residential mortgage-backed securities | 56,147 | ( 262 ) | 74,075 | ( 9,224 ) | 130,222 | ( 9,486 ) |
| Commercial mortgage-backed securities | 4,646 | ( 3 ) | 8,363 | ( 594 ) | 13,009 | ( 597 ) |
| Other asset-backed securities | 85,098 | ( 424 ) | 16,081 | ( 929 ) | 101,179 | ( 1,353 ) |
| Total fixed maturity securities, available-for-sale | 233,041 | ( 1,436 ) | 185,663 | ( 15,394 ) | 418,704 | ( 16,830 ) |
| Fixed maturity securities, held-to-maturity: | — | — | — | — | — | — |
| Other asset-backed securities | 1,912 | ( 48 ) | — | — | 1,912 | ( 48 ) |
| Total fixed maturity securities, held-to-maturity: | 1,912 | ( 48 ) | — | — | 1,912 | ( 48 ) |
| Total | 234,953 | ( 1,484 ) | 185,663 | ( 15,394 ) | 420,616 | ( 16,878 ) |
| Less than 12 Months | 12 Months or More | Total | ||||
|---|---|---|---|---|---|---|
| ($ in thousands) | Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses |
| December 31, 2024 | ||||||
| Fixed maturity securities, available-for-sale: | ||||||
| U.S. government securities | 15,938 | ( 34 ) | 2,297 | ( 92 ) | 18,235 | ( 126 ) |
| Corporate securities and miscellaneous | 136,888 | ( 2,060 ) | 81,232 | ( 11,228 ) | 218,120 | ( 13,288 ) |
| Municipal securities | 41,930 | ( 1,046 ) | 27,687 | ( 4,320 ) | 69,617 | ( 5,366 ) |
| Residential mortgage-backed securities | 201,407 | ( 3,366 ) | 82,496 | ( 13,261 ) | 283,903 | ( 16,627 ) |
| Commercial mortgage-backed securities | 9,411 | ( 126 ) | 13,178 | ( 1,317 ) | 22,589 | ( 1,443 ) |
| Other asset-backed securities | 75,119 | ( 721 ) | 29,851 | ( 1,113 ) | 104,970 | ( 1,834 ) |
| Total fixed maturity securities, available-for-sale | 480,693 | ( 7,353 ) | 236,741 | ( 31,331 ) | 717,434 | ( 38,684 ) |
| Fixed maturity securities, held-to-maturity: | — | — | — | — | — | — |
| Other asset-backed securities | 2,144 | ( 2 ) | 36,573 | ( 434 ) | 38,717 | ( 436 ) |
| Total fixed maturity securities, held-to-maturity: | 2,144 | ( 2 ) | 36,573 | ( 434 ) | 38,717 | ( 436 ) |
| Total | 482,837 | ( 7,355 ) | 273,314 | ( 31,765 ) | 756,151 | ( 39,120 ) |
| ($ in thousands) | Fixed Maturity Securities, Available-For-Sale | Fixed Maturity Securities, Held-to-Maturity |
|---|---|---|
| Balance at December 31, 2024 | — | 243 |
| Current period provision for credit losses | 7,000 | 257 |
| Recoveries of amounts previously written off | — | ( 32 ) |
| Balance at December 31, 2025 | 7,000 | 468 |
| Fixed Maturity Securities, Held-to-Maturity | |
|---|---|
| Balance at December 31, 2023 | 329 |
| Current period provision for credit losses | 18 |
| Recoveries of amounts previously written off | ( 104 ) |
| Balance at December 31, 2024 | 243 |
| ($ in thousands) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross realized gains | |||
| Fixed maturity securities, available-for-sale | 3,002 | 2,662 | 1,042 |
| Equity securities | 34,262 | 8,062 | 6,035 |
| Other | 685 | 213 | 2 |
| Total | 37,949 | 10,937 | 7,079 |
| Gross realized losses | — | — | — |
| Fixed maturity securities, available-for-sale | ( 10,832 ) | ( 8,161 ) | ( 1,879 ) |
| Equity securities | ( 3,000 ) | ( 4,132 ) | ( 5,256 ) |
| Other | ( 413 ) | ( 223 ) | ( 20 ) |
| Total | ( 14,245 ) | ( 12,516 ) | ( 7,155 ) |
| Net unrealized gains (losses) on investments | — | — | — |
| Equity securities | ( 22,908 ) | 7,500 | 11,516 |
| Mortgage loans | ( 7 ) | 421 | ( 386 ) |
| Other | 21,360 | — | — |
| Net investment gains | 22,149 | 6,342 | 11,054 |
| ($ in thousands) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Fixed maturity securities, available-for-sale | 198,195 | 217,468 | 26,626 |
| Equity securities | 126,738 | 37,534 | 40,201 |
| ($ in thousands) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Income (loss): | |||
| Fixed maturity securities, available-for-sale | 80,302 | 57,574 | 34,703 |
| Fixed maturity securities, held-to-maturity | ( 804 ) | 4,091 | 4,181 |
| Equity securities | 1,223 | 2,720 | 3,418 |
| Equity method investments | ( 2,683 ) | 2,524 | ( 9,434 ) |
| Mortgage loans | 1,622 | 5,153 | 5,474 |
| Indirect loans | ( 8,129 ) | ( 2,400 ) | ( 4,155 ) |
| Short-term investments and cash | 12,828 | 14,851 | 11,392 |
| Other | 3,307 | 3,000 | 318 |
| Total investment income | 87,666 | 87,513 | 45,897 |
| Investment expenses | ( 4,047 ) | ( 6,913 ) | ( 5,557 ) |
| Net investment income | 83,619 | 80,600 | 40,340 |
| ($ in thousands) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Fixed maturity securities | 42,594 | 1,046 | 25,952 |
| Deferred income taxes | ( 9,017 ) | ( 213 ) | ( 5,420 ) |
| Total | 33,577 | 833 | 20,532 |
4. Fair Value Measurements
[c. 221; p. 16] 4. Fair Value Measurements
- The Company's financial instruments include assets and liabilities carried at fair value, and assets and liabilities carried at cost or amortized cost but disclosed at fair value.
- The market approach is generally applied to determine fair value, using prices and data from market transactions involving identical or comparable assets and liabilities.
- Fair value of investments is determined using data primarily from third-party investment managers or pricing vendors.
- Periodic analyses are performed on third-party prices to ensure they are reasonable estimates of fair value, including reviewing month-to-month fluctuations and comparing valuations from different pricing services for identical securities.
- Financial instruments are classified into a three-level hierarchy.
- Level 1 inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date.
- Level 2 inputs are observable for the asset or liability through corroboration with market data at the measurement date, other than Level 1 quoted prices.
- Level 3 inputs are unobservable inputs reflecting management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date.
- Methods and assumptions used for fair value disclosures are detailed in the consolidated financial statements and notes.
- U.S. government securities, mutual funds, and common stock: fair value is measured using unadjusted quoted prices for identical instruments in an active exchange, representing Level 1 inputs.
- Preferred stocks, municipal securities, corporate securities, and miscellaneous: fair value is measured using a pricing model with market-based inputs such as trades in illiquid markets for specific securities or active markets for similar securities.
- The pricing model for preferred, municipal, corporate, and miscellaneous securities considers benchmark yields, issuer spreads, security terms and conditions, and other market data, representing Level 2 fair value inputs.
- Commercial mortgage-backed securities, residential mortgage-backed securities, and other asset-backed securities: fair value is measured using a pricing model with market-based inputs including dealer quotes, market spreads, and yield curves.
- The model for mortgage-backed and other asset-backed securities may evaluate individual tranches by determining cash flows using security terms, collateral performance, credit information, benchmark yields, and estimated prepayments, representing Level 2 fair value inputs.
- Fixed maturity securities, available for sale classified as Level 3: includes corporate securities and other asset-backed securities managed by an independent asset manager and priced by an independent provider.
- The provider estimates the value of these securities using the discount net present value of cash flows method with an unobservable discount rate.
- The discount rate spread represents the risk associated with future cash flows, including inflation, opportunity cost, and the time value of money, representing Level 3 fair value inputs.
- Mortgage loans have variable interest rates and are collateralized by real property.
- Fair value of mortgage loans is determined using the income approach with observable and unobservable (Level 3) inputs.
- The unobservable input is the spread applied to a prime rate used to discount cash flows.
- This spread represents the incremental cost of capital based on the borrower’s ability to make future payments and the value of collateral relative to the loan balance, and is subject to judgment and uncertainty.
- Derivatives, included in other assets, consist of certain exchange-traded options contracts.
- Fair values of these options are measured using quoted prices in active markets on the relevant exchange.
- The measurement specifically utilizes either the volume-weighted average price of trades in similar contracts during a specified time window or the last trade settlement price when no trades occur, representing Level 1 inputs.
- Tables set forth the Company’s investments and derivatives within the fair value hierarchy as of December 31, 2025 and 2024.
- Tables also set forth changes in the fair value of instruments carried at fair value with a Level 3 measurement for the years ended December 31, 2025 and 2024.
- The Company measures certain assets, including investments in indirect loans and loan collateral, equity method investments, and other invested assets, at fair value on a nonrecurring basis only when deemed impaired.
- The Company is required to disclose fair values of other financial instruments where practicable to estimate fair value, in addition to those recorded at fair value in the Consolidated Balance Sheets.
- Estimated fair value amounts, defined as the quoted market price, are determined using available market information and appropriate valuation methodologies.
- Considerable judgment is required for fair value estimates when quoted market prices are unavailable, meaning estimates may not indicate amounts realizable in a current market exchange.
- Different market assumptions or estimation methodologies can affect estimated fair value amounts.
- Methods and assumptions used for estimating fair value disclosures of other financial instruments are provided.
- Fixed maturity securities, held-to-maturity: consists of senior and junior notes with target rates of return.
- As of December 31, 2025, fair value for these instruments was determined using the income approach with unobservable (Level 3) inputs.
- Investment in RedBird Capital Partners: included in other long-term investments, this is a limited partnership investment in Bishop Street Underwriters, LLC (MGA).
- The investment had a fair value of USD 55.6m at December 31, 2025, and USD 28.2m at December 31, 2024, determined using net asset value.
- Procedures to assess reasonableness of fair value include obtaining and reviewing audited financial statements.
- The unfunded commitment related to the investment was USD 18.3m at December 31, 2025, and USD 24.4m at December 31, 2024.
- The Company may sell its interest with appropriate prior written notice and general partner approval.
- This investment is measured at fair value using the net asset value per share practical expedient per Accounting Standard Codification 820-10 and is not classified in the fair value hierarchy.
- Net earned premiums related to this agreement were USD 41.5m for the year ended December 31, 2025, and USD 2.5m for the year ended December 31, 2024.
- Notes payable: carrying value approximates estimated fair value because notes accrue interest at current market rates plus a spread.
- Fair value is determined using the income approach with observable (Level 2) inputs.
- Subordinated debt: consists of Unsecured Subordinated Notes, due May 24, 2039, with a fixed interest rate.
- Fair value is determined using the income approach with observable (Level 2) inputs.
- A table sets forth the Company’s carrying and fair values of notes payable and subordinated debt as of December 31, 2025 and 2024.
- Other financial instruments qualify as insurance-related products and are specifically exempted from fair value disclosure requirements.
[c. 222; p. 16]
| 2025 | 2024 | |
|---|---|---|
| High | 11.10% | 8.00% |
| Low | 4.25% | 5.70% |
| Weighted average | 6.40% | 6.60% |
| 2025 | 2024 | |
|---|---|---|
| High | 8.34% | 10.00% |
| Low | 6.55% | 7.00% |
| Weighted average | 7.74% | 7.93% |
| December 31, 2025 | ||||
|---|---|---|---|---|
| ($ in thousands) | Level 1 | Level 2 | Level 3 | Total |
| Fixed maturity securities, available-for-sale: | ||||
| U.S. government securities | 44,468 | — | — | 44,468 |
| Corporate securities and miscellaneous | — | 503,274 | 133,113 | 636,387 |
| Municipal securities | — | 102,116 | — | 102,116 |
| Residential mortgage-backed securities | — | 486,587 | — | 486,587 |
| Commercial mortgage-backed securities | — | 73,050 | — | 73,050 |
| Other asset-backed securities | — | 495,891 | 17,804 | 513,695 |
| Total fixed maturity securities, available-for-sale | 44,468 | 1,660,918 | 150,917 | 1,856,303 |
| Fixed maturity securities, held-to-maturity: | — | — | — | — |
| Other asset-backed securities | — | — | 33,603 | 33,603 |
| Total fixed maturity securities, held-to-maturity | — | — | 33,603 | 33,603 |
| Equity securities: | — | — | — | — |
| Preferred stocks | — | 1,174 | — | 1,174 |
| Total equity securities | — | 1,174 | — | 1,174 |
| Mortgage loans | — | — | 9,902 | 9,902 |
| Short-term investments | 264,299 | — | — | 264,299 |
| Derivatives | 34,857 | — | — | 34,857 |
| Total | 343,624 | 1,662,092 | 194,422 | 2,200,138 |
| December 31, 2024 | ||||
|---|---|---|---|---|
| ($ in thousands) | Level 1 | Level 2 | Level 3 | Total |
| Fixed maturity securities, available-for-sale: | ||||
| U.S. government securities | 26,486 | — | — | 26,486 |
| Corporate securities and miscellaneous | — | 354,815 | 70,813 | 425,628 |
| Municipal securities | — | 84,716 | — | 84,716 |
| Residential mortgage-backed securities | — | 393,833 | — | 393,833 |
| Commercial mortgage-backed securities | — | 69,364 | — | 69,364 |
| Other asset-backed securities | — | 285,084 | 7,107 | 292,191 |
| Total fixed maturity securities, available-for-sale | 26,486 | 1,187,812 | 77,920 | 1,292,218 |
| Fixed maturity securities, held-to-maturity: | — | — | — | — |
| Other asset-backed securities | — | — | 38,717 | 38,717 |
| Total fixed maturity securities, held-to-maturity: | — | — | 38,717 | 38,717 |
| Equity securities: | — | — | — | — |
| Common stocks | 64,251 | — | — | 64,251 |
| Preferred stocks | — | 1,164 | — | 1,164 |
| Mutual funds | 40,839 | — | — | 40,839 |
| Total equity securities | 105,090 | 1,164 | — | 106,254 |
| Mortgage loans | — | — | 26,490 | 26,490 |
| Short-term investments | 274,929 | — | — | 274,929 |
| Total | 406,505 | 1,188,976 | 143,127 | 1,738,608 |
| ($ in thousands) | Fixed Maturity Securities, Available-For-Sale | Mortgage Loans |
|---|---|---|
| Balance at December 31, 2024 | 77,920 | 26,490 |
| Total gains (losses) for the period recognized in net investment gains (losses) | ( 5,180 ) | ( 7 ) |
| Issuances | — | 151 |
| Settlements | — | ( 16,732 ) |
| Transfers into Level 3 | 6,143 | — |
| Purchases | 70,730 | — |
| Sales/Disposals | ( 1,493 ) | — |
| Total unrealized gains for the period recognized in accumulated comprehensive income (loss) | 2,797 | — |
| Balance at December 31, 2025 | 150,917 | 9,902 |
| Total losses for the period recognized in net investment gains attributable to the change in unrealized gains or losses relating to assets held as of period end | — | ( 201 ) |
| ($ in thousands) | Fixed Maturity Securities, Available-For-Sale | Mortgage Loans |
|---|---|---|
| Balance at December 31, 2023 | — | 50,070 |
| Total gains (losses) for the period recognized in net investment gains (losses) | ( 195 ) | 420 |
| Issuances | — | 649 |
| Settlements | — | ( 24,649 ) |
| Purchases | 77,979 | — |
| Sales/Disposals | ( 374 ) | — |
| Total unrealized gains for the period recognized in accumulated comprehensive income (loss) | 510 | — |
| Balance at December 31, 2024 | 77,920 | 26,490 |
| Total gains for the period recognized in net investment gains (losses) attributable to the change in unrealized gains or losses relating to assets held as of period end | — | 411 |
| 2025 | 2024 | |||
|---|---|---|---|---|
| ($ in thousands) | Carrying Value | Fair Value | Carrying Value | Fair Value |
| Notes payable | ||||
| FHLB Loan | 57,000 | 57,458 | 57,000 | 56,200 |
| Revolving Credit Facility | 114,500 | 114,500 | 43,000 | 43,000 |
| Term Loan Facility | 300,000 | 300,000 | — | — |
| Notes payable | 471,500 | 471,958 | 100,000 | 99,200 |
| Subordinated debt | — | — | — | — |
| Unsecured subordinated notes | 19,569 | 21,020 | 19,536 | 20,541 |
| Subordinated debt, net of debt issuance costs | 19,569 | 21,020 | 19,536 | 20,541 |
5. Mortgage Loans
[c. 223; p. 16] Mortgage loan portfolio overview
- The Company has invested in Separately Managed Accounts ("SMA1" and "SMA2").
- As of December 31, 2025 and 2024, the Company held direct investments in mortgage loans from various creditors through SMA1 and SMA2.
- The Company's mortgage loan portfolios are primarily senior loans on real estate across the U.S..
- Loans earn interest at a fixed spread above a prime rate.
- Loans mature in approximately 2 to 4 years from loan origination.
- Principal amounts of the loans are approximately 64% of the property's appraised value at the time the loans were made.
[c. 224; p. 16] Mortgage loan carrying value and income
- The carrying value of the Company's mortgage loans as of December 31, 2025 and 2024 is presented in a table.
- The Company's gross investment income for mortgage loans for the years ended December 31, 2025, 2024, and 2023 is presented in a table.
[c. 225; p. 16] Mortgage loan collectibility and foreclosure status
- Uncollectible amounts on loans are determined on an individual loan basis through consultations with the Company's specialized investment manager and consideration of adverse situations, estimated collateral value, and other relevant factors.
- The Company writes off uncollectible amounts in the period they are determined to be uncollectible.
- There was no write-off for uncollectible amounts during the years ended December 31, 2025 and 2024.
- As of December 31, 2025 and 2024, no mortgage loans were in the process of foreclosure.
- As of December 31, 2025 and 2024, there were no mortgage loans that were not producing income for the previous 12 months.
[c. 226; p. 16]
| ($ in thousands) | 2025 | 2024 |
|---|---|---|
| Commercial | 3,334 | 8,474 |
| Retail | — | 10,032 |
| Hospitality | 6,568 | 7,984 |
| — | 9,902 | 26,490 |
| ($ in thousands) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Commercial | 432 | 2,025 | 2,340 |
| Retail | 304 | 1,853 | 1,853 |
| Hospitality | 886 | 1,277 | 1,034 |
| Office | — | — | 203 |
| Multi-family | — | — | 44 |
| — | 1,622 | 5,155 | 5,474 |
6. Equity Method Investments and Other
[c. 227; p. 16] Equity method investments overview
- The table presents the carrying value and ownership percentage of the Company’s equity method investments as of December 31, 2025 and 2024.
- The table details the components of net investment income (loss) from equity method investments for the years ended December 31, 2025, 2024, and 2023.
- The table outlines the unfunded commitment of equity method investments as of December 31, 2025 and 2024.
[c. 228; p. 16] Equity method investment accounting
- The difference between an investment's cost and its proportionate share of underlying equity in net assets is allocated to the equity method investment's various assets and liabilities.
- The Company amortizes the difference in net assets over the useful life of a similar asset as the underlying equity method investment.
- For the investment in RISCOM, a similar asset is agent relationships, and the Company amortizes this difference over a 15-year useful life.
- The table compares the Company’s recorded investment in RISCOM to its share of underlying equity as of December 31, 2025 and 2024.
- The table compares the Company’s recorded investment in JVM Funds LLC to its share of underlying equity as of December 31, 2025 and 2024.
[c. 229; p. 16] Indirect loans and loan collateral
- As of December 31, 2025 and 2024, the Company held indirect investments in collateralized loans and loan collateral through SMA1 and SMA2.
- The carrying value of SMA1 and SMA2 as of December 31, 2025 and 2024 is presented in a table.
[c. 230; p. 16]
| ($ in thousands) | 2025 | 2024 | ||
|---|---|---|---|---|
| Carrying Value | Ownership % | Carrying Value | Ownership % | |
| Arena Special Opportunities Fund, LP units | 26,936 | 14.0% | 34,936 | 15.3% |
| Arena SOP LP units | — | 11.2% | 1,474 | 10.9% |
| Brewer Lane Ventures Fund II LP units | 2,251 | 2.4% | 1,040 | 2.4% |
| Dowling Capital Partners LP units | 590 | 5.0% | 666 | 5.0% |
| Hudson Ventures Fund 2 LP units | 5,503 | 2.5% | 4,967 | 2.5% |
| JVM Funds LLC units | 14,911 | 10.1% | 17,229 | 10.1% |
| RISCOM | 3,307 | 20.0% | 5,013 | 20.0% |
| — | 53,498 | — | 65,325 | — |
| ($ in thousands) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Arena SOP LP units | ( 1,474 ) | ( 989 ) | ( 6,271 ) |
| Arena Special Opportunities Fund, LP units | ( 3,163 ) | 2,375 | ( 2,880 ) |
| Brewer Lane Ventures Fund II LP | 91 | ( 110 ) | ( 78 ) |
| Dowling Capital Partners LP units | 431 | 1,463 | 927 |
| Hudson Ventures Fund II LP units | 480 | ( 153 ) | 170 |
| JVM Funds LLC | ( 541 ) | ( 1,554 ) | ( 1,198 ) |
| RISCOM | 1,493 | 1,492 | 884 |
| Universa Black Swan LP units | — | — | ( 988 ) |
| — | ( 2,683 ) | 2,524 | ( 9,434 ) |
| ($ in thousands) | 2025 | 2024 |
|---|---|---|
| Brewer Lane Ventures Fund II LP units | 3,237 | 4,077 |
| Dowling Capital Partners LP units | 386 | 386 |
| Hudson Ventures Fund 2 LP units | 166 | 397 |
| Red Bird Capital Partners LP units | 18,305 | 24,400 |
| — | 22,094 | 29,260 |
| ($ in thousands) | 2025 | 2024 |
|---|---|---|
| Investment in RISCOM: | ||
| Underlying equity | 2,292 | 3,756 |
| Difference | 1,015 | 1,258 |
| Recorded investment balance | 3,307 | 5,013 |
| ($ in thousands) | 2025 | 2024 |
|---|---|---|
| Investment in JVM Funds LLC: | ||
| Underlying equity | 14,457 | 16,624 |
| Difference | 454 | 605 |
| Recorded investment balance | 14,911 | 17,229 |
| ($ in thousands) | 2025 | 2024 |
|---|---|---|
| SMA1 | 15,418 | 20,296 |
| SMA2 | 8,449 | 12,973 |
| Investment in indirect loans and loan collateral | 23,867 | 33,269 |
7. Variable Interest Entity
[c. 231; p. 16] HSIC-01 Variable Interest Entity
- Skyward consolidates Separate Account HSIC-01 ("HSIC-01"), established by Mangrove Risk Solutions Bermuda Ltd. ("Mangrove"), pursuant to GAAP consolidation guidance.
- HSIC-01 is a Variable Interest Entity (VIE) for which Skyward is the primary beneficiary.
- The VIE's purpose is to hedge price volatility risks of certain insurance products by investing in dairy and livestock commodities.
- Skyward directly manages the business, leading it to consider itself the primary beneficiary.
- Skyward does not provide performance guarantees and has no other financial obligation to provide funding to HSIC-01, beyond its own capital commitments.
- Assets of consolidated variable interest entities, such as HSIC-01, may only be used to settle obligations of those entities.
- There is no recourse to the assets of HSIC-01 other than to satisfy associated liabilities.
- The table presents the assets of HSIC-01 included in the Consolidated Balance Sheets as of December 31, 2025.
- The presented assets only include third-party net assets and exclude intercompany balances, which were eliminated upon consolidation.
[c. 232; p. 16]
| ($ in thousands) | 2025 |
|---|---|
| Assets | |
| Cash and cash equivalents | 15,816 |
| Other assets | 34,856 |
| Total assets | 50,672 |
8 . Derivatives
[c. 233; p. 16] Derivative use and accounting
- The Company uses derivatives in its financial risk management programs to mitigate price risk in certain insurance contracts exposed to commodity price fluctuations (cattle, milk).
- A hedging strategy using derivatives (put options, futures) is employed to mitigate revenue volatility and support financial stability.
- The primary objective of derivative instruments is to manage exposure to adverse price movements.
- Activity in these instruments reflects current market conditions and shifts in risk exposures throughout the year.
- The notional value of derivative contracts and the degree of hedged exposure are actively managed and vary based on prevailing pricing in cattle, hogs, and milk markets.
- Derivatives are not used for speculative or trading purposes.
- All derivative positions support the overall risk transfer objectives of the business.
- The Company has not elected hedge accounting for these derivatives.
- The net gain (loss) recognized on derivative instruments in economic hedging relationships is presented in "losses and loss adjustment expenses" on the Consolidated Statements of Operations.
- For the year ended December 31, 2025, the Company recognized USD 7.9m of pre-tax net gains in losses and loss adjustment expenses.
[c. 234; p. 16]
| ($ in thousands) | Derivative Assets | |
|---|---|---|
| Notional Amount | Fair Value | |
| Economic hedges | 136,800 | 34,857 |
9. Allowance for Credit Losses
[c. 235; p. 16] Premiums receivable allowance for credit losses
- Tables detailing changes in the allowance for expected credit losses on premiums receivable are provided for the years ended December 31, 2025 and 2024.
[c. 236; p. 16] Reinsurance recoverables credit risk analysis
- The Company analyzes credit risk for reinsurance recoverables by monitoring the financial strength rating of its reinsurers from A.M. Best.
- The financial strength rating is assessed annually and throughout the year as A.M. Best provides updates.
- The Company assesses the adequacy of credit enhancements such as reinsurance payables, letters of credit, and funds held.
- A table sets forth the Company’s reinsurance recoverables net of credit enhancements by A.M. Best as of December 31, 2025.
[c. 237; p. 16] Reinsurance recoverables past due and uncollectible allowance
- Reinsurance balances are considered past due when they are 90 days past due.
- Tables detailing changes in the allowance for estimated uncollectible reinsurance are provided for the years ended December 31, 2025 and 2024.
- On January 31, 2025, the Company commuted the LPT with R&Q Re (Bermuda) Ltd. ("R&Q") related to accident years 2018 and prior.
- During the year ended December 31, 2024, the Company recognized an uncollectible reinsurance recoverable balance related to the LPT as a net increase of USD 13.6m to the allowance for estimated uncollectible reinsurance, which was subsequently written-off.
[c. 238; p. 16]
| ($ in thousands) | Premiums Receivable, Net | Allowance for Estimated Uncollectible Premiums |
|---|---|---|
| Balance at December 31, 2024 | 321,641 | 2,432 |
| Current period change for estimated uncollectible premiums | — | 2,351 |
| Write-offs of uncollectible premiums receivable | — | ( 2,141 ) |
| Recoveries of amounts previously written off | — | 498 |
| Balance at December 31, 2025 | 544,217 | 3,140 |
| ($ in thousands) | Premiums Receivable, Net | Allowance for Estimated Uncollectible Premiums |
|---|---|---|
| Balance at December 31, 2023 | 179,235 | 964 |
| Current period change for estimated uncollectible premiums | — | 3,235 |
| Write-offs of uncollectible premiums receivable | — | ( 1,895 ) |
| Recoveries of amounts previously written off | — | 128 |
| Balance at December 31, 2024 | 321,641 | 2,432 |
| 2025 | ||
|---|---|---|
| A.M. Best Rating | Reinsurance Recoverables, Gross, Amortized Cost | Percent of Total |
| A- and above | 652,178 | 98.2% |
| B++ to B+ | 5,077 | 0.8 |
| B to B - | 28 | — |
| Not rated | 6,919 | 1.0 |
| ($ in thousands) | Reinsurance Recoverables, Net | Allowance for Estimated Uncollectible Reinsurance |
|---|---|---|
| Balance at December 31, 2024 | 857,876 | 2,295 |
| Balance at December 31, 2025 | 1,119,880 | 2,295 |
| ($ in thousands) | Reinsurance Recoverables, Net | Allowance for Estimated Uncollectible Reinsurance |
|---|---|---|
| Balance at December 31, 2023 | 596,334 | 2,295 |
| Current period change for estimated uncollectible reinsurance | — | 13,585 |
| Write-offs of uncollectible reinsurance recoverables | — | ( 13,585 ) |
| Balance at December 31, 2024 | 857,876 | 2,295 |
10. Property and Equipment
[c. 239; p. 16] Property and Equipment Depreciation
- Property and equipment components are included within other assets on the Consolidated Balance Sheets.
- Depreciation expense related to property and equipment was USD 3.3m for the year ended December 31, 2025.
- Depreciation expense related to property and equipment was USD 2.9m for the year ended December 31, 2024.
- Depreciation expense related to property and equipment was USD 3.2m for the year ended December 31, 2023.
- Depreciation expense is presented in underwriting, acquisition, and insurance expenses on the Consolidated Statements of Operations.
[c. 240; p. 16]
| (in thousands) | 2025 | 2024 |
|---|---|---|
| Leasehold improvements | 3,434 | 3,056 |
| Equipment | 4,750 | 4,506 |
| Software | 39,263 | 33,972 |
| — | 47,447 | 41,534 |
| Accumulated depreciation | ( 32,307 ) | ( 29,355 ) |
| Total | 15,140 | 12,179 |
11. Notes Payable & Subordinated Debt
[c. 241; p. 16] FHLB Loan
- On August 30, 2024, the Company entered into the FHLB Loan, a 4.5-year term loan with a principal amount of USD 57.0m.
- The FHLB Loan requires interest-only payments during its term, with principal due in full at maturity.
- The interest rate for the FHLB Loan is fixed at 4.00% over the term.
- The FHLB Loan is fully secured by a pledge of specific investment securities of HSIC.
- Proceeds from the FHLB Loan were used to fund redemptions of draws on the 2023 Revolving Credit Facility.
[c. 242; p. 16] Term Loan Facility
- During Q4 2025, the Company entered into a Term Loan Credit Agreement (the "Term Loan Facility") with a syndicate of banks.
- The Term Loan Facility includes a Tranche A DDTL of USD 150.0m and a Tranche B DDTL of USD 150.0m.
- The Term Loan Facility was used to fund a portion of the consideration for the acquisition of Apollo Group Holdings Limited ("Apollo") and related transaction fees and expenses.
- Amounts drawn bear interest at either term SOFR plus a margin (150 bps to 190 bps) or the base rate plus a margin (50 bps to 90 bps), depending on the Company's debt to capitalization ratio.
- SOFR is calculated with a floor of 0.00% and a credit spread adjustment of 0.10%.
- The base rate is the highest of (i) the Agent’s prime lending rate, (ii) the Federal Funds Rate plus 0.50%, (iii) SOFR plus 1.00%, and (iv) 0%.
- The Company pays a fee ranging from 0.20% to 0.35% on average daily undrawn amounts, depending on the debt to capitalization ratio.
- The Tranche A DDTL matures on January 1, 2028, and the Tranche B DDTL matures on July 2, 2029.
- On December 30, 2025, the Company drew USD 150.0m from Tranche A DDTL and USD 150.0m from Tranche B DDTL for the Apollo acquisition on January 1, 2026.
- The Term Loan Facility includes customary covenants, such as limitations on additional indebtedness exceeding USD 10.0m and on distributions to stockholders, stock redemptions, repurchases, or retirements upon certain events.
- Financial covenants include minimum consolidated net worth, maximum total debt to capitalization, minimum A.M. Best rating, and minimum liquidity.
- As of December 31, 2025, the Company was in compliance with all covenants.
- The Term Loan Facility is unsecured.
- The Company's obligations under the Term Loan Facility are guaranteed by the Company and its existing wholly-owned subsidiaries, and subsequently acquired or organized subsidiaries (excluding insurance company subsidiaries and subject to certain exceptions).
[c. 243; p. 16] Revolving Credit Facilities
- During Q4 2025, the Company entered into a Credit Agreement (the "Revolving Credit Facility") with a syndicate of banks.
- The Revolving Credit Facility is unsecured and initially provided a maximum principal amount of USD 150.0m, which increased to USD 250.0m on the closing date of the Apollo acquisition.
- The Company initially drew USD 43.0m to redeem its prior revolving credit facility.
- On December 30, 2025, an additional USD 71.5m was drawn for the consideration paid for the Apollo acquisition.
- Proceeds from the Term Loan Facility and the Revolving Credit Facility draws are presented net with liabilities on the Consolidated Balance Sheets for the year ended December 31, 2025.
- Interest on the Revolving Credit Facility is payable quarterly.
- Amounts drawn bear interest at either term SOFR plus a margin (150 bps to 190 bps) or the base rate plus a margin (50 bps to 90 bps), depending on the Company’s debt to capitalization ratio.
- SOFR is calculated with a floor of 0.00% and a credit spread adjustment of 0.10%.
- The base rate is the highest of (i) the Agent’s prime lending rate, (ii) the Federal Funds Rate plus 0.50%, (iii) SOFR plus 1.00%, and (iv) 0%.
- The Company pays a fee ranging from 0.20% to 0.35% on average daily undrawn amounts, depending on the debt to capitalization ratio.
- The availability period under the Facility terminates on November 12, 2030.
- The Company is subject to covenants on the Revolving Credit Facility based on minimum net worth, maximum debt to capital ratio, minimum A.M. Best Rating, and minimum liquidity.
- As of December 31, 2025, the Company was in compliance with all covenants.
- In Q1 2023, the Company entered into an agreement for an unsecured revolving credit facility (the "2023 Revolving Credit Facility") of up to USD 150.0m and a letter of credit sub-facility of up to USD 30.0m.
- On November 13, 2025, the Company redeemed the 2023 Revolving Credit Facility, paid USD 0.3m of accrued interest, and recognized USD 0.6m of expense for remaining unamortized deferred financing costs.
[c. 244; p. 16] Debentures
- In May 2019, the Company issued unsecured subordinated notes (the "Notes") with an aggregate principal amount of USD 20.0m.
- Interest on the Notes is fixed at 7.25% for the first 8 years and 8.25% thereafter.
- Early retirement of the debt before the 8-year commitment requires all interest payments to be paid in full, plus the return of outstanding principal.
- Principal is due at maturity on May 24, 2039, and interest is payable quarterly.
- The Notes have junior priority to all previously issued debt.
- Debt related to the Notes is reported on the Consolidated Balance Sheets for December 31, 2025, and 2024, net of debt issuance costs of approximately USD 0.4m and USD 0.5m, respectively.
- These deferred financing costs are presented as a direct deduction from the carrying amount of the subordinated debt.
12. Segment
[c. 245; p. 16] Reportable segment overview and CODM
- The Company has one reportable segment offering commercial property and casualty products and solutions on a non-admitted (E&S) and admitted basis, predominantly in the United States.
- The segment consists of nine distinct underwriting divisions, referred to as "continuing business," with dedicated underwriting leadership and technical staff.
- The segment definition is based on how internally reported financial information is reviewed by the Chief Operating Decision Maker (CODM) to analyze performance, make decisions, and allocate resources.
- The Company's CODM is the chief executive officer.
- The accounting policies of the segment align with those described in Note 1 "Summary of Significant Accounting Policies" of Form 10-K.
- The CODM assesses segment performance and allocates resources based on gross written premiums by net underwriting division, underwriting income, and income before income taxes (reported on Consolidated Statements of Operations).
- Segment assets are reported on the Consolidated Balance Sheets as total consolidated assets.
- Gross written premiums by underwriting division, net underwriting income, and consolidated net income are used to monitor budget versus actual results.
- The CODM uses net underwriting income, annualized return on equity, and growth in book value per share for competitive analysis by benchmarking against competitors.
- Competitive analysis and monitoring of budgeted versus actual results are used to assess segment performance and establish management's compensation.
[c. 246; p. 16] Segment financial data tables
- A table presents gross written premiums by underwriting division for the years ended December 31, 2025, 2024, and 2023.
- A table presents reported segment net underwriting income, significant segment expenses, and a reconciliation of net underwriting income to net income for the years ended December 31, 2025, 2024, and 2023.
- A table presents return on equity and book value per share for the years ended December 31, 2025, 2024, and 2023.
[c. 247; p. 16]
| ($ in thousands) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Accident & Health | 254,102 | 173,073 | 151,701 |
| Agriculture and Credit (Re)insurance | 346,212 | 118,070 | 30,598 |
| Captives | 275,694 | 241,902 | 167,624 |
| Construction & Energy Solutions | 274,318 | 296,582 | 299,748 |
| Global Property | 178,128 | 201,796 | 242,593 |
| Professional Lines | 149,231 | 159,785 | 154,565 |
| Specialty Programs | 322,705 | 218,407 | 178,726 |
| Surety | 168,148 | 143,965 | 106,056 |
| Transactional E&S | 197,779 | 189,669 | 128,236 |
| Total continuing business | 2,166,317 | 1,743,249 | 1,459,847 |
| Exited business | ( 81 ) | ( 17 ) | ( 18 ) |
| Total gross written premiums | 2,166,236 | 1,743,232 | 1,459,829 |
| ($ in thousands) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Underwriting income | |||
| Revenues: | |||
| Net earned premiums | 1,304,505 | 1,056,722 | 829,143 |
| Commission and fee income | 6,855 | 6,703 | 6,064 |
| Total underwriting revenues | 1,311,360 | 1,063,425 | 835,207 |
| Expenses: | — | — | — |
| Losses and LAE | 795,022 | 669,809 | 515,237 |
| Amortization of policy acquisition costs | 195,422 | 149,975 | 108,514 |
| Other operating and general expenses | 181,937 | 161,782 | 134,930 |
| Total underwriting expenses | 1,172,381 | 981,566 | 758,681 |
| Net underwriting income | 138,979 | 81,859 | 76,526 |
| Reconciliation of net underwriting income to net income: | — | — | — |
| Net underwriting income | 138,979 | 81,859 | 76,526 |
| Add: | — | — | — |
| Net investment income | 83,619 | 80,600 | 40,340 |
| Net investment gains | 22,149 | 6,342 | 11,054 |
| Other loss | ( 587 ) | ( 167 ) | ( 632 ) |
| Less: | — | — | — |
| Transaction costs | 14,019 | — | — |
| Interest expense | 7,919 | 9,496 | 10,024 |
| Amortization expense | 1,636 | 2,007 | 1,798 |
| Other expenses | 4,162 | 4,392 | 5,364 |
| Income before income taxes | 216,424 | 152,739 | 110,102 |
| Income tax expense | 46,396 | 33,911 | 24,118 |
| Net income | 170,028 | 118,828 | 85,984 |
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Return on equity | 18.9% | 16.3% | 15.9% |
| Book value per share | 24.92 | 19.79 | 16.72 |
13. Income Taxes
[c. 248; p. 16] Income tax expense components
- Table sets forth components of the Company’s income tax expense for the year ended December 31, 2025 after adoption of ASU 2023-09.
- Table sets forth components of the Company's income tax expense for the years ended December 31, 2024 and 2023 prior to adoption of ASU 2023-09.
[c. 249; p. 16] Effective tax rate reconciliation
- Table reconciles the Company's annual effective tax rate to the U.S. Federal statutory tax rate for the year ended December 31, 2025 after adoption of ASU 2023-09.
- Table presents required disclosures prior to adoption of ASU 2023-09 and reconciles the statutory U.S. federal income tax rate to the Company’s effective tax rate for continuing operations for the years ended December 31, 2024 and 2023.
[c. 250; p. 16] Income taxes paid
- Table presents income taxes paid (net of refunds received) for the year ended December 31, 2025.
- The Company paid USD 37.0m and USD 15.8m in federal income taxes during the years ended December 31, 2024 and 2023, respectively.
[c. 251; p. 16] Deferred tax assets and liabilities
- Table sets forth the tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities at December 31, 2025 and 2024.
[c. 252; p. 16] Net operating loss carryforwards and limitations
- The Company has federal net operating loss carryforwards of approximately USD 40.3m.
- These net operating losses are set to expire beginning in 2032.
- The Company is limited on the utilization of USD 40.3m of net operating losses under Internal Revenue Code Section 382 due to an ownership change in 2014.
- The 382 limitation is expected to result in an expiration of USD 2.8m (USD 0.6m tax effected) of net operating losses.
- In 2025, a valuation allowance was established against the balance expected to expire without utilization.
- Out of the total USD 40.3m federal NOL, USD 0.3m (USD 0.1m tax effected) is related to dual consolidated loss that Skyward is not expected to be able to utilize.
- The Company also has net operating losses in various state and local jurisdictions of USD 0.9m, which are set to expire between 5 and 20 years or carryforward indefinitely, depending on the jurisdiction.
- The Company expects to fully utilize these state and local net operating losses.
[c. 253; p. 16] Valuation allowance changes
- Table presents the change in the Company's valuation allowance for the years ended December 31, 2025 and 2024.
[c. 254; p. 16] Tax examinations and uncertain tax positions
- The Company’s federal income tax returns for tax years 2022-2024 are subject to examination by the Internal Revenue Service.
- As of December 31, 2025, the Company had no provision for uncertain tax positions and no provision for penalties or interest.
- Management does not believe there are any uncertain tax benefits that could be recognized within the next twelve months that would impact the Company’s effective tax rate.
[c. 255; p. 16]
| ($ in thousands) | 2025 |
|---|---|
| Income from continuing operations before income tax expense | |
| United States | 208,763 |
| Foreign | 7,661 |
| Total | 216,424 |
| Income tax expense (benefit) from continuing operations | — |
| Current tax expense | — |
| United States | 51,758 |
| U.S. state and local | 1,107 |
| Deferred tax benefit related to: | — |
| United States | ( 5,584 ) |
| U.S. state and local | ( 885 ) |
| Total income tax expense | 46,396 |
| ($ in thousands) | 2024 | 2023 |
|---|---|---|
| Current income tax expense | 42,626 | 14,736 |
| Deferred tax (benefit) expense related to temporary differences | ( 8,715 ) | 9,382 |
| Total income tax expense | 33,911 | 24,118 |
| 2025 | ||
|---|---|---|
| ($ in thousands) | Amount | Percentage |
| U.S. federal statutory income tax rate | 45,449 | 21.0% |
| State income taxes, net of federal benefit (1) | ( 508 ) | ( 0.3 )% |
| Foreign tax effects | — | — |
| Bermuda statutory rate differential | ( 1,609 ) | ( 0.7 )% |
| Effects of other cross-border tax laws | 717 | 0.3% |
| Change of Valuation Allowance | 68 | —% |
| Nondeductible and Nontaxable items | — | — |
| Nondeductible transaction costs | 1,689 | 0.8% |
| Other nondeductible and nontaxable items | 590 | 0.3% |
| Effective tax rate | 46,396 | 21.4% |
| 2024 | 2023 | |||
|---|---|---|---|---|
| ($ in thousands) | Amount | Percentage | Amount | Percentage |
| Income tax expense at federal statutory rate | 32,075 | 21.0% | 23,121 | 21.0% |
| Tax advantaged investments | ( 239 ) | ( 0.2 ) | ( 295 ) | ( 0.3 ) |
| Other | 2,075 | 1.4 | 1,292 | 1.2 |
| Total income tax expense | 33,911 | 22.2% | 24,118 | 21.9% |
| ($ in thousands) | 2025 |
|---|---|
| United States | 49,830 |
| U.S. state and local (1) | 1,164 |
| Total income taxes paid | 50,994 |
| ($ in thousands) | 2025 | 2024 |
|---|---|---|
| Deferred tax assets: | ||
| Net operating losses | 9,409 | 9,389 |
| Losses and loss adjustment expenses | 21,401 | 16,967 |
| Unearned premiums | 22,775 | 18,178 |
| Unrealized losses on fixed maturity securities, available-for-sale | — | 5,893 |
| Stock options/awards | 2,446 | 2,453 |
| Other | 8,933 | 6,067 |
| Total deferred tax assets before valuation allowance | 64,964 | 58,947 |
| Valuation allowance | ( 654 ) | ( 586 ) |
| Total deferred tax assets | 64,310 | 58,361 |
| Deferred tax liabilities: | — | — |
| Deferred policy acquisition costs | 19,132 | 15,277 |
| Other long-term investments | 2,888 | 2,625 |
| Section 481(a) adjustment | 87 | 1,391 |
| Unrealized gains on equity securities | 7 | 4,818 |
| Unrealized gains on fixed maturity securities, available-for-sale | 3,101 | — |
| Unrealized gains on other investments | 5,465 | — |
| Depreciation | 2,152 | 1,426 |
| Other | 3,613 | 2,338 |
| Total deferred tax liabilities | 36,445 | 27,875 |
| Net deferred tax asset | 27,865 | 30,486 |
| ($ in thousands) | 2025 | 2024 |
|---|---|---|
| Balance at beginning of the period | 586 | 586 |
| Increase related to net operating loss | 68 | — |
| Balance at the end of the period | 654 | 586 |
Tax Legislative Update
[c. 256; p. 16] US tax reform impact
- The One Big Beautiful Bill Act ("OBBB Act"), which includes broad tax reform provisions, was signed into law in the United States on July 4, 2025.
- The OBBB Act did not materially impact the Company's annual effective tax rate in 2025.
- No material impact from the OBBB Act is expected on the Company's annual effective tax rate in 2026.
14. Reserves for Losses and Loss Adjustment Expenses
[c. 257; p. 16] Loss and LAE sub-categories
- The Company presents its loss development on a consolidated basis.
- Net ultimate loss and LAE are evaluated under three sub-categories: multi-line solutions, short-tail/monoline specialty lines, and exited lines.
- These disaggregated groupings have more homogeneous risk characteristics with similar development patterns and are generally subject to similar trends.
- Short-tail/Monoline Specialty Lines include global property & agriculture, accident & health, surety, and professional lines underwriting divisions.
- These are market niches served with monoline solutions that generally have shorter durations for losses to fully develop.
- Losses for short-tail/monoline specialty lines are generally reported within a short period from the date of loss, and claims are typically settled and paid within a relatively short timeframe.
- Short-tail/monoline specialty lines can be impacted by larger, more complex losses due to factors like difficulty determining actual damages, and legal and regulatory impediments that can extend settlement and payment periods.
- Multi-line Solutions include industry solutions, programs, captives, and transactional E&S underwriting divisions.
- These are market niches where the Company provides multiple products, most frequently as an integrated solution.
- The multi-line solution subcategory is predominantly made up of occurrence liability, including general liability, excess liability, and commercial auto.
- Multi-line solutions have a longer duration for losses to fully develop compared to short-tail/monoline specialty lines.
- The unique claim characteristics and longer-tail nature of multi-line solutions introduce more uncertainty, as claims can be impacted by changes in regulation, inflation, and other unforeseen factors over time.
- Exited lines include all underwriting units that the Company placed in run-off and are presented separately from ongoing lines of business.
[c. 258; p. 16] Reconciliation of unpaid losses and LAE
- The following table sets forth the reconciliation of unpaid losses and loss adjustment expenses (“LAE”) as reported in the Consolidated Balance Sheets as of and for the years ended December 31, 2025 and 2024.
- For the year ended December 31, 2025, the Company recognized favorable development related to prior years’ loss and loss expense reserves of USD 7.5m.
- This favorable development was driven by USD 24.6m in short-tail/monoline specialty lines and USD 5.3m in multi-line solutions.
- This was partially offset by USD 22.4m of adverse development in exited lines.
- The adverse development in exited lines was primarily attributable to commercial auto and excess over auto in divisions that have been non-renewed or had significantly reduced exposure over the past three years.
- This was offset by favorable development in surety and property.
- For the year ended December 31, 2024, the Company recognized adverse development related to prior years’ loss and loss expense reserves of USD 25.7m.
- This adverse development was primarily related to losses previously subject to the LPT from accident years 2018 and prior.
- This included USD 10.1m in multi-line solutions and USD 15.2m in exited lines.
- During the year ended December 31, 2023, the Company recognized adverse development related to prior years’ loss and loss expense reserves of USD 10.8m.
- Adverse development of USD 11.7m in multi-line solutions was driven by greater than expected severity in auto, general, and excess liability lines of business, primarily from accident years 2020 to 2022.
- This adverse development was partially offset by favorable development in short-tail/monoline specialty lines.
- The favorable development in short-tail/monoline specialty lines was in the property line of business, primarily from accident years 2021 and 2022.
[c. 259; p. 16]
| ($ in thousands) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Reserves for losses and LAE, beginning of period | 1,782,383 | 1,314,501 | 1,141,757 |
| Less: reinsurance recoverable on unpaid claims, beginning of period | ( 670,846 ) | ( 455,484 ) | ( 435,986 ) |
| Reserves for losses and LAE, beginning of period, net of reinsurance | 1,111,537 | 859,017 | 705,771 |
| Incurred, net of reinsurance, related to: | — | — | — |
| Current period | 810,375 | 657,783 | 505,894 |
| Prior years | ( 7,471 ) | 25,728 | 10,770 |
| Total incurred, net of reinsurance | 802,904 | 683,511 | 516,664 |
| Paid, net of reinsurance, related to: | — | — | — |
| Current period | 144,799 | 136,731 | 109,937 |
| Prior years | 371,913 | 294,260 | 253,481 |
| Total paid | 516,712 | 430,991 | 363,418 |
| Net reserves for losses and LAE, end of period | 1,397,729 | 1,111,537 | 859,017 |
| Plus: reinsurance recoverable on unpaid claims, end of period | 921,165 | 670,846 | 455,484 |
| Reserves for losses and LAE, end of period | 2,318,894 | 1,782,383 | 1,314,501 |
Short Duration Contract Disclosures
[c. 260; p. 16] Losses and LAE reserves
- Losses and LAE reserves represent the Company's best estimate of the ultimate net cost of all reported and unreported losses that are unpaid as of the balance sheet dates.
- Estimated reserves for losses and LAE include:
- Accumulation of estimates for claims reported and unpaid prior to the balance sheet dates.
- Estimates (based on projections of relevant historical data) of increases in claims costs for claims already reported.
- Estimates of claims incurred but not reported.
- Estimates of expenses for investigating and adjusting all incurred and unpaid claims.
- The Company measures claim counts by incident when determining the cumulative number of reported claims.
- Claim counts include all reported claims, even if the Company does not establish a liability for the claim (i.e., reserve for loss and loss adjustment expenses).
Short-tail/Monoline Specialty Lines
[c. 261; p. 16]
| ($ in thousands except number of claims) | |||||||
|---|---|---|---|---|---|---|---|
| Incurred Losses and ALAE, Net of Reinsurance | As of December 31, 2025 | ||||||
| Years Ended December 31, | Reported Claims | ||||||
| Accident Year | 2021* | 2022* | 2023* | 2024* | 2025 | IBNR | Reported Claims |
| 2021 | 92,780 | 93,429 | 92,143 | 92,134 | 99,783 | 1,774 | 1,656 |
| 2022 | — | 108,299 | 105,394 | 104,095 | 96,874 | 6,266 | 2,414 |
| 2023 | — | — | 190,565 | 191,865 | 161,222 | 28,997 | 5,015 |
| 2024 | — | — | — | 280,147 | 292,220 | 99,302 | 5,819 |
| 2025 | — | — | — | — | 422,528 | 275,190 | 5,495 |
| Total | — | — | — | — | 1,072,627 | — | — |
| Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | ( 528,255 ) | — | — |
| Net reserves for loss and ALAE before 2021 | Net reserves for loss and ALAE before 2021 | Net reserves for loss and ALAE before 2021 | Net reserves for loss and ALAE before 2021 | Net reserves for loss and ALAE before 2021 | 1,570 | — | — |
| Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | 545,942 | — | — |
| *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited |
| ($ in thousands) | |||||
|---|---|---|---|---|---|
| Cumulative Paid Losses and ALAE, Net of Reinsurance ($ in thousands) | |||||
| Years Ended December 31, | |||||
| Accident Year | 2021* | 2022* | 2023* | 2024* | 2025 |
| 2021 | 18,447 | 56,803 | 67,912 | 78,439 | 93,560 |
| 2022 | — | 27,773 | 64,594 | 77,150 | 85,696 |
| 2023 | — | — | 33,795 | 100,705 | 114,247 |
| 2024 | — | — | — | 53,691 | 154,896 |
| 2025 | — | — | — | — | 79,856 |
| Total | — | — | — | — | 528,255 |
| *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited |
Multi-line Solutions
[c. 262; p. 16]
| ($ in thousands except number of claims) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Incurred Losses and ALAE, Net of Reinsurance ($ in thousands) | As of December 31, 2025 | |||||||||||
| Accident Year | Years Ended December 31, | Reported Claims | ||||||||||
| Accident Year | 2016* | 2017* | 2018* | 2019* | 2020* | 2021* | 2022* | 2023* | 2024* | 2025 | IBNR | Reported Claims |
| 2016 | 63,223 | 62,843 | 62,843 | 62,643 | 84,579 | 84,579 | 84,829 | 84,829 | 85,434 | 85,098 | 828 | 4,744 |
| 2017 | — | 65,332 | 65,332 | 64,260 | 78,166 | 78,166 | 78,766 | 78,766 | 80,493 | 79,819 | 837 | 5,592 |
| 2018 | — | — | 74,476 | 74,476 | 69,319 | 71,719 | 73,019 | 73,019 | 75,686 | 72,963 | 673 | 5,103 |
| 2019 | — | — | — | 107,432 | 109,226 | 112,378 | 115,530 | 116,230 | 116,206 | 110,564 | 1,384 | 6,113 |
| 2020 | — | — | — | — | 113,030 | 124,076 | 128,111 | 132,495 | 132,125 | 134,281 | 4,174 | 5,542 |
| 2021 | — | — | — | — | — | 156,067 | 158,891 | 160,331 | 160,546 | 157,006 | 7,932 | 6,727 |
| 2022 | — | — | — | — | — | — | 236,909 | 242,097 | 242,358 | 249,317 | 19,315 | 8,679 |
| 2023 | — | — | — | — | — | — | — | 306,511 | 306,511 | 320,637 | 96,700 | 8,468 |
| 2024 | — | — | — | — | — | — | — | — | 353,933 | 336,197 | 155,878 | 7,700 |
| 2025 | — | — | — | — | — | — | — | — | — | 356,590 | 257,468 | 6,139 |
| Total | — | — | — | — | — | — | — | — | — | 1,902,472 | — | — |
| Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | ( 1,162,853 ) | — | — |
| Net reserves for loss and ALAE before 2016 | Net reserves for loss and ALAE before 2016 | Net reserves for loss and ALAE before 2016 | Net reserves for loss and ALAE before 2016 | Net reserves for loss and ALAE before 2016 | Net reserves for loss and ALAE before 2016 | Net reserves for loss and ALAE before 2016 | Net reserves for loss and ALAE before 2016 | Net reserves for loss and ALAE before 2016 | Net reserves for loss and ALAE before 2016 | ( 189 ) | — | — |
| Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | 739,430 | — | — |
| *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited |
| ($ in thousands) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Cumulative Paid Losses and ALAE, Net of Reinsurance ($ in thousands) | ||||||||||
| Years Ended December 31, | ||||||||||
| Accident Year | 2016* | 2017* | 2018* | 2019* | 2020* | 2021* | 2022* | 2023* | 2024* | 2025 |
| 2016 | 23,239 | 42,528 | 53,352 | 58,895 | 69,691 | 72,544 | 75,855 | 77,160 | 77,760 | 77,825 |
| 2017 | — | 23,770 | 41,945 | 53,093 | 61,354 | 67,926 | 71,109 | 73,770 | 75,714 | 77,177 |
| 2018 | — | — | 26,201 | 42,568 | 47,226 | 58,655 | 65,635 | 69,893 | 70,128 | 72,429 |
| 2019 | — | — | — | 33,019 | 50,933 | 71,053 | 87,816 | 99,451 | 106,765 | 106,826 |
| 2020 | — | — | — | — | 29,499 | 60,680 | 82,236 | 105,283 | 121,097 | 126,965 |
| 2021 | — | — | — | — | — | 37,118 | 73,293 | 102,772 | 125,749 | 141,539 |
| 2022 | — | — | — | — | — | — | 50,148 | 114,794 | 165,854 | 205,410 |
| 2023 | — | — | — | — | — | — | — | 63,079 | 122,186 | 181,636 |
| 2024 | — | — | — | — | — | — | — | — | 58,281 | 123,488 |
| 2025 | — | — | — | — | — | — | — | — | — | 49,558 |
| Total | — | — | — | — | — | — | — | — | — | 1,162,853 |
| *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited |
Exited Lines — all lines in runoff
[c. 263; p. 16] Reconciliation of loss development tables
- The table below presents the reconciliation of the net incurred and paid loss development tables to the balance sheet reserves for losses and loss adjustment expenses at December 31, 2025 and 2024.
- The following table sets forth the historical average annual payout of incurred losses and allocated loss adjustment expenses (claims duration) for short-duration contracts, based on the disaggregated information in the paid loss development tables, net of reinsurance.
[c. 264; p. 16]
| ($ in thousands except number of claims) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Incurred Losses and ALAE, Net of Reinsurance ($ in thousands) | As of December 31, 2025 | |||||||||||
| Years Ended December 31, | Reported Claims | |||||||||||
| Accident Year | 2016* | 2017* | 2018* | 2019* | 2020* | 2021* | 2022* | 2023* | 2024* | 2025 | IBNR | Reported Claims |
| 2016 | 93,019 | 92,996 | 91,372 | 93,577 | 97,301 | 98,301 | 100,651 | 100,651 | 102,801 | 104,246 | 1,851 | 4,911 |
| 2017 | — | 75,159 | 79,581 | 81,785 | 65,735 | 68,346 | 68,646 | 68,646 | 70,885 | 72,682 | 1,819 | 4,370 |
| 2018 | — | — | 74,357 | 68,990 | 76,506 | 79,006 | 84,165 | 84,165 | 92,082 | 91,897 | 4,093 | 4,941 |
| 2019 | — | — | — | 87,115 | 73,635 | 77,770 | 79,414 | 79,572 | 79,823 | 86,131 | 9,773 | 5,660 |
| 2020 | — | — | — | — | 132,248 | 136,469 | 137,835 | 137,907 | 137,671 | 138,320 | 10,644 | 4,867 |
| 2021 | — | — | — | — | — | 83,322 | 91,188 | 91,323 | 92,095 | 97,577 | 10,676 | 2,446 |
| 2022 | — | — | — | — | — | — | 12,717 | 12,240 | 11,800 | 14,362 | 2,025 | 246 |
| 2023 | — | — | — | — | — | — | — | — | — | 2 | 1 | 1 |
| 2024 | — | — | — | — | — | — | — | — | — | 5 | 5 | — |
| 2025 | — | — | — | — | — | — | — | — | — | 11 | 11 | — |
| Total | — | — | — | — | — | — | — | — | — | 605,233 | — | — |
| Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | Cumulative net paid loss and ALAE from the table below | ( 538,304 ) | — | — |
| Net reserves for loss and ALAE before 2015 | Net reserves for loss and ALAE before 2015 | Net reserves for loss and ALAE before 2015 | Net reserves for loss and ALAE before 2015 | Net reserves for loss and ALAE before 2015 | Net reserves for loss and ALAE before 2015 | Net reserves for loss and ALAE before 2015 | Net reserves for loss and ALAE before 2015 | Net reserves for loss and ALAE before 2015 | Net reserves for loss and ALAE before 2015 | 14,737 | — | — |
| Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | Total net reserves for loss and ALAE | 81,666 | — | — |
| *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited |
| ($ in thousands) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Cumulative Paid Losses and ALAE, Net of Reinsurance ($ in thousands) | ||||||||||
| Years Ended December 31, | ||||||||||
| Accident Year | 2016* | 2017* | 2018* | 2019* | 2020* | 2021* | 2022* | 2023* | 2024* | 2025 |
| 2016 | 36,592 | 57,638 | 70,253 | 78,070 | 81,181 | 87,482 | 91,556 | 95,114 | 97,462 | 98,831 |
| 2017 | — | 34,176 | 52,103 | 51,985 | 50,545 | 57,457 | 62,924 | 66,498 | 68,480 | 69,798 |
| 2018 | — | — | 25,553 | 60,149 | 39,870 | 54,339 | 67,001 | 74,604 | 79,860 | 82,244 |
| 2019 | — | — | — | 28,636 | 28,954 | 30,948 | 45,696 | 57,341 | 65,847 | 70,367 |
| 2020 | — | — | — | — | 102,725 | 98,202 | 102,132 | 114,543 | 120,831 | 124,139 |
| 2021 | — | — | — | — | — | 41,540 | 57,820 | 66,012 | 72,923 | 81,600 |
| 2022 | — | — | — | — | — | — | 2,155 | 4,077 | 9,211 | 11,325 |
| 2023 | — | — | — | — | — | — | — | — | — | — |
| 2024 | — | — | — | — | — | — | — | — | — | — |
| 2025 | — | — | — | — | — | — | — | — | — | — |
| Total | — | — | — | — | — | — | — | — | — | 538,304 |
| *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited |
| ($ in thousands) | 2025 | 2024 |
|---|---|---|
| Net reserves for losses and ALAE: | ||
| Short-tail/Monoline Specialty Lines | 545,942 | 367,226 |
| Multi-line Solutions | 739,430 | 631,065 |
| Exited Lines | 81,666 | 86,689 |
| Reserves for losses and ALAE, net of reinsurance | 1,367,038 | 1,084,980 |
| Reinsurance recoverable on unpaid claims: | — | — |
| Short-tail/Monoline Specialty Lines | 388,276 | 275,204 |
| Multi-line Solutions | 514,393 | 380,344 |
| Exited Lines | 18,496 | 15,298 |
| Total reinsurance recoverable on unpaid claims | 921,165 | 670,846 |
| Unallocated LAE | 30,691 | 26,557 |
| Reserves for losses and LAE at end of year | 2,318,894 | 1,782,383 |
| Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Years | ||||||||||
| 1* | 2* | 3* | 4* | 5* | 6* | 7* | 8* | 9* | 10* | |
| Short-Tail/Monoline Specialty Lines | 21.1% | 38.1% | 10.8% | 9.7% | 15.2% | N/A | N/A | N/A | N/A | N/A |
| Multi-line Solutions | 23.9% | 21.6% | 15.6% | 13.6% | 10.5% | 4.8% | 1.9% | 2.4% | 1.3% | 0.1% |
| Exited Lines | 27.5% | 12.2% | 4.9% | 9.9% | 8.9% | 6.8% | 4.9% | 2.9% | 2.0% | 1.3% |
| *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | *Supplementary information and unaudited | — | — | — | — | — | — |
15. Commission and Fee Income
[c. 265; p. 16] Skyward Underwriters Agency business
- Skyward Underwriters Agency, Inc. ("SUA") is a subsidiary of the Company.
- SUA acts as a managing general insurance agent and reinsurance broker.
- SUA specializes in property and casualty and accident and health risks in specialty niche markets.
- Commission and fee income is primarily generated from SUA for placing insurance policies with third-party insurance or reinsurance companies.
[c. 266; p. 16] Commission and fee income tables
- The document presents a table of disaggregated revenues from customer contracts for the years ended December 31, 2025, 2024, and 2023.
- The document presents a table of opening and closing balances of contract assets from commission and fee income for the years ended December 31, 2025, 2024, and 2023.
[c. 267; p. 16]
| ($ in thousands) | 2025 | 2024 | 2023 |
|---|---|---|---|
| SUA commission revenue | 8,323 | 7,967 | 7,222 |
| SUA fee revenue | 2,333 | 2,443 | 2,732 |
| Other commission and fee revenue (loss) | 1,725 | 266 | ( 135 ) |
| Total commission and fee revenue | 12,381 | 10,676 | 9,819 |
| Commission and fee expenses | ( 5,526 ) | ( 3,973 ) | ( 3,755 ) |
| Net commission and fee income | 6,855 | 6,703 | 6,064 |
| ($ in thousands) | Contract Assets |
|---|---|
| Balance at December 31, 2023 | 976 |
| Balance at December 31, 2024 | 1,416 |
| Balance at December 31, 2025 | 953 |
16. Underwriting, Acquisition and Insurance Expenses
[c. 268; p. 16] Underwriting, acquisition, and insurance expenses components
- The table below details the components of underwriting, acquisition, and insurance expenses for the years ended December 31, 2025, 2024, and 2023.
[c. 269; p. 16]
| ($ in thousands) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Amortization of policy acquisition costs | 195,422 | 149,975 | 108,514 |
| Other operating and general expenses | 181,937 | 161,782 | 134,930 |
| Total underwriting, acquisition and insurance expenses | 377,359 | 311,757 | 243,444 |
17. Reinsurance
[c. 270; p. 16] Reinsurance agreements and recoverables
- The Company uses various reinsurance agreements to assume and cede premiums and benefits with other insurance companies.
- Reinsurance agreements increase the Company's capacity to write larger risks and maintain loss exposure within its capital resources.
- The Company remains obligated for ceded amounts if reinsurers fail to meet their obligations.
- Tables detail the effects of reinsurance on written and earned premiums and losses and loss adjustment expenses for the years ended December 31, 2025, 2024, and 2023.
- A table outlines the components of reinsurance recoverables and ceded unearned premium as of December 31, 2025 and 2024.
[c. 271; p. 16] Reinsurance security and LPT agreement
- The Company has agreements with several reinsurers where funded trust accounts are established with the Company as the sole beneficiary.
- These trust accounts provide additional security for collecting claim recoverables under reinsurance contracts.
- The Company does not carry these trust accounts on its balance sheet, as it only gains custody upon the reinsurer's failure to pay.
- As of December 31, 2025, the market value of these trust accounts was approximately USD 233.5 million.
- The trust amount is adjusted periodically by mutual agreement based on claim payments and loss reserve recoverables.
- In the first quarter of 2020, the Company entered into an LPT retroactive reinsurance agreement with R&Q.
- As of December 31, 2024, the reinsurance recoverable from R&Q was USD 22.7 million.
- The LPT was commuted effective January 31, 2025, and the Company received the full reinsurance recoverable balance.
[c. 272; p. 16] Deposit method accounting for reinsurance
- Certain ceded reinsurance contracts that transfer only significant timing risk and insufficient underwriting risk are accounted for using the deposit method.
- The Company's deposit asset was USD 22.7 million at December 31, 2025, and USD 25.9 million at December 31, 2024.
- This deposit asset was included in other assets on the Consolidated Balance Sheets.
[c. 273; p. 16]
| 2025 | 2024 | 2023 | ||||
|---|---|---|---|---|---|---|
| ($ in thousands) | Written | Earned | Written | Earned | Written | Earned |
| Direct premiums | 1,684,411 | 1,622,594 | 1,458,637 | 1,375,917 | 1,241,180 | 1,155,835 |
| Assumed premiums | 481,825 | 406,792 | 284,595 | 282,662 | 218,649 | 193,971 |
| Ceded premiums | ( 760,004 ) | ( 724,881 ) | ( 619,654 ) | ( 601,857 ) | ( 549,138 ) | ( 520,663 ) |
| Net premiums | 1,406,232 | 1,304,505 | 1,123,578 | 1,056,722 | 910,691 | 829,143 |
| Ceded losses and LAE incurred | — | 697,978 | — | 534,295 | — | 337,011 |
| ($ in thousands) | 2025 | 2024 |
|---|---|---|
| Ceded unpaid losses and LAE | 921,165 | 670,846 |
| Ceded paid losses and LAE | 201,010 | 166,663 |
| Loss portfolio transfer | — | 22,662 |
| Allowance for credit losses | ( 2,295 ) | ( 2,295 ) |
| Reinsurance recoverables | 1,119,880 | 857,876 |
| Ceded unearned premium | 238,948 | 203,901 |
18. Stock Based Compensation
[c. 274; p. 16] 2022 Long-Term Incentive Plan
- On September 23, 2022, the Board of Directors approved the Company’s 2022 Long-Term Incentive Plan (the “2022 Plan”), effective January 12, 2023, replacing the 2020 Plan.
- The 2022 Plan allows for granting restricted stock, restricted stock units, performance stock units, stock options, and cash-based performance awards to select employees and non-employee directors.
- The 2022 Plan made 3,200,656 shares of common stock available for issuance.
- In November 2024, the Compensation Committee approved a program for independent directors to defer settlement of annual restricted stock units (“RSU”) awards to the fifth anniversary of the grant date, the tenth anniversary of the grant date, or separation of service.
- This deferral program was available for Directors who elected in 2024 to defer settlement of their 2025 RSU awards, which vest in 2026.
[c. 275; p. 16] Stock options
- The grant date fair value of options under the 2022 Plan was determined using the Black-Scholes model, with a contractual term of 10 years less the weighted average service period.
- Volatility for the Black-Scholes model was based on historical volatility of comparable publicly traded insurance companies.
- Stock options granted to employees during the year ended December 31, 2023, were valued at approximately USD 4.4m based on grant date fair value.
- The aggregate intrinsic value of options outstanding was USD 27.4m at December 31, 2025, and USD 27.0m at December 31, 2024.
- The weighted-average remaining contractual life of options outstanding at December 31, 2025, was 7.0 years.
[c. 276; p. 16] Restricted stock awards and units
- The fair value of restricted stock and restricted stock units under the 2022 Plan for awards granted at the Company’s IPO was the IPO price of USD 15.00 per share.
- The fair value of subsequent grants was equal to the closing stock price on the grant date.
- Expense for equity-based incentives is based on fair value at grant date and amortized over the vesting period.
- Restricted stock and restricted stock units granted to employees and the Board of Directors were valued at approximately USD 12.2m in 2025, USD 8.5m in 2024, and USD 17.7m in 2023, based on grant date fair value.
- Board of Directors members were granted 12,579 shares in 2025, 19,453 shares in 2024, and 23,482 shares in 2023, with a service period of one year.
- The total fair value of shares vested for employees and Board members was USD 6.0m at December 31, 2025, USD 3.8m at December 31, 2024, and USD 0.5m at December 31, 2023.
- As of December 31, 2025, total unrecognized compensation cost for non-vested, stock-based awards was USD 17.4m.
- The weighted average period for recognizing this cost is 1.6 years.
- The Company recognized stock-based compensation expense of USD 12.0m in 2025, USD 9.4m in 2024, and USD 8.5m in 2023.
[c. 277; p. 16] Employee Stock Purchase Plan (ESPP)
- On September 23, 2022, the Board of Directors approved the Company’s 2022 Employee Stock Purchase Plan (the “ESPP”), effective May 15, 2023, and administered by the Compensation Committee.
- Under the ESPP, employees can elect to have a percentage of their annual base earnings withheld to purchase common stock at two specified intervals each year.
- The purchase price is 85% of the lower of the beginning-of-interval or end-of-interval market price.
- The Company has reserved 376,548 common shares under the ESPP.
- The grant date fair value of options under the ESPP was determined using the Black-Scholes model, with a term of 6 months (length of time between grant date and exercisable date).
- Volatility for the ESPP Black-Scholes model was based on historical volatility of comparable publicly traded insurance companies.
- As of December 31, 2025, 141,845 shares had been purchased under the ESPP.
- The Company recognized ESPP expense of USD 0.7m in 2025 and USD 0.5m in 2024.
- As of December 31, 2025, the fair value of unrecognized ESPP expense was USD 0.3m.
[c. 278; p. 16]
| Award Payout Range | Requisite Service Period | Target Stock and Stock Units | |
|---|---|---|---|
| Year ended December 31, 2025 | |||
| Market condition awards | 0 %– 150 % | 3 years | 22,495 |
| Performance condition awards | 0 %– 150 % | 3 years | 59,769 |
| Service condition awards | N/A | 1 – 4 years | 144,921 |
| — | — | — | 227,185 |
| Year ended December 31, 2024 | — | — | — |
| Market condition awards | 0 %– 150 % | 3 years | 32,058 |
| Performance condition awards | 0 %– 150 % | 3 years | 76,881 |
| Service condition awards | N/A | 1 – 4 years | 124,025 |
| — | — | — | 232,964 |
| Year ended December 31, 2023 | — | — | — |
| Market condition awards | 0 %– 150 % | 3 years | 37,622 |
| Performance condition awards | 0 %– 150 % | 3 years | 95,456 |
| Service condition awards | N/A | 1 – 4 years | 968,778 |
| Stock options | N/A | 3 – 4 years | 759,990 |
| — | — | — | 1,861,846 |
| Weighted-Average Exercise Price | Stock | |
|---|---|---|
| Outstanding at January 1, 2025 | — | 759,990 |
| Forfeited | 15.00 | ( 219 ) |
| Outstanding at December 31, 2025 | — | 759,771 |
| Stock | |
|---|---|
| Outstanding at January 1, 2024 | 759,990 |
| Outstanding at December 31, 2024 | 759,990 |
| Weighted-Average Grant-Date Fair Value | Stock and Stock Units | |
|---|---|---|
| Non-vested at January 1, 2025 | 19.06 | 1,325,483 |
| Granted (1) | 47.77 | 254,978 |
| Vested | 15.33 | ( 391,746 ) |
| Forfeited (2) | 25.74 | ( 53,247 ) |
| Non-vested at December 31, 2025 | 27.06 | 1,135,468 |
| Non-vested at January 1, 2024 | 15.13 | 1,445,449 |
| Granted (1) | 31.72 | 268,631 |
| Vested | 13.16 | ( 285,957 ) |
| Forfeited (2) | 18.27 | ( 102,640 ) |
| Non-vested at December 31, 2024 | 19.06 | 1,325,483 |
| Non-vested at January 1, 2023 | 12.55 | 419,896 |
| Granted (1) | 16.07 | 1,101,856 |
| Vested | 13.39 | ( 40,645 ) |
| Forfeited (2) | 15.29 | ( 35,658 ) |
| Non-vested at December 31, 2023 | 15.13 | 1,445,449 |
[c. 279; p. 16] Earnings per share computation
- The computation of basic and diluted net earnings per share is set forth for the years ended December 31, 2025, 2024, and 2023.
- Anti-dilutive instruments excluded from the calculation of diluted weighted-average common share equivalents are presented for the years ended December 31, 2025, 2024, and 2023.
- Common share equivalents of contingently issuable instruments excluded from basic earnings per share are presented for the years ended December 31, 2025, 2024, and 2023.
[c. 280; p. 16]
| ($ in thousands, except for share and per share amounts) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Numerator | |||
| Net income | 170,028 | 118,828 | 85,984 |
| Less: Undistributed income allocated to participating securities | — | — | ( 1,677 ) |
| Net income attributable to common stockholders (numerator for basic earnings per share) | 170,028 | 118,828 | 84,307 |
| Add back: Undistributed income allocated to participating securities | — | — | 1,677 |
| Net income (numerator for diluted earnings per share under the two-class method) | 170,028 | 118,828 | 85,984 |
| Denominator | — | — | — |
| Basic weighted-average common shares | 40,407,310 | 40,056,475 | 36,031,907 |
| Dilutive effect of preferred shares | — | — | 716,708 |
| Dilutive effect of stock notes | — | — | 696,110 |
| Dilutive effect of stock units | 897,426 | 917,510 | 736,837 |
| Dilutive effect of options | 503,310 | 403,475 | 135,972 |
| Diluted weighted-average common share equivalents | 41,808,046 | 41,377,460 | 38,317,534 |
| Basic earnings per share | 4.21 | 2.97 | 2.34 |
| Diluted earnings per share | 4.07 | 2.87 | 2.24 |
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Stock units | 104,531 | 20,346 | 3,931 |
| Options | 242 | 859 | 914 |
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Common shares | — | — | 920,864 |
| Total | — | — | 920,864 |
20. Employee Benefit Plan
[c. 281; p. 16] 401(k) Plan contributions
- The Company sponsors the 401(k) Plan ("the Plan"), available to substantially all employees.
- The Plan is subject to the Employee Retirement Income Security Act of 1974.
- The Company matches employee contributions on a discretionary basis.
- Company matching contributions to the Plan were USD 3.9m in 2025, USD 3.2m in 2024, and USD 2.9m in 2023.
RISCOM
[c. 282; p. 16] RISCOM agreements and financial impact
- RISCOM provides wholesale brokerage services to the Company.
- The Company and RISCOM have a managing general agency agreement.
- The Company holds a 20% ownership interest in RISCOM.
- Net earned premiums and gross commission expense related to these agreements for the years ended December 31, 2025, 2024, and 2023 were as follows:
- Net Earned Premiums:
- 2025: USD 102.3m
- 2024: USD 98.7m
- 2023: USD 95.1m
- Gross Commission Expense:
- 2025: USD 15.4m
- 2024: USD 14.8m
- 2023: USD 14.3m
- Net Earned Premiums:
- Premiums receivable as of December 31, 2025, were USD 13.9m.
- Premiums receivable as of December 31, 2024, were USD 12.6m.
[c. 283; p. 16]
| ($ in thousands) | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net earned premium | 120,067 | 108,130 | 99,736 |
| Commissions | 28,728 | 25,372 | 24,177 |
Other
[c. 284; p. 16] Related party transactions
- Advisory and professional services fees and expense reimbursements paid to affiliated stockholders and directors were USD 0.6m for the years ended December 31, 2025 and 2024.
- Advisory and professional services fees and expense reimbursements paid to affiliated stockholders and directors were USD 3.6m for the year ended December 31, 2023.
- Investments involving affiliated companies and additional related party transactions are detailed in Notes 5, 6, and 11.
Litigation
[c. 285; p. 16] Litigation and legal actions
- The Company is a party in various legal actions related to claims under insurance policies and contracts.
- These actions are considered when estimating losses and loss adjustment expense reserves.
- The Company is also a defendant in legal actions concerning bad faith claims, disputes with third parties, or alleged errors and omissions.
- Accruals for these items are recorded when losses are probable and reasonably estimable.
- Based on current information, insurance coverage, and advice from outside legal counsel, the Company believes the resolution of these matters will not have a material adverse effect on its consolidated financial position, results of operations, or cash flows, individually or in the aggregate.
Indemnification
[c. 286; p. 16] Indemnification for asset sales
- The Company has provided indemnifications to certain buyers in conjunction with the sale of business assets and subsidiaries.
- These indemnifications cover typical representations and warranties related to performance under sales contracts.
- The potential exposure from these indemnifications is difficult to determine due to the variety of matters, operations, and scenarios covered.
- Some indemnifications have no time limit.
- The Company currently does not believe any significant claims exist related to these indemnifications.
23. Statutory Accounting Principles and Regulatory Matters
[c. 287; p. 16] Statutory financial performance
- The Company’s statutory net income was USD 159.1m for 2025, USD 108.2m for 2024, and USD 73.1m for 2023.
- The Company’s statutory capital and surplus was USD 872.0m as of December 31, 2025, and USD 710.6m as of December 31, 2024.
[c. 288; p. 16] Insurance company subsidiary restacking
- Effective December 31, 2024, the Company restacked its insurance company subsidiaries, making GMIC the lead insurance company.
- HSIC became a wholly owned subsidiary of GMIC.
- IIC became a wholly owned subsidiary of HSIC.
- OSIC became a wholly owned subsidiary of IIC.
[c. 289; p. 16] Dividend restrictions
- Dividend payments to the Company from GMIC are restricted by Texas state law, requiring regulatory approval for amounts exceeding certain limits.
- The maximum amount of dividends payable by GMIC without prior approval is subject to restrictions related to policyholder surplus, net income, and dividends declared or distributed in the preceding 12 months.
- As of December 31, 2025, GMIC, domiciled in Texas, is restricted to paying dividends of the greater of 10% of prior year-end capital and surplus or prior year net income.
- GMIC did not declare or pay any dividend during the year ended December 31, 2025.
- HSIC did not declare or pay any dividends during the year ended December 31, 2024.
[c. 290; p. 16] Risk Based Capital requirements
- Property and casualty insurance companies are subject to Risk Based Capital ("RBC") requirements specified by the National Association of Insurance Commissioners ("NAIC").
- RBC requirements determine the amount of capital and surplus based on various risk factors.
- As of December 31, 2025 and 2024, GMIC’s statutory capital and surplus substantially exceeded the regulatory requirements.
24. Subsequent Events
[c. 291; p. 16] Apollo Group Holdings Limited acquisition
- On September 2, 2025, the Company entered into two share purchase agreements (the "Apollo Majority SPAs") with institutional and management shareholders of Apollo Group Holdings Limited ("Apollo") (the "Majority Sellers").
- Pursuant to the Apollo Majority SPAs, the Company agreed to acquire all issued shares of Apollo held by the Majority Sellers, representing approximately 87% of Apollo's issued share capital.
- Closing of the transaction ("Closing") was conditioned upon the Company acquiring 100% of Apollo's issued share capital (the “Acquisition”) at Closing through additional short-form share purchase agreements with remaining minority shareholders.
- On January 1, 2026, the Company completed the acquisition for aggregate consideration of approximately USD 555.0m, payable in a combination of cash and newly issued shares of the Company’s common stock.
- The acquisition closed shortly before the issuance of these consolidated financial statements, so initial accounting under ASC 805 is not yet complete.
- The Company is obtaining and evaluating information to determine identifiable assets acquired, liabilities assumed, and any resulting goodwill or intangible assets.
- Required purchase accounting disclosures will be provided in future filings once available.
[c. 292; p. 16] Subsequent events evaluation
- The Company evaluated subsequent events from December 31, 2025, through the date these consolidated financial statements were issued.
- No additional subsequent events requiring disclosure were identified.
Controls and Procedures
Evaluation of Disclosure Controls and Procedures
[c. 293; p. 17] Disclosure Controls and Procedures Evaluation
- Management, including the principal executive officer and principal financial officer, evaluated the effectiveness of disclosure controls and procedures as of the end of the period covered by the Annual Report on Form 10-K.
- Disclosure controls and procedures are defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act).
- Based on the evaluation, the principal executive officer and principal financial officer concluded that as of December 31, 2025, the disclosure controls and procedures were effective at the reasonable assurance level.
- Management acknowledges that controls and procedures can only provide reasonable assurance of achieving their objectives, and judgment is applied in evaluating the cost-benefit relationship of controls and procedures.
Management’s Report on Internal Control over Financial Reporting
[c. 294; p. 17] Management responsibility for internal control over financial reporting
- Management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934, as amended.
- Internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles in the United States of America.
- Internal control over financial reporting includes policies and procedures that pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of assets.
- Internal control over financial reporting includes policies and procedures that provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures are being made only in accordance with authorizations of management and directors.
- Internal control over financial reporting includes policies and procedures that provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of assets that could have a material effect on the financial statements.
Remediation of Material Weakness in Internal Control Over Financial Reporting
[c. 295; p. 17] Material weakness in internal control over financial reporting
- Management concluded that internal control over financial reporting was not effective as of December 31, 2024, due to material weaknesses.
- A material weakness existed related to the ineffective implementation of information technology general controls (ITGCs) in user access for systems supporting financial reporting processes.
- Related process-level IT dependent manual and automated controls relying on affected ITGCs or information from IT systems with affected ITGCs were also deemed ineffective.
[c. 296; p. 17] Remediation actions for internal control deficiencies
- During the year ended December 31, 2025, management took actions to remediate internal control deficiencies.
- Actions included enhancing IT compliance oversight and expanding the team with ITGC design and implementation experience.
- A training program addressing ITGCs and policies was developed, educating control owners on principles and requirements.
- Procedures were implemented to develop and maintain documentation of underlying ITGCs for knowledge transfer during IT personnel and function changes.
- An IT management review and testing procedures were implemented to monitor ITGCs.
- Quarterly reporting on remediation measures was provided to the Audit Committee of the board of directors.
[c. 297; p. 17] Conclusion on internal control effectiveness
- Management believes the described measures remediated the previously identified material weakness.
- Internal control over financial reporting was concluded to be effective at a reasonable assurance level as of December 31, 2025.
- The assessment of internal control effectiveness as of December 31, 2025, was conducted under the supervision and participation of senior management, including the CEO and CFO.
- The assessment used criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in the Internal Control — Integrated Framework (2013 Framework).
- Based on this assessment, management concluded internal control over financial reporting was effective as of December 31, 2025.
- The effectiveness of internal control over financial reporting as of December 31, 2025, was audited by Ernst & Young, LLP, the Company’s independent registered public accounting firm.
Changes in Internal Control over Financial Reporting
[c. 298; p. 17] Internal control over financial reporting
- No change in internal control over financial reporting was identified during the year ended December 31, 2025, except for remediation of a material weakness identified in 2024.
- This evaluation was required by Rule 13a-15(d) and 15d-15(d) of the Exchange Act.
- The identified changes have not materially affected, nor are they reasonably likely to materially affect, internal control over financial reporting.
Limitations on Effectiveness of Controls and Procedures
[c. 299; p. 17] Limitations of internal controls
- Management acknowledges that disclosure controls and procedures, regardless of design and operation, offer only reasonable assurance of achieving control objectives.
- The design of disclosure controls and procedures must consider resource constraints, requiring management to use judgment in assessing benefits against costs.
Other Information
[c. 300; p. 18] Director and officer trading arrangements
- During Q4 2025, none of the company's directors or officers adopted, terminated, or modified a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement.
Directors, Executive Officers and Corporate Governance
[c. 301; p. 19] Proxy statement incorporation
- Information required by Item 10 of Form 10-K will be included in the 2026 Proxy Statement and is incorporated by reference.
Executive Compensation
[c. 302; p. 20] Executive compensation disclosure
- The information required by Item 11 of Form 10-K will be included in the 2026 Proxy Statement and is incorporated herein by reference.
Security Ownership of Certain Beneficial Owner and Management and Related Stockholder Matters
[c. 303; p. 21] Proxy statement incorporation
- Information required by Item 12 of Form 10-K will be included in the 2026 Proxy Statement and is incorporated by reference.
Certain Relationships and Related Transactions, and Director Independence
[c. 304; p. 22] Proxy statement incorporation
- Information required by Item 13 of Form 10-K will be included in the 2026 Proxy Statement and is incorporated by reference.
Principal Accounting Fees and Services
[c. 305; p. 23] Independent Registered Public Accounting Firm
- Our independent registered public accounting firm is Ernst & Young LLP, Houston, Texas.
- Auditor Firm ID: 42.
- The information required by Item 14 of Form 10-K will be included in our 2026 Proxy Statement and is incorporated herein by reference.
Exhibits, Financial Statement Schedules.
[c. 306; p. 24] Financial statements included in Form 10-K
- The following consolidated financial statements of the Company are filed as part of this Form 10-K and are included in Item 8:
- Report of Independent Registered Public Accounting Firm
- Consolidated Balance Sheets as of December 31, 2025 and 2024
- Consolidated Statements of Operations and Comprehensive Income (loss) for the three years in the periods ended December 31, 2025, 2024 and 2023
- Consolidated Statements of Stockholders’ Equity for the three years in the period ended December 31, 2025, 2024 and 2023
- Consolidated Statements of Cash Flows for the three years in the period ended December 31, 2025, 2024 and 2023
[c. 307; p. 24] Listing of exhibits
- (a)(2)
- (a)(3) LISTING OF EXHIBITS
- Items marked with an asterisk (*) are filed herewith.
- Management contract or compensatory plan or arrangement.
[c. 308; p. 24]
| Schedule Number | Schedule Description | Page |
|---|---|---|
| I. | Summary of Investments — Other Than in Related Parties at December 31, 2025 | 113 |
| II. | Financial Information of Registrant (Parent Company) for the years ended December 31, 2025, 2024 and 2023 | 114 |
| IV. | Supplementary Reinsurance Information for the years ended December 31, 2025, 2024, and 2023 | 118 |
| V. | Valuation and Qualifying Accounts for the years ended December 31, 2025, 2024, and 2023 | 119 |
| VI. | Supplementary Information Concerning Property — Casualty Insurance Operations for the years ended December 31, 2025, 2024, and 2023 | 120 |
| Exhibit Number | Exhibit Description |
|---|---|
| 3.1 | Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed with the Commission on January 18, 2023). |
| 3.2 | Amended and Restated Bylaws (incorporated by reference to Exhibit 3.2 to the Company's Current Report on Form 8-K filed with the Commission on January 18, 2023). |
| 4.1 | Amended and Restated Stockholders’ Agreement, dated March 12, 2014, by and among the Company and the stockholders listed therein (incorporated by reference to Exhibit 4.1 to the Company's Registration Statement on Form S-1, filed with the SEC on November 14, 2022). |
| 4.2 | Description of Capital Stock (incorporated by reference to Exhibit 4.2 to the Company’s Annual Report on Form 10-K, filed with the SEC on March 28, 2023). |
| 10.1+ | Share Purchase and Award Agreement and form of agreements thereunder in use before 2016 (incorporated by reference to Exhibit 10.1 to the Company's Registration Statement on Form S-1, filed with the SEC on November 14, 2022). |
| 10.2+ | 2016 Equity Incentive Program and form of award agreements thereunder (incorporated by reference to Exhibit 10.2 to the Company's Registration Statement on Form S-1, filed with the SEC on November 14, 2022). |
| 10.3+ | 2020 Long Term Incentive Plan and form of award agreements thereunder (incorporated by reference to Exhibit 10.3 to the Company's Registration Statement on Form S-1, filed with the SEC on November 14, 2022). |
| 10.4+ | Skyward Specialty Insurance Group, Inc. 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.4 to the Company's Registration Statement on Form S-1, filed with the SEC on November 14, 2022). |
| 10.5+ | Skyward Specialty Insurance Group, Inc. 2022 Employee Stock Purchase Plan (incorporated by reference to Exhibit 10.5 to the Company's Registration Statement on Form S-1, filed with the SEC on November 14, 2022). |
| 10.6+ | Form of Restricted Stock Units Agreement and form of notice under the Company's 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.6 to the Company's Registration Statement on Form S-8, filed with the SEC on January 12, 2023). |
| Exhibit Number | Exhibit Description |
|---|---|
| 10.7+ | Form of Restricted Stock Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.7 to the Company's Registration Statement on Form S-8, filed with the SEC on January 12, 2023). |
| 10.8+ | Form of Nonstatutory Stock Option Agreement and form of notice under the Company's 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.8 to the Company's Registration Statement on Form S-8, filed with the SEC on January 12, 2023). |
| 10.9+ | Form of Incentive Stock Option Agreement and form of notice under the Company's 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.9 to the Company's Registration Statement on Form S-8, filed with the SEC on January 12, 2023). |
| 10.10+ | Form of Performance-Based Restricted Stock Units Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.10 to the Company’s Annual Report on Form 10-K, filed with the SEC on March 28, 2023). |
| 10.11+ | Performance-Based Restricted Stock Units Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.11 to the Company’s Annual Report on Form 10-K, filed with the SEC on March 28, 2023). |
| 10.12+ | Performance Unit Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.12 to the Company’s Annual Report on Form 10-K, filed with the SEC on March 28, 2023). |
| 10.13+ | Amended Form of Performance Share (GBVPS) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.13 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
| 10.14+ | Amended Form of Performance Share (Executives) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.14 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
| 10.15+ | Amended Form of Performance Share (Others) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.15 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
| 10.16+ | Amended Form of Performance Cash Units Agreement under the Company’s Long-Term Incentive Plan. (incorporated by reference to Exhibit 10.16 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
| 10.17+ | Amended Form of the Restricted Stock Unit (Executives) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.17 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
| 10.18+ | Amended Form of Restricted Stock Unit (Others) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.18 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
| 10.19+ | Amended Form of Long-Term Performance Cash Plan and Award Letter under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.19 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
| 10.20+ | Form of Indemnification Agreement (incorporated by reference to Exhibit 10.6 to the Company's Registration Statement on Form S-1, filed with the SEC on November 14, 2022). |
| 10.21+ | Employment Agreement, dated May 22, 2020, by and between the Registrant and Andrew Robinson, with Amendment No. 1 dated January 1, 2022 (incorporated by reference to Exhibit 10.7 to the Company's Registration Statement on Form S-1, filed with the SEC on November 14, 2022). |
| 10.22+ | Form of Non-Employee Director Deferred Restricted Stock Unit Agreement and Form of Notice Under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 10.22 to the Company’s Annual Report on Form 10-K, filed with the SEC on March 3, 2025). |
| 10.23 | Commutation and Release Agreement by and among R&Q Re (Bermuda) Ltd., Skyward Re, Houston Specialty Insurance Company, Imperium Insurance Company, and Great Midwest Insurance Company, dated January 31, 2025 (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the Commission on February 5, 2025). |
| 10.24 | Credit Agreement, dated March 29, 2023, by and among Skyward Specialty Insurance Group, Inc., the lenders from time to time party thereto and Truist Bank, as administrative agent (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the Commission on April 3, 2023). |
| 10.25 | First Amendment dated as of February 26, 2024, to that certain Credit Agreement, dated March 29, 2023, by and among Skyward Specialty Inc., the lenders from time to time party thereto and Truist Bank, as administrative agent (incorporated by reference to Exhibit 10.28 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
| Exhibit Number | Exhibit Description |
|---|---|
| 10.26 | Guaranty Agreement, dated March 29, 2023, by and among Skyward Service Company, Skyward Underwriters Agency, Inc., the loan parties identified on the signature pages thereto and Truist Bank. (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed with the Commission on April 3, 2023). |
| 10.27 | Advances and Security Agreement, dated August 1, 2024, by and between Houston Specialty Insurance Company, a wholly owned insurance company subsidiary of the Company and the Federal Home Loan Bank of Dallas (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Commission on September 6, 2024). |
| 10.28+ | Form of Severance Agreement between the Company and executive officers (other than the CEO) (incorporated by reference to Exhibit 10.30 to the Company’s Annual Report on Form 10-K, filed with the SEC on March 3, 2025). |
| 10.29+ | Amendment No. 2 to Employment Agreement between the Registrant and Andrew Robinson dated March 1, 2025 (incorporated by reference to Exhibit 10.31 to the Company’s Annual Report on Form 10-K, filed with the SEC on March 3, 2025). |
| 10.30+ | Amended Form of Restricted Stock Unit (Executives) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.21 to the Company’s Registration Statement on Form S-8, filed with the SEC on March 5, 2025). |
| 10.31+ | Amended Form of the Restricted Stock Unit (Others) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.22 to the Company’s Registration Statement on Form S-8, filed with the SEC on March 5, 2025). |
| 10.32+ | Amended Form of Performance Share (Executives) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.23 to the Company’s Registration Statement on Form S-8, filed with the SEC on March 5, 2025). |
| 10.33+ | Amended Form of Performance Share (Others) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.24 to the Company’s Registration Statement on Form S-8, filed with the SEC on March 5, 2025). |
| 10.34+ | Amended Form of Performance Share (GBVPS) (Executives) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.25 to the Company’s Registration Statement on Form S-8, filed with the SEC on March 5, 2025). |
| 10.35+ | Amended Form of Performance Share (GBVPS) (Others) Agreement under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.26 to the Company’s Registration Statement on Form S-8, filed with the SEC on March 5, 2025). |
| 10.36+ | Amended Form of Long-Term Performance Cash Plan and Award Letter under the Company’s 2022 Long-Term Incentive Plan (incorporated by reference to Exhibit 99.27 to the Company’s Registration Statement on Form S-8, filed with the SEC on March 5, 2025). |
| 10.37 | Share Purchase Agreement, dated September 2, 2025, by and between Skyward Specialty Insurance Group, Inc. and Apollo institutional shareholders, of Apollo Group Holdings Limited (incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed with the Commission on September 8, 2025). |
| 10.38 | Share Purchase Agreement, dated September 2, 2025, by and between Skyward Specialty Insurance Group, Inc. and Apollo management shareholders, of Apollo Group Holdings Limited (incorporated by reference to Exhibit 2.2 to the Company’s Current Report on Form 8-K filed with the Commission on September 8, 2025). |
| 10.39 | Credit Agreement, dated November 13, 2025, by and between Skyward Specialty Insurance Group, Inc. and Barclays Bank PLC, as Administrative Agent, Truist Securities, Inc., Citizens Bank, N.A. and Texas Capital Bank (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the Commission on November 18, 2025). |
| 10.40 | Guaranty Agreement, dated November 13, 2025, by and among Skyward Specialty Insurance Group, Inc., Skyward Service Company, Skyward Underwriters Agency, Inc., the loan parties identified on the signature pages thereto and Barclays Bank PLC. Barclays Bank PLC (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed with the Commission on November 18, 2025). |
| 10.41 | Term Loan Credit Agreement, dated December 30, 2025, by and among Skyward Specialty Insurance Group, Inc., and Barclays Bank PLC, as Administrative Agent, Truist Securities, Inc., Citizens Bank, N.A. and Texas Capital Bank (incorporated by reference to Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the Commission on January 6, 2026). |
| 10.42 | Guaranty Agreement, dated December 30, 2025, by and among Skyward Specialty Insurance Group, Inc., Skyward Service Company, Skyward Underwriters Agency, Inc., the loan parties identified on the signature pages and Barclays Bank PLC (incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K filed with the Commission on January 6, 2026). |
| Exhibit Number | Exhibit Description |
|---|---|
| 10.43 | First Amendment, dated December 30, 2025, by and among Skyward Specialty Insurance Group, Inc., Skyward Service Company, Skyward Underwriters Agency, Inc., the loan parties identified on the signature pages and Barclays Bank PLC (incorporated by reference to Exhibit 10.3 to the Company's Current Report on Form 8-K filed with the Commission on January 6, 2026). |
| 19 | Skyward Specialty Insurance Securities Trading Policy (incorporated by reference to Exhibit 19 to the Company ’ s Annual Report on Form 10-K, filed with the SEC on March 3, 2025). |
| 19.1* | Skyward Specialty Insurance Securities Trading Policy amended November 5, 2025. |
| 21.1* | List of Subsidiaries of the Company |
| 23.1* | Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm. |
| 31.1* | Certification of Principal Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| 31.2* | Certification of Principal Financial and Accounting Officer pursuant to Rule 13a 14(a) or Rule 15d 14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| 32.1* | Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| 97 | Policy for Recovery of Erroneously Awarded Incentive Compensation (“Clawback Policy”) (incorporated by reference to Exhibit 97 to the Company’s Annual Report on Form 10-K, filed with the SEC on April 1, 2024). |
| 101.INS | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document. |
| 101.SCH | Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents |
| 104 | Cover Page Interactive Date File (embedded within the Inline XBRL document) |
[c. 309; p. 24]
| ($ in thousands) | Cost | Fair Value (if applicable) | Amount on Balance Sheet |
|---|---|---|---|
| December 31, 2025 | |||
| Fixed maturity securities, available for sale: | |||
| U.S. government securities | 44,190 | 44,468 | 44,468 |
| Corporate securities and miscellaneous | 632,244 | 636,387 | 636,387 |
| Municipal securities | 102,691 | 102,116 | 102,116 |
| Residential mortgage-backed securities | 487,145 | 486,587 | 486,587 |
| Commercial mortgage-backed securities | 72,631 | 73,050 | 73,050 |
| Other asset-backed securities | 509,854 | 513,695 | 513,695 |
| Total fixed maturity securities, available for sale | 1,848,755 | 1,856,303 | 1,856,303 |
| Fixed maturity securities, held to maturity: | — | — | — |
| Other asset-backed securities | 33,290 | 33,603 | 32,822 |
| Total fixed maturity securities, held to maturity | 33,290 | 33,603 | 32,822 |
| Equity securities: | — | — | — |
| Preferred stocks | 1,138 | 1,174 | 1,174 |
| Total equity securities | 1,138 | 1,174 | 1,174 |
| Mortgage loans | 10,093 | 9,902 | 9,902 |
| Other long-term investments | 37,290 | 58,650 | 58,650 |
| Short-term investments | 264,299 | 264,299 | 264,299 |
| Total | 2,194,865 | 2,223,931 | 2,223,150 |
Balance sheets (parent company)
[c. 310; p. 24]
| December 31, | ||
|---|---|---|
| ($ in thousands) | 2025 | 2024 |
| Assets | ||
| Investments: | ||
| Investment in subsidiaries | 1,076,288 | 853,670 |
| Short-term investments, at fair value | 14,513 | 14,000 |
| Total investments | 1,090,801 | 867,670 |
| Cash and cash equivalents | 3,500 | 2,943 |
| Deferred income taxes | 27,865 | 30,486 |
| Goodwill and intangible assets, net | 14,349 | 12,641 |
| Other assets | 10,709 | 2,905 |
| Total assets | 1,147,224 | 916,645 |
| Liabilities and Stockholders’ Equity | — | — |
| Liabilities: | — | — |
| Accounts payable and accrued liabilities | 17,680 | 3,110 |
| Notes payable | 100,410 | 100,000 |
| Subordinated debt, net of debt issuance costs | 19,569 | 19,536 |
| Total liabilities | 137,659 | 122,646 |
| Stockholders’ Equity: | — | — |
| Stockholders’ equity | 1,009,565 | 793,999 |
| Total liabilities and stockholders’ equity | 1,147,224 | 916,645 |
(parent company)
[c. 311; p. 24] Financial statement notes
- See accompanying notes to financial statements.
[c. 312; p. 24]
| Years Ended December 31, | |||
|---|---|---|---|
| ($ in thousands) | 2025 | 2024 | 2023 |
| Revenues: | |||
| Net investment income | 3,371 | 3,212 | 3,822 |
| Net investment gains (losses) | — | 963 | ( 963 ) |
| Other loss | — | ( 2 ) | ( 27 ) |
| Total revenues | 3,371 | 4,173 | 2,832 |
| Expenses | — | — | — |
| Operating expenses | 7,899 | 10,632 | — |
| Interest expense | 6,762 | 8,140 | 9,815 |
| Amortization expense | 620 | 920 | 313 |
| Other expenses | 17,962 | 9,646 | 451 |
| Total expenses | 33,243 | 29,338 | 10,579 |
| Loss before income tax expense | ( 29,872 ) | ( 25,165 ) | ( 7,747 ) |
| Income tax expense | 45,860 | 33,578 | 6,808 |
| Loss before equity in earnings of subsidiaries | ( 75,732 ) | ( 58,743 ) | ( 14,555 ) |
| Equity in undistributed earnings of subsidiaries | 245,760 | 177,571 | 100,539 |
| Net income | 170,028 | 118,828 | 85,984 |
Schedule ii — statements of cash flows (parent company)
[c. 313; p. 24] Financial statement notes
- See accompanying notes to financial statements.
[c. 314; p. 24]
| Years Ended December 31, | |||
|---|---|---|---|
| ($ in thousands) | 2025 | 2024 | 2023 |
| Cash flows from operating activities: | |||
| Net income | 170,028 | 118,828 | 85,984 |
| Adjustments to reconcile net income to net cash used in operating activities | ( 175,769 ) | ( 121,563 ) | ( 95,947 ) |
| Net cash used in operating activities | ( 5,741 ) | ( 2,735 ) | ( 9,963 ) |
| Cash flows from investing activities: | — | — | — |
| Purchase of intangible assets and goodwill | ( 2,000 ) | — | — |
| Capital contributions to subsidiaries | ( 100 ) | — | ( 122,800 ) |
| Distributions from investment in subsidiaries | 8,500 | 8,500 | 6,500 |
| Change in short-term investments | ( 513 ) | ( 3,407 ) | ( 10,569 ) |
| Net cash provided by (used in) investing activities | 5,887 | 5,093 | ( 126,869 ) |
| Cash flows from financing activities: | — | — | — |
| Repayment of stock notes receivable | — | 5,561 | 1,350 |
| Proceeds from long term borrowings | 43,411 | 107,000 | 50,000 |
| Payments on long term borrowings and trust preferred | ( 43,000 ) | ( 115,000 ) | ( 50,000 ) |
| Proceeds from equity offerings | — | — | 128,887 |
| Proceeds from employee stock purchase plan | — | — | 710 |
| Net cash provided by (used in) financing activities | 411 | ( 2,439 ) | 130,947 |
| Net increase (decrease) in cash and cash equivalents and restricted cash | 557 | ( 81 ) | ( 5,885 ) |
| Cash and cash equivalents and restricted cash at beginning of year | 2,943 | 3,024 | 8,909 |
| Cash and cash equivalents and restricted cash at end of year | 3,500 | 2,943 | 3,024 |
| Supplemental disclosure of cash flow information: | — | — | — |
| Cash paid for interest | 6,149 | 8,573 | 10,667 |
Notes to Financial Statements
[c. 315; p. 24] Intercompany Loan Promissory Note
- On September 30, 2024, Skyward Specialty entered into an Intercompany Loan Promissory Note ("the Promissory Note") with Houston Specialty Insurance Company ("HSIC").
- Under the Promissory Note, Skyward Specialty borrowed USD 57.0m from HSIC.
- Interest on the Promissory Note is payable monthly at a fixed annual interest rate of 4.00%.
- The principal of the Promissory Note is due at the maturity date.
- There are no prepayment penalties for the Promissory Note.
- No collateral was given as security for the payment of the Promissory Note.
[c. 316; p. 24] New subsidiary and Lloyd's corporate membership
- During the year ended December 31, 2024, Skyward Specialty provided funds for a new subsidiary, Skyward Specialty No. 1 Limited Company.
- Skyward Specialty No. 1 Limited Company is a UK company.
- Skyward Specialty No. 1 Limited Company is authorized as a Lloyd’s corporate member to invest in Lloyd’s syndicates.
Financial Instruments Disclosed, But Not Carried, At Fair Value
[c. 317; p. 24] Promissory Note fair value
- Notes Payable includes the Promissory Note between Skyward Specialty and HSIC.
- Skyward Specialty determined the fair value of the Promissory Note using the income approach with observable inputs.
- The Promissory Note is classified as Level 2 in the fair value hierarchy.
- The table provides the Company's carrying and fair values of the Promissory Note as of December 31, 2025 and 2024.
[c. 318; p. 24] Insurance-related products fair value exemption
- Other financial instruments are exempt from fair value disclosure requirements as they qualify as insurance-related products.
[c. 319; p. 24]
| 2025 | 2024 | |||
|---|---|---|---|---|
| ($ in thousands) | Carrying Value | Fair Value | Carrying Value | Fair Value |
| Notes payable | ||||
| Promissory Note | 57,000 | 57,401 | 57,000 | 56,300 |
Schedule iv — reinsurance
[c. 320; p. 24]
| Years Ended December 31, | ||||||
|---|---|---|---|---|---|---|
| 2025 | 2024 | 2023 | ||||
| ($ in thousands) | Accident & Health | Property & Casualty | Accident & Health | Property & Casualty | Accident & Health | Property & Casualty |
| Gross amount | 254,102 | 1,430,309 | 173,073 | 1,285,564 | 151,702 | 1,089,478 |
| Ceded to other companies | ( 143,811 ) | ( 616,193 ) | ( 86,503 ) | ( 533,151 ) | ( 79,091 ) | ( 470,047 ) |
| Assumed from other companies | — | 481,825 | — | 284,595 | — | 218,649 |
| Net amount | 110,291 | 1,295,941 | 86,570 | 1,037,008 | 72,611 | 838,080 |
| Percentage of amount assumed to net | —% | 37.2% | —% | 27.4% | —% | 26.1% |
Schedule V — valuation and qualifying accounts
[c. 321; p. 24]
| ($ in thousands) | Valuation Allowance For Deferred Tax Assets | Allowance for Uncollectible Reinsurance Recoverable | Allowance for Uncollectible Premiums Receivable |
|---|---|---|---|
| Balance at January 1, 2023 | 586 | — | 629 |
| Cumulative effect of adoption of ASU 2016-13 at January 1, 2023 | — | 2,295 | — |
| Charged to costs and expenses | — | — | 748 |
| Amounts written off | — | — | ( 513 ) |
| Recoveries of amounts previously written off | — | — | 100 |
| Balance at December 31, 2023 | 586 | 2,295 | 964 |
| Charged to costs and expenses | — | 13,585 | 3,235 |
| Amounts written off | — | ( 13,585 ) | ( 1,895 ) |
| Recoveries of amounts previously written off | — | — | 128 |
| Balance at December 31, 2024 | 586 | 2,295 | 2,432 |
| Charged to costs and expenses | 68 | — | 2,351 |
| Amounts written off | — | — | ( 2,141 ) |
| Recoveries of amounts previously written off | — | — | 498 |
| Balance at December 31, 2025 | 654 | 2,295 | 3,140 |
Insurance operations
[c. 322; p. 24]
| As of and Years Ended December 31, | |||
|---|---|---|---|
| ($ in thousands) | 2025 | 2024 | 2023 |
| Deferred policy acquisition costs | 136,100 | 113,183 | 91,955 |
| Reserve for losses and loss adjustment expenses | 2,318,894 | 1,782,383 | 1,314,501 |
| Unearned premiums | 774,035 | 637,185 | 552,532 |
| Net earned premium (1) | 1,304,505 | 1,056,722 | 829,143 |
| Net investment income | 83,619 | 80,686 | 40,322 |
| Losses and loss adjustment expenses (current year) (1) | 810,375 | 657,783 | 516,664 |
| Losses and loss adjustment expenses (prior years) (1)(2) | ( 7,471 ) | 25,728 | — |
| Amortization of policy acquisition costs (1) | 195,422 | 149,975 | 108,514 |
| Paid claims and claim adjustment expenses (1) | 516,712 | 430,991 | 363,418 |
| Net premiums written (1) | 1,406,232 | 1,123,578 | 910,691 |
| Ceded unearned premium | 238,948 | 203,901 | 186,121 |
| Deferred ceding commission | 46,453 | 40,434 | 37,057 |
SIGNATURES
[c. 323; p. 24] Securities Exchange Act of 1934 compliance
- The registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934.
- This report has been signed by the following persons on behalf of the Registrant and in the capacities and on the dates indicated, pursuant to the requirements of the Securities Exchange Act of 1934.
[c. 324; p. 24]
| Skyward Specialty Insurance Group, Inc. | |
|---|---|
| Dated: March 2, 2026 | /s/ Andrew Robinson |
| — | Andrew Robinson Chairman and Chief Executive Officer |
| Signature | Title | Date |
|---|---|---|
| /s/ Andrew Robinson | Chairman and Chief Executive Officer | March 2, 2026 |
| Andrew Robinson | (Principal Executive Officer) | March 2, 2026 |
| /s/ Mark Haushill | Chief Financial Officer | March 2, 2026 |
| Mark Haushill | (Principal Financial and Accounting Officer) | March 2, 2026 |
| /s/ Gena Ashe | Director | March 2, 2026 |
| Gena Ashe | Director | March 2, 2026 |
| /s/ Robert Creager | Director | March 2, 2026 |
| Robert Creager | Director | March 2, 2026 |
| /s/ Marcia Dall | Director | March 2, 2026 |
| Marcia Dall | Director | March 2, 2026 |
| /s/ James Hays | Director | March 2, 2026 |
| James Hays | Director | March 2, 2026 |
| /s/ Anthony J. Kuczinski | Director | March 2, 2026 |
| Anthony J. Kuczinski | Director | March 2, 2026 |
| /s/ Michael Morrissey | Director | March 2, 2026 |
| Michael Morrissey | Director | March 2, 2026 |
| /s/ Christopher L. Peirce | Director | March 2, 2026 |
| Christopher L. Peirce | Director | March 2, 2026 |
| /s/ Katharine Terry | Director | March 2, 2026 |
| Katharine Terry | Director | March 2, 2026 |